10698 |
systemic lupus erythematosis |
04/07/2022 |
10697 |
Management of urinasystemstones |
04/07/2022 |
10696 |
Genetic endocrine syndromes |
04/07/2022 |
10695 |
Efficacités pratiques des moyens de contraception les plus connus |
04/07/2022 |
10694 |
Causes of acute respiratory distress syndrome |
04/07/2022 |
10693 |
Acute Porphyria |
04/07/2022 |
10692 |
Variole du singe |
04/07/2022 |
10691 |
Urgences, soins non programmés _ Élisabeth Borne retient « toutes les propositions » de la mission Braun _ Le Quotidien du Médecin |
04/07/2022 |
10690 |
Topiramate, prégabaline et valproate – l’ANSM alerte sur de nouveaux risques |
04/07/2022 |
10689 |
Sarcoidosis |
04/07/2022 |
10688 |
Most common reasons for diversion |
04/07/2022 |
10687 |
Most common medical problems |
04/07/2022 |
10686 |
Longdistance airbornetransmission of SARS-CoV-2 |
04/07/2022 |
10685 |
Information de sécurité – Intoxications graves à la colchicine – ANSM |
04/07/2022 |
10684 |
Examens complémentaires pour les enfants fébriles, il n’a pas suffi de dire l’Europe, l’Europe… |
04/07/2022 |
10683 |
Evaluation et prise en charge d’une gynécomastie |
04/07/2022 |
10682 |
Elevated troponin |
04/07/2022 |
10681 |
Cryglobulinemia vasculitis |
04/07/2022 |
10680 |
Covid-19 _ la Commission européenne donne son feu vert au vaccin inactivé de Valneva _ Le Quotidien du Médecin |
04/07/2022 |
10679 |
CORONADO |
04/07/2022 |
10678 |
Comment aborder la détermination de la cause d’_un caillot_ |
04/07/2022 |
10677 |
Aortitis |
04/07/2022 |
10676 |
ansm |
04/07/2022 |
10675 |
ansm 2 |
04/07/2022 |
10674 |
COVID mortality in India National survey data and health facility deaths |
10/02/2022 |
10673 |
Structurally abnormal collagen fibrils in abdominal aortic aneurysm resist platelet adhesion |
10/02/2022 |
10672 |
Surveillance des cas de syndrome inflammatoire multi-systémique pédiatrique (PIMS ou MIS-C). Bilan au 27 janvier 2022 |
10/02/2022 |
10671 |
Systematic Review and Meta-Analysis of Iliofemoral Stenting for Post-thrombotic Syndrome |
10/02/2022 |
10670 |
The First 2 Years of COVID-19_ Lessons to Improve Preparedness for the Next Pandemic |
10/02/2022 |
10669 |
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction |
10/02/2022 |
10668 |
The OAC3-PAD Risk Score Predicts Major Bleeding Events one Year after Hospitalisation for Peripheral Artery Disease |
10/02/2022 |
10667 |
The PADDIA_CADDIA survey 2022 |
10/02/2022 |
10666 |
The past, present and future of Registered Reports |
10/02/2022 |
10665 |
The psychological impact of pulmonary embolism_ A mixed?methods study |
10/02/2022 |
10664 |
The year in cardiovascular medicine 2021_ heart failure and cardiomyopathies |
10/02/2022 |
10663 |
Therapeutic strategies targeting inflammation and immunity in atherosclerosis_ how to proceed__compressed |
10/02/2022 |
10662 |
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection |
10/02/2022 |
10661 |
Unprovoked or provoked venous thromboembolism_ not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study |
10/02/2022 |
10660 |
Vaccination pédiatrique anti-COVID – Du Côté de la Science |
10/02/2022 |
10659 |
Venous thromboembolism risk and immune checkpoint inhibitors_ what the literature says. – Icthic Magazine |
10/02/2022 |
10658 |
Vers de nouvelles indications des anticoagulants oraux directs |
10/02/2022 |
10657 |
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months |
10/02/2022 |
10656 |
Waning Immunity after the BNT162b2 Vaccine in Israel |
10/02/2022 |
10655 |
Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy |
10/02/2022 |
10654 |
Smaller size is more suitable for pharmacotherapy among undersized abdominal aortic aneurysm_ a systematic review and meta-analysis |
10/02/2022 |
10653 |
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection_ A Systematic Review |
10/02/2022 |
10652 |
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia |
10/02/2022 |
10651 |
Safety and Validity of the Proposed European Society for Vascular Surgery Infrarenal Endovascular Aneurysm Repair Surveillance Protocol_ A Single Centre Evaluation |
10/02/2022 |
10650 |
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) followingl |
10/02/2022 |
10649 |
Safety and Validity of the Proposed European Society for Vascular Surgery Infrarenal Endovascular Aneurysm Repair Surveillance Protocol_ A Single Centre Evaluation |
10/02/2022 |
10648 |
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) followingl |
10/02/2022 |
10647 |
Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID?19?associated thrombopathy |
10/02/2022 |
10646 |
RIVARO APIXABAN FA JAMA2021 |
10/02/2022 |
10645 |
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection |
10/02/2022 |
10644 |
Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit_ analysis of the French national medicoadministrative database |
10/02/2022 |
10643 |
Retinopathy, Neuropathy, and Foot Care_ Standards of Medical Care in Diabetes—2022 |
10/02/2022 |
10642 |
Research and Practice in Thrombosis and Haemostasis – 2021 – Sholzberg – Randomized trials of therapeutic heparin for |
10/02/2022 |
10641 |
Réponse rapide dans le cadre du COVID-19 Traitement par antiviral des patients à risque de forme grave de la Covid-19 |
10/02/2022 |
10640 |
Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease_ focus on heart failure and renal outcomes |
10/02/2022 |
10639 |
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies |
10/02/2022 |
10638 |
RECOS Mie VEINEUSE ESVS 2022 |
10/02/2022 |
10637 |
Recent Advances in Anticoagulant Treatment of Immune Thrombosis A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome |
10/02/2022 |
10636 |
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2 |
10/02/2022 |
10635 |
Programmes de dépistage |
10/02/2022 |
10634 |
Prise-en-charge-de-la-maladie-thromboembolique-veineuse-en-cance?rologie_2021 |
10/02/2022 |
10633 |
Prévention des hospitalisations pour Covid-19 _ le retour du remdésivir _ |
10/02/2022 |
10632 |
Pre-surgical and Post-surgical Aortic Aneurysm Maximum Diameter Measurement_ Full Automation by Artificial Intelligence |
10/02/2022 |
10631 |
Possibilité de symptômes après la Covid, même avec les formes bénignes ! |
10/02/2022 |
10630 |
Positivité de la RT-PCR et séroconversion pour les enfants atteints de Covid-19, à revoir |
10/02/2022 |
10629 |
Physical forces regulating hemostasis and thrombosis_ Vessels, cells, and molecules in illustrated review |
10/02/2022 |
10628 |
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine |
10/02/2022 |
10627 |
Pharmacovigilance vaccin Arn M Covid RMS2022 |
10/02/2022 |
10626 |
Pfizer contre Omicron, l’incertitude |
10/02/2022 |
10625 |
Persistent Heart Effects of COVID-19 Emphasize the Need for Prevention |
10/02/2022 |
10624 |
Pedal Flow Hemodynamics in Patients With Chronic Limb-Threatening IschemiaJVS2020 |
10/02/2022 |
10623 |
Pathognie des vascularites associes aux ANCAen 2021_ mise au point |
10/02/2022 |
10622 |
Paraneoplastic neurological syndromes_ a practical approach to diagnosis and management |
10/02/2022 |
10621 |
Outcomes of isolated distal thrombosis managed with serial compression ultrasonography |
10/02/2022 |
10620 |
Optimal follow-up after acute pulmonary embolism |
10/02/2022 |
10619 |
Objective Outcome Measures for Trials in Patients With Chronic Limb-Threatening Ischemia Across 2 Decades |
10/02/2022 |
10618 |
Nuisance sonore et HTA, une étude qui pourrait faire du bruit ! |
10/02/2022 |
10617 |
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor_ A Contrarian View |
10/02/2022 |
10616 |
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning |
10/02/2022 |
10615 |
Neuroprotective Effect of SGLT2 Inhibitors |
10/02/2022 |
10614 |
Molecular Imaging of Abdominal Aortic Aneurysms with Positron Emission Tomography_ A Systematic Review |
10/02/2022 |
10613 |
Myocardial Infarction During the COVID-19 Pandemic |
10/02/2022 |
10612 |
Microsoft Word – Texte TIH SFAR GFHT V3 Juin 2019 validé.docx |
10/02/2022 |
10611 |
Mechanisms of abdominal aortic aneurysm progressionVM2022 |
10/02/2022 |
10610 |
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis_ Data from GARFIELD?VTE |
10/02/2022 |
10609 |
Management of anticoagulation in pregnant women with venous thromboembolism_ An international survey of clinical practice |
10/02/2022 |
10608 |
Maladie thromboembolique veineuse et grossesse RMS2021 |
10/02/2022 |
10607 |
Lower Cardiovascular Mortality Rates in Haemodialysis Patients with Radial Artery Based Fistulas |
10/02/2022 |
10606 |
Long COVID in a prospective cohort of home-isolated patients |
10/02/2022 |
10605 |
Lipoprotein(a), the rediscovered risk factor, or how to get “back to the future” |
10/02/2022 |
10604 |
Letter to the Editors-in-Chief |
10/02/2022 |
10603 |
Les autoanticorps sont l’élément le plus prédictif d’un COVID long |
10/02/2022 |
10602 |
Le Pr Didier Raoult, flop 2021 du monde médical _ Le Quotidien du Médecin |
10/02/2022 |
10601 |
Le Masque et la Plume |
10/02/2022 |
10600 |
Le dépistage du cancer colorectal devrait commencer à 45 ans |
10/02/2022 |
10599 |
Le concept de chirurgie verte RMS2022 |
10/02/2022 |
10598 |
La transmission aérienne de la COVID-19 |
10/02/2022 |
10597 |
J of Thrombosis Haemost – 2021 – Toorop – Inter? and intra?individual concentrations of direct oral anticoagulants The |
10/02/2022 |
10596 |
Interventions for Frailty Among Older Adults With Cardiovascular Disease |
10/02/2022 |
10595 |
Innovative Pedagogies of the Future_ An Evidence-Based Selection |
10/02/2022 |
10594 |
Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease_ A Health Claims Data Analysis |
10/02/2022 |
10593 |
Inherited Thrombophilia in the Era of Direct Oral Anticoagulants |
10/02/2022 |
10592 |
Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV |
10/02/2022 |
10591 |
IDM en temps de pandémie, plus graves et moins bien pris en charge… |
10/02/2022 |
10590 |
Hypertension in Pregnancy_ Diagnosis, Blood Pressure Goals, and Pharmacotherapy_ A Scientific Statement From the American Heart Association |
10/02/2022 |
10589 |
Human vs. Machine – or with Machine_ |
10/02/2022 |
10588 |
How Does Female Sex Affect Complex Endovascular Aortic Repair_ A Single Centre Cohort Study |
10/02/2022 |
10587 |
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects a |
10/02/2022 |
10586 |
Effect of Anticoagulant Therapy for 6Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism |
10/02/2022 |
10585 |
DVT detec on with AI |
10/02/2022 |
10584 |
Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients |
10/02/2022 |
10583 |
Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia |
10/02/2022 |
10582 |
Coronavirus Disease-2019 and Heart Failure A Scientific Statement From the Heart Failure Society of America |
10/02/2022 |
10581 |
Certificat de rétablissement et passe vaccinal _ changement de règle inopiné |
10/02/2022 |
10580 |
Atherosclerosis is amajor human killer and non-resolving inflammation is a prime suspect |
10/02/2022 |
10579 |
Associer ézétimibe et simvastatine après un SCA est intéressant, quel que soit le taux de LDL-C |
10/02/2022 |
10578 |
Aider à l’arrêt du tabac pendant la grossesse, cela a peut-être un coût |
10/02/2022 |
10577 |
fda-approves-novartis-leqvio-inclisiran-first-in |
09/02/2022 |
10576 |
External validation of a model to predict women most at risk of postpartum venous thromboembolism_ Maternity clot risk |
09/02/2022 |
10575 |
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents |
09/02/2022 |
10574 |
EULAR Points to Consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs) |
09/02/2022 |
10573 |
Escardio.org-Study suggests women find it more difficult to quit smoking than men |
09/02/2022 |
10572 |
escardio.org-Light-to-moderate coffee drinking associated with health benefits |
09/02/2022 |
10571 |
Endovascular repair for abdominal aortic aneurysms_compressed |
09/02/2022 |
10570 |
Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter_ A systematic review and meta-analysis |
09/02/2022 |
10569 |
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel |
09/02/2022 |
10568 |
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19 |
09/02/2022 |
10567 |
ECR_Gulati_WEB |
09/02/2022 |
10566 |
Doppler waveform |
09/02/2022 |
10565 |
DOAC drug levels_ Does “knowing” lead to safer care |
09/02/2022 |
10564 |
Diagnostic reasoning in cardiovascular medicine |
09/02/2022 |
10563 |
Dépistage de l’athérosclérose dans l hyperCholRMS2021 |
09/02/2022 |
10562 |
D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19_ a systematic review and meta-analysis of 100 studies |
09/02/2022 |
10561 |
Covid-19, anticoagulation et maladie thromboembolique veineuse RMS2021 |
09/02/2022 |
10560 |
Covid-19, anticoagulation et maladie thromboembolique veineuse RMS2021 |
09/02/2022 |
10559 |
COVID mortality in India_ National survey data and health facility deaths |
09/02/2022 |
10558 |
Covid and The Brain |
09/02/2022 |
10557 |
Covid _ comment passer les fêtes de Noël, les 10 recommandations du Conseil scientifique – midilibre.fr |
09/02/2022 |
10556 |
Coronary Atherosclerotic Plaque Regression |
09/02/2022 |
10555 |
Comment évaluer le risque de dissection aortique au cours de la grossesse |
09/02/2022 |
10554 |
Colchicine in Cardiovascular Disease_ In-Depth Review |
09/02/2022 |
10553 |
Chronic Kidney Disease and Risk Management_ Standards of Medical Care in Diabetes—2022 |
09/02/2022 |
10552 |
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale RMS2021 |
09/02/2022 |
10551 |
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale RMS2021 |
09/02/2022 |
10550 |
CFPV-2022Programme-Préliminaire |
09/02/2022 |
10549 |
Ce que la science sait — et ignore encore — sur le variant Omicron – Heidi.news |
09/02/2022 |
10548 |
Cascades of Care After Incidental Findings in a US National Survey of Physicians |
09/02/2022 |
10547 |
Cardiovascular manifestations of hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders |
09/02/2022 |
10546 |
CARDILOGIE RMS2022 |
09/02/2022 |
10545 |
Cannabis use and cannabis use disorder |
09/02/2022 |
10544 |
Burnout et détérioration de la relation médecin-patient, |
09/02/2022 |
10543 |
Bulletin épidémiologique semaines 03-04 – Du Côté de la Science |
09/02/2022 |
10542 |
Atorvastatin versus placebo in patients with covid-19 in intensive care_ randomized controlled trial |
09/02/2022 |
10541 |
Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults |
09/02/2022 |
10540 |
Artificial intelligence in abdominal aortic aneurysm_compressed |
09/02/2022 |
10539 |
Article final CVIR recas chroniques |
09/02/2022 |
10538 |
Approches du risque et usage d’outils electroniques RMS2022 |
09/02/2022 |
10537 |
Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS)_ A prospective cohort study_compressed |
09/02/2022 |
10536 |
Anticoagulation Duration After First Venous Thromboembolism_ Real-Life Data From the International, Observational WHITE Study_compressed |
09/02/2022 |
10535 |
ANDEX |
09/02/2022 |
10534 |
Analysis of the Differences Between the ESVS 2019 and NICE 2020 Guidelines for Abdominal Aortic Aneurysm |
09/02/2022 |
10533 |
An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee_ Systematic review and meta?analysis |
09/02/2022 |
10532 |
An Introduction to Point-of-Care Ultrasound_ Laennec to Lichtenstein_compressed |
09/02/2022 |
10531 |
An estimate of the economic burden of venous leg ulcers VM2022 |
09/02/2022 |
10530 |
An epidemic of redundant meta?analyses |
09/02/2022 |
10529 |
Air pollution and cardiovascular disease_ the Paul Wood Lecture, British Cardiovascular Society 2021 |
09/02/2022 |
10528 |
Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination |
09/02/2022 |
10527 |
Actualité – Traitement des varices _ rappel des conduites à tenir pour réduire les risques cardiovasculaires liés à l’utilisation des sclérosants veineux – ANSM |
08/02/2022 |
10526 |
Abdominal aortic aneurysms part one_ Epidemiology, presentation and preoperative considerations_compressed |
09/02/2022 |
10525 |
A retrospective study of indications and consequences of monitoring direct oral anticoagulant plasma concentrations on patient care in a university hospital_ The Retro-AOD study_compressed |
09/02/2022 |
10524 |
A retrospective study of indications and consequences of monitoring direct oral anticoagulant plasma concentrations on patient care in a university hospital_ The Retro-AOD study_compressed |
09/02/2022 |
10523 |
A National Strategy for the “New Normal” of Life With COVID |
09/02/2022 |
10522 |
Notre maladie, leçons de liberté depuis un lit d’hôpital américain » de Timothy Snyder traduit par Olivier Salvatori _ PerrUche en Automne |
09/02/2022 |
10521 |
2021_puechal_x_gfev_recos_vaccination_covid-19_vascularites_press_med |
09/02/2022 |
10520 |
21_Hanage_Bhattacharyya_Challenges-in-assessing-Omicron-severity_HCPDS-Working-Paper-Volume-21_No-10-1 |
09/02/2022 |
10519 |
« Notre maladie, leçons de liberté depuis un lit d’hôpital américain » de Timothy Snyder traduit par Olivier Salvatori _ PerrUche en Automne |
09/02/2022 |
10518 |
« Bras Covid » post-vaccination |
09/02/2022 |
10517 |
Women and DIABETE |
08/02/2022 |
10516 |
Whole life changed – Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study |
08/02/2022 |
10515 |
VOYAGEUR CIRCULATIIN 2021 |
08/02/2022 |
10514 |
Voici l’IRM le plus puissant du monde, et il est français |
08/02/2022 |
10513 |
Vasodilatateurs pour le phénomène de Raynaud – Evidemment Cochrane |
08/02/2022 |
10512 |
Utilisation des contraceptifs en France quelles évolutions |
08/02/2022 |
10511 |
Vaping and cardiac disease |
08/02/2022 |
10510 |
Vaccine effectiveness and duration of protection |
08/02/2022 |
10509 |
Utilisation des contraceptifs en France quelles évolutions |
08/02/2022 |
10508 |
Update on extended prophylaxis for venous thromboembolism following surgery for gynaecological cancers |
08/02/2022 |
10507 |
Univadis _ La référence en ligne des professionnels de santé_compressed |
08/02/2022 |
10506 |
Understanding and managing the psychological impact of blood clots_compressed |
08/02/2022 |
10505 |
Un risque d’hypercapnie avec les masques FFP2 pour les enfants |
08/02/2022 |
10504 |
Trusca |
08/02/2022 |
10503 |
Trois fois moins de décès liés à la Covid-19 en Israël grâce à la vaccination |
08/02/2022 |
10502 |
Traitement des patients souffrant covid exp BeuchatelRMS2021 |
08/02/2022 |
10501 |
Traitement de l’hyperplasie bénigne de la prostate RMS2021 |
08/02/2022 |
10500 |
Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum |
08/02/2022 |
10499 |
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 |
08/02/2022 |
10498 |
thrombosis-uk-post-thrombotic-panic-syndrome-download |
08/02/2022 |
10497 |
thrombosis-uk-coping-with-worries-meditation-and-mindfulness-print |
08/02/2022 |
10496 |
thrombosis-uk-coping-with-worries-meditation-and-mindfulness |
08/02/2022 |
10495 |
Thrombosis in myeloproliferative neoplasms_ A clinical and pathophysiological perspective |
08/02/2022 |
10494 |
Thrombosis and Haemostasis |
08/02/2022 |
10493 |
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension |
08/02/2022 |
10492 |
The use of qualitative methods in venous thromboembolism research |
08/02/2022 |
10491 |
The Paper of the Month November – World Stroke Organisation – Stroke Academy |
08/02/2022 |
10490 |
The lesson of ivermectin_ meta-analyses based on summary data alone are inherently unreliable |
08/02/2022 |
10489 |
The effect of hormone replacement therapy on the survival of UK women_ a retrospective cohort study 1984?2017 |
08/02/2022 |
10488 |
Syndrome de Marfan _ la grossesse augmente le risque de dissection aortique |
08/02/2022 |
10487 |
Suspicion de SCA _ faire un coroscanner en urgence _ |
08/02/2022 |
10486 |
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 |
08/02/2022 |
10485 |
Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study |
08/02/2022 |
10484 |
Statins for venous event reduction in patients with venous thromboembolism_ A multicenter randomized controlled pilot trial assessing feasibility |
08/02/2022 |
10483 |
Special Collection – De-implementation of low-value health care_ resource prioritization in the COVID-19 pandemic era _ Cochrane Library |
08/02/2022 |
10482 |
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting |
08/02/2022 |
10481 |
Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals |
08/02/2022 |
10480 |
Risk assessment for recurrent venous thromboembolism in patients with cancer |
08/02/2022 |
10479 |
Rétention aiguë d’urine après 50 ans _ chercher le cancer |
08/02/2022 |
10478 |
Resultat-Enquete-Erysipele-et-LO |
08/02/2022 |
10477 |
Reprendre le sport après une infection respiratoire _ plus difficile en cas de Covid _ |
08/02/2022 |
10476 |
Refus de vaccination 3 000 professionnels de santé suspendus |
08/02/2022 |
10475 |
reco368_recommandations_denutrition_pa_cd_20211110_v1 |
08/02/2022 |
10474 |
Quality of life in adolescents with heavy menstrual bleeding Validation of the Adolescent Menstrual Bleeding Questionnaire (aMBQ) |
08/02/2022 |
10473 |
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel |
08/02/2022 |
10472 |
Prise-en-charge-de-la-maladie-thromboembolique-veineuse-en-cance?rologie_2021 |
08/02/2022 |
10471 |
Prévention de la maladie d’Alzheimer RMS2021 |
08/02/2022 |
10470 |
COVID et maladie veineuse thromboembolique |
08/02/2022 |
10469 |
Présentation _ Aide à la demande d’examens de radiologie et imagerie médicale (ADERIM) |
08/02/2022 |
10468 |
Prescription des antiPCSK9 par les médecins vasculaires _ Portail Vasculaire de la SFMV |
08/02/2022 |
10467 |
Pregnancy after iliac vein stenting for pelvic venous insufficiency |
08/02/2022 |
10466 |
Prediction of Major Bleeding in Anticoagulated VTE Riete and VTE BLLED SCores TH2021 |
08/02/2022 |
10465 |
Position statement |
08/02/2022 |
10464 |
POCUS (Point-of-care ultrasonography) en médecine interne générale champ d’application et formation |
08/02/2022 |
10463 |
Pièges et astuces de l’échographie clinique RMS2021 |
08/02/2022 |
10462 |
Physiopathologie de la coagulopathie dans les hémopathies malignes… _ HemaSphere |
08/02/2022 |
10461 |
Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease |
08/02/2022 |
10460 |
Hypertension intracranienne idiopathique quel bilan et quelle prise en charge en medecine interne |
08/02/2022 |
10459 |
ESC guidance for the diagnosis and management of cardiovascular disease |
08/02/2022 |
10458 |
Détection de l’athérosclérose asymptomatique,y-a-t-il une place en pratique quotidienne |
08/02/2022 |
10457 |
Depistage de l’arteriopathie obliterante des membres inferieurs role du medecin de premier recours |
08/02/2022 |
10456 |
Aspirin-free antiplatelet regimens after PCI insights fromthe GLOBAL LEADERS trial and beyond |
08/02/2022 |
10455 |
A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis The EMPOWER study |
08/02/2022 |
10454 |
Pathophysiology_of_Coagulopathy_in_Hematological.3 |
08/02/2022 |
10453 |
passemport vasc RMS2021 |
08/02/2022 |
10452 |
Pas besoin d’une troisième dose maintenant_ les experts autour de l’OMS enfoncent le clou – Heidi.news |
08/02/2022 |
10451 |
Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions_ the IN.PACT BTK randomised trial – EuroIntervention |
08/02/2022 |
10450 |
Où la Covid-19 illustre indirectement l’efficacité de l’ECT |
08/02/2022 |
10449 |
Où l’on tire des leçons de l’évolution de la Covid-19 en cas d’hémoglobinurie paroxystique nocturne |
08/02/2022 |
10448 |
Oral PCSK9 inhibitor found to be safe, effect _ EurekAlert! |
08/02/2022 |
10447 |
Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosis_ A report of the Intersocietal Accreditation Commission (IAC) Vascular Testing Division Carotid Diagnostic Criteria Committee |
08/02/2022 |
10446 |
Omicron _ un variant en marche _ |
08/02/2022 |
10445 |
Obstructive Sleep Apnea, Hypercoagulability, and the Blood–Brain Barrier_compressed |
08/02/2022 |
10444 |
Nosocomiale Covid-19 en tête ! |
08/02/2022 |
10443 |
Non, la vaccination anti-Covid 19 à ARNm n’augmente pas le risque d’avortement ! |
08/02/2022 |
10442 |
NEUROLOGY2021176833 971..972 |
08/02/2022 |
10441 |
Navigating the Passage for Better Understanding and Prognosis for Acute Limb Ischemia After Lower-Extremity Revascularization |
08/02/2022 |
10440 |
Myocardites_ les vaccins ARN font-ils vraiment plus de mal que de bien aux ados_ – Heidi.news |
08/02/2022 |
10439 |
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants |
08/02/2022 |
10438 |
Molnupivarir _ «Pas un remède miracle contre le Covid-19, ni un substitut à la vaccination» – Libération |
08/02/2022 |
10437 |
Molnupiravir_ ce qu’on sait sur la future pilule de Merck contre le Covid-19 – Heidi.news |
08/02/2022 |
10436 |
Milvexian for the Prevention of Venous Thromboembolism |
08/02/2022 |
10435 |
Meta-Analysis and Systematic Review of Randomized Controlled Trials Assessing the Role of Thromboprophylaxis post-Vascular Surgery_compressed |
08/02/2022 |
10434 |
Maladie thromboembolique veineuse et grossesse RMS2021 |
08/02/2022 |
10433 |
main |
08/02/2022 |
10432 |
Long?term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy |
08/02/2022 |
10431 |
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event_ systematic review and meta-analysis |
08/02/2022 |
10430 |
Lipoprotein(a)_ A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease_ A Scientific Statement From the American Heart Association |
08/02/2022 |
10429 |
Les personnes vaccinées contre le COVID |
08/02/2022 |
10428 |
Les passions du Covid-19 – Allez savoir! |
08/02/2022 |
10427 |
Les kystes rénaux complexes sous surveillance |
08/02/2022 |
10426 |
Les histones circulantes jouent un rôle central dans la coagulopathie et la mortalité associées au COVID-19 _ Hématologique |
08/02/2022 |
10425 |
Les experts ne veulent pas d’une troisième dose pour tous aux US_ les grandes étapes de la pandémie – Heidi.news |
08/02/2022 |
10424 |
Le risque de lésions tendineuses liées aux fluoroquinolones est faible chez les ados |
08/02/2022 |
10423 |
Le dérèglement du monde RMS2021 |
08/02/2022 |
10422 |
Late consequences of venous thromboembolism_ Measuring quality of life after deep vein thrombosis and pulmonary embolism |
08/02/2022 |
10421 |
La thrombolyse dans le traitement de la thrombose veineuse profonde aiguë _ Cochrane |
08/02/2022 |
10420 |
La PCR salivaire vaut-elle la PCR naso-pharyngée chez l’enfant _ |
08/02/2022 |
10419 |
La coloscopie doit être faite dans l’année après un test fécal positif ! |
08/02/2022 |
10418 |
L’usage de fénofibrate est associé à une diminution de la morbi-mortalité cardiovasculaire dans une cohorte de patients diabétiques de type 2 _ Société Francophone du Diabète |
08/02/2022 |
10417 |
L’OMS recommande le 1er vaccin antipaludéen chez les enfants d’Afrique |
08/02/2022 |
10416 |
L’histoire des histones dans la Covid-19 |
08/02/2022 |
10415 |
L’endothélite _ clé de l’atteinte multiviscérale du SARSCoV2 |
03/02/2022 |
10414 |
L’algorithme YEARS adapté à la grossesse pour le diagnostic de l’embolie pulmonaire. _ Portail Vasculaire de la SFMV |
08/02/2022 |
10413 |
L’AAA est plus grave chez la femme |
08/02/2022 |
10412 |
Journal Pre-proof |
08/02/2022 |
10411 |
jama_freund_2021_oi_210125_1637771538.18581 |
08/02/2022 |
10410 |
It is our governments’ duty to protect health |
08/02/2022 |
10409 |
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack |
08/02/2022 |
10408 |
Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs_compressed |
08/02/2022 |
10407 |
Integrated multi-omics approaches to improve classification of chronic kidney disease |
08/02/2022 |
10406 |
Initial Anticoagulant Treatment of Pulmonary Embolism |
08/02/2022 |
10405 |
Incidence and causes of early unplanned readmission after hospitalisation with peripheral arterial disease in Australia and New Zealand |
08/02/2022 |
10404 |
Impact of Lower Versus Higher LDL Cholesterol Targets on Cardiovascular Events After Ischemic Stroke in Patients With Diabetes |
08/02/2022 |
10403 |
HTA _ IEC ou ARA en première intention |
08/02/2022 |
10402 |
Hospitalisations et décès après vaccination anti-Covid, des risques calculés |
08/02/2022 |
10401 |
Haematologica August 2021 |
08/02/2022 |
10400 |
Guidelines_mesure_PA_traduites_Vedf 23 11 2021 |
08/02/2022 |
10399 |
Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases |
08/02/2022 |
10398 |
French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted – Retraction Watch |
08/02/2022 |
10397 |
Fluvoxamine dans le Covid-19 _ des résultats prometteurs en ambulatoire, mais à confirmer _ Le Quotidien du Médecin |
08/02/2022 |
10396 |
finerenone |
08/02/2022 |
10395 |
Financial incentives for smoking cessation in pregnancy_ multicentre randomised controlled trial |
08/02/2022 |
10394 |
Femmes et diabète _ Prévenir les maladies cardiaques dans une nouvelle ère de thérapies _ Journal ECR |
08/02/2022 |
10393 |
Faire face à une anomalie biologique en Médecine Vasculaire |
08/02/2022 |
10392 |
Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease |
08/02/2022 |
10391 |
Evidence of lung perfusion defects and ongoing adolescent post covid |
08/02/2022 |
10390 |
Endovascular Celiac Denervation for Glycemic Control in Patients with Type 2 Diabetes Mellitus_compressed |
08/02/2022 |
10389 |
Embolie pulmonaire, phlébite _ ces signes avant-coureurs à connaître absolument |
08/02/2022 |
10388 |
Embolie pulmonaire ambulatoire – Comment sélectionner et organiser le parcours de soins du patient |
08/02/2022 |
10387 |
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19_ The HEP-COVID Randomized Clinical Trial |
08/02/2022 |
10386 |
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19_ the TOGETHER randomised, platform clinical trial |
08/02/2022 |
10385 |
Échographie ciblée en MG SRMS2021 |
08/02/2022 |
10384 |
Échographie ciblée au cabinet médical RMS2021 |
08/02/2022 |
10383 |
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab |
08/02/2022 |
10382 |
DORIS definition of remission in SLE_ final recommendations from an international task force |
08/02/2022 |
10381 |
Direct Oral Anticoagulant Dose Selection_ Challenging Cases |
08/02/2022 |
10380 |
Diabete HTA COVID |
08/02/2022 |
10379 |
Deterioration of vaccine?induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion_ Insight from functional cytometry and serotonin release assay |
08/02/2022 |
10378 |
Des troubles du cycle menstruel après vaccination anti-Covid-19 |
08/02/2022 |
10377 |
Des échecs vaccinaux potentiellement plus nombreux avec le vaccin Janssen _ |
08/02/2022 |
10376 |
Dépistage de l’athérosclérose dans l hyperCholRMS2021 |
08/02/2022 |
10375 |
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges_ an open-label, cluster-randomised trial |
08/02/2022 |
10374 |
CP_Discovery Remdesivir |
08/02/2022 |
10373 |
Covid-19, plus d’anxiété pour la génération Y |
08/02/2022 |
10372 |
Covid-19, des vaccins à ARNm sous haute surveillance |
08/02/2022 |
10371 |
COVID-19 un facteur de risque indépendant d’infarctus du myocarde et d’accidents vasculaires cérébraux |
08/02/2022 |
10370 |
COVID-19 et diabète |
08/02/2022 |
10369 |
Covid-19 et crise des opioïdes, c’est l’overdose aux USA ! |
08/02/2022 |
10368 |
Covid-19 _ le Molnupiravir, remède miracle ou mirage?_ – Libération |
08/02/2022 |
10367 |
COVID-19 – Vaccins – Suivi des effets indésirables – Pfizer BioNTech Comirnaty – Rapport 18 – Periode 02_07_2021 au 26_08_2021 |
08/02/2022 |
10366 |
COVID-19 dans le monde |
08/02/2022 |
10365 |
Contraception orale _ et si le plus simple était le mieux |
08/02/2022 |
10364 |
Considerations in boosting COVID-19 vaccine immune responses |
08/02/2022 |
10363 |
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries |
08/02/2022 |
10362 |
Association of Polypharmacy with Kidney Disease Progression in Adults with CKD |
08/02/2022 |
10361 |
Clinical management of COVID-19 patients_ Living guidance, XX January 2021 |
08/02/2022 |
10360 |
CHOLESTÉROL _ Première version orale d’un inhibiteur de PCSK9 _ santé log |
08/02/2022 |
10359 |
Challenges and novel therapies for vascular access in haemodialysis_compressed |
08/02/2022 |
10358 |
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale RMS2021 |
08/02/2022 |
10357 |
Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity_compressed |
08/02/2022 |
10356 |
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes |
08/02/2022 |
10355 |
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg_dL |
08/02/2022 |
10354 |
Cannabis dans le traitement de la douleur, une vérité qui fait mal ! |
08/02/2022 |
10353 |
C0VID-19 l’opposition vaccinale est un puissant révélateur des tensions socio-politique |
08/02/2022 |
10352 |
C’est l’hiver, la saison des chocs cardiogéniques ! |
08/02/2022 |
10351 |
Bulletin épidémiologique – semaine 37-38 – Du Côté de la Science |
08/02/2022 |
10350 |
Broderick_et_al-2021-Cochrane_Database_of_Systematic_Reviews |
08/02/2022 |
10349 |
Broderick_et_al-2021-Cochrane_Database_of_Systematic_Reviews |
08/02/2022 |
10348 |
Bientôt un antidépresseur contre Covid-19_ On vous dit tout – Heidi.news |
08/02/2022 |
10347 |
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT |
08/02/2022 |
10346 |
Baisse d’efficacité vaccinale, le temps plus que le variant |
08/02/2022 |
10345 |
Association between transportation barriers and anticoagulation control among an inner?city, low?income population_ A prospective observational cohort study |
08/02/2022 |
10344 |
apixaban ou édoxaban ou rivaroxaban |
08/02/2022 |
10343 |
An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism |
08/02/2022 |
10342 |
Algorithme YEARS |
08/02/2022 |
10341 |
AHA_ACC_ASE_CHEST_SAEM_SCCT_SCMR Guideline for the Evaluation and Diagnosis of Chest Pain_ Executive Summary_compressed (1) |
08/02/2022 |
10340 |
AHA focus sur les études |
08/02/2022 |
10339 |
Acute kidney injury in children with COVID-19_ a retrospective study |
08/02/2022 |
10338 |
Acute effects of graduated and progressive compression stockings on leg vein cross-sectional area and viscoelasticity in patients with chronic venous disease |
08/02/2022 |
10337 |
A consensus statement on lipid management after acute coronary syndrome |
08/02/2022 |
10336 |
The role of cardiac rehabilitation in improving cardiovascular outcomes |
26/09/2021 |
10335 |
Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment_compressed |
26/09/2021 |
10334 |
RMS_749_1537 |
26/09/2021 |
10333 |
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism_ a systematic review and meta-analysis protocol |
26/09/2021 |
10332 |
Proposition-Anticoagulants-Covid-HCL-GEMMAT-V2F-07-11-2020 |
26/09/2021 |
10331 |
Popliteal artery entrapment syndromeVM2019 |
26/09/2021 |
10330 |
Pole Test |
26/09/2021 |
10329 |
Pedal Flow Hemodynamics in Patients With Chronic Limb-Threatening IschemiaJVS2020 |
26/09/2021 |
10328 |
Pas besoin d’une troisième dose maintenant_ les experts autour de l’OMS enfoncent le clou – Heidi.news |
26/09/2021 |
10327 |
Evaluation andmanagement of cancer patients presenting with acute cardiovascular disease a Consensus Document of the Acute.. |
26/09/2021 |
10326 |
Atherothrombotic factors and atherosclerotic cardiovascular events themulti-ethnic study of atherosclerosis |
26/09/2021 |
10325 |
Application of artificial intelligence to the electrocardiogram |
26/09/2021 |
10324 |
Loss of statin treatment years during pregnancy Athero2021 |
26/09/2021 |
10323 |
jama_klein_2021_oi_210099_1630597720.15123 |
26/09/2021 |
10322 |
Green nephrology |
26/09/2021 |
10321 |
Embolie pulmonaire ambulatoire – Comment sélectionner et organiser le parcours de soins du patient |
26/09/2021 |
10320 |
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER)_ a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial |
26/09/2021 |
10319 |
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes |
26/09/2021 |
10318 |
Covid-19 _ des études PHARE, d’une vague à l’autre en France |
26/09/2021 |
10317 |
Coronavirus Disease-2019 and Heart Failure |
26/09/2021 |
10316 |
Considerations in boosting COVID-19 vaccine immune reponses |
26/09/2021 |
10315 |
Charlie répond au Criigen – Charlie Hebdo |
26/09/2021 |
10314 |
BTS Guidance on Venous Thromboembolic Disease in patients with COVID-19 |
26/09/2021 |
10313 |
blood1371insidebloodcombined 1..12 |
26/09/2021 |
10312 |
A propos de Oncotype DX Breast Recurrence Score |
26/09/2021 |
10311 |
Update on Guidelines for the Management of Cancer-Associated Thrombosis |
26/09/2021 |
10310 |
The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis |
26/09/2021 |
10309 |
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy |
26/09/2021 |
10308 |
Si les patients intubés pouvaient parler, que diraient-ils_ – Heidi.news |
26/09/2021 |
10307 |
Should Cardiovascular Preventive Therapy Be Over-the-Counter_∗ |
26/09/2021 |
10306 |
SFMV CANNES |
26/09/2021 |
10305 |
Rivaroxaban thromboprophylaxis for gastricgastroesophageal junction tumors versus other tumors A post hoc analysis of the randomized CASSINI trial |
26/09/2021 |
10304 |
Risques vasculaires après les vaccins anti-Covid, la réalité des chiffres |
26/09/2021 |
10303 |
Recommendations and guidelines |
26/09/2021 |
10302 |
PREVENTION CV ESC 2021_compressed |
26/09/2021 |
10301 |
Pas plus d’hospitalisations pour Covid-19 parmi les enseignants… |
26/09/2021 |
10300 |
Particules fines _ au-dessous des seuils, il y a encore un danger |
26/09/2021 |
10299 |
Parlons, cette fois, du vaccin contre le paludisme |
26/09/2021 |
10298 |
OP-EHEA210485 3187..3189 |
26/09/2021 |
10297 |
OP-EHEA191011_online 2313..2340_compressed |
26/09/2021 |
10296 |
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia |
26/09/2021 |
10295 |
Medial Arterial Calcification |
26/09/2021 |
10294 |
Lower Extremity Peripheral Artery Disease_ Contemporary Epidemiology, Management Gaps, and Future Directions_ A Scientific Statement From the American Heart Association |
26/09/2021 |
10293 |
Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project_ pooled analysis |
26/09/2021 |
10292 |
Les professionnels de la santé |
26/09/2021 |
10291 |
Le baracitinib, un nouvel atout contre les Covid-19 sévères |
26/09/2021 |
10290 |
It’s time for all doctors to engage on assisted dying |
26/09/2021 |
10289 |
Hypertension intracrânienne idiopathique quel bilan et quelle prise en charge en médecine interne |
26/09/2021 |
10288 |
Gmail – Flash info vaccination |
26/09/2021 |
10287 |
Formation Médicale Continue |
26/09/2021 |
10286 |
Fluctuation des symptômes en psychiatrie avec la Covid-19 |
26/09/2021 |
10285 |
External validation of a model to predict women most at risk of postpartum venous thromboembolism_ Maternity clot risk |
26/09/2021 |
10284 |
Every 6 seconds in Europe |
26/09/2021 |
10283 |
Erreurs diagnostiques |
26/09/2021 |
10282 |
Des biopsies guidées par l’IRM pour le dépistage du cancer de la prostate _ |
26/09/2021 |
10281 |
Des anti-pass s’attaquent au domicile du directeur de l’AP-HM… mais se trompent d’adresse _ Le Quotidien du médecin |
26/09/2021 |
10280 |
Delta versus alpha, deux fois plus d’hospitalisations _ |
26/09/2021 |
10279 |
Covid-19 _ des études PHARE, d’une vague à l’autre en France |
26/09/2021 |
10278 |
Chronic Meningitis |
26/09/2021 |
10277 |
Charlie répond au Criigen – Charlie Hebdo |
26/09/2021 |
10276 |
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes |
26/09/2021 |
10275 |
A Transatlantic Comparison of Patient-Reported Access to and Use of Aspirin in Contemporary Preventive Cardiology |
26/09/2021 |
10274 |
2 weeks LMWH Distal DVT TWISTER trial |
26/09/2021 |
10273 |
Vaccination SARS-CoV-2 _ au tour des adolescents ! |
24/08/2021 |
10272 |
Tranexamic acid evidence and controversies_ An illustrated review_compressed |
24/08/2021 |
10271 |
The CoVID?TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID?19_compressed (1) |
24/08/2021 |
10270 |
The biology of atherosclerosis comes full circle_ lessons for conquering cardiovascular disease |
24/08/2021 |
10269 |
TAKYASU2021 |
24/08/2021 |
10268 |
Symptomatic and asymptomatic peripheral artery disease and the risk of abdominal aortic aneurysm_ The Atherosclerosis Risk in Communities (ARIC) study_compressed |
24/08/2021 |
10267 |
Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination |
24/08/2021 |
10266 |
Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2 |
24/08/2021 |
10265 |
Retinal Vein Thrombosis and the Association with Inherited Thrombophilia, Cardiovascular Risk Factors and the Risk of Occult Cancer. a Prospective Study – ISTH Congress Abstracts |
24/08/2021 |
10264 |
Remdesivir ou HCQ pour des patients Covid+ hospitalisés _ ça ne marche décidément pas |
24/08/2021 |
10263 |
Radiographies du thorax, ASP et Choose wiselyRMS2021 |
24/08/2021 |
10262 |
Que valent les vaccins anti-Covid pour les hémodialysés et transplantés rénaux _ |
24/08/2021 |
10261 |
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines |
24/08/2021 |
10260 |
pone.0081260 1..11 |
24/08/2021 |
10259 |
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting |
24/08/2021 |
10258 |
Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome |
24/08/2021 |
10257 |
PAHOIMSEIHCOVID-1921018_eng_compressed |
24/08/2021 |
10256 |
OP-EHEA210386 1..13 |
24/08/2021 |
10255 |
Nous sommes tous cet ours blanc à la dérive – Heidi.news |
24/08/2021 |
10254 |
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2 |
24/08/2021 |
10253 |
Management of Cancer Associated Thrombosis in France_ A National Survey in Vascular Disease and Supportive Care Specialists – ISTH Congress Abstracts |
24/08/2021 |
10252 |
Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents |
24/08/2021 |
10251 |
Les US inquiets de la transmission de Delta par les vaccinés – Heidi.news |
24/08/2021 |
10250 |
Les orphelins de la Covid-19, ces oubliés de la pandémie |
24/08/2021 |
10249 |
Les méningiomes – mise au point sur les connaissances actuelles |
24/08/2021 |
10248 |
Les maladies cardiovasculaires et les suicides premières causes de décès maternels en France en 2013-2015_compressed (2) |
24/08/2021 |
10247 |
La schizophrénie au temps de la Covid-19 |
24/08/2021 |
10246 |
La PR complique l’angioplastie coronaire à long terme |
24/08/2021 |
10245 |
La HAS demandeuse d’un débat sur l’élargissement de l’obligation vaccinale |
24/08/2021 |
10244 |
La dénervation rénale diminue l’activité rénine et le taux d’aldostérone plasmatiques |
24/08/2021 |
10243 |
L’hôpital à risque Covid malgré les vaccins_ Une étude israélienne invite à la prudence – Heidi.news |
24/08/2021 |
10242 |
jth.15487 |
24/08/2021 |
10241 |
Intracranial aneurysm is predicted by abdominal aortic calcification index_ A retrospective case-control study_compressed |
24/08/2021 |
10240 |
INFOGRAPHIES. Covid-19 _ à quoi ressemble le rebond épidémique en Europe __compressed (1) |
24/08/2021 |
10239 |
Identification of Patients at High Thrombotic Risk in a Large Prospective Cancer Patient Cohort Undergoing Anticancer Treatment – ISTH Congress Abstracts |
24/08/2021 |
10238 |
Hypothyroïdie congénitale primaire _ poursuivre ou non le traitement à 2 ans _ |
24/08/2021 |
10237 |
Hyperuricémie _ les bienfaits du régime DASH |
24/08/2021 |
10236 |
Fournaise en ville, quelles solutions pour quelques degrés de moins_ – Heidi.news |
24/08/2021 |
10235 |
First case of postmortem study in a patient vaccinated against covid |
24/08/2021 |
10234 |
Extended Thromboprophylaxis Following Major Abdominal_Pelvic Cancer-related Surgery_ A Systematic Review and Meta-analysis of the Literature – ISTH Congress Abstracts |
24/08/2021 |
10233 |
European Society of Hypertension position paper on renal denervation 2021 |
24/08/2021 |
10232 |
EMDR quelle place aux urgence |
24/08/2021 |
10231 |
Embolie pulmonaire à l’ère du choose wisely RMS2021 |
24/08/2021 |
10230 |
Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension |
24/08/2021 |
10229 |
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection_ A Randomized Clinical Trial |
24/08/2021 |
10228 |
Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk__compressed |
24/08/2021 |
10227 |
Doctolib, un nouveau monopole sur ordonnance _ – Libération |
24/08/2021 |
10226 |
Digital pitting scars are associated with a severe disease course and detah in systemic sclerosis 2021 |
24/08/2021 |
10225 |
Determinants and Outcomes of Asymptomatic Intracranial Atherosclerotic Stenosis |
24/08/2021 |
10224 |
Desinfox. Non, on ne manque pas _de recul_ sur les vaccins à ARN messager |
24/08/2021 |
10223 |
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism |
24/08/2021 |
10222 |
Covid-19 _ aucune preuve de l’efficacité de l’ivermectine, selon une revue « Cochrane » _ Le Quotidien du médecin |
24/08/2021 |
10221 |
COVID-19 le vaccin de Novavax montre une efficacité élevée |
24/08/2021 |
10220 |
Covid-19 _ une étude chinoise souligne l’ampleur de la charge virale à la phase précoce de l’infection par le variant Delta – Réalités Biomédicales |
24/08/2021 |
10219 |
Covid-19 _ le temps est-il venu de la vaccination obligatoire _ [Tribune] |
24/08/2021 |
10218 |
Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease_compressed |
24/08/2021 |
10217 |
Conquering Atherosclerotic Cardiovascular Disease — 50 Years of Progress |
24/08/2021 |
10216 |
Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism A Bayesian Network Meta-analysis |
24/08/2021 |
10215 |
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis_ A Review |
24/08/2021 |
10214 |
CLARIFY |
24/08/2021 |
10213 |
Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry_ Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy |
24/08/2021 |
10212 |
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19 |
24/08/2021 |
10211 |
C’est bien connu, les soignants sont tous des psychopathes – Heidi.news |
24/08/2021 |
10210 |
Approche médicamenteuse de l’obésité en France en 2021 – tour d’horizon |
24/08/2021 |
10209 |
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021- a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC2021 |
24/08/2021 |
10208 |
Actualité – Point de situation sur la surveillance des vaccins contre la COVID-19 – Période du 25_06_2021 au 08_07_2021 – ANSM |
24/08/2021 |
10207 |
Absence of hypercoagulability after nCoV-19 vaccination_ An observational pilot study |
24/08/2021 |
10206 |
30% de la population mondiale n’a pas eu accès à une alimentation adéquate en 2020 – Heidi.news |
24/08/2021 |
10205 |
Choosing Wisely for COVID-19 ten evidencebased recommendations for patients and physicians |
15/07/2021 |
10204 |
Venous thrombosis with oral postmenopausal hormone therapy_ Roles of activated protein C resistance and tissue factor pathway inhibitor |
15/07/2021 |
10203 |
Variant indien, un «double mutant» qui n’en est pas un – Heidi.news |
15/07/2021 |
10202 |
Vaccination anti-Covid _ on peut compter sur le Novavax dans le monde ! |
15/07/2021 |
10201 |
Un lien entre rétinopathie et progression des calcifications coronaires |
15/07/2021 |
10200 |
Treatment of bleeding in patients with liver disease |
15/07/2021 |
10199 |
Toward personalized management of chronic hypertension in pregnancy |
15/07/2021 |
10198 |
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector?based COVID?19 vaccine |
15/07/2021 |
10197 |
The Normal Aorta |
15/07/2021 |
10196 |
The Genetic Basis of Hypertriglyceridemia |
15/07/2021 |
10195 |
The CT Scan after 50 years — Continuity and Change |
15/07/2021 |
10194 |
The covid-19 lab leak hypothesis_ did the media fall victim to a misinformation campaign_ |
15/07/2021 |
10193 |
The Coronary Artery Risk Development In Young Adults (CARDIA) Study |
15/07/2021 |
10192 |
Tableau de bord Climat – Les actions à mettre en place |
15/07/2021 |
10191 |
Tableau de bord Climat – Le climat se dérègle |
15/07/2021 |
10190 |
Tableau de bord Climat – De nouvelles menaces |
15/07/2021 |
10189 |
Tableau de bord Climat – C’est notre faute |
15/07/2021 |
10188 |
Synthetic Fibrin-Derived B?15-42 Peptide Delays Thrombus Resolution in a Mouse Model |
15/07/2021 |
10187 |
Secondary Prophylaxis of Venous Thromboembolism with Direct Oral Anticoagulants in Patients with Major Congenital Thrombophilia vs Non-thrombofilic Patients – ISTH Congress Abstracts |
15/07/2021 |
10186 |
SARS-CoV-2 Variants and Vaccines |
15/07/2021 |
10185 |
Role of Individual Venous Symptoms and Signs at Baseline in Predicting Future Development of Post-thrombotic Syndrome_ Sub-analysis of the ATTRACT Trial – ISTH Congress Abstracts |
15/07/2021 |
10184 |
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals |
15/07/2021 |
10183 |
Recommandations canadiennes pour le traitement AVC |
15/07/2021 |
10182 |
Progression of Early Subclinical Atherosclerosis (PESA) Study_compressed |
15/07/2021 |
10181 |
Population-Based Risk Factors for Ascending, Arch, Descending, and Abdominal Aortic Dilations for 60-74-Year-Old Individuals |
15/07/2021 |
10180 |
Pfizer après AstraZeneca, de bons résultats ! |
15/07/2021 |
10179 |
OP-EHEA210238 2422..2438_compressed |
15/07/2021 |
10178 |
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military |
15/07/2021 |
10177 |
Myocardites post-vaccinales 5 études passent au crible des dizaines de cas |
15/07/2021 |
10176 |
Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT) |
15/07/2021 |
10175 |
Machine learning model for predicting out-of-hospital cardiac arrests using meteorological and chronological data |
15/07/2021 |
10174 |
Long-term Survival after Venous Thromboembolism_ A Prospective Cohort Study – ISTH Congress Abstracts |
15/07/2021 |
10173 |
Les États-Unis autorisent un nouveau médicament “controversé” contre Alzheimer |
15/07/2021 |
10172 |
Le plâtre ou l’attelle pour la fracture de la cheville |
15/07/2021 |
10171 |
L’apport de l’eltrombopag face aux thrombopénies des syndromes myélodysplasiques de faible risque |
15/07/2021 |
10170 |
Bons effets d’un vaccin anti-Covid made in China au Chili |
15/07/2021 |
10169 |
Bas de contention au foot, on refait le match ! |
15/07/2021 |
10168 |
Aléas de la vaccination anti-Covid-19 pour les patients souffrant de PR |
15/07/2021 |
10167 |
Le variant Delta à la conquête du monde – Heidi.news |
15/07/2021 |
10166 |
Is the Consensual Threshold for definiting high glucose variability DC2021 |
15/07/2021 |
10165 |
Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations_compressed |
15/07/2021 |
10164 |
INSIGHTS into Superficial Vein Thrombosis Management |
15/07/2021 |
10163 |
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction_ Call for Action to the Cardiology Community |
15/07/2021 |
10162 |
Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women |
15/07/2021 |
10161 |
Hematuria in Adults |
15/07/2021 |
10160 |
Heartbeat_ is postmenopausal hormone therapy a risk factor or preventative therapy for cardiovascular disease in women_ |
15/07/2021 |
10159 |
Frequency of Thrombocytopenia and Platelet Factor 4_Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic |
15/07/2021 |
10158 |
French recommendations for the management of Behçet’s disease _ Orphanet Journal of Rare Diseases _ Full Text |
15/07/2021 |
10157 |
Embolic strokes of undetermined source_ the case for a new clinical construct |
15/07/2021 |
10156 |
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
15/07/2021 |
10155 |
COVID-19 brCOVID-19 variant Delta sur tous les continents, les US n’atteignent pas leurs objectifs_compressedain effects similar to Alzheimer’s, Parkinson’s, autopsy study shows – UPI.com |
15/07/2021 |
10154 |
Covid-19 _ Alpha, Beta, Gamma, Delta, Epsilon… l’émergence sans fin des variants – Réalités Biomédicales |
15/07/2021 |
10153 |
Contact Activation and Coagulation in Residual Venous Obstruction – ISTH Congress Abstracts |
15/07/2021 |
10152 |
Comparison of Real-world Effectiveness and Safety of Enoxaparin versus Tinzaparin or Dalteparin in Cancer Patients with Venous Thromboembolism. The RIETECAT Cohort Study – ISTH Congress Abstracts |
15/07/2021 |
10151 |
Characterisation of Patients with Peripheral Artery Disease at Increased Risk for Cardiovascular Events and Mortality – ISTH Congress Abstracts |
15/07/2021 |
10150 |
Cancer is Associated with an Increased Stroke Risk in Patients with Atrial Fibrillation and CHA2DS2VASc Score ? 2 – ISTH Congress Abstracts |
15/07/2021 |
10149 |
Biomarkers Of Thrombosis As Predictors Of Venous Thromboembolism In Cancer Patients_ Preliminary Results From Fiit Project – ISTH Congress Abstracts |
15/07/2021 |
10148 |
Bier anaemic spots, cyanosis with urticaria?like eruption (BASCULE) syndrome_ a new entity_ |
15/07/2021 |
10147 |
Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures |
15/07/2021 |
10146 |
Beyond the d-dimer – Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism |
15/07/2021 |
10145 |
beeckmanm_peausederm |
15/07/2021 |
10144 |
Aux États-Unis, le prix faramineux du médicament Aduhelm |
15/07/2021 |
10143 |
Automated Quality-Controlled Cardiovascular Magnetic Resonance Pericardial Fat Quantification Using a Convolutional Neural Network in the UK Biobank_compressed |
15/07/2021 |
10142 |
Associations of Residual Venous Obstruction, d-Dimers, fFctor VIII and CRP with Long-term Outcomes of Deep Vein Thrombosis – ISTH Congress Abstracts |
15/07/2021 |
10141 |
Are we there yet_ Menopausal hormone therapy for primary cardiovascular disease prevention |
15/07/2021 |
10140 |
Apple publie une nouvelle liste d’appareils pouvant interférer avec les dispositifs cardiaques |
15/07/2021 |
10139 |
Antiplatelet therapy after percutaneous coronary intervention_ is less more (more or less)_ |
15/07/2021 |
10138 |
Acute VTE in HIV versus Non-HIV population – Nationwide Analysis of Mortality, Morbidity, Demographics and Healthcare Utilization – ISTH Congress Abstracts |
15/07/2021 |
10137 |
Absence of hypercoagulability after nCoV-19 vaccinationAn observational pilot study |
15/07/2021 |
10136 |
ABO Blood Groups as a Risk Factor for the Development of Deep Vein Thrombosis of the Lower Extremities in Elderly and Senile Patients – ISTH Congress Abstracts |
15/07/2021 |
10135 |
A Weight-based Approach to Thromboprophylaxis Dosing for Medical Inpatients with COVID-19 – ISTH Congress Abstracts |
15/07/2021 |
10134 |
«Il y a une population qui persiste entre les vagues_ les Covid longs» – Heidi.news |
15/07/2021 |
10133 |
“Whole life changed” – Experiences of how symptoms derived from acute pulmonary embolism affects lifeTH2021 |
15/07/2021 |
10132 |
Measuring the impact of covid-19 |
15/06/2021 |
10131 |
Walking Exercise Therapy Effects on Lower Extremity Skeletal Muscle in Peripheral Artery Disease |
15/06/2021 |
10130 |
Vaccination_ et si on misait plus sur l’altruisme_ – Heidi.news |
15/06/2021 |
10129 |
vaccin pan-coronavirus – Réalités Biomédicales |
15/06/2021 |
10128 |
Une dose de vaccin Pfizer puis une de Moderna_ Un essai lancé ce dimanche _ Le HuffPost |
15/06/2021 |
10127 |
Un vieillissement accéléré pour les garçons de très petit poids de naissance |
15/06/2021 |
10126 |
Un Italien de 80 ans à la mémoire autobiographique phénoménale – Réalités Biomédicales |
15/06/2021 |
10125 |
Umbrella review of 42 systematic reviews with meta?analyses_ the safety of proton pump inhibitors |
15/06/2021 |
10124 |
Trop de gluten, ça ne donne pas un grain ! |
15/06/2021 |
10123 |
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19 |
15/06/2021 |
10122 |
Television Viewing, physical activity and Venous Thromboembolism Risk_ the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study_compressed (1) |
15/06/2021 |
10121 |
Subtle signatures of risk HH2021 |
15/06/2021 |
10120 |
Site of Deep Venous Thrombosis and Age in the Selection of Patients in the Emergency Department for Hospitalization Versus Home Treatment |
15/06/2021 |
10119 |
Severe COVID-19 outcomes — the role of physical activity |
15/06/2021 |
10118 |
RSA, chômage, aide alimentaire…La pandémie a exacerbé les inégalités entre les Français |
15/06/2021 |
10117 |
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation_ Results from the GARFIELD?AF Registry_compressed |
15/06/2021 |
10116 |
Recommandations ESC 2020 _ cardiologie du sport et activité physique chez les patients atteints de maladies cardiovasculaires_compressed (1) |
15/06/2021 |
10115 |
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19_ Findings From the American Heart Association’s COVID-19 Cardiovascular Disease Registry |
15/06/2021 |
10114 |
PROTOCOLES AVK |
15/06/2021 |
10113 |
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2)_ double blind randomised controlled trial |
15/06/2021 |
10112 |
Physical inactivity is associated with a higher risk for severe COVID-19 outcomes_ a study in 48 440 adult patients |
15/06/2021 |
10111 |
Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations |
15/06/2021 |
10110 |
Mucormycoses et Covid-19 en Inde, un double défi |
15/06/2021 |
10109 |
M-nopause–diab-te–et-risque-cardiovasculaire-_2017_M-decine-des-Maladies-M |
15/06/2021 |
10108 |
La pandémie, jackpot pour les antivaccins – Heidi.news |
15/06/2021 |
10107 |
L’atout cœur des iPDE 5 |
15/06/2021 |
10106 |
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak_ A Practical Review |
15/06/2021 |
10105 |
Feu vert américain pour un médicament débattu contre Alzheimer – Heidi.news |
15/06/2021 |
10104 |
Covid-19 et anticoagulation, faut-il faire évoluer la stratégie _ |
15/06/2021 |
10103 |
Cancer du sein _ opter pour la chirurgie conservatrice |
15/06/2021 |
10102 |
External validation of a model to predict women most at risk of postpartum venous thromboembolism_ Maternity clot risk |
15/06/2021 |
10101 |
Excess deaths associated with covid-19 pandemic in 2020_ age and sex disaggregated time series analysis in 29 high income countries |
15/06/2021 |
10100 |
diabete pandemie oubliee |
15/06/2021 |
10099 |
COVID-19_INESSS_Risques_Thrombothiques |
15/06/2021 |
10098 |
COVID-19 Variant Delta, faux certificats de vaccination… |
15/06/2021 |
10097 |
COVID-19 Vaccination of Health Care Personnel as a Condition of Employment_ A Logical Addition to Institutional Safety Programs |
15/06/2021 |
10096 |
Covid long_ une opportunit pour approcher la complexit des syndromes fonctionnels post-infectieux |
15/06/2021 |
10095 |
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures |
15/06/2021 |
10094 |
Chez les sujets hospitaliss pour COVID-19 avec hypoxmie et inflammation systmique, est-ce que le tocilizumab diminue la mortalit 28 jours comparativement au traitement standard tout en tant scuritaire_ |
15/06/2021 |
10093 |
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures |
15/06/2021 |
10092 |
Chez les sujets hospitaliss pour COVID-19 avec hypoxmie et inflammation systmique, est-ce que le tocilizumab diminue la mortalit 28 jours comparativement au traitement standard tout en tant scuritaire_ |
15/06/2021 |
10091 |
Cerebral Venous Sinus Thrombosis in the US Population, after Adenovirus-basedSARS-CoV-2 Vaccination, and After COVID-1 |
15/06/2021 |
10090 |
Cerebral Venous Sinus Thrombosis in the US Population, after Adenovirus-based SARS-CoV-2 Vaccination, and After COVID-19 |
15/06/2021 |
10089 |
Carotid stenosis management_ time to address the misconceptions (‘furphies’) |
15/06/2021 |
10088 |
Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic_compressed |
15/06/2021 |
10087 |
Associations between body-mass index and COVID-19 severity in 6·9 million people in England_ a prospective, community-based, cohort study |
15/06/2021 |
10086 |
Anti–factor Xa activity assays of direct?acting oral anticoagulants during clinical care_ An observational study |
15/06/2021 |
10085 |
AHA – une étude précise le risque CV associé à la ménopause précoce |
15/06/2021 |
10084 |
A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes |
15/06/2021 |
10083 |
41569_2021_543_MOESM1_ESM |
15/06/2021 |
10082 |
Acide tranexamique dans la prise en charge de l’hémorragie du postpartum connaissances actuelles |
08/06/2021 |
10081 |
VTE RISK CHEST 2021 COVID |
08/06/2021 |
10080 |
VOYAGER PAD _ le rivaroxaban réduit aussi bien la fréquence de survenue du premier que le total des événements ischémiques chez les patients avec AOMI symptomatique revascularisée |
08/06/2021 |
10079 |
VITT guideline for doctors |
08/06/2021 |
10078 |
VII SFAV 10 pts algorithme 16 mai 2019 pdf |
08/06/2021 |
10077 |
Venous thromboembolism in COVID-19_ A systematic review and meta-analysis |
08/06/2021 |
10076 |
Vascular Disease Patient Information Page_ Compression therapy |
08/06/2021 |
10075 |
Vaccins anti Covid-19 et thrombose _ de quoi parle-t-on |
08/06/2021 |
10074 |
Usefulness of orbital colour Doppler ultrasound in vascular-related monocular vision loss |
08/06/2021 |
10073 |
Update on peripheral artery disease_ Epidemiology and evidence-based facts |
08/06/2021 |
10072 |
Understanding and Mitigating Health Inequities — Past, Current, and Future Directions |
08/06/2021 |
10071 |
Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018 |
08/06/2021 |
10070 |
Treatment decisions for patients with peripheral artery disease and symptoms of claudication_ Development process and alpha testing of the SHOW-ME PAD decision aid |
08/06/2021 |
10069 |
Trauma-induced coagulopathy |
08/06/2021 |
10068 |
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination |
08/06/2021 |
10067 |
Thrombotic and Bleeding Risk of Angiogenesis Inhibitors in Patients with and without Malignancy_compressed |
08/06/2021 |
10066 |
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination |
08/06/2021 |
10065 |
thromboses pre?vention – mai 2019 pdf |
08/06/2021 |
10064 |
Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM?Line)_ A two?center open?label pilot randomized controlled trial |
08/06/2021 |
10063 |
Thromboprophylaxis with Rivaroxaban in Patients with Malignancy and Central Venous Lines (TRIM-line)_ a Multi-centre Open-label Pilot Randomized Controlled Trial – ISTH Congress Abstracts |
08/06/2021 |
10062 |
Thromboembolism and the Oxford-AstraZeneca vaccine |
08/06/2021 |
10061 |
Thomson |
08/06/2021 |
10060 |
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19 – Preliminary Report |
08/06/2021 |
10059 |
The possible benefits of vitamin D in COVID-19 |
08/06/2021 |
10058 |
The first and second waves of the COVID-19 pandemic in Africa- a cross-sectional study2 |
08/06/2021 |
10057 |
The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff_compressed |
08/06/2021 |
10056 |
Taking a ‘stand’ against cardiovascular disease in the era of COVID-19 |
08/06/2021 |
10055 |
Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism |
08/06/2021 |
10054 |
Statin but not Aspirin Treatment is Associated with Reduced Cardiovascular Risk in Patients with Diabetes without Obstructive Coronary |
08/06/2021 |
10053 |
SMMV Programme 21 mai |
08/06/2021 |
10052 |
Screening for Hypertension in Adults US Preventive Services Task Force Reaffirmation Recommendation Statement |
08/06/2021 |
10051 |
Screening for Colorectal Cancer US Preventive Services Task Force |
08/06/2021 |
10050 |
Screening for Asymptomatic Carotid Artery Stenosis in Adult Patients_ Unclear Benefit but Downstream Risks |
08/06/2021 |
10049 |
SARS-CoV-2 vaccine and thrombosis Expert opinions 2021 |
08/06/2021 |
10048 |
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event- a randomised controlled trial |
08/06/2021 |
10047 |
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents |
08/06/2021 |
10046 |
Risk Scores for Death in Patients with Cancer-related Venous ThromboembolismStill a Long Road AheadTH2021 |
08/06/2021 |
10045 |
Risk prediction for cancer?associated thrombosis_ A talk with Prof. Pabinger – Icthic Magazine |
08/06/2021 |
10044 |
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid_ A systematic review and meta-analysis |
08/06/2021 |
10043 |
Risk of recurrent venous thromboembolism in patients with autoimmune diseases_ data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
08/06/2021 |
10042 |
Risk of Acute Kidney Injury after Intravenous Contrast Media Administration in Patients with Suspected Pulmonary EmbolismTH2021 |
08/06/2021 |
10041 |
RESEARCH LETTER |
08/06/2021 |
10040 |
recos aomi sfmv |
08/06/2021 |
10039 |
Recommendations for the clinical and laboratory diagnosis of VITT against COVID?19_ Communication from the ISTH SSC Subcommittee on Platelet Immunology |
08/06/2021 |
10038 |
Protecting Olympic Participants from Covid-19 — The Urgent Need for a Risk-Management Approach |
08/06/2021 |
10037 |
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection_ Results From the Big Ten COVID-19 Cardiac Registry_compressed |
08/06/2021 |
10036 |
Prévalence de la maladie cardiovasculaire au cours du diabète _ deux études françaises |
08/06/2021 |
10035 |
Pourquoi, 40 ans après, n’y a-t-il toujours pas de vaccins sida_ – Heidi.news |
08/06/2021 |
10034 |
PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19 |
08/06/2021 |
10033 |
Performance of the Wells score in predicting deep vein thrombosis in medical and surgical hospitalized patients with or without thromboprophylaxis_ The R-WITT study |
08/06/2021 |
10032 |
Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS)- a multicentre, prospective, observational cohort study |
08/06/2021 |
10031 |
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19 |
08/06/2021 |
10030 |
Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosisVM2021 |
08/06/2021 |
10029 |
On The Pandemic_ The dangers of the news using war metaphors – The Georgetown Voice |
08/06/2021 |
10028 |
Mission “UnACCOMPLISHed”_ Optimal Antihypertensive Therapy |
08/06/2021 |
10027 |
Mental health and social interactions of older people with physical disabilities in England during the COVID-19 pandemic- a longitudinal cohort study |
08/06/2021 |
10026 |
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors |
08/06/2021 |
10025 |
L’Inde et le Coronavirus « Exception » Indienne ou Inversion du Monde |
08/06/2021 |
10024 |
Atorvastatin vs Placebo in Patients with COVID-19 Admitted to the ICU |
08/06/2021 |
10023 |
Mammalian enteral ventilation ameliorates respiratory failure |
08/06/2021 |
10022 |
Long?term risk of recurrent venous thromboembolism after a first contraceptive?related event_ Data from REVERSE cohort study |
08/06/2021 |
10021 |
Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries_ The SAFE-PAD Study |
08/06/2021 |
10020 |
Les différents stades d’évolution du web _ 1.0, 2.0, 3.0… – FredCavazza.net |
08/06/2021 |
10019 |
L’OMS baptise les variants avec des lettres grecques_ Les grandes étapes de la pandémie – Heidi.news |
08/06/2021 |
10018 |
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and LactatingWomen |
08/06/2021 |
10017 |
Diabète de type 2 et risque cardiovasculaire _ intérêt du score calcique et rôle du tissu adipeux épicardique |
08/06/2021 |
10016 |
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism |
08/06/2021 |
10015 |
It is time to determine Tocilizumab place in COVID-19 |
08/06/2021 |
10014 |
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak TH2021 |
08/06/2021 |
10013 |
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19_ Rationale and design of the INSPIRATION_INSPIRATION-S studies_compressed |
08/06/2021 |
10012 |
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease |
08/06/2021 |
10011 |
INSPIRATION TRIAL |
08/06/2021 |
10010 |
Infections, Hospitalizations, and Deaths Averted via Direct Effects of the Pfizer-BioNTech BNT162b2 |
08/06/2021 |
10009 |
Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK |
08/06/2021 |
10008 |
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors_ Insights from the EUCLID trial |
08/06/2021 |
10007 |
Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic- nationwide population based cohort stud |
08/06/2021 |
10006 |
HDL in the 21st CenturyA Multifunctional Roadmap for Future HDL ResearchCirc2021 |
08/06/2021 |
10005 |
hcspa20210521_covrecauxpurdairenmilclo |
08/06/2021 |
10004 |
Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American Individuals |
08/06/2021 |
10003 |
From Doppler to duplex_ A personal early history of the vascular laboratory |
08/06/2021 |
10002 |
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control |
08/06/2021 |
10001 |
Ext thrompbopropkylaxis cancer |
08/06/2021 |
10000 |
Excess COVID-19 mortality among critically ill patients in Africa |
08/06/2021 |
9999 |
Evaluating hemostatic thresholds for neuraxial anesthesia in adults with hemorrhagic disorders and tendencies_ A scoping review |
08/06/2021 |
9998 |
epi-phare_premiers_resultats_impact_vaccination_covid_20210521 |
08/06/2021 |
9997 |
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion |
08/06/2021 |
9996 |
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III)_ a single-blind, parallel-group, randomised controlled trial |
08/06/2021 |
9995 |
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19 A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial |
08/06/2021 |
9994 |
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England_ test negative case-control study |
08/06/2021 |
9993 |
Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery_ multicentre, double blind, randomised controlled trial |
08/06/2021 |
9992 |
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities_ A Randomized Clinical Trial |
08/06/2021 |
9991 |
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults_ A Randomized Clinical Trial_compressed |
08/06/2021 |
9990 |
diabete pandemie oubliee |
08/06/2021 |
9989 |
dgs_urgent_52_precisions_sur_la_vaccination_imd |
08/06/2021 |
9988 |
Des chercheurs du laboratoire de Wuhan ont été hospitalisés avec des symptômes du Covid dès novembre 2019_compressed |
08/06/2021 |
9987 |
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) |
08/06/2021 |
9986 |
Covid-19- Variants are spreading in countries with low vaccination rates_1_compressed |
08/06/2021 |
9985 |
COVID-19 vaccine prioritisation for people with disabilities |
08/06/2021 |
9984 |
Covid-19- Single vaccine dose is 33% effective against variant from the bmj _ BMJ 2021_373-n1346 _ doi- 10.1136_bmj.n1346 1 India, data show |
08/06/2021 |
9983 |
COVID-19 et problèmes d’odorat et de goût sans congestion nasale |
08/06/2021 |
9982 |
COVID-19 et pathologie thromboembolique veineuse |
08/06/2021 |
9981 |
Covid-19 _ moindre sensibilité du variant indien B.1.167.2 aux vaccins et aux anticorps monoclonaux – Réalités Biomédicales |
08/06/2021 |
9980 |
COVID-19 – Vaccins – Fiche de synthese – 14_05_2021 au 20_05_2021_compressed |
08/06/2021 |
9979 |
COVID et risque de contamination en intérieur |
08/06/2021 |
9978 |
Covid ‘booster’ trial will give third vaccine dose to UK volunteers _ Medical research _ The Guardian |
08/06/2021 |
9977 |
Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer |
08/06/2021 |
9976 |
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease |
08/06/2021 |
9975 |
CIRCULATIONAHA.121.054183 |
08/06/2021 |
9974 |
CIRCULATIONAHA.120.052780 |
08/06/2021 |
9973 |
CIRCULATIONAHA.120.052737 |
08/06/2021 |
9972 |
Ce qui se passe dans votre bras au moment du vaccin – Heidi.news |
08/06/2021 |
9971 |
CIRCULATIONAHA.120.050545 |
08/06/2021 |
9970 |
Cancer pulmonaire non à petites cellules une biologie prête à cibler RMS2021 |
08/06/2021 |
9969 |
CANCER du sin chez la femme enceinte RMS2021 |
08/06/2021 |
9968 |
BrochureFAV |
08/06/2021 |
9967 |
Bleeding risk in hospitalized patients with COVID?19 receiving intermediate? or therapeutic doses of thromboprophylaxis |
08/06/2021 |
9966 |
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID?19_ A single?center prospective longitudinal study |
08/06/2021 |
9965 |
Bauersachs_VOYAGERPAD |
08/06/2021 |
9964 |
avis_conseil_scientifique_24_mai_2021 |
08/06/2021 |
9963 |
Association of Blood Pressure Classification Using the 2017 |
08/06/2021 |
9962 |
Assessment and management of peripheral arterial disease_ what every cardiologist should know |
08/06/2021 |
9961 |
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway_ population based cohort study_compressed |
08/06/2021 |
9960 |
Are older people with disabilities neglected in the COVID-19 pandemic_ |
08/06/2021 |
9959 |
Aortic stiffness and cerebral microbleeds_ The Framingham Heart Study |
08/06/2021 |
9958 |
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection_compressed |
08/06/2021 |
9957 |
Acute effects of sedentary breaks on vascular health in adults at risk for type 2 diabetes- A systematic reviewVM2021 |
08/06/2021 |
9956 |
Achieved low-density lipoprotein cholest rik stroke |
08/06/2021 |
9955 |
ACFrOgAMQZvwJevZ1UHDoJKzuQ |
08/06/2021 |
9954 |
A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva- a diagnostic accuracy study_compressed |
08/06/2021 |
9953 |
20210528-covid-19-vaccins-astrazeneca-rapport-12-07-05-2021-20-05-2021_compressed |
08/06/2021 |
9952 |
20210514-nl-n9 |
08/06/2021 |
9951 |
2021_goligher_covid-19_formes_severes_prevention_vs_anticoagulation_therapeutique_medrxiv_compressed |
08/06/2021 |
9950 |
21.5.25-Obligation-vaccinale-contre-Covid_compressed |
08/06/2021 |
9949 |
10 Roles For Artificial Intelligence In Education |
08/06/2021 |
9948 |
06_21Thind.indd.pdfPOINT of CARE |
08/06/2021 |
9947 |
“Pill-in-Pocket” Anticoagulation for AF Circ 2021 |
08/06/2021 |
9946 |
EClinical Medicine |
19/05/2021 |
9945 |
vulvar_venous_malformations_surgical_treatment |
19/05/2021 |
9944 |
Venous and Arterial Thromboembolism in Patients With Cancer_compressed |
19/05/2021 |
9943 |
Ultrasonographic features of an intravascular lobular capillary hemangioma originating in the basilic vein_ Case report and literature review_compressed |
19/05/2021 |
9942 |
Three?dimensional ultrasound imaging_ An effective method to detect the effect of moderate intensity statin treatment in slowing carotid plaque progression_compressed |
19/05/2021 |
9941 |
The Voyager PAD Trial in a Surgical Perspective- A Debate |
19/05/2021 |
9940 |
The Use of Near Infrared Spectroscopy to Evaluate the Effect of Exercise on Peripheral Muscle Oxygenation in PAD |
19/05/2021 |
9939 |
The High Origin of the Radial Artery (Brachioradial_compressed |
19/05/2021 |
9938 |
SARS-CoV-2 vaccine and thrombosis Expert opinions 2021_compressed |
19/05/2021 |
9937 |
Oral tranexamic acid and thrombosis risk in women_compressed |
19/05/2021 |
9936 |
Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis Depends on Coeliac and Inferior Mesenteric Artery Status |
19/05/2021 |
9935 |
Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries_ The SAFE-PAD Study |
19/05/2021 |
9934 |
Kyste adventiciel poplité 2021 |
19/05/2021 |
9933 |
indices_de_performance_diagnostic_compressed |
19/05/2021 |
9932 |
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding |
19/05/2021 |
9931 |
Impact of Chronic Kidney Disease Under Nephrology Care on Outcomes of Carotid Endarterectomy |
19/05/2021 |
9930 |
High Mortality Rates in Medicare Patients After Peripheral Artery Disease Revascularization |
19/05/2021 |
9929 |
epidemiologie_etiologique_du_facteur_de_risque_a_la_cause-_compressed |
19/05/2021 |
9928 |
Doxycycline Abdominal Aortic Aneurysm Growth- A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials |
19/05/2021 |
9927 |
Cardio-oncologie? RMS2021 |
19/05/2021 |
9926 |
ADAPTABLE provides answers on aspirin dosing, conduct of pragmatic trials |
19/05/2021 |
9925 |
Accès à l’insuline_ à l’OMS, la France doit soutenir une résolution ambitieuse |
19/05/2021 |
9924 |
Vaccins anti Covid-19 à ARN messager _ quels effets sur la peau _ |
16/05/2021 |
9923 |
Troisième cause de décès aux Etats-Unis en 2020 La Covid-19… |
16/05/2021 |
9922 |
Science Magazine |
16/05/2021 |
9921 |
SARS-CoV-2 vaccine and thrombosis Expert opinions 2021 |
16/05/2021 |
9920 |
Encéphalopathie aiguë et Covid-19 hypothèses physiopathologiques |
16/05/2021 |
9919 |
Précommande du traitement anti-Covid de XENOTHERA |
16/05/2021 |
9918 |
Pas de majoration du risque de maladie veineuse thrombo-embolique sous inhibiteurs de JAK |
16/05/2021 |
9917 |
Novavax contre SARS-Cov2 _ le variant sud-africain a-t-il trouvé son maître _ |
16/05/2021 |
9916 |
Les restrictions médiatiques ont «coûté des vies» – The Lancet |
16/05/2021 |
9915 |
La pandémie de Covid-19 aurait dû être évitée, voici comment empêcher les suivantes _ Le HuffPost |
16/05/2021 |
9914 |
L’immunovirothérapie, un réel espoir pour le traitement des glioblastomes de haut grade pédiatriques |
16/05/2021 |
9913 |
L’échographie des glandes salivaires est bien utile pour le diagnostic du Syndrome de Sjögren |
16/05/2021 |
9912 |
Insuffisance cardiaque en 2021? |
16/05/2021 |
9911 |
Épistaxis aux urgences, ne pas compter sur l’acide tranéxamique topique ! |
16/05/2021 |
9910 |
Direct 12 mai _ la France réserve 30 000 doses d’un anticorps polyclonal _ Un autre variant porteur de la mutation E484K |
16/05/2021 |
9909 |
Combien de temps pouvez-vous rester dans un wagon de métro, sans risque de Covid-19 _ |
16/05/2021 |
9908 |
Coloscopie justifiée en cas de polype avancé chez un parent du 1er degré |
16/05/2021 |
9907 |
Cardio-oncologie? RMS2021 |
16/05/2021 |
9906 |
avis_conseil_scientifique_6_mai_2021 |
16/05/2021 |
9905 |
Systematic Screening DVT Covid19_compressed |
12/05/2021 |
9904 |
Science-Brief_AstraZeneca_General_20210507_version-2.0_published_compressed |
12/05/2021 |
9903 |
S’il y a de l’ARN de SARS-CoV-2 dans le sang |
12/05/2021 |
9902 |
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19_compressed |
12/05/2021 |
9901 |
Recommendations for the clinical and laboratory diagnosis of vaccine?induced immune thrombotic thrombocytopenia (VITT) for SARS?CoV?2 infections_ Communication from the ISTH SSC Subcommittee on Platelet Immunology__compressed |
12/05/2021 |
9900 |
Media restrictions have “cost lives” |
12/05/2021 |
9899 |
Mass-Vaccination Sites — An Essential Innovation to Curb the Covid-19 Pandemic |
12/05/2021 |
9898 |
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents- COVID?A study |
12/05/2021 |
9897 |
Imaging of Oxford_AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia |
12/05/2021 |
9896 |
Diagnostic du Covid-19 en milei ambulatoire RMS2021 |
12/05/2021 |
9895 |
Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia |
12/05/2021 |
9894 |
Dépistage de masse du Covid-19 quelles leçons tirer des récentes expériencesRMS2021 |
12/05/2021 |
9893 |
Dépistage de l’infection à SARS-CoV-2 chez les voyageurs RMS2021 |
12/05/2021 |
9892 |
Delirium triggered by COVID?19 vaccine in an elderly patient |
12/05/2021 |
9891 |
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination_ A registry-based study of 414 cases |
12/05/2021 |
9890 |
COVID-19 vaccine induced prothrombotic immune thrombocytopenia |
12/05/2021 |
9889 |
Covid-19 _ ces variants préoccupants anglais, sud-africain et brésilien qui circulent en Europe – Réalités Biomédicales |
12/05/2021 |
9888 |
Covid-19 dans le genre on peut faire mieux RMS2021 |
12/05/2021 |
9887 |
COVID -19 vaccination |
12/05/2021 |
9886 |
Consultation des voyageurs en temps de pandémie de Covid-19évolution des pratiques et rôle sentinelle RMS2021 |
12/05/2021 |
9885 |
Centre Winton de Cambridge_compressed |
12/05/2021 |
9884 |
Avoiding the Coming Tsunami of Common, Chronic Disease |
12/05/2021 |
9883 |
Avis_conseil_scientifique_6_mai_2021_compressed |
12/05/2021 |
9882 |
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals |
12/05/2021 |
9881 |
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health CareWorkers |
12/05/2021 |
9880 |
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZenec BMJ2021 |
12/05/2021 |
9879 |
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients In contrast to immunocompetent participants in vaccine |
12/05/2021 |
9878 |
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy |
12/05/2021 |
9877 |
Thrombose et saignement après la vaccination contre le covid-19 Oxford-AstraZeneca – Le BMJ |
09/05/2021 |
9876 |
Thromboembolism and the Oxford-AstraZeneca vaccine |
09/05/2021 |
9875 |
Study suggests lupus anticoagulant positivity not associated with VTE or in?hospital mortality in COVID?19 |
09/05/2021 |
9874 |
Scenarios_de_levee_des_mesures_de_freinage_20210426 |
09/05/2021 |
9873 |
SARS-CoV-2 related Paediatric Acute-onset Neuropsychiatric Syndrome |
09/05/2021 |
9872 |
SARS-CoV-2 rapid antigen detection tests2 |
09/05/2021 |
9871 |
SARS-CoV-2 rapid antigen detection tests |
09/05/2021 |
9870 |
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases- the Euro-COVIMID multicentre cross-sectional study |
09/05/2021 |
9869 |
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California |
09/05/2021 |
9868 |
Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19 |
09/05/2021 |
9867 |
Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants |
09/05/2021 |
9866 |
Presence of heart failure with preserved ejection fraction in COVID-19 patients |
09/05/2021 |
9865 |
New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19 |
09/05/2021 |
9864 |
Missing the Point — How Primary Care Can Overcome Covid-19 Vaccine “Hesitancy |
09/05/2021 |
9863 |
Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control |
09/05/2021 |
9862 |
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel- an observational study using national surveillance data |
09/05/2021 |
9861 |
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant |
09/05/2021 |
9860 |
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |
09/05/2021 |
9859 |
Delirium triggered by COVID?19 vaccine in an elderly patient |
09/05/2021 |
9858 |
Covid-19- Sputnik vaccine rockets, thanks to Lancet boost |
09/05/2021 |
9857 |
Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China—More Detailed Studies Are Needed |
09/05/2021 |
9856 |
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers |
09/05/2021 |
9855 |
Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures |
09/05/2021 |
9854 |
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab |
09/05/2021 |
9853 |
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce |
09/05/2021 |
9852 |
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway- population based cohort study |
09/05/2021 |
9851 |
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients |
09/05/2021 |
9850 |
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients |
09/05/2021 |
9849 |
An integrated understanding of long-term sequelae after acute COVID-19 |
09/05/2021 |
9848 |
An Inside Look at a Post–COVID-19 Clinic |
09/05/2021 |
9847 |
Admission criteria and management of critical care patients in a pandemic context- position of the Ethics Commission of the French Intensive Care Society, update of April 2021 |
09/05/2021 |
9846 |
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients |
09/05/2021 |
9845 |
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation- a prospective study |
09/05/2021 |
9844 |
Vaccination anti-COVID-19 la HAS recommande une stratégie de «cocooning» |
09/05/2021 |
9843 |
Un premier registre sur la FA au Maghreb |
09/05/2021 |
9842 |
Transmission du SARS-CoV-2 de la chauve-souris à l’homme l’ANSES explore l’hypothèse de la zoonose |
09/05/2021 |
9841 |
Thrombose et saignement après la vaccination contre le covid-19 Oxford-AstraZeneca – Le BMJ |
09/05/2021 |
9840 |
Prévalence de la maladie cardiovasculaire au cours du diabète _ deux études françaises |
09/05/2021 |
9839 |
Pas de danger pour le cœur des donneurs de rein |
09/05/2021 |
9838 |
Non, les AINS ne rendent pas plus « susceptibles » à la Covid-19 ! |
09/05/2021 |
9837 |
Le surpoids, une grosse part dans le risque de Covid-19 grave |
09/05/2021 |
9836 |
Le nouveau DMP amélioré «Mon espace santé» sera-t-il un concurrent sérieux pour Doctolib |
09/05/2021 |
9835 |
Le nouveau DMP amélioré «Mon espace santé» sera-t-il un concurrent sérieux pour Doctolib _ _ Univadis |
09/05/2021 |
9834 |
Dix arguments pour une transmission aéroportée du virus de la Covid-19 |
09/05/2021 |
9833 |
Diagnostic du Covid-19 en milei ambulatoire RMS2021 |
09/05/2021 |
9832 |
Diabète de type 2 et risque cardiovasculaire _ intérêt du score calcique et rôle du tissu adipeux épicardique |
09/05/2021 |
9831 |
Dépistage de masse du Covid-19 quelles leçons tirer des récentes expériencesRMS2021 |
09/05/2021 |
9830 |
Dépistage de l’infection à SARS-CoV-2 chez les voyageurs RMS2021 |
09/05/2021 |
9829 |
COVID-19 risque d’AVC accru chez les patients hospitalisés |
09/05/2021 |
9828 |
Covid-19 _ ces variants préoccupants anglais, sud-africain et brésilien qui circulent en Europe – Réalités Biomédicales |
09/05/2021 |
9827 |
Covid-19 dans le genre on peut faire mieux RMS2021 |
09/05/2021 |
9826 |
Consultation des voyageurs en temps de pandémie de Covid-19évolution des pratiques et rôle sentinelle RMS2021 |
09/05/2021 |
9825 |
Centre Winton de Cambridge |
09/05/2021 |
9824 |
COVID-19 – LA BREVE |
09/05/2021 |
9823 |
Attestations de vaccination certifiées pour voyager comment ça marche |
09/05/2021 |
9822 |
Acné sévère et isotrétinoïne durcissement des recommandations |
09/05/2021 |
9821 |
Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August–September, 2020 |
04/05/2021 |
9820 |
Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients |
04/05/2021 |
9819 |
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 |
04/05/2021 |
9818 |
Understanding Risk for Newborns Born to SARS-CoV-2–Positive Mothers |
04/05/2021 |
9817 |
Un premier registre sur la FA au Maghreb |
04/05/2021 |
9816 |
Transmission of SARS-CoV-2 on a Patient Transport Van |
04/05/2021 |
9815 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY)- a randomised, controlled, open-label, platform trial |
04/05/2021 |
9814 |
Tocilizumab in COVID-19- some clarity amid controversy |
04/05/2021 |
9813 |
Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) |
04/05/2021 |
9812 |
Thromboprophylaxie pharmacologique chez les patients hospitaliss pour une affection mdicale aigu |
04/05/2021 |
9811 |
The evolving cardiac lymphatic vasculature in development, repair and regeneration |
04/05/2021 |
9810 |
The changing landscape of atherosclerosis |
04/05/2021 |
9809 |
SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection |
04/05/2021 |
9808 |
Sarilumab in patients admitted to hospital with severe or critical COVID-19- a randomised, double-blind, placebo-controlled, phase 3 trial |
04/05/2021 |
9807 |
Sakr2021_Article_CamostatMesylateTherapyInCriti |
04/05/2021 |
9806 |
Safety of Apixaban for Cancer-Associated Thrombosis TN2021 |
04/05/2021 |
9805 |
Response to- ‘Correspondence on ‘Onset of rheumatoid arthritis after COVID-19- coincidence or connected_’’ by Roongta et al |
04/05/2021 |
9804 |
Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing |
04/05/2021 |
9803 |
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS |
04/05/2021 |
9802 |
Propositions-GFHT-argatroban_2021-04-29-1 |
04/05/2021 |
9801 |
Prise en charge diagnostique et thérapeutique des séquelles à moyen et long termes liées à l’infection COVID |
04/05/2021 |
9800 |
Post-covid syndrome in individuals admitted to hospital with covid-19_ retrospective cohort study |
04/05/2021 |
9799 |
Overview of SARS-CoV-2 infection in adults living with HIV |
04/05/2021 |
9798 |
OP-EHEA210155 1..12 |
04/05/2021 |
9797 |
One in every three COVID-19 reinfections result in hospitalization in the US |
04/05/2021 |
9796 |
Neuropathies aiguës sévères induites par l’infection à SARS-CoV-2 |
04/05/2021 |
9795 |
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients |
04/05/2021 |
9794 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 2 |
04/05/2021 |
9793 |
In-hospital fatality and venous thromboembolism during the first |
04/05/2021 |
9792 |
First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection |
04/05/2021 |
9791 |
Epidemiology and management of aortic disease_ aortic aneurysms and acute aortic syndromes |
04/05/2021 |
9790 |
Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel |
04/05/2021 |
9789 |
Disease severity and durability of the SARS-CoV-2 antibody response- A view through the lens of the second year of the pandemic |
04/05/2021 |
9788 |
Development and validation of the long COVID symptom and impact tools, a set of patient- reported instruments constructed from patients’ lived experience |
04/05/2021 |
9787 |
Covid-19- Wider use of FFP3 masks may be needed because of airborne transmission, say scientific advisers |
04/05/2021 |
9786 |
Covid-19- What do we know about airborne transmission of SARS-CoV-2 |
04/05/2021 |
9785 |
Covid19 vaccine janssen lien entre le vaccin et la survenue de thromboses en association avec une thrombocytopénie |
04/05/2021 |
9784 |
COVID-19 severity and obesity- are MAIT cells a factor_ |
04/05/2021 |
9783 |
Covid-19 et AVCassociés ou non |
04/05/2021 |
9782 |
Could a good night’s sleep improve COVID-19 vaccine efficacy_ |
04/05/2021 |
9781 |
Confronting COVID-19-associated cough and the post-COVID syndrome- role of viral neurotropism, neuroinflammation, and neuroimmune responses |
04/05/2021 |
9780 |
Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients(SWIVTER)TH2021 |
04/05/2021 |
9779 |
Clinical Features and Outcome of Thrombotic Microangiopathies Comparison between Patients with and without MalignancyTH2021 |
04/05/2021 |
9778 |
Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures |
04/05/2021 |
9777 |
Associations between body-mass index and COVID-19 severity in 6·9 million people in England- a prospective, community-based, cohort study |
04/05/2021 |
9776 |
Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes |
04/05/2021 |
9775 |
Association between cardiovascular risk factors and colorectal cancer_ A systematic review and meta-analysis of prospective cohort studies |
04/05/2021 |
9774 |
Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine |
04/05/2021 |
9773 |
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients |
04/05/2021 |
9772 |
Age-dependent immune response to the Biontech_Pfizer BNT162b2 COVID-19 vaccination |
04/05/2021 |
9771 |
Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men |
04/05/2021 |
9770 |
Y a-t-il un médicament pour empêcher la Covid-19 _ Pas vraiment… |
02/05/2021 |
9769 |
Webinar SFAV 20 mai 2021 Programme |
02/05/2021 |
9768 |
Validation of the Global Limb Anatomic Staging System in first-time lower extremity revascularization |
02/05/2021 |
9767 |
Vaccination contre la covid-19scomment déclarer les effets indésirables |
02/05/2021 |
9766 |
Vaccination anti-Covid-19 et cancer _ ne pas espacer les doses ! |
02/05/2021 |
9765 |
Un médicament contre la polyarthrite rhumatoïde pourrait atténuer les lésions myocardiques liées aux STEMI aigus |
02/05/2021 |
9764 |
Timing and characteristics of venous thromboembolism after noncancer surgery. Results from the RIETE registry |
02/05/2021 |
9763 |
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms |
02/05/2021 |
9762 |
Syndrome de Sjögren primitif, les spondyloarthrites ne sont pas rares |
02/05/2021 |
9761 |
Suivi des cas d’effets indésirables des vaccins COVID-19 |
02/05/2021 |
9760 |
Society for Vascular Surgery implementation of clinical practice guidelines for patients with an abdominal aortic aneurysm_ Repair of an abdominal aortic aneurysm |
02/05/2021 |
9759 |
Serum Vitamin D, Calcium, and Zinc Levels in Patients with COVID-19 |
02/05/2021 |
9758 |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine |
02/05/2021 |
9757 |
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 |
02/05/2021 |
9756 |
Reliability of preoperative venous mapping ultrasonography in predicting for autogenous arteriovenous fistula maturation |
02/05/2021 |
9755 |
Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030_ Time to Get to Our Feet_ A Policy Statement From the American Heart Association |
02/05/2021 |
9754 |
Rapid progression of carotid stenosis was rare in a large integrated healthcare system during an eight-year period |
02/05/2021 |
9753 |
Pulmonary ultrasound in the diagnosis and monitorization of coronavirus disease (COVID-19)- a systematic review |
02/05/2021 |
9752 |
Propositions-GFHT-argatroban_2021-04-29-1 |
02/05/2021 |
9751 |
Prophylaxis against covid-19_ living systematic review and network meta-analysis |
02/05/2021 |
9750 |
Prise en charge diagnostique et thérapeutique des séquelles à moyen et long termes liées à l’infection COVID |
02/05/2021 |
9749 |
Prise en charge chirurgicale du lymphoedème selon la littérature actuelle |
02/05/2021 |
9748 |
Preparing for the Future — Nanobodies for Covid-19 |
02/05/2021 |
9747 |
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons |
02/05/2021 |
9746 |
Post-covid syndrome in individuals admitted to hospital with covid-19_ retrospective cohort study |
02/05/2021 |
9745 |
Post-COVID seizure |
02/05/2021 |
9744 |
Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations |
02/05/2021 |
9743 |
Parlons de la détresse morale des médecins face aux décisions de fin de vie |
02/05/2021 |
9742 |
Ocytocine _ stop ou encore _ Difficile de trancher… |
02/05/2021 |
9741 |
Obesity and Cardiovascular Disease_ A Scientific Statement From the American Heart Association |
02/05/2021 |
9740 |
note_conseil_scientifique_23_avril_2021 |
02/05/2021 |
9739 |
Neuropathies aiguës sévères induites par l’infection à SARS-CoV-2 |
02/05/2021 |
9738 |
Mayo_et_al-2019-Intensive_Care_Medicine |
02/05/2021 |
9737 |
Long COVID- An overview |
02/05/2021 |
9736 |
Les promesses de Janssen, petit dernier des vaccins contre la Covid-19 |
02/05/2021 |
9735 |
L’inactivité physique, facteur de risque de Covid-19 grave |
02/05/2021 |
9734 |
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease |
02/05/2021 |
9733 |
jth.15341 |
02/05/2021 |
9732 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 |
02/05/2021 |
9731 |
Impaired adhesion of neutrophils expressing Slc44a2 HNA-3b to VWF protects against NETosis under venous shear rates |
02/05/2021 |
9730 |
Fruit and Vegetable Intake and Mortality |
02/05/2021 |
9729 |
Fatal adverse drug reactions_ A worldwide perspective in the World Health Organization pharmacovigilance database |
02/05/2021 |
9728 |
Familial Hypercholesterolemia |
02/05/2021 |
9727 |
Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines |
02/05/2021 |
9726 |
Encéphalopathie aiguë et Covid-19 |
02/05/2021 |
9725 |
emas-conclusion-on-janssen-vaccine-and-blood-clots |
02/05/2021 |
9724 |
E-health StandingTall balance exercise for fall prevention in older people_ results of a two year randomised controlled trial |
02/05/2021 |
9723 |
Dynamic carotid plaque imaging using ultrasonography |
02/05/2021 |
9722 |
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients a randomized, double-blinded multicenter phase 2 trial |
02/05/2021 |
9721 |
Des troubles neuropsychiatriques 6 mois après une Covid-19 |
02/05/2021 |
9720 |
Cytokine Storm REP |
02/05/2021 |
9719 |
COVID-19-associated coagulopathy and antithrombotic agents |
02/05/2021 |
9718 |
Covid-19 et vaccination des enfants, le temps du débat |
02/05/2021 |
9717 |
Covid-19 et AVCassociés ou non |
02/05/2021 |
9716 |
 |
02/05/2021 |
9715 |
Covid-19 et AVCassociés ou non |
02/05/2021 |
9714 |
COVID-19 dynamics after a national immunization program in Israel |
02/05/2021 |
9713 |
COVID-19 and Thrombosis in Cancer Patients_ The Clot Thickens – Icthic Magazine |
02/05/2021 |
9712 |
COVID-19 and haemostasis a position paper rom Italian Society on Thrombosis and Haemostasis (SISET) |
02/05/2021 |
9711 |
COVID-19 and Emissions An Opportunity for sustainable global health |
02/05/2021 |
9710 |
Covid-19 _ sécurité des vaccins à ARNm pour les femmes enceintes |
02/05/2021 |
9709 |
COVID-19 _ Pourquoi l’immunité naturelle collective est un leurre _ santé log |
02/05/2021 |
9708 |
COVID long la HAS répond aux questions des médecins de ville |
02/05/2021 |
9707 |
 |
02/05/2021 |
9706 |
Contraceptif oral à base d’estétrol une pilule de 5ème génération |
02/05/2021 |
9705 |
conseil-scientifique-22_avril 2021 |
02/05/2021 |
9704 |
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures |
02/05/2021 |
9703 |
Clinical prediction rules in practice |
02/05/2021 |
9702 |
Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management a meta-analysis |
02/05/2021 |
9701 |
Carotid endarterectomy remains safe in high-risk patients |
02/05/2021 |
9700 |
Bulletin épidémiologique – Semaine 16 – Du Côté de la Science |
02/05/2021 |
9699 |
avis_conseil_scientifique_16_avril_2021 |
02/05/2021 |
9698 |
Asymptomatic carotid artery stenosis is associated with cerebral hypoperfusion |
02/05/2021 |
9697 |
Association of Guillain-Barre syndrome with COVID-19 infection- An updated systematic review |
02/05/2021 |
9696 |
Association of Facial Paralysis With mRNA COVID-19 Vaccines_ A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database |
02/05/2021 |
9695 |
Anticoagulation et fragilité osseuse quelles implications pour la pratique clinique |
02/05/2021 |
9694 |
Anesthésie quels progrès pour une meilleure récupération des patients |
02/05/2021 |
9693 |
After coronavirus vaccine failures, France laments the state of its biomedical R&D _ Science _ AAAS |
02/05/2021 |
9692 |
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication |
02/05/2021 |
9691 |
Advancing President Biden’s Equity Agenda — Lessons from Disparities Work |
02/05/2021 |
9690 |
A systematic review and meta-analysis of the diagnostic accuracy of point-of-care tests used to establish the presence of peripheral arterial disease in people with diabetes |
02/05/2021 |
9689 |
A Risk Score for Iliofemoral DVT Patients |
02/05/2021 |
9688 |
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2 |
22/04/2021 |
9687 |
Suicide trends in the early months of the COVID-19 pandemic- an interrupted time-series analysis of preliminary data from 21 countries |
22/04/2021 |
9686 |
Successful treatment of vaccine?induced prothrombotic immune thrombocytopenia (VIPIT) |
22/04/2021 |
9685 |
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera_compressed |
22/04/2021 |
9684 |
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults- a prospective cohort study |
22/04/2021 |
9683 |
SARS-CoV-2 reinfection in a closed setting- lessons for the community |
22/04/2021 |
9682 |
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes |
22/04/2021 |
9681 |
Saliva as a gold-standard sample for SARS-CoV-2 detection |
22/04/2021 |
9680 |
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma |
22/04/2021 |
9679 |
Recombinant protein vaccines against SARS-CoV-2 |
22/04/2021 |
9678 |
Rate of Suicide Among Women Nurses Compared With Women in the General Population Before the COVID-19 Global Pandemic |
22/04/2021 |
9677 |
Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination |
22/04/2021 |
9676 |
Presence of antiphospholipid antibodies in COVID-19- a case series study |
22/04/2021 |
9675 |
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes- a nationwide observational study in England |
22/04/2021 |
9674 |
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination |
22/04/2021 |
9673 |
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials_ |
22/04/2021 |
9672 |
Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19 |
22/04/2021 |
9671 |
Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission |
22/04/2021 |
9670 |
Getting hands on a drug for Covid-19- Inhaled and Intranasal Niclosamide |
22/04/2021 |
9669 |
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals |
22/04/2021 |
9668 |
Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham- The VICE and DICE scores |
22/04/2021 |
9667 |
Effect of anakinra on mortality in COVID-19- a patient level meta-analysis |
22/04/2021 |
9666 |
Durability of immunity to SARS-CoV-2 and other respiratory viruses |
22/04/2021 |
9665 |
Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19 |
22/04/2021 |
9664 |
Covid-19_ Vaccine woes highlight vital role of traditional public health |
22/04/2021 |
9663 |
Covid-19_ Colleges publish guidance after patients attend emergency departments with vaccine concerns |
22/04/2021 |
9662 |
COVID-19 in patients with rheumatological diseases treated with anti-TNF |
22/04/2021 |
9661 |
COVID-19 herd immunity by immunisation- are children in the herd |
22/04/2021 |
9660 |
COVID-19 dynamics after a national immunization program in Israel |
22/04/2021 |
9659 |
COVID-19 and hypertension- risks and management. A scientific statement on behalf of the British and Irish Hypertension Society |
22/04/2021 |
9658 |
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland_ prospective cohort study of 55 schools |
22/04/2021 |
9657 |
CARA COVID Airborne Risk Assessment |
22/04/2021 |
9656 |
Bulletin épidémiologique – Semaine 15 – Du Côté de la Science |
22/04/2021 |
9655 |
Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination |
22/04/2021 |
9654 |
avis_conseil_scientifique_16_avril_2021 LE VARIANT « BRESILIEN » P1 ANTICIPER POUR L’ETE |
22/04/2021 |
9653 |
Association between living with children and outcomes from covid-19_ OpenSAFELY cohort study of 12 million adults in England |
22/04/2021 |
9652 |
ac_2021_0026_tests_ag_automatises_sars-cov-2 |
22/04/2021 |
9651 |
A guideline to limit indoor airborne transmission of COVID-19 |
22/04/2021 |
9650 |
A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR |
22/04/2021 |
9649 |
Vaccin Janssen coup d’arrêt au déploiement de la vaccination |
19/04/2021 |
9648 |
Ten things to know about ten cardiovascular disease risk factors_compressed |
19/04/2021 |
9647 |
Réponses immunes à une dose de vaccin administrée après un covid – Revue Médicale Suisse |
19/04/2021 |
9646 |
Ramadan et vaccination contre la Covid-19, dissiper toute inquiétude |
19/04/2021 |
9645 |
Prise_en_charge_en_urgence_TVC_contexte_vaccination_anticovid_SFNV_SFMV_GFHT_ANARLF_SFNR_GIHP_02042021 |
19/04/2021 |
9644 |
Où les inégalités sociales pèsent plus sur la santé que l’hygiène de vie ! |
19/04/2021 |
9643 |
NOVAVX Vaccin |
19/04/2021 |
9642 |
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials |
19/04/2021 |
9641 |
Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus |
19/04/2021 |
9640 |
Literature review of distal deep vein thrombosis |
19/04/2021 |
9639 |
Les aléas de la vaccination Covid-19 chez les patients atteints d’hémopathie maligne |
19/04/2021 |
9638 |
In-Hospital Risks and Management of Deep Venous Thrombosis According to Location of the Thrombus |
19/04/2021 |
9637 |
How medical AI devices are evaluated_ limitations and recommendations from an analysis of FDA approvals_compressed |
19/04/2021 |
9636 |
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality |
19/04/2021 |
9635 |
Fièvre d’origine indéterminée cheval, zèbre ou licorne RMS2021 |
19/04/2021 |
9634 |
Euthanasie et suicide assisté. Vision comparative et réflexive entre la Belgique et la Suisse |
19/04/2021 |
9633 |
Effect of Low-Intensity vs High-Intensity Home-BasedWalking Exercise On Walk Distance in Patients With Peripheral Artery Disease |
19/04/2021 |
9632 |
Echappement vaccinal _ sortez vos cahiers de maths ! |
19/04/2021 |
9631 |
Digital Ulcers in Systemic Sclerosis_compressed |
19/04/2021 |
9630 |
Critical limb ischemia |
19/04/2021 |
9629 |
Covid-19 _ ce qu’il faut savoir sur le variant brésilien P.1 – Réalités Biomédicales |
19/04/2021 |
9628 |
Contraception and Reproductive Planning for Women With Cardiovascular Disease_compressed |
19/04/2021 |
9627 |
Catheter related thrombosis in hospitalized infants_ A neural network approach to predict risk factors_compressed |
19/04/2021 |
9626 |
Canagliflozin impedes ischemic hind-limb recovery in the setting of diabetes_compressed |
19/04/2021 |
9625 |
Blood type biochemistry and human disease |
19/04/2021 |
9624 |
Between a Rock and a Hard Place Clinical and Imaging Features of Vascular Compression Syndromes1 |
19/04/2021 |
9623 |
Association of Intravenous Radiocontrast With Kidney Function_A Regression Discontinuity Analysis (2) |
19/04/2021 |
9622 |
Apixaban in low?weight patients with cancer?associated thrombosis_ A cross sectional study of drug levels |
19/04/2021 |
9621 |
Allergie aux œufs chez l’enfant et l’adulte |
19/04/2021 |
9620 |
A guideline to limit indoor airborne transmission of covid-19 |
19/04/2021 |
9619 |
2021-04_has_avis_2eme_dose_vaccin_post_az_-_55_ans |
19/04/2021 |
9618 |
Vaccins contre le Covid-19 cibles vaccinales, immunogénicité et réactions allergiques |
11/04/2021 |
9617 |
Antiphospholipid antibodies in patients with COVID |
11/04/2021 |
9616 |
Viable SARS-CoV-2 Shedding |
11/04/2021 |
9615 |
Vaccins contre la COVID19 grossesse et allaitement |
11/04/2021 |
9614 |
Vaccin AstraZeneca et accidents thromboemboliques … |
11/04/2021 |
9613 |
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination |
11/04/2021 |
9612 |
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination |
11/04/2021 |
9611 |
Thread by E_BotelhoNevers on Thread Reader App – Thread Reader App_compressed |
11/04/2021 |
9610 |
The Potential Future of the COVID-19 Pandemic Will SARS-CoV-2 Become a Recurrent Seasonal Infection_ |
11/04/2021 |
9609 |
Systematic Duplex Ultrasound Screening in Conventional Units for COVID-19 Patients with Follow-up of 5 Days |
11/04/2021 |
9608 |
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers |
11/04/2021 |
9607 |
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization |
11/04/2021 |
9606 |
Suivi des cas d’effets indésirables des vaccins COVID-19 |
11/04/2021 |
9605 |
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines |
11/04/2021 |
9604 |
Rapport-9-moderna-vfa |
11/04/2021 |
9603 |
rapport N08 covid-19-vaccine-astrazeneca-08-04 |
11/04/2021 |
9602 |
Questions autour de la vaccination contre la Covid_DW MAS GP310321RevPNg-VS-CJ-1+DL |
11/04/2021 |
9601 |
Publics prioritaires – 2021.03.26 |
11/04/2021 |
9600 |
Preparing for the Future — Nanobodies for Covid-19 |
11/04/2021 |
9599 |
Post-Discharge Thromboembolic Outcomes and Mortality of Hospitalized COVID-19 Patients- The CORE-19 Registry |
11/04/2021 |
9598 |
Post-covid syndrome in individuals admitted to hospital with covid-19- retrospective cohort study |
11/04/2021 |
9597 |
Placental growth factor level in plasma predicts COVID?19 severity and in?hospital mortality_compressed |
11/04/2021 |
9596 |
Persistent symptoms and association with inflammatory cytokine signatures in recovered COVID-19 patients |
11/04/2021 |
9595 |
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2 |
11/04/2021 |
9594 |
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 |
11/04/2021 |
9593 |
MICI et Covid-19, des écueils pour le traitement et la vaccination |
11/04/2021 |
9592 |
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots – GOV.UK |
11/04/2021 |
9591 |
MHRA émet de nouveaux conseils, concluant un lien possible entre le vaccin COVID-19 AstraZeneca et des caillots sanguins extrêmement rares et peu probables – GOV.UK |
11/04/2021 |
9590 |
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021 _ Euro |
11/04/2021 |
9589 |
Mechanisms of thrombosis and cardiovascular complications in COVID-19 |
11/04/2021 |
9588 |
Linked electronic health records for research on a nationwide cohort of more than 54 million people in England- data resource |
11/04/2021 |
9587 |
La vaccination obligatoire, «nécessaire dans une société démocratique», estime la CEDH – Le Parisien |
11/04/2021 |
9586 |
Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults |
11/04/2021 |
9585 |
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California |
11/04/2021 |
9584 |
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis |
11/04/2021 |
9583 |
haemagglutination test for rapid detection of antbodies of Sars Cov 2 s41467-021-22045-y |
11/04/2021 |
9582 |
Four cases of aortic thrombosis in patients with COVID-19 |
11/04/2021 |
9581 |
Escaping Catch-22 — Overcoming Covid Vaccine Hesitancy |
11/04/2021 |
9580 |
Enquête de pharmacovigilance du vaccin Pfizer – BioNTech Comirnaty |
11/04/2021 |
9579 |
EN DIRECT N°4 VACCINATION COVID – 9 avril 2021 |
11/04/2021 |
9578 |
Digital Health Passes in the Age of COVID-19 Are “Vaccine Passports” Lawful and Ethical_ |
11/04/2021 |
9577 |
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) |
11/04/2021 |
9576 |
Creactive protein predicts outcome in COVID-19- is it also a therapeutic target__compressed |
11/04/2021 |
9575 |
Covid-19- What do we know about Sputnik V and other Russian vaccines_2 |
11/04/2021 |
9574 |
Covid-19- Middle aged women face greater risk of debilitating long term symptoms2 |
11/04/2021 |
9573 |
Covid-19 et transplantation pulmonaire _ sur quels critères __compressed |
11/04/2021 |
9572 |
COVID-19 47% de réinfections chez les plus de 65 ans, dans une étude danoise |
11/04/2021 |
9571 |
Covid-19 _ bon sang ne saurait mentir _ |
11/04/2021 |
9570 |
Bulletin épidémiologique semaine 13 |
11/04/2021 |
9569 |
Biomarkers of coagulation, endothelial function and fibrinolysis in critically?ill patients with COVID?19_ A single?centre prospective longitudinal study |
11/04/2021 |
9568 |
Avis N 2021.0027_ac_seesp_8_avril_2021_college_has_concernant_le_type_de_vaccin_a_utiliser_pour_la_seconde_dose_chez_les_pers |
11/04/2021 |
9567 |
Avis relatif à l’éviction des professionnels positifs au SARS-CoV-2 travaillant en établissements de santé ou en établissements médico-sociaux |
11/04/2021 |
9566 |
Avis relatif à l’actualisation des recommandations thérapeutiques pour la prise en charge du Covid-19 (tocilizumab et anticorps monoclonaux) |
11/04/2021 |
9565 |
Aux Etats-Unis, une nouvelle vague malgré les vaccins |
11/04/2021 |
9564 |
AstraZeneca’s COVID-19 vaccine_ EMA finds possible link to very rare cases of unusual blood clots wi |
11/04/2021 |
9563 |
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population |
11/04/2021 |
9562 |
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine |
11/04/2021 |
9561 |
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1_compressed |
11/04/2021 |
9560 |
A living WHO guideline on drugs for covid-19 |
11/04/2021 |
9559 |
Quelles sont les particularits thrapeutiques-de la MVTE au cours du cancer |
08/04/2021 |
9558 |
Quelles sont les particularits thrapeutiques |
08/04/2021 |
9557 |
Quelles sont les particularités thérapeutiques de la maladie veineuse thrombo-embolique au cours de la grossesse et du post-partum |
08/04/2021 |
9556 |
Quel parcours de soins proposer aux patients atteints d’une embolie pulmonaire Quels malades traiter en ambulatoire |
08/04/2021 |
9555 |
Quel parcours de soins proposer aux patients avec une th 2021 |
08/04/2021 |
9554 |
Questions autour de la vaccination contre la Covid_DW MAS GP310321RevPNg-VS-CJ-1+DL |
08/04/2021 |
9553 |
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines |
08/04/2021 |
9552 |
Recommandations-de-bonne-pratique-pour-la-prise-en-charge_2021_Revue-des-Mal |
08/04/2021 |
9551 |
Réponses rapides dans le cadre de la COVID-19 Prise en charge de premier recours des patients suspectés de Covid-19 |
08/04/2021 |
9550 |
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran- a population-based cross-sectional study |
08/04/2021 |
9549 |
Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19 |
08/04/2021 |
9548 |
Suis-je-contagieux-Ai-je-ete-infecte-Repondre-par-les-autotests-en-temps-de-Covid-19 |
08/04/2021 |
9547 |
Syndrome prolongé de la Covid-19 _ le point avec le Pr Dominique Salmon-Céron (vidéo) |
08/04/2021 |
9546 |
Quelles sont les particularits thrapeutiques au co 2021 |
08/04/2021 |
9545 |
Syndrome prolongé de la Covid-19 _ le point avec le Pr Dominique Salmon-Céron (vidéo) |
08/04/2021 |
9544 |
The COVID-GRAM Tool for Patients Hospitalized With COVID-19 in Europe |
08/04/2021 |
9543 |
The Leading Causes of Death in the US for 2020 |
08/04/2021 |
9542 |
Thread by @E_BotelhoNevers on Thread Reader App – Thread Reader App |
08/04/2021 |
9541 |
Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia |
08/04/2021 |
9540 |
Tocilizumab in Treatment for PatientsWith COVID-19 |
08/04/2021 |
9539 |
Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System |
08/04/2021 |
9538 |
vaccins contre la covid grossesse et constipation |
08/04/2021 |
9537 |
Venous thromboembolism in COVID-19 systematic review of reported risks and current guidelines |
08/04/2021 |
9536 |
Verified infections with endemic common cold coronaviruses do not entail significant protection against SARS-CoV-2 |
08/04/2021 |
9535 |
Vers un certificat sanitaire européen pour la mi-juin |
08/04/2021 |
9534 |
Vitamine B12 en pratique quand tester Comment tester Et qui substituer |
08/04/2021 |
9533 |
Why indoor spaces are still prime COVID hotspots |
08/04/2021 |
9532 |
Quelles sont les modalits du traitement anticoagulant in 2021 |
08/04/2021 |
9531 |
Quelles sont les indications et les modalits de la repe 2021 |
08/04/2021 |
9530 |
Quelles sont les indications et les modalits de la rep 2021 |
08/04/2021 |
9529 |
Quelles sont les indications du filtre ca 2021 |
08/04/2021 |
9528 |
Quelle est la prise en charge des thromboses veineuses 2021 |
08/04/2021 |
9527 |
Quelle est la prise en charge des thromboses veineu 2021 |
08/04/2021 |
9526 |
Quelle est la prise en charge des thromboses vein 2021 |
08/04/2021 |
9525 |
Quelle est la prise en charge des embolies pulmon 2021 |
08/04/2021 |
9524 |
Quel-bilan–tiologique-r-aliser-au-d-cours-d-_2021_Revue-des-Maladies-Respir |
08/04/2021 |
9523 |
Quand-et-comment-rechercher-un-syndrome-post-thrombotique-_2021_Revue-des-Ma |
08/04/2021 |
9522 |
Quand-et-comment-rechercher-une-hypertension-pulmonaire-_2021_Revue-des-Mala |
08/04/2021 |
9521 |
Publics prioritaires – 2021.03.26 |
08/04/2021 |
9520 |
PrEP un implant d’islatravir pourrait offrir une protection d’un an |
08/04/2021 |
9519 |
Post-covid syndrome in individuals admitted to hospital with covid-19- retrospective cohort study |
08/04/2021 |
9518 |
Obésité et Covid-19 RMS2021 |
08/04/2021 |
9517 |
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications |
08/04/2021 |
9516 |
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination |
08/04/2021 |
9515 |
Multiple Biomarker Approach to Risk Stratification in COVID-19 |
08/04/2021 |
9514 |
Moins de formes asymptomatiques de Covid-19 parmi les vaccinés… |
08/04/2021 |
9513 |
Lung fibrosis- an undervalued finding in COVID-19 pathological series |
08/04/2021 |
9512 |
Le lipœdème?une entité méconnue RMS 2021 |
08/04/2021 |
9511 |
La prévention de la Covid-19, une barrière aux autres infections et vaccinations |
08/04/2021 |
9510 |
jamainternal_salvarani_2021_lr_210005_1617294326.97511 |
08/04/2021 |
9509 |
jamainternal_hermine_2021_lr_210006_1617294325.98774-2 |
08/04/2021 |
9508 |
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine |
08/04/2021 |
9507 |
Infection par le SARS-CoV-2 et manifestations cutanées |
08/04/2021 |
9506 |
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California |
08/04/2021 |
9505 |
Incidence and mortality due to thromboembolic events during the COVID-19 pandemic_ Multi-sourced population-based health records cohort study |
08/04/2021 |
9504 |
Impact of the COVID-19 Vaccine on Asymptomatic Infection |
08/04/2021 |
9503 |
Immunothérapie dans la SEP, une victoire contre le handicap, semble-t-il |
08/04/2021 |
9502 |
Immunothérapie dans la SEP, une victoire contre le handicap, semble-t-il |
08/04/2021 |
9501 |
avis relatif à l’actualisation des recommandations thérapeutiques pour la prise en charge du Covid-19 (tocilizumab et anticorps monoclonaux) |
08/04/2021 |
9500 |
France_ l’ANSM confirme un risque de thrombose rare associé au vaccin AstraZeneca – Le Soir |
08/04/2021 |
9499 |
France 2020 68 000 décès supplémentaires imputables à l’épidémie de Covid-19 |
08/04/2021 |
9498 |
Et voilà pourquoi vous êtes hypertendu ! |
08/04/2021 |
9497 |
Et si la vaccination était bénéfique aux patients atteints de COVID long |
08/04/2021 |
9496 |
Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff- A retrospective, state-wide cohort study |
08/04/2021 |
9495 |
Economie comportementale |
08/04/2021 |
9494 |
Early Release – Novel SARS-CoV-2 Variant Derived from Clade 19B, France – Volume 27, Number 5—May 20 |
08/04/2021 |
9493 |
Double pandémie impact des mesures anti-Covid-19 sur l’obésité |
08/04/2021 |
9492 |
Donor to recipient transmission of SARS?CoV?2 by lung transplantation despite negative donor upper respiratory tract testing |
08/04/2021 |
9491 |
Diabète de type 1la greffe d’îlots pancréatiques en attente de remboursement |
08/04/2021 |
9490 |
Dental procedure aerosols and COVID-19 |
08/04/2021 |
9489 |
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 |
08/04/2021 |
9488 |
CROI 2021 — COVID-19 _ le molnupiravir par voie orale réduit rapidement le virus infectieux _ Univadis |
08/04/2021 |
9487 |
C-reactive protein predicts outcome in COVID-19- is it also a therapeutic target_ |
08/04/2021 |
9486 |
Covid-19, mieux protéger l’école de la République_compressed |
08/04/2021 |
9485 |
COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism |
08/04/2021 |
9484 |
COVID-19 in thrombosis research An editorial perspective_compressed |
08/04/2021 |
9483 |
Covid-19 _ bons échos des vaccins à ARN messager pour la femme enceinte |
08/04/2021 |
9482 |
Coronavirus Occurrence in the HIVE Cohort of Michigan Households- Reinfection frequency and serologic responses to seasonal and SARS coronaviruses |
08/04/2021 |
9481 |
Comment–valuer-le-pronostic-d-une-embolie-pu_2021_Revue-des-Maladies-Respir |
08/04/2021 |
9480 |
Comment-g-rer-les-traitements-anticoagulants-en-cas-de_2021_Revue-des-Maladi |
08/04/2021 |
9479 |
Comment-faire-le-diagnostic-d-une-thrombose-veineu_2021_Revue-des-Maladies-R |
08/04/2021 |
9478 |
Comment-et-chez-qui-faut-il-surveiller-les-traite_2021_Revue-des-Maladies-Re |
08/04/2021 |
9477 |
Cellulite non infectieuse à connaître le syndrome de Wells RMS2021 |
08/04/2021 |
9476 |
CDC report- mRNA COVID-19 vaccines show high efficacy in real-world study |
08/04/2021 |
9475 |
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating varian |
08/04/2021 |
9474 |
Bell’s palsy and SARS-CoV-2 vaccines |
08/04/2021 |
9473 |
Avis-SFM-salive-SARS-CoV-2-V3-_-MAJ-29032021 |
08/04/2021 |
9472 |
Associations between measures of social distancing and SARS-CoV-2 seropositivity- a nationwide population-based study in the Netherlands |
08/04/2021 |
9471 |
Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England- a modelling study |
08/04/2021 |
9470 |
Association between pre-existing respiratory disease and its treatment, and severe COVID-19- a population cohort study |
08/04/2021 |
9469 |
Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2 |
08/04/2021 |
9468 |
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Devic |
08/04/2021 |
9467 |
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 |
08/04/2021 |
9466 |
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 |
08/04/2021 |
9465 |
Anglais, sud-africain ou brésilien, les 3 variants qui inquiètent |
08/04/2021 |
9464 |
Alterations in T and B cell function persist in convalescent COVID-19 patients |
08/04/2021 |
9463 |
Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity |
08/04/2021 |
9462 |
«?Orteils Covid?», expression cutanée d’une résistance innée au SARS-CoV-2 |
08/04/2021 |
9461 |
“Vaccine Passport” Certification — Policy and Ethical Considerations |
08/04/2021 |
9460 |
WHO International Standard for anti-SARS-CoV-2 immunoglobulin |
08/04/2021 |
9459 |
Vitamine B12 en pratique quand tester Comment tester Et qui substituer |
08/04/2021 |
9458 |
Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects |
08/04/2021 |
9457 |
The Open Vein Hypothesis and Postthrombotic Syndrome |
08/04/2021 |
9456 |
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction |
08/04/2021 |
9455 |
The impact of hemoglobin A1c on outcomes after lower extremity bypass |
08/04/2021 |
9454 |
The impact of endovascular treatment on clinical outcomes of stable symptomatic patients with spontaneous superior mesenteric artery dissection |
08/04/2021 |
9453 |
The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease |
08/04/2021 |
9452 |
SVEP1 is a human coronary artery disease locus that promote attherosclerosis 2021_compressed |
08/04/2021 |
9451 |
Suis-je-contagieux-Ai-je-ete-infecte-Repondre-par-les-autotests-en-temps-de-Covid-19 |
08/04/2021 |
9450 |
Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination |
08/04/2021 |
9449 |
Splanchnic vein thrombosisClinical manifestations, risk factors, management, and outcomes_compressed |
08/04/2021 |
9448 |
Society for Vascular Surgery implementation of clinical practice guidelines for patients with an abdominal aortic aneurysm_ Screening for an abdominal aortic aneurysm |
08/04/2021 |
9447 |
ShowMePAD-Brochure-2020 |
08/04/2021 |
9446 |
Short term associations of ambient nitrogen dioxide with daily total, cardiovascular, and respiratory mortality_ multilocation analysis in 398 cities |
08/04/2021 |
9445 |
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate |
08/04/2021 |
9444 |
Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism_compressed |
08/04/2021 |
9443 |
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation_compressed |
08/04/2021 |
9442 |
risk factors for severe outcomes in patients with systemic vasculitis & COVID-19- a bi-national registry-based cohort study_compressed |
08/04/2021 |
9441 |
reponses_rapides_dans_le_cadre_de_la_covid-19_-_demarche_medicale_pour_la_vaccination_contre_la_covid-19__premieres_phases |
08/04/2021 |
9440 |
Relation entre diabète de type 2 etla COVID-19 – les dernières données |
08/04/2021 |
9439 |
Quelles sont les indications du filtre cave |
08/04/2021 |
9438 |
Quelles sont les indications du filtre cave |
08/04/2021 |
9437 |
Quelle est la prise en charge des TVP M.Sup (hors Kc) |
08/04/2021 |
9436 |
Platelet Src family kinasesRPTH2021 |
08/04/2021 |
9435 |
Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification |
08/04/2021 |
9434 |
Oral contraceptives and hormone replacement therapyHow strong a risk factor for venous thromboembolism |
08/04/2021 |
9433 |
Obésité et Covid-19 RMS2021 |
08/04/2021 |
9432 |
Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals |
08/04/2021 |
9431 |
Lipid-lowering therapies in peripheral artery disease_ A review |
08/04/2021 |
9430 |
Les maladies cardiovasculaires et les suicides premières causes de décès maternels en France en 2013-2015 |
08/04/2021 |
9429 |
Le taux de COVID-19 chez les enfants empire |
08/04/2021 |
9428 |
L’ApoB, un bon prédicteur du risque de décès chez les patients traités par statine |
08/04/2021 |
9427 |
Innovation via social media – The importance of Twitter to science |
08/04/2021 |
9426 |
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 |
08/04/2021 |
9425 |
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy |
08/04/2021 |
9424 |
Impact of the influenza vaccine on COVID-19 infection rates and severity |
08/04/2021 |
9423 |
Images in Vascular Medicine_ Usefulness of carotid ultrasonography for diagnosis and management of polymyalgia rheumatica-associated large-vessel vasculitis |
08/04/2021 |
9422 |
France_ l’ANSM confirme un risque de thrombose rare associé au vaccin AstraZeneca – Le Soir |
08/04/2021 |
9421 |
Expression of Interleukin 6 signaling receptors in carotid atherosclerosis_compressed |
08/04/2021 |
9420 |
Efficacy and safety of Apixaban for primary prevention of gastrointestinal cancersTR2021 |
08/04/2021 |
9419 |
Economie comportementale |
08/04/2021 |
9418 |
Double pandémie impact des mesures anti-Covid-19 sur l’obésité |
08/04/2021 |
9417 |
Delaying the second dose of covid-19 vaccines |
08/04/2021 |
9416 |
COVID-19 vaccine response in pregnant and lactating women- a cohort study_compressed |
08/04/2021 |
9415 |
coreb-covidville-23 mars 2021 |
08/04/2021 |
9414 |
coreb-covidhospit-23 mars 2021 |
08/04/2021 |
9413 |
coreb-covidehpad-23 mars 2021 |
08/04/2021 |
9412 |
Clinical relevance of genotype–phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants_compressed |
08/04/2021 |
9411 |
Clinical presentation and outcomes following endovascular management in a mixed pediatric and adult Klippel-Trenaunay Syndrome population |
08/04/2021 |
9410 |
CLINICAL GUIDELINES VS. CURRENT CLINICAL PRACTICE FOR THE MANAGEMENT OF DEEP VEIN THROMBOSIS_ WHERE DO WE STAND_ |
08/04/2021 |
9409 |
Carotid webs management in symptomatic patients |
08/04/2021 |
9408 |
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection |
08/04/2021 |
9407 |
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention |
08/04/2021 |
9406 |
An evidence-based score to detect prevalent peripheral artery disease (PAD) |
08/04/2021 |
9405 |
A significant decrease in D-dimer concentration within one month of anticoagulation therapy TR2021 |
08/04/2021 |
9404 |
2021 Canadian Cardiovascular Society Guidelines for the management dyslipidemia_compressed |
08/04/2021 |
9403 |
Waves of SARS-CoV-2 Infection and Blood TH2021 |
04/04/2021 |
9402 |
Validation of the IMPROVE?DD risk assessment model for venous thromboembolism among hospitalized patients with COVID?19 |
04/04/2021 |
9401 |
Vaccination et Covid 19, un moyen qui ne justifie pas la fin…des mesures barrières |
04/04/2021 |
9400 |
vaccin AZ – thrombose liée a une réponse immunitaire discordante |
04/04/2021 |
9399 |
Vaccin Astra Zeneca _ Communiqué SFMV _ Portail Vasculaire de la SFMV |
04/04/2021 |
9398 |
Update on the safety of COVID-19 Vaccine AstraZeneca |
04/04/2021 |
9397 |
Une adénopathie axillaire après la vaccination contre la Covid-19 _ est-ce le vaccin ou pas |
04/04/2021 |
9396 |
Un étudiant en médecine décède quelques jours après voir reçu le vaccin AstraZeneca, une enquête est en cours _ Le Quotidien du médecin |
04/04/2021 |
9395 |
Troisième vague _ moins d’hospitalisations et de morts, mais des réas toujours saturées |
04/04/2021 |
9394 |
Treatment of unusual thrombotic manifestations |
04/04/2021 |
9393 |
Traitement du SARS-CoV-2 en pédiatrie quelles évidences et quelle utilité |
04/04/2021 |
9392 |
Tout ce que vous voudriez savoir sur le syndrome du Covid-19 long |
04/04/2021 |
9391 |
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report |
04/04/2021 |
9390 |
The Silent Pandemic- Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 |
04/04/2021 |
9389 |
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK- a transmission model-based future scenario analysis and economic evaluation_compressed |
04/04/2021 |
9388 |
The EMA covid-19 data leak, and what it tells us about mRNA instability |
04/04/2021 |
9387 |
Tests et autotests antigéniques nasaux la HAS dit oui à ces tests « moins invasifs » |
04/04/2021 |
9386 |
Tandem high-dose influenza vaccination is associated with more durable |
04/04/2021 |
9385 |
Systematic Review of the Co-Prevalence of Arterial Aneurysms Within the Vasculature |
04/04/2021 |
9384 |
Syndrome de Sjögren du diagnostic au traitement RMS2021 |
04/04/2021 |
9383 |
SVM Communications_ Interview with Writing Committee of Advanced Training Statement on Vascular Medicine and Talking Points from Paclitaxel Coalition |
04/04/2021 |
9382 |
Suspension du vaccin AstraZeneca _ suivisme dangereux et coupable |
04/04/2021 |
9381 |
Surviving COVID-19 After Hospital Discharge- Symptom, Functional, and Adverse Outcomes of Home Health Recipients |
04/04/2021 |
9380 |
Superior Mesenteric Arteriovenous Fistula |
04/04/2021 |
9379 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine_ a pooled analysis of four randomised trials (1)_compressed |
04/04/2021 |
9378 |
Similarities and Perspectives on the two C’s – Cancer and COVID?19_compressed |
04/04/2021 |
9377 |
SFAR-Comite-dethique-Decisions-medicales-d-admission-des-patients-en-unites-de-soins-critiques-en-contexte-pandemique-26-03-20 |
04/04/2021 |
9376 |
Severe covid-19 pneumonia_ pathogenesis and clinical management |
04/04/2021 |
9375 |
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection |
04/04/2021 |
9374 |
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine |
04/04/2021 |
9373 |
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China- a longitudinal, population-level, cross-sectional study |
04/04/2021 |
9372 |
Immunological characteristics govern the transition of COVID-19 to endemicity |
04/04/2021 |
9371 |
SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs)- an active, prospective surveillance study |
04/04/2021 |
9370 |
SARS-CoV-2 et enfants épidémiologie, présentation clinique et contagiosité |
04/04/2021 |
9369 |
Ruptured Abdominal Aortic Aneurysms in Octogenarians_ Are the Outcomes too Dire_ |
04/04/2021 |
9368 |
RMS_730_550 |
04/04/2021 |
9367 |
Risk of SARS-CoV-2 reinfection after natural infection |
04/04/2021 |
9366 |
Research Letter_ Prevalence of COVID-19 risk factors and risks for severe acute respiratory disease markedly higher in patients with symptomatic peripheral arterial occlusive disease |
04/04/2021 |
9365 |
reponses_rapides_dans_le_cadre_de_la_covid-19_-_demarche_medicale_pour_la_vaccination_contre_la_covid-19__premieres_phases_compressed |
04/04/2021 |
9364 |
Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support_ REACT-SCOT case-control study |
04/04/2021 |
9363 |
Relation entre diabète de type 2 etla COVID-19 – les dernières données_compressed |
04/04/2021 |
9362 |
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19_compressed |
04/04/2021 |
9361 |
Qu’attendez-vous de votre prothèse du genou |
04/04/2021 |
9360 |
Proposition-Anticoagulants-Covid-HCL-GEMMAT-V2F-07-11-2020 |
04/04/2021 |
9359 |
Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) |
04/04/2021 |
9358 |
point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-12-03-2021-au-18-03-2021 |
04/04/2021 |
9357 |
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis |
04/04/2021 |
9356 |
Once-Weekly Semaglutide in Adults with Overweight or Obesity |
04/04/2021 |
9355 |
Novavax Completes Enrollment of PREVENT-19, COVID-19 |
04/04/2021 |
9354 |
Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine – Legemiddelverket |
04/04/2021 |
9353 |
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination |
04/04/2021 |
9352 |
Neuroimaging manifestations in children with SARS-CoV-2 infection- a multinational, multicentre collaborative study_compressed |
04/04/2021 |
9351 |
Microthrombi as a Major Cause of Cardiac Injury in COVID-19 |
04/04/2021 |
9350 |
16_Benkirane Les éléments d’une fiche de notification |
04/04/2021 |
9349 |
MARS Message d’Alerte Rapide Sanitaire |
04/04/2021 |
9348 |
Lupus érythémateux systémique et Covid-19 |
04/04/2021 |
9347 |
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence 2021_compressed |
04/04/2021 |
9346 |
Les symptômes musculaires « ordinaires » sous statines, peut-être seulement un effet nocebo |
04/04/2021 |
9345 |
Les maladies cardiovasculaires et les suicides premières causes de décès maternels en France en 2013-2015_compressed |
04/04/2021 |
9344 |
Les idées claires sur le Covid-19 _ l’origine du virus_compressed |
04/04/2021 |
9343 |
Les enjeux pédiatriques autour de la pandémie de Covid-19 |
04/04/2021 |
9342 |
Le variant sud-africain se joue du vaccin AstraZeneca |
04/04/2021 |
9341 |
Le taux de COVID-19 chez les enfants empire |
04/04/2021 |
9340 |
Le groupe A (et AB) rendrait plus vulnérable vis-à-vis de la Covid-19 |
04/04/2021 |
9339 |
Le CNGOF publie ses premières recommandations sur la ménopause 2021 |
04/04/2021 |
9338 |
La suspension d’AstraZeneca trace la route sanitaire de la servitude _ Contrepoints |
04/04/2021 |
9337 |
La connectivite indifférenciée qu’est-ce que c’est |
04/04/2021 |
9336 |
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 |
04/04/2021 |
9335 |
Effect of Intermediate-Dose vs Standard-Dose Prophylactic |
04/04/2021 |
9334 |
Du SARS-CoV-2 et des larmes |
04/04/2021 |
9333 |
Donanémab dans maladie d’Alzheimer débutante, encourageant… |
04/04/2021 |
9332 |
Décrets, arrêtés, circulaires |
04/04/2021 |
9331 |
Davantage de décès avec le « variant anglais » |
04/04/2021 |
9330 |
Covid-19 et SMP _ risque maximal de thromboses veineuses lorsqu’il s’agit de thrombocytémies essentielles |
04/04/2021 |
9329 |
Covid 19, sexe, hormones et immunité |
04/04/2021 |
9328 |
CDC Interim Recommendations for Fully Vaccinated People |
04/04/2021 |
9327 |
Après une Covid-19, une seule dose de vaccin à mARN suffit… |
04/04/2021 |
9326 |
 |
04/04/2021 |
9325 |
Innocuité et efficacité du vaccin oxford-astrazeneca_ analyse intermédiaire de quatre études contrôlées randomisées – Revue Médicale Suisse |
04/04/2021 |
9324 |
Incidence and mortality due to thromboembolic events during the COVID-19 pandemitudy_compressed |
04/04/2021 |
9323 |
Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening |
04/04/2021 |
9322 |
Impact of high dose prophylactic anticoagulation in critically ill patients with COVID-19 pneumonia. Chest. 2021 |
04/04/2021 |
9321 |
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age_ a systematic review and meta-analysis |
04/04/2021 |
9320 |
Impact du Covid-19 sur les enfants et leurs familles |
04/04/2021 |
9319 |
Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures |
04/04/2021 |
9318 |
How to Advise Persons Who Are Antibody Positive for SARS-CoV-2 About Future Infection Risk |
04/04/2021 |
9317 |
hors-serie_ee_covid19 |
04/04/2021 |
9316 |
hcspa20210301_covipriodestestsaliitra |
04/04/2021 |
9315 |
GTH__AstraZeneca_engl._3_22_2021 |
04/04/2021 |
9314 |
Giant Cell Arteritis (GCA)_ Do Not Forget the Aorta! |
04/04/2021 |
9313 |
French recommendations for the management of Behçet’s disease |
04/04/2021 |
9312 |
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 |
04/04/2021 |
9311 |
Fluorodeoxyglucose Positron Emission Tomography_Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis_compressed |
04/04/2021 |
9310 |
Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 |
04/04/2021 |
9309 |
Faudra-t-il vacciner les enfants contre le Covid-19 |
04/04/2021 |
9308 |
Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak_ findings from nationwide mortality registries |
04/04/2021 |
9307 |
Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland |
04/04/2021 |
9306 |
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients |
04/04/2021 |
9305 |
Does “AI” stand for augmenting inequality in the era of covid-19 healthcare_ |
04/04/2021 |
9304 |
document_repere_ethique_ehpad |
04/04/2021 |
9303 |
Does “AI” stand for augmenting inequality in the era of covid-19 healthcare |
04/04/2021 |
9302 |
document_repere_ethique_ehpad |
04/04/2021 |
9301 |
Diagnostic et séroprévalence SARS-CoV-2 chez l’enfant |
04/04/2021 |
9300 |
Dexamethasone in Hospitalized Patients with Covid-19 |
04/04/2021 |
9299 |
Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis |
04/04/2021 |
9298 |
Determinants of Popularity and Natural History of Social Media Accounts in Interventional Cardiology |
04/04/2021 |
9297 |
Crise Covid en Ile-de-France on nous envoie des seaux d’eau alors qu’il faudrait des canadairs! |
04/04/2021 |
9296 |
COVID-19-vaccine-and-Thrombosis-FAQs-March-24-2021 |
04/04/2021 |
9295 |
COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough |
04/04/2021 |
9294 |
COVID-19 Vaccine AstraZeneca_ PRAC investigating cases of thromboembolic events – vaccine’s benefits currently still outweigh risks – Update _ European Medicines Agency |
04/04/2021 |
9293 |
COVID-19 pédiatrique |
04/04/2021 |
9292 |
Covid-19 et chirurgie _ mieux vaut se faire opérer au moins sept semaines après un test PCR positif – Réalités Biomédicales |
04/04/2021 |
9291 |
Covid-19 deaths in Africa_ prospective systematic postmortem surveillance study |
04/04/2021 |
9290 |
COVID-19 _ faut-il augmenter la posologie des anticoagulants _ _ Univadis |
04/04/2021 |
9289 |
COVID-19 _ caractéristiques et facteurs de risque des sujets atteints de trisomie-21 _ Univadis |
04/04/2021 |
9288 |
corecos_fiches_nla_2021_-_score_calcique_et_prevention_de_latherosclerose_cv_2021_03 |
04/04/2021 |
9287 |
coreb-covidehpad-23 mars 2021 |
04/04/2021 |
9286 |
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 |
04/04/2021 |
9285 |
Comparing Safety and Efficacy of Rivaroxaban with Warfarin for Patients after Successful Stent Placement for Chronic Iliofemoral Occlusion_ A Retrospective Single Institution Study |
04/04/2021 |
9284 |
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland- prospective cohort study of 55 schools |
04/04/2021 |
9283 |
Clinical management of COVID-19 patients_ Living guidance, XX January 2021_compressed |
04/04/2021 |
9282 |
Chronic Kidney Disease and Cardiovascular Disease_ A Personalized Approach |
04/04/2021 |
9281 |
Chronic Kidney Disease and Cardiovascular Disease_ A Personalized Approach |
31/03/2021 |
9280 |
Carotid Ulceration in a Young Woman with SAPHO Syndrome |
31/03/2021 |
9279 |
Cardiovascular Disease in Chronic Kidney Disease |
31/03/2021 |
9278 |
Cardiac arrest in COVID-19- characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation _compressed |
31/03/2021 |
9277 |
breve_covid_-_numero_10 |
31/03/2021 |
9276 |
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting |
31/03/2021 |
9275 |
Avis-SFM-salive-SARS-CoV-2-V2-_-MAJ-fev-2021-_-def-21022021 |
31/03/2021 |
9274 |
Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events |
31/03/2021 |
9273 |
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection |
31/03/2021 |
9272 |
Association between living with children and outcomes from covid-19- OpenSAFELY cohort study of 12 million adults in England |
31/03/2021 |
9271 |
Arthritis after SARS- CoV-2 infection |
31/03/2021 |
9270 |
Arterial and venous thromboembolism in COVID-19_ a study-level meta-analysis |
31/03/2021 |
9269 |
Antoine Flahault _ «?Chaque pic de pollution est suivi d’une flambée de Covid-19 et d’hospitalisations?» – Monaco Hebdo |
31/03/2021 |
9268 |
Annexe 3 – Strategie Diagnostic Recherche Act_11488_122 |
31/03/2021 |
9267 |
Annexe 2 – Fiche Strategie Diagnostic Populat_11488_121 |
31/03/2021 |
9266 |
Annexe 1 – COVID-19 Définition de Cas – Lanni_11488_120 |
31/03/2021 |
9265 |
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19_compressed |
31/03/2021 |
9264 |
Acute Ischemic Stroke in Patients With COVID-19 |
31/03/2021 |
9263 |
ac_2021_0015_tdr_trod_autotest_antigeniques_nasal_salivaire_sars-cov-2 |
31/03/2021 |
9262 |
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19 |
31/03/2021 |
9261 |
210224_Boite_decision_Vaccination_Medecin_AZ_VF2 |
31/03/2021 |
9260 |
2019_has_pnds_lymphoedeme_primaire |
31/03/2021 |
9259 |
21.3.8-Obligation-vaccinale-contre-la-Covid-19 |
31/03/2021 |
9258 |
#174 Quelle est l’efficacité des anticorps IV thérapeutiques (ex. bamlanivimab, étesevimab) contre la COVID-19 _ |
31/03/2021 |
9257 |
VALSALVA |
31/03/2021 |
9256 |
Une adénopathie axillaire après la vaccination contre la Covid-19 _ est-ce le vaccin ou pas _ |
31/03/2021 |
9255 |
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A |
31/03/2021 |
9254 |
Supporting patients to be involved in decisions about their health and care_ Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease |
31/03/2021 |
9253 |
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males |
31/03/2021 |
9252 |
Screening for Lung Cancer_ US Preventive Services Task Force Recommendation Statement_compressed |
31/03/2021 |
9251 |
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy |
31/03/2021 |
9250 |
Prognostic significance of concomitant superficial vein thrombosis in patients with deep vein thrombosis of the lower limbs_compressed |
31/03/2021 |
9249 |
Physical activity and living well with kidney disease |
31/03/2021 |
9248 |
note_vaccination_français |
31/03/2021 |
9247 |
NE-SHOT COVID VACCINE GETS US AUTHORIZATION |
31/03/2021 |
9246 |
Microthrombi as a Major Cause of Cardiac Injury in COVID-19 |
31/03/2021 |
9245 |
Manuscript_Complete.docx_compressed |
31/03/2021 |
9244 |
medecins_69 |
31/03/2021 |
9243 |
Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia |
31/03/2021 |
9242 |
L’escalade thérapeutique _ de la diététique aux AC anti-PCSK9_compressed |
31/03/2021 |
9241 |
INCREASING INCIDENCE AND DECLINING MORTALITY AFTER CANCER ASSOCIATED VTE_compressed |
31/03/2021 |
9240 |
Impact of Obesity on Outcomes of Pregnancy in Women With Heart Disease |
31/03/2021 |
9239 |
Impact of high dose prophylactic anticoagulation in critically ill patients with COVID-19 pneumonia. Chest. 2021 |
31/03/2021 |
9238 |
Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality |
31/03/2021 |
9237 |
Des essais à effectif unique comparant une statine à un placebo ne montrent aucun effet sur les symptômes musculaires sévères _ Univadis |
31/03/2021 |
9236 |
Decision-Making in the Management of Venous Thromboembolism_compressed |
31/03/2021 |
9235 |
Covid-19 et chirurgie _ mieux vaut se faire opérer au moins sept semaines après un test PCR positif – Réalités Biomédicales |
31/03/2021 |
9234 |
COVID-19 and the Athlete |
31/03/2021 |
9233 |
Contraception oestro-progestative de 1ère intention _ êtes-vous au clair |
31/03/2021 |
9232 |
accin Moderna _ sensibiliser sur les réactions cutanées d’hypersensibilité retardée |
31/03/2021 |
9231 |
Contrast-enhanced US–guided Interventions- Improving Success Rate and Avoiding Complications Using US Contrast Agents Radiogrpahics 2017 (4)_compressed |
31/03/2021 |
9230 |
Contraception féminine – symptômes, causes, traitements et prévention – VIDAL |
31/03/2021 |
9229 |
Contraception chez la femme à risque cardiovasculaire |
31/03/2021 |
9228 |
Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk_ A network meta-analysis_compressed |
31/03/2021 |
9227 |
Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention A Meta-Analysis of Clinical TrialsJACC2017_compressed |
31/03/2021 |
9226 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY)_ a randomised, controlled, open-label, platform trial |
31/03/2021 |
9225 |
Attributes and predictors of long COVID |
31/03/2021 |
9224 |
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19_compressed |
31/03/2021 |
9223 |
Antiviral drugs in hospitalized patients with COVID-19 – the DisCoVeRy trial |
31/03/2021 |
9222 |
Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome – what is the evidence |
31/03/2021 |
9221 |
ademe_synthese2035-50_010304_compressed |
31/03/2021 |
9220 |
Acute Ischemic Stroke and COVID-19 |
31/03/2021 |
9219 |
Acute Allergic Reactions to mRNA COVID-19 Vaccines |
31/03/2021 |
9218 |
20210305_COVID_Vaccins_Fiche-Synthese_7 |
31/03/2021 |
9217 |
#174 Quelle est l’efficacité des anticorps IV thérapeutiques (ex. bamlanivimab) contre la COVID-19 _ |
31/03/2021 |
9216 |
20210305_COVID_Vaccins_Fiche-Synthese_7 |
31/03/2021 |
9215 |
2021-CCM-Conditions_prescription_pris_charge_inhibiteurs_PCSK9 |
31/03/2021 |
9214 |
21.3.8-Obligation-vaccinale-contre-la-Covid-19 |
31/03/2021 |
9213 |
Un cluster nosocomial d’infections BRETAGNE |
17/03/2021 |
9212 |
Suspension du vaccin AstraZeneca _ suivisme dangereux et coupable |
17/03/2021 |
9211 |
Quand le COVID-19 révèle une maladie du foie |
17/03/2021 |
9210 |
Paul-Ehrlich-Institut – News – The Paul-Ehrlich-Institut informs – Temporary Suspension of Vaccinati |
17/03/2021 |
9209 |
ncentivizing Vaccination Uptake |
17/03/2021 |
9208 |
Lupus érythémateux systémique et Covid-19 |
17/03/2021 |
9207 |
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients |
17/03/2021 |
9206 |
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay |
17/03/2021 |
9205 |
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm |
17/03/2021 |
9204 |
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 |
17/03/2021 |
9203 |
avis_conseil_scientifique_12_fevrier_2021 |
17/03/2021 |
9202 |
Anticiper et differencier les strategies pour sortir des phases aigues de l’epidemie |
17/03/2021 |
9201 |
ac_2021_0015_tdr_trod_autotest_antigeniques_nasal_salivaire_sars-cov-2 |
17/03/2021 |
9200 |
Vaccin PfizerBioNTech ses conditions d’utilisation pourraient être assouplies |
09/03/2021 |
9199 |
Vaccin Moderna _ sensibiliser sur les réactions cutanées d’hypersensibilité retardée |
09/03/2021 |
9198 |
Un polymorphisme génétique associé à la sévérité de la Covid-19 pour les hommes |
09/03/2021 |
9197 |
Sécurité et efficacité du vaccin Sputnik V – Revue Médicale Suisse |
09/03/2021 |
9196 |
Qu’attendre de la digoxine dans l’insuffisance cardiaque à FEVG préservée |
09/03/2021 |
9195 |
Le développement professionnel continu |
09/03/2021 |
9194 |
Lyrica une prescription sur ordonnance sécurisée limitée à 6 mois |
09/03/2021 |
9193 |
Le syndrome de Conn, peut-être trop méconnu |
09/03/2021 |
9192 |
Le (baby) blues de la Covid-19 |
09/03/2021 |
9191 |
Des essais à effectif unique comparant une statine à un placebo ne montrent aucun effet sur les symptômes musculaires sévères _ Univadis |
09/03/2021 |
9190 |
Covid-19 et atteintes myocardiques RMS2021 |
09/03/2021 |
9189 |
Coronavirus SARS-CoV-2 _ recommandations thérapeutiques |
09/03/2021 |
9188 |
Contraception féminine – symptômes, causes, traitements et prévention – VIDAL |
09/03/2021 |
9187 |
Contraception chez la femme à risque cardiovasculaire |
09/03/2021 |
9186 |
Cœur et événements thromboemboliques situation en 2021RMS2021 |
09/03/2021 |
9185 |
Cancer du sein et Covid-19, encore un sujet d’inquiétude |
09/03/2021 |
9184 |
AOD et maladie thromboembolique veineuse _ traitement à la phase aigue |
09/03/2021 |
9183 |
ademe_synthese2035-50_010304 |
09/03/2021 |
9182 |
Provoked versus unprovoked venous thromboembolism Findings from GARFIELD-VTE |
08/03/2021 |
9181 |
In Memory of Professor Guy Meyer, 1957–2020 |
08/03/2021 |
9180 |
Sciences _ le déclin français s’accentue |
08/03/2021 |
9179 |
SGLT2 inhibitors may offer benefit berond diabetes Nat 2021 |
08/03/2021 |
9178 |
Statin treatment and muscle symptoms_ series of randomised, placebo controlled n-of-1 trials |
08/03/2021 |
9177 |
Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark |
08/03/2021 |
9176 |
The psychological impact of pulmonary embolism_ A mixed?methods study |
08/03/2021 |
9175 |
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia |
08/03/2021 |
9174 |
Traitement des cancers cutanés pendant la pandémie _ peut-on attendre |
08/03/2021 |
9173 |
Type 2 diabetes and incidence of cardiovascular diseases_ a cohort study in 1.9 million people |
08/03/2021 |
9172 |
Une douleur plantaire |
08/03/2021 |
9171 |
Vaccination en Israël, c’est concluant ! |
08/03/2021 |
9170 |
Venous thromboembolism and risk of cancer in users of statins_ A Danish population-based cohort study |
08/03/2021 |
9169 |
Visualizing thrombosis to improve thrombus resolution |
08/03/2021 |
9168 |
Widera_mAB_VOCs_medRxiv |
08/03/2021 |
9167 |
Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K AntagonistsTH2021 |
08/03/2021 |
9166 |
SARS-CoV-2 variants and ending the COVID-19 pandemic |
08/03/2021 |
9165 |
SARS-CoV-2 Vaccines |
08/03/2021 |
9164 |
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors_ A meta-analysis of five randomized controlled trials_compressed |
08/03/2021 |
9163 |
Refinement of a modified simplified Pulmonary Embolism Severity Index for elderly patients with acute pulmonary embolism |
08/03/2021 |
9162 |
Reduced lymphatic drainage promotes HFpEF and atherosclerosi NRC2021 |
08/03/2021 |
9161 |
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding |
08/03/2021 |
9160 |
Quel est le pronostic actuel des hémorragies méningée par rupture d’anévrisme _ |
08/03/2021 |
9159 |
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 |
08/03/2021 |
9158 |
Prise en charge de la dermo-hypodermite aigue? non ncrosante bactrienne de ladulte |
08/03/2021 |
9157 |
Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia |
08/03/2021 |
9156 |
Prevention and treatment of the post?thrombotic syndrome |
08/03/2021 |
9155 |
Platelet?Activating Immune Complexes Identified in Critically Ill COVID?19 Patients Suspected of Heparin?Induced Thrombocytopenia |
08/03/2021 |
9154 |
plan_et_si_la_covid_durait_28_octobre_2020 |
08/03/2021 |
9153 |
Patient Satisfaction A Key Component in IncreasingTH2021 |
08/03/2021 |
9152 |
P2Y12 inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention_ An updated meta-analysis of randomized trials |
08/03/2021 |
9151 |
Obésité et perte de poidsun premier médicament commercialisé en France |
08/03/2021 |
9150 |
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor_ A Contrarian View |
08/03/2021 |
9149 |
note_du_cosv_18_fevrier_2021_-_vaccin_astra_zeneca |
08/03/2021 |
9148 |
Misrepresenting Race — The Role of Medical Schools in Propagating Physician Bias |
08/03/2021 |
9147 |
Mieux appréhender la santé cardiovasculaire des femmes un consensus de l’ESC |
08/03/2021 |
9146 |
Management_of_Nonhealable_and_Maintenance_Wounds |
08/03/2021 |
9145 |
Les anticorps monoclonaux – L’histoire d’une recherche fondamentale ou la curiosité comme source de richesse1_compressed |
08/03/2021 |
9144 |
Les anticorps monoclonaux – L’histoire d’une recherche fondamentale ou la curiosité comme source de richesse1 |
08/03/2021 |
9143 |
Le SARS-CoV-2 menace-t-il (aussi) la fertilité masculine |
08/03/2021 |
9142 |
L’OMS se mobilise sur le COVID long |
08/03/2021 |
9141 |
L’atteinte de la main dans la sclérodermie systémique |
08/03/2021 |
9140 |
Intubation ou trachéo pour la poursuite de la ventilation, l’éternel débat |
08/03/2021 |
9139 |
Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup |
08/03/2021 |
9138 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 |
08/03/2021 |
9137 |
Inhibiteurs du SGLT2 dans les néphropathies diabétiques et non diabétiques |
08/03/2021 |
9136 |
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspect |
08/03/2021 |
9135 |
Incapable de reconnaître les sons, cette patiente n’a pas conscience de son trouble – Réalités Biomédicales |
08/03/2021 |
9134 |
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism_ Comparison of high? and low?dose rivaroxaban with aspirin |
08/03/2021 |
9133 |
Guillain-Barré syndrome |
08/03/2021 |
9132 |
Graphical abstract-Chloé |
08/03/2021 |
9131 |
FA _ en prévention d’un AVC, préférer les AOD aux AVK |
08/03/2021 |
9130 |
Experts, médias, crise sanitaire |
08/03/2021 |
9129 |
Experts, médias, crise sanitaire – {Sciences²}_compressed |
08/03/2021 |
9128 |
Experts, médias, crise sanitaire |
08/03/2021 |
9127 |
Embolic Stroke of Undetermined Source TH2021 |
08/03/2021 |
9126 |
Effects of Simvastatin on Tissue Factor Pathway of Blood Coagulation in STATCOPE (Simvastatin in the Prevention of COPD Exacerbations) Trial |
08/03/2021 |
9125 |
Effectiveness and Safety of Apixaban LMWH warfarin amonf VTE cancer TH2021 |
08/03/2021 |
9124 |
Development and prospective validation of a novel risk score for predicting the risk of lower extremity deep vein thrombosis among multiple trauma patients |
08/03/2021 |
9123 |
Des lsions angiomateuses diffuses |
08/03/2021 |
9122 |
Decline in Vascular Deaths Among Patients With Diabetes – The Cardiology Advisor |
08/03/2021 |
9121 |
Covid-19_ No evidence that vaccines can affect fertility, says new guidance |
08/03/2021 |
9120 |
Covid-19 _ probables réinfections chez des résidents d’une maison de retraite – Réalités Biomédicales_compressed |
08/03/2021 |
9119 |
Corona virus update_ Vaccin AstraZeneca et variant sud-africain, données épidémiologiques et étude en laboratoire du variant anglais. Podcast #76 du 16 février 2021 (extraits) |
08/03/2021 |
9118 |
Conquering Atherosclerotic Cardiovascular Disease — 50 Years of Progress |
08/03/2021 |
9117 |
Cœur et événements thromboemboliques situation en 2021RMS2021 |
08/03/2021 |
9116 |
Cancer overtakes vascular disease as leading cause of excess death associated with diabetes |
08/03/2021 |
9115 |
Brouhaha |
08/03/2021 |
9114 |
bamlanivimab_communique?_de_presse_SFPT |
08/03/2021 |
9113 |
Association of Type 2 Diabetes With Cancer_ A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People_compressed |
08/03/2021 |
9112 |
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19_ A Systematic Review and Meta-analysis |
08/03/2021 |
9111 |
Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction |
08/03/2021 |
9110 |
AOD et valve biologique_compressed |
08/03/2021 |
9109 |
AOD et chirurgie coronaire_compressed |
08/03/2021 |
9108 |
AOD et chirurgie cardiaque, quelles sont les données récentes _ Focus sur la valve mécanique |
08/03/2021 |
9107 |
Allocution de Jean Castex, une inaction irresponsable – Du Côté de la Science |
08/03/2021 |
9106 |
Accélérer la vaccination _ des leviers existent… à condition d’ajouter une dose de fermeté politique ! |
08/03/2021 |
9105 |
2021-02-02_recommandations_activites_amp-sars-cov-2_-_v5_compressed |
08/03/2021 |
9104 |
Venous Thromboembolism Incidence and Risk Assessment in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors |
28/02/2021 |
9103 |
Variant anglais _ pas plus pathogène chez l’enfant |
28/02/2021 |
9102 |
Variant anglais _ pas plus pathogène chez l’enfant |
28/02/2021 |
9101 |
Vaccin Novavax NVXCoV2373 _ un nouveau venu sur le podium |
28/02/2021 |
9100 |
Une étude israélienne révèle une baisse de 94% des cas symptomatiques de COVID-19 avec le vaccin Pfizer _ Reuters |
28/02/2021 |
9099 |
Thrombosis and coagulopathy in COVID?19_ An illustrated review |
28/02/2021 |
9098 |
The year in cardiovascularmedicine 2020 digital health and innovation |
28/02/2021 |
9097 |
The US Regulatory System and COVID-19 Vaccines_ The Importance of a Strong and Capable FDA |
28/02/2021 |
9096 |
Symptomatologie de la Covid-19, la pollakiurie aussi |
28/02/2021 |
9095 |
Statines un effet positif sur les complications liées aux adhérences post-opératoires |
28/02/2021 |
9094 |
Severe thrombophilia in a factor V?deficient patient homozygous for the Ala2086Asp mutation (FV Besançon) |
28/02/2021 |
9093 |
Sciences _ le déclin français s’accentue – {Sciences²} |
28/02/2021 |
9092 |
SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases |
28/02/2021 |
9091 |
SARS-CoV-2 et enfants épidémiologie, présentation clinique et contagiosité |
28/02/2021 |
9090 |
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 |
28/02/2021 |
9089 |
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 – Clinical Microbiology and Infection |
28/02/2021 |
9088 |
Repair of Aneurysmal Arteriovenous Fistulae_ A Systematic Review and Meta-analysis |
28/02/2021 |
9087 |
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 – Clinical Microbiology and Infection |
28/02/2021 |
9086 |
Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia |
28/02/2021 |
9085 |
Prédire la mort subite dans les 3 mois qui suivent un IDM |
28/02/2021 |
9084 |
plan_et_si_la_covid_durait_28_octobre_2020 |
28/02/2021 |
9083 |
note_du_cosv_18_fevrier_2021_-_vaccin_astra_zeneca |
28/02/2021 |
9082 |
Les macrolides sont-ils sans danger pendant la grossesse |
28/02/2021 |
9081 |
Les enjeux pédiatriques autour de la pandémie de Covid-19 |
28/02/2021 |
9080 |
La médecine et le principe de précaution |
28/02/2021 |
9079 |
 |
28/02/2021 |
9078 |
Innocuité et efficacité du vaccin oxford-astrazeneca_ analyse intermédiaire de quatre études contrôlées randomisées – Revue Médicale Suisse |
28/02/2021 |
9077 |
Inhibiteurs du SGLT2 dans les néphropathies diabétiques et non diabétiques |
28/02/2021 |
9076 |
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 |
28/02/2021 |
9075 |
Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction |
28/02/2021 |
9074 |
Impact du Covid-19 sur les enfants et leurs familles |
28/02/2021 |
9073 |
Forme sévère de Covid-19 _ des anomalies du globe oculaire détectées à l’IRM – Réalités Biomédicales |
28/02/2021 |
9072 |
Faudra-t-il vacciner les enfants contre le Covid-19 |
28/02/2021 |
9071 |
Extrapulmonary manifestations of COVID-19 |
28/02/2021 |
9070 |
Covid-19 le traitement anticoagulant sauve réellement des vies |
28/02/2021 |
9069 |
Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia |
28/02/2021 |
9068 |
Essential aspects of the follow?up after acute pulmonary embolism_ An illustrated review |
28/02/2021 |
9067 |
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis The ASTEROID Trial |
28/02/2021 |
9066 |
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection_ The COVID A to Z Randomized Clinical Trial |
28/02/2021 |
9065 |
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab oCOVID |
28/02/2021 |
9064 |
Diagnostic et séroprévalence SARS-CoV-2 chez l’enfant |
28/02/2021 |
9063 |
COVID19_Point épidémiologique hebdomadaire du 25 février 2021 |
28/02/2021 |
9062 |
COVID-19 pédiatrique |
28/02/2021 |
9061 |
COVID-19 illness in native and immunosuppressed states_ A clinical–therapeutic staging proposal |
28/02/2021 |
9060 |
Covid-19 en Afrique _ un paradoxe, mais quel paradoxe |
28/02/2021 |
9059 |
Covid-19 _ spéculations sur la contagiosité |
28/02/2021 |
9058 |
Covid-19 _ le tabagisme est-il un facteur de risque et d’aggravation |
28/02/2021 |
9057 |
Corona virus update_ Vaccin AstraZeneca et variant sud-africain, données épidémiologiques et étude en laboratoire du variant anglais. Podcast #76 du 16 février 2021 (extraits) |
28/02/2021 |
9056 |
Combien d’arrêts cardiaques hors hôpital liés à la Covid-19 en pleine pandémie |
28/02/2021 |
9055 |
Cardiac arrest in COVID-19 Swedish Regisqtry EHJ2020 |
28/02/2021 |
9054 |
Avis-SFM-salive-SARS-CoV-2-V2-_-MAJ-fev-2021-_-def-21022021 |
28/02/2021 |
9053 |
avis_du_cosv_28_janvier_2021_-_la_vaccination_des_professionnels_de_sante_de_moins_de_50_ans |
28/02/2021 |
9052 |
avis_du_cosv_21_janvier_2021_-_la_communication_en_direction_des_professionnels_de_sante |
28/02/2021 |
9051 |
Avacopan for the Treatment of ANCA-Associated Vasculitis |
28/02/2021 |
9050 |
Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction_ A Systematic Review and Meta-analysis |
28/02/2021 |
9049 |
Appropriate use of idarucizumab for dabigatran reversal |
28/02/2021 |
9048 |
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention |
28/02/2021 |
9047 |
Anticorps monoclonaux-presentation-ARS-V2 |
28/02/2021 |
9046 |
Anticoagulation prophylactique dans la Covid sévère _ l’idée fait son chemin |
28/02/2021 |
9045 |
Allocution de Jean Castex, une inaction irresponsable – Du Côté de la Science |
28/02/2021 |
9044 |
Affiche COVID 19 |
28/02/2021 |
9043 |
6 médicaments impactant la sexualité masculine |
28/02/2021 |
9042 |
From Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021 |
28/02/2021 |
9041 |
Vitamine D et COVID19 _ la supplémentation présentetelle un intérêt |
28/02/2021 |
9040 |
Vaccin Novavax NVXCoV2373 _ un nouveau venu sur le podium |
28/02/2021 |
9039 |
Vitamine D et COVID19 _ la supplémentation présentetelle un intérêt |
28/02/2021 |
9038 |
Vaccin Novavax NVXCoV2373 _ un nouveau venu sur le podium |
28/02/2021 |
9037 |
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents |
28/02/2021 |
9036 |
The neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival |
28/02/2021 |
9035 |
strategie_de_vaccination_contre_le_sars-cov-2___vaccination_des_personnes_ayant_un_antecedent_de_covid-19_-_synthese |
28/02/2021 |
9034 |
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (1) |
28/02/2021 |
9033 |
Signs of self-sustained inflammatory circuits in severe COVID pneumonia |
28/02/2021 |
9032 |
Severe reinfection with South African SARS-CoV-2 variant 501Y.V2- A case report |
28/02/2021 |
9031 |
Screening for SARS-CoV-2 by RT-PCR saliva or nasopharyngeal swab |
28/02/2021 |
9030 |
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection |
28/02/2021 |
9029 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease- a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement |
28/02/2021 |
9028 |
SARS-CoV-2 setting-specific transmission rates- a systematic review and meta-analysis |
28/02/2021 |
9027 |
Researchers Investigate What COVID-19 Does to the Heart |
28/02/2021 |
9026 |
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results |
28/02/2021 |
9025 |
recovery-press-release-tocilizumab_final |
28/02/2021 |
9024 |
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases- a systematic review and meta-analysis |
28/02/2021 |
9023 |
Populations précaires et Covid-19RMS2021 |
28/02/2021 |
9022 |
meta-analyse_rt-pcr_salive_vd |
28/02/2021 |
9021 |
Les chauves-souris chinoises, réservoirs de coronavirus émergents – Réalités Biomédicales |
28/02/2021 |
9020 |
La vie, quoiqu’il en coûte _ _ Univadis |
28/02/2021 |
9019 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report |
28/02/2021 |
9018 |
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients_ bi-center cohort study |
28/02/2021 |
9017 |
Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More |
28/02/2021 |
9016 |
Emergence of a Novel SARS-CoV-2 Variant in Southern California |
28/02/2021 |
9015 |
Efficacy and tolerability of bevacizumab in patients with severe Covid-19 |
28/02/2021 |
9014 |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial |
28/02/2021 |
9013 |
Edoxaban versus warfarinin patients with atrial fibrillation at the extremes of body weight- an analysis fromthe ENGAGE AF-TIMI 48 trial. |
28/02/2021 |
9012 |
Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality_ a nationwide cohort study of hospitalized patients in the United States |
28/02/2021 |
9011 |
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States- cohort study |
28/02/2021 |
9010 |
DISPAR_1 |
28/02/2021 |
9009 |
Direct Oral Anticoagulant Concentrations in Obese and High Body Weight Patients- A Cohort Study |
28/02/2021 |
9008 |
Decreased SARS-CoV-2 viral load following vaccination |
28/02/2021 |
9007 |
COVID?19–related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy |
28/02/2021 |
9006 |
COVID-19 Vaccination in Pregnant and Lactating Women |
28/02/2021 |
9005 |
Covid-19- The E484K mutation and the risks it poses |
28/02/2021 |
9004 |
COVID-19 in cancer patients_ clinical characteristics and outcome—an analysis of the LEOSS registry |
28/02/2021 |
9003 |
Covid-19 controversies_ the tocilizumab chapter |
28/02/2021 |
9002 |
Covid 19_ Two million deaths, so what went wrong |
28/02/2021 |
9001 |
Covid 19?_ caractéristiques et durée des réponses anticorps et leurs liens à la gravité de la maladie – Revue Médicale Suisse |
28/02/2021 |
9000 |
Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012_01 |
28/02/2021 |
8999 |
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID?19 patients_ A multicenter retrospective study |
28/02/2021 |
8998 |
Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19 |
28/02/2021 |
8997 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY)_ a randomised, controlled, open-label, platform trial |
28/02/2021 |
8996 |
Assessing Brain Capillaries in Coronavirus Disease 2019 |
28/02/2021 |
8995 |
Anticoagulation prior to hospitalization is a potential protective factor for COVID?19_ insight from a French multicenter cohort study |
28/02/2021 |
8994 |
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers |
28/02/2021 |
8993 |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 |
28/02/2021 |
8992 |
American Society of Hematology 2021 guidelines for management of VTE CANCER PATIENTS Blood Ad 2021 |
28/02/2021 |
8991 |
Aerosol emission from the respiratory tract- an analysis of relative risks from oxygen delivery systems |
28/02/2021 |
8990 |
ac_2021_0007_rt-pcr_salivaire_covid-19 |
28/02/2021 |
8989 |
A systematic review of antithrombotic treatment of venous TE in patients with myeloproliferative neoplasm |
28/02/2021 |
8988 |
20210211_COVID_Vaccins_Fiche-Synthese-4 |
28/02/2021 |
8987 |
10.1016-j.avsg.2020.11.011Figure |
28/02/2021 |
8986 |
A new positive SARS-CoV-2 test months after severe COVID-19 illness- reinfection or intermittent viral shedding_ |
28/02/2021 |
8985 |
The psychological impact of pulmonary embolism_ A mixed?methods study |
09/02/2021 |
8984 |
The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) Trial |
09/02/2021 |
8983 |
Symptomatic subsegmental versus more central pulmonary embolism_ Clinical outcomes during anticoagulation |
09/02/2021 |
8982 |
Screening for Asymptomatic Carotid Artery Stenosis in the General Population_ Updated Evidence Report and Systematic Review for the US Preventive Services Task Force |
09/02/2021 |
8981 |
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial |
09/02/2021 |
8980 |
Migration climatique et iniquités?RMS2021 |
09/02/2021 |
8979 |
Enjeux environnementaux et équité en santéRMS2021 |
09/02/2021 |
8978 |
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy_ |
09/02/2021 |
8977 |
Digital Ulcers in Systemic Sclerosis |
09/02/2021 |
8976 |
Clinical significance of subsegmental pulmonary embolism_ An ongoing controversy |
09/02/2021 |
8975 |
Changement climatique et enjeux cliniquesRMS2021 |
09/02/2021 |
8974 |
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes_ A Meta-analysis |
09/02/2021 |
8973 |
Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews systematic review |
09/02/2021 |
8972 |
Direct Oral Anticoagulant Dosing in Extremes of Body Weight |
07/02/2021 |
8971 |
Mechanisms of thrombosis and cardiovascular complications in COVID-19 |
07/02/2021 |
8970 |
Ménorragies de nouvelles recommandations françaises |
07/02/2021 |
8969 |
Migration climatique et iniquités?RMS2021 |
07/02/2021 |
8968 |
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights |
07/02/2021 |
8967 |
Populations précaires et Covid-19RMS2021 |
07/02/2021 |
8966 |
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women |
07/02/2021 |
8965 |
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine_ an interim analysis of a randomised controlled phase 3 trial in Russia |
07/02/2021 |
8964 |
Spoutnik V sur orbite |
07/02/2021 |
8963 |
Tout ce que vous voulez savoir sur le vaccin ARN messager |
07/02/2021 |
8962 |
Toute la population des EHPAD vaccinées d’ici la mi-février |
07/02/2021 |
8961 |
Vaccination en France _ tous les espoirs sont-ils permis |
07/02/2021 |
8960 |
Weekly covid vaccine research update |
07/02/2021 |
8959 |
Ménorragies de nouvelles recommandations françaises |
07/02/2021 |
8958 |
Mechanisms of thrombosis and cardiovascular complications in COVID-19 |
07/02/2021 |
8957 |
Management of Antithrombotic Therapy after Acute Coronary Syndromes |
07/02/2021 |
8956 |
Le variant britannique, plus létal ou non _ That is the question… |
07/02/2021 |
8955 |
Geriatrie prescription RMS 2021 |
07/02/2021 |
8954 |
Enjeux environnementaux et équité en santé RMS2021 |
07/02/2021 |
8953 |
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine |
07/02/2021 |
8952 |
Discontinuation of vascular therapeutics during COVID 19 SFMVJM%V2021 |
07/02/2021 |
8951 |
Direct Oral Anticoagulant Dosing in Extremes of Body Weight |
07/02/2021 |
8950 |
Covid-19 _ Xav-19, un médicament pour traiter la maladie, développé à Nantes par Xenothera |
07/02/2021 |
8949 |
Covid-19 _ utiliser l’azithromycine pour ce qu’elle est… |
07/02/2021 |
8948 |
Covid-19 _ la formation d’auto-anticorps expliquerait les formes sévères |
07/02/2021 |
8947 |
Covid 19?_ caractéristiques et durée des réponses anticorps et leurs liens à la gravité de la maladie – Revue Médicale Suisse |
07/02/2021 |
8946 |
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically-suspected and confirmed pulmonary embolismRIETE2020 |
07/02/2021 |
8945 |
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease |
07/02/2021 |
8944 |
Changement climatique et enjeux cliniquesRMS2021 |
07/02/2021 |
8943 |
Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis |
07/02/2021 |
8942 |
Autotests en France _ de la science-fiction |
07/02/2021 |
8941 |
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children |
07/02/2021 |
8940 |
Arrêt des thérapies vasculaires lors de la première vague de la pandémie COVID-19 en France – ScienceDirect |
07/02/2021 |
8939 |
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism |
07/02/2021 |
8938 |
A Rare Case of Dysplastic Axillary Artery Aneurysm |
07/02/2021 |
8937 |
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 |
07/02/2021 |
8936 |
Formites |
02/02/2021 |
8935 |
Systemic corticosteroid dose equivalents |
02/02/2021 |
8934 |
Tachycardia |
02/02/2021 |
8933 |
10 therapeutic drug target levels |
02/02/2021 |
8932 |
Vaccins Covid _ des incertitudes mais des évolutions positives |
02/02/2021 |
8931 |
Vacciner rapidement les médecins et les soignants l’appel de l’Ordre |
02/02/2021 |
8930 |
Vaccination contre la grippe, il s’agit aussi de protéger le cœur |
02/02/2021 |
8929 |
Résurgence du COVID-19 à Manaus, au Brésil, malgré une forte séroprévalence |
02/02/2021 |
8928 |
Mystère à Manaus |
02/02/2021 |
8927 |
Légifrance – Publications officielles – Journal officiel – JORF n° 0024 du 28_01_2021 |
02/02/2021 |
8926 |
Interactions médicamenteuses en période de COVID-19 |
02/02/2021 |
8925 |
Covid-19 _ Xav-19, un médicament pour traiter la maladie, développé à Nantes par Xenothera |
02/02/2021 |
8924 |
Covid-19 _ les professionnels de santé risquent leur peau |
02/02/2021 |
8923 |
Y a-t-il un lien entre la Covid-19 et des AVC ischémiques chez l’enfant |
31/01/2021 |
8922 |
Vaccins contre la Covid-19 _ n’est-il pas temps d’immuniser le groupe placebo |
31/01/2021 |
8921 |
Traitement du cancer, quels sont les risques de l’attente |
31/01/2021 |
8920 |
Traitement anti-Covid XENOTHERA _ démarrage de la phase 2b de son essai clinique, classé « priorité nationale de recherche » |
31/01/2021 |
8919 |
Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk |
31/01/2021 |
8918 |
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality |
31/01/2021 |
8917 |
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants |
31/01/2021 |
8916 |
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma |
31/01/2021 |
8915 |
Résurgence du COVID-19 à Manaus, au Brésil, malgré une forte séroprévalence |
31/01/2021 |
8914 |
Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19_ rationale for clinical management |
31/01/2021 |
8913 |
Rapport_Oxfam_Davos_Zoom_France_2021 |
31/01/2021 |
8912 |
ouest-france.fr-Covid-19 Leffrayant récit du Dr Anthony Fauci ex-conseiller médical de Donald Trump |
31/01/2021 |
8911 |
NOACs-DOACs Coagulation Tests |
31/01/2021 |
8910 |
NOAC-DOACs Perioperative Management |
31/01/2021 |
8909 |
Neutralization of SARS-CoV-2 spike 69_70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera |
31/01/2021 |
8908 |
Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa |
31/01/2021 |
8907 |
Microthrombi As A Major Cause of Cardiac Injury in COVID-19- A Pathologic Study |
31/01/2021 |
8906 |
Lutter contre le coronavirus par la ventilation des locaux principes et aspects concrets |
31/01/2021 |
8905 |
Le variant sud-africain du SARS-CoV-2 échappe-t-il vraiment aux vaccins actuels |
31/01/2021 |
8904 |
L’Evidence-Based-Medicine (EBM) _ une tentative de définition – Medcritic |
31/01/2021 |
8903 |
Hospitalisation pour Covid-19 _ combien de réadmissions dans les 30 jours après la sortie |
31/01/2021 |
8902 |
France _ petit atlas d’un pays vraiment pas comme les autres…Hashtable |
31/01/2021 |
8901 |
Exclusif _ une majorité de professionnels contre le report de la deuxième dose de vaccin, désormais exclu par le gouvernement |
31/01/2021 |
8900 |
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19 |
31/01/2021 |
8899 |
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19_ A Randomized Clinical Trial |
31/01/2021 |
8898 |
Early vascular surgery response to the COVID-19 pandemic_ Results of a nationwide survey |
31/01/2021 |
8897 |
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 |
31/01/2021 |
8896 |
DOACs in Obesity |
31/01/2021 |
8895 |
DOACS COMPARISON and FAQs |
31/01/2021 |
8894 |
Dix énigmes scientifiques à résoudre au sujet du Covid-19 – Le Temps |
31/01/2021 |
8893 |
Crise sanitaire et détresse des étudiants les doyens de médecine cherchent des solutions |
31/01/2021 |
8892 |
Covid-19- New UK variant may be linked to increased death rate, early the bmj _ BMJ 2021_372-n230 _ doi- 10.1136_bmj.n230 1 data indicate |
31/01/2021 |
8891 |
Covid-19 et corticoïdes _ Dr Jekyll and M. Hyde |
31/01/2021 |
8890 |
Covid-19 _ est-ce l’heure de la colchicine |
31/01/2021 |
8889 |
CANCER AND THROMBOSIS |
31/01/2021 |
8888 |
Beyond the clot- perfusion imaging of the pulmonary vasculature after COVID-19 |
31/01/2021 |
8887 |
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results |
31/01/2021 |
8886 |
AOD-ouAOD-ou-NACO_Prise-en-charge-des-saignements_01 August 2020 |
31/01/2021 |
8885 |
Anti-inflammatory therapy for COVID-19 infection_ the case for colchicine |
31/01/2021 |
8884 |
Anticoagulation in Pts Req APT |
31/01/2021 |
8883 |
Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines |
31/01/2021 |
8882 |
Waves of SARS-CoV-2 Infection and Blood Coagulation—A Link and Beyond |
28/01/2021 |
8881 |
Upper Extremity Deep Vein Thrombosis Symptoms, Diagnosis, and Treatment |
28/01/2021 |
8880 |
Traitement anti-Covid XENOTHERA _ démarrage de la phase 2b de son essai clinique, classé « priorité nationale de recherche » |
28/01/2021 |
8879 |
The Caprini thrombosis risk model predicts the risk of PICC-related upper extremity venous thrombosis in cancer patients |
28/01/2021 |
8878 |
Septic Pulmonary Embolism Secondary to Lemierre Syndrome |
28/01/2021 |
8877 |
Rapport_Oxfam_Davos_Zoom_France_2021 |
28/01/2021 |
8876 |
Rapport_Oxfam_Davos_inegalites_2021 |
28/01/2021 |
8875 |
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A |
28/01/2021 |
8874 |
New Rapid and Cost-Effective Tool for Monitoring DOACs |
28/01/2021 |
8873 |
Monitoring DOACs with a Novel Dielectric |
28/01/2021 |
8872 |
Mendelian Randomization |
28/01/2021 |
8871 |
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease—Brief Report |
28/01/2021 |
8870 |
Management of venous thromboembolism in athletes |
28/01/2021 |
8869 |
L’Evidence-Based-Medicine (EBM) _ une tentative de définition |
28/01/2021 |
8868 |
Is PAD a Hypercoagulable Disorder_ |
28/01/2021 |
8867 |
Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management |
28/01/2021 |
8866 |
Hereditary Disorders of Cardiovascular Calcification |
28/01/2021 |
8865 |
Heparin-Induced Thrombocytopenia |
28/01/2021 |
8864 |
Global absence and targeting of protective immune states in severe COVID-19 |
28/01/2021 |
8863 |
Comparison of the Use of Arterial Doppler Waveform Classifications in Clinical Routine to Describe Lower Limb Flow |
28/01/2021 |
8862 |
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions- a consensus document from European |
28/01/2021 |
8861 |
Ausgabe_A |
28/01/2021 |
8860 |
Association of peripheral artery disease and chronic limb-threatening ischemia with socioeconomic deprivation in people with diabetes_ A population data-linkage and geospatial analysis |
28/01/2021 |
8859 |
Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors |
28/01/2021 |
8858 |
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine |
28/01/2021 |
8857 |
#176 La colchicine est-elle efficace pour prévenir ou traiter la COVID-19 |
28/01/2021 |
8856 |
VTE COVID |
24/01/2021 |
8855 |
Venous thromboembolism after fast-track elective revision hip and knee arthroplasty |
24/01/2021 |
8854 |
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States |
24/01/2021 |
8853 |
UM Today _ Rady Faculty of Health Sciences _ Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial |
24/01/2021 |
8852 |
The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism |
24/01/2021 |
8851 |
Testing in a Pandemic — Improving Access, Coordination, and Prioritization |
24/01/2021 |
8850 |
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 |
24/01/2021 |
8849 |
Recovery from acute kidney injury in patients with pulmonary embolism- A single-center study |
24/01/2021 |
8848 |
Polypills — A Central Strategy for Improving Cardiovascular Health |
24/01/2021 |
8847 |
Polypill with or without Aspirin in Persons without Cardiovascular Disease |
24/01/2021 |
8846 |
platelets in sepsis RPTH 2021 |
24/01/2021 |
8845 |
Medium- and Large-Vessel Vasculitis |
24/01/2021 |
8844 |
Hypercoagulopathy in Severe COVID-19 |
24/01/2021 |
8843 |
How low is safe The frontier of very low 30 mgdL LDL cholesterol |
24/01/2021 |
8842 |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial |
24/01/2021 |
8841 |
Covid-19 _ on vous explique la polémique autour de la sixième dose du vaccin Pfizer-BioNTech |
24/01/2021 |
8840 |
Challenging anticoagulation cases_ Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopeni |
24/01/2021 |
8839 |
Can We Stop a Super Coronavirus_ – DER SPIEGEL |
24/01/2021 |
8838 |
Bertrand2021_Article_PlasmaConcentrationsOfLipoprot |
24/01/2021 |
8837 |
Bio109_Pratique THROMBOPHILIE 2020 |
24/01/2021 |
8836 |
Anticoagulation orale et insuffisance rénale chronique |
24/01/2021 |
8835 |
A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia_ The Breizh MAST2 Arg89Gln variant |
24/01/2021 |
8834 |
Traitement du cancer, quels sont les risques de l’attente |
21/01/2021 |
8833 |
Décès de 71 personnes âgées vaccinées contre le Covid. Que sait-on vraiment |
21/01/2021 |
8832 |
Anticoagulation orale et insuffisance rénale chronique |
21/01/2021 |
8831 |
Séquelles du COVID-19la SPLF appelle à la création d’un parcours de soins dédié |
21/01/2021 |
8830 |
Passage transplacentaire des anticorps de la Covid-19_ plutôt passable |
21/01/2021 |
8829 |
Effet bénéfique de la vitamine D dans la Covid _ quelles sont les données _ _ La Revue du Praticien |
21/01/2021 |
8828 |
Diabétiques de type 2 _ un peu de sucre ne fait pas de mal |
21/01/2021 |
8827 |
COVID-19_ coagulopathie et thrombose |
21/01/2021 |
8826 |
Bientôt un vaccin universel contre les coronavirus et les potentielles futures formes mutantes du SARS-CoV-2 _ |
21/01/2021 |
8825 |
AVIS Haut Conseil de la santé publique 121 Cet avis doit être diffusé dans sa totalité, sans ajout ni modification Relatif au risque de transmission du virus SARS-CoV-2 par la dispersion d’aérosols lors d’activités liées |
21/01/2021 |
8824 |
Après une Covid-19, l’immunité dure 8 mois (au moins) |
21/01/2021 |
8823 |
75 ans et plus, pathologies à haut risque qui et comment pourra-t-on se faire vacciner à partir de lundi |
21/01/2021 |
8822 |
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes_ |
19/01/2021 |
8821 |
Rubio-Salvador coût TVP KBP Env Res Pub health 21 |
19/01/2021 |
8820 |
Recommendations for clinical laboratory testing for protein S deficiency_ Communication from the SSC committee plasma coagulation inhibitors of the ISTH |
19/01/2021 |
8819 |
Pulmonary embolism prevalence among emergency department cohorts_ A systematic review and meta?analysis by country of study |
19/01/2021 |
8818 |
Preventing VTE following total hip and knee arthroplasty_ Is prediction the future_ |
19/01/2021 |
8817 |
New anticoagulants_ Moving beyond the direct oral anticoagulants |
19/01/2021 |
8816 |
Management of antithrombotic therapy after gastrointestinal bleeding_ A mixed methods study of health?care providers |
19/01/2021 |
8815 |
Kenmotsu Cancer medicine 21 |
19/01/2021 |
8814 |
Ethnoracial variations in venous thrombosis_ Implications for management, and a call to action |
19/01/2021 |
8813 |
Development and implementation of common data elements for venous thromboembolism research_ on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH |
19/01/2021 |
8812 |
Cost- effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism |
19/01/2021 |
8811 |
Clinical history of cancer?associated splanchnic vein thrombosis |
19/01/2021 |
8810 |
Aurélie Jean _ « Nous devons comprendre le fonctionnement des algorithmes » – Chut ! |
19/01/2021 |
8809 |
Anticoagulant medication adherence for cancer?associated thrombosis_ A comparison of LMWH to DOACs |
19/01/2021 |
8808 |
Vers de nouvelles indications des anticoagulants oraux directs |
17/01/2021 |
8807 |
Vaccins-covid-19-questions-et-reponses-spilf |
17/01/2021 |
8806 |
Une étude transversale comportant 502 patients a mis en évidence une hyperéchogénicité diffuse de la médullaire rénale chez les patients souffrant de goutte sévère |
17/01/2021 |
8805 |
The year Cardiovascular medicine 2020 |
17/01/2021 |
8804 |
SARS-CoV-2 _ quelles mutations peuvent retentir sur l’efficacité des anticorps neutralisants |
17/01/2021 |
8803 |
Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery |
17/01/2021 |
8802 |
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe |
17/01/2021 |
8801 |
Pharmacovigilance Actus |
17/01/2021 |
8800 |
L’anticoagulation ne serait pas un facteur de risque d’hémorragie digestive chez les patients Covid-19 + hospitalisés |
17/01/2021 |
8799 |
Inventaire de mutations d’une région cruciale du SARS-CoV-2 influant sur la réponse en anticorps – Réalités Biomédicales |
17/01/2021 |
8798 |
Gériatrie News |
17/01/2021 |
8797 |
Ewing’s Sarcoma |
17/01/2021 |
8796 |
Drug-Coated Devices for Peripheral Arterial Disease |
17/01/2021 |
8795 |
Different components involved in the lifetime genesis and evolution of cardiovascular risk. The three most |
17/01/2021 |
8794 |
COVID-19 _ physiopathologie d’une maladie à plusieurs visages |
17/01/2021 |
8793 |
Covid-19 _ moins de formes respiratoires grâce au plasma de convalescent |
17/01/2021 |
8792 |
Covid-19 _ hémodialysés et transplantés rénaux payent un très lourd tribut |
17/01/2021 |
8791 |
Comirnaty_ INN_ COVID-19 mRNA vaccine [nucleoside modified] |
17/01/2021 |
8790 |
COMIRNATY |
17/01/2021 |
8789 |
Cardiovascular risk classification and treatment recommendation to reduce cardiovascular outcomes in patients |
17/01/2021 |
8788 |
Cardiovascular disease and cancer continue to be the major causes of death worldwide and the two conditions |
17/01/2021 |
8787 |
Antithrombotic therapy in obesity |
17/01/2021 |
8786 |
A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant |
17/01/2021 |
8785 |
Vascular Complications of Diabetes_ Mechanisms of Injury and Protective Factors |
11/01/2021 |
8784 |
The year in cardiovascularmedicine 2020 digital health and innovation |
11/01/2021 |
8783 |
The 2020 SVM_SVU Consensus Statement for the Interpretation of Peripheral Arterial and Venous Doppler Waveforms_ An interview with SVM members of the Writing Committee |
11/01/2021 |
8782 |
Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT) |
11/01/2021 |
8781 |
Oral anticoagulation and health care utilization in venous thromboembolism_ What can we do to do better_ |
11/01/2021 |
8780 |
Notable-Articles-of-2020 |
11/01/2021 |
8779 |
Neurological side effects of antipsychotic drugs |
11/01/2021 |
8778 |
Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis |
11/01/2021 |
8777 |
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events_ a systematic review and meta-analysis of randomised trials including 327?037 participants |
11/01/2021 |
8776 |
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism |
11/01/2021 |
8775 |
European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis |
11/01/2021 |
8774 |
Epidemiology and management of aortic disease_ aortic aneurysms and acute aortic syndromes |
11/01/2021 |
8773 |
Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy?associated venous thromboembolism |
11/01/2021 |
8772 |
Ciraparantag, an anticoagulant reversal drug mechanism of action, pharmacokinetics, and reversal of anticoagulants |
11/01/2021 |
8771 |
ciraparantag the next anticoagulant airbag |
11/01/2021 |
8770 |
Association of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients_ A systematic review and meta-analysis |
11/01/2021 |
8769 |
Apolipoprotein B Particles and Cardiovascular Disease |
11/01/2021 |
8768 |
Acute Digital Ischemia After Arterial Injection of Crushed Zolpidem Tablets |
11/01/2021 |
8767 |
Short-range trabsmission potential of ballistic drops and droplet aerosols in the inhalable, thoracuc, and respiratory aerosol size and the effect of facemasks as source control |
10/01/2021 |
8766 |
NOIA-ACG |
10/01/2021 |
8765 |
Vaccination _ la colère cosmétique de Macron n’efface pas cacophonie et suspicions |
10/01/2021 |
8764 |
Vaccin Moderna efficacité, effets secondaires…les données du New England |
10/01/2021 |
8763 |
Troubles neuro-cognitifs majeurs |
10/01/2021 |
8762 |
Traitement-ACG |
10/01/2021 |
8761 |
Therapeutic anticoagulation ups mortality risk among patients hospitalized with COVID-19 |
10/01/2021 |
8760 |
Risks of and risk factors for COVID-19 disease in people with diabetes_ a cohort study of the total population of Scotland |
10/01/2021 |
8759 |
Rapport enquête COVID n°7 |
10/01/2021 |
8758 |
Préservation de la fertilité en cas de cancer du sein, une raison d’espérer |
10/01/2021 |
8757 |
Neurologic Syndromes Predict Higher In-Hospital Mortality in COVID-19 |
10/01/2021 |
8756 |
Masks and Face Coverings for the Lay Public_ A Narrative Update_ Annals of Internal Medicine_ Vol 0, No 0 |
10/01/2021 |
8755 |
In silico dynamics of COVID-19 phenotypes for optimizing clinical management |
10/01/2021 |
8754 |
Il n’y aurait finalement pas de Guillain-Barré avec la Covid-19… |
10/01/2021 |
8753 |
Global, regional, and national estimates of target population sizes for covid-19 vaccination_ descriptive study |
10/01/2021 |
8752 |
Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing |
10/01/2021 |
8751 |
Embolie pulmonaire |
10/01/2021 |
8750 |
Efficacité des masques |
10/01/2021 |
8749 |
Diabète et Covid-19, un modèle écossais |
10/01/2021 |
8748 |
Covid-19_ Russia admits to understating deaths by more than two thirds |
10/01/2021 |
8747 |
Covid-19_ Antibodies protect against reinfection for at least six months, study finds |
10/01/2021 |
8746 |
Covid-19 _ les IEC et ARA2 innocentés par plus d’un million d’hypertendus |
10/01/2021 |
8745 |
Corticothérapie-Sujets agés |
10/01/2021 |
8744 |
AUTOPSIE D’UN DÉSASTRE – Axel Kahn |
10/01/2021 |
8743 |
Aspirine et héparine-Grossesses LES-SAPL |
10/01/2021 |
8742 |
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe |
10/01/2021 |
8741 |
Troubles neuro-cognitifs majeurs |
03/01/2021 |
8740 |
Traitement-ACG |
03/01/2021 |
8739 |
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children |
03/01/2021 |
8738 |
Reduction in Revascularization With Icosapent Ethyl |
03/01/2021 |
8737 |
Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer_ A retrospective cohort study |
03/01/2021 |
8736 |
NOIA-ACG |
03/01/2021 |
8735 |
Mésinterpréatation-p value |
03/01/2021 |
8734 |
Goodbye 2020, hello to our future |
03/01/2021 |
8733 |
Global Burden of Cardiovascular Diseases and Risk Factors |
03/01/2021 |
8732 |
AUTOPSIE D’UN DÉSASTRE – Axel Kahn |
03/01/2021 |
8731 |
Atteintes neurologiques chez les patients Covid-19 |
03/01/2021 |
8730 |
Chest radiograph at admission predicts early intubation among inpatient COVID-19 patients |
03/01/2021 |
8729 |
Underdetection of cases of COVID-19 in France Nature 2020 |
03/01/2021 |
8728 |
Un cocktail d’anticorps monoclonaux pour la Covid-19 ambulatoire |
03/01/2021 |
8727 |
The use of imaging in COVID-19—results of a global survey by the International Society of Radiology |
03/01/2021 |
8726 |
The sensitivity and specificity of chest CT in the diagnosis of COVID-19 |
03/01/2021 |
8725 |
Notable-Articles-of-2020 |
03/01/2021 |
8724 |
Nivet2020_Article_TheAccuracyOfTeleradiologistsI |
03/01/2021 |
8723 |
New anti-diabetic agents_ major advances with unanswered questions |
03/01/2021 |
8722 |
Le COVAX pourra-t-il assurer une distribution équitable du vaccin anti-Covid-19 |
03/01/2021 |
8721 |
Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19 |
03/01/2021 |
8720 |
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine |
03/01/2021 |
8719 |
CT imaging of pulmonary embolism in patients with COVID-19 pneumonia a retrospective analysis |
03/01/2021 |
8718 |
Covid-19_ évolution des symptômes chez des patients ambulatoires – Revue Médicale Suisse |
03/01/2021 |
8717 |
Covid-19 _ beaucoup de cas symptomatiques non détectés en France |
03/01/2021 |
8716 |
Covid 19 _ les asymptomatiques seraient 4 fois moins contagieux |
03/01/2021 |
8715 |
Chlorpromazine versus Covid-19 ou la psychiatrie au service de la virologie… |
03/01/2021 |
8714 |
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers |
03/01/2021 |
8713 |
Risk factors associated with Covid-19-associated pulmonary aspergillosis in ICU patients_ a French multicentric retrospective cohort |
31/12/2020 |
8712 |
Risk factors associated with Covid-19-associated pulmonary aspergillosis in ICU patients_ a French multicentric retrospective cohort |
31/12/2020 |
8711 |
Scientific update on COVID19 |
31/12/2020 |
8710 |
VOEUX 2021 |
31/12/2020 |
8709 |
Twitter promotion predicts citation rates of CV articles |
31/12/2020 |
8708 |
New cardiovascular prevention guidelines_ How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention_ |
31/12/2020 |
8707 |
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes |
31/12/2020 |
8706 |
Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastase |
31/12/2020 |
8705 |
Disparities in Cardiovascular Disease outcomes among pregnant and post partum women |
31/12/2020 |
8704 |
Digital Health—The Need to Assess Benefits, Risks, and Value |
31/12/2020 |
8703 |
Coronary Artery Calcium Score–Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology_American Heart Association_Multisociety Cholesterol Guidelines |
31/12/2020 |
8702 |
Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis_ the GAPS non-inferiority RCT |
31/12/2020 |
8701 |
Acute, major muscular hematoma associated with antithrombotic agentsa multicenter real-world cohortTR |
31/12/2020 |
8700 |
Vers la guérison de la thalassémie et de la drépanocytose par génie génétique _ |
29/12/2020 |
8699 |
Venous Thromboembolism Associated With Pregnancy |
29/12/2020 |
8698 |
vaccins-covid-19-questions-et-reponses-spilf-24dec2020 |
29/12/2020 |
8697 |
Vaccins et COVID-19 _ synthèses des résultats (sécurité, effets indésirables et efficacité contre le SRAS-CoV-2) |
29/12/2020 |
8696 |
Utility of D-Dimer in Predicting Venous Thromboembolism in Non-Mechanically Ventilated COVID-19 Survivor |
29/12/2020 |
8695 |
Transparency in medical AI |
29/12/2020 |
8694 |
The New 2019 AHA_ACC Guideline on the Primary Prevention of Cardiovascular Disease |
29/12/2020 |
8693 |
Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels |
29/12/2020 |
8692 |
Stratégie de vaccination contre la Covid-19 |
29/12/2020 |
8691 |
Social Role Stress, Reward, and the American Heart Association Life’s Simple 7 in Midlife Women_ The Study of Women’s Health Across the Nation |
29/12/2020 |
8690 |
SARS-CoV-2 comment savoir si le variant anglais a déjà atteint un patient français |
29/12/2020 |
8689 |
Results of Survivor Corps Long Hauler Survey July 25 2020 |
29/12/2020 |
8688 |
Quelle survie avec une VNI au domicile |
29/12/2020 |
8687 |
Pseudo-engelures et Covid-19, l’interféron de type 1 est-il le chaînon manquant _ |
29/12/2020 |
8686 |
Outcomes of patients with hematologic malignancies and Covid-19 |
29/12/2020 |
8685 |
Nouveau variant du SARS-CoV-2 au Royaume-Uni questions-réponses |
29/12/2020 |
8684 |
New SARS-CoV-2 strain in the United Kingdom with increased transmissio n potential |
29/12/2020 |
8683 |
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease |
29/12/2020 |
8682 |
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome |
29/12/2020 |
8681 |
Maladies héréditaires du métabolisme _ des besoins en médicaments partiellement satisfaits |
29/12/2020 |
8680 |
Le sémaglutide améliore l’inflammation mais pas la fibrose de la NASH |
29/12/2020 |
8679 |
Le COVAX pourra-t-il assurer une distribution équitable du vaccin anti-Covid-19 _ |
29/12/2020 |
8678 |
Le coronavirus est en train de muter – est-ce important |
29/12/2020 |
8677 |
Incidence of venous thromboembolism in hospitalized patients with COVID?19 |
29/12/2020 |
8676 |
Glucovigilance in COVID-19 |
29/12/2020 |
8675 |
Feu vert de l’EMA pour le vaccin de Pfizer-BioNtech |
29/12/2020 |
8674 |
Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis |
29/12/2020 |
8673 |
Deaths From COVID-19 |
29/12/2020 |
8672 |
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and ?-Thalassemia |
29/12/2020 |
8671 |
Covid-19_ What have we learnt about the new variant in the UK |
29/12/2020 |
8670 |
Covid-19, chronique d’une émergence annoncée – La Vie des idées |
29/12/2020 |
8669 |
COVID-19 Infection in Critically Ill Patients Carries a High Risk for Venous Thromboembolism |
29/12/2020 |
8668 |
COVID-19 clinical trials_ learning from exceptions in the research chaos |
29/12/2020 |
8667 |
Comment fonctionne le vaccin de Moderna |
29/12/2020 |
8666 |
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic |
28/12/2020 |
8665 |
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China_ Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention |
28/12/2020 |
8664 |
Cardiovascular risks of climate change |
28/12/2020 |
8663 |
Arterial thrombosis in antiphospholipid syndrome (APS)_ Clinical approach and treatment. A systematic review |
28/12/2020 |
8662 |
Ageing and atherosclerosis_ vascular intrinsic and extrinsic factors and potential role of IL-6 |
28/12/2020 |
8661 |
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |
28/12/2020 |
8660 |
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy |
28/12/2020 |
8659 |
2021_ research and medical trends in a post-pandemic world |
28/12/2020 |
8658 |
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy JACC |
28/12/2020 |
8657 |
Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels |
27/12/2020 |
8656 |
Strategie_vaccination_covid_19_place_vaccin_a_arnm_comirnaty_bnt162b2 |
27/12/2020 |
8655 |
Research and medical trends in a post-pandemic world |
27/12/2020 |
8654 |
Outcomes of patients with hematologic malignancies and Covid-19 |
27/12/2020 |
8653 |
New SARS-CoV-2 strain in the United Kingdom with increased transmissio n potential |
27/12/2020 |
8652 |
Deaths From COVID-19 |
27/12/2020 |
8651 |
Covid-19_ What have we learnt about the new variant in the UK_ |
27/12/2020 |
8650 |
Covid-19, chronique d’une émergence annoncée – La Vie des idées |
27/12/2020 |
8649 |
COVID-19 Infection in Critically Ill Patients Carries a High Risk for Venous Thromboembolism |
27/12/2020 |
8648 |
COVID-19 clinical trials_ learning from exceptions in the research chaos |
27/12/2020 |
8647 |
Comment fonctionne le vaccin de Moderna – The New York Times |
27/12/2020 |
8646 |
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic |
27/12/2020 |
8645 |
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy |
27/12/2020 |
8644 |
La Check-List de la vaccination anti Covid-19 |
27/12/2020 |
8643 |
COREB_REACTing_211220_Virology |
27/12/2020 |
8642 |
COREB_REACTing_211220_Vaccines |
27/12/2020 |
8641 |
COREB_REACTing_211220_Therapeutics |
27/12/2020 |
8640 |
COREB_REACTing_211220_Epidemio |
27/12/2020 |
8639 |
COREB_REACTing_211220_Clinics_pathophysiology |
27/12/2020 |
8638 |
Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection |
22/12/2020 |
8637 |
Utility of d-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection |
22/12/2020 |
8636 |
Stratégie de prise en charge des personnes suivant l’interprétation du niveau de réplication virale par technique de RT-PCR SARS-CoV-2 ainsi que la pertinence du prélèvement nasal pour RT-PCR SARS-CoV-2 |
22/12/2020 |
8635 |
Tracking Changes in SARS-CoV-2 Spike_ Evidence that D614G Increases Infectivity of the COVID-19 Virus (2) |
22/12/2020 |
8634 |
Stratégie de prise en charge des personnes suivant l’interprétation du niveau de réplication virale par technique de RT-PCR SARS-CoV-2 ainsi que la pertinence du prélèvement nasal pour RT-PCR SARS-CoV-2 |
22/12/2020 |
8633 |
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France_ a population-based, observational study |
22/12/2020 |
8632 |
Nouveau variant du SARS-CoV-2 au Royaume-Uni questions-réponses |
22/12/2020 |
8631 |
Making sense of coronavirus mutations |
22/12/2020 |
8630 |
High Prevalence of Deep Venous Thrombosis in Non-Severe COVID-19 Patients Hospitalized for a Neurovascular Disease |
22/12/2020 |
8629 |
Covid-19_ New coronavirus variant is identified in UK |
22/12/2020 |
8628 |
Corticosteroid therapy for sepsis_ a clinical practice guideline |
22/12/2020 |
8627 |
Arterial thrombotic covid 19 |
22/12/2020 |
8626 |
Addendum a l’avis Haut Conseil de la santé publique 18 Cet avis doit être diffusé dans sa totalité, sans ajout ni modification du 10 septembre 2020 relatif au risque de transmission du SARS-CoV-2 par aérosols en milieux d |
21/12/2020 |
8625 |
Toxicological analysis of George’s marvellous medicine_ literature review |
20/12/2020 |
8624 |
The Babinski sign in Renaissance paintings—a reappraisal of the toe phenomenon in representations of the Christ Child_ observational analysis |
20/12/2020 |
8623 |
Short-term outcome of primary stent graft for peripheral artery aneurysm in patients with BehCet disease |
20/12/2020 |
8622 |
Sexism in the management of bleeding disorders |
20/12/2020 |
8621 |
Outcome benefit of arterial duplex stent imaging after superficial femoral artery stent implantation |
20/12/2020 |
8620 |
Loss to follow-up 1 year after lower extremity peripheral vascular intervention is associated with worse survival |
20/12/2020 |
8619 |
Long-term outcome after nonsurgical management of Paget-Schroetter syndrome |
20/12/2020 |
8618 |
Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database |
20/12/2020 |
8617 |
Egg consumption and health outcomes |
20/12/2020 |
8616 |
Direct oral anticoagulants in antiphospholipid syndrome_ Meta-analysis of randomized controlled trials |
20/12/2020 |
8615 |
Development of New International Antiphospholipid Syndrome Classification Criteria Phase I_II Report_ Generation and Reduction of Candidate Criteria |
20/12/2020 |
8614 |
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting |
20/12/2020 |
8613 |
Cost-effectiveness of contrast-enhanced ultrasound for the detection of endovascular aneurysm repair-related endoleaks requiring treatment |
20/12/2020 |
8612 |
Contemporary nationwide trends and in-hospital outcomes of adjunctive stenting in patients undergoing catheter-directed thrombolysis for proximal deep venous thrombosis |
20/12/2020 |
8611 |
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically-suspected and confirmed pulmonary embolism |
20/12/2020 |
8610 |
Classification and treatment of endothermal heat-induced thrombosis_ Recommendations from the American Venous Forum and the Society for Vascular Surgery |
20/12/2020 |
8609 |
Assessing Health-Related Quality of Life among Patients with Peripheral Artery Disease_ A Review of the Literature and Focus on Patient-Reported Outcome Measures |
20/12/2020 |
8608 |
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase |
20/12/2020 |
8607 |
VTE COVID 19 TH 2020 |
20/12/2020 |
8606 |
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 |
20/12/2020 |
8605 |
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System |
20/12/2020 |
8604 |
Implications of the severe acute respiratory syndrome associated with the novel coronavirus-2 on vascular surgery practices |
20/12/2020 |
8603 |
Embolie pulmonaire et augmentation des taux de D-dimère chez les patients atteints de maladie à coronavirus – Volume 26, numéro 8 – août 2020 – Revue des maladies infectieuses émergentes – CDC |
20/12/2020 |
8602 |
Development of New International Antiphospholipid Syndrome Classification Criteria Phase I_II Report_ Generation and Reduction of Candidate Criteria |
20/12/2020 |
8601 |
D-dimer measurement in COVID-19_ Silver bullet or clinical distraction |
20/12/2020 |
8600 |
COVID-19 as the Leading Cause of Death in the United States |
20/12/2020 |
8599 |
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza_ a nationwide, population-based retrospective cohort study |
20/12/2020 |
8598 |
Cardiovascular disease due to novel coronavirus and the search for investigational therapies |
20/12/2020 |
8597 |
Acute aortoiliac occlusion in a patient with novel coronavirus disease-2019 |
20/12/2020 |
8596 |
Vaccines and Related Biological Products Advisory Committee Meeting Presentation |
17/12/2020 |
8595 |
Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research_ Why the Heart Fails |
17/12/2020 |
8594 |
mRNA vaccines — a new era in vaccinology |
17/12/2020 |
8593 |
Equipoise, Trust, and the Need for Cardiologists to Randomly Assign Patients Into Anticoagulation Trials in the Time of COVID |
17/12/2020 |
8592 |
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection |
17/12/2020 |
8591 |
Quelle stratégie thérapeutique sur les lipides en pratique _ |
17/12/2020 |
8590 |
Oral anticoagulation and health care utilization in venous thromboembolism_ What can we do to do better_ |
17/12/2020 |
8589 |
Nouveautés dans le traitement des malformations veineuses complexes le laser endoveineuxRMS2020 |
17/12/2020 |
8588 |
L’ischémie digitale RMS2020 |
17/12/2020 |
8587 |
Implémentation des stratégies ERP RMS2020 |
17/12/2020 |
8586 |
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism |
17/12/2020 |
8585 |
Évolution dans la prise en charge endovasculaire de l’artériopathie des membres inférieursRMS2020 |
17/12/2020 |
8584 |
Dvc et prise en cvharge EP RMS2020 |
17/12/2020 |
8583 |
Contraception et maladie thromboembolique veineuseRMS2020 |
17/12/2020 |
8582 |
CMG_Maladies-rares-PRISE-EN-CHARGE |
17/12/2020 |
8581 |
CMG_Maladies-rares-fiche-DIAGNOSTIC |
17/12/2020 |
8580 |
Calf muscle pump function as a predictor of all-cause mortality |
17/12/2020 |
8579 |
Artériofit RMS2020 |
17/12/2020 |
8578 |
Vascular Disease Patient Information Page_ COVID–19-related thrombosis |
17/12/2020 |
8577 |
Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Briefing Document- FDA |
17/12/2020 |
8576 |
Tout ce que vous voulez savoir sur le vaccin ARN messager |
17/12/2020 |
8575 |
Supplementary appendix |
17/12/2020 |
8574 |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine |
17/12/2020 |
8573 |
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine |
17/12/2020 |
8572 |
Oxford–AstraZeneca COVID-19 vaccine efficacy |
17/12/2020 |
8571 |
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 |
17/12/2020 |
8570 |
Covid-19 _ persistance du SARS-CoV-2 dans l’intestin trois mois après le début des symptômes – Réalités Biomédicales |
17/12/2020 |
8569 |
Vaccines and Related Biological Products Advisory Committee Meeting Presentation |
17/12/2020 |
8568 |
Vaccin Astra-Zeneca_Oxford, des résultats satisfaisants aux analyses intermédiaires |
17/12/2020 |
8567 |
Tout ce que vous voulez savoir sur le vaccin ARN messager |
17/12/2020 |
8566 |
Novarax et la protéine spike, un vaccin d’un autre type |
17/12/2020 |
8565 |
note_d_eclairage_conseil_scientifique_modifiee_14_decembre_2020 |
17/12/2020 |
8564 |
Il a suffi du battement d’aile d’un tweet entre 5G et Covid-19 |
17/12/2020 |
8563 |
Covid-19 _ il court, il court le furet…avec le molnupiravir |
17/12/2020 |
8562 |
Corona virus update DROSTEN |
17/12/2020 |
8561 |
Corona virus update DROSTEN |
17/12/2020 |
8560 |
Contre la Covid-19, O rhésus moins |
17/12/2020 |
8559 |
Comment-s-informent-les-complotistes |
17/12/2020 |
8558 |
Communiqué de presse de la Société de Pathologie de Langue Française (SPILF) 09122020 |
17/12/2020 |
8557 |
Vaccin Moderna _ des anticorps pendant au moins 90 jours |
17/12/2020 |
8556 |
Vaccin d’Oxford que disent les nouvelles données publiées |
17/12/2020 |
8555 |
Un rideau de fer s’est-il abattu sur la planète vaccinale |
17/12/2020 |
8554 |
Traitement de la polyarthrite rhumatoïde débutante _ le méthotrexate reste en première ligne |
17/12/2020 |
8553 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK |
17/12/2020 |
8552 |
Quelle stratégie thérapeutique sur les lipides en pratique _ |
17/12/2020 |
8551 |
Quand le gouvernement donne aux CPAM le droit de vous « déconventionner en urgence » |
17/12/2020 |
8550 |
COVID-19 Selection of peer-reviewed articles |
17/12/2020 |
8549 |
L’ischémie digitale un défi diagnostique |
17/12/2020 |
8548 |
Le choix de la surveillance active pour le cancer de la prostate repose surtout sur l’IRM multiparamétrique |
17/12/2020 |
8547 |
L’insuffisance surrénale au cours d’une Covid-19 fait évoquer…un syndrome des antiphospholipides |
17/12/2020 |
8546 |
Implémentation des stratégies ERP RMS2020 |
17/12/2020 |
8545 |
Évolution dans la prise en charge endovasculaire de l’artériopathie des membres inférieursRMS2020 |
17/12/2020 |
8544 |
Dvc et prise en cvharge EP RMS2020 |
17/12/2020 |
8543 |
Covid-19 _ persistance du SARS-CoV-2 dans l’intestin trois mois après le début des symptômes – Réalités Biomédicales |
17/12/2020 |
8542 |
Covid-19 _ la metformine pourrait réduire la mortalité pour les femmes diabétiques |
17/12/2020 |
8541 |
Contraception et maladie thromboembolique veineuseRMS2020 |
17/12/2020 |
8540 |
Combien de temps dure l’immunité contre le SARS-CoV-2 _ _ Univadis |
17/12/2020 |
8539 |
CMG_Maladies-rares-PRISE-EN-CHARGE |
17/12/2020 |
8538 |
CMG_Maladies-rares-fiche-DIAGNOSTIC |
17/12/2020 |
8537 |
Cancers de la vessie et du testicule la consommation de cannabis fortement suspectée |
17/12/2020 |
8536 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK |
16/12/2020 |
8535 |
Oxford–AstraZeneca COVID-19 vaccine efficacy |
16/12/2020 |
8534 |
Appendix |
16/12/2020 |
8533 |
SARS?CoV?2 SPIKE PROTEIN an optimal immunological target for vaccines |
16/12/2020 |
8532 |
Results of the First Phase I II linical Vaccination Trial with direct vaccination of mRNA2008 |
16/12/2020 |
8531 |
Rapport_-_immunite_au_cours_de_linfection_par_le_sars-cov |
16/12/2020 |
8530 |
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients |
16/12/2020 |
8529 |
Immunological considerations for COVID-19 vaccine strategies |
16/12/2020 |
8528 |
Guide-pr-en-charge-sequelles-respiratoires-sars-cov2 |
16/12/2020 |
8527 |
Covid-19_ Asymptomatic cases may not be infectious, Wuhan study indicates |
16/12/2020 |
8526 |
Covid-19_ Air travellers should not be considered high risk, says European guidance |
16/12/2020 |
8525 |
COVID-19 Vaccine A comprehensive status report |
16/12/2020 |
8524 |
Covid-19 _ comment fonctionnent les futurs vaccins |
16/12/2020 |
8523 |
Covid -19, misinformation, and antimicrobial resistance |
16/12/2020 |
8522 |
Code covid version numerique |
16/12/2020 |
8521 |
Bilateral Adrenal Hemorrhage in Coronavirus Disease 2019 Patient |
16/12/2020 |
8520 |
Avis relatif à l’actualisation des recommandations thérapeutiques dans le Covid-19 |
16/12/2020 |
8519 |
An Evidence Based Perspective on mRNA-SARSCoV-2 Vaccine Development |
16/12/2020 |
8518 |
Hyperglycémie et Covid-19 |
16/12/2020 |
8517 |
COVID-19 Prise en charge et suivi du patient hospitalisé |
16/12/2020 |
8516 |
COVID-19 Prise en charge et suivi du patient en médecine de ville |
16/12/2020 |
8515 |
COVID-19 en EHPAD repérer et prendre en charge |
16/12/2020 |
8514 |
Venous thromboembolism after lower extremity orthopedic surgery_ A population‐_based nationwide cohort study |
16/12/2020 |
8513 |
The relationship between DOAC levels and clinical outcomesJTH2020 |
16/12/2020 |
8512 |
Symptomatic subsegmental versus more central pulmonary embolism_ Clinical outcomes during anticoagulation |
16/12/2020 |
8511 |
Post-interventional antithrombotic management after venous stenting of the ilio femorl trcatJTH2020 |
16/12/2020 |
8510 |
Inherited and acquired thrombophilia in adults with retinal cascocclusion JTH2020 |
16/12/2020 |
8509 |
Incidence and predictors of splanchnic vein thrombosis post surgJTH2020 |
16/12/2020 |
8508 |
Impacts environnementaux de la mobilité motorisée |
16/12/2020 |
8507 |
External validation of the YEARS diagnostic algorithm for suspected PE JTH2020 |
16/12/2020 |
8506 |
Comparative clinical prognosis of massive and non-massive PRERiete JTH2020 |
16/12/2020 |
8505 |
Communication des risques en santé? RMS2020 |
16/12/2020 |
8504 |
Cobénéfices santé-environnement concepts et recommandations pour la pratique clinique |
16/12/2020 |
8503 |
Cobénéfices pour l’alimentation, la mobilité et le contact avec la nature |
16/12/2020 |
8502 |
Bleeding, death, and costs of care during hospitalization for acute pulmonary embolism_ Insights from the Saint Luke’s Outcomes of Pulmonary Embolism (SLOPE) study |
16/12/2020 |
8501 |
Accuracy of contralateral Villalta score to assess for pre exiting CVI with unila DVT JTH2020 |
16/12/2020 |
8500 |
Vaccination anti-Covid-19 _ interrogations sur le niveau de protection |
16/12/2020 |
8499 |
Rapport_-_immunite_au_cours_de_linfection_par_le_sars-cov |
16/12/2020 |
8498 |
Plasma de convalescent dans la Covid-19, décidément pas convaincant |
16/12/2020 |
8497 |
Le plurilinguisme, un atout pour le cerveau |
16/12/2020 |
8496 |
MICI en rémission, il peut persister un syndrome de l’intestin irritable |
16/12/2020 |
8495 |
Méthodes de désinfection contre la Covid-19, il faut faire le ménage ! |
16/12/2020 |
8494 |
Le Conseil scientifique réservé sur le dépistage de masse…pour le moment |
16/12/2020 |
8493 |
Encore beaucoup d’inconnues sur l’élimination du SARS-CoV-2 et l’immunité chez l’enfant |
16/12/2020 |
8492 |
Diabète et infection à COVID-19 |
16/12/2020 |
8491 |
COVID-19 un rôle de plus en plus prégnant pour la vitamine D |
16/12/2020 |
8490 |
C’est en les calcifiant que les statines évitent la rupture des plaques d’athérome |
16/12/2020 |
8489 |
Avis relatif à l’actualisation des recommandations thérapeutiques dans le Covid-19 |
16/12/2020 |
8488 |
Traitement médicamenteux de la gonarthrose premières recommandations de la SFR |
16/12/2020 |
8487 |
referentiel_covid_ght06_nov15_2020_v3 |
16/12/2020 |
8486 |
Pour mieux soigner, des médicaments à écarter bilan 2021 |
16/12/2020 |
8485 |
Patient avec Covid-19 en USI _ n’oublions pas la famille ! |
16/12/2020 |
8484 |
Où la surinformation rime avec dépression |
16/12/2020 |
8483 |
La méthode scientifique n’est pas soluble dans l’urgence – Libération |
16/12/2020 |
8482 |
Inhalation d’INF bêta dans le COVID-19 _ résultats d’une étude de phase 2 _ Univadis |
16/12/2020 |
8481 |
Hyperactivité vésicale idiopathique la rééducation périnéo-sphinctérienne fonctionne très bien |
16/12/2020 |
8480 |
Haute Autorité de Santé – Vaccins Covid-19 _ quelle stratégie de priorisation à l’initiation de la campagne _ |
16/12/2020 |
8479 |
Faut-il rechercher la présence du SARS-CoV-2 dans les selles |
16/12/2020 |
8478 |
Dix bonnes raisons pour prescrire la corticothérapie dans les formes sévères de la Covid-19 |
16/12/2020 |
8477 |
When Will We Have a Vaccine_” — Understanding Questions and Answers about Covid-19 Vaccination |
16/12/2020 |
8476 |
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality- A systematic review and meta-analysis |
16/12/2020 |
8475 |
Therapy for Early COVID-19_ A Critical Need |
16/12/2020 |
8474 |
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer |
16/12/2020 |
8473 |
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results |
16/12/2020 |
8472 |
Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them |
16/12/2020 |
8471 |
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host |
16/12/2020 |
8470 |
Haute Autorité de Santé – Vaccins Covid-19 _ quelle stratégie de priorisation à l’initiation de la campagne _ |
16/12/2020 |
8469 |
FDA Approval of Remdesivir — A Step in the Right Direction |
16/12/2020 |
8468 |
Diabète et infection à COVID-19 |
16/12/2020 |
8467 |
Cytokine Storm |
16/12/2020 |
8466 |
Admission hyperglycemiaas a predictor of mortality in patients hospitalized with COVID-19 regardless |
16/12/2020 |
8465 |
A Large, Simple Trial Leading to Complex Questions |
16/12/2020 |
8464 |
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160Â kg or more |
16/12/2020 |
8463 |
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease |
16/12/2020 |
8462 |
Opinion and Practice Survey about the Use of Prognostic Models in acute PE |
16/12/2020 |
8461 |
Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical recommendations, and an algorithm for maintenance |
16/12/2020 |
8460 |
Microsoft Word – InnoVTE.docx |
16/12/2020 |
8459 |
Manifeste-Un_nouveau_souffle-HTAP |
16/12/2020 |
8458 |
Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia |
16/12/2020 |
8457 |
Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism_ From the COMMAND VTE registry |
16/12/2020 |
8456 |
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19 |
16/12/2020 |
8455 |
Extended screening guidelines for the diagnosis of abdominal aortic aneurysm |
16/12/2020 |
8454 |
Contrast-enhanced ultrasound detects type II endoleaks during follow-up for endovascular aneurysm repair |
16/12/2020 |
8453 |
Communique-de-presse-Janssen-HTAP-Manifeste-Un-nouveau-souffle-24nov2020 |
16/12/2020 |
8452 |
Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures |
16/12/2020 |
8451 |
2020_snitem-booklet-loi-anticadeaux |
16/12/2020 |
8450 |
Vaccins, crise aux Etats-Unis, restrictions de Noëll’actualité internationale marquante de la semaine |
28/11/2020 |
8449 |
Une polyarthrite rhumatoïde après une Covid-19, pas vraiment une coïncidence |
28/11/2020 |
8448 |
Un complément alimentaire pour les cheveux « vraisemblablement associé à des hépatites aiguës |
28/11/2020 |
8447 |
RT-PCR Positif Covid 19, que dire aux patients |
28/11/2020 |
8446 |
Pas de fumée sans feu avec l’e-cigarette |
28/11/2020 |
8445 |
Mortalité de la Covid-19, pauvres pays riches… |
28/11/2020 |
8444 |
Migraineux sévères privés de traitements innovants médecins et patients dénoncent la situation |
28/11/2020 |
8443 |
Grippe, Covid vers un vaccin produit à partir de plantes |
28/11/2020 |
8442 |
Et maintenant, ne pas rater l’étape du vaccin – Libération |
28/11/2020 |
8441 |
Environ 30 % de diagnostics positifs en moins par rapport à la semaine précédente |
28/11/2020 |
8440 |
Diabète de type 2, pas de bol avec le riz |
28/11/2020 |
8439 |
Des recommandations pour traiter au mieux le diabète en cas d’IRC |
28/11/2020 |
8438 |
Covid-19 dans les EHPADs, enquête au Pays de Galles |
28/11/2020 |
8437 |
Covid-19 _ une prochaine vague…de suicides |
28/11/2020 |
8436 |
Covid–19 _ le vaccin d’Oxford est efficace et bien toléré chez les adultes âgés ! |
28/11/2020 |
8435 |
Veille sur les médicaments de la COVID-19 |
26/11/2020 |
8434 |
SARS-CoV-2 _ allo Houston, nous avons un nouveau SNP ! |
26/11/2020 |
8433 |
Réponses rapides dans le cadre du COVID-19 – Prise en charge de premier recours des patients suspectés de COVID-19 |
26/11/2020 |
8432 |
avis relatif aux stratégies de dépistage du Covid-19 dans les établissements de santé et les établissements médico-sociaux |
26/11/2020 |
8431 |
Où parodontite rime avec artérite |
26/11/2020 |
8430 |
Haute Autorité de Santé – Vaccination contre la Covid-19 _ transparence, pragmatisme et flexibilité |
26/11/2020 |
8429 |
Haute Autorité de Santé – Tests, isolement, traitements _ quelle prise en charge en médecine de ville |
26/11/2020 |
8428 |
Dépister toute la population _ l’arme absolue contre l’épidémie _ Interview du Pr Amouyel |
26/11/2020 |
8427 |
Covid19 Comment protéger vos proches lors des visites en EHPAD |
26/11/2020 |
8426 |
Covid-19 au 1er trimestre de la grossesse, pas de danger |
26/11/2020 |
8425 |
Covid-19 _ trois fois plus de risque d’hospitalisation pour les soignants |
26/11/2020 |
8424 |
Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis |
26/11/2020 |
8423 |
Treatment of epithelial ovarian cancer |
26/11/2020 |
8422 |
The good, bad and the ugly of the Acute Venous Thrombosis- Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis |
26/11/2020 |
8421 |
Shared Decisions_ A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin?Associated Side Effects |
26/11/2020 |
8420 |
safety rivaroxaban obesity |
26/11/2020 |
8419 |
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization- Impact of Concomitant Clopidogrel on Efficacy and Safety Circ2020 |
26/11/2020 |
8418 |
Prevalence and Impact of Coagulation Dysfunction in COVID-9 in China A Meta-AnalysisTH2020 (1) |
26/11/2020 |
8417 |
Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes |
26/11/2020 |
8416 |
Letter to the Editors-in-Chief |
26/11/2020 |
8415 |
Les nouvelles recommandations HAS pour la prise en charge des patients suspectés de COVID en premier recours une réelle avancée |
26/11/2020 |
8414 |
Ischaemic vs Bleeding risk |
26/11/2020 |
8413 |
Heparin-Induced Thrombocytopenia in Severe COVID-19 |
26/11/2020 |
8412 |
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice |
26/11/2020 |
8411 |
Current estimates of the incidence of acute venous thromboembolic disease in Canada_ A meta-analysis |
26/11/2020 |
8410 |
Correction of international normalised ratio in major bleeding |
26/11/2020 |
8409 |
Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous ThromboembolismA Bayesian Network Meta-analysis |
26/11/2020 |
8408 |
Challenging anticoagulation cases_ A case of incidental subsegmental pulmonary embolism in a patient with cancer |
26/11/2020 |
8407 |
Associations of Late Adolescent or Young Adult Cardiovascular Health with Premature Cardiovascular Disease and Mortality |
26/11/2020 |
8406 |
Aspirin for Primary Atherosclerotic Cardiovascular Disease Prevention as Baseline Risk Increases_ A Meta-Regression Analysis |
26/11/2020 |
8405 |
Un nouveau souffle avec l’interféron bêta-1a en inhalation dans la Covid-19 |
26/11/2020 |
8404 |
SIMS de la Covid-19 _ les enfants touchés au cœur |
26/11/2020 |
8403 |
Pourquoi Emmanuel Macron devrait-il finalement éviter de donner des chiffres _ |
26/11/2020 |
8402 |
Mort en réanimation une réalité complexe |
26/11/2020 |
8401 |
Maladie de Kawasaki, retour au Japon |
26/11/2020 |
8400 |
Le baricitinib, un candidat (de plus) pour traiter la Covid-19 |
26/11/2020 |
8399 |
La méthode scientifique n’est pas soluble dans l’urgence – Libération |
26/11/2020 |
8398 |
L’OMS déconseille l’utilisation du remdesivir |
26/11/2020 |
8397 |
COVID19 Prise en charge et suivi du patient hospitalisé |
26/11/2020 |
8396 |
COVID19 Prise en charge et suivi du patient en médecine de ville |
26/11/2020 |
8395 |
Covid-19 avec EP, une sale histoire |
26/11/2020 |
8394 |
Covid-19 _ un impact sur la santé mentale…et inversement |
26/11/2020 |
8393 |
Autres nouvelles de l’infection à SARS-CoV-2 du nouveau-né |
26/11/2020 |
8392 |
Vaccins contre le SARS-CoV-2 où en est la recherche clinique |
26/11/2020 |
8391 |
Vaccin Covid-19 _ alors que des résultats sont dévoilés, la France doit préparer une campagne inédite |
26/11/2020 |
8390 |
SIMS de la Covid-19 _ les enfants touchés au cœur |
26/11/2020 |
8389 |
Réponses rapides dans le cadre de la Covid-19 – Prise en charge de premier recours des patients suspectés de Covid-19 |
26/11/2020 |
8388 |
Quelles sont les mesures étatiques les plus efficaces contre Covid-19_ – Heidi.news |
26/11/2020 |
8387 |
La vaccination massive a déjà commencé en Chine |
26/11/2020 |
8386 |
L’essai SAMSON attribue la plupart des effets indésirables des statines à un effet nocebo |
26/11/2020 |
8385 |
Inrae-dp-one health-web |
26/11/2020 |
8384 |
Grippe |
26/11/2020 |
8383 |
Enjeux éthiques de la prise en charge et de l’accès aux soins pour tous en situation de forte tension liée à l’épidémie de Covid-19 |
26/11/2020 |
8382 |
Diagnostic sérologique de la covid-19 _ une sensibilité surestimée pour le test rapide AbC-19 |
26/11/2020 |
8381 |
Davantage d’AVC chez la femme jeune que chez l’homme jeune |
26/11/2020 |
8380 |
Covid-19, y a-t-il un risque thyroïdien |
26/11/2020 |
8379 |
COVID-19 des interrogations persistantes autour de la réponse immunitaire |
26/11/2020 |
8378 |
A quand une stratégie claire face à la pandémie |
26/11/2020 |
8377 |
Vous reprendrez bien un peu d’aspirine en prévention primaire |
26/11/2020 |
8376 |
Vol au-dessus d’un nid de Covid-19 |
26/11/2020 |
8375 |
VIH et SARS-CoV-2, la mauvaise connexion |
26/11/2020 |
8374 |
VIDAL – Vaccins contre la COVID-19 _ un point sur les essais de phase III en cours – Actualités |
26/11/2020 |
8373 |
Vaccin contre la Covid _ beaucoup de bruit… et beaucoup de bruit |
26/11/2020 |
8372 |
SARS-Cov-2 _ le retour de l’accident de laboratoire |
26/11/2020 |
8371 |
Protéine ALMS1 une nouvelle piste thérapeutique pour le diabète de type 2 |
26/11/2020 |
8370 |
Protéine ALMS1 une nouvelle piste thérapeutique pour le diabète de type 2 |
19/11/2020 |
8369 |
Plaquette-thr |
26/11/2020 |
8368 |
Plaquette-inr |
26/11/2020 |
8367 |
Hormones |
26/11/2020 |
8366 |
Plaquette-cvm |
26/11/2020 |
8365 |
Efficacité du vaccin Pfizer des questions en suspens |
26/11/2020 |
8364 |
Covid-19 et cirrhose, une lourde mortalité |
26/11/2020 |
8363 |
COVID-19 proposer une oxygénothérapie à domicile devient possible sous certaines conditions |
26/11/2020 |
8362 |
Arrêter de fumer pour éviter les bouffées…de chaleur à la ménopause |
26/11/2020 |
8361 |
Anti-vitamine K |
26/11/2020 |
8360 |
Anticoagulant |
26/11/2020 |
8359 |
Anticoagulant par voie sous cutanée |
26/11/2020 |
8358 |
Une troisième artère dans nos avant-bras grâce au processus évolutif |
26/11/2020 |
8357 |
Surveillance des anticoagulants oraux directs |
26/11/2020 |
8356 |
Rivaroxaban in Peripheral Artery Disease after Revascularization |
26/11/2020 |
8355 |
Recently increased prevalence of the human median artery of the forearm_ A microevolutionary change |
26/11/2020 |
8354 |
Pragmatic Care in CardiologyJACC2020 |
26/11/2020 |
8353 |
One Health, une seule santé pour la Terre, les animaux et les Hommes |
26/11/2020 |
8352 |
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects |
26/11/2020 |
8351 |
New Decade, New FDA Guidance for Diabetes Drug Development |
26/11/2020 |
8350 |
Management of Antiphospholipid Syndrome |
26/11/2020 |
8349 |
Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old_ a French prospective cohort |
26/11/2020 |
8348 |
L’artere des facteurs de risque 115 outil |
26/11/2020 |
8347 |
Images in Vascular Medicine_ Trapped thrombus underneath a recently placed inferior vena cava filter |
26/11/2020 |
8346 |
Essai Randomisé FBecjer Phlébologie |
26/11/2020 |
8345 |
escardio.org-Management of dyslipidaemia in the elderly |
26/11/2020 |
8344 |
 |
26/11/2020 |
8343 |
Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S. |
26/11/2020 |
8342 |
Diagnosis and Treatment of Lower Extremity Venous ThromboembolismJAMA2020 |
26/11/2020 |
8341 |
DEVELOPMENT AND IMPLEMENTATION OF COMMON DATA ELEMENTS FOR VENOUS THROMBOEMBOLISM RESEARCH Official Communication from the SSC OF THE ISTH |
26/11/2020 |
8340 |
Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention |
26/11/2020 |
8339 |
Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs |
26/11/2020 |
8338 |
Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes Intermediate Vascular Traits, and All-Cause Mortality A Systematic Review and Meta-analysis |
26/11/2020 |
8337 |
Veille des etudes cliniques publiees pour certains medicaments du covid19_20_octobre_2020 |
25/11/2020 |
8336 |
Stratégie vaccinale contre la Covid-19 |
25/11/2020 |
8335 |
SARS-CoV-2 _ allo Houston, nous avons un nouveau SNP ! |
25/11/2020 |
8334 |
Prise en charge de premier recours des patients suspectés de COVID-19 |
25/11/2020 |
8333 |
Où parodontite rime avec artérite |
25/11/2020 |
8332 |
Haute Autorité de Santé – Vaccination contre la Covid-19 _ transparence, pragmatisme et flexibilité |
25/11/2020 |
8331 |
Haute Autorité de Santé – Tests, isolement, traitements _ quelle prise en charge en médecine de ville |
25/11/2020 |
8330 |
Dépister toute la population _ l’arme absolue contre l’épidémie _ Interview du Pr Amouyel |
25/11/2020 |
8329 |
Covid19 Comment protéger vos proches lors des visites en EHPAD |
25/11/2020 |
8328 |
Covid-19 au 1er trimestre de la grossesse, pas de danger |
25/11/2020 |
8327 |
Covid-19 _ trois fois plus de risque d’hospitalisation pour les soignants |
25/11/2020 |
8326 |
Avis relatif aux stratégies de dépistage du Covid-19 dans les établissements de santé et les établissements médico-sociaux |
25/11/2020 |
8325 |
Venous Thromboembolism Associated With Pregnancy |
11/11/2020 |
8324 |
Underuse of medical thromboprophylaxis in mobile elderly inpatients- The SWITCO65+ cohort |
11/11/2020 |
8323 |
Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism |
11/11/2020 |
8322 |
Risk of peripheral arterial disease in patients with periodontitis_ A nationwide, population-based, matched cohort study |
11/11/2020 |
8321 |
POEM PERT SOINS |
11/11/2020 |
8320 |
Pénurie de vaccins contre la grippe la polémique enfle |
11/11/2020 |
8319 |
Nomenclature for kidney function and disease EHJ2020 |
11/11/2020 |
8318 |
How I treat venous thromboembolism in pregnancy |
11/11/2020 |
8317 |
Hémangiome caverneux de l’orbite diagnostic et prise en charge RMS2020 |
11/11/2020 |
8316 |
Effect of anticoagulants on fibrin clot structure- A comparison between vitamin K antagonists and factor Xa inhibitors |
11/11/2020 |
8315 |
Clinical Management of Hyperkalemia 2020 |
11/11/2020 |
8314 |
Chronic Mesenteric Ischemia Clinical Practice Guideline from the Society for Vascular Surgery |
11/11/2020 |
8313 |
Asymptomatic carotid artery stenosis is associated with cerebral hypoperfusion |
11/11/2020 |
8312 |
Antithrombotic Management of Venous Thromboembolism JACC2020 |
11/11/2020 |
8311 |
veille_des_etudes_cliniques_publiees_pour_certains_medicaments_du_covid19_-_20_octobre_2020 |
11/11/2020 |
8310 |
Un aperçu des valeurs de cycle seuil et de leur rôle dans l’interprétation des résultats des tests de dépistage du SARS-CoV-2 par PCR en temps réel |
11/11/2020 |
8309 |
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts_ a retrospective cohort study |
11/11/2020 |
8308 |
Risk of Severe COVID-19 AmongWorkers and Their Household Members |
11/11/2020 |
8307 |
Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households_ nationwide linkage cohort study |
11/11/2020 |
8306 |
Réponses rapides dans le cadre du COVID-19 – Prise en charge de premier recours des patients suspectés de COVID-19 |
11/11/2020 |
8305 |
relatif aux stratégies de dépistage du Covid-19 dans les établissements de santé et les établissements médico-sociaux |
11/11/2020 |
8304 |
Recommandations d’experts portant sur la prise en charge en réanimation des patients infectés à SARS-CoV2 |
11/11/2020 |
8303 |
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study |
11/11/2020 |
8302 |
Pathological features of COVID-19-associated myocardial injury |
11/11/2020 |
8301 |
hcspa20201011_stratgidedpistagducovid |
11/11/2020 |
8300 |
Haute Autorité de Santé – Vaccination contre la Covid-19 _ transparence, pragmatisme et flexibilité |
11/11/2020 |
8299 |
Haute Autorité de Santé – Tests, isolement, traitements _ quelle prise en charge en médecine de vill |
11/11/2020 |
8298 |
has_66_avis_ceu_strategie_vaccinale_covid_2020_11_05_mel_2020-11-09_10-30-53_177 |
11/11/2020 |
8297 |
Eurosurveillance _ Syndrome inflammatoire multisystémique pédiatrique lié au SRAS-CoV-2, une étude épidémiologique, France, 1er mars au 17 mai 2020 |
11/11/2020 |
8296 |
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 A Randomized Clinical Trial |
11/11/2020 |
8295 |
Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients |
11/11/2020 |
8294 |
covid19 Comment protéger vos proches lors des visites en EHPAD |
11/11/2020 |
8293 |
Covid-19 Le CHRU de Nancy va diriger une recherche nationale inédite sur les risques de thromboses veineuses |
11/11/2020 |
8292 |
COVID-19 Artificial Intelligence Diagnosis EMB 09208795 |
11/11/2020 |
8291 |
Actualisation des recommandations d’imagerie thoracique dans la pneumonie COVID-19 _ SFR e-Bulletin |
11/11/2020 |
8290 |
VTE COVID 19 TH 2020 |
08/11/2020 |
8289 |
The COVID-19 pandemic_ a catalyst to improve clinical trials |
08/11/2020 |
8288 |
suivi_régional_indicateur_contact_tracing_modelem |
08/11/2020 |
8287 |
Mortality due to cancer treatment delay_ systematic review and meta-analysis _ The BMJ |
08/11/2020 |
8286 |
La première vague de Covid-19 en France et les soins primaires RMS2020 |
08/11/2020 |
8285 |
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 |
08/11/2020 |
8284 |
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit_ A proof-of-concept study |
08/11/2020 |
8283 |
Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact |
08/11/2020 |
8282 |
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines |
08/11/2020 |
8281 |
Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 |
08/11/2020 |
8280 |
4 Cases of Aortic Thrombosis in Patients With COVID-19 |
08/11/2020 |
8279 |
“A Menace to the Public Health” — Contact Tracing and the Limits of Persuasion |
08/11/2020 |
8278 |
synthese_mesures_de_soutien_-_note_unapl_du_05112020 |
08/11/2020 |
8277 |
Retard de prise en charge du cancer et Covid-19 _ parfois c’est trop tard |
08/11/2020 |
8276 |
Quelles recommandations vaccinales avant, pendant et après une grossesse |
08/11/2020 |
8275 |
Pénurie de vaccins contre la grippe la polémique enfle |
08/11/2020 |
8274 |
olyglobulie de Vaquez et thrombocytémie essentielle _ la charge allélique JAK2 V617F diminue peu sous hydroxyurée |
08/11/2020 |
8273 |
note_conseil_scientifique_26_octobre_2020 |
08/11/2020 |
8272 |
Mourir de la Covid-19 à Stockholm après 70 ans |
08/11/2020 |
8271 |
Les fluoroquinolones augmentent les risques d’atteintes des valves cardiaques |
08/11/2020 |
8270 |
Le lien entre THS et cancer est à nouveau confirmé, mais pas de panique ! |
08/11/2020 |
8269 |
La première vague de Covid-19 en France et les soins primaires RMS2020 |
08/11/2020 |
8268 |
Hydroxychloroquine et lupus, les rhumatologues donnent l’alerte |
08/11/2020 |
8267 |
Eurosurveillance _ Syndrome inflammatoire multisystémique pédiatrique lié au SRAS-CoV-2, une étude épidémiologique, France, 1er mars au 17 mai 2020 |
08/11/2020 |
8266 |
Covid-19 en réanimation _ les leçons de la première vague |
08/11/2020 |
8265 |
Covid-19 en France _ on se perd en conjecture ! |
08/11/2020 |
8264 |
Covid-19 _ les leçons du traçage à Singapour |
08/11/2020 |
8263 |
Eurosurveillance _ Syndrome inflammatoire multisystémique pédiatrique lié au SRAS-CoV-2, une étude épidémiologique, France, 1er mars au 17 mai 2020 |
08/11/2020 |
8262 |
Des millions de visons vont être abattus au Danemark en raison d’une mutation du SARS-CoV-2 |
08/11/2020 |
8261 |
Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg |
08/11/2020 |
8260 |
Your Voice, Your Vote, Your Power |
08/11/2020 |
8259 |
TVP et EP PRESCRIRE 2020 |
08/11/2020 |
8258 |
Outcomes of subintimal arterial flossing with antegrade–retrograde intervention on patients with critical limb ischemia and tissue loss |
08/11/2020 |
8257 |
Multiparametric Ultrasound to Assess Adult Carotid Arteries |
08/11/2020 |
8256 |
Incidental Saccular Popliteal Vein Aneurysm_ Two Case Reports |
08/11/2020 |
8255 |
Images in Vascular Medicine_ Dual assessment of abnormal microvascular foot perfusion and lower extremity calcium burden in a patient with critical limb ischemia using hybrid SPECT_CT imaging |
08/11/2020 |
8254 |
Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients withpolycythemia vera or essential thrombocythemia. |
08/11/2020 |
8253 |
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome |
08/11/2020 |
8252 |
Cavernous Venous Insufficiency_ An Underestimated Vascular Disease Causing Erectile Dysfunction Resistant to Medical Treatment |
08/11/2020 |
8251 |
ASH GUIDELINES 2020 MTEV |
08/11/2020 |
8250 |
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 |
08/11/2020 |
8249 |
Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020 |
08/11/2020 |
8248 |
Open Science Saves Lives_ Lessons from the COVID-19 Pandemic |
08/11/2020 |
8247 |
note_conseil_scientifique_26_octobre_2020 |
08/11/2020 |
8246 |
New Cause of COVID-19 Blood Clots Identified |
08/11/2020 |
8245 |
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19 |
08/11/2020 |
8244 |
mm6944e3 Update_ Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 |
08/11/2020 |
8243 |
Is the COVID?19 thrombotic catastrophe complement?connected_ |
08/11/2020 |
8242 |
How COVID-19 may trigger dangerous blood clots _ Science News |
08/11/2020 |
8241 |
Déprogrammations des actes cela doit rester une décision médicale » et non administrative |
08/11/2020 |
8240 |
Comité départemental de suivi de la situation sanitaire CD3S |
08/11/2020 |
8239 |
Consensus?based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID?19–related illness |
08/11/2020 |
8238 |
Cardiometabolic Traits, Sepsis, and Severe COVID-19 |
08/11/2020 |
8237 |
Anticoagulant interventions in hospitalized patients with COVID?19_ A scoping review of randomized controlled trials and call for international collaboration |
08/11/2020 |
8236 |
Age-specific mortality and immunity patterns of SARS-CoV-2 |
08/11/2020 |
8235 |
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS)_ Two?year outcomes after the study closure |
03/11/2020 |
8234 |
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low?risk for chromosomal abnormalities |
03/11/2020 |
8233 |
Résultats de l’appel franco-germano-japonais _ un bel exemple de coopération internationale pour l’intelligence artificielle _ INS2I |
03/11/2020 |
8232 |
Real?world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism |
03/11/2020 |
8231 |
Non?invasive recanalization of deep venous thrombosis by high frequency ultrasound in a swine model with follow?up |
03/11/2020 |
8230 |
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography |
03/11/2020 |
8229 |
Iliac vein aneurysms_ a comprehensive review |
03/11/2020 |
8228 |
Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura |
03/11/2020 |
8227 |
Definition of major bleeding_ Prognostic classification |
03/11/2020 |
8226 |
Control of data variations in intravital microscopy thrombosis models |
03/11/2020 |
8225 |
Comparative clinical prognosis of massive and non?massive pulmonary embolism_ a registry?based cohort study |
03/11/2020 |
8224 |
Anticoagulant protein S—New insights on interactions and functions |
03/11/2020 |
8223 |
Anticoagulant Medication Adherence for Cancer Associated Thrombosis_ A Comparison of LMWH to DOACs |
03/11/2020 |
8222 |
Infographie COVID 19 coagulopathy |
02/11/2020 |
8221 |
IA et Insuff Rénale |
02/11/2020 |
8220 |
Effet bénéfique possible des anti-PCSK9 face au risque de MVTE |
02/11/2020 |
8219 |
Covid-19, et si l’on prenait de l’aspirine _ |
02/11/2020 |
8218 |
Covid-19 chez le nouveau-né _ quels symptômes _ |
02/11/2020 |
8217 |
Covid l’alerte lancée a l’exécutif par le Conseil scientifique français |
02/11/2020 |
8216 |
Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28 jours comparativement au traitement standard |
02/11/2020 |
8215 |
Anticiper les complications aigües de la Covid-19 _ quand une IA peut prédire le degré de gravité _ APHP |
02/11/2020 |
8214 |
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskEHJ2020 |
02/11/2020 |
8213 |
Use of hormone replacement therapy and risk of breast cancer_ nested case-control studies using the QResearch and CPRD databases |
02/11/2020 |
8212 |
The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism |
02/11/2020 |
8211 |
Syndrome de congestion pelvienne une cause fréquente de douleur chroniqueRMS2020 |
02/11/2020 |
8210 |
Reservoir of Fibroblasts Promotes Recovery From Limb Ischemia |
02/11/2020 |
8209 |
Produits du tabac et du vapotage _ l’Anses publie un panorama inédit des produits vendus en France _ Anses – Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail |
02/11/2020 |
8208 |
Patient outcomes in myeloproliferative neoplasm-related thrombosis_ Insights from the National Inpatient Sample |
02/11/2020 |
8207 |
Paclitaxel-coated balloons- a safe alternative to drug-eluting stents for coronary in-stent restenosisEHJ2020 |
02/11/2020 |
8206 |
Mortality after use of paclitaxel-based devices in peripheral arteries |
02/11/2020 |
8205 |
Lipid-lowering therapies in peripheral artery disease_ A review |
02/11/2020 |
8204 |
Inter-rater Reliability of 4-Item Arterial Doppler Waveform Classification System for Description of Arterial Doppler Waveforms |
02/11/2020 |
8203 |
Influence and management of conflicts of interest in randomised clinical trials_ qualitative interview study |
02/11/2020 |
8202 |
IA et Insuff Rénale |
02/11/2020 |
8201 |
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program |
02/11/2020 |
8200 |
Effect of sodium-glucose Cotransporter 2 inhibitors on cardiovascular and kidney outcomes |
02/11/2020 |
8199 |
DNA Content in Ischemic Stroke Thrombi Can Help Identify Cardioembolic Strokes Among Strokes of Undetermined Cause |
02/11/2020 |
8198 |
Coffee, Caffeine, and Health NEJM2020 |
02/11/2020 |
8197 |
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease_ A Scientific Statement From the American Heart Association – Copie (1) |
02/11/2020 |
8196 |
Canagliflozin impedes ischemic hind-limb recovery in the setting of diabetes |
02/11/2020 |
8195 |
Syndrome de congestion pelvienne une cause fréquente de douleur chroniqueRMS2020 |
02/11/2020 |
8194 |
Produits du tabac et du vapotage _ l’Anses publie un panorama inédit des produits vendus en France _ Anses – Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail |
02/11/2020 |
8193 |
Post-COVID-19 la fatigue persistante est indépendante de la gravité de l’infection |
02/11/2020 |
8192 |
Peut-être un nouveau souffle pour le diagnostic de la Covid-19 |
02/11/2020 |
8191 |
Lettre Ministre Santeaux Medecins liberaux |
02/11/2020 |
8190 |
Facteurs de risque, prévention, dépistage, traitements _ le point sur les dernières avancées dans le cancer du sein |
02/11/2020 |
8189 |
COVID-19 les événements thromboemboliques restent élevés malgré la prophylaxie |
02/11/2020 |
8188 |
Covid-19 aux USA _ on vote pour les anticorps monoclonaux neutralisants _ |
02/11/2020 |
8187 |
Covid-19 _ l’insoutenable légèreté de l’immunité humorale |
02/11/2020 |
8186 |
COVID-19 l’ANSM dit non à l’hydroxychloroquine |
02/11/2020 |
8185 |
« Covid _ les nouvelles projections qui effraient le gouvernement » |
02/11/2020 |
8184 |
Coronavirus Disease 2019 and the Athletic Heart |
02/11/2020 |
8183 |
Viswanathan_et_al-2020-Cochrane_Database_of_Systematic_Reviews |
02/11/2020 |
8182 |
Mild or Moderate Covid-19 |
02/11/2020 |
8181 |
Lettre Ministre Santeaux Medecins liberaux |
02/11/2020 |
8180 |
Infographie COVID 19 coagulopathy |
02/11/2020 |
8179 |
Humoral Immune Response to SARS-CoV-2 in Iceland |
02/11/2020 |
8178 |
Harmonizing Hypercoagulable Heterogeneity_ Baseline VTE Risk in COVID?19 |
02/11/2020 |
8177 |
Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine |
02/11/2020 |
8176 |
Evolution and effects of COVID-19 outbreaks in care homes_ a population analysis in 189 care homes in one geographical region of the UK |
02/11/2020 |
8175 |
Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust |
02/11/2020 |
8174 |
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 |
02/11/2020 |
8173 |
Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach |
02/11/2020 |
8172 |
COVID-19 l’ANSM dit non à l’hydroxychloroquine |
02/11/2020 |
8171 |
Characterization of Myocardial Injury in Patients With COVID-19 |
02/11/2020 |
8170 |
Anticiper les complications aigües de la Covid-19 _ quand une IA peut prédire le degré de gravité _ APHP |
02/11/2020 |
8169 |
AI-Driven quantification, staging and outcome prediction of COVID19 pneumonia |
02/11/2020 |
8168 |
« Covid _ les nouvelles projections qui effraient le gouvernement » |
02/11/2020 |
8167 |
Periods of VRE Risk for COVIS-19 Patients |
27/10/2020 |
8166 |
Une équipe internationale de chercheurs a identifié des vulnérabilités communes aux coronavirus SARS-CoV-2, SARS-CoV-1 et MERS-CoV _ Institut Pasteur |
27/10/2020 |
8165 |
Severe COVID-19 Is a Microvascular Disease |
27/10/2020 |
8164 |
SARS-CoV-2, portage viral et séroprévalence au sein des travailleurs hospitaliers asymptomatiques _ inégalités entre services |
27/10/2020 |
8163 |
Psychiatric Disorders and Hydroxychloquine for coronavirus Disease 2019 (COVID-19) A VigiBase Study |
27/10/2020 |
8162 |
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions |
27/10/2020 |
8161 |
Prediction models for covid-19 outcomes |
27/10/2020 |
8160 |
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults_ national derivation and validation cohort study |
27/10/2020 |
8159 |
HCQ et risque de décès |
27/10/2020 |
8158 |
Fondaparinux- Should It Be Studied in Patients with COVID-19 Disease_ |
27/10/2020 |
8157 |
Effect of school closures on mortality from coronavirus disease 2019_ old and new predictions |
27/10/2020 |
8156 |
Covid19.2010ep-Presenting characteristics, Tt patterns, and … with VTE during hospitalization for COVID-19_Fernández-Capitán, STH (1) |
27/10/2020 |
8155 |
Covid l’alerte lancée a l’exécutif par le Conseil scientifique français |
27/10/2020 |
8154 |
Coronavirus Historical Perspective, Disease Mechanisms, and Clinical _Outcomes |
27/10/2020 |
8153 |
Clinical and Laboratory characteristics of patients with COVID-19 Infection and Deep Venous Thrombosis |
27/10/2020 |
8152 |
Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28 jours comparativement au traitement standard |
27/10/2020 |
8151 |
Bibliometric Analysis of Early COVID-19 Research_ The Top 50 Cited Papers |
27/10/2020 |
8150 |
Australie _ nourrissons décédés, seringues réutilisées, les couacs d’un confinement strict |
27/10/2020 |
8149 |
Anticoagulant interventions in hospitalized patients with COVID-19 A scoping review of randomized controlled trials and call for international collaboration |
27/10/2020 |
8148 |
VTE COVID 19 TH 2020 |
26/10/2020 |
8147 |
Typicaltherapeutic applications of penicillin G |
25/10/2020 |
8146 |
Spotting bad science |
25/10/2020 |
8145 |
Increased Urinary Frequency |
25/10/2020 |
8144 |
How to make a diagnosis of systemic lupus |
25/10/2020 |
8143 |
Guidelines forthe diagnosticand management of diabetic ketoacidosis |
25/10/2020 |
8142 |
Drug Facts for your personal formulary_Inhibitors of the RAS |
25/10/2020 |
8141 |
Diffuse parenchymal lung disease |
25/10/2020 |
8140 |
Differentiation of causes of hyperthyroidism according to pattern of radionucleotide uptake |
25/10/2020 |
8139 |
Classification of some antimicrobial agents by their sites of action |
25/10/2020 |
8138 |
Anemia of Chronic Disease |
25/10/2020 |
8137 |
Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization |
25/10/2020 |
8136 |
Thromboprophylaxis practice after outpatient endovenous thermal ablation |
25/10/2020 |
8135 |
The addition of echocardiographic parameters PESISCORE 2020 |
25/10/2020 |
8134 |
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophiliaTH2020 |
25/10/2020 |
8133 |
Référentiel relatif aux traitements de données à caractère personnel destinées à la gestion des cabinets médicaux et paramédicaux |
25/10/2020 |
8132 |
Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy |
25/10/2020 |
8131 |
La mesure d’élasticité de la paroi artérielle _ état de l’art et perspectives |
25/10/2020 |
8130 |
Images in Vascular Medicine_ Vasa vasorum associated with endoleak after endovascular repair of abdominal aortic aneurysm |
25/10/2020 |
8129 |
Global burden of 87 risk factors in 204 countries and territories, 1990–2019_ a systematic analysis for the Global Burden of Disease Study 2019 |
25/10/2020 |
8128 |
CardioVascular Coalition Applauds Introduction of Legislation to Reduce Amputations, Improve Peripheral Artery Disease Awareness & Screening – CardioVascular Coalition |
25/10/2020 |
8127 |
Age-specific reference values for carotid arterial stiffness estimated by ultrasonic wall tracking |
25/10/2020 |
8126 |
Vascular Disease Patient Information Page_ COVID–19-related thrombosis |
22/10/2020 |
8125 |
Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia |
22/10/2020 |
8124 |
synthese_tests_antigeniques_vd |
22/10/2020 |
8123 |
Sudden irreversible hearing loss post COVID-19 |
22/10/2020 |
8122 |
Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic |
22/10/2020 |
8121 |
Navigating COVID-19 Testing, Special Considerations for the Cardiovascular Clinician |
22/10/2020 |
8120 |
Multi-organ impairment in low-risk individuals with long COVID |
22/10/2020 |
8119 |
euxième vague de COVID-19 les oncologues sont-ils prêts |
22/10/2020 |
8118 |
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia_ A Randomized Clinical Trial |
22/10/2020 |
8117 |
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia |
22/10/2020 |
8116 |
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia |
22/10/2020 |
8115 |
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 |
22/10/2020 |
8114 |
Déploiement des tests antigéniques _ vers un rendez-vous raté _ |
22/10/2020 |
8113 |
Cytokine elevation in severe and critical COVID-19-Lancet 2020 |
22/10/2020 |
8112 |
Covid-19 Molecular Diagnostic Testing — Lessons Learned |
22/10/2020 |
8111 |
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia JACC2020 |
22/10/2020 |
8110 |
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 |
22/10/2020 |
8109 |
Anticoagulation in Hospitalized Patients with Covid-19 |
22/10/2020 |
8108 |
A Framework for Biomarkers of COVID-19 Based on Coordination of Speech-Production Subsystems |
22/10/2020 |
8107 |
A Framework for Biomarkers of COVID-19 Based on Coordination of Speech-Production Subsystems |
22/10/2020 |
8106 |
synthese_tests_antigeniques_vd |
22/10/2020 |
8105 |
Vous êtes sourd _ C’est la Covid-19 ! |
22/10/2020 |
8104 |
Un vaccin inactivé contre la Covid-19, classique mais prometteur ! |
22/10/2020 |
8103 |
Référentiel relatif aux traitements de données à caractère personnel destinées à la gestion des cabinets médicaux et paramédicaux |
22/10/2020 |
8102 |
Probiotiques? bienfaits et méfaits RMS2020 |
22/10/2020 |
8101 |
Nouveau dispositif anti-cadeaux renforcé quelles modalités |
22/10/2020 |
8100 |
Mortalité plus élevée chez les patients souffrant de troubles mentaux hospitalisés pour COVID-19 |
22/10/2020 |
8099 |
Les traitements et le Covid 19, Enjeux et réalités scientifiques |
22/10/2020 |
8098 |
La prévention de la Covid 19, une barrière à la prématurité |
22/10/2020 |
8097 |
Huit mythes persistants sur le COVID-19 et pourquoi les gens les croient – Scientific American |
22/10/2020 |
8096 |
HCQ, et l’on oublie RECOVERY… |
22/10/2020 |
8095 |
euxième vague de COVID-19 les oncologues sont-ils prêts |
22/10/2020 |
8094 |
Déploiement des tests antigéniques _ vers un rendez-vous raté _ |
22/10/2020 |
8093 |
Covid-19, je vous écris d’Italie |
22/10/2020 |
8092 |
COVID-19 et médicaments où en est-on |
22/10/2020 |
8091 |
Combien d’années de vie gagnées grâce à la chirurgie bariatrique chez les patients obèses _ _ Univadis |
22/10/2020 |
8090 |
Arrêt du tabac et grossesse _ l’ADN placentaire garderait une mémoire épigénétique |
22/10/2020 |
8089 |
AP-HP – confirmation des premiers résultats de l’essai CORIMUNO-TOCI-1 _ Le tocilizumab limite l’aggravation et la nécessité de transfert en réanimation des patients atteints de pneumonie COVID-19 modérée à sévère _ APHP |
22/10/2020 |
8088 |
« BCGite » secondaire à l’instillation intravésicale de bacille de Calmette-GuérinRMS2020 |
22/10/2020 |
8087 |
Menopause |
20/10/2020 |
8086 |
Liver Chemistry Interpretattion |
20/10/2020 |
8085 |
Venous thromboembolism in multiple myeloma is associated with increased mortality |
20/10/2020 |
8084 |
Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women |
20/10/2020 |
8083 |
Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for Cardiologists |
20/10/2020 |
8082 |
Nouveau dispositif anti-cadeaux renforcé quelles modalités _ |
20/10/2020 |
8081 |
Management of hypertriglyceridemia |
20/10/2020 |
8080 |
Images in Vascular Medicine_ Peripheral artery thrombosis in critically ill patients with COVID-19 |
20/10/2020 |
8079 |
Hormonal contraception in Women with Hypertension. JAMA, 2020 |
20/10/2020 |
8078 |
First three months of anticoagulation for venous thromboembolism in non-cancer patients_ LMWH VS. VKAs. Findings from the RIETE registry |
20/10/2020 |
8077 |
Current and emerging drug treatment strategies for peripheral arterial disease |
20/10/2020 |
8076 |
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with APL Coch2020 |
20/10/2020 |
8075 |
Active smoking is associated with higher rates of incomplete wound healing after endovascular treatment of critical limb ischemia |
20/10/2020 |
8074 |
Therapeutic Management _ COVID-19 Treatment Guidelines |
18/10/2020 |
8073 |
Scientific consensus on the COVID-19 pandemic_ we need to act now |
18/10/2020 |
8072 |
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates |
18/10/2020 |
8071 |
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results |
18/10/2020 |
8070 |
MEMORANDUM JOHN SNOW – Mémorandum John Snow |
18/10/2020 |
8069 |
LOPINAVIR RITONAVIR COVID ECHEC |
18/10/2020 |
8068 |
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks |
18/10/2020 |
8067 |
Genomewide Association Study of Severe Covid-19 with Respiratory Failure |
18/10/2020 |
8066 |
Genetic Risk of Severe Covid-19 |
18/10/2020 |
8065 |
Fibrin-derived peptide B?15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome |
18/10/2020 |
8064 |
Excess Deaths From COVID-19 and Other Causes, March-July 2020 |
18/10/2020 |
8063 |
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates |
18/10/2020 |
8062 |
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions |
18/10/2020 |
8061 |
Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28 jours comparativement au traitement standardPM2020 |
18/10/2020 |
8060 |
Liver Chemistry Interpretation |
18/10/2020 |
8059 |
Une mammographie tous les ans dès 40 ans |
18/10/2020 |
8058 |
Traitement hormonal de la ménopause et risque TEV ’intérêt de la voie transdermique confirmé |
18/10/2020 |
8057 |
Rapport Pittet |
18/10/2020 |
8056 |
Quand Stop Covid devient… Alerte Covid |
18/10/2020 |
8055 |
Proposition de présentation des documents de recommandations et références professionnelles |
18/10/2020 |
8054 |
Procédure accélérée pour l’approbation des médicaments, ce n’est pas toujours justifié… |
18/10/2020 |
8053 |
Pour la CSMF, le divorce est consommé avec le gouvernement |
18/10/2020 |
8052 |
Peu de chances de survie après un arrêt cardiaque dans les formes sévères de Covid-19 |
18/10/2020 |
8051 |
LOPINAVIR RITONAVIR COVID ECHEC |
18/10/2020 |
8050 |
Le rapport Pittet donne la moyenne à la France pour sa gestion de la crise |
18/10/2020 |
8049 |
Le choix d’une contraception hormonale chez la femme hypertendue |
18/10/2020 |
8048 |
La CNAM le confirme _ aucune revalorisation pour les médecins libéraux avant 2024 ! |
18/10/2020 |
8047 |
Exclusif _ les professionnels estiment que les tests RT-PCR devraient être pratiqués sur ordonnance |
18/10/2020 |
8046 |
EAS 2020 — Des interventions agressives deviennent nécessaires alors que l’Europe ne parvient pas à atteindre les cibles lipidiques optimales _ Univadis |
18/10/2020 |
8045 |
Des auto-anticorps anti-INF de type I dans les formes de Covid-19 menaçant le pronostic vital |
18/10/2020 |
8044 |
Décubitus ventral et patients intubésventilés pour COVIque sait-on |
18/10/2020 |
8043 |
Covid-19, y a-t-il un avenir pour le remdésivir _ |
18/10/2020 |
8042 |
Covid-19, l’espoir naquit un jour du FX06 |
18/10/2020 |
8041 |
Covid-19 et persistance du virus sur les surfaces, pas un (faux) mythe |
18/10/2020 |
8040 |
Covid-19 _ une menace invisible sur la santé mentale |
18/10/2020 |
8039 |
Covid-19 _ le surpoids même modéré obère le pronostic |
18/10/2020 |
8038 |
Covid-19 _ il serait temps de changer de test de dépistage… |
18/10/2020 |
8037 |
Chez les sujets hospitalisés pour COVID-19, est-ce que la dexaméthasone diminue la mortalité à 28 jours comparativement au traitement standardPM2020 |
18/10/2020 |
8036 |
Anosmie de la Covid-19, fréquente à vue de nez et objectivement ! |
18/10/2020 |
8035 |
20.10.9-Tests-Covid-Stratégie |
18/10/2020 |
8034 |
« Une nation solidaire » plutôt qu’une « société d’individus libres » _ couvre feu sanitaire pour 18 millions de Français |
18/10/2020 |
8033 |
Les 5 Type de personnalités face au covid.pdf |
15/10/2020 |
8032 |
American Society of Hematology 2020 guidelines for management of. venous thromboembolism treatment of deep vein thrombosis and pulmonary embolism |
15/10/2020 |
8031 |
Venous Thrombosis |
15/10/2020 |
8030 |
Thrombosis |
15/10/2020 |
8029 |
Syndrome de Sjögren contribution de l’ORL au bilan diagnostiqueRMS2020 |
15/10/2020 |
8028 |
Serial block-face scanning electron microscopy |
15/10/2020 |
8027 |
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous ThromboembolismThe RIETE |
15/10/2020 |
8026 |
Proposition de présentation des documents de recommandations et références professionnelles |
15/10/2020 |
8025 |
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users_ The Coronary Artery Calcium Consortium |
15/10/2020 |
8024 |
Pathophysiology of DKA and HHS |
15/10/2020 |
8023 |
Arteriosclerosis, Thrombosis, and Vascular Biology |
15/10/2020 |
8022 |
ISCHAEMIC STROKE |
15/10/2020 |
8021 |
Icodec ou la possibilité d’une seule injection d’insuline par semaine dans le diabète de type 2 |
15/10/2020 |
8020 |
Essential aspects of optimal care after acute PE |
15/10/2020 |
8019 |
Changing Trends in Hospital Admissions for Pulmonary Embolism in Spain from 2001 to 2018RIETE |
15/10/2020 |
8018 |
Diverticulosis and angiodysplasia |
14/10/2020 |
8017 |
Exercise for intermittent claudication |
14/10/2020 |
8016 |
Therapeutic Management _ COVID-19 Treatment Guidelines |
14/10/2020 |
8015 |
Tests Covid-19 à la recherche d’une stratégie |
14/10/2020 |
8014 |
Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19_ rationale for clinical management |
14/10/2020 |
8013 |
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 |
14/10/2020 |
8012 |
Parcours hospitalier des patients atteints de la Covid-19 lors de la première vague de l’épidémie |
14/10/2020 |
8011 |
In-hospital cardiac arrest in critically ill patients with covid-19_ multicenter cohort study |
14/10/2020 |
8010 |
Excess Deaths From COVID-19 and Other Causes, March-July 2020 |
14/10/2020 |
8009 |
Dying in a Leadership Vacuum |
14/10/2020 |
8008 |
Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic |
14/10/2020 |
8007 |
D-dimer measurement in COVID-19 Silver bullet or clinical distraction |
14/10/2020 |
8006 |
COVID-19 Dépister grâce à l’olfaction de chiens entraînés |
14/10/2020 |
8005 |
COVID-19 and its implications for thrombosis |
14/10/2020 |
8004 |
COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries |
14/10/2020 |
8003 |
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC) a prospective interventional, non-randomised, controlled study |
14/10/2020 |
8002 |
Vascular Disease Patient Information Page- Direct oral anticoagulants 2020 VM |
14/10/2020 |
8001 |
Triage of patients with venous and lymphatic diseases during the COVID-19 pandemic – The Venous and Lymphatic Triage and Acuity Scale (VELTAS)_ |
14/10/2020 |
8000 |
Treatment of systemic necrotizing vasculitides_ The 40-year experience of the French Vasculitis Study Group |
14/10/2020 |
7999 |
Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease |
14/10/2020 |
7998 |
Risk factors in 50-year-old men predicting development of abdominal aortic aneurysm |
14/10/2020 |
7997 |
Family history of atherosclerotic vascular disease is associated with the presence of abdominal aortic aneurysm |
14/10/2020 |
7996 |
Diagnostic performance of lower extremity Doppler ultrasound in detecting iliocaval obstruction |
14/10/2020 |
7995 |
Diabetes medications and risk of Parkinson’s disease a cohort study of patients with diabetes Brain2020 |
14/10/2020 |
7994 |
Developing a vaccine against atherosclerosis |
14/10/2020 |
7993 |
Can an anti-Xa assay for unfractionated heparin be used to assess the presence of rivaroxaban in critical situations_ |
14/10/2020 |
7992 |
Association of obesity with arterial stiffness_ The Multi-Ethnic Study of Atherosclerosis (MESA) |
14/10/2020 |
7991 |
Artériopathie oblitérante des membres inférieurs |
14/10/2020 |
7990 |
ANCA-associated vasculitides_ Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance |
14/10/2020 |
7989 |
Analysis of patent, unstented lower extremity vein segment diameters in 266 patients with venous disease |
14/10/2020 |
7988 |
masque_Covid |
14/10/2020 |
7987 |
Qu’est-ce que la santé _ C’est du chocolat ! |
14/10/2020 |
7986 |
Première vague hospitalière _ une mortalité de 19 % |
14/10/2020 |
7985 |
Post-Covid-19 _ pas de corrélation entre symptômes, imagerie et tests fonctionnels |
14/10/2020 |
7984 |
Parcours hospitalier des patients atteints de la Covid-19 lors de la première vague de l’épidémie |
14/10/2020 |
7983 |
Négociations télémédecine _ ça bugue ! |
14/10/2020 |
7982 |
Les médecins confrontés aux demandes de «?certificat de virginité?» – Revue Médicale Suisse |
14/10/2020 |
7981 |
Le choix d’une contraception hormonale chez la femme hypertendue |
14/10/2020 |
7980 |
La vie des patients atteints de SEP, c’est un peu mieux avec les extraits de cannabis… |
14/10/2020 |
7979 |
L’immunité protectrice contre les coronavirus saisonniers est de courte durée |
14/10/2020 |
7978 |
Embolie pulmonaire dans la Covid-19, les leçons d’une cohorte française |
14/10/2020 |
7977 |
Des antibiotiques pour l’appendicite, un intérêt à l’ère de la Covid-19… |
14/10/2020 |
7976 |
COVID-19 Dépister grâce à l’olfaction de chiens entraînés |
14/10/2020 |
7975 |
Covid-19 une maladie vasculaire associée à une coagulopathie |
14/10/2020 |
7974 |
COVID-19 évolution de la prise en charge thérapeutique en France sur 3 mois |
14/10/2020 |
7973 |
COVID-19 et pollution atmosphérique _ Univadis |
14/10/2020 |
7972 |
JAMA Internal Medicine |
14/10/2020 |
7971 |
COVID-19 Natural history |
14/10/2020 |
7970 |
Salameh_et_al-2020-Cochrane_Database_of_Systematic_Reviews |
14/10/2020 |
7969 |
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol_ development and validation of the 4C Mortality Score |
14/10/2020 |
7968 |
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19 |
14/10/2020 |
7967 |
Négociations télémédecine _ ça bugue ! |
14/10/2020 |
7966 |
Matt Morgan_ Treating a VIP patient |
14/10/2020 |
7965 |
Long-term Health Consequences of COVID-19 |
14/10/2020 |
7964 |
In-hospital cardiac arrest in critically ill patients with covid-19_ multicenter cohort study |
14/10/2020 |
7963 |
Covid-19 _ plus de formes asymptomatiques grâce aux masques et peut-être une « variolisation » |
14/10/2020 |
7962 |
Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States |
14/10/2020 |
7961 |
COVID-19-associated vasculitis and vasculopathy |
14/10/2020 |
7960 |
Covid-19_ People are gathering again, but can crowds be made safe |
14/10/2020 |
7959 |
COVID-19 évolution de la prise en charge thérapeutique en France sur 3 mois |
14/10/2020 |
7958 |
COVID HEARTFAILURE |
14/10/2020 |
7957 |
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia |
14/10/2020 |
7956 |
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS?CoV?2 infection |
14/10/2020 |
7955 |
Anticipating the long-term cardiovascular effects of COVID-19 |
14/10/2020 |
7954 |
Syndrome de Clarkson |
14/10/2020 |
7953 |
Potential brain mechanisms for preventive strategies in dementia |
14/10/2020 |
7952 |
POEMS syndrome Diagnosis and treatment |
14/10/2020 |
7951 |
Yield of ultrasonography in patients with or without post?thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis |
14/10/2020 |
7950 |
Tranexamic acid in acute gastrointestinal bleeding – A cautionary tale |
14/10/2020 |
7949 |
The hazard of (sub)therapeutic doses of anticoagulants in non?critically ill patients with Covid?19_ The Padua province experience |
14/10/2020 |
7948 |
The cancer patient and cardiology EHJ2020 |
14/10/2020 |
7947 |
Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism |
14/10/2020 |
7946 |
Risk scores for occult cancer in patients with unprovoked venous thromboembolism_ Results from an individual patient data meta?analysis |
14/10/2020 |
7945 |
Quand un « game changer » se confirme _ PerrUche en Automne |
14/10/2020 |
7944 |
Preeclampsia-Pathophysiology and Clinical PresentationsJACC2020 |
14/10/2020 |
7943 |
Intracranial Arterial Calcification_ Prevalence, Risk Factors, and _Consequences |
14/10/2020 |
7942 |
International Variations and Sex Disparities in the Treatment of Peripheral Arterial Occlusive Disease_ A Report from VASCUNET and the International Consortium of Vascular Registries |
14/10/2020 |
7941 |
Increased Ddimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolismTR2020 |
14/10/2020 |
7940 |
Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care UnitTH2020 |
14/10/2020 |
7939 |
Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous Thromboembolism |
14/10/2020 |
7938 |
Clinical Characteristics and Outcomes of Women presenting VTE pregnancy Riete TH 2020 |
14/10/2020 |
7937 |
People with heart failure are more vulnerable to covid-19 |
14/10/2020 |
7936 |
COVID-19 Transmission |
14/10/2020 |
7935 |
Vers une médecine de précision dans le diabète |
14/10/2020 |
7934 |
Vaccins contre le COVID-19 où en est la recherche clinique fin septembre |
14/10/2020 |
7933 |
Surprise d’octobre _ Donald Trump testé positif au Covid-19 |
14/10/2020 |
7932 |
Referentiel COVID GHT06 v2 |
14/10/2020 |
7931 |
Quand un « game changer » se confirme _ PerrUche en Automne |
14/10/2020 |
7930 |
patients atteints de COVID19 récupérés sur 10 ressentent des effets secondaires |
14/10/2020 |
7929 |
Où l’alcool conduit à la démence, à plus d’un titre |
14/10/2020 |
7928 |
Mauvais impact du SARS-CoV-2 sur les maladies chroniques du foie, et inversement |
14/10/2020 |
7927 |
La corticothérapie inhalée pour BPCO ou asthme n’augmente pas la mortalité liée à la Covid-19 |
14/10/2020 |
7926 |
Hydroxychloroquine _ les recommandations des agences sanitaires.. |
14/10/2020 |
7925 |
Alerte épidémique Prise en charge des patients atteints de la maladie COVID-19 Etat des connaissances |
14/10/2020 |
7924 |
Covid-19 grave _ la piste prometteuse de l’ACE2 humaine recombinante |
14/10/2020 |
7923 |
Covid-19 et réanimation _ des tests sérologiques rapides pour faire le tri _ |
14/10/2020 |
7922 |
Anticoagulation du sujet âgé vulnérable avec fibrillation auriculaire?risques et bénéficeRMS2020 |
14/10/2020 |
7921 |
A la rencontre d’un nouveau type de test diagnostique pour la Covid-19 |
14/10/2020 |
7920 |
Séquence don une histoire de coeur |
07/10/2020 |
7919 |
Recommandations SAPL, thrombose et anticoagulants |
07/10/2020 |
7918 |
La Covid-19 en plein coeur |
07/10/2020 |
7917 |
Du cygne noir au rhinocéros gris en passant par le cygne blanc |
07/10/2020 |
7916 |
People with heart failure are more vulnerable to COVI-19 |
01/10/2020 |
7915 |
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals |
01/10/2020 |
7914 |
Sous le film, se cache la satisfaction _ L’efficacité de XYBILUN® en vie réelle |
01/10/2020 |
7913 |
Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2 |
01/10/2020 |
7912 |
rth2.12439-min |
01/10/2020 |
7911 |
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment |
01/10/2020 |
7910 |
Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease_ US Multi-center Study |
01/10/2020 |
7909 |
Covid-19 sévère _ ne pas attendre l’USI pour les corticoïdes… |
01/10/2020 |
7908 |
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm |
01/10/2020 |
7907 |
Hydroxychloroquine _ les recommandations des agences sanitaires.. |
01/10/2020 |
7906 |
Human Challenge Vaccine 2011 |
01/10/2020 |
7905 |
Efficacy of Corticosteroids in Non-Intensive Care Unit patients with COVID-19 pneumonia from the New York Metropolitan region |
01/10/2020 |
7904 |
COVID-19 versus HIT hypercoagulability |
01/10/2020 |
7903 |
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong |
01/10/2020 |
7902 |
Australian firm says its nasal spray reduced coronavirus growth in animal study _ Reuters |
01/10/2020 |
7901 |
GPL-1 |
29/09/2020 |
7900 |
Tubular Acidifications Defect in Adults with Sickle Cell Disease |
29/09/2020 |
7899 |
Cutaneous manifestattions of monoclonal gammopathy |
29/09/2020 |
7898 |
Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease |
29/09/2020 |
7897 |
Retention of Point-of-care Ultrasound Skills among Practicing PhysiciansAJM2020 |
29/09/2020 |
7896 |
Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders |
29/09/2020 |
7895 |
Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonistsTR2020 |
29/09/2020 |
7894 |
Heparins as cancer therapy_ in theory, they should have worked |
29/09/2020 |
7893 |
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program |
29/09/2020 |
7892 |
Evaluating prophylactic heparin in ambulatory patients with solid tumours_ a systematic review and individual participant data meta-analysis |
29/09/2020 |
7891 |
Epidemiology and 3?year outcomes of combined oral contraceptive–associated distal deep vein thrombosis |
29/09/2020 |
7890 |
Cost-effectiveness analysis of asymptomatic PAD disease screening with ABI testy VM 2018 |
29/09/2020 |
7889 |
Carotid Intima-Media Thickness and the Risk of sufdden cardiac death 2020 JAHA |
29/09/2020 |
7888 |
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease_ A Scientific Statement From the American Heart Association |
29/09/2020 |
7887 |
Apport de l’échographie rénale dans l’hypertension artérielleRMS2020 |
29/09/2020 |
7886 |
Anticoagulation du sujet âgé vulnérable avec fibrillation auriculaire?risques et bénéficeRMS2020 |
29/09/2020 |
7885 |
Un collectif de médecins favorable à l’HCQ fait référence à Mengele… et est sévèrement condamné par l’Ordre |
27/09/2020 |
7884 |
Quand la Covid inspire les médecins libéraux 3 récits de crise |
27/09/2020 |
7883 |
Prise de poids lors des corticothérapies au long cours, plus de 10 % dans 10 % des cas |
27/09/2020 |
7882 |
Post-Covid-19 _ pas de corrélation entre symptômes, imagerie et tests fonctionnels |
27/09/2020 |
7881 |
Pollution et arythmie, les PM 2,5 matter… |
27/09/2020 |
7880 |
Nouveau mic-mac autour du Remdesivir |
27/09/2020 |
7879 |
Les nouveautés en prévention primaire et stratification du risque cardiovasculaire |
27/09/2020 |
7878 |
La Chine entre prudence et triomphalisme |
27/09/2020 |
7877 |
Du sport après la prothèse du genou |
27/09/2020 |
7876 |
Covid-19 _ les injonctions contradictoires faites aux français |
27/09/2020 |
7875 |
Covid-19 _ le coût humain de l’immunité collective |
27/09/2020 |
7874 |
Chiffres du Covid-19 en France _ couacs en stock |
27/09/2020 |
7873 |
Embolie pulmonaire à risque intermédiaire. Point sur la stratification du risque et implications thérapeutiquesRMS2020 |
27/09/2020 |
7872 |
Covid-19 _ quand de jeunes enfants ramènent le coronavirus à la maison – Réalités Biomédicales |
27/09/2020 |
7871 |
AKI in patients treated with anti-PD1 for advanced melanoma a real-life study in a single centre cohort of 239 patients |
27/09/2020 |
7870 |
Angioedémes bradykiniques |
27/09/2020 |
7869 |
Cutaneous manifestations associated with myelodysplastic syndrome |
27/09/2020 |
7868 |
Ocular Ultrasound Pocket Card |
27/09/2020 |
7867 |
Some mechanisms of resistance to antibiotics |
27/09/2020 |
7866 |
Symptoms and signs of Heart Failure |
27/09/2020 |
7865 |
VTE risk assessment in pregnancyRPTH2020 |
27/09/2020 |
7864 |
Sex-related characteristics of cerebral vein thrombosis A secondary analysis of a multicenter international cohort study |
27/09/2020 |
7863 |
Résultat des saignements intracrâniens gérés avec le concentré de complexe prothrombique chez les patients sous inhibiteurs directs du facteur Xa ou antagonistes de la vitamine KTR2020 |
27/09/2020 |
7862 |
Olivier Véran face au fiasco des tests PCR |
27/09/2020 |
7861 |
Evaluation of Oral Factor Xa inhibitor?associated Extracranial Bleeding Reversal with Andexanet alfa |
27/09/2020 |
7860 |
Embolie pulmonaire à risque intermédiaire. Point sur la stratification du risque et implications thérapeutiquesRMS2020 |
27/09/2020 |
7859 |
Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous ThromboembolismValidation Study from RIETE Registry |
27/09/2020 |
7858 |
A Requisite Concept for the Emergence of Point-of-Care Ultrasound.pdf |
27/09/2020 |
7857 |
2020_kahn_sr_prevention_mtev_chirurgie_orthopedique_tr |
27/09/2020 |
7856 |
Surveillance de la Covid-19 par test salivaire _ on mélange tout ! |
27/09/2020 |
7855 |
SHERLOCK à la recherche du SARS-CoV-2, c’est devenu élémentaire ! |
27/09/2020 |
7854 |
Ségur _ la revalorisation des futurs médecins et des PH officiellement adoptée |
27/09/2020 |
7853 |
recos HAS tests antigéniquesrecos HAS tests antigéniques |
27/09/2020 |
7852 |
Protection contre le SARS-CoV-2 par les lunettes, c’est à voir ! |
27/09/2020 |
7851 |
Mise-à-jour-transmission-aeroportee-du-SARS-C-oV-2 |
27/09/2020 |
7850 |
L’_éthylotest_ de la Covid-19 _ des équipes lyonnaises à l’origine d’un système de dépistage révolutionnaire |
27/09/2020 |
7849 |
Faire de l’exercice empêcherait la progression des AAA de petite taille ! |
27/09/2020 |
7848 |
Enoxaparine après chirurgie pour cancers hépatobiliaires et pancréatiques, le bon choix |
27/09/2020 |
7847 |
covid19-coreb-dia14sept2020 |
27/09/2020 |
7846 |
Covid-19 nous a changé |
27/09/2020 |
7845 |
Covid-19 nous a changé |
27/09/2020 |
7844 |
COVID-19 ET VACCINATION CONTRE LA GRIPPE_L’ÉQUATION FRANÇAISE |
27/09/2020 |
7843 |
Covid-19 et retard au dépistage du cancer colorectal, un autre dossier à charge |
27/09/2020 |
7842 |
COVID-19 et maladie thromboembolique veineuse |
27/09/2020 |
7841 |
Covid-19 _ l’hypokaliémie annoncerait une forme sévère |
27/09/2020 |
7840 |
Covid-19 _ et voilà pourquoi les enfants sont moins gravement atteints |
27/09/2020 |
7839 |
Confinement en France, 30 % d’admissions pour IDM en moins |
27/09/2020 |
7838 |
avis_n_2020.0049acseap_du_24_septembre_2020_du_college_de_la_haute_autorite_de_sante_relatif_a_linscription_sur_la_liste_des |
27/09/2020 |
7837 |
« L’infodémie » le mal du siècle |
27/09/2020 |
7836 |
MEDICAMENT ET INTERCATION CANCER |
27/09/2020 |
7835 |
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome_ Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis |
27/09/2020 |
7834 |
recos HAS tests antigéniques |
27/09/2020 |
7833 |
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19 |
27/09/2020 |
7832 |
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 |
27/09/2020 |
7831 |
NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring _ National Institutes of Health (NIH) |
27/09/2020 |
7830 |
Mise-à-jour-transmission-aeroportee-du-SARS-C-oV-2 |
27/09/2020 |
7829 |
Mise-à-jour-transmission-aeroportee-du-SARS-C-oV-2 |
27/09/2020 |
7828 |
IRA et COVID19 |
27/09/2020 |
7827 |
Le danger du fondaparinux chez les patients non gravement malades atteints de COVID-19étude contrôlée rétrospective versus énoxaparine |
27/09/2020 |
7826 |
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers a randomized trial |
27/09/2020 |
7825 |
Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19 |
27/09/2020 |
7824 |
COVID?19_ A collision of complement, coagulation and inflammatory pathways |
27/09/2020 |
7823 |
Alerte épidémique Prise en charge des patients atteints de la maladie COVID-19 Etat des connaissances |
27/09/2020 |
7822 |
COVID?19_ A collision of complement, coagulation and inflammatory pathways |
27/09/2020 |
7821 |
COVID-19 et maladie thromboembolique veineuse |
27/09/2020 |
7820 |
Covid-19- Do many people have pre-existing immunity_ |
27/09/2020 |
7819 |
COVID-19 clinical trials_ learning from exceptions in the research chaos |
27/09/2020 |
7818 |
 |
27/09/2020 |
7817 |
COVID-19 can affect the heart |
27/09/2020 |
7816 |
Covid-19 _ quand de jeunes enfants ramènent le coronavirus à la maison – Réalités Biomédicales |
27/09/2020 |
7815 |
Coagulopathy in COVID?19 |
27/09/2020 |
7814 |
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19 |
27/09/2020 |
7813 |
Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020 |
27/09/2020 |
7812 |
avis_n_2020.0049acseap_du_24_septembre_2020_du_college_de_la_haute_autorite_de_sante_relatif_a_linscription_sur_la_liste_des |
27/09/2020 |
7811 |
Association of SARS-CoV-2 Test Status and Pregnancy Outcomes |
27/09/2020 |
7810 |
Anticoagulation thérapeutique versus prophylactique pour COVID-19 sévère essai clinique randomisé de phase II (HESACOVID)TR2020 |
27/09/2020 |
7809 |
Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak |
27/09/2020 |
7808 |
Recommandations pour la prise en charge des patients atteints de maladies vasculaires ou de facteurs de risque cardiovasculaire et COVID-19 |
20/09/2020 |
7807 |
Tyrrell_et_al-2020-Nature_Reviews_Cardiology |
20/09/2020 |
7806 |
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism |
20/09/2020 |
7805 |
Reconstituer le puzzle du lymphoedème primaire _ UCLouvain |
20/09/2020 |
7804 |
Microvascular Disease Increases Amputation in Patients With Peripheral Artery Disease |
20/09/2020 |
7803 |
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health |
20/09/2020 |
7802 |
Long-term anticoagulant treatment in patients with inferior vena cava agenesis and deep vein thrombosis |
20/09/2020 |
7801 |
Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines |
20/09/2020 |
7800 |
Cerebral venous sinus thrombosis EMCrit Project |
20/09/2020 |
7799 |
Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus |
20/09/2020 |
7798 |
Association of Factor V Leiden with Subsequent Atherothrombotic Events_ A GENIUS-CHD Study of Individual Participant Data |
20/09/2020 |
7797 |
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system |
20/09/2020 |
7796 |
CheckList commande |
20/09/2020 |
7795 |
Eh8MukcWkAA5JH4 |
20/09/2020 |
7794 |
vaccins dans le monde lancet |
20/09/2020 |
7793 |
Use of “normal” risk to improve understanding of dangers of covid-19 |
20/09/2020 |
7792 |
Un collectif de médecins favorable à l’HCQ fait référence à Mengele… et est sévèrement condamné par l’Ordre |
20/09/2020 |
7791 |
The Lancet Derivation and validation of a predictive score for disease worsening in patients with COVID-19. The COMPASS-COVID-19 prospective observational cohort study |
20/09/2020 |
7790 |
Should countries aim for elimination in the covid-19 pandemic |
20/09/2020 |
7789 |
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 |
20/09/2020 |
7788 |
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol_ development and validation of the 4C Mortality Score |
20/09/2020 |
7787 |
Post-Covid-19 _ pas de corrélation entre symptômes, imagerie et tests fonctionnels |
20/09/2020 |
7786 |
Molecular architecture of the SARS-CoV-2 virus |
20/09/2020 |
7785 |
Long-term anticoagulant treatment in patients with inferior vena cava agenesis and deep vein thrombosis |
20/09/2020 |
7784 |
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19 Position Paper from VAS-European Independent Foundation in Angiology Vascular Medicine |
20/09/2020 |
7783 |
Effect of gastrointestinal symptoms on patients infected with COVID-19 |
20/09/2020 |
7782 |
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation |
20/09/2020 |
7781 |
Azithromycin for severe COVID-19 |
20/09/2020 |
7780 |
Association between Covid-19 and Pulmonary Embolism (AC-19-PE study) |
20/09/2020 |
7779 |
Transplantation hépatique et Covid-19 _ une liaison pas si dangereuse |
20/09/2020 |
7778 |
Thrombose artérielle et athérome _ le facteur V Leiden n’y est pour rien |
20/09/2020 |
7777 |
Sur la piste des anticorps contre le SARS-CoV-2 en Islande |
20/09/2020 |
7776 |
Statines liées à une réduction de la mortalité chez COVID-19 _ Cardiologie MDedge |
20/09/2020 |
7775 |
SARS-CoV-2 _ le point de vue des pharmacologues |
20/09/2020 |
7774 |
Leurrer le virus de la Covid-19, une brillante idée |
20/09/2020 |
7773 |
Les nouveaux médicaments remboursés pour les patients diabétiques etou à très haut risque CV |
20/09/2020 |
7772 |
Le Royaume-Uni rattrapée par la reprise de l’épidémie |
20/09/2020 |
7771 |
Le cas d’Alain Cocq, atteint d’une maladie incurable, relance le débat sur les limites de la loi Leonetti |
20/09/2020 |
7770 |
Il y avait des bronchiolites à coronavirus avant la Covid-19 ! |
20/09/2020 |
7769 |
Gmail – 100 milliards pour la relance, dont 6 pour la santé |
20/09/2020 |
7768 |
Formes sévères de COVID-19faut-il renforcer l’anticoagulation |
20/09/2020 |
7767 |
ESC 2020 — La colchicine à faible dose est bénéfique chez les patients atteints d’une maladie coronarienne chronique _ Univadis |
20/09/2020 |
7766 |
Des infiltrations de dextrose pour le syndrome du canal carpien, bénéfiques à long terme… |
20/09/2020 |
7765 |
Covid-19 et inhibiteurs de checkpoint immunitaire, rien n’est sous contrôle |
20/09/2020 |
7764 |
Covid-19 _ Oui aux corticoïdes dans les formes graves |
20/09/2020 |
7763 |
Covid _ le point sur 3 candidats vaccins _ La Revue du Praticien |
20/09/2020 |
7762 |
Colorations permanentes et cancer, un risque en demi-teinte |
20/09/2020 |
7761 |
APMnews – Covid-19_ le conseil scientifique recommande de limiter la durée d’_isolement à 7 jours pleins |
20/09/2020 |
7760 |
20.9.7 Du bon usage masques |
20/09/2020 |
7759 |
COVID-19 Le loto gagnant |
09/09/2020 |
7758 |
COVID-19 est, en en fin de compte, une maladie endothéliale |
09/09/2020 |
7757 |
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD |
09/09/2020 |
7756 |
What’s new in VTE risk and prevention in orthopedic surgery |
09/09/2020 |
7755 |
Utilisation clinique et coût des tests de thrombophilie chez les patients atteints de thromboembolie veineuse |
09/09/2020 |
7754 |
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism |
09/09/2020 |
7753 |
The incidence of thrombotic events with idarucizumab and andexanet alfa- A systematic review and meta-analysis |
09/09/2020 |
7752 |
The Expected 30-Year Benefits of Early CV prevention |
09/09/2020 |
7751 |
Surveillance Imaging After Endovascular Abdominal Aortic Aneurysm Repair_ A Necessary Enigma! |
09/09/2020 |
7750 |
Paclitaxel and Mortality Following Peripheral Angioplasty_ An Adjusted and Case Matched Multicentre Analysis |
09/09/2020 |
7749 |
Long Distance Triathlete With Iliac Endofibrosis |
09/09/2020 |
7748 |
How I treat von Willebrand disease |
09/09/2020 |
7747 |
Exposure to Air Pollution and Particle |
09/09/2020 |
7746 |
Clinical Outcomes of May–Thurner Syndrome in Pediatric PatientsA Single Institutional Experience |
09/09/2020 |
7745 |
Chez les sujets avec maladie artérielle périphérique symptomatique ayant eu une revascularisation aux membres inférieurs, est-ce que le rivaroxaban 2,5?mg deux fois par jour |
09/09/2020 |
7744 |
Apixaban for Stroke Prevention in Atrial Fibrillation Why are Event Rates Higher in Clinical Practice than in Randomized TrialsTH2020 |
09/09/2020 |
7743 |
Un essai clinique pour vérifier si l’héparine peut traiter la COVID-19 _ Coronavirus _ Radio-Canada.ca |
03/09/2020 |
7742 |
Séquençage de SARS-CoV-2 _ la spécificité française |
03/09/2020 |
7741 |
Score calcique nul ne veut pas dire risque CV zéro |
03/09/2020 |
7740 |
Politique de santé — Les mesures contre le Covid-19 ont été _trop p… – HOSPIMEDIA |
03/09/2020 |
7739 |
Le test salivaire, une alternative fiable pour le diagnostic de la Covid-19 ! |
03/09/2020 |
7738 |
IDM avant 50 ans, mieux vaut arrêter de fumer ! |
03/09/2020 |
7737 |
Hydroxychloroquine avec ou sans azithromycine dans la Covid 19 _ le chant du cygne _ |
03/09/2020 |
7736 |
Donald Trump a trouvé son anti-Fauci |
03/09/2020 |
7735 |
Direct 1er septembre _ Enquête judiciaire sur les pénuries de masques au bloc _ France _ les chiffres de la réa en hausse |
03/09/2020 |
7734 |
COVID-19 _ le report de FIV s’accompagne de plus d’anxiété ou de dépression |
03/09/2020 |
7733 |
Cancer et Covid-19 _ le risque n’est pas le même pour tous |
03/09/2020 |
7732 |
Traitement des patients diabétiques de type 2 à risque cardio-rénal?ESC versus ADA-EASDRMS2020 |
03/09/2020 |
7731 |
Thrombophilia assessment in presence of a venous thromboembolic disease and therapeutic consequencesJMV2020 |
03/09/2020 |
7730 |
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease_ Insights from the COMPASS Trial |
03/09/2020 |
7729 |
Symptomatic carotid web_ About a rare ultrasound finding |
03/09/2020 |
7728 |
Protection cardiorénale avec les inhibiteurs des SGLT2? d’EMPA-REG OUTCOME à VERTIS CVRMS2020 |
03/09/2020 |
7727 |
Pneumopathies associées au vapotage RMS2020 |
03/09/2020 |
7726 |
Phenomics, Not Genomics, for Cardiovascular Risk Assessment |
03/09/2020 |
7725 |
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi |
03/09/2020 |
7724 |
Management of upper extremity deep vein thrombosis in Occitanie_ practice assessment |
03/09/2020 |
7723 |
Efficacy and Safety of Low-Molecular-Weight Heparin on Prevention of Venous Thromboembolism after Laparoscopic Operation for Gastrointestinal Malignancy in Japanese Patients |
03/09/2020 |
7722 |
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy_ The PREVENTER Randomized Clinical Trial |
03/09/2020 |
7721 |
Early detection of the existence or absence of the treatment effect |
03/09/2020 |
7720 |
De la différence entre consensus d’experts et recommandations |
03/09/2020 |
7719 |
Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments?RMS |
03/09/2020 |
7718 |
Atherosclerotic Plaque Healing |
03/09/2020 |
7717 |
Air pollution and family related determinants of asthma onset and persistent wheezing in children- nationwide case-control study |
03/09/2020 |
7716 |
Traitement des patients diabétiques de type 2 à risque cardio-rénal?ESC versus ADA-EASDRMS2020 |
30/08/2020 |
7715 |
Réadaptation post-COVID-19? retour d’expérience RMS |
30/08/2020 |
7714 |
Protection cardiorénale avec les inhibiteurs des SGLT2? d’EMPA-REG OUTCOME à VERTIS CVRMS2020 |
30/08/2020 |
7713 |
Pneumopathies associées au vapotage RMS2020 |
30/08/2020 |
7712 |
Nouveau témoignage de l’absence d’impact des inhibiteurs du SRAA sur l’évolution de la Covid-19_ |
30/08/2020 |
7711 |
Formes sévères de COVID-19 _ faut-il pousser l’anticoagulation _ _ Univadis |
30/08/2020 |
7710 |
De la différence entre consensus d’experts et recommandations |
30/08/2020 |
7709 |
Covid-19, un traitement héroïque |
30/08/2020 |
7708 |
Covid-19, hashtag désinformation…virale |
30/08/2020 |
7707 |
COVID-19 – La distanciation physique est efficace sur l’incidence et les taux de mortalité _ Univadis |
30/08/2020 |
7706 |
Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments?RMS |
30/08/2020 |
7705 |
Calprotectine élevée et anomalies myéloïdes dans les formes sévères de Covid-19 |
30/08/2020 |
7704 |
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19 |
27/08/2020 |
7703 |
The protective rather than prothrombotic fibrinogen in COVID?19 and other inflammatory states |
27/08/2020 |
7702 |
Racial Disproportionality in Covid Clinical Trials |
27/08/2020 |
7701 |
Quousque-tandem-abutere |
27/08/2020 |
7700 |
Open Science Saves Lives_ Lessons from the COVID-19 Pandemic |
27/08/2020 |
7699 |
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized |
27/08/2020 |
7698 |
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19_ A Randomized Clinical Trial |
27/08/2020 |
7697 |
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients_ a systematic review and meta-analysis |
27/08/2020 |
7696 |
Direct 26 août _ Maladie professionnelle et Covid _ indemnisations pour les formes graves _ Nouvelles suspicions de réinfections _ |
27/08/2020 |
7695 |
COVID-19_ Myocardial injury in survivors Circ2020 |
27/08/2020 |
7694 |
Covid-19 and Immunity in Aging Populations — A New Research Agenda |
27/08/2020 |
7693 |
COVID-19 au 20 août, incidence en hausse chez les moins de 40 ans |
27/08/2020 |
7692 |
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID?19 |
27/08/2020 |
7691 |
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19_ A Single Health System Study |
27/08/2020 |
7690 |
Les épidémies marquantes aux 20ème et 21 ème siècles |
27/08/2020 |
7689 |
L’alcool voila l’enemi |
27/08/2020 |
7688 |
Vaccination obligatoire contre la Covid-19 _ un débat mondial est lancé |
27/08/2020 |
7687 |
SARS-CoV-2, une mutation qui change (peut-être) tout _ |
27/08/2020 |
7686 |
Professionnels de santé vous revenez de congés, faites-vous dépister |
27/08/2020 |
7685 |
Le cœur dans la Covid-19, souvent et longtemps atteint |
27/08/2020 |
7684 |
Hôpitaux publics pas prêts pour une deuxième vague, selon le CIH |
27/08/2020 |
7683 |
Direct 26 août _ Maladie professionnelle et Covid _ indemnisations pour les formes graves _ Nouvelles suspicions de réinfections _ |
27/08/2020 |
7682 |
Diagnostiquer la mort cérébrale |
27/08/2020 |
7681 |
COVID-19la hausse des états dépressifs met la psychiatrie en alerte |
27/08/2020 |
7680 |
Covid-19 et famotidine, une nouvelle piste |
27/08/2020 |
7679 |
COVID-19 et ECMO _ osons ! |
27/08/2020 |
7678 |
Covid-19 et confinement _ un impact sur la santé mentale |
27/08/2020 |
7677 |
Covid-19 _ Haut-les Masques ou petit abrégé de masquologie |
27/08/2020 |
7676 |
Covid-19 _ et si l’incubation était plus longue |
27/08/2020 |
7675 |
Coronavirus _ un premier cas de réinfection confirmé par des chercheurs – Le Point |
27/08/2020 |
7674 |
 |
27/08/2020 |
7673 |
Haw to make your blood pressure at home |
25/08/2020 |
7672 |
Traumatic Vascular Injury to the Hand |
25/08/2020 |
7671 |
Evinacumab for Homozygous Familial Hypercholesterolemia |
25/08/2020 |
7670 |
Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas |
25/08/2020 |
7669 |
Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. |
25/08/2020 |
7668 |
Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration 70 mgdL |
25/08/2020 |
7667 |
Built Environment Approaches to Increase Physical ActivityA Science Advisory From the American Heart Association. |
25/08/2020 |
7666 |
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults |
25/08/2020 |
7665 |
A single center retrospective cohort study evaluating use of direct oral anticoagulants (DOACs) in morbidly obese veteran population |
25/08/2020 |
7664 |
Venous thromboembolism in patients with COVID-19TH2020 |
24/08/2020 |
7663 |
Venous thromboembolism after fast-track unicompartmental knee arthroplasty – A prospective multicentre cohort study of 3927 procedures |
24/08/2020 |
7662 |
Vaccination obligatoire contre la Covid-19 _ un débat mondial est lancé |
24/08/2020 |
7661 |
Successful Elimination of Covid-19 Transmission in New Zealand |
24/08/2020 |
7660 |
Soins dentaires et Covid _ on ouvre le parapluie |
24/08/2020 |
7659 |
Plans and Pandemics |
24/08/2020 |
7658 |
Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19 |
24/08/2020 |
7657 |
More on Covid-19 in Immune-Mediated Inflammatory Diseases |
24/08/2020 |
7656 |
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients_ A Systematic Review and Meta-Analysis |
24/08/2020 |
7655 |
Incidence of venous and arterial thromboembolic complications in Covid19 |
24/08/2020 |
7654 |
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19 |
24/08/2020 |
7653 |
Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities |
24/08/2020 |
7652 |
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China_ A retrospective cohort study |
24/08/2020 |
7651 |
Challenges of “Return to Work” in an Ongoing Pandemic |
24/08/2020 |
7650 |
Case 26-2020_ A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Side |
24/08/2020 |
7649 |
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit |
24/08/2020 |
7648 |
Haut Conseil de la santé publique |
24/08/2020 |
7647 |
Soins dentaires et Covid _ on ouvre le parapluie |
24/08/2020 |
7646 |
Risque élevé de mort subite chez les jeunes diabétiques |
24/08/2020 |
7645 |
Relations soignantssoignés dans le monde d’après résultats du Baromètre Santé 360 NehsOdox |
24/08/2020 |
7644 |
Patients hémodialysés _ un lien entre hyperphosphatémie et AOMI |
24/08/2020 |
7643 |
Orteils COVID et autres éruptions cutanées associées au COVID-19 – Consultez QD |
24/08/2020 |
7642 |
Obésité _ l’anakinra (anti-IL-1) diminuerait la pression artérielle |
24/08/2020 |
7641 |
FA _ en cas de seconde ablation de FA, préférez l’empirisme pour prévenir les récidives |
24/08/2020 |
7640 |
COVID-19 quel impact en hépatologie |
24/08/2020 |
7639 |
Covid-19 et sexualité, quels rapports |
24/08/2020 |
7638 |
Covid-19 des enfants et jeunes adultes, pas toujours bénigne |
24/08/2020 |
7637 |
Covid-19 _ surmortalité hospitalière en cas de diabète, de type 1 comme de type 2 |
24/08/2020 |
7636 |
COVID-19 et système cardiovasculaire |
24/08/2020 |
7635 |
Moins de Soin, est-ce moins bien soigner _ Réflexions sur la pratique de la cardiologie – Insuffisant Cardiologue |
24/08/2020 |
7634 |
Coronavirus, goccioline vive e infettive isolate nell’aria – Corriere.it |
24/08/2020 |
7633 |
Contrôles de santé généraux chez les adultes pour réduire la morbidité et la mortalité dues à la maladie – Krogsbøll, LT – 2019 _ Bibliothèque Cochrane (1) |
24/08/2020 |
7632 |
ISCHEMIA-CKD Circ 2020 |
24/08/2020 |
7631 |
Spontaneous Coronary Artery Dissection |
24/08/2020 |
7630 |
Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy |
24/08/2020 |
7629 |
Placebos without deception reduce self-report and neural measures of emotional distress |
24/08/2020 |
7628 |
Moins de Soin, est-ce moins bien soigner _ Réflexions sur la pratique de la cardiologie – Insuffisant Cardiologue |
24/08/2020 |
7627 |
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk |
24/08/2020 |
7626 |
Liban plus de la moitié des hôpitaux hors service et hausse spectaculaire des cas de COVID |
24/08/2020 |
7625 |
Interactions médicament-médicament affectant les niveaux de médicaments des anticoagulants oraux directs dans le monde réel |
24/08/2020 |
7624 |
How I treat venous thromboembolism in pregnancy Blood2020 |
24/08/2020 |
7623 |
Does Reduced Carotid Intima Media Thickness Progression Predict Cardiovascular Risk Reduction_ |
24/08/2020 |
7622 |
Contrôles de santé généraux chez les adultes pour réduire la morbidité et la mortalité dues à la maladie – Krogsbøll, LT – 2019 _ Bibliothèque Cochrane |
24/08/2020 |
7621 |
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk |
24/08/2020 |
7620 |
Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data.Circ2020 |
24/08/2020 |
7619 |
Ambient air pollution and cause-specific risk of hospital admission in China_ A nationwide time-series study |
24/08/2020 |
7618 |
Le défi du diagnostic |
15/08/2020 |
7617 |
Soins intensifs survie à quel prix |
15/08/2020 |
7616 |
COVID 19 et médecine ambulatoire |
15/08/2020 |
7615 |
COVID-19? QUE SAIT ON AUJOURD HUI SUR SES DIFFÉRENTES SÉQUELLES? |
15/08/2020 |
7614 |
Vaccin anti SARS-CoV-2 qui et comment faudra-t-il vacciner |
15/08/2020 |
7613 |
Statines _ un arrêt sur 3 est influencé par les médias |
15/08/2020 |
7612 |
Mutation dans la protéine Spike de SARS-CoV-2 – Revue Médicale Suisse |
15/08/2020 |
7611 |
Liban plus de la moitié des hôpitaux hors service et hausse spectaculaire des cas de COVID |
15/08/2020 |
7610 |
La course au vaccin remportée par la Russie |
15/08/2020 |
7609 |
Des chiens dressés à détecter l’odeur du COVID |
15/08/2020 |
7608 |
Covid-19 _ faut-il vraiment craindre l’ibuprofène |
15/08/2020 |
7607 |
Peripheral artery thrombosis in critically ill patients with COVID-19VM2020 |
25/07/2020 |
7606 |
Intravascular fasciitis of the common femoral vein mimicking deep venous thrombosisVM2020 |
25/07/2020 |
7605 |
Unmasking and Addressing the Toll of COVID-19 on |
18/07/2020 |
7604 |
Transmission de la Covid-19 par les objets inanimés_ un risque exagéré _ |
18/07/2020 |
7603 |
Surfing the Waves of the COVID-19 |
18/07/2020 |
7602 |
SARS-CoV-2 T cell immunity_ Specificity, function, durability, and role in protection |
18/07/2020 |
7601 |
Remdesivir _ obtention d’une ATUc pour le traitement du COVID-19 _ Univadis |
18/07/2020 |
7600 |
An mRNA Vaccine against SARS-CoV-2 |
18/07/2020 |
7599 |
Reconstruction of the full transmission dynamics of COVID-19 in Wuhan |
18/07/2020 |
7598 |
Pulmonary embolism in hospitalised patients with COVID-19 |
18/07/2020 |
7597 |
Physical distancing interventions and incidence of coronavirus disease 2019_ natural experiment in 149 countries |
18/07/2020 |
7596 |
Microsoft Word – Séquelles Avis.docx |
18/07/2020 |
7595 |
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 |
18/07/2020 |
7594 |
Le furet, bon modèle d’infection au SARS-CoV-2 |
18/07/2020 |
7593 |
Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism |
18/07/2020 |
7592 |
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19_ A Randomized Trial_ Annals of Internal Medicine_ Vol 0, No 0 |
18/07/2020 |
7591 |
Extremely High Incidence of Lower |
18/07/2020 |
7590 |
Exaggerated risk of transmission of COVID-19 by fomites |
18/07/2020 |
7589 |
Direct oral anticoagulant plasma levels’ COVID |
18/07/2020 |
7588 |
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report |
18/07/2020 |
7587 |
COVID19 the worst |
18/07/2020 |
7586 |
COVID-19 Myocardial injury in survivors |
18/07/2020 |
7585 |
Covid-19 — A Reminder to Reason |
18/07/2020 |
7584 |
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China_ A retrospective cohort study |
18/07/2020 |
7583 |
Case 22-2020_ A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic |
18/07/2020 |
7582 |
Cardiovascular complications in COVID-19 |
18/07/2020 |
7581 |
Activité physique, épreuves d’effort et réhabilitation en post-Covid |
18/07/2020 |
7580 |
Use of metformin and risk of breast and colorectal cancer |
18/07/2020 |
7579 |
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury |
18/07/2020 |
7578 |
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA |
18/07/2020 |
7577 |
The COMPASS Trial CIRC2020 |
18/07/2020 |
7576 |
Endothelium function dependence of acute changes in pulse wave velocity and flow-mediated slowing |
18/07/2020 |
7575 |
Deep_Vein_Thrombosis_in_the_Uninjured_Limb_in_Pati |
18/07/2020 |
7574 |
Climatic influence on the risk of abdominal aortic aneurysm rupture |
18/07/2020 |
7573 |
Bayer’s Finerenone Meets Primary Endpoint in Phase III FIDELIO-DKD Renal Outcomes Study in Patients With Chronic Kidney Disease and Type 2 Diabetes _ Business Wire |
18/07/2020 |
7572 |
Antiplatelet Treatment to Prevent Early Recurrent Stroke |
18/07/2020 |
7571 |
Acute Ischemic Stroke |
18/07/2020 |
7570 |
ABCDAIRE ASPIRINE |
18/07/2020 |
7569 |
ANTICORPS |
16/07/2020 |
7568 |
Un lien entre épistaxis et HTA |
16/07/2020 |
7567 |
NIH-Wide Strategic Plan for COVID-19 Research |
16/07/2020 |
7566 |
Moins de cancers sous metformine |
16/07/2020 |
7565 |
MIS-C liés au SARS-CoV-2 ou le pseudo-Kawasaki des enfants US |
16/07/2020 |
7564 |
Covid-19 et THROMBOSIS |
16/07/2020 |
7563 |
Le point (provisoire) sur les complications cardiovasculaires de la Covid-19 |
16/07/2020 |
7562 |
La Covid-19 pourrait être un facteur de risque indépendant d’AVC ischémique |
16/07/2020 |
7561 |
Immunité contre le Covid-19 que sait-on à ce stade |
16/07/2020 |
7560 |
Covid-19 _ hécatombe dans les résidences pour personnes âgées au Canada |
16/07/2020 |
7559 |
COVID-19 _ l’angiopoïétine-2 comme marqueur pour repérer les patients à risque d’évolution défavorable _ Univadis |
16/07/2020 |
7558 |
Covid 19 _ l’immunité croisée remise en question |
16/07/2020 |
7557 |
Cet épisode Covid a eu une vertu considérable remettre la clinique en 1ère ligne » |
16/07/2020 |
7556 |
AVC après 90 ans _ de bons résultats avec la thrombectomie mécanique ! |
16/07/2020 |
7555 |
Anosmie, migraines…_ ces symptômes neurologiques qui persistent post-COVID-19 _ Univadis |
16/07/2020 |
7554 |
Anosmie, migraineces symptômes neurologiques qui persistent post-COVID |
16/07/2020 |
7553 |
Covid-19 Antibody Testing – A Cochrane Review |
16/07/2020 |
7552 |
The COVID-19 Pandemic A Global Natural Experiment. |
16/07/2020 |
7551 |
Remdesivir for the Treatment of Covid-19 — Preliminary Report |
16/07/2020 |
7550 |
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 |
16/07/2020 |
7549 |
OPEN SAFELY Fact Ass Covid 19 17 milliuons patients Nature |
16/07/2020 |
7548 |
Obesity Is a Risk Factor for Severe COVID-19 InfectionMultiple Potential Mechanisms |
16/07/2020 |
7547 |
MIS-C liés au SARS-CoV-2 ou le pseudo-Kawasaki des enfants US |
16/07/2020 |
7546 |
Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China_ Prevalence, Risk Factors, and Outcome |
16/07/2020 |
7545 |
COVID-19-associated acute respiratory distress syndrome_ is a different approach to management warranted_ |
16/07/2020 |
7544 |
COVID-19, Arrhythmic Risk, and Inflammation Mind the Gap! |
16/07/2020 |
7543 |
Covid-19 _ hécatombe dans les résidences pour personnes âgées au Canada |
16/07/2020 |
7542 |
COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke |
16/07/2020 |
7541 |
CIRCULATIONAHA.120.047293COVID-19, Arrhythmic Risk, and Inflammation |
16/07/2020 |
7540 |
ISTH State of Art Aspirine 2020 |
16/07/2020 |
7539 |
Céphalées |
15/07/2020 |
7538 |
Covid-19 recovery consulting |
15/07/2020 |
7537 |
covid-19 medium-risk |
15/07/2020 |
7536 |
covid-19 medium-high-risk |
15/07/2020 |
7535 |
covid-19- low-medium-risk |
15/07/2020 |
7534 |
covid-19 high-risk |
15/07/2020 |
7533 |
MIS pédiatrique lié au COVID-19 _ une apparition retardée et la présence de symptômes cardiovasculaires dominent le tableau _ Univadis |
15/07/2020 |
7532 |
La transmission au sein du foyer, élément déterminant de la propagation du SARS-CoV-2 _ Univadis |
15/07/2020 |
7531 |
La polyarthrite rhumatoïde serait plus fréquente chez les patients atteints de MICI |
15/07/2020 |
7530 |
Des IDM sans sténose dans la Covid-19 |
15/07/2020 |
7529 |
COVID-19 _ ne pas passer à côté de certains symptômes inhabituels _ Univadis |
15/07/2020 |
7528 |
Covid-19 _ dépister systématiquement le risque nutritionnel |
15/07/2020 |
7527 |
Confinement _ 5 385 Vieux prennent la parole ! |
15/07/2020 |
7526 |
Anosmie, migraineces symptômes neurologiques qui persistent post-COVID |
15/07/2020 |
7525 |
Prescrire XABAN Attention 07 2020 |
06/07/2020 |
7524 |
VTE Treatment in Routine Clinical Practice_ A Pre-specified Combined Evaluation of XALIA and XALIA-LEA with Additional Analyses of Special Patient Populations – ISTH Congress Abstracts |
06/07/2020 |
7523 |
Upper Extremities Deep Vein Thrombosis and DOAC Treatment_ a Prospective Cohort Study – ISTH Congress Abstracts |
06/07/2020 |
7522 |
Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER Study)_ Final Analysis of 242 Patients – ISTH Congress Abstracts |
06/07/2020 |
7521 |
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (The TILE Pilot Study)_ Rationale and Study Protocol – ISTH Congress Abstracts |
06/07/2020 |
7520 |
The Psychosocial Impact of Venous Thromboembolism_ An Exploratory Systematic Review and Narrative Synthesis – ISTH Congress Abstracts |
06/07/2020 |
7519 |
Systematic Review of the Risk of Bleeding in Patients with Chronic Kidney Disease Treated with Tinzaparin – ISTH Congress Abstracts |
06/07/2020 |
7518 |
Single Centre Experience of DOAC Use in Patients with Antiphospholipid Syndrome (APS) with Venous Thromboembolism – ISTH Congress Abstracts |
06/07/2020 |
7517 |
Rivaroxaban versus Warfarin for Treatment and Prevention of Recurrent Venous Thromboembolism in Obese Patients – ISTH Congress Abstracts |
06/07/2020 |
7516 |
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients_ Insights from the Mariner Trial – ISTH Congress Abstracts |
06/07/2020 |
7515 |
Rivaroxaban for Extended Thromboprophylaxis in Acutely Ill Medical Patients 75 Years of Age or Older – ISTH Congress Abstracts |
06/07/2020 |
7514 |
Risk of Bleeding of Concomitant Antiplatelet and Anticoagulation Therapy in Patient Treated for a Venous Thormboembolic Event – ISTH Congress Abstracts |
06/07/2020 |
7513 |
Predicting Recurrence and Bleeding in Patients with Venous Thromboembolism_ A Systematic Review and Critical Appraisal of Prediction Models – ISTH Congress Abstracts |
06/07/2020 |
7512 |
Post-Thrombotic Syndrome in Patients with Venous Thromboembolism Treated with Dabigatran or Warfarin – a Long-Term Cross-Sectional Follow-up of RE-COVER Study Patients – ISTH Congress Abstracts |
06/07/2020 |
7511 |
Oral Anticoagulation Therapy for Venous Thromboembolism in Norway_ Patient Characteristics, Treatment Trends and Patterns – ISTH Congress Abstracts |
06/07/2020 |
7510 |
Lupus Anticoagulant and Antiphospholipid Antibodies_ A Real-World Study – ISTH Congress Abstracts |
06/07/2020 |
7509 |
Leukocyte Gene Expression in Post-Thrombotic Syndrome – ISTH Congress Abstracts |
06/07/2020 |
7508 |
Hypermenorrhea and Menometrorrhagia during Rivaroxaban Therapy – ISTH Congress Abstracts |
06/07/2020 |
7507 |
Home Treatment Compared to Initial Hospitalization in Patients with Acute Pulmonary Embolism in the Netherlands_ A Cost Analysis – ISTH Congress Abstracts |
06/07/2020 |
7506 |
Histopathological Features of Cancer-Associated Venous Thromboembolism in Human – ISTH Congress Abstracts |
06/07/2020 |
7505 |
Heparinox, a Generic Version of Low Molecular Weight Heparin Enoxaparin, Is Bioequivalent to the Branded Version – ISTH Congress Abstracts |
06/07/2020 |
7504 |
Exploring Alternative Approaches of Using the Villalta Scale to Capture the Post-Thrombotic Syndrome_ A Sub-analysis of the ATTRACT Trial – ISTH Congress Abstracts |
06/07/2020 |
7503 |
Direct Oral Anticoagulants versus Vitamin K Antagonists in Antiphospholipid Syndrome_ A Meta-analysis – ISTH Congress Abstracts |
06/07/2020 |
7502 |
Direct Oral Anticoagulants in Comparison with Vitamin K Antagonists and Antiplatelet Agents on Timing and Outcomes in Hip Fracture Surgery Patients Older than 75_ The ORTHO-GER-DOAC Study – ISTH Congress Abstracts |
06/07/2020 |
7501 |
Demographics and Clinical Outcomes of Older Adults Treated for Acute Venous Thromboembolism – ISTH Congress Abstracts |
06/07/2020 |
7500 |
Correlation between Anti-Xa Activity and Plasmatic Levels of Apixaban – ISTH Congress Abstracts |
06/07/2020 |
7499 |
Clinical Characteristics and Outcomes of Non-cancer, Non-CVC Associated upper Extremity DVT – ISTH Congress Abstracts |
06/07/2020 |
7498 |
abstracts_isth_org_abstract_hokusai_post_dvt_study_a_follow_up_study_on_long_term_outcomes_of_deep_vein_thrombosis_in_patients_treated_with_edoxaban_vs_warfarin |
06/07/2020 |
7497 |
VTE and its complications_ A Real World View Daryl Pollock, RN, MN CNS Thrombosis_Haemostasis – ISTH Congress Abstracts |
06/07/2020 |
7496 |
Upper Extremities Deep Vein Thrombosis and DOAC Treatment_ a Prospective Cohort Study – ISTH Congress Abstracts |
06/07/2020 |
7495 |
Uncovering Clinical Gaps in Treatment of Cancer-Associated Thrombosis_ A Clinical Practice Assessment – ISTH Congress Abstracts |
06/07/2020 |
7494 |
Study of the Endothelial Dysfuncion in Patients with Cancer_ Preliminary Results – ISTH Congress Abstracts |
06/07/2020 |
7493 |
Risk of venous Thromboembolism among Subgroups of Cancer Patients Undergoing Chemotherapy_ Post-Hoc Analysis of the AVERT Trial – ISTH Congress Abstracts |
06/07/2020 |
7492 |
Recanalization of Venous Thrombosis by Robotic Assisted High Frequency Pulsed Cavitational Ultrasound Therapy_ 2 Weeks Follow-up in a Swine Model – ISTH Congress Abstracts |
06/07/2020 |
7491 |
Rationale and Design for the Study Apixaban versus ClopidoGRel on a Background of Aspirin in Patients Undergoing InfraPoPliteal Angioplasty for Critical Limb Ischemia – AGRIPPA Trial – ISTH Congress Abstracts |
06/07/2020 |
7490 |
Patency and Clinical Outcomes of Venous Recanalization in the Treatment of Postthrombotic Syndrome – ISTH Congress Abstracts |
06/07/2020 |
7489 |
Management of Acute Venous Thromboembolism in Patients Taking Antiplatelet Therapy_ A Bi-Center Analysis – ISTH Congress Abstracts |
06/07/2020 |
7488 |
Long-Term Management of Anticoagulants in Patients with Cancer-Associated Thrombosis (CAT) Beyond 6 Months_ A 432-Patient Retrospective Non-Interventional Study – ISTH Congress Abstracts |
06/07/2020 |
7487 |
Influence of Tumor Site on Clinical Outcomes in Cancer Patients with Venous Thromboembolism. Insights from the Prospective PREDICARE Cohort Study – ISTH Congress Abstracts |
06/07/2020 |
7486 |
Hold Your Breath for 498 (Alternative) Diagnoses in Pregnant Women Suspected of Pulmonary Embolism – ISTH Congress Abstracts |
06/07/2020 |
7485 |
Hokusai Post-DVT Study_ A Follow-up Study on Long-term Outcomes of Deep Vein Thrombosis in Patients Treated with Edoxaban vs Warfarin – ISTH Congress Abstracts |
06/07/2020 |
7484 |
High Levels of Uric Acid Are Associated with Increased Risk of Recurrent Venous Thromboembolism – ISTH Congress Abstracts |
06/07/2020 |
7483 |
Factor V Leiden but Not Factor II 20210G_A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease – ISTH Congress Abstracts |
06/07/2020 |
7482 |
ETNA-VTE Global_ Evaluation of Bleeding Risk Based on VTE-BLEED Score on 12-month Outcomes in a Population Treated with Edoxaban – ISTH Congress Abstracts |
06/07/2020 |
7481 |
ETNA-VTE Europe_ The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban – ISTH Congress Abstracts |
06/07/2020 |
7480 |
Edoxaban Treatment of Venous Thromboembolism in Routine Clinical Practice in the Non-Interventional Global ETNA-VTE Program_ A Sub-Analysis by Age Groups – ISTH Congress Abstracts |
06/07/2020 |
7479 |
Deep Vein Thrombosis Associated with Protein S Deficiency – ISTH Congress Abstracts |
06/07/2020 |
7478 |
D-Dimer Plasma Levels and the Anatomical Extension of Acute Symptomatic Deep Vein Thrombosis of the Lower Limbs – ISTH Congress Abstracts |
06/07/2020 |
7477 |
Clinical Presentation and Outcomes of Cancer-associated Distal Deep Vein Thrombosis_ Data from the RIETE Registry – ISTH Congress Abstracts |
06/07/2020 |
7476 |
Cancer Associated Thrombosis_ Are DOACs a Treatment Option_ Systematic Review and Meta-analysis of Randomised Controlled Trials – ISTH Congress Abstracts |
06/07/2020 |
7475 |
Association between Initial and Residual Pulmonary Vascular Obstruction and Venous Thromboembolism Recurrence, a Pooled Analysis – ISTH Congress Abstracts |
06/07/2020 |
7474 |
Aspirin Antiplatelet Effects Are Associated with Body Weight – ISTH Congress Abstracts |
06/07/2020 |
7473 |
Apixaban versus Heparin_Warfarin Treatment in Pulmonary Embolism_ Results from the UK Apixaban Length-of-Stay Pulmonary Embolism – Hospital Admissions Study (ALPHA-PE) – ISTH Congress Abstracts |
06/07/2020 |
7472 |
Anti-Platelet Drug Ticagrelor Has a Direct Anticancer Activity – ISTH Congress Abstracts |
06/07/2020 |
7471 |
Anticoagulant Therapy for Splanchnic Vein Thrombosis_ A Systematic Review and Meta-Analysis – ISTH Congress Abstracts |
06/07/2020 |
7470 |
A Non-invasive Diagnostic Work-up Is Safe and Efficient to Exclude Pulmonary Embolism in Low Risk Pregnant Women with Suspected Pulmonary Embolism_ A Systematic Review and Meta-analysis – ISTH Congress Abstracts |
06/07/2020 |
7469 |
A Decade of Experience in Peripherally Inserted Central Catheter (PICC) Related Thrombosis in Hematological Malignancies of a Single Spanish Center – ISTH Congress Abstracts |
06/07/2020 |
7468 |
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China_ cross sectional study |
06/07/2020 |
7467 |
Staying updated on COVID?19_ social media to amplify science in thrombosis and haemostasis |
06/07/2020 |
7466 |
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques |
06/07/2020 |
7465 |
Les Britanniques ont-ils surdosé l’hydroxychloroquine dans leur essai Recovery_ – Heidi.news |
06/07/2020 |
7464 |
France?le Conseil scientifique Covid-19, rôle et fonctionnement RMS2020 |
06/07/2020 |
7463 |
Excess Deaths From COVID-19 and Other Causes, March-April 2020 |
06/07/2020 |
7462 |
Évaluer la fragilité dans les pratiques des soins covid RMS2020 |
06/07/2020 |
7461 |
Comme les avions sur les Twin Towers, le COVID-19 a touché le cœur de notre médecine technologique RMS2020 |
06/07/2020 |
7460 |
Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic |
06/07/2020 |
7459 |
Après l’épidémie de COVID-19, les spécialistes redoutent une vague de fatigue chronique |
06/07/2020 |
7458 |
Antiviral Anticoagulation |
06/07/2020 |
7457 |
Anticoagulant oral – clarithromycine un sur-risque hémorragique cliniquement confirmé |
06/07/2020 |
7456 |
Anosmie, migraineces symptômes neurologiques qui persistent post-COVID |
06/07/2020 |
7455 |
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine_azithromycin and other regimens in Marseille, France_ A retrospective analysis |
06/07/2020 |
7454 |
Multisystem Inflammatory Syndrome in Children in New York State |
06/07/2020 |
7453 |
Immunity to COVID-19 is probably higher than tests have shown _ Karolinska Institutet Nyheter |
06/07/2020 |
7452 |
Évolution du nombre de décès depuis le 1?? mai 2020 ? Nombre de décès quotidiens _ Insee |
06/07/2020 |
7451 |
Electrocardiographic Findings in COVID-19 Insights on Mortality and underlying myocardial prosesses |
06/07/2020 |
7450 |
COVID et greffe rénale |
06/07/2020 |
7449 |
Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases_ cluster randomised controlled trial _ The BMJ |
06/07/2020 |
7448 |
Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism TR2020 |
06/07/2020 |
7447 |
Recurrent Thrombosis in Patients with Antiphospholipid Antibodies and an Initial Venous or Arterial Thromboembolic Event_ A Systematic Review and Meta?Analysis |
06/07/2020 |
7446 |
Performance of 18F-fluorodesoxyglucose positron-emission tomographycomputed tomography for cancer screening in patients with unprovoked venous thromboembolismTR2020 |
06/07/2020 |
7445 |
Microsoft Word – Guide_déonto_à remettre en forme aout 2013 |
06/07/2020 |
7444 |
Heritable thrombophilia test utilization and cost savings following guideline-based restrictions_ An interrupted time series analysis |
06/07/2020 |
7443 |
Utilisation du test de thrombophilie héréditaire et économies de coûts suivant les restrictions basées sur les directives_ une analyse des séries chronologiques interrompue – ScienceDirect |
06/07/2020 |
7442 |
Retinal Vein Thrombosis and the Association with Inherited Thrombophilia, Cardiovascular Risk Factors and the Risk of Occult Cancer. a Prospective Study – ISTH Congress Abstracts |
06/07/2020 |
7441 |
Point sur le COVID-19 aux États-Unis _ imposer le port du masque et des mesures restrictives sur les plages à l’approche de l’été _ Univadis |
06/07/2020 |
7440 |
Les orteils et la Covid-19, une ténébreuse affaire |
06/07/2020 |
7439 |
Les défis de l’activité chirurgicale pendant la pandémie de Covid-19 |
06/07/2020 |
7438 |
Les Britanniques ont-ils surdosé l’hydroxychloroquine dans leur essai Recovery_ – Heidi.news |
06/07/2020 |
7437 |
Le coronavirus sauvera-t-il le cannabis canadien |
06/07/2020 |
7436 |
Il faut sauver le stéthoscope…de la Covid-19 |
06/07/2020 |
7435 |
France?le Conseil scientifique Covid-19, rôle et fonctionnement RMS2020 |
06/07/2020 |
7434 |
Évolution du nombre de décès depuis le 1?? mai 2020 ? Nombre de décès quotidiens _ Insee |
06/07/2020 |
7433 |
Évaluer la fragilité dans les pratiques des soins covid RMS2020 |
06/07/2020 |
7432 |
COVID-19 _ des résultats à l’ECG prédisent la mortalité _ Univadis |
06/07/2020 |
7431 |
Covid-19 de l’enfant _ excrétion virale prolongée dans les formes symptomatiques |
06/07/2020 |
7430 |
Covid-19 chez les Noirs, l’inégalité |
06/07/2020 |
7429 |
Comme les avions sur les Twin Towers, le COVID-19 a touché le cœur de notre médecine technologique RMS2020 |
06/07/2020 |
7428 |
Arrêt du TAO et dépendance aux opioïdes, un risque mortel |
06/07/2020 |
7427 |
Après l’épidémie de COVID-19, les spécialistes redoutent une vague de fatigue chronique |
06/07/2020 |
7426 |
Anticoagulant oral – clarithromycine un surrisque hémorragique cliniquement confirmé |
06/07/2020 |
7425 |
Inflammatory Cytokines |
02/07/2020 |
7424 |
The COVID-19 Pandemic- A Global Natural Experiment.Circ2020 |
02/07/2020 |
7423 |
ST-Elevation Myocardial Infarction in Patients With COVID-19- Clinical and Angiographic Outcomes.Circ2020 |
02/07/2020 |
7422 |
Pulmonary Embolism in COVID-19 Patients-Circ2020 |
02/07/2020 |
7421 |
Pandemic Pandemonium- Pausing Clinical Research During the COVID-19 OutbreakCirc2020 |
02/07/2020 |
7420 |
Obesity a Risk Factor for Severe COVID-19 Infection- Multiple Potential Mechanisms.Circ2020 |
02/07/2020 |
7419 |
NY Innocence LOST Circ 2020 |
02/07/2020 |
7418 |
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade_ A literature reviewTR2020 |
02/07/2020 |
7417 |
COVID-19 and Renin Angiotensin Blockers Circ 2020 |
02/07/2020 |
7416 |
Vous avez dit populations vulnérables? |
27/06/2020 |
7415 |
Se souvenir que la grippe aussi peut être grave ! |
27/06/2020 |
7414 |
Prévention de la Covid-19 après le confinement _ pour un retour rapide « à la vie d’avant » |
27/06/2020 |
7413 |
Politique de santé Les mesures contre le Covid-19 ont été _trop HOSPIMEDIA |
27/06/2020 |
7412 |
La FDA conseille aux consommateurs de ne pas utiliser de produits désinfectants pour les mains fabriqués par Eskbiochem _ FDA |
27/06/2020 |
7411 |
COVID-19 sévère les médecins français n’ont pas attendu l’essai RECOVERY pour prescrire des corticoïdes |
27/06/2020 |
7410 |
COVID-19 et dexaméthasone _ Messieurs les Anglais ont tiré les premiers |
27/06/2020 |
7409 |
Covid-19 _ une place pour l’inhibition du GM-CSF dans l’orage cytokinique _ |
27/06/2020 |
7408 |
COVID-19 _ caractéristiques cliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie |
27/06/2020 |
7407 |
Comment le COVID-19 a ravagé le peuple Navajo |
27/06/2020 |
7406 |
Cardiologie interventionnelle _ la clinique Rhône Durance, à la pointe de l’innovation et de son évaluation |
27/06/2020 |
7405 |
Bientôt un stock de tests…périmés |
27/06/2020 |
7404 |
« Ce qui devait arriver arriva » _ sans gestes barrières, un tournoi qui tourne au cluster |
27/06/2020 |
7403 |
The hypercoagulable state in COVID-19 Incidence, pathophysiology, and management |
27/06/2020 |
7402 |
Platelet Gene Expression and Function in COVID-19 PatientsBllood2020 |
27/06/2020 |
7401 |
Retraction_ Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI_ 10.1056_NEJMoa2007621_ |
27/06/2020 |
7400 |
Prévention de la Covid-19 après le confinement _ pour un retour rapide « à la vie d’avant » |
27/06/2020 |
7399 |
Politique de santé Les mesures contre le Covid-19 ont été _trop HOSPIMEDIA |
27/06/2020 |
7398 |
More on Neurologic Features in Severe SARS-CoV-2 Infection |
27/06/2020 |
7397 |
La FDA conseille aux consommateurs de ne pas utiliser de produits désinfectants pour les mains fabriqués par Eskbiochem _ FDA |
27/06/2020 |
7396 |
Hospitalization and Mortality among Black Patients and White Patients with Covid-19 |
27/06/2020 |
7395 |
Guillain–Barré Syndrome Associated with SARS-CoV-2 |
27/06/2020 |
7394 |
Excess of PE out patients COVID outbreak |
27/06/2020 |
7393 |
COVID-19 _ physiopathologie d’une maladie à plusieurs visages |
27/06/2020 |
7392 |
COVID-19 _ caractéristiques cliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie |
27/06/2020 |
7391 |
Venous thromboembolic events in inflammatory bowel diseases_ A review of current evidence and guidance on risk in the post-hospitalization setting |
27/06/2020 |
7390 |
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants TH2020 |
27/06/2020 |
7389 |
Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants fo |
27/06/2020 |
7388 |
Predictors of residual pulmonary vascular obstruction after pulmonary embolism_ Results from a prospective cohort study |
27/06/2020 |
7387 |
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major€Thromboembolic Events in Medically€Ill€Patients |
27/06/2020 |
7386 |
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors |
27/06/2020 |
7385 |
HIV and antiretroviral therapy-related fat alterations |
27/06/2020 |
7384 |
Haematological Effects of Intermittent Pneumatic compression TH2020 |
27/06/2020 |
7383 |
Fréquence et facteurs prédictifs de thrombose veineuse au cours de la maladie de Behçet |
27/06/2020 |
7382 |
Direct Oral Anticoagulant Use- A Practical Guide to Common Clinical Challenges |
27/06/2020 |
7381 |
Clinical presentation and outcomes of patients with isolated subsegmental pulmonary embolism_ A tertiary care center experience |
27/06/2020 |
7380 |
Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment TH2020 |
27/06/2020 |
7379 |
The end of social confinement and COVID-19 re-emergence risk |
25/06/2020 |
7378 |
Vous avez dit populations vulnérables? |
25/06/2020 |
7377 |
Solidarity in the wake of COVID-19_ reimagining the International Health Regulations |
25/06/2020 |
7376 |
Situation guyanaise _ un présage pour la métropole |
25/06/2020 |
7375 |
Peut-être une prédisposition génétique pour les formes graves de Covid-19 |
25/06/2020 |
7374 |
Opinion_ In the wake of COVID-19, academia needs new solutions to ensure gender equity |
25/06/2020 |
7373 |
New York City Innocence Lost |
25/06/2020 |
7372 |
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019 A New ChallengeTH2020 |
25/06/2020 |
7371 |
High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients |
25/06/2020 |
7370 |
Effect of Dexamethasone in Hospitalized Patients with COVID-19_ Preliminary Report |
25/06/2020 |
7369 |
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory FailureTH2020 |
25/06/2020 |
7368 |
COVID-19-associated coagulopathy_ An exploration of mechanisms |
25/06/2020 |
7367 |
COVID-19 and Renin Angiotensin Blockers |
25/06/2020 |
7366 |
Clinical Implications of SARS-CoV-2 _Interaction With Renin Angiotensin System |
25/06/2020 |
7365 |
Une forme clinique émergente de pancréatite aiguë dans la Covid-19 |
20/06/2020 |
7364 |
Un test salivaire ultra-rapide pour dépister le Covid-19 |
20/06/2020 |
7363 |
Pseudo-Kawasaki et Covid-19 en France _ des particularités |
20/06/2020 |
7362 |
Pas souvent de SARS-CoV-2 dans le LCR |
20/06/2020 |
7361 |
Mangeons des noix ! |
20/06/2020 |
7360 |
forfaits dpc 2020 medecins |
20/06/2020 |
7359 |
Dexamethasone _ espoir et prudence dans le monde |
20/06/2020 |
7358 |
Dexamethasone _ espoir et prudence dans le monde |
20/06/2020 |
7357 |
Covid-19 _ à qui profite la recherche |
20/06/2020 |
7356 |
Corticothérapie dans les affections graves _ et maintenant Recovery… |
20/06/2020 |
7355 |
Comment prendre en charge les symptômes post-Covid Le point avec le Dr Davido |
20/06/2020 |
7354 |
Artériopathie oblitérante des membres inférieurs _ une maladie trompeuse ! _ Univadis |
20/06/2020 |
7353 |
Accalmie de la Covid-19 en Europe _ génie propre de l’Homme ou de l’épidémie |
20/06/2020 |
7352 |
«Nous sommes tous rincés» – Libération |
20/06/2020 |
7351 |
The American Heart Association COVID-19 CVD Registry powered by Get With The Guidelines |
20/06/2020 |
7350 |
Un test salivaire ultra-rapide pour dépister le Covid-19 |
20/06/2020 |
7349 |
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic_ rapid review |
20/06/2020 |
7348 |
Portal vein thrombosis in a patient with COVID-19 |
20/06/2020 |
7347 |
Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic_ Ramping up Safely to a New Normal |
20/06/2020 |
7346 |
L’institut Montaigne critique l’action publique française face au COVID |
20/06/2020 |
7345 |
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium |
20/06/2020 |
7344 |
Features of 20?133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol_ prospective observational cohort study |
20/06/2020 |
7343 |
Curative anticoagulation prevents endothelial lesion in COVID?19 patients JTH2020 |
20/06/2020 |
7342 |
COVID-19’s Crushing Effects on Medical Practices, Some of Which Might Not Survive |
20/06/2020 |
7341 |
Corticothérapie dans les affections graves _ et maintenant Recovery… |
20/06/2020 |
7340 |
Comment le COVID-19 a ravagé le peuple Navajo |
20/06/2020 |
7339 |
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality |
20/06/2020 |
7338 |
Curative anticoagulation prevents endothelial lesion in COVID?19 patients JTH2020 |
20/06/2020 |
7337 |
The evolution of the heart-healthy diet for vascular health- A walk through timeVM2020 |
20/06/2020 |
7336 |
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease |
20/06/2020 |
7335 |
Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants |
20/06/2020 |
7334 |
Retinal artery occlusion does not portend an increased risk of stroke |
20/06/2020 |
7333 |
Periprocedural Bridging Anticoagulation in Patients with Venous Thromboembolism_ A Registry?based Cohort Study |
20/06/2020 |
7332 |
Patients undergoing interventions for claudication experience low perioperative morbidity but are at risk for worsening functional status and limb loss |
20/06/2020 |
7331 |
MIT, guided by open access principles, ends Elsevier negotiations _ MIT News |
20/06/2020 |
7330 |
Les maladies qui disparaissent spontanément |
20/06/2020 |
7329 |
Five-year survival following endovascular repair of ruptured abdominal aortic aneurysms is improving |
20/06/2020 |
7328 |
computed tomography aortography versus color duplex US of EVAR |
20/06/2020 |
7327 |
Characteristics of high-cost inpatients with peripheral artery disease |
20/06/2020 |
7326 |
Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women |
20/06/2020 |
7325 |
The Future of Cardiovascular Prevention |
20/06/2020 |
7324 |
Retracted coronavirus (COVID-19) papers – Retraction Watch |
20/06/2020 |
7323 |
Reperfusion of ST-Segment–Elevation Myocardial Infarction in the COVID-19 Era |
20/06/2020 |
7322 |
Rapid Implementation of an Outpatient Covid-19 Monitoring Program |
20/06/2020 |
7321 |
Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic |
20/06/2020 |
7320 |
Pattern of vascular disease in Lombardy, Italy, during the first month of the COVID-19 outbreak |
20/06/2020 |
7319 |
Overview of Testing for SARS-CoV-2 _ CDC |
20/06/2020 |
7318 |
Mutated coronavirus shows significant boost in infectivity _ Scripps Research |
20/06/2020 |
7317 |
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City |
20/06/2020 |
7316 |
Multi-System Inflammatory Syndrome in Children in Association with COVID-19 |
20/06/2020 |
7315 |
La crise du Coronavirus _ l’État d’urgence révélateur de l’avenir de la démocratie et des désordres qui affectent notre conception des droits fondamentaux _ – Le Club des Juristes |
20/06/2020 |
7314 |
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France_ prospective observational study |
20/06/2020 |
7313 |
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium |
20/06/2020 |
7312 |
Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital |
20/06/2020 |
7311 |
Direct oral anticoagulant plasma levels’ striking increase in severe COVID?19 respiratory syndrome patients treated with antiviral agents_ The Cremona experience |
20/06/2020 |
7310 |
Convalescent Plasma and COVID-19 |
20/06/2020 |
7309 |
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment |
20/06/2020 |
7308 |
Clinical Implications of SARS-CoV-2€Interaction With Renin Angiotensin System |
20/06/2020 |
7307 |
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 |
20/06/2020 |
7306 |
Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients_ A Policy Statement From the American Heart Association |
20/06/2020 |
7305 |
Vascular medicine and cardio-oncology – A new, evolving clinical frontier |
20/06/2020 |
7304 |
Vascular effects of cancer treatments |
20/06/2020 |
7303 |
Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults |
20/06/2020 |
7302 |
Rethinking the approach to thrombosis in patients with cancer |
20/06/2020 |
7301 |
Predictors of residual pulmonary vascular obstruction after pulmonary embolism_ Results from a prospective cohort study |
20/06/2020 |
7300 |
Knowledge of peripheral artery disease_ What do the public, healthcare practitioners, and trainees know_ |
20/06/2020 |
7299 |
forfaits dpc 2020 medecins |
20/06/2020 |
7298 |
Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors |
20/06/2020 |
7297 |
Assessment of foot perfusion_ Overview of modalities, review of evidence, and identification of evidence gaps |
20/06/2020 |
7296 |
Artériopathie oblitérante des membres inférieurs en 2019 |
20/06/2020 |
7295 |
Presymptomatic_Asymptomatic |
15/06/2020 |
7294 |
Blood Pressure Classification |
15/06/2020 |
7293 |
Une thyroïdite de De Quervain à l’heure du SARS-CoV-2 |
15/06/2020 |
7292 |
Propagation de la Covid-19 _ un rôle modeste pour les enfants ! |
15/06/2020 |
7291 |
Parmi les animaux malades de la Covid-19, on demande le vison |
15/06/2020 |
7290 |
Le confinement a évité 3 millions de morts dans 11 pays européens |
15/06/2020 |
7289 |
La crise du Coronavirus _ l’État d’urgence révélateur de l’avenir de la démocratie et des désordres qui affectent notre conception des droits fondamentaux _ – Le Club des Juristes |
15/06/2020 |
7288 |
La chirurgie des cancers pendant la pandémie de covid-19, une priorité |
15/06/2020 |
7287 |
Hydroxy-chloroquine et covid-19 |
15/06/2020 |
7286 |
COVID-19 le Brésil pris dans une tempête sanitaire et politique |
15/06/2020 |
7285 |
Covid-19 _ pourquoi les hommes |
15/06/2020 |
7284 |
Chirurgie gynécologique cœlioscopique et Covid-19 _ quelles précautions |
15/06/2020 |
7283 |
The South African Response to the Pandemic |
14/06/2020 |
7282 |
Temporary reduction in daily global CO2 emissions during the COVID-19 forced confinement |
14/06/2020 |
7281 |
Spread of SARS-CoV-2 in the Icelandic Population |
14/06/2020 |
7280 |
Preliminary analysis of SARS-CoV-2 importation & establishment of UK transmission lineages – Virological |
14/06/2020 |
7279 |
Not Dying Alone — Modern Compassionate Care in the Covid-19 Pandemic |
14/06/2020 |
7278 |
New (re)Purpose for an old drug purinergic receptor blockade may extinguish the COVID-19 thrombo-inflammatory firestorm |
14/06/2020 |
7277 |
he Dual Epidemics of COVID-19 and Influenza |
14/06/2020 |
7276 |
Face Masks Considerably Reduce COVID-19 Cases in Germany_ A Synthetic Control Method Approach |
14/06/2020 |
7275 |
Drug Evaluation during the Covid-19 Pandemic |
14/06/2020 |
7274 |
Compassionate Use of Remdesivir for Patients with Severe Covid-19 |
14/06/2020 |
7273 |
Clinical Characteristics of Covid-19 in New York City |
14/06/2020 |
7272 |
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York_ retrospective case series |
14/06/2020 |
7271 |
Between Scylla and Charybdis — Oncologic Decision Making in the Time of Covid-19 |
14/06/2020 |
7270 |
Blood Pressure Classification |
12/06/2020 |
7269 |
Retour sur la Covid-19 de l’enfant et de la femme enceinte |
12/06/2020 |
7268 |
Prendre soin des soignants pendant les pandémies |
12/06/2020 |
7267 |
Le premier grand scandale de recherche de la pandémie éclate |
12/06/2020 |
7266 |
Le placenta de la Covid-19, vasculaire plutôt qu’inflammatoire |
12/06/2020 |
7265 |
Le confinement a évité 3 millions de morts dans 11 pays européens |
12/06/2020 |
7264 |
L’HCQ en post exposition, pas de repêchage |
12/06/2020 |
7263 |
Deux grandes revues rétractent des études sur l’hydroxychloroquine et les antihypertenseurs dans le COVID-19 |
12/06/2020 |
7262 |
Covid-19, des AVC pas comme les autres |
12/06/2020 |
7261 |
COVID-19 des cas probables en Alsace dès la mi-novembre |
12/06/2020 |
7260 |
Covid-19 chez les femmes traitées pour cancer du sein, une gravité particulière |
12/06/2020 |
7259 |
Covid-19 _ coup de grâce pour la Sécu |
12/06/2020 |
7258 |
Ces scientifiques soudain devenus des femmes et des hommes politiques – Ethique et Pandémie |
12/06/2020 |
7257 |
Estimating the effects of non pharmaceutical interventions on COVID-19 in Europ |
12/06/2020 |
7256 |
Un foyer de coranavirus de chauves-souris ressemblant au SARS pourrait contaminer les êtres humains |
12/06/2020 |
7255 |
The ABO blood group locus and a chromosome 3 gene cluster associate with SARSCoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis |
12/06/2020 |
7254 |
Temporal dynamics in viral shedding and transmissibility of COVID-19 |
12/06/2020 |
7253 |
Severe acute respiratory syndrome-related coronavirus_ The species and its viruses – a statement of the Coronavirus Study Group |
12/06/2020 |
7252 |
Ethical considerations during the COVID-19 pandemic |
12/06/2020 |
7251 |
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 |
12/06/2020 |
7250 |
Propagation de la Covid-19 _ un rôle modeste pour les enfants ! |
12/06/2020 |
7249 |
Panupattanapong_Kawasaki.indd |
12/06/2020 |
7248 |
Le premier grand scandale de recherche de la pandémie éclate |
12/06/2020 |
7247 |
Le confinement a évité 3 millions de morts dans 11 pays européens |
12/06/2020 |
7246 |
hydroxy chloroquine et covid-19 |
12/06/2020 |
7245 |
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome |
12/06/2020 |
7244 |
Covid-19 _ plusieurs patients jeunes et guéris développent des embolies pulmonaires |
12/06/2020 |
7243 |
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 |
12/06/2020 |
7242 |
Circulating plasma concentrations of angiotensin- converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J., 2020 |
12/06/2020 |
7241 |
Cardiovascular manifestations and treatment considerations in covid-19 |
12/06/2020 |
7240 |
Cardiopulmonary Resuscitation During the COVID-19 Pandemic |
12/06/2020 |
7239 |
Anticoagulation, Immortality, and Observations of COVID?19 |
12/06/2020 |
7238 |
Does doxycycline reduce the growth of small infrarenal abdominal aortic aneurysms |
09/06/2020 |
7237 |
The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients- A Systematic Review and Meta-AnalysisTH2020 |
09/06/2020 |
7236 |
Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients |
09/06/2020 |
7235 |
Relationship between body mass index, risk of VTE and PE TR2020 |
09/06/2020 |
7234 |
Recommandations de bonne pratique clinique pour la prise en charge de l’ischemie chronique menaçante des mi |
09/06/2020 |
7233 |
Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study)_ randomised controlled trial |
09/06/2020 |
7232 |
Étude descriptive de la perception par les médecins généralistes des anticoagulants oraux directs et du risque de saignement génital chez les femmes en âge de procréer |
09/06/2020 |
7231 |
Étude descriptive de la perception par les médecins généralistes des anticoagulants oraux directs et du risque de saignement génital chez les femmes en âge de procréer |
09/06/2020 |
7230 |
Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic AneurysmsJAMA2020 |
09/06/2020 |
7229 |
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer BA2020 |
09/06/2020 |
7228 |
Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis- Updated systematic review and meta-analysis of randomized controlled trials |
09/06/2020 |
7227 |
Descriptive study of the general practitioners’ perception of direct oral anticoagulants and the risk of genital bleeding in women of childbearing age |
09/06/2020 |
7226 |
Defining the Role of Duplex Ultrasound Assessment to Determine Severity of Arterial Calcification_ An Analysis of the Superficial Femoral Artery |
09/06/2020 |
7225 |
Confirmation de l’effet protecteur des inhibiteurs du SGLT2 sur le rein |
09/06/2020 |
7224 |
Comprehensive Case Review of a Diabetic Patient With Chronic Limb-Threatening Ischemia |
09/06/2020 |
7223 |
Calciphylaxis and Mönckberg’s Arteriosclerosis in a Diabetic Patient |
09/06/2020 |
7222 |
Artifacts in Diagnostic Ultrasonography |
09/06/2020 |
7221 |
Vascular Regeneration in Peripheral Artery Disease 2020AT |
09/06/2020 |
7220 |
The role of high cholesterol in age-related COVID19 lethality |
09/06/2020 |
7219 |
The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients- A Systematic Review and Meta-AnalysisTH2020 |
09/06/2020 |
7218 |
TGFB (Transforming Growth Factor-Beta)–Activated Kinase 1 Regulates Arteriovenous Fistula Maturation |
09/06/2020 |
7217 |
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected DVT |
09/06/2020 |
7216 |
Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous ThromboembolismTH2020 |
09/06/2020 |
7215 |
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease_ A Systematic Review and Meta-Analysis |
09/06/2020 |
7214 |
Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to AnticoagulationTH2020 |
09/06/2020 |
7213 |
MAST2 and venous thrombosis |
09/06/2020 |
7212 |
L’oxygénothérapie locale dans le traitement des plaies du pied diabétique |
09/06/2020 |
7211 |
In Abdominal Aortic Aneurysm, Antiplatelets Seem to Guard Against Aortic Dissection and Rupture – Consult QD |
09/06/2020 |
7210 |
Diabetes Care |
09/06/2020 |
7209 |
Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019_ The Multi-Ethnic Study of Atherosclerosis (MESA) |
09/06/2020 |
7208 |
Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis |
09/06/2020 |
7207 |
Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”_ Keep calm and carry on |
09/06/2020 |
7206 |
Aspirin for Prevention of Cardiovascular Disease |
09/06/2020 |
7205 |
Comment les désinfectants pour les mains protégent contre les infections |
06/06/2020 |
7204 |
Comment fonctionnent les tests de détection des coronavirus |
06/06/2020 |
7203 |
Quatre moyens de détruire les coronavirus |
06/06/2020 |
7202 |
Plus de 29 000 décès en France _ Aux praticiens la patrie reconnaissante |
06/06/2020 |
7201 |
La question de la surveillance ophtalmologique dans les lupus traités par HCQ |
06/06/2020 |
7200 |
ENQUÊTE FRANCEINFO. Chloroquine _ sur les traces de Surgisphere, la société au cœur du scandale de l’étude du _Lancet |
06/06/2020 |
7199 |
Covid-19 avec une MICI, est-ce pire |
06/06/2020 |
7198 |
Avis conseil scientifique 02 juin 2020 |
06/06/2020 |
7197 |
Mourir à Paris en pleine pandémie…d’un arrêt cardiaque |
05/06/2020 |
7196 |
Le cancer actif augmente le risque de décès chez les patients atteints de COVID-19 |
05/06/2020 |
7195 |
L’oxygénothérapie locale dans le traitement des plaies du pied diabétique |
05/06/2020 |
7194 |
Diabète et Covid-19, voir l’HbA1c de base |
05/06/2020 |
7193 |
COVID-19 grave résultats prometteurs avec l’anti-IL1 anakinra |
05/06/2020 |
7192 |
Covid-19 à New York City _ c’est vraiment le Bronx ! |
05/06/2020 |
7191 |
Confinement, masques, tests, Plaquenil…ce que les généralistes en pensent |
05/06/2020 |
7190 |
Anakinra contre Covid-19 _ intérêt confirmé par un essai français |
05/06/2020 |
7189 |
The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials |
05/06/2020 |
7188 |
Ramipril in High Risk Patients with COVID-19 |
05/06/2020 |
7187 |
Pour lutter contre la Covid-19, changeons de logique |
05/06/2020 |
7186 |
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom |
05/06/2020 |
7185 |
High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients |
05/06/2020 |
7184 |
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK- a modelling studyTH2020 |
05/06/2020 |
7183 |
Declining Admissions for Acute Cardiovascular Illness_ The Covid-19 Paradox |
05/06/2020 |
7182 |
Covid-19 pourquoi tant de confusions |
05/06/2020 |
7181 |
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet2019 |
05/06/2020 |
7180 |
Chloroquine and hydroxychloroquine in the management of COVID-19_ Much kerfuffle but little evidence |
05/06/2020 |
7179 |
Transmission secondaire de SARS-CoV-2?pendant combien de temps un cas symptomatique peut-il transmettre le virus?RMS |
05/06/2020 |
7178 |
The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients- A Systematic Review and Meta-AnalysisTH2020 |
05/06/2020 |
7177 |
Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing |
05/06/2020 |
7176 |
Personnes âgées hospitalisées |
05/06/2020 |
7175 |
Patients Covid-19 convalescents FINAL |
05/06/2020 |
7174 |
Myocardial injury in severe COVID EHJ2020 |
05/06/2020 |
7173 |
Le bilan des dispositifs de soutien |
05/06/2020 |
7172 |
La crise offre une représentation hiérarchisée |
05/06/2020 |
7171 |
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence |
05/06/2020 |
7170 |
Coagulopathy and thrombosis in COVID-19 patients_ parameters to be checked to assess disease severity |
05/06/2020 |
7169 |
Chloroquine or hydroxychloroquine for COVID-19- why might they be hazardous |
05/06/2020 |
7168 |
Au coeur du covid RMS2020 |
05/06/2020 |
7167 |
An analysis of SARS-CoV-2 viral load by patient age |
05/06/2020 |
7166 |
Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic |
01/06/2020 |
7165 |
Ségur de la santé _ une synthèse impossible |
01/06/2020 |
7164 |
Scientific and Standardization Committee Communication Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID- |
01/06/2020 |
7163 |
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United State |
01/06/2020 |
7162 |
Open Letter the statistical analysis and data integrity of Mehra et al_Final |
01/06/2020 |
7161 |
Obésité et Covid RMS2020 |
01/06/2020 |
7160 |
Interleukine 1 et blocage du COVID-19 |
01/06/2020 |
7159 |
Il était une fois les masques…indéfiniment réutilisables |
01/06/2020 |
7158 |
Covid-19, un SDRA puis une fibrose pulmonaire |
01/06/2020 |
7157 |
Covid-19 _ ce que révèle l’imagerie abdominale |
01/06/2020 |
7156 |
Covid-19 et chloroquine_ nouvelle étude, même incertitude – Sciences et Avenir |
01/06/2020 |
7155 |
Covid-19 _ les chiens comme les chats |
01/06/2020 |
7154 |
COVID-19 _ et si l’immunité de groupe était bientôt atteinte |
01/06/2020 |
7153 |
Covid-19 _ de l’immunité à l’immunité croisée |
01/06/2020 |
7152 |
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China |
01/06/2020 |
7151 |
Beaucoup d’IRA dans les Covid-19 graves |
01/06/2020 |
7150 |
Angiopoietin 2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID?19 patients |
01/06/2020 |
7149 |
Virologist Christian Drosten_We Managed to Stop a Pandemic Wave with Relatively Mild Measures_ DER SPIEGEL |
01/06/2020 |
7148 |
The delights and perils of publishing, knowledge-sharing and critique during a pandemic_ Observations from COVID-19 coagulopathies |
01/06/2020 |
7147 |
Pharmacological Agents Targeting thromboinflammation in Covid-19 TH 2020 |
01/06/2020 |
7146 |
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France |
01/06/2020 |
7145 |
Lechien COVID-19 modéré symptomes |
01/06/2020 |
7144 |
Le coronavirus peut être une maladie vasculaire, qui explique tout _ Élémentaire |
01/06/2020 |
7143 |
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients |
01/06/2020 |
7142 |
COVID-19 in the footsteps of Ernest Shackleton |
01/06/2020 |
7141 |
Covid-19 de l’immunité à l’immunité croisée |
01/06/2020 |
7140 |
Communiqué Déontologie et Tt Covid |
01/06/2020 |
7139 |
Coagulopathy_of_Coronavirus_Disease |
01/06/2020 |
7138 |
Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19)_ a systematic review and pooled analysis |
01/06/2020 |
7137 |
Anakinra for severe forms of COVID-19_ a cohort study |
01/06/2020 |
7136 |
Faites vous les bons gestes dedans et dehors |
30/05/2020 |
7135 |
vaccinations france 2020 |
30/05/2020 |
7134 |
Vaccin contre la Covid-19 à Oxford _ succès chez le macaque |
30/05/2020 |
7133 |
Remdesivir l’étude qui a valu le feu vert de la FDA |
30/05/2020 |
7132 |
Première analyse de registre de patients MICI atteints de COVID-19 _ Univadis |
30/05/2020 |
7131 |
Plus de 80 clusters détectés en France |
30/05/2020 |
7130 |
Phase 2 du déconfinement _ vers plus de différences entre rouges et verts |
30/05/2020 |
7129 |
La prise en charge des maladies CV est-elle passée au second plan pendant le pic de l’épidémie |
30/05/2020 |
7128 |
Hydroxy chloroquine et covid-19 |
30/05/2020 |
7127 |
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19 a multinational registry analysis |
30/05/2020 |
7126 |
Hydroxychloroquine dans la Covid-19 _ point final |
30/05/2020 |
7125 |
Femmes enceintes avec Covid-19 au Royaume-Uni |
30/05/2020 |
7124 |
Early diagnosis and management of COVID-19 patients_ a real-life cohort study of 3,737 patients, Marseille, France – IHU |
30/05/2020 |
7123 |
Du SARS-CoV-2 dans le lait maternel |
30/05/2020 |
7122 |
Dernière ligne droite pour Stop Covid |
30/05/2020 |
7121 |
COVID-19 un registre français des manifestations neurologiques |
30/05/2020 |
7120 |
COVID-19_ différences de symptomatologie entre la Chine et l’Europe – Revue Médicale Suisse |
30/05/2020 |
7119 |
COVID-19 faut-il abandonner la piste de l’hydroxychloroquine |
30/05/2020 |
7118 |
Covid-19 _ super propagateurs et super propagation |
30/05/2020 |
7117 |
COVID-19 _ Quoi de neuf sur le traçage numérique _ Univadis |
30/05/2020 |
7116 |
COVID-19 _ les manifestations neurologiques passées à la loupe _ Univadis |
30/05/2020 |
7115 |
Covid-19 _ la France insoumise… à la future vaccination |
30/05/2020 |
7114 |
Covid-19 _ l’analyse de poumons de patients décédés livre des résultats inattendus – Réalités Biomédicales |
30/05/2020 |
7113 |
Remdesivir for the Treatment of Covid-19_Preliminary Report |
30/05/2020 |
7112 |
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 |
30/05/2020 |
7111 |
Remdesivir An Important First Step |
30/05/2020 |
7110 |
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility |
30/05/2020 |
7109 |
Obésité et risque de COVID-19 sévère RMS2020 |
30/05/2020 |
7108 |
Interleukine-1 et blocage du COVID-19 – Revue Médicale Suisse |
30/05/2020 |
7107 |
Early diagnosis and management of COVID-19 patients_ a real-life cohort study of 3,737 patients, Marseille, France – IHU |
30/05/2020 |
7106 |
COVID-19_ différences de symptomatologie entre la Chine et l’Europe – Revue Médicale Suisse |
30/05/2020 |
7105 |
Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID |
30/05/2020 |
7104 |
A 68 Year Old Man with Covid-19 and Acute Kidney Injury |
30/05/2020 |
7103 |
Risk of death from SARS COV-2 |
28/05/2020 |
7102 |
Pilmonary Vasc Endothelialitis thrombosis and angiogenesis covid-19 NEJM |
28/05/2020 |
7101 |
Vaccin contre la Covid-19 à Oxford _ succès chez le macaque |
28/05/2020 |
7100 |
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreJAMA2020 |
28/05/2020 |
7099 |
La prise en charge des maladies CV est-elle passée au second plan pendant le pic de l’épidémie |
28/05/2020 |
7098 |
Hydroxychloroquine in the treatment and prophylaxis of SARS-CoV-2 infection in non- human primates |
28/05/2020 |
7097 |
Dernière ligne droite pour Stop Covid |
28/05/2020 |
7096 |
“Is It Safe for Me to Go to Work_” Risk Stratification for Workers during the Covid-19 Pandemic |
28/05/2020 |
7095 |
VITD et COVID |
27/05/2020 |
7094 |
UK public health response to covid BMJ |
27/05/2020 |
7093 |
Remdesivir for the Treatment of Covid-19 — Preliminary Report |
27/05/2020 |
7092 |
Identifying and Interrupting |
27/05/2020 |
7091 |
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19 a multinational registry analysis |
27/05/2020 |
7090 |
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol BMJ2020 |
27/05/2020 |
7089 |
COVID-19 un registre français des manifestations neurologiques |
27/05/2020 |
7088 |
COVID-19 screening of health-care workers in a London maternity hospital |
27/05/2020 |
7087 |
COVID-19 illness in native and immunosuppressed states_ A clinical–therapeutic staging proposal |
27/05/2020 |
7086 |
Covid-19 _ l’analyse de poumons de patients décédés livre des résultats inattendus – Réalités Biomédicales |
27/05/2020 |
7085 |
Placentas from COVID-19-positive pregnant women show injury – Northwestern Now |
26/05/2020 |
7084 |
Lemierre syndrome, a rare complication of otitis media |
26/05/2020 |
7083 |
Icosapent Ethyl Significantly Reduces Revascularizations in Statin Patients _ DAIC |
26/05/2020 |
7082 |
Icosapent Ethyl réduit significativement les revascularisations chez les patients statines _ DAIC |
26/05/2020 |
7081 |
Estrogen and thrombosis_ A bench to bedside review |
26/05/2020 |
7080 |
COVID-19 illness in native and immunosuppressed states_ A clinical–therapeutic staging proposal |
26/05/2020 |
7079 |
COVID-19 and hypercoagulability in the outpatient setting |
26/05/2020 |
7078 |
Circumstances of provoked recurrent venous thromboembolism_ the Austrian study on recurrent venous thromboembolism |
26/05/2020 |
7077 |
Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19 |
26/05/2020 |
7076 |
Association Between Reperfusion Therapy and Outcomes in Patients with Acute Pulmonary Embolism and Right Heart ThrombiEJR2020 |
26/05/2020 |
7075 |
Article thrombose covid 19 |
26/05/2020 |
7074 |
Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation |
26/05/2020 |
7073 |
An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals |
26/05/2020 |
7072 |
Tests sérologiques de diagnostic rapide des difficultés d’interprétation |
26/05/2020 |
7071 |
Rapport_tests_serologiques_rapides_covid-19 |
26/05/2020 |
7070 |
Quels liens entre le SARS-CoV-2 et la maladie de Kawasaki _ – Revue Médicale Suisse |
26/05/2020 |
7069 |
Quand le confinement met la pollution en quarantaine |
26/05/2020 |
7068 |
Plasma de convalescence pour Covid-19, c’est acceptable |
26/05/2020 |
7067 |
Dangers du Covid-19 pour les soignants, fallait-il une méta-analyse… |
26/05/2020 |
7066 |
Covid-19, résultats de l’autopsie |
26/05/2020 |
7065 |
COVID-19 _ comparaison des dynamiques d’évolution de l’épidémie dans six métropoles _ Univadis |
26/05/2020 |
7064 |
COVID-19 _ comparaison des dynamiques d’évolution de l’épidémie dans six métropoles _ Univadis – Copie |
26/05/2020 |
7063 |
Covid-19 _ chacun garde son chat |
26/05/2020 |
7062 |
COVID-19 ce que nous savons sur la réponse immunitaire au virus |
26/05/2020 |
7061 |
Avis depistage hospitalier |
26/05/2020 |
7060 |
Universal Masking in Hospitals in the Covid-19 Era |
26/05/2020 |
7059 |
Leadership for the Social Climate |
26/05/2020 |
7058 |
La reprise des activités chirurgicales une urgence sanitaire et une contribution à la reprise économique |
26/05/2020 |
7057 |
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19 a multinational registry analysis |
26/05/2020 |
7056 |
Heparin resistance in COVID-19 patients in the intensive care unit |
26/05/2020 |
7055 |
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington |
26/05/2020 |
7054 |
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients |
26/05/2020 |
7053 |
Developing Covid-19 Vaccines at Pandemic Speed |
26/05/2020 |
7052 |
Decentralized Clinical Trials_ The future of clinical trials is now – Endpoints News |
26/05/2020 |
7051 |
Crise sanitaire et crise suicidaire?éclairages en miroir RMS |
26/05/2020 |
7050 |
Covid-19 _ les leçons à tirer de la baisse des émissions de CO2 |
26/05/2020 |
7049 |
COVID-19 screening of health-care workers in a London maternity hospital |
26/05/2020 |
7048 |
Covid-19 in Critically Ill Patients in the Seattle Region |
26/05/2020 |
7047 |
Venous thromboembolism in adults- summary of updated NICE guidance on diagnosis, management, and thrombophilia testingBMJ2020 (1) |
21/05/2020 |
7046 |
Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active CancerTH2020 |
21/05/2020 |
7045 |
The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism |
21/05/2020 |
7044 |
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women |
21/05/2020 |
7043 |
Statins and Major Adverse Limb Events in Patients with Peripheral Artery DiseaseA Systematic Review and Meta-AnalysisTH2020 |
21/05/2020 |
7042 |
Rivaroxaban in Peripheral Artery Disease after Revascularization |
21/05/2020 |
7041 |
Refining Risk Prediction for Recurrent Venous ThromboembolismCan We Do BetterTH2020 |
21/05/2020 |
7040 |
Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to AnticoagulationTH2020 |
21/05/2020 |
7039 |
Meta-analysis of the Usefulness of Inferior Vena Cava Filters in massive and sub massive PE 2020AJC |
21/05/2020 |
7038 |
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke |
21/05/2020 |
7037 |
Effect on Mortality With Inferior Vena Cava Filters in Patients Undergoing Pulmonary Embolectomy |
21/05/2020 |
7036 |
Appendix voyager |
21/05/2020 |
7035 |
A downward dog seldom bites_ A rare case of bilateral ulnar artery thrombosis from yoga |
21/05/2020 |
7034 |
A Bon VOYAGER for Peripheral Artery Disease |
21/05/2020 |
7033 |
Une surmortalité générale de 22 %… mais une forte baisse du nombre de morts des moins de 25 ans |
21/05/2020 |
7032 |
Susceptible supply limits the role of climate in the early SARS-CoV2 pandemic |
21/05/2020 |
7031 |
Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis |
21/05/2020 |
7030 |
Severe Covid-19 |
21/05/2020 |
7029 |
Neprilysin inhibitor–ACE2 sacabutril |
21/05/2020 |
7028 |
Les médicaments contre le Covid-19 et les vieux démons de la recherche clinique en France _ le diagnostic sans concession du Pr Jean-François Bergmann _ Le Quotidien du médecin |
21/05/2020 |
7027 |
Getting a handle on asymptomatic SARS-CoV-2 infection _ Scripps Research |
21/05/2020 |
7026 |
Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan |
21/05/2020 |
7025 |
Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission systematic review and meta-analysis |
21/05/2020 |
7024 |
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age_ a population-based cohort study |
21/05/2020 |
7023 |
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic |
21/05/2020 |
7022 |
Covid-19 _ mieux décrire la protéine Spike pour améliorer le diagnostic et les perspectives vaccinales _ Inserm – La science pour la santé |
21/05/2020 |
7021 |
Covid-19 Testing 1 |
21/05/2020 |
7020 |
Covid-19 pandemic-some cardiovascular considerations from the trench |
21/05/2020 |
7019 |
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease |
21/05/2020 |
7018 |
Clinical course of severe and critical COVID-19 in hospitalized pregnancies_ a US cohort study |
21/05/2020 |
7017 |
Oral Anticoagulant Conversion |
21/05/2020 |
7016 |
The Diversity–Innovation Paradox in Science |
21/05/2020 |
7015 |
Traitement de l’artériopathie oblitérante des membres inférieurs (AOMI) _ l’utilisation de ballons ou de stents au paclitaxel doit toujours être réservée aux patients les plus sévères _ Portail Vasculaire de la SFMV |
21/05/2020 |
7014 |
Vascular Disease Patient Information Page_ Cancer-associated thrombosis |
21/05/2020 |
7013 |
Vascular Disease Patient Information Page_ Direct oral anticoagulants – 2020 update |
21/05/2020 |
7012 |
Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia_ A systematic review and meta-analysis |
21/05/2020 |
7011 |
Patient-Level, Institutional, and Temporal Variations in Use of Imaging Modalities to Confirm Pulmonary EmbolismRIETE |
21/05/2020 |
7010 |
Long-term mortality after massive, submassive, and low-risk pulmonary embolism |
21/05/2020 |
7009 |
Heparin-induced thrombocytopenia (HIT)_ Review of incidence, diagnosis, and management |
21/05/2020 |
7008 |
Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion |
21/05/2020 |
7007 |
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease_ Analysis from the TRA 2°P-TIMI 50 trial |
21/05/2020 |
7006 |
Data linkage analysis of giant cell arteritis in Italy_ Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) |
21/05/2020 |
7005 |
Abdominal aortic aneurysm_ diagnosis and management |
21/05/2020 |
7004 |
Une trithérapie efficace contre le Covid-19 |
17/05/2020 |
7003 |
Travel medicine and infectious disease |
17/05/2020 |
7002 |
The Covid-19 Vascular service (COVER) Study_ An International Vascular and Endovascular Research Network (VERN) Pandemic |
17/05/2020 |
7001 |
Peut-on prédire le nombre de cas pédiatriques graves de Covid-19 |
17/05/2020 |
7000 |
Les bloqueurs du système rénine- angiotensine-aldostérone en temps de pandémie Covid-19? amis ou ennemis |
17/05/2020 |
6999 |
Le paradoxe des services d’urgence durant la crise du Covid-19 |
17/05/2020 |
6998 |
Le coronavirus conduira-t-il à des sociétés plus justes_ Thomas Piketty explore la perspective _ Nouvelles du monde _ Le gardien |
17/05/2020 |
6997 |
L’épidémie de Covid va-t-elle faire exploser la mortalité du Sida et les contaminations par le VIH |
17/05/2020 |
6996 |
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019- open label, randomised controlled trial |
17/05/2020 |
6995 |
Hépatite aiguë _ pensez Covid-19 |
17/05/2020 |
6994 |
Estimating the burden of SARS-CoV-2 in France |
17/05/2020 |
6993 |
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 |
17/05/2020 |
6992 |
Covid-19 et notre monde se referma comme une huître |
17/05/2020 |
6991 |
Covid-19 à Taiwan _ que donne le traçage |
17/05/2020 |
6990 |
Covid-19 _ une place pour l’anakinra |
17/05/2020 |
6989 |
Covid-19 _ la piste des anti-androgènes |
17/05/2020 |
6988 |
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen- observational comparative study using routine care data |
17/05/2020 |
6987 |
Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit |
17/05/2020 |
6986 |
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic an observational cohort study |
17/05/2020 |
6985 |
Value of Ultrasound in the Diagnosis of Neurogenic Thoracic Outlet Syndrome |
17/05/2020 |
6984 |
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely |
17/05/2020 |
6983 |
The Voyager PAD Trial – New Path for Post-revascularisation PAD Patients |
17/05/2020 |
6982 |
Systematic Review and Meta-Analysis of Outcomes of Open and Endovascular Repair of Ruptured Abdominal Aortic Aneurysm in Patients with Hostile vs. Friendly Aortic Anatomy |
17/05/2020 |
6981 |
Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic Aneurysm |
17/05/2020 |
6980 |
Recommendations and Guidelines |
17/05/2020 |
6979 |
Quand et quel bilan de thrombophilie réaliser 2020 |
17/05/2020 |
6978 |
Quand et quel bilan de thrombophilie réaliser |
17/05/2020 |
6977 |
NICE Abdominal Aortic Aneurysm Guidelines Finally Published How Will They In?uence Aortic Practice in the UK and Beyond |
17/05/2020 |
6976 |
Morbid obesity and mortality in patients with venous thromboembolism. Findings from real life clinical practice |
17/05/2020 |
6975 |
Hypertension artérielle synthèse des recommandations internationales 2020 |
17/05/2020 |
6974 |
Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus_ Insights from the DECLARE-TIMI 58 Trial |
17/05/2020 |
6973 |
CIRCULATIONAHA.119.043756Inherited Thoracic Aortic Disease |
17/05/2020 |
6972 |
Direct oral anticoagulants for cancer-associated venous thromboembolisma systematic reviewBllod2020 |
17/05/2020 |
6971 |
Call to Action to Prevent Venous TE Hosp patients Circ 2020 |
17/05/2020 |
6970 |
Analysis of the Differences Between the European Society for Vascular Surgery 2019 and National Institute for Health and Care Excellence 2020 Guidelines for Abdominal Aortic Aneurysm |
17/05/2020 |
6969 |
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019- open label, randomised controlled trial |
17/05/2020 |
6968 |
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen- observational comparative study using routine care data |
17/05/2020 |
6967 |
Le Conseil Constitutionnel précise les modalités du traçage des sujets contaminés |
15/05/2020 |
6966 |
Une trithérapie efficace contre le Covid-19 |
15/05/2020 |
6965 |
COVID-19 la piste de l’antipsychotique chlorprozamine |
15/05/2020 |
6964 |
COVID-19 la piste de l’antipsychotique chlorprozamine |
15/05/2020 |
6963 |
COVID-19 et maladie thromboembolique _ prévention, traitement anti-thrombotique et suivi |
15/05/2020 |
6962 |
COVID-19 des cas probables en Alsace dès la mi-novembre |
15/05/2020 |
6961 |
Covid-19 _ les malades semblent bien produire des anticorps – Sciences et Avenir |
15/05/2020 |
6960 |
science_a noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 |
15/05/2020 |
6959 |
SARS-CoV-2 et COVID-19 _ le point à 4 mois d’une pandémie _ Cardiologie Pratique |
15/05/2020 |
6958 |
rth2.12362 |
15/05/2020 |
6957 |
Recherche-clinique-et-Covid-19-la-science-n’est-pas-une-option |
15/05/2020 |
6956 |
jama_COVID-19 and health equity-a new kind of herd immunity |
15/05/2020 |
6955 |
Géneralités sur les virus |
15/05/2020 |
6954 |
Essay-interpretation-covid-19-diagnosis |
15/05/2020 |
6953 |
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome |
15/05/2020 |
6952 |
COVID-19 et maladie thromboembolique _ prévention, traitement anti-thrombotique et suivi |
15/05/2020 |
6951 |
Covid-19 _ ce que les autopsies nous apprennent sur les caillots sanguins et embolies pulmonaires – Réalités Biomédicales |
15/05/2020 |
6950 |
Cariou-in-press covid diabete |
15/05/2020 |
6949 |
ACE2 épée double tranchant |
15/05/2020 |
6948 |
Exhortation aux médecins de la peste |
12/05/2020 |
6947 |
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China- A Report of 1014 Cases |
12/05/2020 |
6946 |
Clinical characteristics of 113 deceased patients with coronavirus disease 2019_ retrospective study |
12/05/2020 |
6945 |
Cariou-in-press covid diabete |
12/05/2020 |
6944 |
Covid-19 _ ce que les autopsies nous apprennent sur les caillots sanguins et embolies pulmonaires – Réalités Biomédicales |
12/05/2020 |
6943 |
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome |
12/05/2020 |
6942 |
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva- an analysis in ex-vivo and in-vitro cultures |
12/05/2020 |
6941 |
Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection |
12/05/2020 |
6940 |
L’hydroxychloroquine aux Etats-Unis, non conclusive |
12/05/2020 |
6939 |
jama_ Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with covid-19 in new york state |
12/05/2020 |
6938 |
Hyperinflammatory shock in children during COVID-19 pandemic |
12/05/2020 |
6937 |
Généralités sur les virus |
12/05/2020 |
6936 |
Covid-19 hypothesis activated protein C for therapy of virus induced pathologic thromboinflammation |
12/05/2020 |
6935 |
COVID-19 et maladie thromboembolique _ prévention, traitement anti-thrombotique et suivi |
12/05/2020 |
6934 |
Aphm_lettre_transplantes_covid-19 |
12/05/2020 |
6933 |
A human monoclonal antibody blocking SARS-CoV-2 infection |
12/05/2020 |
6932 |
covid-19 health disparities and solutions |
12/05/2020 |
6931 |
Recherche-clinique-et-Covid-19-la-science-n’est-pas-une-option |
12/05/2020 |
6930 |
Pseudo-Kawasaki, une autre manifestation de l’infection à SARS-CoV-2 chez l’enfant |
12/05/2020 |
6929 |
Moins de FA dans le diabète de type 2 sous dapaglifozine |
12/05/2020 |
6928 |
Le sélénium, un rôle dans le COVID 19 |
12/05/2020 |
6927 |
L’hydroxychloroquine aux Etats-Unis, non conclusive |
12/05/2020 |
6926 |
Kawasaki les 25 enfants d’Ile-de-France tous testés positifs au COVID-19 |
12/05/2020 |
6925 |
COVID-19 des cas probables en Alsace dès la mi-novembre |
12/05/2020 |
6924 |
Aphm_covid19 et transplantation rénale |
12/05/2020 |
6923 |
Sérologies SARS-CoV-2 COVID19, pourquoi _ Chez qui _ – Atoute.org |
10/05/2020 |
6922 |
Remise en cause des certitudes les enfants COVID sont-ils aussi contagieux que les adultes |
10/05/2020 |
6921 |
Qui est immunisé contre le COVID |
10/05/2020 |
6920 |
Quand et quel bilan de thrombophilie réaliser 2020 |
10/05/2020 |
6919 |
Plaidoyer pour un débat sur le déconfinement – Atoute.org |
10/05/2020 |
6918 |
OpenSAFELY_ factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients_ |
10/05/2020 |
6917 |
JIM.fr – Pour contrer la pandémie, un modèle ne suffit pas |
10/05/2020 |
6916 |
JIM.fr – Masques _ l’étrange défaite |
10/05/2020 |
6915 |
JIM.fr – Intoxications aux produits ménagers et Covid-19, ça fait tache… |
10/05/2020 |
6914 |
JIM.fr – Diabète de type 2 et Covid-19, l’impact majeur de la glycémie |
10/05/2020 |
6913 |
Jama, clinical characteristics and results of semen tests among men with coronavirus disease 2019 |
10/05/2020 |
6912 |
Interpreting Diagnostic Tests for SARS-CoV-2 |
10/05/2020 |
6911 |
Covid-19_ Survivre au long chemin à parcourir _ Le BMJ |
10/05/2020 |
6910 |
Comment le coronavirus tue-t-il |
10/05/2020 |
6909 |
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes |
10/05/2020 |
6908 |
analysis-of-SARS-CoV-2-viral-load-by-patient-age |
10/05/2020 |
6907 |
An analysis of SARS-COV-2 viral load by patient age |
10/05/2020 |
6906 |
Walter Gusmini patients COVID ou non COVID, telle est la question |
09/05/2020 |
6905 |
Utilité du GT-scan thoracique pour le diagnostic et le triage des patients suspects de vovid19 |
09/05/2020 |
6904 |
SARS COV2 un point dans la tourmente |
09/05/2020 |
6903 |
phlébo covid 2 |
09/05/2020 |
6902 |
OP-EHEA200125_online 1588..1601 HTAconsensu 2020 |
09/05/2020 |
6901 |
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 |
09/05/2020 |
6900 |
Miscellanées coronavirales animales végétales et inclassables |
09/05/2020 |
6899 |
JIM.fr – Grossesse et Covid-19 _ interrogations après un cas de fausse couche au 2ème trimestre |
09/05/2020 |
6898 |
JIM.fr – De Rome à Wuhan ou comment évoluent les signes radiologiques du Covid-19 |
09/05/2020 |
6897 |
JIM.fr – Contrôle de l’épidémie de Covid-19, aux confins de l’isolement |
09/05/2020 |
6896 |
ESC |
09/05/2020 |
6895 |
Jean Marie Michel, nous ne sommes pas encore au stade post-COVID |
09/05/2020 |
6894 |
Immunology of COVID-19_ current state of the science |
09/05/2020 |
6893 |
Epidemiology of Covid-19 |
09/05/2020 |
6892 |
Covid-19_ La FDA approuve un test sanguin fiable à 99,8% – Sciences et Avenir |
09/05/2020 |
6891 |
COVID-19 la troublante découverte des possibles vertus de la nicotine |
09/05/2020 |
6890 |
Coronella, pour une surveillance efficace du COVID-19 |
09/05/2020 |
6889 |
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 |
09/05/2020 |
6888 |
Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 |
08/05/2020 |
6887 |
TRIBUNE. Confinement _ « Il faut savoir dire _ “Nous nous sommes trompés !” » |
08/05/2020 |
6886 |
The versatile heparin in COVID?19 |
08/05/2020 |
6885 |
rth2.12362 |
08/05/2020 |
6884 |
Reactive lymphocytes in patients with Covid?19 |
08/05/2020 |
6883 |
journal pre-proof |
08/05/2020 |
6882 |
JIM.fr – Les médecins de ville peuvent-ils prescrire de l’hydroxychloroquine pour le traitement du Covid-19 _ Non [Tribune] |
08/05/2020 |
6881 |
JIM.fr – BCG et Covid-19, jamais sans un essai clinique |
08/05/2020 |
6880 |
jama_khullar_2020_vp_200076 |
08/05/2020 |
6879 |
jama_effect of high vs low doses of chloroquine diphosphate |
08/05/2020 |
6878 |
jama_berwick_2020_vp_200085 |
08/05/2020 |
6877 |
jama_bauchner_2020_ed_200043 |
08/05/2020 |
6876 |
Environmental Contamination of SARS-CoV-2 in Healthcare Premises |
08/05/2020 |
6875 |
Covid-19_ La FDA approuve un test sanguin fiable à 99,8% – Sciences et Avenir |
08/05/2020 |
6874 |
Covid-19 in South Korea — Challenges of Subclinical Manifestations |
08/05/2020 |
6873 |
Considering BCG vaccination to reduce the impact of COVID-19 |
08/05/2020 |
6872 |
Clinical features of COVID-19 in elderly patients- A comparison with young and middle-aged patients |
08/05/2020 |
6871 |
CIRCULATIONAHA.120.048126 |
08/05/2020 |
6870 |
Adaptations and Lessons in the Province of Bergamo |
08/05/2020 |
6869 |
Acute Cor Pulmonale in Critically Ill Patients with Covid-19 |
08/05/2020 |
6868 |
Abortion during the Covid-19 Pandemic — Ensuring Access to an Essential Health Service |
08/05/2020 |
6867 |
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 |
08/05/2020 |
6866 |
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma |
06/05/2020 |
6865 |
the race fort covid vaccines |
06/05/2020 |
6864 |
STV covid-19 et médecine vasculaire |
06/05/2020 |
6863 |
Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston |
06/05/2020 |
6862 |
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area |
06/05/2020 |
6861 |
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy |
06/05/2020 |
6860 |
Leçons du XXe siècle pour une pandémie de coronavirus moderne _ Histoire de la médecine _ JAMA _ Réseau JAMA |
06/05/2020 |
6859 |
Japan aims to fast-track review of anti-viral drug remdesivir – Reuters |
06/05/2020 |
6858 |
jama_cutler the business of medicine in the era of covid-19 |
06/05/2020 |
6857 |
Eric Topol _ catastrophe annoncée, les États-Unis trahissent les soignants _ Univadis |
06/05/2020 |
6856 |
Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection |
06/05/2020 |
6855 |
Debat Thromboprophylaxis should be considered in all patients with cancer YesTR2020 |
06/05/2020 |
6854 |
Clinical and virological data of the first cases of COVID-19 in Europe_ a case series |
06/05/2020 |
6853 |
Circulation du coronavirus- Santé publique France reclasse neuf départements (DGS) |
06/05/2020 |
6852 |
Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population_ a retrospective cohort study |
06/05/2020 |
6851 |
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France |
06/05/2020 |
6850 |
Suicide in the Time of COVID?19_ A Perfect Storm |
06/05/2020 |
6849 |
JIM.fr – Interview _ Pourquoi le test SARS-COV-2 R-GENE®, un test PCR à haute sensibilité, développé et produit en France répond aux enjeux de la pandémie COVID-19 _ |
06/05/2020 |
6848 |
JIM.fr – Covid-19 et hypoxémie _ de nouvelles anomalies à la TDM spectrale |
06/05/2020 |
6847 |
JIM.fr – Brigades _ une mécanique qui n’a pas le droit à l’erreur |
06/05/2020 |
6846 |
jama internal medicine |
06/05/2020 |
6845 |
hcspa20200501_covibaigeteauxissudumilinatu |
06/05/2020 |
6844 |
DIC in COVID19 imlications for prognosis and treatment |
06/05/2020 |
6843 |
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) |
06/05/2020 |
6842 |
COVID19-Report 20 a subnational analysis with future scenarios |
06/05/2020 |
6841 |
COVID-19 and smoking- A systematic review of the evidence |
06/05/2020 |
6840 |
Covid-19 _ le lama, la nouvelle solution pour lutter contre le virus _ – Le Parisien |
06/05/2020 |
6839 |
Covid 19 Coagulopathy in Caucasian patients |
06/05/2020 |
6838 |
Clinical and imaging features of COVID-19 |
06/05/2020 |
6837 |
CELL_CELL-D-20-00891 |
06/05/2020 |
6836 |
carial eruption in COVID-19 infection |
06/05/2020 |
6835 |
veran cartes |
03/05/2020 |
6834 |
covid 19 et medecine vasculaire |
03/05/2020 |
6833 |
JIM.fr – Covid-19 et remdesivir, ne vois-tu rien venir _ |
03/05/2020 |
6832 |
Impacts organisationnels et défis cliniques de la pandémie COVID-19 pour un service hospitalier de médecine interne universitaire – Revue Médicale Suisse |
03/05/2020 |
6831 |
Dix points clés que les médecins vasculaires ont appris très rapidement sur COVID-19 – ScienceDirect |
03/05/2020 |
6830 |
COVID-19?Prise en charge aux soins intensifs RMS2020 |
03/05/2020 |
6829 |
COVID-19?_ impact pédiatrique – Revue Médicale Suisse |
03/05/2020 |
6828 |
Covid-19 est aussi une maladie inflammatoire vasculaire – Réalités Biomédicales |
03/05/2020 |
6827 |
Coronavirus- quoi de neuf depuis mardi_ (synthèse) |
03/05/2020 |
6826 |
Confinement?_ solidarité ou individualisme?_ – Revue Médicale Suisse |
03/05/2020 |
6825 |
Comment la démocratie coréenne a-t-elle dompté Covid-19_ _ Le Club de Mediapart |
03/05/2020 |
6824 |
Circulation du coronavirus- Santé publique France reclasse neuf départements (DGS) |
03/05/2020 |
6823 |
Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 (1) |
03/05/2020 |
6822 |
propositions_sfp_pathologies_chroniques |
03/05/2020 |
6821 |
JIM.fr – Syndrome inflammatoire chez l’enfant et SARS-CoV-2 _ alerte en Europe |
03/05/2020 |
6820 |
JIM.fr – Il y aurait des formes atypiques de Covid-19 chez le nourrisson ! |
03/05/2020 |
6819 |
JIM.fr – Comment traiter les femmes enceintes infectées par le SARS-CoV-2 _ |
03/05/2020 |
6818 |
Internet Searches for Unproven COVID-19 Therapies in the United States |
03/05/2020 |
6817 |
Hopes rise for coronavirus drug remdesivir |
03/05/2020 |
6816 |
haut conseil de la santé publique |
03/05/2020 |
6815 |
Effet de la pandémie de COVID-19 sur le traitement et la recherche sur le cancer – ScienceDirect |
03/05/2020 |
6814 |
Décès et contamination des soignants _ l’heure des comptes est venue |
03/05/2020 |
6813 |
COVID-19 et cancer les oncologues craignent un effet rebond |
03/05/2020 |
6812 |
Covid-19 est aussi une maladie inflammatoire vasculaire – Réalités Biomédicales |
03/05/2020 |
6811 |
COVID-19 and the cardiovascular system EHJ2020 |
03/05/2020 |
6810 |
Coronavirus- quoi de neuf depuis mardi_ (synthèse) |
03/05/2020 |
6809 |
Confirmation of the high cumulative incidence of thrombotic COVIDTR2020 |
03/05/2020 |
6808 |
cadrage_tests_serologiques_covid-19 |
03/05/2020 |
6807 |
borba_2020_oi_200372 |
03/05/2020 |
6806 |
2020 04 24 COMMUNIQUE ARS PACA SEROLOGIE |
03/05/2020 |
6805 |
Vue sur le COVID-19 depuis la néphrologie |
03/05/2020 |
6804 |
Urgences préhospitalières?crise COVID-19RM%S2020 |
03/05/2020 |
6803 |
Traitements aggravant une infection par le COVID-19? vraiment?RMS2020 |
03/05/2020 |
6802 |
The many faces of the anti-COVID immune response |
03/05/2020 |
6801 |
The laboratory tests and host immunity of COVID-19 patients with different severity of illness |
03/05/2020 |
6800 |
Rhumatologie et COVID-19 – Revue Médicale Suisse |
03/05/2020 |
6799 |
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 (1) |
03/05/2020 |
6798 |
Remdesivir in adults with severe COVID-19- a randomised, double-blind, placebo-controlled, multicentre trial |
03/05/2020 |
6797 |
Remdesivir for COVID-19- challenges of underpowered studies |
03/05/2020 |
6796 |
Prise en charge des patients avec maladies digestives et hépatiques durant la pandémie COVID-19 – Revue Médicale Suisse |
03/05/2020 |
6795 |
Place des tests sérologiques dans la stratégie de prise en charge de la maladie COVID-19 |
03/05/2020 |
6794 |
Origine de SARS-CoV-2? le probable et le possible |
03/05/2020 |
6793 |
Oncologie?naviguer la pandémie de COVID-19 et garder le capRMS2020 |
03/05/2020 |
6792 |
nejmoa2007621 |
03/05/2020 |
6791 |
Maladies autoimmunes dans le contexte de la pandémie COVID-19RMS2020 |
03/05/2020 |
6790 |
Les complications cardiaques de la maladie COVID-19 sont-elles associées à une mortalité plus élevée _ – Revue Médicale Suisse |
03/05/2020 |
6789 |
L’hématologie au temps du COVID-19RMS2020 |
03/05/2020 |
6788 |
jama_wadhera_2020_ld_200038 |
03/05/2020 |
6787 |
jama_rubin_2020_mn_200025 |
03/05/2020 |
6786 |
jama_baud_2020_ld_200040 |
03/05/2020 |
6785 |
Infection COVID-19 chez les personnes âgées en Suisse Romande |
03/05/2020 |
6784 |
Covid-19_ Leading statistician slams UK’s reporting of swab tests as “travesty of science” |
03/05/2020 |
6783 |
COVID-19, une maladie endothéliale _ – Revue Médicale Suisse |
03/05/2020 |
6782 |
COVID-19, une approche polyphoniqueRMS2020 |
03/05/2020 |
6781 |
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset |
03/05/2020 |
6780 |
Circulation du coronavirus- Santé publique France reclasse neuf départements (DGS) |
03/05/2020 |
6779 |
Cahier des charges définissant les modalités d’évaluation des performances des tests sérologiques détectant les anticorps dirigés contre le SARS-CoV-2 |
03/05/2020 |
6778 |
anosmie RMS2020 |
03/05/2020 |
6777 |
Against pandemic research exceptionalism _ Science |
03/05/2020 |
6776 |
propositions_sfp_pathologies_chroniques |
03/05/2020 |
6775 |
JIM.fr – Les médecins libéraux, soldats oubliés de la bataille. Interview du Dr Jean-Paul Ortiz (CSMF) |
03/05/2020 |
6774 |
JIM.fr – Les greffés rénaux, très menacés par le Covid-19 |
03/05/2020 |
6773 |
JIM.fr – Le SARS-CoV-2 reste plus longtemps dans les selles que dans l’arbre respiratoire |
03/05/2020 |
6772 |
hcspa20200428_codacpaprdetedalecadelpico |
03/05/2020 |
6771 |
Enfants et coronavirus le Royaume-Uni s’inquiète de rares cas de syndrome inflammatoire |
03/05/2020 |
6770 |
Effet de la pandémie de COVID-19 sur le traitement et la recherche sur le cancer – ScienceDirect |
03/05/2020 |
6769 |
Décès et contamination des soignants _ l’heure des comptes est venue |
03/05/2020 |
6768 |
COVID-19 et cancer les oncologues craignent un effet rebond |
03/05/2020 |
6767 |
Covid-19 est aussi une maladie inflammatoire vasculaire – Réalités Biomédicales |
03/05/2020 |
6766 |
COVID-19 des recommandations pour réduire le risque thromboembolique |
03/05/2020 |
6765 |
Coronavirus – quoi de neuf depuis vendredi_ (synthèse) |
03/05/2020 |
6764 |
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL CholesterolNEJM2020 |
03/05/2020 |
6763 |
Thrombose artérielle et veineuse_ quel est le lien_ Une revue narrative – ScienceDirect |
03/05/2020 |
6762 |
Prevalence and diagnostic value of nail fold capillary microscopy in hereditary hemorrhagic telangiectasia_ A retrospective study |
03/05/2020 |
6761 |
PNDS Takayasu |
03/05/2020 |
6760 |
PNDS Takayasu (1) |
03/05/2020 |
6759 |
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular ThrombiJAMA2020 |
03/05/2020 |
6758 |
Neovascularization in carotid atherosclerotic plaques can be effectively evaluated by superb microvascular imaging (SMI)_ Initial experienceVM2020 |
03/05/2020 |
6757 |
Intensive care management of coronavirus disease 2019 (COVID-19)_ challenges and recommendations |
03/05/2020 |
6756 |
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population post-hoc analysis of the PADIS-PE trialAQJM2020 |
03/05/2020 |
6755 |
Effect of frailty syndrome on the outcomes of patients with carotid stenosisJVS2020 |
03/05/2020 |
6754 |
Effect of frailty syndrome on the outcomes of patients with carotid stenosis – ScienceDirect FranceJVS2020 |
03/05/2020 |
6753 |
DebateThromboprophylaxis should be considered in all patients NO |
03/05/2020 |
6752 |
Correlation between short-term air pollution exposure and unprovoked lung embolism TE2020 |
03/05/2020 |
6751 |
Complications thrombotiques de patients admis aux soins intensifs avec COVID-19 dans un hôpital universitaire au Royaume-Uni – ScienceDirect |
03/05/2020 |
6750 |
Comparative effectiveness of oral anticoagulants in venous thromboembolismGARFIELD-VTE |
03/05/2020 |
6749 |
Clinical impact of sex on carotid revascularizationJVS2020 |
03/05/2020 |
6748 |
Characteristics and Outcomes of Retinal Artery Occlusion |
03/05/2020 |
6747 |
caro_sfar_cgnof_prevention_mtev_femme_enceinte_covid19 |
03/05/2020 |
6746 |
Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney DiseaseCIRC2020 |
03/05/2020 |
6745 |
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer _ NEJM |
03/05/2020 |
6744 |
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19- Report of the National Institute for Public Health of the Netherlands (1) |
29/04/2020 |
6743 |
Testing the association between blood type and COVID-19 infection, intubation, and death |
29/04/2020 |
6742 |
SUIVI DES EFFETS INDESIRABLES DES MEDICAMENTS UTILISES DANS LA PRISE EN CHARGE DU COVID-19 |
29/04/2020 |
6741 |
Pulmonary, Cerebral, and Renal Thromboembolic Disease Associated with COVID-19 InfectionRad2020 |
29/04/2020 |
6740 |
Pulmonary Embolism in COVID-19 Patients_ Awareness of an Increased Prevalence |
29/04/2020 |
6739 |
Occitanie_PER_COVID19_20200423 (2) |
29/04/2020 |
6738 |
Management of COVID-19 Respiratory Distress |
29/04/2020 |
6737 |
COVID19_PE_20200423 (1) |
29/04/2020 |
6736 |
Conséquences cardiaques associées aux médicaments prescrits dans le cadre du Covid-19 et susceptibles de prolonger l’intervalle QTc |
29/04/2020 |
6735 |
Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California |
29/04/2020 |
6734 |
BILAN DES EFFETS INDESIRABLES VALIDES DANS LA BASE NATIONALE DE PHARMACOVIGILANCE COVID |
29/04/2020 |
6733 |
An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19) (1) |
29/04/2020 |
6732 |
Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D- Dimer Levels |
29/04/2020 |
6731 |
Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography |
29/04/2020 |
6730 |
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) |
29/04/2020 |
6729 |
Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston |
29/04/2020 |
6728 |
PICS-statement-re-novel-KD-C19-presentation-v2-27042020 |
29/04/2020 |
6727 |
Méfiez-vous de la deuxième vague de COVID-19 – ScienceDirect |
29/04/2020 |
6726 |
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young |
29/04/2020 |
6725 |
JIM.fr – L’IDM par temps de Covid-19, une véritable course d’obstacles |
29/04/2020 |
6724 |
Edouard Philippe présente aux députés un plan de déconfinement progressif et modulable selon les territoires |
29/04/2020 |
6723 |
CT, [18F]FDG-PET_CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour |
29/04/2020 |
6722 |
Complications thrombotiques de patients admis aux soins intensifs avec COVID-19 dans un hôpital universitaire au Royaume-Uni – ScienceDirect |
29/04/2020 |
6721 |
commission transaparence LOVENOX 12 et 15 |
29/04/2020 |
6720 |
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) |
29/04/2020 |
6719 |
Assez de masques dans le pays pour faire face aux besoins à partir du 11 mai_ (Edouard Philippe) |
29/04/2020 |
6718 |
escardio.org-ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic (1) |
29/04/2020 |
6717 |
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy |
29/04/2020 |
6716 |
Thrombotic events in SARS-CoV-2 patients_ an urgent call for ultrasound screening |
29/04/2020 |
6715 |
The Powerful Immune System Against Powerful COVID-19- A Hypothesis |
29/04/2020 |
6714 |
note_enfants_ecoles_environnements_familiaux_24_avri_2020 |
29/04/2020 |
6713 |
Microsoft Word – FFA-CP-Nicotine-Covid19-2020_04_22.doc |
29/04/2020 |
6712 |
Les maladies cardiaques sont la condition préexistante la plus courante pour les décès liés à Covid-19 |
29/04/2020 |
6711 |
JIM.fr – Le Covid-19 est-il une maladie saisonnière _ |
29/04/2020 |
6710 |
Gestion de l’épidémie de la COVID-19 parles établissements publics de santé—– analyse de la Fédération hospitalière deFrance |
29/04/2020 |
6709 |
Diabète et COVID-19 |
29/04/2020 |
6708 |
Crépy-en-Valois premières données sur l‘immunité collective au COVID-19 en milieu lycéen |
29/04/2020 |
6707 |
Clinical characteristics of older patients infected with COVID-19_ A descriptive study |
29/04/2020 |
6706 |
Chloroquine et hydroxychloroquine dans covid-19 _ Le BMJ |
29/04/2020 |
6705 |
avis_conseil_scientifique_20_avril_2020 |
29/04/2020 |
6704 |
Clinical and immunological features of severe and moderate coronavirus disease 2019 (1) |
29/04/2020 |
6703 |
urtcarial eruption in COVID-19 infection |
29/04/2020 |
6702 |
Thrombotic events in SARS-CoV-2 patients_ an urgent call for ultrasound screening |
29/04/2020 |
6701 |
SUIVI DES EFFETS INDESIRABLES DES MEDICAMENTS UTILISES DANS LA PRISE EN CHARGE DU COVID-19 |
29/04/2020 |
6700 |
SUIVI DES EFFETS INDESIRABLES DES MEDICAMENTS UTILISES DANS LA PRISE EN CHARGE DU COVID-19 |
29/04/2020 |
6699 |
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease (1) (1) |
29/04/2020 |
6698 |
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility |
29/04/2020 |
6697 |
note_enfants_ecoles_environnements_familiaux_24_avri_2020 |
29/04/2020 |
6696 |
Mild or Moderate Covid-19 |
29/04/2020 |
6695 |
JIM.fr – Recommandations pour le traitement du myélome en période de Covid-19 |
29/04/2020 |
6694 |
JIM.fr – Covid-19 _ coup de tabac sur la nicotine _ |
29/04/2020 |
6693 |
GOVIDe-69 _ PerrUche en Automne |
29/04/2020 |
6692 |
Gestion de l’épidémie de la COVID-19 parles établissements publics de santé—– analyse de la Fédération hospitalière deFrance |
29/04/2020 |
6691 |
Features of anosmia in COVID-19 |
29/04/2020 |
6690 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial |
29/04/2020 |
6689 |
DOAC COVID19 JTH2020 |
29/04/2020 |
6688 |
Diabète et COVID-19 (1) |
29/04/2020 |
6687 |
Covid-19 and Kidney Transplantation |
29/04/2020 |
6686 |
BILAN DES EFFETS INDESIRABLES VALIDES DANS LA BASE NATIONALE DE PHARMACOVIGILANCE COVID |
29/04/2020 |
6685 |
Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |
29/04/2020 |
6684 |
Estimating the burden of SARS-CoV-2 in France (1) (1) |
26/04/2020 |
6683 |
Masks and Coronavirus Disease 2019 (COVID-19) |
26/04/2020 |
6682 |
Microsoft Word – Le choix des masques v5.docx |
26/04/2020 |
6681 |
Nervous system involvement after infection with COVID-19 and other coronaviruses |
26/04/2020 |
6680 |
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement_ results of a study using routinely collected data to emulate a target trial attention PREPRINT |
26/04/2020 |
6679 |
Ovide_ la science en temps de crise_ |
26/04/2020 |
6678 |
Quoi de neuf depuis vendredi_ (synthèse) |
26/04/2020 |
6677 |
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection |
26/04/2020 |
6676 |
Twitter promotion predicts citation rates of CV articles EHJ2020 |
26/04/2020 |
6675 |
fiche-obesite-covid-19 |
26/04/2020 |
6674 |
Endothelial cell infection and endotheliitis in COVID-19 |
26/04/2020 |
6673 |
Clinical Manifestations of Children with COVID-19- a Systematic Review [1] |
26/04/2020 |
6672 |
A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy |
26/04/2020 |
6671 |
Universal weekly testing as the UK COVID-19 lockdown exit strategy |
26/04/2020 |
6670 |
Smoking is Associated with COVID-19 Progression- A Meta-Analysis |
26/04/2020 |
6669 |
SARS-CoV-2 Infection in Children |
26/04/2020 |
6668 |
Reco PEC et suivi des maladies vasculaires medecins et chirurgiens 210420 (1) |
26/04/2020 |
6667 |
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area |
26/04/2020 |
6666 |
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 |
26/04/2020 |
6665 |
La faible part de fumeurs parmi les malades du Covid-19 laisse supposer un effet protecteur de la nicotine (1) |
26/04/2020 |
6664 |
L’utilisation-de-Smartphones-pour-le-suivi-du-déconfinement-du-Covid-19-en-France-1 |
26/04/2020 |
6663 |
JIM.fr – Une endothélite à SARS-CoV-2, à l’origine de la défaillance multiviscérale _ |
26/04/2020 |
6662 |
JIM.fr – Tests sérologiques _ il faut sortir de la grande confusion |
26/04/2020 |
6661 |
JIM.fr – Recherche _ records battus pour la COVID |
26/04/2020 |
6660 |
French Pandemic Resistance |
26/04/2020 |
6659 |
EHJ BRIEF COMMUNICATION |
26/04/2020 |
6658 |
Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 |
26/04/2020 |
6657 |
covid-19-le-masque-et-la-plume-22-04 (1) |
26/04/2020 |
6656 |
Covid-19-confinement-et-addictions-1 |
26/04/2020 |
6655 |
Covid-19- le nombre de décès plus que doublé chez les patients sous hydroxychloroquine dans une étude américaine |
26/04/2020 |
6654 |
Covid-19 and Immunity in Aging Populations — A New Research Agenda |
26/04/2020 |
6653 |
COVID-19 _ ce qui inquiète les professionnels de santé _ Univadis |
26/04/2020 |
6652 |
Aux-masques-citoyens- |
26/04/2020 |
6651 |
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection |
26/04/2020 |
6650 |
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications – Article (Preprint v2) _ Qeios |
26/04/2020 |
6649 |
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications – Article (Preprint v1) _ QeiosFrançais |
26/04/2020 |
6648 |
2020_04_21_CP_nAchR |
26/04/2020 |
6647 |
20.4.14-Contamination-du-personnel-soignant-FINAL (2) |
26/04/2020 |
6646 |
Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain_ a mathematical modeling study |
26/04/2020 |
6645 |
Ten Weeks to Crush the Curve |
26/04/2020 |
6644 |
SARS-CoV-2 Infection in Children |
26/04/2020 |
6643 |
Revues électroniques Thieme – Thrombose et hémostase _ Texte intégral |
26/04/2020 |
6642 |
Reco PEC et suivi des maladies vasculaires medecins et chirurgiens 210420 (2) |
26/04/2020 |
6641 |
Microsoft Word – ry_200642_in press.docx |
26/04/2020 |
6640 |
Le rein, une cible du SARS CoV-2 |
26/04/2020 |
6639 |
La faible part de fumeurs parmi les malades du Covid-19 laisse supposer un effet protecteur de la nicotine |
26/04/2020 |
6638 |
JIM.fr – Le confinement a-t-il vraiment permis de sauver 60 000 personnes en France _ |
26/04/2020 |
6637 |
JIM.fr – Direct 23 avril _ Dialyse et Covid _ Du cannabis thérapeutique dans les EHPAD _ |
26/04/2020 |
6636 |
Flooded by the torrent_ the COVID-19 drug pipeline |
26/04/2020 |
6635 |
Ethnicity and COVID-19_ an urgent public health research priorityLancet |
26/04/2020 |
6634 |
Espoirs et difficultés expérimentales contre le covid-19RMS2020 |
26/04/2020 |
6633 |
Dermatologie. Lésions liées au Covid |
26/04/2020 |
6632 |
Covid-19- le nombre de décès plus que doublé chez les patients sous hydroxychloroquine dans une étude américaine |
26/04/2020 |
6631 |
COVID-19 et diabète quels mécanismes en cause |
26/04/2020 |
6630 |
COVID-19 l’énigmatique rôle de la nicotine |
26/04/2020 |
6629 |
Coronavirus – Tests sérologiques _ enfin les premiers résultats en France – Le Point |
26/04/2020 |
6628 |
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 |
26/04/2020 |
6627 |
«Nous ne sommes pas dans un blockbuster hollywoodien» – Libération |
26/04/2020 |
6626 |
«Il faut sortir de la crise intelligemment et rapidement?»RAMS2020 |
26/04/2020 |
6625 |
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020_ retrospective cohort study |
26/04/2020 |
6624 |
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease |
26/04/2020 |
6623 |
COVID and the renin angiotensin system |
26/04/2020 |
6622 |
Global-Humanitarian-Response-Plan-COVID-19 |
26/04/2020 |
6621 |
Early Release – COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, |
26/04/2020 |
6620 |
COVID-19_ One-month impact of the French lockdown on the epidemic burden |
26/04/2020 |
6619 |
Cluster of COVID-19 in northern France- A retrospective closed cohort study |
26/04/2020 |
6618 |
Clinical and immunological features of severe and moderate coronavirus disease 2019 |
26/04/2020 |
6617 |
Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate |
26/04/2020 |
6616 |
BMJ Practice COVID-19 |
26/04/2020 |
6615 |
An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19) |
26/04/2020 |
6614 |
structural basis for the recognition of SARS-cov-2 bye full length human ACE2 |
26/04/2020 |
6613 |
20-0764-TECHAPP1 |
26/04/2020 |
6612 |
recos TH 2020 COVID-19 |
26/04/2020 |
6611 |
Literature_COVID2019_16-04-2020-min |
21/04/2020 |
6610 |
JIM.fr – Taiwan, le pays qui a vaincu l’épidémie |
21/04/2020 |
6609 |
JIM.fr – Détection du SARS-CoV-2 _ pourquoi pas un test salivaire _ |
21/04/2020 |
6608 |
Epidémie Contagiosité R0-18042020 Def |
21/04/2020 |
6607 |
COVID-19 et obésité sévère 7 fois plus de patients ventilés |
21/04/2020 |
6606 |
COVID-19 des conseils pour les patients diabétiques |
21/04/2020 |
6605 |
The effect of corticosteroid treatment on patients with coronavirus infection- a systematic review and meta-analysis |
21/04/2020 |
6604 |
Sans recherche active des porteurs du Sars- CoV-2, déconfiner avant juin conduira à une 2e vague importante en Ile-de-France (Inserm) |
21/04/2020 |
6603 |
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications |
21/04/2020 |
6602 |
jama_wang_2020_vp_200035 |
21/04/2020 |
6601 |
inserm-covid-19_report_lockdown_idf-20200412 (1) |
21/04/2020 |
6600 |
Hydroxychloroquine (Plaquenil)?_ un vieux médicament au profil toujours très intéressant _ La Revue du Praticien |
21/04/2020 |
6599 |
Cytokine Storm in COVID-19 and Treatment |
21/04/2020 |
6598 |
COVID-19, Arrhythmic Risk and Inflammation_ Mind the Gap! |
21/04/2020 |
6597 |
COVID-19- Gastrointestinal Manifestations and Potential Fecal-Oral Transmission |
21/04/2020 |
6596 |
Covid-19 et l’intégrité scientifique – {Sciences²} |
21/04/2020 |
6595 |
bmj.m1375.full |
21/04/2020 |
6594 |
ARS-THESAURUS-CHIRURGIE-URGENTE (1) |
21/04/2020 |
6593 |
A Dermatologic Manifestation of COVID-19- Transient Livedo Reticularis |
21/04/2020 |
6592 |
Sérologies Covid-19 |
21/04/2020 |
6591 |
Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering |
21/04/2020 |
6590 |
serologie_covid_19_mise_en_garde_du_cnp_de_bm |
21/04/2020 |
6589 |
Propositions SFMV COVID MTEV |
21/04/2020 |
6588 |
Pandémie COVID-19 – impact sur le systeme cardiovasculaire.Données disponibles au 1eravril 2020 |
21/04/2020 |
6587 |
Lésions acrales et Covid message SFMV |
21/04/2020 |
6586 |
Immune Thrombocytopenic Purpura in a Patient with Covid-19 |
21/04/2020 |
6585 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection- causality or coincidence_ |
21/04/2020 |
6584 |
Dementia care during COVID-19 |
21/04/2020 |
6583 |
Covid-19 et l’intégrité scientifique – {Sciences²} |
21/04/2020 |
6582 |
COVID-19 and Thrombotic or Thromboembolic Disease_ Implications for Prevention, Antithrombotic Therapy, and Follow-up |
21/04/2020 |
6581 |
Covid-19 and the Stiff Upper Lip — The Pandemic Response in the United Kingdom |
21/04/2020 |
6580 |
COVID-19 – point épidémiologique du 16 avril 2020 (1) (1) |
21/04/2020 |
6579 |
choix-des-masques-14-avril-2020 |
21/04/2020 |
6578 |
Cardiopulmonary resuscitation after hospital admission with covid-19 |
21/04/2020 |
6577 |
A Sneeze |
21/04/2020 |
6576 |
200407_cp_tests_serologiques_deconfinement |
21/04/2020 |
6575 |
1-s2.0-S0140673620307467-main (1) |
21/04/2020 |
6574 |
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery |
21/04/2020 |
6573 |
The proximal origin of SARS-CoV-2 |
21/04/2020 |
6572 |
Spread of SARS-CoV-2 in the Icelandic Population |
21/04/2020 |
6571 |
RMS_COVID C-2_17 |
21/04/2020 |
6570 |
Patients retournez chez le médecin ! |
21/04/2020 |
6569 |
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies (1) |
21/04/2020 |
6568 |
How to Obtain a Nasopharyngeal Swab Specimen |
21/04/2020 |
6567 |
article coag COVID ICM R2 |
21/04/2020 |
6566 |
anne nivat des pays en guerre |
21/04/2020 |
6565 |
Where do we stand with antithrombotic prophylaxis in patients with COVID-19TR2020 |
21/04/2020 |
6564 |
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery |
21/04/2020 |
6563 |
Thrombocytopenia and Its Association with Mortality in Patients with COVID?19 |
21/04/2020 |
6562 |
Temporal dynamics in viral shedding and transmissibility of COVID-19 |
21/04/2020 |
6561 |
Severe COVID-19 during Pregnancy and PossibleTB2020 |
21/04/2020 |
6560 |
serologie_covid_19_mise_en_garde_du_cnp_de_bm |
21/04/2020 |
6559 |
salivai is a rliable tool to detect COVID |
21/04/2020 |
6558 |
RMS_690_756 (1) |
21/04/2020 |
6557 |
RMS_690_711 |
21/04/2020 |
6556 |
Pulmonary embolism in a young pregnant woman with Covid-19TR2020 |
21/04/2020 |
6555 |
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China_ a retrospective case series |
21/04/2020 |
6554 |
Management of Acute Myocardial Infarction During the COVID-19 Pandemic |
21/04/2020 |
6553 |
Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19[v1] _ Preprints |
21/04/2020 |
6552 |
ESGE and ESGENA Position Statement on gastrointestinalTH2020 |
21/04/2020 |
6551 |
Disseminated intravascular coagulation in patients with 2019?nCoV pneumonia |
21/04/2020 |
6550 |
D?dimer levels on admission to predict in?hospital mortality in patients with Covid?19 |
21/04/2020 |
6549 |
Angiologie. Prévention MTEV femme enceinte |
21/04/2020 |
6548 |
200407_cp_tests_serologiques_deconfinement |
21/04/2020 |
6547 |
2020.04.10.20060699v1.full |
21/04/2020 |
6546 |
idsa-covid-19-gl-tx-and-mgmt-4-11-20-1058-am-edt (1) |
16/04/2020 |
6545 |
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery (1) |
16/04/2020 |
6544 |
Radiologie prise en charge des patients suspects ou non de COVID-19 en pratique de ville |
16/04/2020 |
6543 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)_ A Review |
16/04/2020 |
6542 |
Performance du frottis nasopharyngé-PCR pour le diagnostic du Covid-19. Recommandations pratiquesRMS2020 |
16/04/2020 |
6541 |
PEC_NUT_HOPITAL_COVID19_SFNCM |
16/04/2020 |
6540 |
PEC_NAD_COVID19_SFNCM |
16/04/2020 |
6539 |
La HAS déconseille la vaccination en urgence contre le pneumocoque, non justifiée dans le contexte de Covid-19 |
16/04/2020 |
6538 |
JIM.fr – Vu de l’étranger _ l’incroyable efficacité du système hospitalier français |
16/04/2020 |
6537 |
JIM.fr – La maternité aux temps du Covid-19 |
16/04/2020 |
6536 |
JIM.fr – Covid-19, un effet nicotine positif _ |
16/04/2020 |
6535 |
JIM.fr – Covid-19 _ quelle assistance respiratoire dans l’antichambre du service de Réa _ |
16/04/2020 |
6534 |
Hydroxychloroquine (Plaquenil)?_ un vieux médicament au profil toujours très intéressant _ La Revue du Praticien |
16/04/2020 |
6533 |
Covid-19 dans les brouillards français de l’hydroxychloroquine – Revue Médicale Suisse |
16/04/2020 |
6532 |
COVID-19 et Rein_patients (1) |
16/04/2020 |
6531 |
COVID-19 and maternal mental health_ Are we getting the balance right_ |
16/04/2020 |
6530 |
COVID-19 _ impact des mesures de confinement analysé dans 11 pays européens _ Univadis |
16/04/2020 |
6529 |
APMnews – Après l’_infection par Sars-Cov-2, 30% des patients présentent de très faibles concentrations en anticorps neutralisants |
16/04/2020 |
6528 |
2020.04.10.20060699v1.full.pdf.pdf |
16/04/2020 |
6527 |
COVID-19 with Different Severity_ A Multi-center Study of Clinical Features |
15/04/2020 |
6526 |
Des échantillons |
15/04/2020 |
6525 |
covid-19-le-masque-et-la-plume-12-04 (1) |
15/04/2020 |
6524 |
Performance du frottis nasopharyngé-PCR pour le diagnostic du Covid-19. Recommandations pratiquesRMS2020 |
15/04/2020 |
6523 |
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy- CT and MRI Features (1) |
15/04/2020 |
6522 |
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor_ A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) |
15/04/2020 |
6521 |
Smoking, vaping and hospitalization for COVID-19 – Article (Preprint v13) _ Qeios |
15/04/2020 |
6520 |
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery |
15/04/2020 |
6519 |
Selon l’agence belge des médicaments, l’hydroxychloroquine peut endommager les globules rouges – Le Soir |
15/04/2020 |
6518 |
Radiologie prise en charge des patients suspects ou non de COVID-19 en pratique de ville |
15/04/2020 |
6517 |
Presumed Asymptomatic Carrier Transmission of COVID-19 |
15/04/2020 |
6516 |
JIM.fr – Quand un patient Covid 19+ tousse…même masqué |
15/04/2020 |
6515 |
First protocol on how to use lung ultrasound to triage COVID-19 _ MDedge Internal Medicine |
15/04/2020 |
6514 |
Dexamethasone treatment for the acute respiratory distress syndrome_ a multicentre, randomised controlled trialLR2020 |
15/04/2020 |
6513 |
Covid-19, dans les brouillards français de l’hydroxychloroquine – Revue Médicale Suisse |
15/04/2020 |
6512 |
COVID-19, Arrhythmic Risk and Inflammation_ Mind the Gap! |
15/04/2020 |
6511 |
COVID grave et si l’intubation n’était pas la solution |
15/04/2020 |
6510 |
COVID 19 – liens utiles pour avoir des informations sur les recommandations faites par la DGS et les Conseils Nationaux Professionnels |
15/04/2020 |
6509 |
Battelle cleared to sterilize N95 masks at max capacity, operate in other states to fight coronaviru (1) |
15/04/2020 |
6508 |
Venous thromboembolism in patients hospitalized for hip jointTR2020 |
14/04/2020 |
6507 |
TWILIGHT-DM l’arrêt précoce de l’aspirine est aussi bénéfique chez les diabétiques |
14/04/2020 |
6506 |
Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary InterventionJACC2020 |
14/04/2020 |
6505 |
The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous ThromboembolismTH2020 |
14/04/2020 |
6504 |
Secondary Prevention for Atherosclerotic Cardiovascular Disease |
14/04/2020 |
6503 |
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention COMPASSPCI |
14/04/2020 |
6502 |
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI) |
14/04/2020 |
6501 |
nejmoa2000052_appendix VOYAGER NEJM2020 |
14/04/2020 |
6500 |
nejmoa1915103_appendixCARAVAGGIO |
14/04/2020 |
6499 |
JIM.fr – Contraception par pilule progestative seule _ recommandations et nouveauté |
14/04/2020 |
6498 |
Initial Invasive or Conservative Strategy for Stable Coronary DiseaseNEJM2020 |
14/04/2020 |
6497 |
Comparing Primary Prevention Recommendations |
14/04/2020 |
6496 |
Cardiovascular Medicine in Sweden |
14/04/2020 |
6495 |
Cancer et MTEV apixaban aussi efficace que l’HBPM sans plus de risque de saignements majeurs dans CARAVAGGIO |
14/04/2020 |
6494 |
Arrêté du 24 mars 2020 modifiant la liste des spécialités pharmaceutiques remboursables aux assurés sociaux _ Legifrance |
14/04/2020 |
6493 |
Antiplatelet Medications Protect Against Aortic Dissection and Rupture in Patients With Abdominal Aortic AneurysmsJACC2020 |
14/04/2020 |
6492 |
Angiœdèmes héréditaires sur déficit en C1-inhibiteur? nouveautés thérapeutiquesRMS2020 |
14/04/2020 |
6491 |
A high variability of arterial Doppler waveform descriptions exists in ChinaVM2020 |
14/04/2020 |
6490 |
suggested initial controller treatment in adults and adolescents with a diagnosis of asthma |
13/04/2020 |
6489 |
schema théorique de la réaction immunitaire à une infection virale |
13/04/2020 |
6488 |
covid19 transmission |
13/04/2020 |
6487 |
The Restructuring of Structural Heart Disease Practice During The Covid-19 PandemicJACC |
13/04/2020 |
6486 |
The Mental Health Consequences of COVID-19 and Physical Distancing The Need for Prevention and Early Intervention |
13/04/2020 |
6485 |
Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan |
13/04/2020 |
6484 |
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection |
13/04/2020 |
6483 |
premier essai hydroxychloroquine et azithromycine |
13/04/2020 |
6482 |
JIM.fr – La colère et la solidarité |
13/04/2020 |
6481 |
JIM.fr – Covid-19 _ patience et longueur de temps pour la réa du SDRA |
13/04/2020 |
6480 |
jamaneurology_mao_2020_oi_200025 |
13/04/2020 |
6479 |
jama_pan_2020_oi_200040 |
13/04/2020 |
6478 |
HAS – Réponses rapides Covid-19 |
13/04/2020 |
6477 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection_ causality or coincidence_ |
13/04/2020 |
6476 |
COVID-19_ A Lesson in Humility and An Opportunity for Sagacity and Hope |
13/04/2020 |
6475 |
Covid-19 _ le risque de transmission par des porteurs sains se confirme _ Inserm – La science pour l |
13/04/2020 |
6474 |
Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome |
13/04/2020 |
6473 |
Coronavirus_ depuis le premier mort en Chine, comment les chiffres officiels ont semé le trouble _ Le Huffington Post |
13/04/2020 |
6472 |
Coronavirus- quoi de neuf depuis mardi_ |
13/04/2020 |
6471 |
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) TreatmentJACC2020 |
13/04/2020 |
6470 |
Compassionate Use of Remdesivir for Patients with Severe Covid-19 |
13/04/2020 |
6469 |
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
13/04/2020 |
6468 |
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China |
13/04/2020 |
6467 |
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection |
13/04/2020 |
6466 |
Why are pregnant women susceptible to COVID-19_ An immunological viewpoint _ Elsevier Enhanced Reade |
13/04/2020 |
6465 |
WHO-2019-nCoV-Food_Safety-2020.1-eng |
13/04/2020 |
6464 |
Two Cases of COVID-19 Related Cardiomyopathy in Pregnancy. |
13/04/2020 |
6463 |
The scandals of covid-19 |
13/04/2020 |
6462 |
Kidney disease is associated with in-hospital death of patients with COVID-19 |
13/04/2020 |
6461 |
JIM.fr – Premier cas de méningo-encéphalite à SARS-CoV-2 au Japon |
13/04/2020 |
6460 |
JIM.fr – Covid-19 _ pourquoi il faut doser la troponine |
13/04/2020 |
6459 |
JIM.fr – Covid-19 _ le rein, une autre cible |
13/04/2020 |
6458 |
Incidence of thrombotic complications in critically ill ICU patients with COVID-1 |
13/04/2020 |
6457 |
High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19 |
13/04/2020 |
6456 |
Food Safety and the Coronavirus Disease 2019 (COVID-19) _ FDA |
13/04/2020 |
6455 |
Food Safety and COVID-19 |
13/04/2020 |
6454 |
COVID-19 (coronavirus) and food safety _ NZ Food Safety _ NZ Government |
13/04/2020 |
6453 |
Coronavirus_ les tests sérologiques sont-ils vraiment la clé du déconfinement _ _ Le Huffington Post |
13/04/2020 |
6452 |
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 |
13/04/2020 |
6451 |
A first Case of Meningitis_Encephalitis associated with SARS-Coronavirus-2 |
13/04/2020 |
6450 |
science.abb7015.full |
13/04/2020 |
6449 |
Prediction models for diagnosis and prognosis of covid-19 infection- systematic review and critical appraisal |
13/04/2020 |
6448 |
Neher-Potential-impact-of-seasonal-forcing-on-a-SARS-Cov2-pandemic-1 |
13/04/2020 |
6447 |
Ma-Potential-utilities-of-mask-wearing-and-instant-hand-hygiene-for-fighting-SARS-CoV-2 |
13/04/2020 |
6446 |
JIM.fr – Transmission materno-fœtale du SARS-CoV-2 _ encore des doutes _ |
13/04/2020 |
6445 |
jama_omer_2020_vp_200072 |
13/04/2020 |
6444 |
jama_hogan_2020_ld_200028 |
13/04/2020 |
6443 |
jama_grasselli_2020_oi_200037 |
13/04/2020 |
6442 |
Intensive care management of coronavirus disease 2019 (COVID-19)_ challenges and recommendationsLance RD2020 |
13/04/2020 |
6441 |
High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19CIRC2020 |
13/04/2020 |
6440 |
COVID-19 and Italy- what next_ |
13/04/2020 |
6439 |
Covid-19 _ les dermatologues appellent à la vigilance sur les acrosyndromes et érythèmes faciaux _ Le Quotidien du médecin |
13/04/2020 |
6438 |
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China- A Report of 1014 Cases (2) (1) |
13/04/2020 |
6437 |
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 |
13/04/2020 |
6436 |
A German Exception_ Why the Country’s Coronavirus Death Rate Is Low – The New York Times |
13/04/2020 |
6435 |
1-s2.0-S1568997220300926-main |
13/04/2020 |
6434 |
Tissue Plasminogen Activator (tPA) Treatment for COVID?19 Associated Acute Respiratory Distress Syndrome (ARDS)_ A Case Series |
13/04/2020 |
6433 |
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19_ a multinational, network cohort and self-controlled case series study |
13/04/2020 |
6432 |
SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19) |
13/04/2020 |
6431 |
recommandations_afero_actualisation_du_10_avril_2020_1 |
13/04/2020 |
6430 |
Pulmonary and Cardiac Pathology in Covid-19- The First Autopsy Series from New Orleans |
13/04/2020 |
6429 |
MTEV_covid060420 (2) |
13/04/2020 |
6428 |
JIM.fr – Raoult, saison 1, épisode 3 _ on reste sur sa faim |
13/04/2020 |
6427 |
JIM.fr – BPCO, asthme et Covid-19, une sorte de paradoxe |
13/04/2020 |
6426 |
covid-19-le-masque-et-la-plume-12-04 (1) |
13/04/2020 |
6425 |
COVID grave et si l’intubation n’était pas la solution |
13/04/2020 |
6424 |
COVID 19 – liens utiles pour avoir des informations sur les recommandations faites par la DGS et les Conseils Nationaux Professionnels |
13/04/2020 |
6423 |
Collaborative Delirium Prevention in the Age of COVID-19 |
13/04/2020 |
6422 |
Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020 (1) |
13/04/2020 |
6421 |
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) |
13/04/2020 |
6420 |
Chest CT Features of COVID-19 in Rome, Italy (2) |
13/04/2020 |
6419 |
Table_final_website_IHU_09_04_2020 |
13/04/2020 |
6418 |
POS anticaogulants patients non hospitalisés |
13/04/2020 |
6417 |
covid-19 in South Korea — Challenges of Subclinical Manifestations |
13/04/2020 |
6416 |
No Association of COVID-19 transmission with temperature or UV radiation in Chinese cities |
13/04/2020 |
6415 |
Literature_COVID2019_09-04-2020-min |
13/04/2020 |
6414 |
Les « faiseurs de miracles » du Covid-19 _ Hippocrate dépassé par la post-vérité |
13/04/2020 |
6413 |
FICHE AUTO-INJECTION HEPARINE CAC |
13/04/2020 |
6412 |
CConsiderations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment |
13/04/2020 |
6411 |
Abstract_Raoult_EarlyTrtCovid19_09042020_vD1v |
13/04/2020 |
6410 |
Acrosyndromes et COVID R.pptx.pptx.pptx.pptx-2 |
09/04/2020 |
6409 |
journal of pharmaceutical analysis |
09/04/2020 |
6408 |
covid-19-le-masque-et-la-plume-04-04 |
09/04/2020 |
6407 |
covid-19 mass testing facilities could end the epidemic rapidly |
09/04/2020 |
6406 |
JIM.fr – Sérologie du Covid-19 _ nous y sommes |
09/04/2020 |
6405 |
Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test (1) |
09/04/2020 |
6404 |
Can SARS-CoV-2 Infection Be Acquired In Utero_More Definitive Evidence Is Needed |
09/04/2020 |
6403 |
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |
09/04/2020 |
6402 |
20.4.7-CNOM-Décisions-médicales-dans-un-contexte-de-crise-sanitaire-et-dexception |
09/04/2020 |
6401 |
jclinpath-2020-206522.full |
09/04/2020 |
6400 |
COVID-19 _ les autopsies donnent des détails pour le traitement clinique |
09/04/2020 |
6399 |
COVID-19 immune response and steroids |
06/04/2020 |
6398 |
haw far droplets travel |
06/04/2020 |
6397 |
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection |
06/04/2020 |
6396 |
Thrombocytopenia is associated with severe coronavirus disease 2019 |
06/04/2020 |
6395 |
QuickGuide_Hospitalist |
06/04/2020 |
6394 |
Publication d’une étude, dans la revue The Lancet Infectious Diseases, portant sur les cinq premiers cas de COVID-19 identifiés en France, et en Europe, entre le 24 et le 29 janvier 2020. _ APHP |
06/04/2020 |
6393 |
prevention_mtev-covid_chu_montpellier |
06/04/2020 |
6392 |
Pourquoi le coronavirus tue-t-il plus les hommes que les femmes_ _ Le Huffington Post |
06/04/2020 |
6391 |
Obesity, diabetes and COVID-19_ What PCPs need to know |
06/04/2020 |
6390 |
Médiapart sur les masques |
06/04/2020 |
6389 |
Madiapart sur les Ephad |
06/04/2020 |
6388 |
JIM.fr – Covid-19 _ la RT-PCR pourrait rester positive jusqu’à 8 jours après la guérison clinique |
06/04/2020 |
6387 |
How Scientists Predict How Many People Will Get COVID-19 |
06/04/2020 |
6386 |
Estimates of the severity of coronavirus disease 2019- a model-based analysis |
06/04/2020 |
6385 |
COVID19 MGH treatment guidance 031820_pdf (3) (1) |
06/04/2020 |
6384 |
COVID-19 and Coagulopathy – Hematology.org |
06/04/2020 |
6383 |
COVID-19 AHA Guidance on Hypertension, Latest on Angiotensin Link |
06/04/2020 |
6382 |
Clinical and virological data of the first cases of COVID-19 in Europe_ a case series |
06/04/2020 |
6381 |
An Uncomplicated Delivery in a Patient with Covid-19 in the United StatesNEJM |
06/04/2020 |
6380 |
202004011827360.avis_conseil_scientifique_30_mars_2020-_note_ehpad_cs_30_mars_2020 |
06/04/2020 |
6379 |
202004011642270.200330-Avis_duCCNE_ |
06/04/2020 |
6378 |
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China |
03/04/2020 |
6377 |
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection |
03/04/2020 |
6376 |
Stérilisation des masques |
03/04/2020 |
6375 |
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China |
03/04/2020 |
6374 |
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19NEJM2020 |
03/04/2020 |
6373 |
PIIS1473309920302322 |
03/04/2020 |
6372 |
PEKIN COVID INFACTION EHJ2020 |
03/04/2020 |
6371 |
Nlle étude hydrocloroquine promoteur CHU Angers |
03/04/2020 |
6370 |
Ne pas porter de masque pour se protéger du coronavirus est une « grande erreur », affirme un scientifique chinois haut placé |
03/04/2020 |
6369 |
JIM.fr – Sérologie _ bientôt un test rapide disponible en France _ |
03/04/2020 |
6368 |
JIM.fr – Hydroxychloroquine et Covid-19 _ nouvel essai randomisé chinois… «positif» |
03/04/2020 |
6367 |
Initial Invasive or Conservative Strategy for Stable Coronary DiseaseNEJM2020 |
03/04/2020 |
6366 |
Findings from a Retrospective Case Study of COVID-19 Infection |
03/04/2020 |
6365 |
Des chercheurs néerlandais analysent l’effet du vaccin BCG contre la tuberculose sur le coronavirus |
03/04/2020 |
6364 |
C-reactive protein levels in the early stage of COVID-1 RMI2020 |
03/04/2020 |
6363 |
CR long cliniciens COVID 30.3.20 |
03/04/2020 |
6362 |
COVID-19_protocole_surveillance_ehpad_ems_HCSP |
03/04/2020 |
6361 |
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China 2020 |
03/04/2020 |
6360 |
Acute pulmonary embolism and COVID-19 pneumonia a random associationEHJ2020 |
03/04/2020 |
6359 |
COVID19 |
01/04/2020 |
6358 |
CARAVAGGIO |
01/04/2020 |
6357 |
La contamination par les aliments existe t elle |
01/04/2020 |
6356 |
Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center2020 |
01/04/2020 |
6355 |
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection 2020 |
01/04/2020 |
6354 |
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease_ Insights from the COMPASS TrialCirc2020 |
01/04/2020 |
6353 |
The risk of misdiagnosis in acute thoracic aortic dissection_ a review of current guidelinesH2020 |
01/04/2020 |
6352 |
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19) |
01/04/2020 |
6351 |
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19) |
01/04/2020 |
6350 |
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery NEJM2020 |
01/04/2020 |
6349 |
L’impact du COVID-19 sur les pratiques de publication des chercheurs et des revues _ Univadis |
01/04/2020 |
6348 |
JIM.fr – Un score pronostique au scanner pour le Covid-19 |
01/04/2020 |
6347 |
In vitro testing of Hydroxychloroquine and Azithromycin on SARS-CoV-2 shows Raoult2020 |
01/04/2020 |
6346 |
Gratuité _ en Italie, une autre économie, par Geraldina Colotti (Le Monde diplomatique, octobre 2012) |
01/04/2020 |
6345 |
COVID-19_ Abnormal Clotting Common in More Severe Disease _ MedPage Today |
01/04/2020 |
6344 |
Clinical and microbiological effect of a combination of hydroxychloroquine IM Marseille Raoilt 2020 90 patienst |
01/04/2020 |
6343 |
Anticoagulant Therapy for Venous Thromboembolism in Cancer Caravggion NEJM2020 |
01/04/2020 |
6342 |
Analyse_Dominique_Costagliola_Article_chloroquine_Raoult |
01/04/2020 |
6341 |
200327_avis_CS_CNGE_Hydrochlroquine_vsite |
01/04/2020 |
6340 |
The challenge of an expanded therapeutic window in pulmonary hypertensionNRC2020 |
01/04/2020 |
6339 |
th-and-covid-25-march-2020-final |
01/04/2020 |
6338 |
Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes_ The DCCT_EDIC Study DC2020 |
01/04/2020 |
6337 |
Potential Effects of Coronaviruses on the Cardiovascular System_ A Review JAMA2020 |
01/04/2020 |
6336 |
jth |
01/04/2020 |
6335 |
jama_shen_2020_pc_200002 |
01/04/2020 |
6334 |
Is There a Role For Statin Therapy in Acute Viral Infections_ – American College of Cardiology |
01/04/2020 |
6333 |
ICNARC COVID-19 report 2020-03-27.pdf |
01/04/2020 |
6332 |
From the Masters_ A sea-change for TransAtlantic Inter-Society Consensus (TASC)VM2020 |
01/04/2020 |
6331 |
COVID-19 _ quelques faits marquants en Europe pour la semaine du 22 au 28 mars _ Univadis |
01/04/2020 |
6330 |
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer |
01/04/2020 |
6329 |
Anticoagulant Therapy for Venous Thromboembolism in Cancer Caravggion NEJM2020 |
01/04/2020 |
6328 |
maladie veineuse thrombo-embolique(MTEV) et ARDS – COVID19 |
30/03/2020 |
6327 |
20.3.27 Communiqué Epidémie Covid-19 dans les EHPAD |
30/03/2020 |
6326 |
COVID19 ressources |
30/03/2020 |
6325 |
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection 2007 |
30/03/2020 |
6324 |
Relationship between the ABO Blood Group and the COVID-19 Susceptibility2020 |
30/03/2020 |
6323 |
JIM.fr – Covid-19 _ ce que révèle la FDG-TEP-TDM |
30/03/2020 |
6322 |
HERM_070_0088 |
30/03/2020 |
6321 |
COVID-19 pandemicpalliative care for elderly 2020 |
30/03/2020 |
6320 |
COVID-19 pandemic triage for intensive-care treatment under resource scarcity2020 |
30/03/2020 |
6319 |
Covid-19 _ les soignants des Ehpad pourront-ils tous respecter leur «devoir d’humanité»_ _ Journalisme et Santé Publique |
30/03/2020 |
6318 |
Antihypertensive drugs and risk of COVID-19Lancet2020 |
30/03/2020 |
6317 |
ACC 2020 les études à ne pas manquer, selon le Pr G. Steg |
30/03/2020 |
6316 |
20.3.27 Communiqué Epidémie Covid-19 dans les EHPAD |
30/03/2020 |
6315 |
COVID19 |
30/03/2020 |
6314 |
top 10 geriatric clinical pearls 2 |
30/03/2020 |
6313 |
top 10 geriatric clinical pearls |
30/03/2020 |
6312 |
RPC NICE-ST PAUL UCBG COVID-19 et CANCERS DU SEIN VF |
30/03/2020 |
6311 |
JIM.fr – Interview _ « Une anosmie, totale, brutale, sans obstruction nasale est pathognomonique du Covid-19 » |
30/03/2020 |
6310 |
Defining the Epidemiology of Covid-19 — Studies NeededNEJM2020 |
30/03/2020 |
6309 |
CPR & Emergency Cardiovascular Care Interim Guidance for Healthcare Providers during COVID-19 Outbreak |
30/03/2020 |
6308 |
Clinical characteristics of 113 deceased patients with COVIS BMJ2020 |
30/03/2020 |
6307 |
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, ChinaJAMA2020 |
30/03/2020 |
6306 |
A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19) |
30/03/2020 |
6305 |
[Dépistage] Au-delà des tests PCR du Covid-19, les tests sérologiques approchent |
30/03/2020 |
6304 |
10amET-VOYAGER-PAD-acc-2020 |
30/03/2020 |
6303 |
COVID disease 2019 italy |
29/03/2020 |
6302 |
N95 shortage during covid19 |
29/03/2020 |
6301 |
devrais-je rester a la maison |
29/03/2020 |
6300 |
should you go out |
29/03/2020 |
6299 |
la distanciation sociale |
29/03/2020 |
6298 |
desinfox covid19 |
29/03/2020 |
6297 |
Switching from vitamin K antagonists to direct oral anticoagulants_ Treatment satisfaction and patient concernsJTH2020 |
29/03/2020 |
6296 |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China a retrospective cohort study |
29/03/2020 |
6295 |
Misguided drug advice for COVID-19 |
29/03/2020 |
6294 |
Leaflet Statines patients cercle coeur et métabolismes-vf |
29/03/2020 |
6293 |
How Does The COVID-19 Coronavirus Kill_ What Happens When You Get Infected |
29/03/2020 |
6292 |
Coronavirus Disease 2019 (COVID-19) and Pregnancy_ What obstetricians need to know |
29/03/2020 |
6291 |
A cluster randomised trial of cloth masks compared with medical masks in healthcare workersBMJ2020 |
29/03/2020 |
6290 |
2020-03-21-covid19-pregnancy-guidance-2118 |
29/03/2020 |
6289 |
Place des implants péniens d’érection dans le traitement de la dysfonction érectile?_ le point en 2020 – Revue Médicale Suisse |
29/03/2020 |
6288 |
pidemiological Characteristics of 2143 Pediatric Patients Covid Ped2020 |
29/03/2020 |
6287 |
JIM.fr – Des formes graves de covid-19 chez les enfants aussi |
29/03/2020 |
6286 |
Heparin-induced thrombocytopenia (HIT)_ Review of incidence, diagnosis, and managementVM2020 |
29/03/2020 |
6285 |
Épidémie de coronavirus vs libertés individuelles – Revue Médicale Suisse |
29/03/2020 |
6284 |
Deep vein thrombosis in lower extremities of an exceptional cause_ Isolated internal iliac artery aneurysm and ilio-iliac arteriovenous fistula |
29/03/2020 |
6283 |
Âge avancé, déclin cognitif et sexualité dans les institutions de santé – Revue Médicale Suisse |
29/03/2020 |
6282 |
evaluation de la concentrations en particules fines a paris |
23/03/2020 |
6281 |
Draft hydroxychloroquine COVID-ACCEPTED (00000003)2020 |
23/03/2020 |
6280 |
JIM.fr – COVID-19 _ objets inanimés, êtes-vous contaminés _ |
23/03/2020 |
6279 |
JIM.fr – Covid-19 _ profil des patients décédés en Italie |
23/03/2020 |
6278 |
JIM.fr – Sans masque, l’inquiétude gagne ceux qui continuent à travailler |
23/03/2020 |
6277 |
Kidney disease is associated with in-hospital death of patients with COVID-19 |
23/03/2020 |
6276 |
Surveillance à domicile |
23/03/2020 |
6275 |
Total Cost of Her COVID-19 Treatment_ $34,927.43 _ Time |
23/03/2020 |
6274 |
most western countries are on the same coronavirus trajectory |
23/03/2020 |
6273 |
nombre de lits en soins aigus pour 1000 habitants |
23/03/2020 |
6272 |
Viral dynamics in mild and severe cases of COVID-19 |
23/03/2020 |
6271 |
Literature_COVID2019_19-03-2020 |
23/03/2020 |
6270 |
JIM.fr – Sans masque, l’inquiétude gagne ceux qui continuent à travailler |
23/03/2020 |
6269 |
JIM.fr – Covid _ plusieurs millions de vies en jeu selon l’OMS |
23/03/2020 |
6268 |
COVID-19ACC Advises Caution on Use of Troponin, Natriuretic Peptide Tests |
23/03/2020 |
6267 |
« Fin de partie ! pour le Covid » _ le Pr Raoult et la chloroquine _ Le Club de Mediapart |
23/03/2020 |
6266 |
PredictedFrenchHospitNeeds-EHESP-20200316 |
23/03/2020 |
6265 |
Select Drug-Drug Interactions With Direct _Oral AnticoagulantsJACC2020 |
19/03/2020 |
6264 |
Of chloroquine and COVID-192020 |
19/03/2020 |
6263 |
Coronaviruses and the cardiovascular system acute and long-term implicationsEHJ2020 |
19/03/2020 |
6262 |
Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality InitiativeCir2020 |
19/03/2020 |
6261 |
Cardiovascular Implications of COVID-19 _ Cardionerds |
19/03/2020 |
6260 |
Prise en Charge |
18/03/2020 |
6259 |
Covid-19 organisation du cabinet de médecine générale |
18/03/2020 |
6258 |
Short-term exposure to PM2.5 and risk of venous thromboembolismTR2020 |
18/03/2020 |
6257 |
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With CoronavirusJAMA2020 |
18/03/2020 |
6256 |
Low Density Lipoprotein Cholesterol–Lowering Strategies and Population HealthCirc2020 |
18/03/2020 |
6255 |
Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery RevascularizationJACC2020 |
18/03/2020 |
6254 |
Liver Cancer Risk Reduced by Aspirin in Chronic Viral Hepatitis |
18/03/2020 |
6253 |
Hematocrit and incidence of venous thromboembolismRPTH2020 |
18/03/2020 |
6252 |
Ultrasound assessment of carotid arteries_ Current concepts, methodologies, diagnostic criteria, and technological advancements Echo2018 |
18/03/2020 |
6251 |
Ultrasonic risk stratification of carotid web 2019 |
18/03/2020 |
6250 |
Traitements ciblés des connectivites et vascularitesRMS2020 |
18/03/2020 |
6249 |
Petites molécules dans la polyarthrite rhumatoïdeRMS2020 |
18/03/2020 |
6248 |
Perioperative interventions for prevention of postoperative pulmonary complicationsBMJ2020 |
18/03/2020 |
6247 |
Le point sur l’arthrose RMS2020 |
18/03/2020 |
6246 |
FR pneumonie et covid-19 |
18/03/2020 |
6245 |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China_ a retrospective cohort studyLancet2020 |
18/03/2020 |
6244 |
Cardiovascular risk of electronic cigarettes- a review of preclinical and clinical studiesEHJ2019 |
18/03/2020 |
6243 |
Artificial intelligence in medical imaging CVD EHJ2020 |
18/03/2020 |
6242 |
Arterial Stiffness Accelerates Within 1 Year of the Final Menstrual Period 2020 |
18/03/2020 |
6241 |
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoringJTT2020 |
15/03/2020 |
6240 |
The evolution of the heart-healthy diet for vascular health_ A walk through timeVM2020 |
15/03/2020 |
6239 |
The Effect of Coconut Oil Consumption on CVR FactorsCirc2020 |
15/03/2020 |
6238 |
Rumpel–Leede phenomenon in a patient with chronic lymphocytic leukemia treated with acalabrutinibVM2020 |
15/03/2020 |
6237 |
Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular DiseaseAJM2020 |
15/03/2020 |
6236 |
Reducing the Risk of Cardiovascular DiseaseBrick by BRICSCirc2020 |
15/03/2020 |
6235 |
Optimal Prescription of the Lower Dose of Apixaban&lowastJACC2020 |
15/03/2020 |
6234 |
impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus Circ2020 |
15/03/2020 |
6233 |
High prevalence of arterial dissection in patients with Loeys–Dietz syndrome and cerebral aneurysmVM2020 |
15/03/2020 |
6232 |
From CANTOS to CIRT to COLCOT to ClinicWill All Atherosclerosis Patients Combination Lipid-Lowering and Inflammation-Inhibiting AgentsCirc2020 |
15/03/2020 |
6231 |
Fifteen-Year Trends of Cardiogenic Shock and Mortality in Patients with Diabetes and Acute Coronary SyndromesAJM2020 |
15/03/2020 |
6230 |
Do we need prophylactic anticoagulation in ambulatory patients with lung cancer_ A reviewVM2020 |
15/03/2020 |
6229 |
COVID-19 implications sur la prise en charge des patients avec des antécédents cardiovasculaires |
15/03/2020 |
6228 |
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE TrialJACC2020 |
15/03/2020 |
6227 |
Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality InitiativeCir2020 |
15/03/2020 |
6226 |
Cardiovascular Prevention Strategies in _Breast CancerJACC2019 |
15/03/2020 |
6225 |
Assessing patient preferences for switching from warfarin to direct oral anticoagulantsJTT2019 |
15/03/2020 |
6224 |
Anticoagulant Comparison Chart |
15/03/2020 |
6223 |
What’s new in VTE risk and prevention in orthopedic surgeryRPTH2020 |
15/03/2020 |
6222 |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
15/03/2020 |
6221 |
S014067362305663.pdf |
15/03/2020 |
6220 |
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation_ A Scientific Statement From the American Heart AssociationCirc2020 |
15/03/2020 |
6219 |
JIM.fr – Diagnostiquer le Covid 19 sur l’imagerie, un autre défi… |
15/03/2020 |
6218 |
International Society for Peritoneal Dialysis practice recommendations2020 |
15/03/2020 |
6217 |
Fatigue after initiating rivaroxaban for venous thromboembolismRPTH2020 (1) |
15/03/2020 |
6216 |
External validation of the SOX‐_PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosisJTH2020 |
15/03/2020 |
6215 |
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease2020 |
15/03/2020 |
6214 |
COVID-19 and the cardiovascular systemNat2020 |
15/03/2020 |
6213 |
Clinical Review on Triglycerides – American College of Cardiology JACC2020 |
15/03/2020 |
6212 |
Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery_ insights from the RIETE registryJTT2020 |
15/03/2020 |
6211 |
Auer2019_Article_StrokeSeverityInPatientsWithPr |
15/03/2020 |
6210 |
Takayasu Arteritis Type V EJVES2020 |
15/03/2020 |
6209 |
Loss of life expectancy from air pollution compared to other risk factorsa worldwide perspectiveEHJ2020 |
15/03/2020 |
6208 |
Impact of diabetes mellitus on 5-year clinical outcomes following successful endovascular revascularization for peripheral artery diseaseVM2020 |
15/03/2020 |
6207 |
congres out usa |
15/03/2020 |
6206 |
« Le Covid-19 est un réel danger ! », deux scientifiques font le point sur le coronavirus SARS-CoV-2 _ Le Quotidien du médecin |
15/03/2020 |
6205 |
Vitamin K antagonists and osteoporotic fracturesinsights from comparisons with the NOACsEHJ2020 |
15/03/2020 |
6204 |
The gut microbiome and thromboembolism TR2020 |
15/03/2020 |
6203 |
Meta-Analysis and Meta-Regression Analysis of Outcomes of Endovascular and Open Repair for Ruptured Abdominal Aortic AneurysmEJVES2020 |
15/03/2020 |
6202 |
Menopause and hormone replacement therapy in the 21st centuryH2020 |
15/03/2020 |
6201 |
Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose EJVES2020 |
15/03/2020 |
6200 |
Endovascular vs. Open Repair for Abdominal Aortic Aneurysm_ Systematic Review and Meta-analysis of Updated Peri-operative EJVES2020 |
15/03/2020 |
6199 |
Egg consumption and risk of cardiovascular disease_ three large prospective US cohort studies, systematic review, and updated meta-analysisBMJ2020 |
15/03/2020 |
6198 |
« Le Covid-19 est un réel danger ! », deux scientifiques font le point sur le coronavirus SARS-CoV-2 _ Le Quotidien du médecin |
15/03/2020 |
6197 |
 |
15/03/2020 |
6196 |
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyNEJM2020 |
15/03/2020 |
6195 |
The Apple Watch can detect atrial fibrillationso what now NCard2020 |
15/03/2020 |
6194 |
Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic AneurysmEJVES2020 |
15/03/2020 |
6193 |
Prognostic Role of Pre-Operative Symptom Status in Carotid Endarterectomy_ A Systematic Review and Meta-AnalysisEJVES2020 |
15/03/2020 |
6192 |
Ischaemic stroke |
15/03/2020 |
6191 |
How will country-based mitigation measures influence the course of the COVID-19 epidemicLancet2020 |
15/03/2020 |
6190 |
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism Bllod2020 |
15/03/2020 |
6189 |
Global, regional, and national burden of chronic kidney disease, 19902017 a systematic analysis for the Global Burden of Disease Study 2017Lancet2020 |
15/03/2020 |
6188 |
Extended Thromboprophylaxis for Medical PatientsAJM2020 |
15/03/2020 |
6187 |
Endogenous sex hormones and risk of venous thromboembolism in young womenJTH2019 |
15/03/2020 |
6186 |
Effectiveness of Inferior Vena Cava Filters in Patients With Stable and Unstable Pulmonary Embolism and Trends in Their UseAJM2020 |
15/03/2020 |
6185 |
Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism managementJT2020 |
15/03/2020 |
6184 |
Age at period cessation and trajectories of cardiovascular risk factors across mid and later lifeH2019 |
15/03/2020 |
6183 |
Acute heart failure NatMed2020 |
15/03/2020 |
6182 |
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurelyTR2020 |
15/03/2020 |
6181 |
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on HemodialysisCirc2020 |
15/03/2020 |
6180 |
Sleep Irregularity and Risk of Cardiovascular EventsJACC2020 |
15/03/2020 |
6179 |
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial FibrillationJAMA2020 |
15/03/2020 |
6178 |
Nouvelles recommandations européennes et américaines pour les dyslipidémies?similitudes et différenceRMS2020 |
15/03/2020 |
6177 |
Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEFJACC2020 |
15/03/2020 |
6176 |
Management of oral anticoagulants prior to emergency surgery or with major bleeding_ A survey of perioperative practices in North America_RPTH2020 |
15/03/2020 |
6175 |
Lower Extremity Venous Stent Placement_ A Large Retrospective Single-Center Analysis JVIR2020 |
15/03/2020 |
6174 |
Increasing use of anticoagulants in Germany and its impact on hospitalization rates for genitourinary bleedingJTT2020 |
15/03/2020 |
6173 |
From multi-target anticoagulants to DOACs, and intrinsic coagulation factor inhibitorsBRew2020 |
15/03/2020 |
6172 |
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐_Dimer analysis_ A prospective studyJTH2020-compressé |
15/03/2020 |
6171 |
Do asymptomatic clots in children matterTR2020 |
15/03/2020 |
6170 |
Cardiovascular Mortality After Type _1 _and _Type 2 Myocardial Infarction in _Young AdultsJACC2020 |
15/03/2020 |
6169 |
Recos-SRLF-SFAR-SFMU-GFRUP-SPILF |
15/03/2020 |
6168 |
Recos-SRLF-SFAR-SFMU-GFRUP-SPILF |
15/03/2020 |
6167 |
How will country-based mitigation measures influence the course of the COVID-19 epidemicLancet2020 |
15/03/2020 |
6166 |
The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous ForumJVSL2020_1 |
12/03/2020 |
6165 |
The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous ForumJVSL2020 |
12/03/2020 |
6164 |
Patient radiation exposure for endovascular deep venous interventionsJVSL2020 |
12/03/2020 |
6163 |
Midterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosisJVSL2020 |
12/03/2020 |
6162 |
Indocyanine green lymphography findings in older patients with lower limb lymphedemaJVSL2020 |
12/03/2020 |
6161 |
Evaluation of pain incidence due to venous malformation based on data from 85 institutions in JapanJVSL2020 |
12/03/2020 |
6160 |
Etiology of iliocaval stent thrombosisJVSL2020 |
12/03/2020 |
6159 |
CEAP classification system and reporting standard, revision 2020JVSL2020 |
12/03/2020 |
6158 |
Acute superior mesenteric venous thrombosis results in high rates of readmission and morbidityJVSL2020 |
12/03/2020 |
6157 |
A new way to treat proximal deep venous thrombosis using E-selectin inhibitionJVSL2020 |
12/03/2020 |
6156 |
 |
12/03/2020 |
6155 |
The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous ForumJVSL2020 |
12/03/2020 |
6154 |
Patient radiation exposure for endovascular deep venous interventionsJVSL2020 |
12/03/2020 |
6153 |
Midterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosisJVSL2020 |
12/03/2020 |
6152 |
Indocyanine green lymphography findings in older patients with lower limb lymphedemaJVSL2020 |
12/03/2020 |
6151 |
Evaluation of pain incidence due to venous malformation based on data from 85 institutions in JapanJVSL2020 |
12/03/2020 |
6150 |
Etiology of iliocaval stent thrombosisJVSL2020 |
12/03/2020 |
6149 |
Diagnostic performance of lower extremity Doppler ultrasound in detecting iliocaval obstructionJVSL2020 |
12/03/2020 |
6148 |
CEAP classification system and reporting standard, revision 2020JVSL2020 |
12/03/2020 |
6147 |
Acute superior mesenteric venous thrombosis results in high rates of readmission and morbidityJVSL2020 |
12/03/2020 |
6146 |
A new way to treat proximal deep venous thrombosis using E-selectin inhibitionJVSL2020 |
12/03/2020 |
6145 |
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment- Insights from the MAGELLAN and MARINER TrialsTH2020 |
12/03/2020 |
6144 |
The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous ThromboembolismTH2020 |
12/03/2020 |
6143 |
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients- A Systematic Need for New StrategieTH2020 |
12/03/2020 |
6142 |
Olive Oil Consumption and Cardiovascular Risk in U.S. AdultsJACC2020 |
12/03/2020 |
6141 |
Hypothyroidism and the Risk of Venous Thromboembolism- A Nationwide Cohort StudyTH2020 |
12/03/2020 |
6140 |
Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI- The Smoking Cessation Paradox StudyTH2010 |
12/03/2020 |
6139 |
Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism—The Tromsø StudyTH2020 |
12/03/2020 |
6138 |
Validation of the VTE?BLEED score’s long?term performance for major bleeding in patients with venous thromboembolisms- From the COMMAND VTE registryJTH2020 |
12/03/2020 |
6137 |
The Contextualized Genetics of Human _LongevityJACC2020 |
12/03/2020 |
6136 |
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolismTR2020 |
12/03/2020 |
6135 |
Microvascular Disease Increases Amputation in Patients With Peripheral Artery DiseaseA2020 |
12/03/2020 |
6134 |
May?Thurner syndrome- History of understanding and need for defining population prevalenceJTH2020 |
12/03/2020 |
6133 |
External validation of the simplified Geneva risk assessment model for hospital?associated venous thromboembolism in the Padua cohortJTH2020 |
12/03/2020 |
6132 |
DOAC CANCER GROWTH TH2020 |
12/03/2020 |
6131 |
Comparative validation study of risk assessment models for pediatric hospital?acquired venous thromboembolismJTH2020 |
12/03/2020 |
6130 |
Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients- The Cleveland Clinic experienceJTH2020 |
12/03/2020 |
6129 |
A practical approach to evaluating postoperative thrombocytopenia BADV2020 |
12/03/2020 |
6128 |
The Climate Crisis and Clinical Practice NEJM2020 |
12/03/2020 |
6127 |
Suprarenal Inferior Vena Cava Filter Placement and Retrieval_ Safety AnalysisJVAR2020 |
12/03/2020 |
6126 |
Sex-Specific Risks of Major _Cardiovascular and Limb _Events _in _Patients With Symptomatic Peripheral Artery Disease JACC 2020 |
12/03/2020 |
6125 |
Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies JACC2020 |
12/03/2020 |
6124 |
Patient characteristics and long–term outcomes beyond the first 6?months after a diagnosis of cancer-associated venous thromboembolismtr2020 |
12/03/2020 |
6123 |
NOAC Adherence AF Real Worls TH2020 |
12/03/2020 |
6122 |
Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillationEHJ2020 |
12/03/2020 |
6121 |
Factors Influencing In-Stent Occlusion after Femoropopliteal Artery Stent Placement with Intravascular Ultrasound EvaluationJVRI2020 |
12/03/2020 |
6120 |
Clinical Outcomes of Women With PAD JACC2020 |
12/03/2020 |
6119 |
Ambient Air Pollution and Mortality After _Cardiac Transplantation JACC2019 |
12/03/2020 |
6118 |
Accelerated surgery versus standard care in hip fracture (HIP ATTACK)_ an international, randomised, controlled trialLancet2020 |
12/03/2020 |
6117 |
Xeljanz® nouvelles recommandations en cas de facteurs de risque de thrombose MedSCape2020 |
12/03/2020 |
6116 |
The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke-EHJ2020 |
12/03/2020 |
6115 |
Resting heart rate and incident venous thromboembolism- the Multi-Ethnic Study of AtherosclerosisOpH2020 |
12/03/2020 |
6114 |
Primary Thromboprophylaxis in Children with CancerA Road Less TravelledTH2019 |
12/03/2020 |
6113 |
jamainternal_savage_2020_oi_190114 |
12/03/2020 |
6112 |
How to manage patients with symptomatic subsegmental pulmonary embolism2020 |
12/03/2020 |
6111 |
Fumée de tabac, cigarette électronique et dérivés nicotiniques pendant la grossesse?le point de la situationRMS2020 |
12/03/2020 |
6110 |
Chloroquine phosphate has shown apparent efficacy in ttt of covid 9BST2020 |
12/03/2020 |
6109 |
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA2020 |
12/03/2020 |
6108 |
Carotid Surgery Bests Stenting in Older Asymptomatic PatientsMedScape2020 |
12/03/2020 |
6107 |
Cardiovascular Diseases and Lifestyle |
12/03/2020 |
6106 |
What diagnostic strategies can help differentiate cellulitis from other causes of red legs in primary careBMJ2020 |
12/03/2020 |
6105 |
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer_ ASCO Clinical Practice Guideline Update2020 |
12/03/2020 |
6104 |
Patient-Clinician Communication_ American Society of Clinical Oncology Consensus Guideline |
12/03/2020 |
6103 |
Integration of Palliative Care Into Standard Oncology Care_ American Society of Clinical Oncology Clinical Practice Guideline Update2017 |
12/03/2020 |
6102 |
Héparines de bas poids moléculaires dans la maladie thromboembolique veineuse liée au cancer _ quelle place en 2019 _ |
12/03/2020 |
6101 |
Dental extractions on direct oral anticoagulants vs. warfarin_ The DENTST studyRPTH2020 |
12/03/2020 |
6100 |
Childhood risk factors and carotid atherosclerotic plaque in adulthood_ The cardiovascular risk in young finns studyATHER2020 |
12/03/2020 |
6099 |
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast CancerCirc2020 |
12/03/2020 |
6098 |
Thoracic Aortic Aneurysm and DissectionJACC2014 |
12/03/2020 |
6097 |
The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular RiskCirc2020 |
12/03/2020 |
6096 |
Long-Term Exposure to Fine Particulate Matter and Cardiovascular Disease in ChinaJACC2020 |
12/03/2020 |
6095 |
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease_ The Cocoa-Pad Pilot Randomized Clinical Trial |
12/03/2020 |
6094 |
CFPV RIETE |
12/03/2020 |
6093 |
Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism TreatmentTH2020 |
12/03/2020 |
6092 |
ASDIN white paper_ Assessment and management of hemodialysis access-induced distal ischemia by interventional nephrologistsJVA2020 |
12/03/2020 |
6091 |
Key to denervation response for hypertension may be in carotid body _ MDedge Cardiology |
12/03/2020 |
6090 |
Coronary Artery bDisease in Patients _ 80 JACC2018 |
12/03/2020 |
6089 |
Biological Versus Chronological AgingJACC2020 |
12/03/2020 |
6088 |
Application of the 2019 ESC_EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarctionEHJ2020 |
12/03/2020 |
6087 |
1-s2.0-S0735109719325136-main |
12/03/2020 |
6086 |
1-s2.0-073510979592554I-main |
12/03/2020 |
6085 |
Thromboses et thrombopathies dans les syndromes myéloprolifératifsRMI2020 |
17/02/2020 |
6084 |
Should Routine Screening for Coronary Artery Disease Be Recommended_ A Comparison With Routine Screening for Colon CancerAJM2020 |
17/02/2020 |
6083 |
Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patientsTR2020 |
17/02/2020 |
6082 |
Risk of death Paclitaxel infra popliteals arteries JVI2020 |
17/02/2020 |
6081 |
Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies JACC2020 |
17/02/2020 |
6080 |
Radiofrequency and laser vein ablation for patients receiving warfarin anticoagulation is safe, effective, and durableJVSL2020 |
17/02/2020 |
6079 |
Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term DialysisJACC2020 |
17/02/2020 |
6078 |
Naftidrofuryl dans l’artériopathie oblitérante des membres inférieurs _ une revue systématique de la littératureRMI2020 |
17/02/2020 |
6077 |
Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery RevascularizationJACC2020 |
17/02/2020 |
6076 |
Le syndrome des jambes sans repos |
17/02/2020 |
6075 |
Un coup de Trafalgar contre le cancer du poumon |
17/02/2020 |
6074 |
Traitement hormonal de la ménopause _ la physiologie conforte la théorie de la fenêtre critique d’efficacité |
17/02/2020 |
6073 |
De l’intérêt d’adjoindre de l’EPA aux statines |
17/02/2020 |
6072 |
Incidental venous thromboembolism, detected by chance, but still venous thromboembolismERJ2020 |
17/02/2020 |
6071 |
Impact of Endovascular Repair on the Outcomes of Octogenarians with Ruptured Abdominal Aortic Aneurysms- A Nationwide Japanese StudyEJVES2020 |
17/02/2020 |
6070 |
How To Treat the Patient With Antiphospholipid Antibody Syndrome Who Needs Anticoagulation2020Hematologist |
17/02/2020 |
6069 |
Des guidelines pour l’intelligence artificielle RMI2020 |
17/02/2020 |
6068 |
De la fibrogenèse à la fibrose _ mécanismes physiopathologiques et présentations cliniquesRMI2020 |
17/02/2020 |
6067 |
Chez les patients avec infarctus du myocarde récent, la colchicine est-elle efficace pour prévenir les événements cardiovasculaires RMI2020 |
17/02/2020 |
6066 |
Avancées thérapeutiques dans la drépanocytose _ vers des thérapies cibléesRMI2020 |
17/02/2020 |
6065 |
Artérite gigantocellulaire _ apport de l’écho-dopplerRMI2020 |
17/02/2020 |
6064 |
Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial CKJ2020 |
17/02/2020 |
6063 |
Pemafibrate, a New Selective PPAR? Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases |
11/02/2020 |
6062 |
World Scientists’ Warning of a Climate Emergency 2020 |
11/02/2020 |
6061 |
Venous thromboembolism complications after endovenous laser ablation for varicose veins and role of duplex ultrasound scan 2019 |
11/02/2020 |
6060 |
Vascular calcificationany place left for nicotinamide2020 |
11/02/2020 |
6059 |
Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapyVM2019 |
11/02/2020 |
6058 |
Ulcer metastasis_ Anatomical locations of recurrence for patients in diabetic foot remissionJFAR2020 |
11/02/2020 |
6057 |
Trial of Anifrolumab in Active Systemic Lupus ErythematosusNEJM2020 |
11/02/2020 |
6056 |
Treating Hypertension in Chronic Obstructive Pulmonary DiseaseNEJM2020 |
11/02/2020 |
6055 |
TRANSCRANIAL COLOR-CODED SONOGRAPHY DTC FOR THE DETECTION OF CEREBRAL VEINS UMB2019 |
11/02/2020 |
6054 |
Thrombose portale chez l’adulte 2018 |
11/02/2020 |
6053 |
The Role of Preoperative Duplex Ultrasound Vessel Mapping in Determining Primary Failure of Pediatric Hemodialysis Arteriovenous FistulaJVU2019 |
11/02/2020 |
6052 |
The futility of surveillance for old and small aneurysmsJVS2020 |
11/02/2020 |
6051 |
The False Promise of Natural GasNEJM2020 |
11/02/2020 |
6050 |
The American Heart Association 2030 Impact Goal Circ2020 |
11/02/2020 |
6049 |
Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery dis- ease and peripheral artery disease in the UK, 2006–2015EHJ2019 |
11/02/2020 |
6048 |
Summary of Revisions_ Standards of Medical Care in Diabetes—2020 |
11/02/2020 |
6047 |
Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia_ A systematic review and meta-analysisVM2020 |
11/02/2020 |
6046 |
Splanchnic Vein Thromboses associated with Myeloproliferative Neoplasms_ an international, retrospective study on 518 cases_AJH2020 |
11/02/2020 |
6045 |
Splanchnic Vein Thromboses associated with Myeloproliferative Neoplasms_ an international, retrospective study on 518 cases_AJH2020 |
11/02/2020 |
6044 |
Sodium-glucose cotransporter 2 inhibitorsextending the indication to nondiabetic kidney diseaseNDT2020 |
11/02/2020 |
6043 |
Sex differences in perioperative outcomes after complex abdominal aortic aneurysm repairJVS2020 |
11/02/2020 |
6042 |
Sex and gender in cardiovascular medicine- presentation and outcomes of acute coronary syndromeEHJ2020 |
11/02/2020 |
6041 |
Score EPICES – Laurent Gerbaud |
11/02/2020 |
6040 |
Risque élevé de thrombo-embolie veineuse chez les insuffisants cardiaques2020 |
11/02/2020 |
6039 |
Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular DiseaseCirc2019 |
11/02/2020 |
6038 |
Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism- From the COMMAND VTE RegistrTR2020 |
11/02/2020 |
6037 |
REDUCE-IT USAResults From the 3146 Patients Randomized in the United StatesCirc2020 |
11/02/2020 |
6036 |
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialNEJM2020 |
11/02/2020 |
6035 |
Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism_ Findings from the RIETE Registry |
11/02/2020 |
6034 |
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease ESC2020 |
11/02/2020 |
6033 |
Raising awareness of the AAA screening programme in rural areas – PHE Screening |
11/02/2020 |
6032 |
Réhabilitation améliorée après chirurgie orthopédique lourde du membre inférieur |
11/02/2020 |
6031 |
Quelle gestion des AOD avant et pendant une chirurgie programmée 2020 |
11/02/2020 |
6030 |
Quatre atouts à ramener à votre cabinet sur les maladies inflammatoires de l’intestinRMS2020 |
11/02/2020 |
6029 |
Quantifying atherogenic lipoproteins for lipid-lowering strategies- Consensus-based recommendations from EAS and EFLMATH2020 |
11/02/2020 |
6028 |
Quand ne faut-il pas dilater une sténose unilatérale de l’artère rénale?RMS2020 |
11/02/2020 |
6027 |
Pulmonary Illness Related to E-Cigarette UseNEJM2020 |
11/02/2020 |
6026 |
Pulmonary embolism home treatment- What GP want_TR2020 |
11/02/2020 |
6025 |
Progress in the prevention and treatment of atherosclerotic cardiovascular diseas EHJ2020 |
11/02/2020 |
6024 |
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trialEHJ2019 |
11/02/2020 |
6023 |
Point-of-care ultrasound curriculum for internal medicine residents_ what do you desire_ A national surveyBMC2020 |
11/02/2020 |
6022 |
Placebo and Nocebo EffectsNEJM2020 |
11/02/2020 |
6021 |
Pedal Flow Hemodynamics in Patients With Chronic Limb-Threatening IschemiaJVS2020 |
11/02/2020 |
6020 |
Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm‐_associated venous thromboembolism in a large tertiary centre in the UK2020 |
11/02/2020 |
6019 |
Outcomes after venous thromboembolism in patients with gastric cancer_ Analysis of the RIETE RegistryVM2020 |
11/02/2020 |
6018 |
Novel Antithrombotic Strategies for Treatment of Venous ThromboembolismBllod2020 |
11/02/2020 |
6017 |
More on the Pathology of Vaping-Associated Lung InjuryNEJM2020 |
11/02/2020 |
6016 |
Morbidity and mortality associated with atherosclerotic peripheral artery disease_ A systematic reviewAth2020 |
11/02/2020 |
6015 |
Morbid obesity and mortality in patients with venous thromboembolism. Findings from real life clinical practicCHEST2020 |
11/02/2020 |
6014 |
Mind the Gap White Paper – CardioVascular Coalition |
11/02/2020 |
6013 |
Mesure tensionnelle les nouvelles recommandations expliquées par Xavier Girerd2020 |
11/02/2020 |
6012 |
Médicalement Geek_ Dragi Webdo n°250 _ Recos diabète (SFDiabéto), anévrisme aorte abdo (recos US), dépistage dysthyroïdie (reco canada), HTA sujet noir, ondanstron, oseltamivir |
11/02/2020 |
6011 |
Management of cancer-related thrombosis in the era of direct oral anticoagulants_ A comprehensive review of the 2019 ITAC-CME clinical practice guidelinesJMV2020 |
11/02/2020 |
6010 |
Machine learning to predict venous thrombosis in acutely ill medical patientsRPTH2020 |
11/02/2020 |
6009 |
Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical riskEHJ2020 |
11/02/2020 |
6008 |
LYMPHOEDEMA JAMA ONCO 2018 |
11/02/2020 |
6007 |
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN)- a randomised, double-blind, placebo-controlled trialLancet2020 |
11/02/2020 |
6006 |
Long-term treatment of venous thromboembolism Blood2020 |
11/02/2020 |
6005 |
Long-term death and recurrence in patients with acute venous thromboembolism_ The MASTER registryTR2012 |
11/02/2020 |
6004 |
Long?term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d?dimer results; A cohort study |
11/02/2020 |
6003 |
Lipoprotein(a) Reduction in Persons with Cardiovascular DiseaseNEJM |
11/02/2020 |
6002 |
Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid?Lowering Medication_ A Cohort StudyJKA020 |
11/02/2020 |
6001 |
Les recommandations américaines ne limitent plus le cholestérol alimentaire (mais attention aux œufs) |
11/02/2020 |
6000 |
Leicester_leicestershire_and_rutland_qa_visit_abdominal_aortic_aneurysm_executive_summary_february_2019__1_ |
11/02/2020 |
5999 |
Leaving cancer diagnosis to the computersEHJ2020 |
11/02/2020 |
5998 |
La démarche diagnostique de la maladie coronarienne stable à quel risque se fier RMS2020 |
11/02/2020 |
5997 |
Knowledge of peripheral artery disease- What do the public, healthcare practitioners, and trainees know_VM2020 |
11/02/2020 |
5996 |
JIM.fr – Où l’on teste un oligonucléotide antisens pour réduire les taux de lipoprotéine (a) |
11/02/2020 |
5995 |
JIM.fr – Néoplasies myéloprolifératives avec thrombose splanchnique, quelles caractéristiques _ |
11/02/2020 |
5994 |
JIM.fr – La thrombolyse sans crainte, même avec des AOD _ |
11/02/2020 |
5993 |
JIM.fr – IPP et MCV, l’ombre d’un soupçon |
11/02/2020 |
5992 |
JIM.fr – Evolocumab et statines à forte dose pour atteindre les taux cibles de LDL-C en cas de SCA |
11/02/2020 |
5991 |
JIM.fr – Après le premier, la menace d’un deuxième cancer |
11/02/2020 |
5990 |
JIM.fr – AOMI, toujours un lourd tribut en termes de morbidité et de mortalité |
11/02/2020 |
5989 |
Internal to Common Carotid Artery Peak Systolic Velocity Ratios for Predicting North American Symptomatic Carotid Endarterectomy Trial StenosisJVU2019 |
11/02/2020 |
5988 |
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspectIJC2020 |
11/02/2020 |
5987 |
Individuals, institutions can counter medication overload – STAT |
11/02/2020 |
5986 |
Incidence and features of thrombosis in children with inherited antithrombin deficiency Haem2019 |
11/02/2020 |
5985 |
In Lupus, Can Atherosclerosis Be Halted_ _ Medpage Today2020 |
11/02/2020 |
5984 |
Impact of high risk thrombophilia status on recurrence among children and adults with VTE_ An observational multicenter cohort study |
11/02/2020 |
5983 |
Hypertensive Complications of Pregnancy and Risk of Venous ThromboembolismHypert2020 |
11/02/2020 |
5982 |
Hypertensive Complications of Pregnancy and Risk of Venous ThromboembolismHypert2020 |
11/02/2020 |
5981 |
How I Treat Obese Patients with Oral AnticoagulantsBlood2020 |
11/02/2020 |
5980 |
How I treat cancer-associated thrombosisESMD2020 |
11/02/2020 |
5979 |
How I treat acute myeloid leukemia in the era of new drugsBlood2020 |
11/02/2020 |
5978 |
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolismBllod2019 |
11/02/2020 |
5977 |
How I assess and manage the risk of bleeding during treatment of patients with venous thromboembolismBLOOD2020 |
11/02/2020 |
5976 |
Hormone Therapy for Postmenopausal WomenNEJM2020 |
11/02/2020 |
5975 |
High Incidence of Venous Thromboembolism Recurrence in Patients with Sickle Cell Disease |
11/02/2020 |
5974 |
Hermida RC, et al. Bedtime hypertension 2019 EHJ |
11/02/2020 |
5973 |
Héparines de bas poids moléculaires dans la maladie thromboembolique veineuse liée au cancer _ quelle place en 2019 _ |
11/02/2020 |
5972 |
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes_ prospective cohort studyBMJ2020 |
11/02/2020 |
5971 |
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes_ prospective cohort studyBMJ2020 |
11/02/2020 |
5970 |
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events |
11/02/2020 |
5969 |
Global Use of Idarucizumab in Clinical Practice Outcomes of the RE-VECTO Surveillance ProgramTH2020 |
11/02/2020 |
5968 |
First Evidence Dietary Flavonols Linked to Lower Alzheimer RiskMedSacpe2020 |
11/02/2020 |
5967 |
FDA Approves CVD Benefit for Once-Weekly Semaglutide MedScape2020 |
11/02/2020 |
5966 |
Fazili_et_al-2020-Research_and_Practice_in_Thrombosis_and_Haemostasis APL DOAC EMA |
11/02/2020 |
5965 |
Fatal Cytomegalovirus Infection in an Adult with Inherited NOS2 DeficiencyNEJM2020 |
11/02/2020 |
5964 |
Familial hypercholesterolemia_ Detect, treat, and ask about familyClev2020 |
11/02/2020 |
5963 |
Factors associated with in-hospital complications and long-term implications of these complications in elderly patients undergoing endovascular aneurysm repairJVS2020 |
11/02/2020 |
5962 |
Evolocumab for Early Reduction of LDL _Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)JACC2020 |
11/02/2020 |
5961 |
Estimating the magnitude of cancer overdiagnosis in Australia 2020 |
11/02/2020 |
5960 |
Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleedingBJH2020 |
11/02/2020 |
5959 |
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery diseaseVM2020 |
11/02/2020 |
5958 |
Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry) |
11/02/2020 |
5957 |
Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levelsNat2020 |
11/02/2020 |
5956 |
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee ArthroplastyJAMA2020 |
11/02/2020 |
5955 |
Effect of a Patient Decision Aid on Lung Cancer Screening Decision-Making by Persons Who Smoke_ A Randomized Clinical TrialJAMA2020 |
11/02/2020 |
5954 |
Early Surgery or Conservative Care for Asymptomatic Aortic StenosisNEJM2020 |
11/02/2020 |
5953 |
Diagnosis of suspected recurrent ipsilateral deep vein thrombosis with magnetic resonance direct thrombus imagingBlood2020 |
11/02/2020 |
5952 |
Could Colchicine Be the New Aspirin MedScape2020 |
11/02/2020 |
5951 |
Concussions Linked With Erectile Dysfunction in Football Player StudyJAMA2020 |
11/02/2020 |
5950 |
Comparison of rivaroxaban and dalrepatin VTE Gynecologic cancer 2020 |
11/02/2020 |
5949 |
Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen_ A Cohort StudyJAGS2020 |
11/02/2020 |
5948 |
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet2019 |
11/02/2020 |
5947 |
Cigarette électronique : quelles précautions ? Ce qu’il faut savoir sur la vape après le battage médiatique de l’épidémie nord-américaine de 2019 |
11/02/2020 |
5946 |
Chronic kidney disease is associated with increased risk of venous thromboembolism recurrenceTR2017 |
11/02/2020 |
5945 |
Chirurgie urgente sous AODquelle place pour les antidotes2020 |
11/02/2020 |
5944 |
Case of a Malignant Carotid Body Tumor With Systemic Metastases_ The Utility of Multimodal ImagingJVU2019 |
11/02/2020 |
5943 |
Carotid endarterectomy for asymptomatic carotid stenosis is safe in octogenarianJVS2020 |
11/02/2020 |
5942 |
Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 yearsa nationwide population-based cohort study in France EHJ2019 |
11/02/2020 |
5941 |
Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism TreatmentTH2020 |
11/02/2020 |
5940 |
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events_A Systematic Review and Meta-analysisjama2019 |
11/02/2020 |
5939 |
Aortic atherosclerosis complicated by retroperitoneal fibrosis treated only by optimal cardiovascular risk factors managementJMV2020 |
11/02/2020 |
5938 |
Anti-thrombotic strategies in elderly patients receiving platelet inhibitors EHJ2020 |
11/02/2020 |
5937 |
Anti-thrombotic strategies in elderly patients receiving platelet inhibitors EHJ2020 |
11/02/2020 |
5936 |
Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism TR2020 |
11/02/2020 |
5935 |
Angioplasie-stenting d’un diaphragme carotidien symptomatique 2017 |
11/02/2020 |
5934 |
An Unusual Suspect for a Traumatic Arteriovenous Fistula in the Left Vertebral ArteryJVU2019 |
11/02/2020 |
5933 |
All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calciumA long-term, competing risk analysis in the Coronary Artery Calcium ConsortiumATH2019 |
11/02/2020 |
5932 |
Adherence to Guideline?Recommended Therapyincluding Supervised Exercise Therapy ReferralAcross Peripheral Artery Disease Specialty Clinics_ Insights From the International PORTRAIT Registry2020 |
11/02/2020 |
5931 |
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter TrialTH2020 |
11/02/2020 |
5930 |
Absence of Long-term Benefit of Revascularization in Patients with Intermittent Claudication – Five Year Clinical Effectiveness and Cost-effectiveness Results from the Ironic Randomized Controlled Trial |
11/02/2020 |
5929 |
screeners and nurses enjoy development and networking events – PHE Screening |
11/02/2020 |
5928 |
A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal modelsTR2020 |
11/02/2020 |
5927 |
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer_ The Prospective COMPASS–Cancer?Associated Thrombosis StudyOnc2020 |
11/02/2020 |
5926 |
A novel coronavirus outbreak of global health concern Lancet2020 |
11/02/2020 |
5925 |
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacementmejm2020 |
11/02/2020 |
5924 |
A Case Series Representing Dissections in the Abdominal Aorta and Common Carotid ArteriesJVU2019 |
11/02/2020 |
5923 |
A Bibliometric Analysis of Citation Classics in the Journal of Ultrasound in Medicine JUM2020 |
11/02/2020 |
5922 |
Cardiovascular Disease and Risk Management_ Standards of Medical Care in Diabetes |
11/02/2020 |
5921 |
Vein is Best |
19/01/2020 |
5920 |
Using maximal systolic acceleration to diagnose and assess the severity of peripheral artery disease in a flow model study.Lancet En2019 |
19/01/2020 |
5919 |
Using maximal systolic acceleration to diagnose and assess the severity of peripheral artery disease in a flow model study.JVS2020 |
19/01/2020 |
5918 |
Treatment of unusual thrombotic manifestationsBLOOD2020 |
19/01/2020 |
5917 |
Treatment of carotid restenoses after endarterectomy_ A retrospective monocentric study. – PubMed – NCBI |
19/01/2020 |
5916 |
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease ESC2020 |
19/01/2020 |
5915 |
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosisJVSL2020 |
19/01/2020 |
5914 |
Popliteal Aneurysms are Common Among Men With Screening Detected Abdominal Aortic Aneurysms, and Prevalence Correlates With the Diameters of the Common Iliac ArteriesEJVES2020 |
19/01/2020 |
5913 |
Point?of?Care Lung Sonography- An Audit of 1150 ExaminationsUlyt2017 |
19/01/2020 |
5912 |
Paclitaxel-coated peripheral artery devices are not associated with increased mortalityJVS2020 |
19/01/2020 |
5911 |
Outcome of Ruptured Abdominal Aortic Aneurysm Repair in Octogenarians- A Systematic Review and Meta-AnalysisEJVES2020 |
19/01/2020 |
5910 |
Nation-Wide Use of Periprocedural Bridging Anticoagulation in Patients With Atrial Fibrillation2019 |
19/01/2020 |
5909 |
Midterm outcome of pharmacomechanical catheter-directed thrombolysis combined with stenting for treatment of iliac vein compression syndrome with acute iliofemoral deep venous thrombosisJVSL2020 |
19/01/2020 |
5908 |
FA sous AVK _ moins de relais par HBPM en cas d’intervention chirurgicale |
19/01/2020 |
5907 |
Cannabis au volant _ des conséquences prolongées surtout pour les fumeurs occasionnels |
19/01/2020 |
5906 |
Diagnostic Capacity of Pocket-Sized Ultrasound Devices at Point of Care by a Non-radiologist Resident in Patients with Suspected Abdominal PathologyUMB2020 |
19/01/2020 |
5905 |
Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany- A Trend Analysis of Health Insurance Claims DataEJVES2020 |
19/01/2020 |
5904 |
Association between venous reflux and diameter of great saphenous vein in lower thighJVSL2020 |
19/01/2020 |
5903 |
Aspirin Therapy for Primary Prevention TH2020 |
19/01/2020 |
5902 |
A population-based study of cardiovascular disease mortality risk in US cancer patientsESC2019 |
19/01/2020 |
5901 |
A Pilot Prospective Study to Validate Point-of-Care Ultrasound in Comparison to X-Ray Examination in Detecting FracturesUMB2019 |
19/01/2020 |
5900 |
VTE risk assessment in pregnancy |
09/01/2020 |
5899 |
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease_ Practical Implications2019 |
09/01/2020 |
5898 |
The year in cardiologyaorta and peripheral circulationThe year in cardiology 2019 EHJ2020 |
09/01/2020 |
5897 |
Prise en charge de l’HTA en France des chiffres de plus en plus mauvais |
09/01/2020 |
5896 |
JIM.fr – Où la e-cigarette fait tousser les psy ! |
09/01/2020 |
5895 |
Maladie artérielle périphérique _ ayez la rétine à l’œil ! |
09/01/2020 |
5894 |
Exclusif : une courte majorité de professionnels de santé favorables à un « Mois sans alcool » |
09/01/2020 |
5893 |
Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncopeRPTH2019 |
09/01/2020 |
5892 |
RENal hemodialysis patients ALlocated apixaban versus warfarin in Atrial Fibrillation (RENAL-AF) |
09/01/2020 |
5891 |
Venous Thrombosis during Spaceflight NEJM2020 |
08/01/2020 |
5890 |
Venous thromboembolism in breast cancer patients receiving cyclin dependent kinase inhibitorsJTH2020 |
08/01/2020 |
5889 |
Un nouvel outil de prédiction du risque CV sur la vie entière basé sur le non-HDL-C2020 |
08/01/2020 |
5888 |
Sexspecific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registryJTH2020 |
08/01/2020 |
5887 |
nouveaux_medicaments___le_droit_de_savoir (1) |
08/01/2020 |
5886 |
Supplementary Appendix |
08/01/2020 |
5885 |
Supplementary Appendix |
08/01/2020 |
5884 |
MARVELOUS rcidive MTEV FD nin BMJ 2019 |
08/01/2020 |
5883 |
Lon term Risk of PostThrombotic Syndrome after Symptomatic Distal Deep_Vein Thrombosis_ The CACTU PTS StudyJTH2020 |
08/01/2020 |
5882 |
Gliflozines la Société francophone du diabète met la pression, la HAS se défend 2019 |
08/01/2020 |
5881 |
Direct-Acting Oral Anticoagulants in Critically Ill PatientsCHEST2020 |
08/01/2020 |
5880 |
Couverture vaccinale anti grippale insuffisante dans l’artérite à cellules géantesRMI2020 |
08/01/2020 |
5879 |
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer. A case-control study.Blood2019 |
08/01/2020 |
5878 |
Application of non-HDL cholesterol for population-based cardiovascular risk stratification_ results from the Multinational Cardiovascular Risk ConsortiumLancet2019 |
08/01/2020 |
5877 |
Women and Peripheral Arterial Disease_ A Review of Sex Differences in Epidemiology, Clinical Manifestations, and OutcomesCJC2018 |
05/01/2020 |
5876 |
Venous Thrombosis during Spaceflight NEJM2020 |
05/01/2020 |
5875 |
Venous thromboembolism incidence in hematologic malignanciesBR2019 |
05/01/2020 |
5874 |
Twiddler’s Syndrome Combined With Subclavian Crush Syndrome: A Case of ICD Lead Failure and Potential Challenging Lead Extraction |
05/01/2020 |
5873 |
The risk of death within 5 years of first hospital admission in older adults CMAJ 2019 |
05/01/2020 |
5872 |
The Physical Activity Guidelines for Americans JAMA2018 |
05/01/2020 |
5871 |
The Physical Activity Guidelines for Americans JAMA |
05/01/2020 |
5870 |
The eagle jugular syndrome BMJN 2019 |
05/01/2020 |
5869 |
The Dapagliflozin And Prevention of AdverseEHJ2020 |
05/01/2020 |
5868 |
The art of life and death_ 14 year follow-up analyses of associations between arts engagement and mortality in the English Longitudinal Study of AgeingBMJ2019 |
05/01/2020 |
5867 |
The American Heart Association Takes on Vaping JAMA 2020 |
05/01/2020 |
5866 |
Takayasu Arteritis Type V |
05/01/2020 |
5865 |
Sex Related Differences in Peri-operative Mortality after Elective Repair of an Asymptomatic Abdominal Aortic Aneurysm in the Netherlands_ a Retrospective Analysis of 2013 to 2018EJVES2019 |
05/01/2020 |
5864 |
Sex as a Key Variable in Predicting Cardiovascular Outcomes_ Rapidly Evolving Knowledge but Much More NeededCJC2020 |
05/01/2020 |
5863 |
Screening strategies for pulmonary arterial EHJ2019 |
05/01/2020 |
5862 |
Safety and efficacy of endovenous ablations in octogenarians, nonagenarians, and centenarians JVSVL2020 |
05/01/2020 |
5861 |
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children_ a randomised, controlled, phase 3 trialLH2019 |
05/01/2020 |
5860 |
Reversal of Direct Oral Anticoagulants_ Guidance from the Anticoagulation Forum2019 |
05/01/2020 |
5859 |
Recommandations arthrite septique une prise en charge médico-chirurgicale dans l’urgence 2020 |
05/01/2020 |
5858 |
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis JVS2020 |
05/01/2020 |
5857 |
Prevent Heart Disease |
05/01/2020 |
5856 |
Prevalence of obstructive sleep apnea syndrome in patients with lymphedema referred for complete decongestive therapyJVSVL2020 |
05/01/2020 |
5855 |
Preeclampsia Brings the Risk of Premature Cardiovascular Disease in Women Closer to That of MenCJC2020 |
05/01/2020 |
5854 |
Peripheral arterial disease_ Scoping review of patient-centered outcomes2019 |
05/01/2020 |
5853 |
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial Circ2020 |
05/01/2020 |
5852 |
Long-term mortality after massive, submassive, and low-risk pulmonary embolismVM2019 |
05/01/2020 |
5851 |
Long term exposure to ambient fine particulate matter and incidence of stroke_ prospective cohort study from the China-PAR projectBMJ2019 |
05/01/2020 |
5850 |
Traitement optimal de l’érysipèle et de la cellulite, consensus sur l’absence de consensus |
05/01/2020 |
5849 |
 |
05/01/2020 |
5848 |
L’ibrutinibe expose à la survenue de graves événements cardio-vasculaires |
05/01/2020 |
5847 |
Efficacité et la bonne tolérance de l’évolocumab sont confirmées à 5 ans |
05/01/2020 |
5846 |
Changer pour la cigarette électronique améliore, en un mois, la fonction vasculaire des fumeurs ! |
05/01/2020 |
5845 |
How I treat patients with hereditary antithrombin deficiencyBLOOD2019 |
05/01/2020 |
5844 |
Heart-Attack |
05/01/2020 |
5843 |
For Mortality, Busting the Myth of 10 000 Steps per DayJAMA2019 |
05/01/2020 |
5842 |
Faut-il toujours répondre à la demande esthétique en médecine vasculaire JMV2019 |
05/01/2020 |
5841 |
 |
05/01/2020 |
5840 |
Factors predicting failure of retrieval of inferior vena cava filtersJVSVL2020 |
05/01/2020 |
5839 |
Etiology of iliocaval stent thrombosis JVSVL2020 |
05/01/2020 |
5838 |
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer_ Results from the Hokusai VTE Cancer studyTR2020 |
05/01/2020 |
5837 |
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism_ Impact of the European Medicines Agency guidanceRPTH2019 |
05/01/2020 |
5836 |
Des veines anormales RMI2020 |
05/01/2020 |
5835 |
Des guidelines pour l’intelligence artificielle RMI2020 |
05/01/2020 |
5834 |
SHARED DECISION-MAKING |
05/01/2020 |
5833 |
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged _50 yearsSR2020 |
05/01/2020 |
5832 |
Combination of Colour Duplex and Contrast Enhanced Ultrasound as an Alternative to Computed Tomography Angiography in Isolated Mesenteric Artery Dissection SurveillanceEJVES2019 |
05/01/2020 |
5831 |
Causes of Failed EVAR_ A Cautionary Tale in Images – Consult QD |
05/01/2020 |
5830 |
Blood-Pressure |
05/01/2020 |
5829 |
Asymptomatic, Multiple Stent Fractures JIC 2020 |
05/01/2020 |
5828 |
Approach to Tibiopedal Retrograde Revascularization of Below-The-Knee Peripheral Arterial DiseaseJIC2020 |
05/01/2020 |
5827 |
Alcohol Abstinence in Drinkers with Atrial Fibrillation NEJM2020 |
05/01/2020 |
5826 |
A Comparison of Two LDL Cholesterol Targets after Ischemic StrokeNEJM2020 |
05/01/2020 |
5825 |
Variation in center-level frailty burden and the impact of frailty on long-term survival in patients undergoing elective repair for abdominal aortic aneurysmsJVS2019 |
26/12/2019 |
5824 |
Using maximal systolic acceleration to diagnose and assess the severity of peripheral artery disease in a flow model studyJVS2019 |
26/12/2019 |
5823 |
Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers |
26/12/2019 |
5822 |
Réduction du risque CV l’oméga 3 Vascepa autorisé par la FDA 2019 |
26/12/2019 |
5821 |
Overuse of early peripheral vascular interventions for claudication JVS2019 |
26/12/2019 |
5820 |
Outcomes for carotid endarterectomy in nonagenariansJVS2019 |
26/12/2019 |
5819 |
Miel, huiles essentielles, asticots peuvent-ils aider à la prise en charge des plaies 2019 |
26/12/2019 |
5818 |
Un diagnostic parfois tardif pour le Syndrome de Sturge |
26/12/2019 |
5817 |
Safety and Efficacy of Dabigatran Etexilate vs Dose-AdjustedWarfarin in Patients With Cerebral Venous Thrombosis |
26/12/2019 |
5816 |
Haute Autorité de Santé – Traitement médicamenteux du diabète de type 2 _ évaluation des gliflozines par la HAS |
26/12/2019 |
5815 |
Focus sur les dyslipidémies |
26/12/2019 |
5814 |
Exercise as medicine VM2019 |
26/12/2019 |
5813 |
Diabetes Care 2020 Summary |
26/12/2019 |
5812 |
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus |
26/12/2019 |
5811 |
Cardiovascular Disease and Risk Management- Standards of Medical Care in Diabetes—2020 |
26/12/2019 |
5810 |
A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosisJVS2019 |
26/12/2019 |
5809 |
2019 CVD Primary Prevention Guideline 5 Things to Know |
26/12/2019 |
5808 |
Subsegmental pulmonary embolism_ May not be a killer but indicates significant risk |
25/12/2019 |
5807 |
Stress et pathologie cardiovasculaire AMCV2019 |
25/12/2019 |
5806 |
Réduction du risque CV l’oméga 3 Vascepa autorisé par la FDA 2019 |
25/12/2019 |
5805 |
Pollution atmosphérique et maladies coronariennesAMCV2019 |
25/12/2019 |
5804 |
Pathologies artérielles _ quelle imagerie au-delà de l’échographie _AMCV2019 |
25/12/2019 |
5803 |
Miel, huiles essentielles, asticots peuvent-ils aider à la prise en charge des plaies 2019 |
25/12/2019 |
5802 |
Ischémie critique menaçante des membres inférieurs _ ce qui a changé ACV2019 |
25/12/2019 |
5801 |
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES Circ2019 |
25/12/2019 |
5800 |
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017Circ2019 |
25/12/2019 |
5799 |
Year in Review_ Coronary and Peripheral Artery Disease _ Medpage Today2019 |
23/12/2019 |
5798 |
Venous thromboembolism incidence in hematologic malignanciesBR2019 |
23/12/2019 |
5797 |
Vascular Disease Patient Information Page_ Exercise for peripheral artery diseaseVM2019 |
23/12/2019 |
5796 |
Thrombolysis During Resuscitation for Out-of-Hospital Cardiac Arrest Caused by _Pulmonary Embolism Increases 30-Day Survivalchest2019 |
23/12/2019 |
5795 |
Association des analogues du GLP-1 et des inhibiteurs du SGLT2″: de nouvelles perspectives”? |
23/12/2019 |
5794 |
Reversal of Direct Oral Anticoagulants_ Guidance from the Anticoagulation Forum AJH2019 |
23/12/2019 |
5793 |
Primary Care Screening for Abdominal Aortic AneurysmJAMA2019 |
23/12/2019 |
5792 |
Prevalence of prothrombotic factors in patients with Budd?Chiari syndrome or noncirrhotic nonmalignant portal vein thrombosis_ A hospital?based observational study2019 |
23/12/2019 |
5791 |
Miracle Cancer Drugs Are Making Big Pharma Billions. Others Are Getting Left Behind – Bloomberg |
23/12/2019 |
5790 |
Lipedema VM |
23/12/2019 |
5789 |
Effectiveness of a Hospital-Based Computerized Decision Support System on Clinician Recommendations and Patient OutcomesJAMA2019 |
23/12/2019 |
5788 |
Direct-Acting Oral Anticoagulants in Critically Ill Patients Chest 2019 |
23/12/2019 |
5787 |
DIABETES TYPE 2 UPDATE 2019 ADA EASD2019 |
23/12/2019 |
5786 |
diabete_de_type_2_ozempic_nouvel_analogue_du_glp_1_en_injection_hebdomadaire_sous_cutanee |
23/12/2019 |
5785 |
Clinical review on triglycerides EHJ2019 |
23/12/2019 |
5784 |
AVCbientôt des recommandations spécifiques aux femmesMedSCape2019 |
23/12/2019 |
5783 |
Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialJAMA2019 |
23/12/2019 |
5782 |
“Asset exchange”—interactions between patient groups and pharmaceutical industry-BMJ2019 |
23/12/2019 |
5781 |
Sex differences in stroke- Review of current knowledge and evidenceVM2017 |
17/12/2019 |
5780 |
Sceening For AAA US PREVENTIVEV SErvies recommendations JAMA2019 |
17/12/2019 |
5779 |
Paper_ Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication |
17/12/2019 |
5778 |
Hypercoagulable states in arterial and venous thrombosis_ When, how, and who to testVM2019 |
17/12/2019 |
5777 |
Correlation between significant asymptomatic carotid artery stenosis and severity of peripheral arterial occlusive disease in the lower limb_ a retrospective study on 200 patients2019 |
17/12/2019 |
5776 |
Can risk modelling improve treatment decisions in asymptomatic carotid stenosisBMJN2019 |
17/12/2019 |
5775 |
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapyESC2019 |
17/12/2019 |
5774 |
American Society of Hematology 2019 guidelines for management of venous thromboembolism- prevention of venous thromboembolism in surgical hospitalized patientsBA2019 |
17/12/2019 |
5773 |
2018 American Heart AssociationAmerican College of CardiologyMultisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention2019JAMAC |
17/12/2019 |
5772 |
Vascular ultrasound, the potential of integration of multiparametric ultrasound into routine clinical practice US2018 |
17/12/2019 |
5771 |
VapingThe new wave of nicotine addiction RMS2019 |
17/12/2019 |
5770 |
Traitement par l’exercice physique chez le patient avec une artériopathie oblitérante des membres inférieursRMS2019 |
17/12/2019 |
5769 |
Traitement par l’exercice physique chez le patient avec une artériopathie oblitérante des membres inférieursRMS2019 |
17/12/2019 |
5768 |
Study_ Potent Cholesterol Drug + Statins = Lowered Heart Attack, Stroke Risk – Health Essentials from Cleveland Clinic |
17/12/2019 |
5767 |
Sevrage tabagique – vaincre la « nicotinophobie » des patients … et des prescripteurs PM2019 |
17/12/2019 |
5766 |
Risk factors for cancer‐_associated venous thromboembolism_ The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐_PACC) studyJTH2019 |
17/12/2019 |
5765 |
Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism) |
17/12/2019 |
5764 |
Predictive value of venous thromboembolism (VTE)‐_BLEED2018 |
17/12/2019 |
5763 |
pour_mieux_soigner,_des_medicaments_a_ecarter___bilan_2020 |
17/12/2019 |
5762 |
Popliteal Aneurysms are Common Among Men With Screening Detected Abdominal Aortic Aneurysms, and Prevalence Correlates With the Diameters of the Common Iliac ArteriesEJVES2019 |
17/12/2019 |
5761 |
Plantar Acceleration Time. A Novel Technique to Evaluate Arterial Flow to the FootAnn Vasc Surg2019 |
17/12/2019 |
5760 |
Outcome of Ruptured Abdominal Aortic Aneurysm Repair in Octogenarians- A Systematic Review and Meta-AnalysisEJVES2019 |
17/12/2019 |
5759 |
Off-label and oft-prescribedCl2019 |
17/12/2019 |
5758 |
Naftidrofuryl dans l’artériopathie oblitérante des membres inférieurs _ une revue systématique de la littérature2019medInt |
17/12/2019 |
5757 |
Multiple Visceral Artery Stenoses in Williams-Beuren SyndromeEJVES2019 |
17/12/2019 |
5756 |
Mortality Sky-High After MI at Vascular Surgery, But MI Risk Low |
17/12/2019 |
5755 |
Managing the competing risks of thrombosis, bleeding, Blood Adv2019 |
17/12/2019 |
5754 |
Maladies vasculaires appel à agir RMS2019 |
17/12/2019 |
5753 |
Maladies inflammatoires chroniques intestinales – un facteur de risque cardiovasculaire à part entièrePM2019 |
17/12/2019 |
5752 |
De nouvelles charges contre les particules fines |
17/12/2019 |
5751 |
Infarctus du myocarde du sujet jeune – spécificités épidémiologiques et facteurs de risquePM2019 |
17/12/2019 |
5750 |
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism- Findings from RIETE JVSL2019 |
17/12/2019 |
5749 |
Icosapent ethyl dominant vs. standard care in cost per QALY |
17/12/2019 |
5748 |
Future in Medicine Nat2019 |
17/12/2019 |
5747 |
Frailty assessment in older adults undergoing interventions for peripheral arterial diseaseJVS2019 |
17/12/2019 |
5746 |
Faut-il dépister l’artériopathie daibete type 2 RMS2019 |
17/12/2019 |
5745 |
Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial2019 |
17/12/2019 |
5744 |
e-Cigarette Use Among Youth in the United States, 2019JAMA2019 |
17/12/2019 |
5743 |
Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany- A Trend Analysis of Health Insurance Claims DataEJVES2019 |
17/12/2019 |
5742 |
Clinical Outcomes of Isolated Distal Deep Vein Thrombosis versus Proximal Venous Thromboembolism in Cancer Patients_ The Cleveland Clinic ExperienceJTH2019 |
17/12/2019 |
5741 |
Association between polycystic ovary syndrome and venous thromboembolism_ A systematic review and meta-analysisTR2020 |
17/12/2019 |
5740 |
Artériopathie oblitérante des membres inférieurs?nouveautés dans la thérapie médicamenteuseRMS2019 |
17/12/2019 |
5739 |
Artériopathie oblitérante des membres inférieurs? complications locales et systémiquesRMS2019 |
17/12/2019 |
5738 |
Anticoagulants oraux directs dans le traitement des événements thromboemboliques veineux liés au cancerRMS2019 |
17/12/2019 |
5737 |
American Society of Hematology 2019 guidelines for management of venous thromboembolism- prevention of venous thromboembolism in surgical hospitalized patientsBA2019 |
17/12/2019 |
5736 |
Accidents hémorragiques graves sous antiplaquettaires – que faire PM2019 |
17/12/2019 |
5735 |
World Journal of Gastrointestinal Oncology |
16/12/2019 |
5734 |
Venous thrombosis at altitude presents with distinct biochemical profilesBAD2019 |
16/12/2019 |
5733 |
Venous Thromboembolism After Major Cancer Surgery_ Temporal Trends and Patterns of CareJAMA |
16/12/2019 |
5732 |
Using it wisely_ catheter-directed thrombolysis for deep vein thrombosis |
16/12/2019 |
5731 |
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA)andomised trial2019 |
16/12/2019 |
5730 |
Trial of Apremilast for Oral Ulcers in Behçet’s SyndromeNEJM2019 |
16/12/2019 |
5729 |
Traitement par l’exercice physique chez le patient avec une artériopathie oblitérante des membres inférieursRMS2019 |
16/12/2019 |
5728 |
TL_Countdown_ExecutiveSummary_French-1573659911007 |
16/12/2019 |
5727 |
Ticagrelor with or without Aspirin in High-Risk Patients after PCINEJM2019 |
16/12/2019 |
5726 |
Thrombosis of previously silent Persistent Sciatic Vein in non Klippel-Trenaunay syndrome patientJMV2019 |
16/12/2019 |
5725 |
The Polypill RevisitedCirc2019 |
16/12/2019 |
5724 |
The health effects of fine particulate air pollutionBMJ2019 |
16/12/2019 |
5723 |
Subsegmental pulmonary embolism_ May not be a killer but indicates significant riskTR2019 |
16/12/2019 |
5722 |
Spécificités du traitement médicamenteux antihypertenseur chez la femmePM2019 |
16/12/2019 |
5721 |
Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population_ time stratified, case crossover studybmj2019 |
16/12/2019 |
5720 |
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children_ a randomised, controlled, phase 3 trial2019 |
16/12/2019 |
5719 |
Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous ThromboembolismJAMA |
16/12/2019 |
5718 |
Relationship of Lower-extremity Deep Venous Thrombosis Density at CT Venography to Acute Pulmonary Embolism and the Risk of Postthrombotic SyndromeRad2019 |
16/12/2019 |
5717 |
Relationship between metformin and abdominal aortic aneurysmJVS2019 |
16/12/2019 |
5716 |
Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventionsVM2019 |
16/12/2019 |
5715 |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJAMA2019 |
16/12/2019 |
5714 |
Panorama-de-la-sante-2019-Comment-la-France-se-compare |
16/12/2019 |
5713 |
Orion 10 ou l’inclisiran en prévention secondaire |
16/12/2019 |
5712 |
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes NEJM2019 |
16/12/2019 |
5711 |
Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle_ A UK Biobank study |
16/12/2019 |
5710 |
Mortality reduction with physical activity in patients with and without cardiovascular diseaseEHJ2019 |
16/12/2019 |
5709 |
Maladies vasculaires appel à agir RMS2019 |
16/12/2019 |
5708 |
Lower extremity artery disease in patients with type 2 diabetesEPC2019 |
16/12/2019 |
5707 |
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsNEJM2019 |
16/12/2019 |
5706 |
JIM.fr – L’antidote du dabigatran est efficace quelle que soit la fonction rénale |
16/12/2019 |
5705 |
interactions_medicamenteuses_et_cyp450 |
16/12/2019 |
5704 |
Interaction between frailty and sex on mortality after elective abdominal aortic aneurysm repairJVS2019 |
16/12/2019 |
5703 |
Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry)AJC2019 |
16/12/2019 |
5702 |
Implementation Strategies for Cardiovascular PolypillsJAMA2019 |
16/12/2019 |
5701 |
Impact des mutations du gène MTHFR en médecine (fertilité notamment) et intérêt de la prise en charge thérapeutique _ Gynéco Online |
16/12/2019 |
5700 |
IEC, ARAII et gliptines penser à l’angioedème bradykinique2019 |
16/12/2019 |
5699 |
HTA et traitement hormonal de la menopausePM2019 |
16/12/2019 |
5698 |
Home treatment of patients with cancer-associated venous thromboembolism – An evaluation of daily practiceTR2019 |
16/12/2019 |
5697 |
High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolismTR2019 |
16/12/2019 |
5696 |
Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery diseaseCVR2019 |
16/12/2019 |
5695 |
Faut-il dépister l’artériopathie daibete type 2 RMS2019 |
16/12/2019 |
5694 |
False-negative upper extremity ultrasound in the initial evaluation of patients with suspected subclavian vein thrombosis due to thoracic outlet syndrome (Paget-Schroetter syndrome)JVSLV2019 |
16/12/2019 |
5693 |
Evaluation of the predictive value of the bleeding prediction score VTE‐_BLEED for recurrent venous thromboembolismRPTH |
16/12/2019 |
5692 |
Essential Thrombocythemia NEJM2019 |
16/12/2019 |
5691 |
Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in FranceACD2019 |
16/12/2019 |
5690 |
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionNEJM2019 |
16/12/2019 |
5689 |
Effect of Statins on Recurrent Venous Thromboembolism (From the COMMAND VTE Registry)AJC2019 |
16/12/2019 |
5688 |
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular DiseaseJAMA2019 |
16/12/2019 |
5687 |
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease_ The CLEAR Wisdom Randomized Clinical Trial |
16/12/2019 |
5686 |
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer_ Results from the Hokusai VTE Cancer studyTR2020 |
16/12/2019 |
5685 |
Early in-hospital exposure to statins and outcome after intracerebral haemorrhage – Results from the Virtual International Stroke Trials ArchiveESJ2019 |
16/12/2019 |
5684 |
Short-terme-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase |
16/12/2019 |
5683 |
Douleurs neuropathiques www.vidal.fr |
16/12/2019 |
5682 |
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillationTR2019 |
16/12/2019 |
5681 |
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityNEJM2019 |
16/12/2019 |
5680 |
Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulantsTR2019 |
16/12/2019 |
5679 |
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNEJM2019 |
16/12/2019 |
5678 |
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformationsTR2018 |
16/12/2019 |
5677 |
COMMISSION DE LA TRANSPARENCE Avis 9 octobre 2019 |
16/12/2019 |
5676 |
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017C2019 |
16/12/2019 |
5675 |
Cigarette smoking intensity informs outcomes after open revascularization for peripheral artery diseaseJVS2019 |
16/12/2019 |
5674 |
Changement de perspective dans la prise en charge de l’HTA gravidique et de la prééclampsie2019 |
16/12/2019 |
5673 |
Case of Incidental Asymptomatic Carotid body tumor |
16/12/2019 |
5672 |
Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular diseaseTR2019 |
16/12/2019 |
5671 |
Cardiovascular Disease Prevention at a Crossroads_Precision Medicine or Polypill_JAMA2019 |
16/12/2019 |
5670 |
Cannabidiol Products Are Everywhere, but Should People Be Using ThemJAMA2019 |
16/12/2019 |
5669 |
Cancer patients are at higher risk of dying from heart disease and strokeEHJ2019 |
16/12/2019 |
5668 |
Association of troponin level and age with mortality in 250?000 patients_ cohort study across five UK acute care centresBMJ2019 |
16/12/2019 |
5667 |
Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During SpaceflightJAMA2019 |
16/12/2019 |
5666 |
Artériopathie oblitérante des membres inférieurs?nouveautés dans la thérapie médicamenteuseRMS2019 |
16/12/2019 |
5665 |
Artériopathie oblitérante des membres inférieurs? complications locales et systémiquesRMS2019 |
16/12/2019 |
5664 |
Anticoagulants oraux directs dans le traitement des événements thromboemboliques veineux liés au cancerRMS2019 |
16/12/2019 |
5663 |
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease_ systematic review and meta-analysis |
16/12/2019 |
5662 |
AHA une étude précise le risque CV associé à la ménopause précoce 2019 |
16/12/2019 |
5661 |
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in UrineTH2019 |
16/12/2019 |
5660 |
Interactions médicamenteuses, cytochromes P450 et P-glycoprotéine (Pgp) |
16/12/2019 |
5659 |
A Comparison of Two LDL Cholesterol Targets after Ischemic StrokeNEJM2019 |
16/12/2019 |
5658 |
15-year study finds treatment gaps exist for patients with peripheral arterial disease _ EurekAlert! Science News |
16/12/2019 |
5657 |
5_Fiche_MAV_Traitement_et_evolution_angiome_kystique |
16/12/2019 |
5656 |
Vascular medicine residents lack adequate training for limb pressure measurement_ A nationwide survey in FranceVM2019 |
15/12/2019 |
5655 |
Vascular Disease Patient Information Page_ Spontaneous coronary artery dissection (SCAD)VM2019 |
15/12/2019 |
5654 |
Vascular Disease Patient Information Page_ Pelvic venous reflux (pelvic congestion syndrome)VM2019 |
15/12/2019 |
5653 |
Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapyVM2019 |
15/12/2019 |
5652 |
ULTRASOUND EVALUATION OF THE DIAMETER OF PEDAL ARTERIES IN PATIENTS WITH HIGH PREVALENCE OF PERIPHERAL ARTERIAL DISEASE_ PEDAL FIRSTJACC2019 |
15/12/2019 |
5651 |
ULTRASOUND EVALUATION OF THE DIAMETER OF PEDAL ARTERIES IN PATIENTS WITH HIGH PREVALENCE OF PERIPHERAL ARTERIAL DISEASE_ PEDAL FIRSTJACC2019 |
15/12/2019 |
5650 |
Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapyVM2019 |
15/12/2019 |
5649 |
Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug AdministrationWarnings |
15/12/2019 |
5648 |
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery systemVM2019 |
15/12/2019 |
5647 |
Trends in mortality related to pulmonary embolism in the European Region, 2000–15_ analysis of vital registration data from the WHO Mortality DatabaseLancet2019 |
15/12/2019 |
5646 |
Time to Add a Fifth Pillar to Bedside Physical Examination JC2019 |
15/12/2019 |
5645 |
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesNEJM2019 |
15/12/2019 |
5644 |
Thrombophilia evaluation in pulmonary embolismCOC2019 |
15/12/2019 |
5643 |
The risk of major bleeding in patients with suspected heparin‐_induced thrombocytopeniaJTH2019 |
15/12/2019 |
5642 |
Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes_ A Prospective Parallel-Arm Cohort StudyDC2019 |
15/12/2019 |
5641 |
Statins for primary prevention of cardiovascular diseaseBMJ2019 |
15/12/2019 |
5640 |
Sometimes less is more_ The role of carotid revascularization prior to open heart surgery |
15/12/2019 |
5639 |
rivaroxaban-for-preventing-atherothrombotic-events-in-people-with-coronary-or-peripheral-artery-diseaseNICE2019 |
15/12/2019 |
5638 |
Risk of Recurrent Bleeding Events in Nonvalvular Atrial TH OP2019 |
15/12/2019 |
5637 |
Rat bite fever_ A rare case of critical limb ischemiaVM2019 |
15/12/2019 |
5636 |
Quality of life and functional limitations after pulmonary embolism and its prognostic relevanceJTH2019 |
15/12/2019 |
5635 |
Pseudoxanthoma elasticum with prominent arterial calcifications evoking CD73 deficiencyVM2019 |
15/12/2019 |
5634 |
Progrès et place actuelle de l’imagerie des gros troncs dans l’artérite à cellules géantes _ du diagnostic au suiviMedInt2019 |
15/12/2019 |
5633 |
Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric populationJTH2019 |
15/12/2019 |
5632 |
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score_ Results From the FOURIER Trial C2019 |
15/12/2019 |
5631 |
Paclitaxel-Coated Balloons and Eluting Stents_ Is There a Mortality Risk in Patients With Peripheral Artery DiseaseCirc2019 |
15/12/2019 |
5630 |
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment Updated Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA2018 |
15/12/2019 |
5629 |
New guidelines from the Thrombosis and Haemostasis NZ et AUSTRALIE 2019 |
15/12/2019 |
5628 |
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation2019 |
15/12/2019 |
5627 |
National risk prediction model for perioperative mortality in noncardiac surgeryBJS2019 |
15/12/2019 |
5626 |
Myalgies et statines – démêler le vrai du fauxMyalgia and statinsPM2019 |
15/12/2019 |
5625 |
Management of recurrent venous thromboembolism in patients with cancer_ A reviewTR2018 |
15/12/2019 |
5624 |
Management of frailty_ opportunities, challenges, and future directionsLancet2019 |
15/12/2019 |
5623 |
Lipid Management for the Prevention of Atherosclerotic Cardiovascular DiseaseNEJM2019 |
15/12/2019 |
5622 |
La cigarette électronique _ quels bénéfices, quels risques MedInt2019 |
15/12/2019 |
5621 |
Indications and potential pitfalls of anticoagulants in pulmonary hypertension_ Would DOACs become a better option than VKAs_BR2019 |
15/12/2019 |
5620 |
Incremental effects of diabetes mellitus and chronic kidney disease in medial arterial calcification_ Synergistic pathways for peripheral artery disease progressionVM2019 |
15/12/2019 |
5619 |
Idiopathic Renal Infarction and Anticoagulation THOP2019 |
15/12/2019 |
5618 |
HTA essentielle résistante – place de la spironolactonePM2019 |
15/12/2019 |
5617 |
Guidelines Australie 2019 MTEV |
15/12/2019 |
5616 |
Frequency of arterial thromboembolism in populations with malignancies_ A systematic reviewTR2019 |
15/12/2019 |
5615 |
Financial barriers in accessing medical care for peripheral artery disease are associated with delay of presentation and adverse health status outcomes in the United States VM2019 |
15/12/2019 |
5614 |
Extended treatment with edoxaban in cancer patients with venous thromboembolism_ A post‐_hoc analysis of the Hokusai‐_VTE Cancer studyJTH2019 |
15/12/2019 |
5613 |
ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon 2017 |
15/12/2019 |
5612 |
Emerging glucose-lowering therapies_ a guide for cardiologists Heat 2019 |
15/12/2019 |
5611 |
Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal womenTR2019 |
15/12/2019 |
5610 |
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular DiseaseJAMA2019 |
15/12/2019 |
5609 |
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES Circ 2019 |
15/12/2019 |
5608 |
Dysfonction érectile et traitement antihypertenseurPM2019 |
15/12/2019 |
5607 |
Dual specificity phosphatase 5 regulates perfusion recovery in experimental peripheral artery diseaseVM2019 |
15/12/2019 |
5606 |
Complete regression of coronary atherosclerosisEHJ2019 |
15/12/2019 |
5605 |
Cochrane corner_ does the Mediterranean-style diet help in the prevention of cardiovascular disease_H2019 |
15/12/2019 |
5604 |
Clot regression effects of rivaroxaban in CANCER VTE BMJO2019 |
15/12/2019 |
5603 |
Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolismTR2019 |
15/12/2019 |
5602 |
Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis_ From the COMMAND VTE RegistryTR2019 |
15/12/2019 |
5601 |
CLINICAL IMPACT OF ANKLE-BRACHIAL INDEX IMPROVEMENT AFTER ENDOVASCULAR THERAPY FOR PERIPHERAL ARTERIAL DISEASEJACC2019 |
15/12/2019 |
5600 |
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease_ The EUCLID trialVM2019 |
15/12/2019 |
5599 |
Cancer and platelet crosstalk_ opportunities and challenges for aspirin and other antiplatelet agents |
15/12/2019 |
5598 |
Blood markers for cancerBMJ2019 |
15/12/2019 |
5597 |
Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis Circ2019 |
15/12/2019 |
5596 |
Aspirin for primary prevention of cardiovascular disease_ a meta-analysis with a particular focus on subgroupsBMC2019 |
15/12/2019 |
5595 |
Arterial and venous thrombosis by high platelet count and high hematocrit_ 108 _521 individuals from the Copenhagen General Population StudyJTH2019 |
15/12/2019 |
5594 |
Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism2017 |
15/12/2019 |
5593 |
Adherence and persistence to direct oral anticoagulants in atrial fibrillation_ a population-based studyH2019 |
15/12/2019 |
5592 |
Acute Severe Hypertension NEJM2019 |
15/12/2019 |
5591 |
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery diseaseVM2019 |
15/12/2019 |
5590 |
Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery |
15/12/2019 |
5589 |
20-Year Follow-up of Statins in Children with Familial HypercholesterolemiaNEJM2019 |
15/12/2019 |
5588 |
7_Fiche_MAV_Traitement_Malf_arterioveineuse |
15/12/2019 |
5587 |
6_Fiche_MAV_Techniques_exploration_malf_arterioveineuse |
15/12/2019 |
5586 |
4_Fiche_MAV_Traitement_evolution_malf_arterioveineuse |
15/12/2019 |
5585 |
3_Fiche_MAV_Techniques_exploration_malf_flux_lent |
15/12/2019 |
5584 |
2_Fiche_MAV_Malf_Vasc_au_quotidien |
15/12/2019 |
5583 |
1_Fiche_MAV_Vous_et_votre_malformation_vasculaire |
15/12/2019 |
5582 |
Venous thromboembolism complications after endovenous laser ablation for varicose veins and role of duplex ultrasound scanJVSVL2019 |
10/12/2019 |
5581 |
Variation in the elective management of small abdominal aortic aneurysms and physician practice patternsJVS2019 |
10/12/2019 |
5580 |
Value of Contrast-Enhanced Ultrasound in Detecting Competent and Incompetent Lower-Extremity Perforating VeinsUMB2019 |
10/12/2019 |
5579 |
The Small Saphenous Vein- An Underestimated Source for Autologous Distal Vein BypassEJVES2019 |
10/12/2019 |
5578 |
Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registryEJIM2019 |
10/12/2019 |
5577 |
Spot stenting versus full coverage stenting after endovascular therapy for femoropopliteal artery lesionsJVS2019 |
10/12/2019 |
5576 |
Comment effectuer une présentation orale scientifique |
10/12/2019 |
5575 |
Comment se préparer à une présentation orale |
10/12/2019 |
5574 |
Comment rédiger un abstract scientifique |
10/12/2019 |
5573 |
Comment rédiger un case report |
10/12/2019 |
5572 |
Comment rédiger un article scientifique de type revue narrative de la littérature |
10/12/2019 |
5571 |
Pulmonary hypertension in patients with myeloproliferative neoplasms- A large cohort of 183 patientsEJIM20919 (1) |
10/12/2019 |
5570 |
propositions-tih-gihp-gfht-sfar |
10/12/2019 |
5569 |
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK2019 |
10/12/2019 |
5568 |
Preoperative intravascular ultrasonographic evaluation of leiomyosarcoma of the inferior vena cava- A case reportJCU2019 (1) |
10/12/2019 |
5567 |
Peripheral arterial disease in women- The gender effect2019 |
10/12/2019 |
5566 |
Peripheral arterial disease diagnosis and management in primary care- a qualitative studyBJGP2019 |
10/12/2019 |
5565 |
Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosisJVSVL2019 (1) |
10/12/2019 |
5564 |
Observational study of the medical management of patients with peripheral artery diseaseBJS2019 |
10/12/2019 |
5563 |
Observational study of the medical management of patients with peripheral artery diseaseBJS2P019 |
10/12/2019 |
5562 |
Obesity paradox in peripheral artery diseaseCN2019 |
10/12/2019 |
5561 |
Matthews_et_al-2017-British_Journal_of_Surgery-2 |
10/12/2019 |
5560 |
Major Amputation Rates in Patients with Peripheral Arterial Disease Aged 50 Years and Over in DenmarkEJVES2019 |
10/12/2019 |
5559 |
Lower extremity critical limb ischemia- A review of clinical features and managementTCM2019 |
10/12/2019 |
5558 |
La cigarette électronique _ quels bénéfices, quels risques RMI2019 |
10/12/2019 |
5557 |
Investigation of Complications Following Port Insertion in a Cancer Patient Population- A Retrospective AnalysisCMIO2019 |
10/12/2019 |
5556 |
Intra-clot Microbubble-Enhanced Ultrasound Accelerates Catheter-Directed Thrombolysis for Deep Vein ThrombosisJCU2019 |
10/12/2019 |
5555 |
Heterogeneity in Standard Operating Procedures for Catheter Directed Thrombolysis for Peripheral Arterial Occlusions in The Netherlands- A Nationwide OverviewEJVES2019 |
10/12/2019 |
5554 |
Grading venous stenosis is different from arterial lesionsJVSL2019 |
10/12/2019 |
5553 |
Duplex ultrasound surveillance of renal branch grafts after fenestrated endovascular aneurysm repairJVS2019 |
10/12/2019 |
5552 |
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients_ Potential for drug–drug interactionsCRO2018 |
10/12/2019 |
5551 |
Coughlin_et_al-2018-British_Journal_of_Surgery |
10/12/2019 |
5550 |
Comparison of Outcomes and Cost of Endovascular Management Versus Surgical Bypass for the Management of Lower Extremities Peripheral Arterial DiseaseAJC2018 |
10/12/2019 |
5549 |
An Ex Vivo Evaluation of Tomographic 3-D Ultrasound, B-Mode Ultrasound, JUB2019 |
10/12/2019 |
5548 |
Agreement of clinical tests for the diagnosis of peripheral arterial disease DC2019 |
10/12/2019 |
5547 |
Additional Risk Stratification Using Local and Systemic Factors for Patients with Critical Limb Ischaemia Undergoing Endovascular Therapy in the WIfI EraEJVES2019 |
10/12/2019 |
5546 |
A complication of enoxaparin injection CC2019 |
10/12/2019 |
5545 |
2019 Update in perioperative CV 2019 |
10/12/2019 |
5544 |
“The renal foot” – Angiographic pattern of patients with chronic limb threatening ischemia and end-stage renal diseaseCRM2019 |
10/12/2019 |
5543 |
Ticagrelor in Patients with Stable Coronary Disease and Diabetes THEMIS NEJM2019 |
10/12/2019 |
5542 |
TheLancetCountdown_2018_ExecutiveSummary_French |
10/12/2019 |
5541 |
Ruell_et_al-2019-Journal_of_Thrombosis_and_Haemostasis BRIDGING |
10/12/2019 |
5540 |
Promoting physical activity to patientsBMJ2019 |
10/12/2019 |
5539 |
Prevention VTE 2019 |
10/12/2019 |
5538 |
Outcomes of direct oral anticoagulant- and warfarin-associated hemorrhageTR2019 |
10/12/2019 |
5537 |
Managing conflicts of interests in clinical guidelines Lancet2019 |
10/12/2019 |
5536 |
Lipedema_ A Call to Action 2019 |
10/12/2019 |
5535 |
Kraaijpoel_et_al-2019-Journal_of_Thrombosis_and_Haemostasis PE |
10/12/2019 |
5534 |
JIM.fr – Réduire plus encore le LDL pour les patients à très haut risque cardiovasculaire |
10/12/2019 |
5533 |
jamaoncology_fitzmaurice_2019_oi_190065 |
10/12/2019 |
5532 |
Intensive Lipid Lowering in Elderly Patient JAMA CARD2019 |
10/12/2019 |
5531 |
Hsu_et_al-2018-Cochrane_Database_of_Systematic_Reviews (1)Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb?threatening ischaemia |
10/12/2019 |
5530 |
Haas_et_al-2019-Journal_of_Thrombosis_and_Haemostasis Garfield VTE |
10/12/2019 |
5529 |
Engeseth_et_al-2019-Journal_of_Thrombosis_and_Haemostasis VILLALTA |
10/12/2019 |
5528 |
Ehlers-Danlos syndromes BMJ2019 |
10/12/2019 |
5527 |
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels One-Year Follow-up of the ORION- Randomized Clinical Trial.JC2019 |
10/12/2019 |
5526 |
CANCER VTE US TR 2019 |
10/12/2019 |
5525 |
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr)_ results from three multicentre, single-arm, phase 2 studiesLancet2019 |
10/12/2019 |
5524 |
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr)_ results from three multicentre, single-arm, phase 2 studiesLancet2019 (1) |
10/12/2019 |
5523 |
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients_ Pooled analysis of nine ODYSSEY trials of alirocumab versus control |
10/12/2019 |
5522 |
PLACE DE L’ECHO DOPPLER VEINEUX DANS LE DIAGNOSTIC, LE CHOIX THERAPEUTIQUE ET LE SUIVI DE L’INSUFFISANCE VEINEUSE SUPERFICIELLE |
10/12/2019 |
5521 |
Virchow’s triad in “silent” deep vein thrombosis |
09/12/2019 |
5520 |
Venous thromboembolism complications after endovenous laser ablation for varicose veins and role of duplex ultrasound scan JVS2019 |
09/12/2019 |
5519 |
Venothromboembolic signs and medical eponymsPart II TR2019 |
09/12/2019 |
5518 |
Venothromboembolic signs and medical eponyms_ Part ITR2019 |
09/12/2019 |
5517 |
VAPING aqmon US teems BMJ 2019 |
09/12/2019 |
5516 |
Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularizationJVS2019 |
09/12/2019 |
5515 |
Ulcère veineux 2019 Quelles nouveautés depuis les recommandations de la HAS de 2010 |
09/12/2019 |
5514 |
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery systemVM2019 |
09/12/2019 |
5513 |
Transcranial Doppler 24 Hours after Carotid Endarterectomy Accurately Identifies Patients Not at Risk of Cerebral Hyperperfusion Syndrome EJVES2019 |
09/12/2019 |
5512 |
The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy_ A systematic review and meta-analysis of randomized controlled trialsTR2019 |
09/12/2019 |
5511 |
The Ottawa score performs poorly in cancer patients with incidental pulmonary embolismTR2019 |
09/12/2019 |
5510 |
Statins and Lp(a)_ The plot thickens Ath2019 |
09/12/2019 |
5509 |
CHOLESTÉROL LDL CHEZ LES ADULTES EN FRANCE MÉTROPOLITAINE CONCENTRATION MOYENNE, CONNAISSANCE ET TRAITEMENT EN 2015, ÉVOLUTIONS DEPUIS 2006 |
09/12/2019 |
5508 |
cardiovascular disease and risk management: standards of medical car in diabetes |
09/12/2019 |
5507 |
Rivaroxaban in the treatment of upper extremity deep vein thrombosis_ A single-center experience and review of the literatureTR2019 |
09/12/2019 |
5506 |
Revisiting the Role of Aspirin for the |
09/12/2019 |
5505 |
Quality Indicators in Peripheral Arterial Occlusive Disease Treatment_ A Systematic ReviewEJVES2019 |
09/12/2019 |
5504 |
Promoting physical activity to patientsBMJ2019 |
09/12/2019 |
5503 |
Preventing hospital associated venous thromboembolism |
09/12/2019 |
5502 |
Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018JAMA2019 |
09/12/2019 |
5501 |
Prescribing Statins to Reduce Cardiovascular Disease_ 10 Common MisconceptionsAJM2019 |
09/12/2019 |
5500 |
Prediction system for risk of allograft loss in patients receiving kidney transplants- international derivation and validation studyBMJ2019 |
09/12/2019 |
5499 |
Polypill for Cardiovascular Disease Prevention in an Underserved Population NEJM2019 |
09/12/2019 |
5498 |
Myalgies et statines _ démêler le vrai du faux PM2019 |
09/12/2019 |
5497 |
Managing conflicts of interests in clinical guidelines Lancet2019 |
09/12/2019 |
5496 |
Long-term durability of Oakes salvage procedure to preserve Brescia-Cimino arteriovenous fistula JVS2019 |
09/12/2019 |
5495 |
Lipedema_ A Call to Action 2019 |
09/12/2019 |
5494 |
Lancet_commission_on_hypertension_group_position.97120 2019 |
09/12/2019 |
5493 |
JIM.fr – Rareté confirmée pour le syndrome des antiphospholipides |
09/12/2019 |
5492 |
Groupe Tabac et Toxiques SPLF |
09/12/2019 |
5491 |
GENOTYPAGE ESC 2019 |
09/12/2019 |
5490 |
Extended treatment with edoxaban in cancer patients with venous thromboembolism_ A post‐_hoc analysis of the Hokusai‐_VTE Cancer studyJTH2019 |
09/12/2019 |
5489 |
Evaluation of pain incidence due to venous malformation based on data from 85 institutions in JapanJVSL2019 |
09/12/2019 |
5488 |
Ehlers-Danlos syndromes BMJ2019 |
09/12/2019 |
5487 |
Durability of Open Repair of Juxtarenal Abdominal Aortic Aneurysms_ A Multicentre Retrospective Study in Five French Academic Centres EJVES2019 |
09/12/2019 |
5486 |
Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants |
09/12/2019 |
5485 |
Clinical Characteristics and Outcomes of Patients with VTE Cancer Lung Riete TH2018 |
09/12/2019 |
5484 |
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr)_ results from three multicentre, single-arm, phase 2 studiesLancet2019 |
09/12/2019 |
5483 |
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes_ A Secondary Analysis of the COMPASS TrialJAMA2019 |
09/12/2019 |
5482 |
Artérite de Takayasu et athérosclérose JMV2019 |
09/12/2019 |
5481 |
Are e-cigarettes killing people in the US_BMJ2019 |
09/12/2019 |
5480 |
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseNEJM2019 |
09/12/2019 |
5479 |
Anticoagulation for Subsegmental Pulmonary Embolism NEJM2019 |
09/12/2019 |
5478 |
Anemia of Inflammation NEJM2019 |
09/12/2019 |
5477 |
Alerte sanitaire ecig SPLF |
09/12/2019 |
5476 |
Affections chroniques multiples Prise en charge multidisciplinaire de la multimorbiditéRMS2019 |
09/12/2019 |
5475 |
2019 Duarte-Garcia SAPL épidémio Arthritis Rheumatol |
09/12/2019 |
5474 |
2019 CHOOSE WISELY ED IVS |
09/12/2019 |
5473 |
2019 ACCAHA Guideline on the Primary Prevention of Cardiovascular Disease Executive SummaryC2019 |
09/12/2019 |
5472 |
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA)_ a pragmatic, open-label, randomised controlled trialLancet2019 |
17/10/2019 |
5471 |
Very elderly patients with venous thromboembolism on oral AC2019 TR |
17/10/2019 |
5470 |
Variation of all-cause and cause-specific mortality with body mass index in one million Swedish parent-son pairsAn instrumental variable analysisPLOS2019 |
17/10/2019 |
5469 |
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesNEJM2019 |
17/10/2019 |
5468 |
The compelling arguments for the need of medical vascular physicians in Europe |
17/10/2019 |
5467 |
Temporal trends in bleeding events in acute myocardial infarction insights from the SWEDEHEART registryEHJ2019 |
17/10/2019 |
5466 |
Quality of Warfarin Therapy and Quality of Life are Improved by Self-Management for Two Years |
17/10/2019 |
5465 |
Post& thrombotic syndrome in children_ Measurement properties of CAPTSure, a new diagnostic toolRPTH2019 |
17/10/2019 |
5464 |
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA)_ A comparative study using DOAC Stop and andexanet alfaTH2019 |
17/10/2019 |
5463 |
Multiple Renal Arteries NEJM2019 |
17/10/2019 |
5462 |
Modifiable risk factors, cardiovascular disease, and mortality in 155?722 individuals from 21 high-income, middle-income, and low-income countries (PURE) a prospective cohort studyLancet2019 |
17/10/2019 |
5461 |
Menopausal hormone therapy and 20-year breast cancer mortality |
17/10/2019 |
5460 |
Management of cardiogenic shock complicating myocardial infarctionan update 2019EHJ |
17/10/2019 |
5459 |
Low NOAC Adherence Worse Than Taking Warfarin_ _ Medpage Today2019 |
17/10/2019 |
5458 |
Long-term cardiovascular health after stopping pre-eclampsia |
17/10/2019 |
5457 |
Inflammatory Bowel Disease 2017 |
17/10/2019 |
5456 |
French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease 2019 |
17/10/2019 |
5455 |
Focus sur le coroscanner, un couteau suisse sous-employé |
17/10/2019 |
5454 |
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life |
17/10/2019 |
5453 |
Effect of Nut Consumption on Erectile and Sexual Function in Healthy Males_ A Secondary Outcome Analysis of the FERTINUTS Randomized Controlled Trial |
17/10/2019 |
5452 |
Direct Oral Anticoagulant Drugs On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effec2019 |
17/10/2019 |
5451 |
Blood Adv AOD MTEV 2019 |
17/10/2019 |
5450 |
Apixaban for the prevention of thromboembolism in Immunomodulatory-treated myeloma patients_ Myelaxat, a phase 2 pilot study_AJH2019 |
17/10/2019 |
5449 |
Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease _ Ovid |
17/10/2019 |
5448 |
Ambient Particulate Air Pollution and Daily Mortality in 652 CitiesNEJM2019 |
17/10/2019 |
5447 |
Acute Effects of Electronic Cigarette Aerosol Inhalation on Vascular Function Detected at Quantitative MRIRad2019 |
17/10/2019 |
5446 |
AAA Screening Should Be ExpandedC2019 |
17/10/2019 |
5445 |
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer LO2019 |
17/10/2019 |
5444 |
Thrombosis and hemostasis health in pregnancy-RPTH2019 |
04/09/2019 |
5443 |
Recours à la biothérapie dans la prise en charge de la maladie de Behçet dans un service de médecine interneMI2019 |
04/09/2019 |
5442 |
Quelle place pour les anticoagulants oraux directs en cancérologie LD2019 |
04/09/2019 |
5441 |
Quelle place pour les anticoagulants oraux directs en cancérologie BC2019 |
04/09/2019 |
5440 |
Primary Prevention of Cardiovascular Disease in Individuals With Type 2 Diabetes_ Time for Cardiology to Get Back in the Game – American College of Cardiology |
04/09/2019 |
5439 |
Primary Prevention of Cardiovascular Disease in Diabetes MellitusJACC2017 |
04/09/2019 |
5438 |
Obésité et cancer |
04/09/2019 |
5437 |
Hybrid Management of Tandem Carotid Arterial Stenoses with Contralateral Carotid OcclusionEJVES2019 |
04/09/2019 |
5436 |
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes |
04/09/2019 |
5435 |
Épidémiologie descriptive des cancers en France métropolitaine – incidence, survie et prévalenceBC2019 |
04/09/2019 |
5434 |
Cardiovascular Disease in Type 2 DiabeteMC |
04/09/2019 |
5433 |
Atrophie Blanche (C4b) Can Be Reversible After Targeted TreatmentEJVES2019 |
04/09/2019 |
5432 |
Atrial fibrillation in patients with end?stage renal disease on hemodialysis- Magnitude of the problem and new approach to oral anticoagulationRPTH2019 |
04/09/2019 |
5431 |
Apport de l’imagerie (hors Doppler) pour le diagnostic et le suivi de l’artérite à cellules géantesPM2019 |
04/09/2019 |
5430 |
Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment |
04/09/2019 |
5429 |
Validation of apixaban anti-factor Xa assay and impact of body weighTR2019 |
04/09/2019 |
5428 |
Traumatismes de la face après tirs de Flash-Ball des médecins français alerten |
04/09/2019 |
5427 |
The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy A systematic review and meta-analysis of randomized controlled trialsTR2019 |
04/09/2019 |
5426 |
The progression rate of peripheral arterial disease in patients with intermittent claudication a systematic review2019 |
04/09/2019 |
5425 |
The progression rate of peripheral arterial disease in patients with intermittent claudication a systematic review2019 |
04/09/2019 |
5424 |
Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registryEJIM2019 |
04/09/2019 |
5423 |
Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolismComparative effectiveness, safety, and costsTR2019 |
04/09/2019 |
5422 |
Rivaroxaban in the treatment of upper extremity deep vein thrombosisA single-center experience and review of the literatureTR2019 |
04/09/2019 |
5421 |
Risk factors for Cancer‐_Associated Venous Thromboembolism_ the Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE‐_PACC) StudyJTH2019 |
04/09/2019 |
5420 |
Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015JAMA2019 |
04/09/2019 |
5419 |
Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndromeJVS2019 (1) |
04/09/2019 |
5418 |
Prise en charge des traumatismes craniocérébraux simples dans les sports de contacRMS2019 |
04/09/2019 |
5417 |
Polypills for primary prevention of cardiovascular disease |
04/09/2019 |
5416 |
Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndromeJVS2019 (1) |
04/09/2019 |
5415 |
Polypills for primary prevention of cardiovascular disease |
04/09/2019 |
5414 |
Polypill cuts major cardiovascular events by a third, study finds |
04/09/2019 |
5413 |
Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndromeJVS2019 (1) |
04/09/2019 |
5412 |
Métastases elles pourraient se former bien avant que le cancer soit détectable |
04/09/2019 |
5411 |
Medical Use of Cannabis in 2019 |
04/09/2019 |
5410 |
Lifestyle factors and high-risk EFHP21019 |
04/09/2019 |
5409 |
Le trail?un défi pour les intervenants du dispositif sanitaireRMS2019 |
04/09/2019 |
5408 |
Plus l’HTA débute tôt et plus les organes cibles sont atteints _ c’est sur et certain |
04/09/2019 |
5407 |
La CRP pour évaluer le risque d’athérome carotidien |
04/09/2019 |
5406 |
Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease |
04/09/2019 |
5405 |
Inflammatory Bowel Disease Increases the Risks of Deep Vein Thrombosis and Pulmonary Embolism in the Hospitalized Patients_ A Nationwide Cohort Study |
04/09/2019 |
5404 |
Hospital volume and outcomes for acute pulmonary embolismRIETE 2019 |
04/09/2019 |
5403 |
High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210ATR2019 |
04/09/2019 |
5402 |
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleedingTR2019 |
04/09/2019 |
5401 |
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection_ a systematic review, meta-analysis, and modelling study2019 |
04/09/2019 |
5400 |
Facilitating Magnetic Resonance Imaging in Patients With a Cardiac DeviceCirc2019 |
04/09/2019 |
5399 |
ESC Guidelines for the diagnosis and management of acute pulmonaryembolism developed in collaboration with the European Respiratory Society (ERS) |
04/09/2019 |
5398 |
ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
04/09/2019 |
5397 |
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD |
04/09/2019 |
5396 |
Effet diabétogène des statines?balance bénéfices-risquesRMS2019 |
04/09/2019 |
5395 |
Effect of Simvastatin-Ezetimibe Compared 75 Jama C2019 |
04/09/2019 |
5394 |
Atherosclerosis |
04/09/2019 |
5393 |
Delayed gratification and adherence to exercise among patients with claudicationVM2019 |
04/09/2019 |
5392 |
D-dimer levels and risk of recurrence following provoked venous thromboembolism: Findings from the RIETE registry. |
04/09/2019 |
5391 |
Cardiovascular Risk Reduction in Young Adults |
04/09/2019 |
5390 |
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease |
04/09/2019 |
5389 |
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease_ The EUCLID trial |
04/09/2019 |
5388 |
Changes in carotid artery structure with smoking cessationVM2019 |
04/09/2019 |
5387 |
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr)results from three multicentre, single-arm, phase 2 studiesLH2019 |
04/09/2019 |
5386 |
Avoiding disease mongering_ A checklist for vascular physicians and researchersTR2019 |
04/09/2019 |
5385 |
Atherosclerosis Nat2019 |
04/09/2019 |
5384 |
Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants_ a systematic review and meta‐_analysis |
04/09/2019 |
5383 |
Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung FunctionJAMA2019 |
04/09/2019 |
5382 |
Assessment of the procoagulant potential and associated risk factors in pregnant patients with inflammatory bowel diseasesEJIM2019 |
04/09/2019 |
5381 |
Aspirin 4,000 years and still learning ClC2019 |
04/09/2019 |
5380 |
An easy-to-use tool to flag patients at risk of poor INR control_ A streak of subtherapeutic INRsTR2019 |
04/09/2019 |
5379 |
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome- ODYSSEY OUTCOMES TrialJACC2019 |
04/09/2019 |
5378 |
Acute Limb Ischemia in Peripheral Artery Disease |
04/09/2019 |
5377 |
Activité sportive et mortalité CV RMS2019 |
04/09/2019 |
5376 |
Activité sportive et mortalité CV RMS2019 |
04/09/2019 |
5375 |
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. A systematic review and meta-analysis |
04/09/2019 |
5374 |
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors |
04/09/2019 |
5373 |
 |
04/09/2019 |
5372 |
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer_ ASCO Clinical Practice Guideline Update2019 |
13/08/2019 |
5371 |
Une nouvelle analyse révèle l’absence de données probantes indiquant l’apport d’un bénéfice supplémentaire pour un grand nombre de nouveaux médicaments _ Univadis |
13/08/2019 |
5370 |
Systematic review and meta-analysis of the association between intraluminal thrombus volume and abdominal aortic aneurysm rupture |
13/08/2019 |
5369 |
Les 2 composantes systolique et diastolique de la PA influencent indépendamment le risque cardiovasculaire |
13/08/2019 |
5368 |
Research & practice in thtombosis & haemostasis |
13/08/2019 |
5367 |
Facilitating Magnetic Resonance Imaging in Patients With a Cardiac DeviceCirc2019 |
13/08/2019 |
5366 |
Duplex ultrasound surveillance of renal branch grafts after fenestrated endovascular aneurysm repair |
13/08/2019 |
5365 |
D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulantsPLOS2019 |
13/08/2019 |
5364 |
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease_ The EUCLID trial |
13/08/2019 |
5363 |
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. A systematic review and meta-analysis |
05/08/2019 |
5362 |
Air Pollution and Cardiovascular DiseaseJACC State-of-the-Art ReviewJACC2018 |
05/08/2019 |
5361 |
The Ottawa score performs poorly in cancer patients with incidental pulmonary embolismTR2019 |
05/08/2019 |
5360 |
Venous thromboembolism incidence in hematologic malignanciesBR2019 |
05/08/2019 |
5359 |
Venous thromboembolism incidence in hematologic malignanciesBR2019 |
05/08/2019 |
5358 |
Aortite de l’artérite à cellules géantes _ diagnostic, pronostic et traitementPM2019 |
05/08/2019 |
5357 |
Apport de l’écho-doppler pour le diagnostic d’artérite à cellules géantesPM2019 |
05/08/2019 |
5356 |
Aortite de l’artérite à cellules géantes diagnostic, pronostic et traitementPM2019 |
05/08/2019 |
5355 |
L’exposition à la pollution automobile, un bon moyen pour contracter une dysfonction érectile _ |
05/08/2019 |
5354 |
Dysfonction érectile et traitement antihypertenseur impact des différentes classes thérapeutiques et conduite à tenir à l’égard du traitementPM2019 |
05/08/2019 |
5353 |
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial FibrillationA Systematic Review and Meta?AnalysisJHA2019 |
05/08/2019 |
5352 |
Three Public Health Interventions Could Save 94 Million Lives in 25 Years Global Impact Assessment AnalysisC2019 |
05/08/2019 |
5351 |
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetesan analysis from the DECLARE–TIMI 58 randomised trialLE2019 |
05/08/2019 |
5350 |
Venous Thromboembolism in Denmark Seasonality in Occurrence and MortalityTH2019 |
05/08/2019 |
5349 |
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular DiseaseThe Multi-Ethnic Study Of Atherosclerosis (MESA)2016 |
05/08/2019 |
5348 |
Treatment of cancer-associated venous thrombo- embolism in the age of direct oral anticoagulantsAONCO2019 |
05/08/2019 |
5347 |
Ten Commandments for patient-centred treatment2015 |
05/08/2019 |
5346 |
Blood Grouping Identifies Patients at Risk for Developing Venous Thromboembolism – Consult QD |
05/08/2019 |
5345 |
Publications scientifiques _ la guerre est déclarée – Sciences et Avenir 2019 |
05/08/2019 |
5344 |
Prévention trois cibles pour sauver près de 100 millions de vies en 20402019 |
05/08/2019 |
5343 |
Defining High Bleeding Risk in Patients Circ2019 |
05/08/2019 |
5342 |
Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous ThromboembolismTHOPEN 2018 |
05/08/2019 |
5341 |
Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals |
05/08/2019 |
5340 |
AOD et TEST |
05/08/2019 |
5339 |
ISTH201926 |
05/08/2019 |
5338 |
The risk of arterial thromboembolic events after cancer diagnosisRPTH2018 |
05/08/2019 |
5337 |
Preventing hospital associated venous thromboembolismBMJ201ç |
05/08/2019 |
5336 |
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery diseaseVM2019 |
05/08/2019 |
5335 |
Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction- Differences between factor IIa and factor Xa inhibitionPT2019 |
05/08/2019 |
5334 |
A Multicenter Trial of Vena Cava Filters in Severely Injured PatientsNEJM2019 |
05/08/2019 |
5333 |
The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancyTR2019 |
05/08/2019 |
5332 |
Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesisBLOOD201 |
05/08/2019 |
5331 |
Self-reported Daily, Weekly, and Monthly Cannabis Use Among Women Before and During PregnancyJAMA2019 |
05/08/2019 |
5330 |
Acute and Chronic Effects of Cocaine on Cardiovascular Health2019 |
05/08/2019 |
5329 |
Un faible taux de LDL-cholestérol favoriserait-il les hémorragies cérébrales2019 |
05/08/2019 |
5328 |
How I treat cancer-associated venous thromboembolismBlood2019 |
05/08/2019 |
5327 |
Le cannabis rendrait-il les hommes stériles |
05/08/2019 |
5326 |
Extended treatment of cancer-associated thrombosisTR2019 |
05/08/2019 |
5325 |
EINSTEIN-JrRivaroxaban Safe, Effective in Kids With Venous Thromboembolism2019 |
05/08/2019 |
5324 |
Rationale and Design of the Coronary Artery Calcium Consortium_ A Multicenter Cohort Study2017 |
05/08/2019 |
5323 |
Mise au point sur les sclérodermies très précoces et précoces MI2019 |
05/08/2019 |
5322 |
Efficacy and safety of alirocumab and evolocumab a systematic review and meta-analysis of randomized controlled trialsEHJ2019 |
05/08/2019 |
5321 |
Lymphœdème des membres inférieurs _ une manifestation rare des spondyloarthritesMI2019 |
05/08/2019 |
5320 |
Prophylaxie primaire de la maladie thromboembolique veineuse chez les patients cancéreux ambulatoires traités par les antinéoplasiquesRPI2019 |
05/08/2019 |
5319 |
Aortite de l’artérite à cellules géantes _ diagnostic, pronostic et traitementPM2019 |
05/08/2019 |
5318 |
Aortite de l’artérite à cellules géantes diagnostic, pronostic et traitementPM2019 |
05/08/2019 |
5317 |
Apport de l’écho-doppler pour le diagnostic d’artérite à cellules géantesPM2019 |
05/08/2019 |
5316 |
Dysfonction érectile et traitement antihypertenseur impact des différentes classes thérapeutiques et conduite à tenir à l’égard du traitementPM2019 |
05/08/2019 |
5315 |
Genome-wide association study of peripheral artery disease in the Million Veteran ProgramNatMed2019 |
05/08/2019 |
5314 |
Microvascular Disease, Peripheral Artery Disease and AmputationCirc2019 |
05/08/2019 |
5313 |
Survenue de cancers au cours de la sclérodermie systémique facteurs de risque, impact sur la survie et revue de la littératureRMI2019 |
05/08/2019 |
5312 |
Prise en charge des infections cutanées bactériennes courantes – Février 2019 |
05/08/2019 |
5311 |
Type 2 diabetesEvolving concepts and treatmenClCl2019 |
05/08/2019 |
5310 |
Évaluation par le patient du rôle du médecin traitant et du médecin vasculaire dans l’information médicale des patients souffrant d’une maladie thromboembolique veineuse |
05/08/2019 |
5309 |
Microbubble Enhanced UltrasoundAssisted Catheter-Directed Thrombolysis for VTEA Sound IdeaTH2019 |
05/08/2019 |
5308 |
Actualisation des recommandations pour la prise en charge des hypercholestérolémies |
05/08/2019 |
5307 |
Giant cell arteritis An updated review of an old diseaseClCl2019 |
05/08/2019 |
5306 |
Long-Term Management of Venous Thromboembolism Lessons from EINSTEIN CHOICE and Other Extension TrialsTH2019 |
05/08/2019 |
5305 |
Diagnostic de l’embolie pulmonaire PM2019 |
05/08/2019 |
5304 |
Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein ThrombosisTH2019 |
05/08/2019 |
5303 |
Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke A Practice-Derived StudyTH2019 |
05/08/2019 |
5302 |
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.Circ2019 |
05/08/2019 |
5301 |
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.Circ2019 |
05/08/2019 |
5300 |
Clinical trials More to learn than the results |
05/08/2019 |
5299 |
Synthèse à destination du médecin traitant Juin 2019 |
11/07/2019 |
5298 |
Synthèse à destination du médecin traitant Juin 2019 |
11/07/2019 |
5297 |
Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular |
11/07/2019 |
5296 |
Standardization of Carotid Ultrasound A Hemodynamic Method to Normalize for Interindividual and Interequipment Variability |
11/07/2019 |
5295 |
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction |
11/07/2019 |
5294 |
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the As |
11/07/2019 |
5293 |
Real?world assessment of off?label direct oral anticoagulant dosing for venous thromboembolism |
11/07/2019 |
5292 |
Periprocedural interruption of anticoagulation in patients with cancer?associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes |
11/07/2019 |
5291 |
Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent |
11/07/2019 |
5290 |
Menopausal Hormone Therapy |
11/07/2019 |
5289 |
Management of venous thromboembolism in far-advanced cancer: current practice |
11/07/2019 |
5288 |
Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next? |
11/07/2019 |
5287 |
RPTH Research and pratice in thrombosis et hemostasis 12 |
11/07/2019 |
5286 |
RPTH Research and pratice in thrombosis et hemostasis 12 |
11/07/2019 |
5285 |
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests |
11/07/2019 |
5284 |
Evaluating utilization patterns of oral anticoagulants in routine care |
11/07/2019 |
5283 |
Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy?associated venous thromboembolism |
11/07/2019 |
5282 |
BAROMÈTRE DE SANTÉ PUBLIQUE FRANCE 2017 USAGE DE LA CIGARETTE ÉLECTRONIQUE, TABAGISME ET OPINIONS DES 18-75 ANS |
11/07/2019 |
5281 |
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial |
11/07/2019 |
5280 |
 |
10/07/2019 |
5279 |
Commentaires et propositions du Groupe d’Intérêt en Hémostase Périopératoire (GIHP) sur les recommandations de la Société Européenne d’Anesthésie : « European Guidelines on perioperative venous thromboembolism prophylaxis » |
09/07/2019 |
5278 |
Vascular medicine and social media, highlights from the practice and compensation survey, and the future of vascular medicine training |
09/07/2019 |
5277 |
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease |
09/07/2019 |
5276 |
Traitement médical de l’artériopathie chronique oblitérante des membres inférieurs (AOMI) : la folie des grandeurs |
09/07/2019 |
5275 |
The Role of a specialist bridging service. A New Zealand prospective study of 600 patients. |
09/07/2019 |
5274 |
The risk of arterial thromboembolic events after cancer diagnosis |
09/07/2019 |
5273 |
The rise and fall of aspirin in the primary prevention of cardiovascular disease |
09/07/2019 |
5272 |
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial |
09/07/2019 |
5271 |
Reflections on Randomized Trials and Observational Studies |
09/07/2019 |
5270 |
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database |
09/07/2019 |
5269 |
Physical activity trajectories and mortality: population based cohort study |
09/07/2019 |
5268 |
Pharmacokinetic variability of anticoagulants in patients with cancerassociated thrombosis: Clinical consequences |
09/07/2019 |
5267 |
Perspectives et enjeux au sein de la chirurgie pour les années à venir |
09/07/2019 |
5266 |
Overview of venous pathology related to repetitive vascular trauma in athletes |
09/07/2019 |
5265 |
Extended treatment with edoxaban in cancer patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE Cancer study |
09/07/2019 |
5264 |
Most noninferiority trials were not designed to preserve active comparator treatment effects |
09/07/2019 |
5263 |
Management of venous thromboembolism in far-advanced cancer: current practice | BMJ Supportive & Palliative Care |
09/07/2019 |
5262 |
Lymphedema-associated comorbidities and treatment gap |
09/07/2019 |
5261 |
LDL below 70 mg/dL increases hemorrhagic stroke risk |
09/07/2019 |
5260 |
Rhinophyma : une indication majeure du laser |
09/07/2019 |
5259 |
Arrêt cardiorespiratoire hors du milieu hospitalier : quelle évolution des manoeuvres de réanimation au fil des recommandations |
09/07/2019 |
5258 |
RPTH Research and pratice in thrombosis et hemostasis 14 |
09/07/2019 |
5257 |
RPTH Research and pratice in thrombosis et hemostasis 13 |
09/07/2019 |
5256 |
RPTH Research and pratice in thrombosis et hemostasis 113 |
09/07/2019 |
5255 |
RPTH Research and pratice in thrombosis et hemostasis 12 |
09/07/2019 |
5254 |
RPTH Research and pratice in thrombosis et hemostasis 11 |
09/07/2019 |
5253 |
RPTH Research and pratice in thrombosis et hemostasis 10 |
09/07/2019 |
5252 |
RPTH Research and pratice in thrombosis et hemostasis 9 |
09/07/2019 |
5251 |
RPTH Research and pratice in thrombosis et hemostasis 8 |
09/07/2019 |
5250 |
RPTH Research and pratice in thrombosis et hemostasis 7 |
09/07/2019 |
5249 |
RPTH Research and pratice in thrombosis et hemostasis 6 |
09/07/2019 |
5248 |
RPTH Research and pratice in thrombosis et hemostasis 5 |
09/07/2019 |
5247 |
RPTH Research and pratice in thrombosis et hemostasis 5 |
09/07/2019 |
5246 |
RPTH Research and pratice in thrombosis et hemostasis 4 |
09/07/2019 |
5245 |
RPTH Research and pratice in thrombosis et hemostasis 3 |
09/07/2019 |
5244 |
RPTH Research and pratice in thrombosis et hemostasis 2 |
09/07/2019 |
5243 |
Increased vein wall thickness in Behçet disease |
09/07/2019 |
5242 |
Illustrated State?of?the?Art Capsules of the ISTH 2019 Congress in Melbourne, Australia |
09/07/2019 |
5241 |
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy |
09/07/2019 |
5240 |
Recommandations de bonne pratique pourla prise en charge de la maladie veineuse thromboembolique chez l’adulte |
09/07/2019 |
5239 |
Faut-il prescrire plus d’inhibiteurs SGLT-2 |
09/07/2019 |
5238 |
Extended treatment of cancer-associated thrombosis |
09/07/2019 |
5237 |
Extended Anticoagulation for VTE A Systematic Review and Meta-Analysis |
09/07/2019 |
5236 |
Evidence-based medicine et recommandations : la recherche clinique doit évoluer |
09/07/2019 |
5235 |
Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion |
09/07/2019 |
5234 |
Effects of a standardized emergency department protocol on after-hours use of venous duplex ultrasound |
09/07/2019 |
5233 |
Effect of pedometer-based walking interventions on long-term health outcomes: Prospective 4-year follow-up of two randomised controlled trials using routine primary care data |
09/07/2019 |
5232 |
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017 |
09/07/2019 |
5231 |
Diffuse aortoiliac occlusion with formation of extensive collateral circulation in Takayasu’s arteritis |
09/07/2019 |
5230 |
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium |
09/07/2019 |
5229 |
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium |
09/07/2019 |
5228 |
Diabète, cancer et obésité? une relation sans équivoque |
09/07/2019 |
5227 |
Aspirin plus clopidogrel versus aspirin monotherapy for ischemic stroke: a meta-analysis |
09/07/2019 |
5226 |
Analogues du GLP-1 en 2019 : pour qui et comment |
09/07/2019 |
5225 |
RPTH agnellei |
09/07/2019 |
5224 |
A systematic review of high-intensity interval training as an exercise intervention for intermittent claudication |
09/07/2019 |
5223 |
A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE |
09/07/2019 |
5222 |
A Practical Approach to Low-Dose Aspirin for Primary Prevention |
09/07/2019 |
5221 |
RPTH Research and pratice in thrombosis et hemostasis |
09/07/2019 |
5220 |
IWGDF Guideline on the classification of diabetic foot ulcers |
09/07/2019 |
5219 |
IWGDF Guideline on interventions to enhance healing of foot ulcers in persons with diabetes |
09/07/2019 |
5218 |
IWGDF Guideline on the diagnosis and treatment of foot infection in persons with diabetes |
09/07/2019 |
5217 |
IWGDF Guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a foot ulcer and diabetes |
09/07/2019 |
5216 |
IWGDF Guideline on offloading foot ulcers in persons with diabetes |
09/07/2019 |
5215 |
IWGDF Guideline on the prevention of foot ulcers in persons with diabetes Part of the 2019 IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease IWGDF Guidelines |
09/07/2019 |
5214 |
IWGDF Practical guidelines on the prevention and management of diabetic foot disease |
09/07/2019 |
5213 |
Venous thromboembolism risk in psychiatric in-patients: a multicentre cross-sectional study |
08/07/2019 |
5212 |
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction |
08/07/2019 |
5211 |
Use of oral anticoagulant drugs is associated with carotid intraplaque hemorrhage in atherosclerosis patients: a meta?analysis |
08/07/2019 |
5210 |
Update on Clinical Trials of Losartan With andWithout ?-Blockers to Block Aneurysm Growth in PatientsWith Marfan Syndrome |
08/07/2019 |
5209 |
Unique aspects of peripheral artery disease in patients with chronic kidney disease |
08/07/2019 |
5208 |
Comment tester les traitements |
08/07/2019 |
5207 |
Troponine élevée sans infarctus du myocarde |
08/07/2019 |
5206 |
Treatment ofVenousMalformations: The Data,WhereWeAre,andHowItIsDone |
08/07/2019 |
5205 |
Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants |
08/07/2019 |
5204 |
Traitements des angioedèmes héréditaires : recommandations du centre de référence national des angioedèmes (consensus 2014 de Bordeaux) |
08/07/2019 |
5203 |
Traitement des adénomes de la prostate par embolisation |
08/07/2019 |
5202 |
Training the physician of the future |
08/07/2019 |
5201 |
Thirty-day readmission after endovascular or surgical revascularization for chronic mesenteric ischemia: Insights from the Nationwide Readmissions Database |
08/07/2019 |
5200 |
The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis |
08/07/2019 |
5199 |
Télésurveillance et accompagnement thérapeutique des diabétiques: notre devoir de médecin? |
08/07/2019 |
5198 |
Some patients with IBD need thromboprophylaxis after hospitalization |
08/07/2019 |
5197 |
Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial |
08/07/2019 |
5196 |
Short- and long-term mortality after pulmonary embolism in patients with and without cancer |
08/07/2019 |
5195 |
SDF-1 plasmid treatment for patients with peripheral artery disease (STOP-PAD): Randomized, double-blind, placebo-controlled clinical trial |
08/07/2019 |
5194 |
Thrombophilie : investiguer ou ne pas investiguer |
08/07/2019 |
5193 |
Rivaroxaban vs warfarine dans le SAPL à haut risque thrombotique |
08/07/2019 |
5192 |
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction |
08/07/2019 |
5191 |
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis |
08/07/2019 |
5190 |
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis |
08/07/2019 |
5189 |
Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study |
08/07/2019 |
5188 |
Resolving atherosclerosis and Alzheimer disease |
08/07/2019 |
5187 |
Regular use of aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study |
08/07/2019 |
5186 |
Reducing the hospital burden associated with the treatment of pulmonary embolism |
08/07/2019 |
5185 |
Recommendations for Registry Data Collection for Revascularisations of Acute Limb Ischaemia: A Delphi Consensus from the International Consortium of Vascular Registries |
08/07/2019 |
5184 |
Récidive d’AVC cryptogénétique : le risque pourait être diminué par le rivaroxaban en présence d’une oreillette gauche dilatée |
08/07/2019 |
5183 |
Randomized clinical trial of mechanochemical and endovenous thermal ablation of great saphenous varicose veins |
08/07/2019 |
5182 |
Pyoderma gangrenosum mistaken for diabetic ulcer |
08/07/2019 |
5181 |
Prévention CV primaire par statines: les patients britanniques sontils sous-traités |
08/07/2019 |
5180 |
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)—Rationale and Design |
08/07/2019 |
5179 |
Plaque carotidienne : corrélation Histologie – Ultrasonographie (PCUS) – Immunohistochimie. |
08/07/2019 |
5178 |
Pied diabétique Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique |
08/07/2019 |
5177 |
Peroxynitrite-Mediated SIRT (Sirtuin)-1 Inactivation Contributes to Nicotine-Induced Arterial Stiffness in Mice |
08/07/2019 |
5176 |
Periprocedural Interruption of Anticoagulation in Patients with Cancer?Associated VTEAn Analysis of Thrombotic and Bleeding Outcomes |
08/07/2019 |
5175 |
Application of PCSK9 Inhibitors in Practice Part 2: The Patient Experience |
08/07/2019 |
5174 |
Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial |
08/07/2019 |
5173 |
Patient-level adherence and interventions in an interdisciplinary DOAC clinic |
08/07/2019 |
5172 |
Ovid: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events |
08/07/2019 |
5171 |
Outcomes following pancreatic surgery using three different thromboprophylaxis regimens |
08/07/2019 |
5170 |
Outcomes following pancreatic surgery using three different thromboprophylaxis regimens |
08/07/2019 |
5169 |
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack A Systematic Review and Meta-Analysis |
08/07/2019 |
5168 |
Novel cardiovascular risk factors: air pollution, air temperature, pain, and sleep duration |
08/07/2019 |
5167 |
Guideline Summary and Secondary Prevention Recommendations |
08/07/2019 |
5166 |
Meta-analysis of the outcomes of treatment of internal carotid artery near occlusion |
08/07/2019 |
5165 |
Myélome multiplearrêt des inclusions dans tous les essais sur le venetoclax2019 |
08/07/2019 |
5164 |
Meta-analysis of long-term survival after elective endovascular or open repair of abdominal aortic aneurysm |
08/07/2019 |
5163 |
Meta-analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease |
08/07/2019 |
5162 |
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
08/07/2019 |
5161 |
Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to D-dimer results; a cohort study |
08/07/2019 |
5160 |
Le risque cardiovasculaire nettement accru après un choc émotionnel ou physique |
08/07/2019 |
5159 |
Kidney disease in the Global Burden of Disease Study 2017 |
08/07/2019 |
5158 |
Le binge drinking avant 25 ans facteur de risque de dépendance à l’alcool |
08/07/2019 |
5157 |
Dépistage du cancer colorectal : le point sur les recommandations |
08/07/2019 |
5156 |
Innovative Arterial Duplex Examination: A Guide to Evaluate Flow in the Foot Using Pedal Acceleration Time |
08/07/2019 |
5155 |
ICH Risk Increased With Low-Dose Aspirin in Primary Prevention |
08/07/2019 |
5154 |
Hypertension artérielle (HTA) Une a????ection cardiovasculaire fréquente aux conséquences sévères |
08/07/2019 |
5153 |
Hypertension artérielle (HTA) Une a????ection cardiovasculaire fréquente aux conséquences sévères |
08/07/2019 |
5152 |
How to Examine a Vascular Access: Part 2 The Physical Exam |
08/07/2019 |
5151 |
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome |
08/07/2019 |
5150 |
Hemodialysis Catheter Complications (And What To Do About Them) |
08/07/2019 |
5149 |
Golfer’s vasculitis |
08/07/2019 |
5148 |
Gangrène de Fournier : de plus en plus de cas avec les inhibiteurs du SLGT2 |
08/07/2019 |
5147 |
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease |
08/07/2019 |
5146 |
Financial Conflicts of Interest and Authorship of Clinical Practice GuidelinesTrust Is Fragile |
08/07/2019 |
5145 |
Fibrose rétropéritonéale ou maladie d’Ormond |
08/07/2019 |
5144 |
Factors associated with thrombotic complications in pediatric patients with vascular malformations |
08/07/2019 |
5143 |
Factor XI and recurrent venous thrombosis: an observational cohort study |
08/07/2019 |
5142 |
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis |
08/07/2019 |
5141 |
Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis |
08/07/2019 |
5140 |
Evènements à long terme et facteurs pronostiques de complications dans la maladie de Buerger : une étude multicentrique de 224 patients. |
08/07/2019 |
5139 |
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan |
08/07/2019 |
5138 |
Estimating pollution-attributablemortality at the regional and global scales: challenges in uncertainty estimation and causal inference |
08/07/2019 |
5137 |
Endogenous sex hormones and risk of venous thromboembolism in young women |
08/07/2019 |
5136 |
Emborrhoïd : traitement des hémorroïdes par embolisation des artères rectales |
08/07/2019 |
5135 |
Electronic cigarettes |
08/07/2019 |
5134 |
Effects of Aspirin in the Healthy Elderly |
08/07/2019 |
5133 |
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease A Prespecified Analysis From the FOURIER Trial |
08/07/2019 |
5132 |
Effectiveness and safety of selfmanaged oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation |
08/07/2019 |
5131 |
Echographie ciblée aux urgences : état des lieux et concept d’implémentation |
08/07/2019 |
5130 |
“Doctor, Should I Keep Taking an Aspirin a Day?” |
08/07/2019 |
5129 |
Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study |
08/07/2019 |
5128 |
Diabète de type 2: un ancien antipaludique aussi efficace que la canagliflozine? |
08/07/2019 |
5127 |
Deprescribing in Older Adults With Cardiovascular Disease |
08/07/2019 |
5126 |
Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work |
08/07/2019 |
5125 |
Daily Aspirin May Lower Risk for Fatty Liver Progression |
08/07/2019 |
5124 |
Dabigatraninduced esophagitis |
08/07/2019 |
5123 |
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations |
08/07/2019 |
5122 |
Cost-effectiveness analysis of a randomized clinical trial of early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration |
08/07/2019 |
5121 |
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease |
08/07/2019 |
5120 |
L’ESSENTIEL DE LA CHIMIOTHÉRAPIE EN FRANCE EN 2017 |
08/07/2019 |
5119 |
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial |
08/07/2019 |
5118 |
Characteristics in Non–Vitamin K Antagonist Oral Anticoagulant–Related Intracerebral Hemorrhage |
08/07/2019 |
5117 |
Cardiovascular disease burden fromambient air pollution in Europe reassessed using novel hazard ratio functions |
08/07/2019 |
5116 |
Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery |
08/07/2019 |
5115 |
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment |
08/07/2019 |
5114 |
Association of Stroke Among Adults Aged 18 to 49 Years With Long-term Mortality |
08/07/2019 |
5113 |
Association of Life’s Simple 7 with reduced clinically manifest abdominal aortic aneurysm: The ARIC study |
08/07/2019 |
5112 |
Apport de l’échographie dans les tendinopathies |
08/07/2019 |
5111 |
Application of PCSK9 Inhibitors in Practice Challenges and Opportunities |
08/07/2019 |
5110 |
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? |
08/07/2019 |
5109 |
Antiphospholipides (syndrome des SAPL) | SNFMI |
08/07/2019 |
5108 |
Anticoagulation Strategies in Patients With Cancer |
08/07/2019 |
5107 |
Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism |
08/07/2019 |
5106 |
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis |
08/07/2019 |
5105 |
EULAR recommendations for the management of antiphospholipid syndrome in adults |
08/07/2019 |
5104 |
Angioedèmes bradykiniques acquis non médicamenteux |
08/07/2019 |
5103 |
Acetylsalicylic acid on primary prevention of cardiovascular diseases |
08/07/2019 |
5102 |
Editor’s Choice e A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer |
08/07/2019 |
5101 |
A Novel Diagnostic and Prognostic Score for Abdominal Aortic Aneurysms Based on D-Dimer and a Comprehensive Analysis of Myeloid Cell Parameters |
08/07/2019 |
5100 |
ECHO-DOPPLER VASCULAIRE ARTERES ET VEINES |
08/07/2019 |
5099 |
THROMBOSE VEINEUSE EMBOLIE PULMONAIRE évaluation de votre risque |
08/07/2019 |
5098 |
Prévention phlébite |
08/07/2019 |
5097 |
2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol–Secondary Prevention |
08/07/2019 |
5096 |
Exemple de relais préopératoire AVK-héparine en vue d’un acte chirurgical programmé |
08/07/2019 |
5095 |
Why randomized controlled trials do not always reflect reality |
07/07/2019 |
5094 |
Where There Is Smoke, There Is Fire Impact of Air Pollution on HDL (High-Density Lipoprotein) Function and Inflammation |
07/07/2019 |
5093 |
When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis? |
07/07/2019 |
5092 |
The Diagnosis and Management of Venous thromboembolism – Guidelines of the Thrombosis and Haemostasis Society of Australia and New Zealand |
07/07/2019 |
5091 |
Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial |
07/07/2019 |
5090 |
Venous thromboembolism: A clinician update |
07/07/2019 |
5089 |
Updates of Recent Aortic Aneurysm Research |
07/07/2019 |
5088 |
comRECOMMENDATIONSUnresolved questions on venousthromboembolic disease. Consensusstatement of the French Society forVascular Medicine (SFMV) |
07/07/2019 |
5087 |
Traitement médical de l’artériopathie chronique oblitérante des membres inférieurs (AOMI) : la folie des grandeurs |
07/07/2019 |
5086 |
Traitement hormonal de la ménopause : effets osseux et sur la composition corporelle |
07/07/2019 |
5085 |
The Cost of Defensive Medicine on 3 Hospital Medicine Services |
07/07/2019 |
5084 |
Syndrome de l’artère mésenterique supérieure |
07/07/2019 |
5083 |
Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease |
07/07/2019 |
5082 |
Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study |
07/07/2019 |
5081 |
Stents/ballons au paclitaxel dans l’AOMI : des experts européens appellent à préférer des alternatives |
07/07/2019 |
5080 |
Sources of Increased Health Care Spending in the United States |
07/07/2019 |
5079 |
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study |
07/07/2019 |
5078 |
Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study |
07/07/2019 |
5077 |
Retrospective Study of Hemodynamic Changes Before and After Carotid Stenosis Formation by Vessel Surface Repairing |
07/07/2019 |
5076 |
Resurgence in Diabetes-Related Complications |
07/07/2019 |
5075 |
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 |
07/07/2019 |
5074 |
Inégalités de santé selon le sexe pour les maladies cardiovasculaires |
07/07/2019 |
5073 |
Questions non résolues sur la maladiethrombo-embolique veineuse. Consensus dela Société franc¸aise de médecine vasculaire |
07/07/2019 |
5072 |
Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons |
07/07/2019 |
5071 |
Quantifying Importance of Major Risk Factors for Coronary Heart Disease |
07/07/2019 |
5070 |
prevenir_un_premier_accident_cardiovasculaire |
07/07/2019 |
5069 |
Présentation des nouveaux algorithmes de dosage d’ANCA |
07/07/2019 |
5068 |
Popliteal artery entrapment syndrome |
07/07/2019 |
5067 |
Peyronie’s Disease Expert on ‘Erectile Insufficiency’ and New Guide to Safe Sex |
07/07/2019 |
5066 |
Persistance de la veine cave supérieure gauche |
07/07/2019 |
5065 |
Pulmonary Embolism |
07/07/2019 |
5064 |
Paclitaxel-Based Therapies for Patients With Peripheral Artery Disease |
07/07/2019 |
5063 |
Outcomes and management costs of peripheral arterial disease in France |
07/07/2019 |
5062 |
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction |
07/07/2019 |
5061 |
New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism |
07/07/2019 |
5060 |
Neoatherosclerosis – From basic concept to clinical implication |
07/07/2019 |
5059 |
Neoatherosclerosis – From basic concept to clinical implication |
07/07/2019 |
5058 |
Monkeys reject unequal pay Nat |
07/07/2019 |
5057 |
Mise au point sur les sclérodermies très précoces et précoces |
07/07/2019 |
5056 |
MICI : un nouveau facteur de risque cardiovasculaire à prendre en compte |
07/07/2019 |
5055 |
Thrombose associée au cancer : que suggèrent les données les plus récentes concernant les AOD |
07/07/2019 |
5054 |
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy |
07/07/2019 |
5053 |
Low Cholesterol Linked to Higher Hemorrhagic Stroke Risk |
07/07/2019 |
5052 |
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients |
07/07/2019 |
5051 |
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data |
07/07/2019 |
5050 |
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk |
07/07/2019 |
5049 |
Leave No Limb Behind |
07/07/2019 |
5048 |
Large-Vessel Vasculitis Classification: Draft Criteria Presented at ACR/ARHP 2018 |
07/07/2019 |
5047 |
Prévention des thromboses en USI : la compression pneumatique fait pschitt |
07/07/2019 |
5046 |
Pour vivre vieux (en bonne santé), mangeons varié |
07/07/2019 |
5045 |
Où les médecins français se mettent progressivement aux NACOs |
07/07/2019 |
5044 |
Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia – Results from two nationwide cohorts |
07/07/2019 |
5043 |
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events |
07/07/2019 |
5042 |
High incidence and clinical characteristics of fibromuscular dysplasia in patients with spontaneous cervical artery dissection: The ARCADIA-POL study |
07/07/2019 |
5041 |
How vascular surgeons can learn ultrasound SVS2019 |
07/07/2019 |
5040 |
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemiaBlood |
07/07/2019 |
5039 |
Hospitalist assessment of venous thromboembolism and bleeding risk: A survey study |
07/07/2019 |
5038 |
Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants |
07/07/2019 |
5037 |
Lack of Association Between Heart Failure and Incident Cancer |
07/07/2019 |
5036 |
Grossesse: nouvel algorithme diagnos-tique de l’embolie pulmonaire |
07/07/2019 |
5035 |
Four-extremity venous duplex ultrasound for suspected deep venous thrombosis is an anachronism |
07/07/2019 |
5034 |
18F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction |
07/07/2019 |
5033 |
Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials |
07/07/2019 |
5032 |
Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials |
07/07/2019 |
5031 |
Endovascular treatment for multiple aortic narrowings in a patient with Takayasu arteritis |
07/07/2019 |
5030 |
Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum: The JECS Birth Cohort |
07/07/2019 |
5029 |
En prévention cardiovasculaire dite secondaire : ajouter du rivaroxaban à l’aspirine |
07/07/2019 |
5028 |
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials |
07/07/2019 |
5027 |
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT |
07/07/2019 |
5026 |
Effects of body mass index on the safety and effectiveness of direct oral anticoagulants: a retrospective review |
07/07/2019 |
5025 |
Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease |
07/07/2019 |
5024 |
Early Trends Among Seven Recommendations From the Choosing Wisely Campaign |
07/07/2019 |
5023 |
Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism |
07/07/2019 |
5022 |
Dietary components and risk of cardiovascular disease and all-cause mortality: a review of evidence from meta-analyses |
07/07/2019 |
5021 |
 |
07/07/2019 |
5020 |
Diagnosis and Management of Crohn Disease |
07/07/2019 |
5019 |
Determinants of severe post-thrombotic syndrome: The role of thrombus location |
07/07/2019 |
5018 |
Defensive medicine: It is time to finally slow down an epidemic |
07/07/2019 |
5017 |
Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry |
07/07/2019 |
5016 |
Cryoglobulinaemia |
07/07/2019 |
5015 |
Critical Care Ultrasound: A Systematic Review of International Training Competencies and Program |
07/07/2019 |
5014 |
Conciliation médicamenteuse d’entrée en service de médecine interne : retour d’expérience après un an de pratique |
07/07/2019 |
5013 |
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis |
07/07/2019 |
5012 |
Outpatient versus inpatient treatment for acute pulmonary embolism |
07/07/2019 |
5011 |
Carotid web treated with web excision and patch angioplasty |
07/07/2019 |
5010 |
Carotid artery imaging: the study of intra-plaque vascularization and hemorrhage in the era of the “vulnerable” plaque |
07/07/2019 |
5009 |
Cardiovascular Risk Factors Associated With Venous Thromboembolism |
07/07/2019 |
5008 |
Cardio-Oncology: Vascular and Metabolic Perspectives |
07/07/2019 |
5007 |
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors |
07/07/2019 |
5006 |
Caractéristiques des patients de moins et de plus de 75 ans atteints d’artérite à cellules géantes : étude comparative de 164 patients |
07/07/2019 |
5005 |
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy |
07/07/2019 |
5004 |
Blood Flow Lateralization and Collateral Compensatory Mechanisms in Patients With Carotid Artery Stenosis |
07/07/2019 |
5003 |
Benefits of Exercise Training on Coronary Blood Flow in Coronary Artery Disease Patients |
07/07/2019 |
5002 |
Managing clinical knowledge for health care imrovement |
07/07/2019 |
5001 |
Associations of edge-detected and manual-traced common carotid artery intima-media thickness with incident peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis |
07/07/2019 |
5000 |
Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality |
07/07/2019 |
4999 |
Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices |
07/07/2019 |
4998 |
Association of opioid use and peripheral artery disease |
07/07/2019 |
4997 |
Association of Life’s Simple 7 with reduced clinically manifest abdominal aortic aneurysm: The ARIC study |
07/07/2019 |
4996 |
Association Between Push-up Exercise Capacity and Future Cardiovascular Events Among Active Adult Men |
07/07/2019 |
4995 |
Arterial thromboembolic events preceding the diagnosis of cancer in older persons |
07/07/2019 |
4994 |
Arterial Inflammation The Heat Before the Storm |
07/07/2019 |
4993 |
Antithrombotics in stable peripheral artery disease |
07/07/2019 |
4992 |
Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism |
07/07/2019 |
4991 |
 |
07/07/2019 |
4990 |
Angiomes superficiels : traitements |
07/07/2019 |
4989 |
Age but not sex is associated with higher risk of in-hospital stroke or death after carotid artery stenting in symptomatic and asymptomatic carotid stenosis |
07/07/2019 |
4988 |
Anticoagulation Strategies in Patients With Cancer |
07/07/2019 |
4987 |
Absence of Coronary Artery Calcium Identifies Asymptomatic Diabetic Individuals at Low Near-Term But Not Long-Term Risk |
07/07/2019 |
4986 |
Spécificités du risque cardiovasculaire de la femme : comment améliorer la prise en charge |
07/07/2019 |
4985 |
Recours à la biothérapie dans la prise en charge de la maladie de Behçet dans un service de médecine interne |
07/07/2019 |
4984 |
 |
07/07/2019 |
4983 |
Why randomized controlled trials do not always reflect reality |
04/07/2019 |
4982 |
Where There Is Smoke, There Is Fire Impact of Air Pollution on HDL (High-Density Lipoprotein) Function and Inflammation |
04/07/2019 |
4981 |
When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis? |
04/07/2019 |
4980 |
What is ‘LDL cholesterol’? |
04/07/2019 |
4979 |
What is ‘LDL cholesterol’? |
04/07/2019 |
4978 |
Were High-Risk Patients the Wrong Targets in CASSINI and AVERT? |
04/07/2019 |
4977 |
Current Understanding and Gaps in Research of CarotidWebs in Ischemic Strokes |
04/07/2019 |
4976 |
Venous thromboembolism in young adults: Findings from the RIETE registry |
04/07/2019 |
4975 |
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants |
04/07/2019 |
4974 |
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation |
04/07/2019 |
4973 |
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications |
04/07/2019 |
4972 |
Variation in the elective management of small abdominal aortic aneurysms and physician practice patterns |
04/07/2019 |
4971 |
Updates of Recent Aortic Aneurysm Research |
04/07/2019 |
4970 |
Une cause inhabituelle d’oedème du membre supérieur |
04/07/2019 |
4969 |
Underdosing of direct oral anticoagulants harmful in AF |
04/07/2019 |
4968 |
Ultrasound assessment of carotid arteries: Current concepts, methodologies, diagnostic criteria, and technological advancements |
04/07/2019 |
4967 |
Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials |
04/07/2019 |
4966 |
THEMIS Top-Line Results: Ticagrelor Cuts CV Event Risk in Diabetics With Coronary Disease |
04/07/2019 |
4965 |
The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures |
04/07/2019 |
4964 |
The remarkable story of awonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin! |
04/07/2019 |
4963 |
The problem of under-diagnosis and over-diagnosis of pulmonary embolism |
04/07/2019 |
4962 |
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk |
04/07/2019 |
4961 |
Suspicion de coronaropathie chez le diabétique: faut-il privilégier le coroscanner? |
04/07/2019 |
4960 |
Deep Vein Thrombosis in Los Angeles Lakers Forward Could Indicate Thoracic Outlet Syndrome |
04/07/2019 |
4959 |
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study |
04/07/2019 |
4958 |
Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence |
04/07/2019 |
4957 |
Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASP |
04/07/2019 |
4956 |
Risk Assessment and Management of Venous Thromboembolism inWomen during Pregnancy and Puerperium (SAVE): An International, Cross-sectional Study |
04/07/2019 |
4955 |
Abdominal aortic aneurysm: update on pathogenesis and medical treatments |
04/07/2019 |
4954 |
PCSK9 inhibitors: clinical evidence and implementation |
04/07/2019 |
4953 |
Research Misconduct Identified by the US Food and Drug Administration |
04/07/2019 |
4952 |
Reducing the hospital burden associated with the treatment of pulmonary embolism |
04/07/2019 |
4951 |
Recurrence Risk after First Symptomatic Distal versus Proximal Deep Vein Thrombosis According to Baseline Risk Factors |
04/07/2019 |
4950 |
Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry |
04/07/2019 |
4949 |
Quel traitement antithrombotique optimal après SCA et/ou angioplastie chez des patients ayant une FA ? Les résultats d’AUGUSTUS |
04/07/2019 |
4948 |
Progress in the monitoring of direct oral anticoagulant therapy |
04/07/2019 |
4947 |
primary prevention lifestyle changes and team based care |
04/07/2019 |
4946 |
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease |
04/07/2019 |
4945 |
PREDICTIVE VALUE OF DUPLEX ULTRASOUND FOR SIGNIFICANT IN-STENT RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL RENAL ARTERY STENT PLACEMENT: A PROPENSITY SCORE MATCHING ANALYSIS |
04/07/2019 |
4944 |
Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons |
04/07/2019 |
4943 |
POST-ACUTE CORONARY SYNDROME PATIENTS WITH POLYVASCULAR DISEASE DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: ODYSSEY OUTCOMES |
04/07/2019 |
4942 |
Platelet biology and functions: new concepts and clinical perspectives |
04/07/2019 |
4941 |
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention |
04/07/2019 |
4940 |
Patterns of direct oral anticoagulant drug prescription in France in 2010–2013: a study in the Midi-Pyrénées area |
04/07/2019 |
4939 |
Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial |
04/07/2019 |
4938 |
Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease |
04/07/2019 |
4937 |
Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis |
04/07/2019 |
4936 |
Multimodality Imaging in Carotid Web |
04/07/2019 |
4935 |
Microvascular Response to the Roos Test Has Excellent Feasibility and Good Reliability in Patients With Suspected Thoracic Outlet Syndrome |
04/07/2019 |
4934 |
Meta-analysis of negative pressure wound therapy of closed groin incisions in arterial surgery |
04/07/2019 |
4933 |
Thrombose associée au cancer : que suggèrent les données les plus récentes concernant les AOD ? |
04/07/2019 |
4932 |
Magnitude of Venous Thromboembolism Risk in US Hospitals: Impact of Evolving National Guidelines for Prevention of Venous Thromboembolism |
04/07/2019 |
4931 |
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study |
04/07/2019 |
4930 |
Long-term psychosocial impact of venous thromboembolism: a qualitative study in the community |
04/07/2019 |
4929 |
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk |
04/07/2019 |
4928 |
Level of Scientific Evidence Underlying the Current American College of Cardiology/ American Heart Association Clinical Practice Guidelines |
04/07/2019 |
4927 |
Un risque plus élevé de thromboses veineuses mais aussi artérielles en cas de cancer |
04/07/2019 |
4926 |
La thrombolyse est efficace même pour les EP hémodynamiquement instables ! |
04/07/2019 |
4925 |
Association ofWarfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years |
04/07/2019 |
4924 |
Is it reasonable to use a lower DOAC dose in some patients with VTE_ NOIEM2017 |
04/07/2019 |
4923 |
Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: A new challenge for personalized therapy |
04/07/2019 |
4922 |
Increased vein wall thickness in Behçet disease |
04/07/2019 |
4921 |
How much medicine is too much? |
04/07/2019 |
4920 |
Heart Failure Cancer JACC2019 |
04/07/2019 |
4919 |
Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials |
04/07/2019 |
4918 |
Evaluation of the Inclusion of Studies Identified by theFDAasHaving FalsifiedData in theResults ofMeta-analyses: The Example of the Apixaban Trials |
04/07/2019 |
4917 |
Étude CASSINI : le rivaroxaban peine à démontrer son bénéfice dans certaines situations spécifiques… |
04/07/2019 |
4916 |
Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review |
04/07/2019 |
4915 |
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial |
04/07/2019 |
4914 |
Medial vascular calcification revisited: review and perspectives |
04/07/2019 |
4913 |
Aspirine et prévention cardio-vasculaire primaire et secondaire, certitudes et incertitudes |
04/07/2019 |
4912 |
Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials |
04/07/2019 |
4911 |
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT |
04/07/2019 |
4910 |
Direct oral anticoagulants: When to consider laboratory testing? |
04/07/2019 |
4909 |
Is it reasonable to use a lower DOAC dose in some patients with VTE? NO |
04/07/2019 |
4908 |
Deep vein thrombosis in a well-trained masters cyclist, is popliteal vein entrapment syndrome to blame? |
04/07/2019 |
4907 |
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial |
04/07/2019 |
4906 |
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice |
04/07/2019 |
4905 |
Cardio-Oncology: Vascular and Metabolic Perspectives |
04/07/2019 |
4904 |
Canakinumab: Promises and Future in Cardiometabolic Diseases and Malignancy |
04/07/2019 |
4903 |
Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy |
04/07/2019 |
4902 |
Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism |
04/07/2019 |
4901 |
Betrixaban: Safely Reducing Venous Thromboembolic Events with Extended Prophylaxis |
04/07/2019 |
4900 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty |
04/07/2019 |
4899 |
ARTERIAL STIFFNESS ASSESSMENT BY SHEAR WAVE ELASTOGRAPHY AND ULTRAFAST PULSE WAVE IMAGING: COMPARISON WITH REFERENCE TECHNIQUES IN NORMOTENSIVES AND HYPERTENSIVES |
04/07/2019 |
4898 |
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation |
04/07/2019 |
4897 |
Antiphospholipid Syndrome: Can the Direct Oral Anticoagulants Be Used? |
04/07/2019 |
4896 |
Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review |
04/07/2019 |
4895 |
Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism |
04/07/2019 |
4894 |
Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid |
04/07/2019 |
4893 |
anticoagulant_oral_dans_la_fibrillation_auriculaire |
04/07/2019 |
4892 |
ANNEXA-4 : l’efficacité de l’andexanet alfa sur les hémorragies majeures confirmée |
04/07/2019 |
4891 |
An Aspirin a Day? Not for All |
04/07/2019 |
4890 |
Feu vert pour l’andexanet, antidote des anticoagulants apixaban et rivaroxaban |
04/07/2019 |
4889 |
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events |
04/07/2019 |
4888 |
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack |
04/07/2019 |
4887 |
Activité physique, prévention et traitement des maladies chroniques |
04/07/2019 |
4886 |
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary |
04/07/2019 |
4885 |
Anticoagulation Strategies in Patients With Cancer |
04/07/2019 |
4884 |
Abdominal Aortic Aneurysm Screening Is Safe yet Lacks Effectiveness |
04/07/2019 |
4883 |
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary |
04/07/2019 |
4882 |
Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial |
04/07/2019 |
4881 |
ULTRASOUND WITH MICROBUBBLE CONTRAST AGENT AND UROKINASE FOR THROMBOSIS |
04/07/2019 |
4880 |
Treatment of bleeding complications in patients on anticoagulant therapy |
27/06/2019 |
4879 |
Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism |
27/06/2019 |
4878 |
Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis |
27/06/2019 |
4877 |
Venous thromboembolism and cancer: Current and future role of directacting oral anticoagulants |
27/06/2019 |
4876 |
Extended treatment of venous thromboembolism: a systematic review and network meta-analysis |
27/06/2019 |
4875 |
Venous Leg Ulcer Clinical Practice Guidelines: What is AGREEd? |
27/06/2019 |
4874 |
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease |
27/06/2019 |
4873 |
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study |
27/06/2019 |
4872 |
Treatment of popliteal vein aneurysms |
27/06/2019 |
4871 |
Testing for heritable thrombophilia in acute venous thromboembolism |
27/06/2019 |
4870 |
The intrinsic prognostic value of the ankle–brachial index is independent from its mode of calculation |
27/06/2019 |
4869 |
TheComparisonofInappropriate-Low-DosesUseamong4DirectOralAnticoagulantsinPatientswithAtrialFibrillation:FromtheDatabaseofaSingle-CenterRegistry |
27/06/2019 |
4868 |
Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management |
27/06/2019 |
4867 |
Sudden Cardiac Death in Women Causes of Death, Autopsy Findings, and Electrocardiographic Risk Markers |
27/06/2019 |
4866 |
Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016 |
27/06/2019 |
4865 |
Recommandations de bonne pratique pourla prise en charge de la maladie veineusethromboembolique chez l’adulte. Versioncourte |
27/06/2019 |
4864 |
Progressive Guidance on the Modern Management of Abdominal Aorto-iliac Artery Aneurysms |
27/06/2019 |
4863 |
Post-thrombotic syndrome: Short and long-term incidence and risk factors |
27/06/2019 |
4862 |
Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and metaanalysis |
27/06/2019 |
4861 |
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease A Secondary Analysis of the EUCLID Trial |
27/06/2019 |
4860 |
Perioperative management of anticoagulant and antiplatelet therapy |
27/06/2019 |
4859 |
Pediatric deep venous thrombosis |
27/06/2019 |
4858 |
Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism |
27/06/2019 |
4857 |
Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study |
27/06/2019 |
4856 |
Novel Antiplatelet Therapies for Atherothrombotic Diseases |
27/06/2019 |
4855 |
Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world |
27/06/2019 |
4854 |
Nailfold videocapillaroscopy changes in Takayasu arteritis and their association with disease activity and subclavian artery involvement |
27/06/2019 |
4853 |
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism |
27/06/2019 |
4852 |
Editor’s Choice e Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm |
27/06/2019 |
4851 |
Management of Cardiovascular Disease in Women With Breast Cancer |
27/06/2019 |
4850 |
Macrovascular disease: pathogenesis and risk assessment |
27/06/2019 |
4849 |
Johnson and Johnson will be first US pharma company to reveal a drug’s price in TV advertisement |
27/06/2019 |
4848 |
Un risque accru d’athérosclérose infraclinique diffuse quand on dort peu et mal |
27/06/2019 |
4847 |
La prévention primaire, un évangile selon Saint-Thomas |
27/06/2019 |
4846 |
La croissance des anévrismes de l’aorte thoracique serait accélérée chez les femmes |
27/06/2019 |
4845 |
Des anticoagulants oraux pour prévenir les thromboses liées au cancer |
27/06/2019 |
4844 |
Cholestérol : facteurs de risque personnalisés et nouveaux traitements |
27/06/2019 |
4843 |
Ischaemic heart disease and pregnancy |
27/06/2019 |
4842 |
Is venous thromboembolism a problem in patients with cancer in palliative care? |
27/06/2019 |
4841 |
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs |
27/06/2019 |
4840 |
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial |
27/06/2019 |
4839 |
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial |
27/06/2019 |
4838 |
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events |
27/06/2019 |
4837 |
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women |
27/06/2019 |
4836 |
If Trousseau had a stroke |
27/06/2019 |
4835 |
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding |
27/06/2019 |
4834 |
How to prescribe loop diuretics in oedema Steven |
27/06/2019 |
4833 |
How I treat low von Willebrand factor levels |
27/06/2019 |
4832 |
Haematological management of major bleeding associated with direct oral anticoagulants – UK experience |
27/06/2019 |
4831 |
2018 AHA/ACC/AACVPR/AAPA/ ABC/ACPM/ADA/AGS/APhA/ASPC/ NLA/PCNA Guideline on the Management of Blood Cholesterol |
27/06/2019 |
4830 |
Fibromuscular Dysplasia and Its Neurologic Manifestations A Systematic Review |
27/06/2019 |
4829 |
Extended treatment of venous thromboembolism: a systematic review and network meta-analysis |
27/06/2019 |
4828 |
Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials |
27/06/2019 |
4827 |
Exercise?based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator |
27/06/2019 |
4826 |
Evidence-Based Medicine and the American Thoracic Society Clinical Practice Guidelines |
27/06/2019 |
4825 |
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy |
27/06/2019 |
4824 |
Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation |
27/06/2019 |
4823 |
ClinicianÕs Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2 |
27/06/2019 |
4822 |
EFFECTIVENESS AND SAFETY OF OFF-LABEL DOSE-REDUCED DIRECT ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION |
27/06/2019 |
4821 |
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight |
27/06/2019 |
4820 |
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight |
27/06/2019 |
4819 |
Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer |
27/06/2019 |
4818 |
Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry |
27/06/2019 |
4817 |
Creatine Supplementation and Venous Thrombotic Events |
27/06/2019 |
4816 |
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families |
27/06/2019 |
4815 |
Carotid Artery Echolucency, Texture Features, and Incident Cardiovascular Disease Events: The MESA Study |
27/06/2019 |
4814 |
Cardiovascular Risk Factors Associated With Venous Thromboembolism |
27/06/2019 |
4813 |
Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications |
27/06/2019 |
4812 |
Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications |
27/06/2019 |
4811 |
Caractéristiques des patients de moins et de plus de 75 ans atteintsd’artérite à cellules géantes : étude comparative de 164 patients |
27/06/2019 |
4810 |
Caractéristiques des patients de moins et de plus de 75 ans atteintsd’artérite à cellules géantes : étude comparative de 164 patients |
27/06/2019 |
4809 |
Beyond the AAA Guidelines: Core Outcome Sets to Make Life Better for Patients |
27/06/2019 |
4808 |
Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes A Secondary Analysis of the PLCO Cancer Screening Trial |
27/06/2019 |
4807 |
Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank |
27/06/2019 |
4806 |
Association between the Number of Childbirths and the Progress of Atherosclerosis among Women with Diabetes: A Cohort Study Based on Chinese Population |
27/06/2019 |
4805 |
Association Between Self-rated Health, Coronary Artery CalciumScores, and Atherosclerotic Cardiovascular Disease Risk |
27/06/2019 |
4804 |
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease |
27/06/2019 |
4803 |
Artificial intelligence for cancer-associated thrombosis risk assessment |
27/06/2019 |
4802 |
Arterial thromboembolic events preceding the diagnosis of cancer in older persons |
27/06/2019 |
4801 |
Antithrombotics in stable peripheral artery disease |
27/06/2019 |
4800 |
Antithrombotic Agents New Directions in Antithrombotic Therapy |
27/06/2019 |
4799 |
Antiplatelets, Anticoagulants Similar After Cervical Dissection |
27/06/2019 |
4798 |
Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism |
27/06/2019 |
4797 |
Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act |
27/06/2019 |
4796 |
Anticoagulants in frail patients. Seven situations at risk |
27/06/2019 |
4795 |
Andexanet Alfa: More garbage science in the New England Journal of Medicine |
27/06/2019 |
4794 |
Andexanet Alfa: More garbage science in the New England Journal of Medicine |
27/06/2019 |
4793 |
Analyse post-hoc de SCOT-HEART : le coro-scanner marque un point dans l’évaluation de l’angor stable |
27/06/2019 |
4792 |
AL-SAMKARI AND CONNORS |
27/06/2019 |
4791 |
Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis |
27/06/2019 |
4790 |
2018 ESC Guidelines for the diagnosis and management of syncope |
27/06/2019 |
4789 |
Recommandations de bonne pratique pourla prise en charge de la maladie veineusethromboembolique chez l’adulte. Versioncourte |
27/06/2019 |
4788 |
“Four weddings and …” |
27/06/2019 |
4787 |
Le traitement des statines doit être personnalisé |
27/06/2019 |
4786 |
Why Is Nonadherence to Cancer Screening AssociatedWith IncreasedMortality? |
26/06/2019 |
4785 |
Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories |
26/06/2019 |
4784 |
UNDERUTILIZATION OF ASPIRIN IN PATIENTS WITH ADVANCED COLORECTAL POLYPS |
26/06/2019 |
4783 |
Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis |
26/06/2019 |
4782 |
Impact of Conventional Stroke Risk Factors on Stroke in Women |
26/06/2019 |
4781 |
Focused Update of Sex Differences in Patient Reported Outcome Measures After Stroke |
24/06/2019 |
4780 |
Preeclampsia Association With Posterior Reversible Encephalopathy Syndrome and Stroke |
24/06/2019 |
4779 |
Stroke Risk Factors Unique to Women |
24/06/2019 |
4778 |
Statin use improves limb salvage after intervention for peripheral arterial disease |
24/06/2019 |
4777 |
 |
24/06/2019 |
4776 |
Sprint mind Effect of intensive vs standard blood ppressure control on probable Dementia |
24/06/2019 |
4775 |
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial |
24/06/2019 |
4774 |
Risk factors associated with pain in patients with venous malformations of the extremities |
24/06/2019 |
4773 |
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy |
24/06/2019 |
4772 |
Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis |
24/06/2019 |
4771 |
Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis |
24/06/2019 |
4770 |
Recommendations on thromboprophylaxis in major joint arthroplasty – many guidelines, little consensus |
24/06/2019 |
4769 |
Racial Differences in Sudden Cardiac Death Atherosclerosis Risk in Communities Study |
24/06/2019 |
4768 |
Questions non résolues sur la maladie thrombo-embolique veineuse. Consensus de la Société française de médecine vasculaire |
24/06/2019 |
4767 |
Proton pump inhibitors |
24/06/2019 |
4766 |
Pearls and Myths in the Evaluation of Patients with Suspected Acute Pulmonary Embolism |
24/06/2019 |
4765 |
Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis |
24/06/2019 |
4764 |
Outcomes beyond the Third Month of Anticoagulation in Patients Aged _75 Years with a First Episode of Unprovoked Venous Thromboembolism |
24/06/2019 |
4763 |
Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation |
24/06/2019 |
4762 |
Non-invasive ultrasound-based imaging of atherosclerosis |
24/06/2019 |
4761 |
New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism |
24/06/2019 |
4760 |
Nature Reviews Disease Primers |
24/06/2019 |
4759 |
Modifiable Risk Factors in Young Adults With First Myocardial Infarction |
24/06/2019 |
4758 |
Major Bleeding Rates in Atrial Fibrillation |
24/06/2019 |
4757 |
Long-term psychosocial impact of venous thromboembolism |
24/06/2019 |
4756 |
La grippe – mise au point pour les cliniciens |
24/06/2019 |
4755 |
La cigarette électronique efficace pour sortir du tabagisme, selon un essai randomisé |
24/06/2019 |
4754 |
Juxtaluminal hypoechoic area in ultrasonic images of carotid plaques and hemispheric symptoms |
24/06/2019 |
4753 |
Les AVC en France, il faut encore des progrès |
24/06/2019 |
4752 |
HTAP post-embolique et SAOS font mauvais ménage |
24/06/2019 |
4751 |
Ischaemic heart disease and pregnancy Heart |
24/06/2019 |
4750 |
International diabetes federation |
24/06/2019 |
4749 |
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding |
24/06/2019 |
4748 |
Hospital admission on weekends for patients who have surgery and 30-day mortality in Ontario, CanadaA matched cohort study |
24/06/2019 |
4747 |
holesterol-Lowering Agents Statins—For Everyone |
24/06/2019 |
4746 |
Higher VTE Risk Associated Most With Older Age, Smoking, and Adiposity |
24/06/2019 |
4745 |
High Risk of Major Bleeding Observed in Danish A-fib Population on Triple, Dual Antithrombotic Therapy |
24/06/2019 |
4744 |
Giant, 20 cm Diameter, Ruptured Abdominal Aortic Aneurysm: A Case Report |
24/06/2019 |
4743 |
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors |
24/06/2019 |
4742 |
Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum: The JECS Birth Cohort |
24/06/2019 |
4741 |
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials |
24/06/2019 |
4740 |
Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease |
24/06/2019 |
4739 |
Primeview obesity |
24/06/2019 |
4738 |
Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: A Systematic Review and Meta-Analysis |
24/06/2019 |
4737 |
Diagnostic de l’embolie pulmonaire |
24/06/2019 |
4736 |
Cost-effectiveness of targeted screening for abdominal aortic aneurysm in siblings |
24/06/2019 |
4735 |
Coronary Embolus An Underappreciated Cause of Acute Coronary Syndromes |
24/06/2019 |
4734 |
Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation |
24/06/2019 |
4733 |
Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and Interna |
24/06/2019 |
4732 |
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families |
24/06/2019 |
4731 |
Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families |
24/06/2019 |
4730 |
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study |
24/06/2019 |
4729 |
Atherothrombosis Drugs Compendium |
24/06/2019 |
4728 |
Atypical Carotid Origin of the Vertebral Artery |
24/06/2019 |
4727 |
Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes A Secondary Analysis of the PLCO Cancer Screening Trial |
24/06/2019 |
4726 |
Aspirin to Prevent Sudden Cardiac Death in Athletes with High Coronary Artery Calcium Scores |
24/06/2019 |
4725 |
Antithrombotic Agents New Directions in Antithrombotic Therapy |
24/06/2019 |
4724 |
Antiphospholipid Syndrome |
24/06/2019 |
4723 |
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy |
24/06/2019 |
4722 |
 |
24/06/2019 |
4721 |
Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism |
23/06/2019 |
4720 |
Utility of current thrombophilia screening in young patients with stroke and TIA |
23/06/2019 |
4719 |
Treatment of cancer-associated thrombosis |
23/06/2019 |
4718 |
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases |
23/06/2019 |
4717 |
Stroke and Cerebrovascular Disease in Pregnancy Incidence, Temporal Trends, and Risk Factors |
23/06/2019 |
4716 |
Smoking is Associated with Increased Risk of Major Bleeding: A Prospective Cohort Study |
23/06/2019 |
4715 |
Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis |
23/06/2019 |
4714 |
Sex may matter when it comes to the presenting location of deep vein thrombosis |
23/06/2019 |
4713 |
Safety of Men with Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the National Health Service Screening Programme |
23/06/2019 |
4712 |
Les biosimilaires en France, bien en comprendre les enjeux pour bien les utiliser |
23/06/2019 |
4711 |
Anatomie échographique abdominale de base |
23/06/2019 |
4710 |
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs |
23/06/2019 |
4709 |
Presentation, diagnosis, and management of popliteal artery entrapment syndrome: 11 years of experience with 61 legs |
23/06/2019 |
4708 |
Predictors of stent thrombosis and their implications for clinical practice |
23/06/2019 |
4707 |
Plus d’accidents artério-thrombotiques dans l’année qui précède un cancer |
23/06/2019 |
4706 |
Patient organizations and conflict of interest |
23/06/2019 |
4705 |
ASH Annual Meeting |
23/06/2019 |
4704 |
PADUA score as a predictor for pulmonary embolism: a potential strategy for reducing unnecessary imaging |
23/06/2019 |
4703 |
Optimal Exercise Programs for Patients With Peripheral Artery Disease A Scientific |
23/06/2019 |
4702 |
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer |
23/06/2019 |
4701 |
Modalités de relais des traitements anticoagulants |
23/06/2019 |
4700 |
Faut-il arrêter les antiagrégants plaquettaires avant une opération non cardiaque ? |
23/06/2019 |
4699 |
Mesure de la pression artérielle : nouvelles recommandations, ce qui change |
23/06/2019 |
4698 |
Low reproducibility of the diagnosis of subsegmental pulmonary embolism in symptomatic patients |
23/06/2019 |
4697 |
Les biosimilaires en Médecine Interne : bien les connaître pour bien les prescrire |
23/06/2019 |
4696 |
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis |
23/06/2019 |
4695 |
Le THS, par voie transdermique de préférence |
23/06/2019 |
4694 |
L’impact de l’âge sur la relation SAOS et complications cardiovasculaires |
23/06/2019 |
4693 |
ISSVA classification for vascular anomalies |
23/06/2019 |
4692 |
Initial result of an angioscopy-guided wire crossing technique under continuous saline infusion for chronic total occlusion in femoropopliteal disease |
23/06/2019 |
4691 |
Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis |
23/06/2019 |
4690 |
Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems |
23/06/2019 |
4689 |
The best direct-acting oral anticoagulant for treatment of venous thromboembolism? |
23/06/2019 |
4688 |
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism |
23/06/2019 |
4687 |
EFFECT OF ANTICOAGULANT TREATMENT ON PAIN IN DISTAL DEEP VEIN THROMBOSIS: AN ANCILLARY ANALYSIS FROM THE CACTUS TRIAL |
23/06/2019 |
4686 |
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis |
23/06/2019 |
4685 |
Asymptomatic cerebral infarction is a predictor of long-termsurvival and vascular or limb events in peripheral arterial disease |
23/06/2019 |
4684 |
Association of Sleep Duration and Quality With Subclinical Atherosclerosis |
23/06/2019 |
4683 |
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial |
23/06/2019 |
4682 |
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial |
23/06/2019 |
4681 |
ACC AHA SCAI SIR SVM 2018 AOMI INTERVENTION |
23/06/2019 |
4680 |
Replication, Duplication, and Waste in a Quarter Million Systematic Reviews and Meta-Analyses |
09/01/2019 |
4679 |
Overview of Systematic Reviews of Non– Vitamin K Oral Anticoagulants in Atrial Fibrillation |
09/01/2019 |
4678 |
Tests ADN sous le sapin : un cadeau empoisonné ? |
09/01/2019 |
4677 |
In-FlightMedical Emergencies |
09/01/2019 |
4676 |
Gestion desagentsantiplaquettairespour une procédureinvasiveprogrammée. PropositionsduGrouped’intérêt en hémostasepériopératoire(GIHP) et duGroupefrançaisd’étudessur l’hémostase etlathrombose(GFHT) en collaborationaveclaSociétéfrançaise d’anesthésie-réani |
09/01/2019 |
4675 |
Future of Personalized Cardiovascular Medicine |
09/01/2019 |
4674 |
EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS |
09/01/2019 |
4673 |
Extreme Hypertriglyceridemia Confers High Cardiovascular Risk Regardless of Genetics |
09/01/2019 |
4672 |
Optimizing the Technique of Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts |
09/01/2019 |
4671 |
Direct oral anticoagulants in extremely obese patients: OK to use? |
09/01/2019 |
4670 |
Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review |
09/01/2019 |
4669 |
Contemporary Management and Outcomes of Patients with Massive and Submassive Pulmonary Embolism |
09/01/2019 |
4668 |
Arterial Thromboembolic Events Preceding the Diagnosis of Cancer in Older Persons |
09/01/2019 |
4667 |
Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities – Systematic Review |
09/01/2019 |
4666 |
The Top Cardiology Trials of 2018 in Review |
09/01/2019 |
4665 |
The Role of Statins in Cancer Therapy |
09/01/2019 |
4664 |
The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence |
09/01/2019 |
4663 |
Screening for Cardiovascular Disease. Too Early and Too Late? |
09/01/2019 |
4662 |
Clinical Haemostasis and Thrombosis |
09/01/2019 |
4661 |
Optimal Exercise Programs for Patients With Peripheral Artery Disease |
09/01/2019 |
4660 |
Management of recurrent venous thromboembolism in patients with cancer: A review |
09/01/2019 |
4659 |
Embolie pulmonaire massive ou presque : quel pronostic et quel traitement ? |
09/01/2019 |
4658 |
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial |
09/01/2019 |
4657 |
DTC FOP |
09/01/2019 |
4656 |
Deep vein thrombosis in a well-trained masters cyclist, is popliteal vein entrapment syndrome to blame? |
09/01/2019 |
4655 |
Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and Interna |
09/01/2019 |
4654 |
Blood Grouping Identifies Patients at Risk for Developing Venous Thromboembolism |
09/01/2019 |
4653 |
Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past? |
09/01/2019 |
4652 |
The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial |
09/01/2019 |
4651 |
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis |
09/01/2019 |
4650 |
Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants |
09/01/2019 |
4649 |
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes |
09/01/2019 |
4648 |
Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction |
09/01/2019 |
4647 |
Hypertension et dysfonction érectile : les nouvelles recommandations de la SFHTA |
09/01/2019 |
4646 |
Evaluation of patency rates of different lymphaticovenous anastomosis techniques and risk factors for obstruction in secondary upper extremity lymphedema |
09/01/2019 |
4645 |
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial |
09/01/2019 |
4644 |
Can heart failure cause cancer? |
09/01/2019 |
4643 |
DIABETES |
09/01/2019 |
4642 |
GARFIELD-VTE Taking a real-world deep dive into VTE |
09/01/2019 |
4641 |
Peripheral-Artery-Disease |
09/01/2019 |
4640 |
MEDICATION ADHERENCE |
09/01/2019 |
4639 |
Diversities |
09/01/2019 |
4638 |
 |
09/01/2019 |
4637 |
Traitement médical optimal de l’artériopathie oblitérante des membres inférieurs en 2018 |
06/01/2019 |
4636 |
Analysis ofclinicalfactors affecting theratesoffatal pulmonary embolismand bleeding incancerpatients with venousthromboembolism |
06/01/2019 |
4635 |
Malformations artérioveineuses : prise en charge complexe |
06/01/2019 |
4634 |
Les traitements anticoagulants oraux chez les personnes âgées : faut-il encore prescrire des antivitamines K ? |
06/01/2019 |
4633 |
Antithrombotiques dans le syndrome des anticorps antiphospholipides thrombotique |
06/01/2019 |
4632 |
Simultaneous Multi-Supra-Aortic Artery Bypass Successfully Implemented in 17 Patients with Type I Takayasu Arteritis |
06/01/2019 |
4631 |
Patients with Peripheral Artery Disease in the COMPASS Trial |
06/01/2019 |
4630 |
European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms |
06/01/2019 |
4629 |
Editor’s Choice e Direct vs. Indirect Angiosomal Revascularisation of Infrapopliteal Arteries, an Updated Systematic Review and Meta-analysis |
06/01/2019 |
4628 |
Influence of multiple stents on periprocedural stroke after carotid artery stenting in the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) |
06/01/2019 |
4627 |
Analysis of Effect of National Institute for Health and Care Excellence Clinical Guideline CG168 on Management of Varicose Veins in Primary Care Using the Health Improvement Network Database |
06/01/2019 |
4626 |
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial |
06/01/2019 |
4625 |
Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial |
06/01/2019 |
4624 |
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia |
06/01/2019 |
4623 |
Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction |
06/01/2019 |
4622 |
NICE draft guideline casts shadow over EVAR for unruptured aneurysms |
06/01/2019 |
4621 |
Management of venous thromboembolism in patients with cancer |
06/01/2019 |
4620 |
Low-molecular weight heparin or direct oral anticoagulants for the treatment of cancer associated thrombosis. Are we at the crossroad? |
06/01/2019 |
4619 |
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A costeffectiveness analysis from the publicly funded health care systems |
06/01/2019 |
4618 |
How I treat cancer-associated venous thromboembolism |
06/01/2019 |
4617 |
Thromboangiitis Obliterans: 110 Years Old and Little Progress Made |
06/01/2019 |
4616 |
Dysfonction érectile, une prise en charge urologique et multidisciplinaire |
06/01/2019 |
4615 |
Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus |
06/01/2019 |
4614 |
Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger’s Disease): A Multicenter Study of 224 Patients |
06/01/2019 |
4613 |
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial |
06/01/2019 |
4612 |
Venous thrombosis following lower-leg cast immobilization and knee arthroscopy: From a population-based approach to individualized therapy |
06/01/2019 |
4611 |
The incidence of carotid in-stent stenosis is underestimated $50% or $80% and its clinical implications |
06/01/2019 |
4610 |
Survival after abdominal aortic aneurysm repair is affected by socioeconomic status |
06/01/2019 |
4609 |
Statin Safety and Associated Adverse Events A Scientific Statement From the American Heart Association |
06/01/2019 |
4608 |
Role of PCSK9 inhibition continues to evolve |
06/01/2019 |
4607 |
Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry |
06/01/2019 |
4606 |
Meta-Analysis of Venous Thromboembolism Prophylaxis in Medically Ill Patients |
06/01/2019 |
4605 |
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients |
06/01/2019 |
4604 |
How to do a 3-minute diabetic foot exam |
06/01/2019 |
4603 |
Cathéters centraux insérés par voie périphérique Indications, contre-indications et complications |
06/01/2019 |
4602 |
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial |
06/01/2019 |
4601 |
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients |
06/01/2019 |
4600 |
Abdominal Aortic Aneurysm Screening: A Systematic Review and Meta-analysis of Efficacy and Cost |
06/01/2019 |
4599 |
Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease |
06/01/2019 |
4598 |
Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk Threshold |
06/01/2019 |
4597 |
Reversing anti–factor Xa agents and the unmet needs in trauma patients |
06/01/2019 |
4596 |
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe |
06/01/2019 |
4595 |
How I treat the postthrombotic syndrome |
06/01/2019 |
4594 |
How I treat cryoglobulinemia |
06/01/2019 |
4593 |
Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke |
06/01/2019 |
4592 |
Let’s Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked |
06/01/2019 |
4591 |
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe |
06/01/2019 |
4590 |
Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease |
06/01/2019 |
4589 |
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe |
06/01/2019 |
4588 |
Kidneys are key in secondary hypertension: a case of fibromuscular dysplasia |
06/01/2019 |
4587 |
RiskofRecurrentVenousThromboembolism:ADanishNationwideCohortStudy |
06/01/2019 |
4586 |
Meta-analyses: 5 Things to Know |
17/12/2018 |
4585 |
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 |
17/12/2018 |
4584 |
Gene therapy for peripheral arterial disease (Review) |
17/12/2018 |
4583 |
Endovascular Treatment of a Carotid Pseudoaneurysm Following Endarterectomy |
17/12/2018 |
4582 |
Elastic compression therapy to prevent post-thrombotic syndrome |
17/12/2018 |
4581 |
Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK |
17/12/2018 |
4580 |
Cholestérol : les nouvelles recommandations US amorcent une marche arrière |
17/12/2018 |
4579 |
Adherence to Prescribed Drugs Among 65e74 Year Old Men Diagnosed with Abdominal Aortic Aneurysm or Peripheral Arterial Disease in a Screening Trial: A VIVA Substudy |
17/12/2018 |
4578 |
AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol |
17/12/2018 |
4577 |
AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol |
17/12/2018 |
4576 |
Which patients with pulmonary embolism need echocardiography? |
17/12/2018 |
4575 |
Treatment pattern of consecutive patients with chronic venous disease |
17/12/2018 |
4574 |
Systematic review and meta-analysis of the anatomic variants of the saphenofemoral junction |
17/12/2018 |
4573 |
Renal vein thrombosis and pulmonary embolism |
17/12/2018 |
4572 |
Pulmonary infarction due to pulmonary embolism |
17/12/2018 |
4571 |
Perioperative cardiovascular medicine: 5 questions for 2018 |
17/12/2018 |
4570 |
Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature |
17/12/2018 |
4569 |
A COMPARISON OF ENOXAPARIN WITH PLACEBO FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN ACUTELY ILL MEDICAL PATIENTS |
17/12/2018 |
4568 |
Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis |
17/12/2018 |
4567 |
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study |
17/12/2018 |
4566 |
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-relatedmortality andmorbidity in people with unprovoked VTE (Review) |
17/12/2018 |
4565 |
Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism |
17/12/2018 |
4564 |
Back pain as a sign of inferior vena cava fi lter complications |
17/12/2018 |
4563 |
Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable |
17/12/2018 |
4562 |
Venous duplex ultrasound protocol for iliocaval disease |
17/12/2018 |
4561 |
Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis |
17/12/2018 |
4560 |
Left iliac vein compression is not associated with infrainguinal deep venous thrombosis but is associated with iliac vein involvement |
17/12/2018 |
4559 |
Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies |
17/12/2018 |
4558 |
CKD, arterial calcification, atherosclerosis and bone health: Interrelationships and controversies |
17/12/2018 |
4557 |
Catheter-directed thrombolysis through anterior tibial vein for treating acute extensive deep venous thrombosis |
17/12/2018 |
4556 |
Time-Dependent Hypotensive Effect of Aspirin in Mice |
17/12/2018 |
4555 |
Serum triglycerides predict first cardiovascular events in diabetic patients with hypercholesterolemia and retinopathy |
17/12/2018 |
4554 |
Air Pollution and Cardiovascular Disease |
17/12/2018 |
4553 |
peripheral artery disease |
17/12/2018 |
4552 |
MEDICATION ADHERENCE |
17/12/2018 |
4551 |
Long-term trends in incidence and risk factors for ischaemic stroke subtypes: Prospective population study of the South London Stroke Register |
17/12/2018 |
4550 |
Inflammation, Immunity, and Infection in Atherothrombosis |
17/12/2018 |
4549 |
HEALTH TIPS FOR OLDER ADULTS |
17/12/2018 |
4548 |
Carotid Consensus Panel duplex criteria can replace modified University of Washington criteria without affecting accuracy |
17/12/2018 |
4547 |
Preoperative ultrasound improves patency and cost effectiveness in av fistula surgery |
17/12/2018 |
4546 |
Venous thrombosis and breast cancer in older women: Racial differences in risk factors and mortality |
17/12/2018 |
4545 |
Symptomatic pulmonary embolism following hip fracture: A nationwide study |
17/12/2018 |
4544 |
Quelle place pour la décision médicale partagée en médecine interne ? |
17/12/2018 |
4543 |
Predicted chance that global warming will temporarily exceed 1.5oC. |
17/12/2018 |
4542 |
Great Saphenous Vein Diameters in Phlebological Practice in France: A Report of the DIAGRAVES Study by the French Society of Phlebology |
17/12/2018 |
4541 |
Direct-Acting Oral Anticoagulants: Less is not always more |
17/12/2018 |
4540 |
Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study |
17/12/2018 |
4539 |
Venous Thromboembolism Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism (DissolVE-2) – a cross-sectional study |
17/12/2018 |
4538 |
The ASPREE Aftermath: A Geriatric Perspective on the Role of Aspirin in Older Adults |
17/12/2018 |
4537 |
PATIENT BRUSQUEMENT ESSOUFFLÉ |
17/12/2018 |
4536 |
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
17/12/2018 |
4535 |
Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties |
17/12/2018 |
4534 |
Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study |
17/12/2018 |
4533 |
Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension |
17/12/2018 |
4532 |
Endovascular Treatment of Patients with Isolated Mesenteric Artery Dissection Aneurysm: Bare Stents Alone Versus Stent Assisted Coiling |
17/12/2018 |
4531 |
Danish Trends in Major Amputation After Vascular Reconstruction in Patients With Peripheral Arterial Disease 2002e2014 |
17/12/2018 |
4530 |
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study |
19/11/2018 |
4529 |
Nearly half of older patients stop taking statins within a year, study finds |
11/11/2018 |
4528 |
Maintien à domicile : quelles dimensions prendre en compte chez les personnes âgées ? |
11/11/2018 |
4527 |
La FA post-chirurgie non cardiaque, jugée transitoire et bénigne, ne l’est pas ! |
11/11/2018 |
4526 |
Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease |
11/11/2018 |
4525 |
Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism |
11/11/2018 |
4524 |
Impact of a public media event on the use of statins in the French population |
11/11/2018 |
4523 |
How to Read and Understand a Scienti..c Paper |
11/11/2018 |
4522 |
Nearly half of older patients stop taking statins within a year, study finds |
11/11/2018 |
4521 |
Maintien à domicile : quelles dimensions prendre en compte chez les personnes âgées ? |
11/11/2018 |
4520 |
La FA post-chirurgie non cardiaque, jugée transitoire et bénigne, ne l’est pas ! |
11/11/2018 |
4519 |
Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease |
11/11/2018 |
4518 |
Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism |
11/11/2018 |
4517 |
Impact of a public media event on the use of statins in the French population |
11/11/2018 |
4516 |
Patients Helping Patients Blog |
11/11/2018 |
4515 |
Fluoroquinolones par voie systémique ou inhalée : risque de survenue d’anévrisme et de dissection aortique |
11/11/2018 |
4514 |
Conduite automobile et diabète Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique |
11/11/2018 |
4513 |
Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis |
11/11/2018 |
4512 |
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia |
11/11/2018 |
4511 |
Association of HIV infection with age and symptomatic carotid atherosclerotic disease at the time of carotid intervention in the United States |
11/11/2018 |
4510 |
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome |
11/11/2018 |
4509 |
Medical conflicts of interest: when a declaration isn’t enough |
11/11/2018 |
4508 |
The new england journal of medicine |
11/11/2018 |
4507 |
2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol |
11/11/2018 |
4506 |
Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives A Safety Study Using the Sentinel Distributed Database |
11/11/2018 |
4505 |
Coronary and Abdominal Aortic Aneurysms |
11/11/2018 |
4504 |
Estimated Costs of Pivotal Trials forNovel TherapeuticAgents Approved by theUSFood and DrugAdministration, 2015-2016 |
11/11/2018 |
4503 |
Contrast Enhanced Three Dimensional Ultrasound for Intraluminal Thrombus Assessment in Abdominal Aortic Aneurysms |
11/11/2018 |
4502 |
Identification of Vulnerable Carotid Plaques: Contrasting Results from Contrast Enhanced Ultrasound Scan Studies |
11/11/2018 |
4501 |
Diagnostic Imaging in Vascular Graft Infection: A Systematic Review and Meta-Analysis |
11/11/2018 |
4500 |
Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease |
11/11/2018 |
4499 |
Editor’s Choice e Systematic Review and Meta-Analysis of Very Urgent Carotid Intervention for Symptomatic Carotid Disease |
11/11/2018 |
4498 |
Nonagenarians will be the Future Challenge for Vascular Specialists |
11/11/2018 |
4497 |
Risk factors associated with the venous leg ulcer that fails to heal after 1 year of treatment |
11/11/2018 |
4496 |
Meta-analysis of the accuracy of contrast-enhanced ultrasound for the detection of endoleak after endovascular aneurysm repair |
11/11/2018 |
4495 |
Ultrasound diagnosis and follow-up of Takayasu arteritis with femoral vein involvement |
11/11/2018 |
4494 |
MISSION DE RECERTIFICATION DES MÉDECINS |
11/11/2018 |
4493 |
Contrast Enhanced Ultrasound (CEUS) Is Not Able to Identify Vulnerable Plaques in Asymptomatic Carotid Atherosclerotic Disease |
11/11/2018 |
4492 |
High Density of Periaortic Adipose Tissue in Abdominal Aortic Aneurysm |
11/11/2018 |
4491 |
Diversities 4 |
07/11/2018 |
4490 |
Management of upper gastrointestinal bleeding |
07/11/2018 |
4489 |
The importance of the superficial and profunda femoris arteries in limb salvage following endovascular treatment of chronic aortoiliac occlusive disease |
07/11/2018 |
4488 |
The effect of statin use and intensity on stroke and myocardial infarction after carotid endarterectomy |
07/11/2018 |
4487 |
Sulodexide in Venous Disease |
07/11/2018 |
4486 |
Les biosimilaires en France, bien en comprendre les enjeux pour bienles utiliserBiosimilars |
07/11/2018 |
4485 |
Gestion de l’incertitude et compétence médicale : une réflexionclinique et pédagogique |
07/11/2018 |
4484 |
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study |
07/11/2018 |
4483 |
Analysis of venous thromboembolism in neurosurgical patients undergoing standard versus routine ultrasonography |
07/11/2018 |
4482 |
Acute upper gastrointestinal bleeding |
07/11/2018 |
4481 |
 |
07/11/2018 |
4480 |
MISSION DE RECERTIFICATION DES MÉDECINS |
06/11/2018 |
4479 |
Treatment of Lower Extremity Superficial Thrombophlebitis |
06/11/2018 |
4478 |
Thoracic aortic aneurysm |
06/11/2018 |
4477 |
Bénéfi ce d’une prescription antiplaquettaire plus effi cace (et plus précoce) dans l’AVC mineur et l’AIT |
06/11/2018 |
4476 |
Statin use and risk of contralateral breast cancer: a nationwide cohort study |
06/11/2018 |
4475 |
Safety and efficacy of statin therapy |
06/11/2018 |
4474 |
Risk factors associated with pain in patients with venous malformations of the extremities |
06/11/2018 |
4473 |
Pathogenesis of large vessel vasculitis: Implications for disease classification and future therapies |
06/11/2018 |
4472 |
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk |
06/11/2018 |
4471 |
Myocardial Injury After Non-cardiac Surgery: What this “MINS” for the Vascular Surgeon? |
06/11/2018 |
4470 |
Lipid management in patients with chronic kidney disease |
06/11/2018 |
4469 |
Effect of Statins on Renal Function in Chronic Kidney Disease Patients |
06/11/2018 |
4468 |
Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs |
06/11/2018 |
4467 |
Causes and prevention of postoperative myocardial injury |
06/11/2018 |
4466 |
Le patient diabétique de type 2 à haut risque CV dans la pratique clinique |
06/11/2018 |
4465 |
 |
06/11/2018 |
4464 |
Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus |
04/11/2018 |
4463 |
Quelle contraception après 40 ans ? |
04/11/2018 |
4462 |
Patients avec FA et antécédent de cancer : l’apport du cardiologue |
04/11/2018 |
4461 |
May-Thurner syndrome and thrombosis: A systematic review of antithrombotic use after endovascular stent placement |
04/11/2018 |
4460 |
Long-term follow-up of the stenting across the iliocaval confluence in patients with iliac venous lesions |
04/11/2018 |
4459 |
Sevrage tabagique : la prise en compte du genre du patient est fondamentale |
04/11/2018 |
4458 |
Est-ce rentable de payer médecins et patients pour atteindre les seuils de LDL-chol ? |
04/11/2018 |
4457 |
Abdominal aortic aneurysms Nature2018 |
04/11/2018 |
4456 |
Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed-methods study |
04/11/2018 |
4455 |
INVITATION A UN COURS DE FORMATION SUR LA MICROCIRCULATION |
04/11/2018 |
4454 |
1ère Newsletter 2018 : ASPIRINE EN PREVENTION PRIMAIRE 1er novembre 2018 |
04/11/2018 |
4453 |
 |
04/11/2018 |
4452 |
The Medical Letter® on Drugs and Therapeutics |
25/10/2018 |
4451 |
Doppler Ultrasound and Magnetic Resonance Imaging Findings of Penile Mondor’s Disease: Case Report and Literature Review |
24/10/2018 |
4450 |
 |
24/10/2018 |
4449 |
 |
16/10/2018 |
4448 |
Global public awareness of venous thromboembolism |
14/10/2018 |
4447 |
ENSEMBLE POIUR LES VAISSEAUX et le WORLD THROMBOSIS DAY |
14/10/2018 |
4446 |
THROMBOSE VEINEUSE EMBOLIE PULMONAIRE évaluation de votre risque |
14/10/2018 |
4445 |
ANNÉE DE LA PREVENTION DE LA THROMBOSE VEINEUSE ET DE L’EMBOLIE PULMONAIRE |
14/10/2018 |
4444 |
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction |
10/10/2018 |
4443 |
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer |
10/10/2018 |
4442 |
Penile Mondor s Disease Triggered by May-Thurner Syndrome |
10/10/2018 |
4441 |
Mondor s Disease: A Review of the Literature |
10/10/2018 |
4440 |
Mondor s disease – a rare cause of chest pain: a case report |
10/10/2018 |
4439 |
FA et observance thérapeutique : les AOD ne font pas mieux que les AVK |
10/10/2018 |
4438 |
Diagnosis of Mondor’s Disease in the Emergency Department with Bedside Ultrasound |
10/10/2018 |
4437 |
Diagnosis of Mondor’s Disease in the Emergency Department with Bedside Ultrasound |
10/10/2018 |
4436 |
Cardiovascular disease in dialysis patients |
10/10/2018 |
4435 |
Appendicite aiguë non compliquée : des données à 5 ans favorables à l’antibiothérapie |
10/10/2018 |
4434 |
FA et observance thérapeutique : les AOD ne font pas mieux que les AVK |
10/10/2018 |
4433 |
FA et observance thérapeutique : les AOD ne font pas mieux que les AVK |
10/10/2018 |
4432 |
Taking a real-world deep dive into VTE |
10/10/2018 |
4431 |
GLOBAL WARMING OF 1.5 °C |
10/10/2018 |
4430 |
Splanchnic vein thrombosis: what are the long-term risks? |
10/10/2018 |
4429 |
Prevention of stroke: a global perspective |
10/10/2018 |
4428 |
Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer |
10/10/2018 |
4427 |
New Oral Anticoagulants and the Cancer Patient |
10/10/2018 |
4426 |
Lipoprotein(a): lodestar for future clinical trials |
10/10/2018 |
4425 |
Intracerebral haemorrhage: current approaches to acute management |
10/10/2018 |
4424 |
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials |
10/10/2018 |
4423 |
Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions A Comparative Effectiveness Analysis |
10/10/2018 |
4422 |
le GIEC |
10/10/2018 |
4421 |
 |
10/10/2018 |
4420 |
Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery |
08/10/2018 |
4419 |
Venous thromboembolism in patients with liver diseases |
08/10/2018 |
4418 |
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism |
08/10/2018 |
4417 |
Chapitre VI La lutte contre les maladies cardioneurovasculaires : une priorité à donner à la prévention et à la qualité des soins |
08/10/2018 |
4416 |
Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism |
08/10/2018 |
4415 |
La maladie de Willebrand |
08/10/2018 |
4414 |
L’hypertension artérielle en France, une situation préoccupante : une réplique du tremblement de terre cholestérol/statines ? |
08/10/2018 |
4413 |
Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis |
08/10/2018 |
4412 |
Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-b 2glycoprotein I antibody detection assays |
08/10/2018 |
4411 |
Cerebral venous sinus thrombosis |
08/10/2018 |
4410 |
Sequential aneurysms of the internal carotid artery with fibromuscular dysplasia |
07/10/2018 |
4409 |
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome |
07/10/2018 |
4408 |
Predictors of health-related quality of life in patients with symptomatic peripheral artery disease |
07/10/2018 |
4407 |
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer |
07/10/2018 |
4406 |
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events |
07/10/2018 |
4405 |
Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population |
07/10/2018 |
4404 |
Higher-risk APS: do we dare to DOAC? |
07/10/2018 |
4403 |
Le score EPICES : L’indicateur de précarité des Centres d’examens de santé financés par l’Assurance Maladie |
07/10/2018 |
4402 |
Fever of Unknown Origin due to a Mycotic Abdominal Aortic Aneurysm First Diagnosed with Bone 99mTc Scintigraphy |
07/10/2018 |
4401 |
Higher-risk APS: do we dare to DOAC? |
07/10/2018 |
4400 |
Le score EPICES : L’indicateur de précarité des Centres d’examens de santé financés par l’Assurance Maladie |
07/10/2018 |
4399 |
Fever of Unknown Origin due to a Mycotic Abdominal Aortic Aneurysm First Diagnosed with Bone 99mTc Scintigraphy |
07/10/2018 |
4398 |
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation |
07/10/2018 |
4397 |
All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism |
07/10/2018 |
4396 |
All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism |
07/10/2018 |
4395 |
Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score |
07/10/2018 |
4394 |
The impact of co-morbidity on the disease burden of VTE |
07/10/2018 |
4393 |
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction |
07/10/2018 |
4392 |
Vol.:(0112 33456789) Journal of Thrombosis and Thrombolysis https://doi.org/10.1007/s11239-018-1748-5 Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot study |
07/10/2018 |
4391 |
CKD, arterial calcification, atherosclerosis and bone health: Interrelationships and controversies |
07/10/2018 |
4390 |
A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures |
07/10/2018 |
4389 |
 |
07/10/2018 |
4388 |
 |
07/10/2018 |
4387 |
Diversities 2 |
03/10/2018 |
4386 |
Sequential aneurysms of the internal carotid artery with fibromuscular dysplasia |
03/10/2018 |
4385 |
Predictors of health-related quality of life in patients with symptomatic peripheral artery disease |
03/10/2018 |
4384 |
Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population |
03/10/2018 |
4383 |
Higher-risk APS: do we dare to DOAC? |
03/10/2018 |
4382 |
Le score EPICES : L indicateur de précarité des Centres d examens de santé financés par l Assurance Maladie |
03/10/2018 |
4381 |
Fever of Unknown Origin due to a Mycotic Abdominal Aortic Aneurysm First Diagnosed with Bone 99mTc Scintigraphy |
03/10/2018 |
4380 |
angor_stable_et_antithrombotique._Ajout_de_rivaroxaban_a_l aspirine___benefice_incertain,_risques_averes |
03/10/2018 |
4379 |
Diversities |
02/10/2018 |
4378 |
 |
03/10/2018 |
4377 |
Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry |
02/10/2018 |
4376 |
Thrombophilie biologique |
02/10/2018 |
4375 |
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use |
02/10/2018 |
4374 |
Nursing Home Residents with Venous Thrombosis: A Vulnerable, Fragile and Disenfranchised Population |
02/10/2018 |
4373 |
Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia |
02/10/2018 |
4372 |
Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia |
02/10/2018 |
4371 |
Gender differences in patients with venous thromboembolism and five common sites of cancer |
02/10/2018 |
4370 |
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study |
02/10/2018 |
4369 |
 |
02/10/2018 |
4368 |
Transaxillary decompression of thoracic outlet syndrome patients presenting with cervical ribs |
30/09/2018 |
4367 |
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves Is the Door Still Open |
30/09/2018 |
4366 |
Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes—A Proposed MARE Definition |
30/09/2018 |
4365 |
Clinical and Genetic Determinants of Varicose Veins |
30/09/2018 |
4364 |
Seasonal variations in the onset of positive and negative renal ANCA-associated vasculitis in Spain |
30/09/2018 |
4363 |
Anti-Angiogenic VEGF165b Regulates Macrophage-Polarization via S100A8/S100A9 in Peripheral Artery Disease |
30/09/2018 |
4362 |
Nouvelles perspectives nosologiques et thérapeutiques pour les malformations vasculaires syndromiques à composante veino-lymphatique |
30/09/2018 |
4361 |
Ultrasound carotid plaque features, cardiovascular disease risk factors and events: The Multi-Ethnic Study of Atherosclerosis |
30/09/2018 |
4360 |
The Education of Prescribers for Safe and Effective Use of Medications |
30/09/2018 |
4359 |
Comparison of antithrombin- dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots |
30/09/2018 |
4358 |
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs |
30/09/2018 |
4357 |
Lowering LDL-Cholesterol and CV Benefits: Is There a Limit to How Low LDL-C Needs to be for Optimal Health Benefits? |
30/09/2018 |
4356 |
Lipid Lowering Therapy for Atherosclerotic Cardiovascular Disease: It Is Not So Simple |
30/09/2018 |
4355 |
Précisions sur HBPM et Insuffisance Rénale |
30/09/2018 |
4354 |
Remboursement des substituts nicotiniques : l’occasion de (re)proposer le sevrage chez l’insuffisant rénal |
30/09/2018 |
4353 |
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A costeffectiveness analysis from the publicly funded health care systems |
30/09/2018 |
4352 |
Diagnosis and surgical treatment of patients with femoral vein compression from hip joint synovial cyst |
30/09/2018 |
4351 |
Clinical and Genetic Determinants of Varicose Veins |
30/09/2018 |
4350 |
ArterialIschemicEventsAreaMajorComplicationinCancerPatientswithVenousThromboembolism |
30/09/2018 |
4349 |
Nouvelles perspectives nosologiques et thérapeutiques pour les malformations vasculaires syndromiques à composante veino-lymphatique |
30/09/2018 |
4348 |
Exercise training for intermittent claudication |
30/09/2018 |
4347 |
 |
30/09/2018 |
4346 |
Residual vein occlusion in relation to immediate compression and post thrombotic syndrome in deep vein thrombosis |
25/09/2018 |
4345 |
Transcranial Doppler and Transcranial Color Duplex in Defining Collateral Cerebral Blood Flow |
25/09/2018 |
4344 |
Polyvascular disease and risk: When two is not better than one |
25/09/2018 |
4343 |
Traitements du Parkinson : le plan d’action de l’ANSM face à la rupture de stock |
25/09/2018 |
4342 |
Nouvelles cibles tensionnelles : beaucoup de bruit pour rien ? |
25/09/2018 |
4341 |
Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism |
25/09/2018 |
4340 |
In patients with unprovoked VTE, does the addition of FDG PET/ CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems |
25/09/2018 |
4339 |
Bénéfices de la méditation chez laduite hypertenuRMS2018 |
25/09/2018 |
4338 |
A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures |
25/09/2018 |
4337 |
Lower Limb Deep Vein Diameters Beneath Medical Compression Stockings in the Standing Position |
24/09/2018 |
4336 |
Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism |
24/09/2018 |
4335 |
Correlation Between Computed Tomography Features and Clinical Presentation and Management of Isolated Superior Mesenteric Artery Dissection |
24/09/2018 |
4334 |
Validation of the Predictive Model of the European Society of Cardiology for Early Mortality in Acute Pulmonary Embolism |
24/09/2018 |
4333 |
All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism |
24/09/2018 |
4332 |
Thrombophilie biologique |
23/09/2018 |
4331 |
QUAND FAIRE UN BILAN DE THROMBOPHILIE? |
23/09/2018 |
4330 |
PROPHYLAXIE THROMBO – EMBOLIQUE PÉRIOPÉRATOIRE |
23/09/2018 |
4329 |
LES NOUVEAUX ANTICOAGULANTS ORAUX: HALTE À LA POLÉMIQUE ! |
23/09/2018 |
4328 |
Les nouveaux anticoagulants dans le traitement de la maladie thromboembolique veineuse |
23/09/2018 |
4327 |
Grossesse et thrombose veineuse |
23/09/2018 |
4326 |
L’embolie pulmonaire aux urgences : que disent les recommandations ? |
23/09/2018 |
4325 |
Bilan étiologique de la maladie veineuse thromboembolique |
23/09/2018 |
4324 |
 |
23/09/2018 |
4323 |
Prices are hidden behind insurance deals, hospital consolidation pushes up costs and the health sector is a growing power in the economy |
23/09/2018 |
4322 |
White paper: statement on conflicts of interest |
23/09/2018 |
4321 |
Ultrasound Elastography is useful to distinguish Acute and Chronic Deep Vein Thrombosis |
23/09/2018 |
4320 |
Surdiagnostic : causes et conséquences en soins primaires |
23/09/2018 |
4319 |
Subclavian Vein Aneurysm |
23/09/2018 |
4318 |
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH |
23/09/2018 |
4317 |
Repeated assessments of physical activity and risk of incident venous thromboembolism |
23/09/2018 |
4316 |
brèveUlcérations des extrémités : une manifestation inhabituelle de lamaladie de Behc¸ et |
23/09/2018 |
4315 |
Pathology of Peripheral Artery Disease in Critical Limb Ischemia |
23/09/2018 |
4314 |
Oral Fluoroquinolone and the Risk of Aortic Dissection |
23/09/2018 |
4313 |
La réduction de l’hyperglycémie entraîne-t- elle un bénéfice cardiovasculaire ? |
23/09/2018 |
4312 |
L’embolie pulmonaire aux urgences : que disent les recommandations ? |
23/09/2018 |
4311 |
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer |
23/09/2018 |
4310 |
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly |
23/09/2018 |
4309 |
Éducation thérapeutique du sujet âgé |
23/09/2018 |
4308 |
Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy |
23/09/2018 |
4307 |
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry |
23/09/2018 |
4306 |
 |
23/09/2018 |
4305 |
Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement |
23/09/2018 |
4304 |
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events |
18/09/2018 |
4303 |
Substantial recurrence risk after venous thromboembolism provoked by minor risk factors |
18/09/2018 |
4302 |
Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada |
18/09/2018 |
4301 |
Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study |
18/09/2018 |
4300 |
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort |
18/09/2018 |
4299 |
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry |
18/09/2018 |
4298 |
Alcohol consumption and the risk of incident pulmonary embolism in US women and men |
18/09/2018 |
4297 |
 |
18/09/2018 |
4296 |
Mesurer la science |
18/09/2018 |
4295 |
What Surgeons Should KnowAbout Non–Vitamin K Oral Anticoagulants |
18/09/2018 |
4294 |
Venous thromboembolism, factor VIII and chronic kidney disease |
18/09/2018 |
4293 |
Venous thromboembolism, factor VIII and chronic kidney disease |
18/09/2018 |
4292 |
Venous thromboembolism, factor VIII and chronic kidney disease |
18/09/2018 |
4291 |
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial |
18/09/2018 |
4290 |
Une bandelette pour détecter la présence d’anticoagulant direct par voie orale dans les urines aux urgences |
18/09/2018 |
4289 |
Thrombose veineuse profonde distale : quel risque de syndrome postthrombotique ? |
18/09/2018 |
4288 |
Quand arrêter un anticoagulant direct par voie orale avant une procédure à faible risque de saignement ? |
18/09/2018 |
4287 |
Programmer les interventions dentaires en début de journée pour favoriser la coagulation ? |
18/09/2018 |
4286 |
E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: A randomized, double-blinded pilot study |
18/09/2018 |
4285 |
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study |
18/09/2018 |
4284 |
Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study |
18/09/2018 |
4283 |
Oral Anticoagulation in Patients With Liver Disease |
18/09/2018 |
4282 |
Statines en prévention primaire chez les personnes très âgées : en cas de diabète seulement |
18/09/2018 |
4281 |
researchAgreement of clinical tests for the diagnosis ofperipheral arterial disease |
18/09/2018 |
4280 |
2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy |
18/09/2018 |
4279 |
Car free cities: Pathway to healthy urban living |
18/09/2018 |
4278 |
Illusory Angiographic Signs of Significant Iliac Vein Compression in Healthy Volunteers |
18/09/2018 |
4277 |
 |
18/09/2018 |
4276 |
 |
18/09/2018 |
4275 |
 |
12/09/2018 |
4274 |
targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes |
09/09/2018 |
4273 |
Margaret McCartney: A summary of four and a half years of columns in one column |
09/09/2018 |
4272 |
Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes |
09/09/2018 |
4271 |
Identifying risk factors associated with infection in patients with chronic leg ulcers |
09/09/2018 |
4270 |
High risk of recurrent venous thrombosis in patients with lower-leg cast immobilization |
09/09/2018 |
4269 |
Factors associated with physical activity levels in people with venous leg ulcers: A multicentre, prospective, cohort study |
09/09/2018 |
4268 |
Endovenous laser treatment of groin and popliteal varicose veins recurrence |
09/09/2018 |
4267 |
Effects and associations of nutrition in patients with venous leg ulcers: A systematic review |
09/09/2018 |
4266 |
Kompressionsverbände mit und ohne Unterpolsterung |
09/09/2018 |
4265 |
Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation Study |
09/09/2018 |
4264 |
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia |
09/09/2018 |
4263 |
A Comparison of Concomitant Tributary Laser Ablation and Foam Sclerotherapy in Patients Undergoing Truncal Endovenous Laser Ablation for Lower Limb Varicose Veins |
09/09/2018 |
4262 |
2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy |
09/09/2018 |
4261 |
Car free cities: Pathway to healthy urban living |
09/09/2018 |
4260 |
 |
09/09/2018 |
4259 |
Pollution de l air a l interieur des habitations |
04/09/2018 |
4258 |
Qui est le plus touche par la pollution de l air ? |
04/09/2018 |
4257 |
Deces lies a la polution de l air exterieur et interieur |
04/09/2018 |
4256 |
la polution d air un tueur silencieux |
04/09/2018 |
4255 |
trends in IVC Filter insertions and Prophylactic use |
04/09/2018 |
4254 |
Profunda femoris vein thrombosis |
04/09/2018 |
4253 |
Solutions |
04/09/2018 |
4252 |
Profunda femoris vein thrombosis |
04/09/2018 |
4251 |
Managing thrombosis in cancer patients |
04/09/2018 |
4250 |
Safety of Early Carotid Artery Stenting for Symptomatic Stenosis in Daily Practice |
04/09/2018 |
4249 |
Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis |
04/09/2018 |
4248 |
Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm |
04/09/2018 |
4247 |
Illusory Angiographic Signs of Significant Iliac Vein Compression in Healthy Volunteers |
04/09/2018 |
4246 |
Bleeding in patients treated with anticoagulants should stimulate search for cancer |
04/09/2018 |
4245 |
Endovenous ablation of superficial reflux: is it time to focus on technique rather than modality? |
04/09/2018 |
4244 |
Contrast Enhanced Three Dimensional Ultrasound for Intraluminal Thrombus Assessment in Abdominal Aortic Aneurysms |
04/09/2018 |
4243 |
 |
04/09/2018 |
4242 |
Coronary Artery Disease |
02/09/2018 |
4241 |
Elastic Modulus of Muscle and Tendon with Shear Wave Ultrasound Elastography: Variations with Different Technical Settings |
02/09/2018 |
4240 |
Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease? |
02/09/2018 |
4239 |
The role of compression after endovenous ablation of varicose veins |
02/09/2018 |
4238 |
The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia |
02/09/2018 |
4237 |
Safety of Early Carotid Artery Stenting for Symptomatic Stenosis in Daily Practice |
02/09/2018 |
4236 |
Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis |
02/09/2018 |
4235 |
Phlebectomy Techniques for Varicose Veins |
02/09/2018 |
4234 |
Phlebectomy Techniques for Varicose Veins |
02/09/2018 |
4233 |
Pathophysiology of Chronic Venous Disease and Venous Ulcers |
02/09/2018 |
4232 |
Novel developments in foam sclerotherapy: Focus on Varithena (polidocanol endovenous microfoam) in the management of varicose veins |
02/09/2018 |
4231 |
Molecular identity of arteries, veins, and lymphatics |
02/09/2018 |
4230 |
Liquid and Foam Sclerotherapy for Spider and Varicose Veins |
02/09/2018 |
4229 |
Is radiofrequency ablation of varicose veins a valuable option? A systematic review of the literature with a cost analysis |
02/09/2018 |
4228 |
Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement |
02/09/2018 |
4227 |
Illusory Angiographic Signs of Significant Iliac Vein Compression in Healthy Volunteers |
02/09/2018 |
4226 |
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD) A Randomized Superiority Trial |
02/09/2018 |
4225 |
Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis |
02/09/2018 |
4224 |
Contrast Enhanced Three Dimensional Ultrasound for Intraluminal Thrombus Assessment in Abdominal Aortic Aneurysms |
02/09/2018 |
4223 |
Arterial stiffness in end-stage renal disease—pathogenesis, clinical epidemiology, and therapeutic potentials |
02/09/2018 |
4222 |
Accuracy and interobserver reliability of the simplified pulmonary embolism severity index versus the hestia criteria for patients with pulmonary embolismAEM2018 |
02/09/2018 |
4221 |
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial |
02/09/2018 |
4220 |
Treatment of incompetent perforators in recurrent venous insufficiency with adhesive embolization and sclerotherapy |
02/09/2018 |
4219 |
Treatment of foot varicose veins: A study of 119 consecutive patients |
02/09/2018 |
4218 |
Symptomatic recurrent varicose veins due to primary avalvular varicose anomalies (PAVA): A previously unreported cause of recurrence |
02/09/2018 |
4217 |
Supervised exercise training as an adjunct therapy for venous leg ulcers: a randomised controlled feasibility trial |
02/09/2018 |
4216 |
Prévention de la maladie thromboembolique veineuse: faut-il la prolonger après la sortie de l’hôpital ? |
02/09/2018 |
4215 |
Les manifestations oculaires de la maladie de Behc¸ et |
02/09/2018 |
4214 |
Haemorrhage from varicose veins and varicose ulceration: A systematic review |
02/09/2018 |
4213 |
Five-year follow-up of a randomized clinical trial comparing open surgery, foam sclerotherapy and endovenous laser ablation for great saphenous varicose veins |
02/09/2018 |
4212 |
Épidémiologie des thromboses veineuses des membres supérieurs :étude rétrospective de 160 thromboses aiguës |
02/09/2018 |
4211 |
Endovenous Thermal Ablation of Recurrent Varicose Veins due to Residual Great Saphenous Venous Insufficiency After Saphenous Venous Surgery: A Comparative Study |
02/09/2018 |
4210 |
Effects of isokinetic calf muscle exercise program on muscle strength and venous function in patients with chronic venous insufficiency |
02/09/2018 |
4209 |
Effectiveness of the strategies of an orientation programme for the lifestyle and wound-healing process in patients with venous ulcer: A randomised controlled trial |
02/09/2018 |
4208 |
Échographie ultraportable en médecine interne : retour d’expérienceet point de vue |
02/09/2018 |
4207 |
Daily Aspirin Fails to Lower CV Risk in Long-term, Primary Prevention ARRIVE Trial |
02/09/2018 |
4206 |
Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry |
02/09/2018 |
4205 |
Change in perception of sclerotherapy results after exposure to pre–post intervention photographs |
02/09/2018 |
4204 |
A Randomized Trial of Early Endovenous Ablation in Venous Ulceration |
02/09/2018 |
4203 |
Air Pollution |
30/08/2018 |
4202 |
Blood Colts |
30/08/2018 |
4201 |
VTE |
30/08/2018 |
4200 |
Nicotine Patches V6 |
30/08/2018 |
4199 |
Infographics |
30/08/2018 |
4198 |
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please |
29/08/2018 |
4197 |
Warfarin control in patients transitioning to warfarin after nonvitamin K oral anticoagulant (NOAC) therapy |
29/08/2018 |
4196 |
ORIGINAL ARTICLE Thromboembolic risk after lumbar spine surgery: a cohort study on 325 000 French patients |
29/08/2018 |
4195 |
Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction |
29/08/2018 |
4194 |
ORIGINAL ARTICLE Reduction in physical function in women after venous thromboembolism |
29/08/2018 |
4193 |
Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry |
29/08/2018 |
4192 |
Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization The Low-Risk Pulmonary Embolism Prospective Management Study |
29/08/2018 |
4191 |
Jusqu’où faut-il réduire les taux de LDL-cholestérol ? |
29/08/2018 |
4190 |
Identification of high thrombotic risk triple positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-?2glycoprotein I antibody detection assays |
29/08/2018 |
4189 |
Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. |
29/08/2018 |
4188 |
Graphics and statistics for cardiology: designing effective tables for presentation and publication |
29/08/2018 |
4187 |
Direct oral anticoagulants in patients with liver cirrhosis: A systematic review |
29/08/2018 |
4186 |
Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine |
29/08/2018 |
4185 |
Clinical and economic impact of compression in the acute phase of deep vein thrombosis |
29/08/2018 |
4184 |
Assessment of patients post reversal with idarucizumab |
29/08/2018 |
4183 |
POUR LES ÉTUDIANTS ET LEURS FUTURS PATIENTS, DES ÉTUDES MÉDICALES RÉNOVÉES |
29/08/2018 |
4182 |
Organisation de la prise en charge précoce de l’accident vasculaire cérébral ischémique aigu par thrombectomie mécanique |
29/08/2018 |
4181 |
2018 ESC/ESH Guidelines for themanagement of arterial hypertension |
29/08/2018 |
4180 |
 |
29/08/2018 |
4179 |
 |
29/08/2018 |
4178 |
 |
28/08/2018 |
4177 |
What Are We Looking For? The Needle in the Haystack or the Usual Suspect? |
27/08/2018 |
4176 |
POINTTraitement curatif de la maladiethromboembolique veineuse chez lespatients atteints de cancer : quelle placepour les anticoagulants oraux directs en2018 ? |
27/08/2018 |
4175 |
The Impact of Frailty on Outcomes of Elderly Patients After Major Vascular Surgery: A Systematic Review and Meta-analysis |
27/08/2018 |
4174 |
The Effect of Stenting on Venous Hypertension: Results Using a Treadmill Stress Test with Invasive Pressure Measurements in Patients with Iliofemoral Venous Obstruction |
27/08/2018 |
4173 |
Oral Anticoagulation for Primary Prophylaxis of Venous Thromboembolism in Patients with Cancer |
27/08/2018 |
4172 |
Inadequate Health Literacy in Patients with Arterial Vascular Disease |
27/08/2018 |
4171 |
Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation Understanding the Gaps in Evidence |
27/08/2018 |
4170 |
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness |
27/08/2018 |
4169 |
Évaluation des technologies de santé : un règlement européen à corriger |
27/08/2018 |
4168 |
Endovascular Today: Give Me a Narrowing in the Venous System, and I Shall Stent It |
27/08/2018 |
4167 |
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism |
27/08/2018 |
4166 |
Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment |
27/08/2018 |
4165 |
Decision making with D-dimer in the diagnosis of pulmonary embolism |
27/08/2018 |
4164 |
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease Analysis From FOURIER |
27/08/2018 |
4163 |
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy |
27/08/2018 |
4162 |
comREVIEWAnticoagulants in frail patients. Sevensituations at riskAnticoagulants |
27/08/2018 |
4161 |
2018 ESC/ESH Guidelines for themanagement of arterial hypertension |
27/08/2018 |
4160 |
18F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis |
27/08/2018 |
4159 |
Stratégie de prévention de la maladie thromboembolique postopératoire lors d’une chirurgie urgente |
27/08/2018 |
4158 |
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care |
27/08/2018 |
4157 |
Risk of recurrent venous thromboembolism according to baseline risk factor profiles |
27/08/2018 |
4156 |
Revue des traitements endoveineux des varices des membres inférieurs (partie 2) |
27/08/2018 |
4155 |
Les polyglobulies en 10 questions |
27/08/2018 |
4154 |
Le bonheur est-il un nouvel objectif en prévention cardiovasculaire ? |
27/08/2018 |
4153 |
Epidemiology, aetiology, and management of ischaemic stroke in young adults |
27/08/2018 |
4152 |
Dyspnée sous Brilique: faut-il réévaluer le rapport bénéfice-risque du ticagrélor ? |
27/08/2018 |
4151 |
Cardiovascular Disease Prevention by Diet Modification |
27/08/2018 |
4150 |
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP) |
27/08/2018 |
4149 |
Strategies for endovascular treatment of complicated splenic artery aneurysms |
27/08/2018 |
4148 |
Socrates on Quality |
27/08/2018 |
4147 |
Pharmacothérapie : éviter l’empilement et penser à la désescalade ! |
27/08/2018 |
4146 |
Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function |
27/08/2018 |
4145 |
No level of alcohol consumption improves health |
27/08/2018 |
4144 |
Thrombopénie et grossesse : faut-il s’alarmer ? |
27/08/2018 |
4143 |
Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization |
27/08/2018 |
4142 |
Inhibiteur des SGLT2 ou analogue du GLP-1 chez un patient diabétique avec maladie cardiovasculaire ? |
27/08/2018 |
4141 |
D-Dimer and thrombus burden in acute pulmonary embolism |
27/08/2018 |
4140 |
Cookbook Medicine Is the Recipe for Successfully Managing Patients With PAD |
27/08/2018 |
4139 |
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 |
27/08/2018 |
4138 |
Air pollution may claim 36 000 lives a year in UK |
27/08/2018 |
4137 |
Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival |
27/08/2018 |
4136 |
Systematic Review and Meta-Analysis of Very Urgent Carotid Intervention for Symptomatic Carotid Disease |
27/08/2018 |
4135 |
Valsartan : comment faire face aux prochaines ruptures de stock? |
27/08/2018 |
4134 |
Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent |
27/08/2018 |
4133 |
Treatment of postoperative high-volume lymphatic complications using isosulfan blue |
27/08/2018 |
4132 |
Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis |
27/08/2018 |
4131 |
Interventional management of central vein occlusion in patients with peripherally inserted central catheter placement |
27/08/2018 |
4130 |
Diagnostic Imaging in Vascular Graft Infection: A Systematic Review and Meta-Analysis |
27/08/2018 |
4129 |
Long-term complications of inferior vena cava filters |
27/08/2018 |
4128 |
A randomized trial of class 2 and class 3 elastic compression in the prevention of recurrence of venous ulceration |
27/08/2018 |
4127 |
WTD |
26/08/2018 |
4126 |
Did you know that blood colts affect Athletes ? |
26/08/2018 |
4125 |
Document 1 |
26/08/2018 |
4124 |
The role of neutrophils in thrombosis |
26/08/2018 |
4123 |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials |
26/08/2018 |
4122 |
Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality |
26/08/2018 |
4121 |
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
26/08/2018 |
4120 |
Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model |
26/08/2018 |
4119 |
Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice |
26/08/2018 |
4118 |
Out-of- range INR results lead to increased health-care utilization in four large anticoagulation clinics |
26/08/2018 |
4117 |
Novel aspects of antiplatelet therapy in cardiovascular disease |
26/08/2018 |
4116 |
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset |
26/08/2018 |
4115 |
Managing thrombosis in cancer patients |
26/08/2018 |
4114 |
Extended anticoagulation for unprovoked venous thromboembolism |
26/08/2018 |
4113 |
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model |
26/08/2018 |
4112 |
Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals |
26/08/2018 |
4111 |
Dépistage des cancers chez le sujet âgé |
26/08/2018 |
4110 |
Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work |
26/08/2018 |
4109 |
Cancer-associated thrombosis: The search for the holy grail continues |
26/08/2018 |
4108 |
Calcifi c uremic arteriolopathy |
26/08/2018 |
4107 |
Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study |
26/08/2018 |
4106 |
Diagnosis and management of venous leg ulcers |
26/08/2018 |
4105 |
Time to adjust aspirin dose to body weight |
26/08/2018 |
4104 |
Systematic review and meta-analysis of current evidence in spontaneous isolated celiac and superior mesenteric artery dissection |
26/08/2018 |
4103 |
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions |
26/08/2018 |
4102 |
Prise en charge moderne des ischémies mésentériques |
26/08/2018 |
4101 |
Pre-operative Color Doppler Ultrasonography Predicts Endovenous Heat Induced Thrombosis after Endovenous Radiofrequency Ablation |
26/08/2018 |
4100 |
PCSK9 inhibition for patients with and without prior coronary revascularization: Potential additional benefit of a novel therapeutic agent |
26/08/2018 |
4099 |
Optimal medical management before lower extremity bypass for claudication in the veteran population |
26/08/2018 |
4098 |
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty |
26/08/2018 |
4097 |
Incidence and risk factors of early deep venous thrombosis after varicose vein surgery with routine use of a tourniquet |
26/08/2018 |
4096 |
Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities |
26/08/2018 |
4095 |
Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model |
26/08/2018 |
4094 |
Dépistage des cancers chez le sujet âgé |
26/08/2018 |
4093 |
A toolkit for decreasing unnecessary emergency department laboratory testing |
26/08/2018 |
4092 |
Case Records of the Massachusetts General Hospital |
26/08/2018 |
4091 |
A Qualitative Study to Appraise Patients and Family Members Perceptions, Knowledge, and Attitudes towards Venous Thromboembolism Risk |
26/08/2018 |
4090 |
 |
26/08/2018 |
4089 |
 |
01/08/2018 |
4088 |
 |
31/07/2018 |
4087 |
 |
30/07/2018 |
4086 |
The impact of current smoking on outcomes after infrainguinal bypass for claudication |
29/07/2018 |
4085 |
Statin therapy is associated with higher long-term but not perioperative survival after abdominal aortic aneurysm repair |
29/07/2018 |
4084 |
Short-term and midterm survival of ruptured abdominal aortic aneurysms in the contemporary endovascular era |
29/07/2018 |
4083 |
SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL |
29/07/2018 |
4082 |
Pyoderma Gangrenosum in Ulcerative Colitis |
29/07/2018 |
4081 |
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema |
29/07/2018 |
4080 |
‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies |
29/07/2018 |
4079 |
Epidemiology of lower extremity peripheral artery disease in veterans |
29/07/2018 |
4078 |
Calciphylaxis |
29/07/2018 |
4077 |
Andexxa—An Antidote for Apixaban and Rivaroxaban |
29/07/2018 |
4076 |
Analysis of clinical benefit, harms, and cost-effectiveness of screening women for abdominal aortic aneurysm |
29/07/2018 |
4075 |
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
29/07/2018 |
4074 |
Advances in Stroke Prevention in 2018 |
29/07/2018 |
4073 |
 |
29/07/2018 |
4072 |
Weight-adjusted aspirin for cardiovascular prevention |
25/07/2018 |
4071 |
VTE |
25/07/2018 |
4070 |
Know the risk factors of VTE |
25/07/2018 |
4069 |
Risque thromboembolique accru chez les femmes transgenres |
25/07/2018 |
4068 |
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens |
25/07/2018 |
4067 |
Bilan de thrombophilie |
25/07/2018 |
4066 |
Manger dans les transports urbains : un comportement à déconseiller pour la santé et l’hygiène |
25/07/2018 |
4065 |
Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population |
25/07/2018 |
4064 |
Impact d’une évaluation des pratiques professionnelles sur la pertinence des prescriptions d’inhibiteurs de la pompe à protons à l’hôpital |
25/07/2018 |
4063 |
First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation |
25/07/2018 |
4062 |
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials |
25/07/2018 |
4061 |
more than one billion people in the world need assistive technology |
25/07/2018 |
4060 |
are you at risk for heart disease ? |
25/07/2018 |
4059 |
Tobacco threatens us all |
25/07/2018 |
4058 |
life style changes for lower blood pressure |
25/07/2018 |
4057 |
know thrombosis |
25/07/2018 |
4056 |
ways to reduce your cancer risk |
25/07/2018 |
4055 |
inflamation in the atheroscleoritic process |
25/07/2018 |
4054 |
What problems associated with atrial fibrillation |
25/07/2018 |
4053 |
Dépistage des cancers chez le sujet âgé |
25/07/2018 |
4052 |
Anticoagulation Toolkit |
25/07/2018 |
4051 |
 |
23/07/2018 |
4050 |
Y a-t-il un docteur dans l’avion ? |
22/07/2018 |
4049 |
Short-term association between ambient temperature and acute myocardial infarction hospitalizations for diabetes mellitus patients: A time series study |
22/07/2018 |
4048 |
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer |
22/07/2018 |
4047 |
Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers |
22/07/2018 |
4046 |
Outcome Measures After Sclerotherapy of Venous Malformations: A Systematic Review |
22/07/2018 |
4045 |
Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study |
22/07/2018 |
4044 |
Un cas de thrombose de la veine mésentérique supérieure au cours d’une grossesse par FIV |
22/07/2018 |
4043 |
Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen |
22/07/2018 |
4042 |
FVIII, Protein C and the Risk of Arterial Thrombosis: More than the Sum of Its Parts |
22/07/2018 |
4041 |
Evaluation and Management of PatientsWith Syncope |
22/07/2018 |
4040 |
Direct oral anticoagulants: What will be their role in children? |
22/07/2018 |
4039 |
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA |
22/07/2018 |
4038 |
Carbon pricing, co-pollutants, and climate policy: Evidence from California |
22/07/2018 |
4037 |
Utilisation du fondaparinux dans le traitement des thrombopénies induites par I’héparine |
22/07/2018 |
4036 |
A Prospective Clinical Study of a Percutaneous Vascular Access System for Hemodialysis Catheters |
22/07/2018 |
4035 |
Arrêté du 18 juillet 2018 fixant les listes permettant l’exercice infirmier en pratique avancée en application de l’article R. 4301-3 du code de santé publique |
22/07/2018 |
4034 |
Infirmier.e en pratique avancée : un nouveau métier est né ! |
22/07/2018 |
4033 |
Use of NOACs in the Peri-OperativeManagement of Patients with Atrial Fibrillation: To Stop, Bridge or Continue? |
22/07/2018 |
4032 |
Tumeur … d’ennui ? Ou le bâillement qui n’en finissait pas |
22/07/2018 |
4031 |
Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease |
22/07/2018 |
4030 |
Savoir c’est pouvoir agir |
22/07/2018 |
4029 |
Régimes « sans » : est-ce que tout cela a vraiment du sens ? |
22/07/2018 |
4028 |
Nurses as substitutes for doctors in primary care (Review) |
22/07/2018 |
4027 |
Les indications dermatologiques de la compression veineuse |
22/07/2018 |
4026 |
Incomplete circle of Willis is associated with a higher incidence of neurologic events during carotid eversion endarterectomy without shunting |
22/07/2018 |
4025 |
Faut-il une antibioprophylaxie pour les endocardites infectieuses sur bicuspidie aortique et prolapsus de valve mitrale ? |
22/07/2018 |
4024 |
Coronary Calcium Score and Cardiovascular Risk |
22/07/2018 |
4023 |
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness |
22/07/2018 |
4022 |
Association of non-invasive hemodynamics with arterial stiffness in rheumatoid arthritis |
22/07/2018 |
4021 |
Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality |
22/07/2018 |
4020 |
A Combined TCD and MRA Screening for Significant Siphon Portion of Internal Carotid Artery (S-ICA) Stenosis |
22/07/2018 |
4019 |
Les indications dermatologiques de la compression veineuse |
18/07/2018 |
4018 |
Vascular Malformations and Health-Related Quality of Life A Systematic Review and Meta-analysis |
17/07/2018 |
4017 |
Training in Structural Heart Disease |
17/07/2018 |
4016 |
Screening for Peripheral Artery Disease With Ankle-Brachial Index |
17/07/2018 |
4015 |
Role of the gut microbiota in nutrition and health |
17/07/2018 |
4014 |
Pills are not the answer to unhealthy lifestyles |
17/07/2018 |
4013 |
Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States |
17/07/2018 |
4012 |
New Definition Means Almost Half the World’s Adult Population Now Hypertensive |
17/07/2018 |
4011 |
MicroV Technology to Improve Transcranial Color Coded Doppler Examinations |
17/07/2018 |
4010 |
Increased Mortality With Vena Cava Filters Stirs Controversy |
17/07/2018 |
4009 |
Hypercoagulable Workup in Thrombotic Cardiovascular Diseases |
17/07/2018 |
4008 |
Efficacy of Topical Sirolimus (Rapamycin) for the ttt of microcysric lymph malf JAMA D2017 |
17/07/2018 |
4007 |
Definition of hidden drug cardiotoxicity: paradigmchange in cardiac safety testing and its clinical implications |
17/07/2018 |
4006 |
Deciphering the Role of Lipid Droplets in Cardiovascular Disease A Report From the 2017 National Heart, Lung, and Blood Institute Workshop |
17/07/2018 |
4005 |
Research: Treatment Clinical examination and non-invasive screening tests in the diagnosis of peripheral artery disease in people with diabetes-related foot ulceration |
17/07/2018 |
4004 |
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease |
17/07/2018 |
4003 |
Aspirin- free strategies in cardiovascular disease and cardioembolic stroke prevention |
17/07/2018 |
4002 |
Acute Ischemic Stroke Biology Demands Fast Treatment |
17/07/2018 |
4001 |
Premières Journées Phlébo-Thermes 14-15 Septembre 2018 Thermes de La Léchère |
16/07/2018 |
4000 |
 |
16/07/2018 |
3999 |
Syncope : recommandations pour l’évaluation et la prise en charge |
16/07/2018 |
3998 |
Platelet Chemokine Receptor CXCR7 Mediates an Anti-thrombotic and Anti-thromboinflammatory Effect |
16/07/2018 |
3997 |
Awarness to action partner toolkit |
16/07/2018 |
3996 |
New Definition Means Almost Half the World’s Adult Population Now Hypertensive |
16/07/2018 |
3995 |
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials |
16/07/2018 |
3994 |
Increased Mortality With Vena Cava Filters Stirs Controversy |
16/07/2018 |
3993 |
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials |
16/07/2018 |
3992 |
CORTICOTHÉRAPIE GÉNÉRALE |
16/07/2018 |
3991 |
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease |
16/07/2018 |
3990 |
Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease |
16/07/2018 |
3989 |
Chronic Limb-Threatening Ischemia |
16/07/2018 |
3988 |
Breast Cancer in Men |
16/07/2018 |
3987 |
Associations of exercise ankle–brachial index, pain-free walking distance and maximum walking distance with the Peripheral Artery Questionnaire: Finding from the PORTRAIT PAD Registry |
16/07/2018 |
3986 |
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial |
16/07/2018 |
3985 |
The Evolving Future of PCSK9 Inhibitors |
15/07/2018 |
3984 |
Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy |
15/07/2018 |
3983 |
Predictors of coronary stent thrombosis: a case–control study |
15/07/2018 |
3982 |
Peri-procedural antithrombotic management: time to burn the bridge? |
15/07/2018 |
3981 |
Natural history of venous thromboembolism in patients from the Mediterranean region. A systematic review |
15/07/2018 |
3980 |
McMaster RARE-Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome |
15/07/2018 |
3979 |
Sports de compétition et traitements interdits : tout savoir sur les dérogations |
15/07/2018 |
3978 |
Simplicity versus complexity: an existential dilemma as risk tools evolve |
15/07/2018 |
3977 |
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care |
15/07/2018 |
3976 |
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement |
15/07/2018 |
3975 |
Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy |
15/07/2018 |
3974 |
Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events? |
15/07/2018 |
3973 |
Reduced cognitive function during a heat wave among residents of non-air-conditioned buildings: An observational study of young adults in the summer of 2016 |
15/07/2018 |
3972 |
Present and future options for treatment of infrainguinal deep vein disease |
15/07/2018 |
3971 |
PCSK9 Inhibitors Economics and Policy |
15/07/2018 |
3970 |
PCSK9 Antibodies for the Treatment of Hypercholesterolemia |
15/07/2018 |
3969 |
Occlusion de la veine centrale de la rétine chez un sujet jeune :chercher d’où vient l’augmentation de pression intraoculaireRetinal |
15/07/2018 |
3968 |
Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines for the Society for Vascular Surgery and the American Venous Forum. |
15/07/2018 |
3967 |
Inflammatory and Cholesterol Risk in the FOURIER Trial |
15/07/2018 |
3966 |
Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels |
15/07/2018 |
3965 |
Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease |
15/07/2018 |
3964 |
LES INHIBITEURS DE PCSK9 : UNE NOUVELLE CLASSE D’HYPOLIPÉMIANTS |
15/07/2018 |
3963 |
L’hypertension artérielle en France, une situation préoccupante : une réplique du tremblement de terre cholestérol/statines ? |
15/07/2018 |
3962 |
Increases in atmospheric carbon dioxide: Anticipated negative effects on food quality |
15/07/2018 |
3961 |
Le syndrome post-thrombotique : prévention, diagnostic et traitement. |
15/07/2018 |
3960 |
Estimating the costs of air pollution to the National Health Service and social care: An assessment and forecast up to 2035 |
15/07/2018 |
3959 |
Ten-year association of coronary artery calciumwith atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) |
15/07/2018 |
3958 |
Diabetes and long-termoutcomes of ischaemic stroke: findings from GetWith The Guidelines-Stroke |
15/07/2018 |
3957 |
diffusesDiffuse calcifications |
15/07/2018 |
3956 |
Chronic Limb-Threatening Ischemia |
15/07/2018 |
3955 |
Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond |
15/07/2018 |
3954 |
Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study |
15/07/2018 |
3953 |
Antithrombotic Therapy Following Venous Stenting: International Delphi Consensus |
15/07/2018 |
3952 |
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? |
15/07/2018 |
3951 |
Anticipated burden and mitigation of carbondioxide- induced nutritional deficiencies and related diseases: A simulation modeling study |
15/07/2018 |
3950 |
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts |
15/07/2018 |
3949 |
PLAN NATIONAL MALADIES RARES 2018-2022 |
15/07/2018 |
3948 |
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention |
08/07/2018 |
3947 |
Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study |
08/07/2018 |
3946 |
Systematic review of risk prediction scores for venous thromboembolism following joint replacement |
08/07/2018 |
3945 |
Risk factors and obstetric outcomes in pregnancies complicated by pelvic vein thrombosis, and in the subsequent pregnancy |
08/07/2018 |
3944 |
Remboursement des substituts nicotiniques : l’occasion de (re)proposer le sevrage chez l’insuffisant rénal |
08/07/2018 |
3943 |
Recommandations du Collège des enseignants de médecine vasculaire (CEMV) : analyse des flux artériels Doppler (classification de Saint-Bonnet simplifiée) |
08/07/2018 |
3942 |
Rapidly progressive arterial aneurysms in a patient with Ehlers–Danlos syndrome |
08/07/2018 |
3941 |
Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis |
08/07/2018 |
3940 |
Occult type I or III endoleaks are a common cause of failure of type II endoleak treatment after endovascular aortic repair |
08/07/2018 |
3939 |
Natural history and management of renal artery aneurysms in a single tertiary referral center |
08/07/2018 |
3938 |
Love story avec la metformine : faut-il tourner la page ? |
08/07/2018 |
3937 |
Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds |
08/07/2018 |
3936 |
Lights and shadows of long-term dual antiplatelet therapy in “real life” clinical scenarios |
08/07/2018 |
3935 |
If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease |
08/07/2018 |
3934 |
Family history of atherosclerotic vascular disease is associated with the presence of abdominal aortic aneurysm |
08/07/2018 |
3933 |
Diabète : augmentation du nombre d’effets indésirables liés au FreeStyle Libre |
08/07/2018 |
3932 |
 |
08/07/2018 |
3931 |
A Consortium-Developed Quick Reference for Anticoagulation |
08/07/2018 |
3930 |
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis |
04/07/2018 |
3929 |
Role of direct oral anticoagulants in treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH |
04/07/2018 |
3928 |
Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study |
04/07/2018 |
3927 |
Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer |
04/07/2018 |
3926 |
Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis |
04/07/2018 |
3925 |
Real-world evidence of superiority of endovascular repair in treating ruptured abdominal aortic aneurysm |
04/07/2018 |
3924 |
New method for ultrasound-guided inferior vena cava filter placement |
04/07/2018 |
3923 |
Natural history of spontaneous isolated celiac artery dissection after conservative treatment |
04/07/2018 |
3922 |
Natural history and management of renal artery aneurysms in a single tertiary referral center |
04/07/2018 |
3921 |
May-Thurner syndrome and the risk of pulmonary embolism in patients with acute deep venous thrombosis |
04/07/2018 |
3920 |
Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort |
04/07/2018 |
3919 |
Epidemiology, treatment, and outcomes of acute limb ischemia in the pediatric population |
04/07/2018 |
3918 |
Diabetes is inversely associated, while metabolic syndrome is positively associated, with AAA occurrence |
04/07/2018 |
3917 |
Prediction of short-term prognosis in elderly patients with acute pulmonary embolism: validation of the RIETE score |
04/07/2018 |
3916 |
A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH |
04/07/2018 |
3915 |
Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients |
03/07/2018 |
3914 |
Pre-operative Color Doppler Ultrasonography Predicts Endovenous Heat Induced Thrombosis after Endovenous Radiofrequency Ablation5 |
03/07/2018 |
3913 |
Nonfatal Bleeding Risk in General Population Rises with Age |
03/07/2018 |
3912 |
New ADA/EASD Guidance on Diabetes: Assess CV Status First |
03/07/2018 |
3911 |
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes |
03/07/2018 |
3910 |
Tinzaparin vsWarfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer |
03/07/2018 |
3909 |
Direct oral anticoagulants: What will be their role in children? |
03/07/2018 |
3908 |
Catheterrelated upper extremity venous thrombosis |
03/07/2018 |
3907 |
Catheter-related venous thrombosis |
03/07/2018 |
3906 |
Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men |
03/07/2018 |
3905 |
Aspirin for thePrevention ofCardiovascular Events in Patients With Peripheral Artery Disease |
03/07/2018 |
3904 |
Journeés de la SFP Paris |
03/07/2018 |
3903 |
ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients |
27/06/2018 |
3902 |
Prevalence of diabetes and dyslipidemia in hypertensive patients in the areaof Blida (Algeria) |
13/06/2018 |
3901 |
originalFacteurs de risque cardio-vasculaires en Algérie. Une analyse du sous-groupede l’étude « Africa/Middle East Cardiovascular Epidemiological » |
13/06/2018 |
3900 |
There are many ways to be active – walking, cycling, sport, active recreation, dance and play – and many policy opportunities to increase participation. |
13/06/2018 |
3899 |
Venous thromboembolism after induced abortion: the shorter the pregnancy, the lower the risk? |
13/06/2018 |
3898 |
Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US Cohort |
13/06/2018 |
3897 |
Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium |
13/06/2018 |
3896 |
The Pivotal Multicenter Trial of Ultrasound- Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access |
13/06/2018 |
3895 |
Structure and function of anticoagulation clinics in the United States: an AC forum membership survey |
13/06/2018 |
3894 |
Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolismSafety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolys |
13/06/2018 |
3893 |
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system |
13/06/2018 |
3892 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis |
13/06/2018 |
3891 |
Novel aspects of antiplatelet therapy in cardiovascular disease |
13/06/2018 |
3890 |
More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin |
13/06/2018 |
3889 |
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort |
13/06/2018 |
3888 |
Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada |
13/06/2018 |
3887 |
Extended anticoagulation for unprovoked venous thromboembolism |
13/06/2018 |
3886 |
Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events |
13/06/2018 |
3885 |
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study |
13/06/2018 |
3884 |
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs |
13/06/2018 |
3883 |
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts |
13/06/2018 |
3882 |
Translating Evidence into Practice: Surveillance after Carotid Interventions |
06/06/2018 |
3881 |
The Effect of Stenting on Venous Hypertension: Results Using a Treadmill Stress Test with Invasive Pressure Measurements in Patients with Iliofemoral Venous Obstruction |
06/06/2018 |
3880 |
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients |
06/06/2018 |
3879 |
Dizziness |
06/06/2018 |
3878 |
cardiovascular disease prevention |
06/06/2018 |
3877 |
Un MOOC pour partager expériences et connaissances sur les maladies rénales |
06/06/2018 |
3876 |
Medical Nutrition Education, Training, and Competencies to Advance Guideline-Based Diet Counseling by Physicians |
06/06/2018 |
3875 |
Advance directives in hospital practice: A matter of concern for every healthcareprofessional and consumerT. |
06/06/2018 |
3874 |
Adrénaline en cas d’arrêt cardiaque non choquable : chaque minute compte ! |
06/06/2018 |
3873 |
Deep vein thrombosis: a clinical review |
06/06/2018 |
3872 |
International Variations in Amputation Practice: A VASCUNET Report |
06/06/2018 |
3871 |
International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularisation Registry Data Collection |
06/06/2018 |
3870 |
Improved Cardiovascular Risk Factors Control Associated with a Large-Scale Population Management Program Among Diabetes Patients |
06/06/2018 |
3869 |
How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized? |
06/06/2018 |
3868 |
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease |
06/06/2018 |
3867 |
Development and Validation of a Practical Two-Step Prediction Model and Clinical Risk Score for Post-Thrombotic Syndrome |
06/06/2018 |
3866 |
Antithrombotic Therapy for Peripheral Artery Disease in 2018 |
06/06/2018 |
3865 |
Extending the angiosome model to targeted, real-time, angiography-guided restoration of target tissue perfusion. |
06/06/2018 |
3864 |
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia |
06/06/2018 |
3863 |
What is the effect of exercise on wound healing in patients with venous leg ulcers? A systematic review |
05/06/2018 |
3862 |
Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in aWoman with a Patent Foramen Ovale |
05/06/2018 |
3861 |
Systematic Review and Meta-Analysis of Endovascular and Surgical Revascularization for Patients with Chronic Lower Extremity Venous Insufficiency and Varicose Veins |
05/06/2018 |
3860 |
Suppressed networks of inflammatory mediators characterize chronic venous insufficiency |
05/06/2018 |
3859 |
Prospective randomized controlled study of patient compliance in using a compression stocking: Importance of recommendations of the practitioner as a factor for better compliance |
05/06/2018 |
3858 |
Prospective comparison of effect of ligation and foam sclerotherapy with foam sclerotherapy alone for varicose veins |
05/06/2018 |
3857 |
Numerical Model Reduction for the Prediction of Interface Pressure Applied by Compression Bandages on the Lower Leg |
05/06/2018 |
3856 |
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events |
05/06/2018 |
3855 |
Midterm result of endovascular treatment for iliac vein compression syndrome from a single center |
05/06/2018 |
3854 |
Management of venous ulcers according to their anatomical relationship with varicose veins |
05/06/2018 |
3853 |
Incidence of Cellulitis among Children with Primary Lymphedema |
05/06/2018 |
3852 |
Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations |
05/06/2018 |
3851 |
Framingham at 70: WhatWe’ve Learned AboutWomen and Heart Disease |
05/06/2018 |
3850 |
Day surgery versus Outpatient setting for endovenous laser ablation treatment. A prospective cohort study |
05/06/2018 |
3849 |
Cost-effectiveness of using a collagencontaining dressing plus compression therapy in non-healing venous leg ulcers |
05/06/2018 |
3848 |
Compression therapy for congenital low-flow vascular malformations of the extremities: A systematic review |
05/06/2018 |
3847 |
Advantages and disadvantages of graduated and inverse graduated compression hosiery in patients with chronic venous insufficiency and healthy volunteers: A prospective, mono-centric, blinded, open randomised, controlled and cross-over trial |
05/06/2018 |
3846 |
A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix®) allograft for the treatment of venous leg ulcers |
05/06/2018 |
3845 |
A case-control study of risk factors of chronic venous ulceration in patients with varicose veins |
05/06/2018 |
3844 |
Use of direct oral anticoagulants in antiphospholipid syndrome |
04/06/2018 |
3843 |
Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta-analysis of the management outcome studies |
04/06/2018 |
3842 |
Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation |
04/06/2018 |
3841 |
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH |
04/06/2018 |
3840 |
Clinical and economic impact of compression in the acute phase of deep vein thrombosis |
04/06/2018 |
3839 |
Guidelines risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal |
04/06/2018 |
3838 |
L avis sur les bénéfices/risques des statines de l’Académie de médecine ne fait pas l’unanimité |
04/06/2018 |
3837 |
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests |
04/06/2018 |
3836 |
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer |
04/06/2018 |
3835 |
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study |
04/06/2018 |
3834 |
Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism |
04/06/2018 |
3833 |
Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism |
04/06/2018 |
3832 |
First Successful Experimental Implantation of a Drainage Device to Reduce Lymphoedema in a Rat Lymphoedema Model |
03/06/2018 |
3831 |
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study |
03/06/2018 |
3830 |
Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications |
03/06/2018 |
3829 |
Editor’s Choice e Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)5 |
03/06/2018 |
3828 |
A Randomized Trial of Early Endovenous Ablation in Venous Ulceration |
03/06/2018 |
3827 |
Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain |
03/06/2018 |
3826 |
Usefulness of Statins for Prevention of Venous Thromboembolism |
31/05/2018 |
3825 |
Efficacité et effets indésirables des statines : évidences et polémiques |
30/05/2018 |
3824 |
Some asymptomatic abdominal aortic aneurysms smaller than 5.5 cm can be considered for elective repair |
30/05/2018 |
3823 |
Severe contralateral carotid stenosis or occlusion does not have an impact on risk of ipsilateral stroke after carotid endarterectomy |
30/05/2018 |
3822 |
Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism |
30/05/2018 |
3821 |
Organiser les soins non programmés dans les territoires Rapport de Thomas Mesnier Député de Charente |
30/05/2018 |
3820 |
Protein S deficiency in patients from the French Basque Country with various thrombotic conditions: a rarer inherited trait in autochthonous individuals? |
30/05/2018 |
3819 |
Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary Embolism Are Guidelines |
30/05/2018 |
3818 |
Limited Adherence to Peripheral Arterial Disease Guidelines and Suboptimal Ankle Brachial Index Reliability in Dutch Primary Care |
30/05/2018 |
3817 |
Predictors of subclinical carotid atherosclerosis in middle-aged women |
30/05/2018 |
3816 |
The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus |
30/05/2018 |
3815 |
The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus |
30/05/2018 |
3814 |
Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease |
30/05/2018 |
3813 |
Endovascular Versus Open Surgical Intervention in Patients with Takayasu’s Arteritis: A Meta-analysis |
30/05/2018 |
3812 |
Endovascular Versus Open Surgical Intervention in Patients with Takayasu’s Arteritis: A Meta-analysis |
30/05/2018 |
3811 |
Diagnosis and surgical management of inferior vena cava leiomyomatosis |
30/05/2018 |
3810 |
Clinical Effect and Cost-Effectiveness of Screening for Asymptomatic Carotid Stenosis: A Markov Model |
30/05/2018 |
3809 |
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) |
30/05/2018 |
3808 |
18F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis |
30/05/2018 |
3807 |
Wounds That Would Not Heal: Pyoderma Gangrenosum |
28/05/2018 |
3806 |
Vitamin K Antagonists After 6 Months of Low- Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism |
28/05/2018 |
3805 |
The Frequency of Unnecessary Testing in Hospitalized Patients |
28/05/2018 |
3804 |
Statin Use in Men and New Onset of Erectile Dysfunction: A Systematic Review and Meta-Analysis |
28/05/2018 |
3803 |
Risk of Venous Thromboembolism Following Peripherally Inserted Central Catheter Exchange: An Analysis of 23,000 Hospitalized Patients |
28/05/2018 |
3802 |
Improved Cardiovascular Risk Factors Control Associated with a Large-Scale Population Management Program Among Diabetes Patients |
28/05/2018 |
3801 |
Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease |
28/05/2018 |
3800 |
Inferior Vena Cava Filters in Patients with Acute Pulmonary Embolism and Cancer |
28/05/2018 |
3799 |
Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism |
28/05/2018 |
3798 |
Retinal Vasculitis in Takayasu’s Arteritis |
27/05/2018 |
3797 |
Anticoagulants oraux d’action directe |
27/05/2018 |
3796 |
Presentation, diagnosis, and management of popliteal artery entrapment syndrome: 11 years of experience with 61 legs |
27/05/2018 |
3795 |
Interventions for lower extremity peripheral artery disease |
27/05/2018 |
3794 |
How I treat the postthrombotic syndrome |
27/05/2018 |
3793 |
Fibrose myocardique détectée à l’IRM cardiaque : un substrat aux arythmies ventriculaires et à la mort subite |
27/05/2018 |
3792 |
Diagnosis and Management of the Antiphospholipid Syndrome |
27/05/2018 |
3791 |
L’Europe étend l’AMM de l’anti PCSK9 evolocumab aux patients à haut risque CV |
27/05/2018 |
3790 |
Anticoagulants oraux d’action directe |
23/05/2018 |
3789 |
Chronic Thromboembolic Pulmonary Hypertension |
23/05/2018 |
3788 |
Antithrombotic Therapy for Peripheral Artery Disease |
23/05/2018 |
3787 |
L’Europe étend l’AMM de l’anti PCSK9 evolocumab aux patients à haut risque CV |
20/05/2018 |
3786 |
Poor NOAC Adherence in AF Wreaks Havoc on Efficacy vs Warfarin |
20/05/2018 |
3785 |
TranscranialDopplermonitoringformicroemboli:a marker ofahigh-riskcarotidplaque |
17/05/2018 |
3784 |
Medical treatmentstrategiestoreduceperioperative morbidity andmortalityaftercarotidsurgery |
17/05/2018 |
3783 |
Introduction:Evolutionofcarotidatherosclerotic disease therapies |
17/05/2018 |
3782 |
Imaging ofthehigh-riskcarotidplaque:magnetic resonance imaging |
17/05/2018 |
3781 |
Imaging ofhigh-riskcarotidplaques:ultrasound |
17/05/2018 |
3780 |
High-risk carotidplaque:lessonslearnedfrom histopathology |
17/05/2018 |
3779 |
carotid arterydisease |
17/05/2018 |
3778 |
Clinical need,design,andgoalsfortheCarotid RevascularizationandMedicalManagementfor Asymptomatic CarotidStenosistrial |
17/05/2018 |
3777 |
Socioeconomic Status and Cardiovascular Outcomes Challenges and Interventions |
16/05/2018 |
3776 |
Ablation vs traitement médicamenteux dans la FA: les résultats de CABANA divisent |
16/05/2018 |
3775 |
Management appropriateness and outcomes of patients with acute pulmonary embolism |
16/05/2018 |
3774 |
Mammograms identify heart disease risk |
16/05/2018 |
3773 |
Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism – Coming to consensus when the debate rages on |
16/05/2018 |
3772 |
European consensus on the diagnosis and management of fibromuscular dysplasia |
16/05/2018 |
3771 |
European consensus on the diagnosis and management of fibromuscular dysplasia |
16/05/2018 |
3770 |
 |
16/05/2018 |
3769 |
Échographie Doppler des artères rénales. Recommandations et facteurs prédictifs de la présence d’une sténose serrée. Analyse rétrospective de 450 examens consécutifs |
16/05/2018 |
3768 |
Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules |
16/05/2018 |
3767 |
RELATIONSHIP OF BREAST ARTERY CALCIFICATION TO CORONARY ARTERY STENOSIS: IS MAMMOGRAPHY THE NEW SCREENING TEST FOR CORONARY ARTERY STENOSIS IN WOMEN? |
16/05/2018 |
3766 |
A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice |
16/05/2018 |
3765 |
Congrès Royal Society of Medecine/Société Française de Phlébologie Venous Forum – 25-27 JUIN 2018 LONDRES |
16/05/2018 |
3764 |
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) |
13/05/2018 |
3763 |
Usefulness of a systematic screening of carotid atherosclerosis inasymptomatic people with type 2 diabetes for cardiovascular riskreclassification |
13/05/2018 |
3762 |
Risk and Prognosis of Cancer after Lower Limb Arterial Thrombosis |
13/05/2018 |
3761 |
Non-thrombotic pulmonary artery embolism – Don’t forget the differential |
13/05/2018 |
3760 |
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants |
13/05/2018 |
3759 |
L’effet Nocebo : particularités et conséquences pour le clinicien |
13/05/2018 |
3758 |
Démographie médicale : jusqu’ici tout va presque bien (ou pas si mal) |
13/05/2018 |
3757 |
European consensus on the diagnosis and management of fibromuscular dysplasia |
13/05/2018 |
3756 |
Essais de non-infériorité et d’équivalence : les points clés de leur méthodologie |
13/05/2018 |
3755 |
Editor’s Choice e Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) |
13/05/2018 |
3754 |
Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs |
13/05/2018 |
3753 |
Chest Pain and Mental Stress–Induced Myocardial Ischemia: Sex Differences |
13/05/2018 |
3752 |
Calciphylaxis |
13/05/2018 |
3751 |
Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women |
13/05/2018 |
3750 |
Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice |
13/05/2018 |
3749 |
Managing thrombosis in cancer patients |
13/05/2018 |
3748 |
Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays |
13/05/2018 |
3747 |
Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness |
13/05/2018 |
3746 |
About ICTHIC |
09/05/2018 |
3745 |
Risk and Prognosis of Cancer after Lower Limb Arterial Thrombosis |
07/05/2018 |
3744 |
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants |
07/05/2018 |
3743 |
L’effet Nocebo : particularités et conséquences pour le clinicien |
07/05/2018 |
3742 |
Démographie médicale : jusqu’ici tout va presque bien (ou pas si mal) |
07/05/2018 |
3741 |
European consensus on the diagnosis and management of fibromuscular dysplasia |
07/05/2018 |
3740 |
Essais de non-infériorité et d’équivalence : les points clés de leur méthodologie |
07/05/2018 |
3739 |
Editor’s Choice e Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) |
07/05/2018 |
3738 |
Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs |
07/05/2018 |
3737 |
Chest Pain and Mental Stress–Induced Myocardial Ischemia: Sex Differences |
07/05/2018 |
3736 |
Calciphylaxis |
07/05/2018 |
3735 |
Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women |
07/05/2018 |
3734 |
Commencez avec MEGA |
07/05/2018 |
3733 |
Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice |
07/05/2018 |
3732 |
Managing thrombosis in cancer patients |
07/05/2018 |
3731 |
Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays |
07/05/2018 |
3730 |
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation |
06/05/2018 |
3729 |
Tolérance rénale des anticoagulants oraux : AVK / AOD ? |
06/05/2018 |
3728 |
The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants |
06/05/2018 |
3727 |
Syndrome de Lemierre : diagnostic, exploration, traitement |
06/05/2018 |
3726 |
Surdosages en antivitamines K : audit de la prise en charge hospitalière |
06/05/2018 |
3725 |
Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism |
06/05/2018 |
3724 |
Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum |
06/05/2018 |
3723 |
Protocole National de Diagnostic et de Soins (PNDS) Syndrome de Marfan et apparentés |
06/05/2018 |
3722 |
Filière FAVA-Multi Maladies Vasculaires Rares avec atteinte multisystémique |
06/05/2018 |
3721 |
Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States |
06/05/2018 |
3720 |
PCSK9 inhibition for LDL lowering and beyond – implications for patients with peripheral artery disease |
06/05/2018 |
3719 |
Variation of renal function over time is associated with majorbleeding in patients treated with direct oral anticoagulants JTH2018 |
05/05/2018 |
3718 |
Tolérance rénale des anticoagulants oraux AVK AOD ICAR2018 |
05/05/2018 |
3717 |
The HAS-BLED, ATRIA, and ORBIT Bleeding Scores DOAC AJM2018 |
05/05/2018 |
3716 |
Syndrome de Lemierre diagnostic exploration, traitementRMI2018 |
05/05/2018 |
3715 |
Surdosages en antivitamines K audit de la prise en charge hospitalièreRMI2018 |
05/05/2018 |
3714 |
Sex-speci?c performance of pre-imaging diagnostic algorithmsfor pulmonary embolismJTH2018 |
05/05/2018 |
3713 |
Risk of early-onset breast cancer among women exposed tothoracic computed tomography in pregnancy JTH2018 |
05/05/2018 |
3712 |
Reversal agents for non-vitamin K Anticoa NRC2018 |
05/05/2018 |
3711 |
Protocole National de Diagnostic et de Soins (PNDS) MARFAN MARS 2018 |
05/05/2018 |
3710 |
Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United StatesNEJM2018 |
05/05/2018 |
3709 |
PCSK9 inhibition for LDL lowering and beyond-implications for patients with PADVASA2018 |
05/05/2018 |
3708 |
FDA Approves First Factor Xa Inhibitor Antidote, Andexxa |
05/05/2018 |
3707 |
Risk Assessment and Management of Venous Thromboembolism inWomen during Pregnancy and Puerperium (SAVE): An International, Cross-sectional Study |
29/04/2018 |
3706 |
Predictors of Early Mortality in Cancer-Associated Thrombosis: Analysis of the RIETE Database |
29/04/2018 |
3705 |
Screening for Lung Cancer CHEST Guideline and Expert Panel Report |
29/04/2018 |
3704 |
Major Adverse Limb Events in Lower Extremity Peripheral Artery Disease: COMPASS Trial |
29/04/2018 |
3703 |
Duration of anticoagulation after venous thromboembolismin realworld clinical practice |
29/04/2018 |
3702 |
C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study |
29/04/2018 |
3701 |
Correction to: 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
29/04/2018 |
3700 |
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus |
29/04/2018 |
3699 |
Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease |
29/04/2018 |
3698 |
Age and sex of surgeons and mortality of older surgical patients: observational study |
29/04/2018 |
3697 |
Influence of different types of compression garments on exercise-induced muscle damage markers after a soccer match |
24/04/2018 |
3696 |
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial |
24/04/2018 |
3695 |
Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival |
24/04/2018 |
3694 |
Externally applied compression therapy for Fontan patients |
24/04/2018 |
3693 |
Effect of graduated compression stockings on venous lower limb hemodynamics in healthy amateur runners |
24/04/2018 |
3692 |
Effect of graduated compression stockings on venous lower limb hemodynamics in healthy amateur runners |
24/04/2018 |
3691 |
Acute venous iliofemoral thrombosis: early surgical thrombectomy is effective and durable |
24/04/2018 |
3690 |
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials |
24/04/2018 |
3689 |
Deep Vein Thrombosis After Complex Posterior Spine Surgery: Does Staged Surgery Make a Difference? |
24/04/2018 |
3688 |
Comparison between two-point and three-point compression ultrasound for the diagnosis of deep vein thrombosis |
24/04/2018 |
3687 |
Acute Effects of Graduated Elastic Compression Stockings in Patients with Symptomatic Varicose Veins: A Randomised Double Blind Placebo Controlled Trial |
24/04/2018 |
3686 |
Absent Inferior Vena Cava Leading to Recurrent Lower Extremity Deep Vein Thrombosis in a United States Marine |
24/04/2018 |
3685 |
A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux |
24/04/2018 |
3684 |
A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer – A real world experience |
24/04/2018 |
3683 |
A New Two Component Compression System Turning an Elastic Bandage into an Inelastic Compression Device: Interface Pressure, Stiffness, and Haemodynamic Effectiveness |
24/04/2018 |
3682 |
Inscriptions à la XIXème journée du GITA |
24/04/2018 |
3681 |
Si la lettre d |
16/04/2018 |
3680 |
Les nouvelles en direct de l |
16/04/2018 |
3679 |
Palliative is not only terminal |
15/04/2018 |
3678 |
Review the prevalence of occult cancer detection in patients with venous thromboembolism (VTE) |
15/04/2018 |
3677 |
En direct de l’ICTHIC |
15/04/2018 |
3676 |
 |
10/04/2018 |
3675 |
 |
09/04/2018 |
3674 |
 |
05/04/2018 |
3673 |
 |
04/04/2018 |
3672 |
What I wish I’d known before my hospital discharge |
03/04/2018 |
3671 |
Summary of opinion1 (post authorisation) |
03/04/2018 |
3670 |
Ultrasound for Lower Extremity Deep Venous Thrombosis |
03/04/2018 |
3669 |
Statins in Peripheral Artery Disease What Are We Waiting For? |
03/04/2018 |
3668 |
Pollution Exposure Counteracts Exercise Benefits Exercise in Green Spaces, Pollution Reductions Recommended |
03/04/2018 |
3667 |
Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes |
03/04/2018 |
3666 |
Outcomes after early and delayed carotid endarterectomy in patients with symptomatic carotid artery stenosis |
03/04/2018 |
3665 |
Management of antiplatelet therapy inpatients undergoing elective invasiveprocedures: Proposals from the FrenchWorking Group on perioperative hemostasis(GIHP) and the French Study Group onthrombosis and hemostasis (GFHT). Incollaboration with the French S |
03/04/2018 |
3664 |
Levels of ambient air pollution according to mode of transport: a systematic review |
03/04/2018 |
3663 |
Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics? |
03/04/2018 |
3662 |
How I treat type 2B von Willebrand disease |
03/04/2018 |
3661 |
How I treat heavy menstrual bleeding associated with anticoagulants |
03/04/2018 |
3660 |
Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease |
03/04/2018 |
3659 |
Anticoagulants oraux directs (AOD) : unemise au point nécessaire |
03/04/2018 |
3658 |
Reduction in major adverse limb events in the COMPASS trial |
01/04/2018 |
3657 |
Evolution of type II endoleaks based on different ultrasound-identified patterns |
01/04/2018 |
3656 |
Phytothérapie : peut-on prescrire sans risque chez le patient insuffisant rénal ? |
01/04/2018 |
3655 |
Non-invasive imaging techniques in lower extremity artery disease |
01/04/2018 |
3654 |
Epidemiology of lower extremity peripheral artery disease in veterans |
01/04/2018 |
3653 |
Clinical characteristics of spontaneous isolated visceral artery dissection |
01/04/2018 |
3652 |
Clinical characteristics and outcome of isolated infrarenal aortic stenosis in young patients |
01/04/2018 |
3651 |
Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care |
01/04/2018 |
3650 |
Avis EMA : levolocumab bientôt autorisé chez les patients à haut risque CV |
01/04/2018 |
3649 |
Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients |
01/04/2018 |
3648 |
Arterial reconstructions for chronic lower extremity ischemia in preadolescent and adolescent children |
01/04/2018 |
3647 |
Air pollution and health |
01/04/2018 |
3646 |
What have we learned from real-world NOAC studies in venous thromboembolism treatment? |
01/04/2018 |
3645 |
Pulmonary embolism severity assessment and prognostication |
01/04/2018 |
3644 |
Preface to Diagnosis of venous thromboembolism |
01/04/2018 |
3643 |
New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism |
01/04/2018 |
3642 |
Modern diagnosis of chronic thromboembolic pulmonary hypertension |
01/04/2018 |
3641 |
Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review |
01/04/2018 |
3640 |
Diagnosis of venous thromboembolism in pregnancy |
01/04/2018 |
3639 |
Diagnosis of recurrent venous thromboembolism |
01/04/2018 |
3638 |
Diagnosis of deep-vein thrombosis |
01/04/2018 |
3637 |
Diagnosis and Exclusion of Pulmonary Embolism |
01/04/2018 |
3636 |
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses |
01/04/2018 |
3635 |
Occult cancer detection in patients with hemostatic disorder and venous thromboembolism |
01/04/2018 |
3634 |
Treatment outcomes in diabetic patients with chronic limb-threatening ischemia |
27/03/2018 |
3633 |
The Lancet Commission on pollution and health |
27/03/2018 |
3632 |
The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study |
27/03/2018 |
3631 |
Ten-year review of isolated spontaneous mesenteric arterial dissections Courtney E. Morgan, |
27/03/2018 |
3630 |
Stroke Risk Factors Unique to Women |
27/03/2018 |
3629 |
Stroke in Women Recognizing Opportunities for Prevention and Treatment |
27/03/2018 |
3628 |
Leiomyosarcoma of the inferior vena cava presenting as a cardiac mass |
27/03/2018 |
3627 |
Cancer et récidive thromboembolique veineuse : les clés d’une prise en charge optimale |
27/03/2018 |
3626 |
Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis |
27/03/2018 |
3625 |
Peri-procedural antithrombotic management: time to burn the bridge? |
27/03/2018 |
3624 |
Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study |
27/03/2018 |
3623 |
Venous Thromboembolism Quality Measures Fail to Accurately Measure Quality |
25/03/2018 |
3622 |
Utilité du TTR (temps passé dans la ciblethérapeutique) dans le suivi des patientssous antivitamine K : analyse d’une cohortede patients |
25/03/2018 |
3621 |
Ulcère de jambe : une cause peut en cacher une autre |
25/03/2018 |
3620 |
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads |
25/03/2018 |
3619 |
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm |
25/03/2018 |
3618 |
Spontaneous Coronary Artery Dissection: Current State of the Science A Scientific Statement From the American Heart Association |
25/03/2018 |
3617 |
Résultats à long terme (? 10 ans) après chirurgie bariatrique : revue de la littérature |
25/03/2018 |
3616 |
Les maladies cardiovasculaires sont responsables de 37 % des décès en Europe |
25/03/2018 |
3615 |
Prevalence of Renal Insufficiency in Cancer Patients and Implications for Anticancer Drug Management The Renal Insufficiency and Anticancer Medications (IRMA) Study |
25/03/2018 |
3614 |
Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood |
25/03/2018 |
3613 |
Gender balance in time-keeping at life science conferences |
25/03/2018 |
3612 |
Et_si tabac CH |
25/03/2018 |
3611 |
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation |
25/03/2018 |
3610 |
Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes Implications for the Cardiovascular Disease Specialist |
25/03/2018 |
3609 |
ACC : De FOURIER à ODYSSEY : l’e |
25/03/2018 |
3608 |
Abdominal aortic aneurysm in women |
25/03/2018 |
3607 |
Comment évolue le tabagisme en France ? |
25/03/2018 |
3606 |
Comparison of ultrasound-guided endovenous laser ablation and radiofrequency for the varicose veins treatment: An updated meta-analysis |
25/03/2018 |
3605 |
Résultats à long terme (? 10 ans) après chirurgie bariatrique : revue de la littérature |
25/03/2018 |
3604 |
Transinguinal interstitial (intranodal) lymphatic embolization to treat high-output postoperative lymphocele |
21/03/2018 |
3603 |
The Target of Rapamycin and Mechanisms of Cell Growth |
21/03/2018 |
3602 |
The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm |
21/03/2018 |
3601 |
Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose |
21/03/2018 |
3600 |
Outcomes of endovascular reconstruction of the inferior vena cava with self-expanding nitinol stents |
21/03/2018 |
3599 |
COMPASS-guided secondary prevention |
21/03/2018 |
3598 |
Putting on the brakes: NOAC antidotes |
21/03/2018 |
3597 |
Quest to find the optimal duration |
21/03/2018 |
3596 |
Balancing ischaemia and bleeding risks with novel oral anticoagulants |
21/03/2018 |
3595 |
Anticoagulant drugs Eduardo Ramacciotti and Jawed Fareed |
21/03/2018 |
3594 |
Diagnosis of acute Pulmonary Embolism |
21/03/2018 |
3593 |
Endovascular revascularisation versus conservative management for intermittent claudication (Review) |
21/03/2018 |
3592 |
Cancer-associated ischemic stroke: A retrospective multicentre cohort study |
21/03/2018 |
3591 |
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis |
21/03/2018 |
3590 |
Accuracy of Routine Endoscopy Diagnosing Colonic Ischaemia After Abdominal Aortic Aneurysm Repair: A Meta-analysis |
21/03/2018 |
3589 |
A Propensity Matched Comparison for Open and Endovascular Treatment of Post-carotid Endarterectomy Restenosis |
21/03/2018 |
3588 |
COEUR, ARTÈRES ET FEMMES AUJOURD’HUI, LES FEMMES SONT MOINS PROTÉGÉES QUE LES HOMMES |
21/03/2018 |
3587 |
ACTIVITÉ PHYSIQUE A VOUS DE BOUGER POUR PROTÉGER VOTRE COEUR ! |
21/03/2018 |
3586 |
Transinguinal interstitial (intranodal) lymphatic embolization to treat high-output postoperative lymphocele |
20/03/2018 |
3585 |
The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm |
20/03/2018 |
3584 |
The Investigation and Management of Iliac Artery Endofibrosis: Lessons Learned from a Case Series |
20/03/2018 |
3583 |
VEST : 35 % de décès évités dans les 3 mois post-IDM avec la « veste défibrillateur » |
20/03/2018 |
3582 |
Surdosages en antivitamines K : audit de la prise en chargehospitalière |
20/03/2018 |
3581 |
Right heart thrombi in pulmonary embolism |
20/03/2018 |
3580 |
Novel anticoagulants: general overview and practical considerations for dental practitioners |
20/03/2018 |
3579 |
Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants |
20/03/2018 |
3578 |
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment |
20/03/2018 |
3577 |
Outcomes of endovascular reconstruction of the inferior vena cava with self-expanding nitinol stents |
20/03/2018 |
3576 |
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism |
20/03/2018 |
3575 |
MICROEMBOLIC SIGNALS PREDICT RECURRENCE OF ISCHEMIC EVENTS IN SYMPTOMATIC PATIENTS WITH MIDDLE CEREBRALARTERY STENOSIS |
20/03/2018 |
3574 |
Eliminer l’embolie pulmonaire à moindre frais chez les patients à bas risque |
20/03/2018 |
3573 |
Review: An overview and analysis of novel oral anticoagulants and their dental implications |
20/03/2018 |
3572 |
Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients The PROPER Randomized Clinical Trial |
20/03/2018 |
3571 |
Drug-induced thrombocytopenia after anticoagulation with rivaroxaban |
20/03/2018 |
3570 |
Prevention and treatment of the post-thrombotic syndrome |
20/03/2018 |
3569 |
MALADIES DES ARTÈRES |
20/03/2018 |
3568 |
Outcomes and management costs of peripheral artery disease in France |
13/03/2018 |
3567 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists a comprehensive systematic review and metaanalysisJN2018 |
11/03/2018 |
3566 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis |
11/03/2018 |
3565 |
ODYSSEY Outcomes: Alirocumab Cuts CV Events, All-Cause Death Post-ACS |
11/03/2018 |
3564 |
Diabète : à la rencontre des autres types |
11/03/2018 |
3563 |
Extracranial vertebral artery dissection Findings and advantages of ultrasonography |
11/03/2018 |
3562 |
The year 2017 in cardiology: aorta and peripheral circulation |
11/03/2018 |
3561 |
The 2017 ESC Guidelines on PADs: what’s new? |
11/03/2018 |
3560 |
The ‘Ten Commandments’ of 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases |
11/03/2018 |
3559 |
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer |
11/03/2018 |
3558 |
ROLE OF A CLINICAL PREDICTION SCORE IN A CTEPH RULE-OUT STRATEGY |
11/03/2018 |
3557 |
Peripheral arterial disease guidelines: the Cinderella of cardiovascular medicine gets the attention it deserves |
11/03/2018 |
3556 |
Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials |
11/03/2018 |
3555 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis |
11/03/2018 |
3554 |
MICI : nouvelles recommandations européennes sur le diagnostic et la surveillance |
11/03/2018 |
3553 |
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus Mechanistic Links, Clinical Data, and Future Directions |
11/03/2018 |
3552 |
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) |
11/03/2018 |
3551 |
Maladie thromboembolique veineuse chez le sujet jeune – A propos d’un cas |
11/03/2018 |
3550 |
Lipides – État des lieux…il y a peu encore, c’est-à-dire avant 2015 |
11/03/2018 |
3549 |
Les statines diminuent la mortalité en prévention primaire : il n’y a pas de doute à avoir sur ce point |
11/03/2018 |
3548 |
La sclérodermie systémique |
11/03/2018 |
3547 |
Acute aortic syndromes: diagnosis and management, an update |
11/03/2018 |
3546 |
Endarterectomy for Symptomatic and Asymptomatic Carotid Stenosis Peter M. Rothwell, MD, PhD, FRCP, FMedSci |
11/03/2018 |
3545 |
What have we learned from real-world NOAC studies in venous thromboembolism treatment? |
07/03/2018 |
3544 |
Use of Direct Oral Anticoagulants in Patients on Hemodialysis |
07/03/2018 |
3543 |
Thrombophilia testing in children: What and when should be tested? |
07/03/2018 |
3542 |
The coagulation system in atherothrombosis: Implications for new therapeutic strategies |
07/03/2018 |
3541 |
THE ASSESSMENT OF DIAGNOSTIC ACCURACY FOR BASILAR ARTERY STENOSIS BY TRANSCRANIAL COLOR-CODED SONOGRAPHY |
07/03/2018 |
3540 |
Scoring systems for the post-thrombotic syndrome |
07/03/2018 |
3539 |
Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study |
07/03/2018 |
3538 |
Alzheimer et performance cognitive : à un stade précoce, le cerveau compense |
07/03/2018 |
3537 |
L exercice physique pour le traitement de la claudication intermittente |
07/03/2018 |
3536 |
Éducation thérapeutique en prévention primaire cardiovasculaire :intérêt prolongé à 4 ans |
07/03/2018 |
3535 |
Direct oral anticoagulants after bariatric surgery: To use or not to use |
07/03/2018 |
3534 |
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis |
07/03/2018 |
3533 |
Le changement climatique est avant tout une question de santé publique |
07/03/2018 |
3532 |
Clinical relevance of syncope in patients with pulmonary embolism |
07/03/2018 |
3531 |
What’s coming for health science and policy in 2018? Global experts look ahead in their field |
07/03/2018 |
3530 |
What’s coming for health science and policy in 2018? Global experts look ahead in their field |
07/03/2018 |
3529 |
What have we learned from real-world NOAC studies in venous thromboembolism treatment? |
07/03/2018 |
3528 |
Symptômes musculaires associés aux statines : quelle prise en charge en 2018 ? |
07/03/2018 |
3527 |
Stimulateurs et les défibrillateurs « anciens » : l’IRM ne devrait plus être refusée |
07/03/2018 |
3526 |
Rivaroxaban vs Warfarin and Risk of Post-Thrombotic Syndrome among Patients with Venous Thromboembolism |
07/03/2018 |
3525 |
Nouvelles recommandations pour les dyslipidémies en 2018 : une revue critique des preuves |
07/03/2018 |
3524 |
Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population |
07/03/2018 |
3523 |
Evaluating the Potential of Routine Blood Tests to Identify the Risk of Deep Vein Thrombosis: A 1-Year Monocenter Cohort Study |
07/03/2018 |
3522 |
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis |
07/03/2018 |
3521 |
Dépistage de l’athérosclérose pour prévenir le risque cardiovasculaire : un débat pro-contre |
07/03/2018 |
3520 |
Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease |
07/03/2018 |
3519 |
Rivaroxaban vs Warfarin and Risk of Post-Thrombotic Syndrome among Patients with Venous Thromboembolism |
07/03/2018 |
3518 |
Great Debates in Vascular Medicine: Should all inferior vena cava (IVC) filters be removed? |
07/03/2018 |
3517 |
Vitamin K Antagonists after 6 Months of Low- Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism |
07/03/2018 |
3516 |
 |
07/03/2018 |
3515 |
The 2017 ESC Guidelines on PADs what’s new ESC2018 |
05/03/2018 |
3514 |
L’artériopathie des membres inférieurs PM2018 |
05/03/2018 |
3513 |
The ‘Ten Commandments’ of 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases ESC2018 |
05/03/2018 |
3512 |
Réadaptation vasculaire de l’artériopathie oblitérante des membres inférieurs en 2018PM2018 |
05/03/2018 |
3511 |
Peripheral arterial disease guidelines the Cinderella of cardiovascular medicine gets the attention it deservesESC2018 |
05/03/2018 |
3510 |
the Cinderella of cardiovascular medicine gets the attention it deserves |
05/03/2018 |
3509 |
Épidémiologie de l’artériopathie des membres inférieurs |
05/03/2018 |
3508 |
Artériopathie des membres inférieurs athéromateuse : diagnostic |
05/03/2018 |
3507 |
Artériopathie des membres inférieurs : le traitement |
05/03/2018 |
3506 |
 |
05/03/2018 |
3505 |
Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease |
05/03/2018 |
3504 |
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-relatedmortality andmorbidity in people with unprovoked VTE (Review) |
01/03/2018 |
3503 |
Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service |
01/03/2018 |
3502 |
Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism |
01/03/2018 |
3501 |
Detection of intrathrombotic endothelial progenitor cells and its application to thrombus age estimation in a murine deep vein thrombosis model |
01/03/2018 |
3500 |
Cost-Effectiveness Analysis of Treatment Acute Deep Vein Thrombosis in Clinic of Vascular Surgery Sarajevo |
01/03/2018 |
3499 |
Clot structure predicts recurrent thrombosis |
01/03/2018 |
3498 |
Clinical characteristics, risk factors, and outcomes of usual and unusual site venous thromboembolism |
01/03/2018 |
3497 |
Chronic complications of venous thromboembolism |
01/03/2018 |
3496 |
Catheter-directed thrombolysis to avoid late consequences of acute deep vein thrombosis |
01/03/2018 |
3495 |
Bedside Diagnosis of Deep Vein Thrombosis Using a Pocket- Sized Ultrasound Device |
01/03/2018 |
3494 |
Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study |
01/03/2018 |
3493 |
Are revision hip arthroplasty patients at higher risk for venous thromboembolic events than primary hip arthroplasty patients? |
01/03/2018 |
3492 |
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study |
01/03/2018 |
3491 |
Utility of a Clinical Prediction Rule to Exclude Pulmonary Embolism Among Low-Risk Emergency Department Patients Reason to PERC Up |
27/02/2018 |
3490 |
Prise en charge de la thrombose veineuse profonde des membres inférieurs au stade aigu |
27/02/2018 |
3489 |
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study |
27/02/2018 |
3488 |
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs) |
27/02/2018 |
3487 |
Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells |
27/02/2018 |
3486 |
Initial Treatment of Hypertension |
27/02/2018 |
3485 |
Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism |
27/02/2018 |
3484 |
Risk of early onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum |
27/02/2018 |
3483 |
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state |
27/02/2018 |
3482 |
Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients |
27/02/2018 |
3481 |
Deep vein thrombosis |
27/02/2018 |
3480 |
GP who altered notes of patient who died after DVT was missed is suspended |
27/02/2018 |
3479 |
VARIATION OF RENAL FUNCTION OVER TIME IS ASSOCIATED WITH MAJOR BLEEDING IN PATIENTS TREATED WITH DIRECT ORAL ANTICOAGULANTS FOR ATRIAL FIBRILLATION |
27/02/2018 |
3478 |
TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study |
27/02/2018 |
3477 |
Thrombophilia testing in children: What and when should be tested? |
27/02/2018 |
3476 |
Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome5 |
27/02/2018 |
3475 |
Pulmonary embolism in Europe – Burden of illness in relationship to healthcare resource utilization and return to work |
27/02/2018 |
3474 |
Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children |
27/02/2018 |
3473 |
L’artériopathie oblitérantedesmembres inférieurs chezlafemme |
27/02/2018 |
3472 |
Épidémiologie del’artériopathiedes membresinférieurs |
27/02/2018 |
3471 |
Du nouveaudanslesanévrysmesthoraco- abdominaux |
27/02/2018 |
3470 |
The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis |
27/02/2018 |
3469 |
Risk factors of postthrombotic syndrome before and after deep venous thrombosis treatment |
27/02/2018 |
3468 |
Population impact of lung cancer screening in the United States: Projections from a microsimulation model |
27/02/2018 |
3467 |
PFO closure for secondary stroke prevention: is the discussion closed? |
27/02/2018 |
3466 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty |
27/02/2018 |
3465 |
Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty |
27/02/2018 |
3464 |
Myeloid-related protein-14 regulates deep vein thrombosis |
27/02/2018 |
3463 |
Mise au point Les thromboses veineuses distales : problématique de leur diagnostic et de leur traitement Distal deep-venous thrombosis: Diagnostic and therapeutic issues |
27/02/2018 |
3462 |
Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism |
27/02/2018 |
3461 |
Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study |
27/02/2018 |
3460 |
Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke |
27/02/2018 |
3459 |
Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
27/02/2018 |
3458 |
Epidemiology of cardiovascular disease: the new ESC Atlas and beyond |
27/02/2018 |
3457 |
Epidemiological and outcome data in Japanese patients with deep vein thrombosis with and without malignancy |
27/02/2018 |
3456 |
Combining oral anticoagulation and antiplatelet therapies: appropriate patient selection |
27/02/2018 |
3455 |
Treating blocked leg arteries |
27/02/2018 |
3454 |
xantia |
26/02/2018 |
3453 |
The coagulation system in atherothrombosis: Implications for new therapeutic strategies |
26/02/2018 |
3452 |
stv-311361-prise_en_charge_de_la_thrombose_veineuse_profonde_des_membres_inferieurs_au_stade_aigu-bernardlevy1-Wo2hY38AAQEAAEqNSccAAAAC-u |
26/02/2018 |
3451 |
Maladie cardiovasculaire chez la femme: quels facteurs de risque prendre en compte? |
26/02/2018 |
3450 |
Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial InfarctionCirc2018 |
26/02/2018 |
3449 |
Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstructionRPTH2018 |
26/02/2018 |
3448 |
Reference Values During Pregnancy |
26/02/2018 |
3447 |
Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis |
26/02/2018 |
3446 |
Liposuction as an effective treatment for lower extremity lymphoedema |
26/02/2018 |
3445 |
Indocyanine green near- infrared lymphangiography for evaluation of effectiveness of edema fluid flow under therapeutic compression |
26/02/2018 |
3444 |
Immediate effects of active exercise with compression therapy on lower-limb lymphedema |
26/02/2018 |
3443 |
GenderSex as a Social Determinant of Cardiovascular Risk Circ2018 |
26/02/2018 |
3442 |
Cardiovascular effects of marijuana and synthetic cannabinoidshe good, the bad, and the ugly Nat2018 |
26/02/2018 |
3441 |
Prise en charge de la thrombose veineuse profonde des membres inférieurs au stade aigu |
26/02/2018 |
3440 |
Deep vein thrombosis |
26/02/2018 |
3439 |
Wound Discharge after Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty |
26/02/2018 |
3438 |
Venous thromboembolism in patients with pemphigus: A cohort study |
26/02/2018 |
3437 |
Venous Thromboembolic Prophylaxis in Foot and Ankle Surgery |
26/02/2018 |
3436 |
The use of natural language processing on pediatric diagnostic radiology reports in the electronic health record to identify deep venous thrombosis in children |
26/02/2018 |
3435 |
Statins and venous thromboembolism: do they represent a viable therapeutic agent? |
26/02/2018 |
3434 |
Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study |
26/02/2018 |
3433 |
Sex disparities in hospitalization and mortality rates for venous thromboembolism |
26/02/2018 |
3432 |
Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR |
26/02/2018 |
3431 |
Prothrombin time?international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty |
26/02/2018 |
3430 |
Prevalence and risk factors of deep vein thrombosis in patients undergoing lumbar spine surgery |
26/02/2018 |
3429 |
Preliminary data on utility of subcutaneous unfractionated heparin in patients with deep cerebral venous thrombosis |
26/02/2018 |
3428 |
Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study |
26/02/2018 |
3427 |
Management of direct oral anticoagulant associated bleeding Results of a multinational surveyTR2018 |
26/02/2018 |
3426 |
Inferior vena cava atresia predisposing to acute lower extremity deep vein thrombosis in children: A descriptive dual-center study |
26/02/2018 |
3425 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty |
22/02/2018 |
3424 |
Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty |
22/02/2018 |
3423 |
 |
22/02/2018 |
3422 |
 |
21/02/2018 |
3421 |
Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events Result of the HNR Study (Heinz Nixdorf Recall) |
20/02/2018 |
3420 |
Treatment of Femoral Vein Obstruction Concomitant with Iliofemoral Stenting in Patients with Severe Post-thrombotic Syndrome |
20/02/2018 |
3419 |
The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis |
20/02/2018 |
3418 |
Sex-Based Assessment of Patient Presentation, Lesion Characteristics, and Treatment Modalities in Patients Undergoing Peripheral Vascular Intervention |
20/02/2018 |
3417 |
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension |
20/02/2018 |
3416 |
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension |
20/02/2018 |
3415 |
Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials |
20/02/2018 |
3414 |
Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease |
20/02/2018 |
3413 |
Meditation and Cardiovascular Risk Reduction A Scientific Statement From the American Heart Association |
20/02/2018 |
3412 |
Long-term Yoga May Reduce Inflammation in Metabolic Syndrome |
20/02/2018 |
3411 |
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants |
20/02/2018 |
3410 |
Failing health of the United States The role of challenging life conditions and the policies behind them |
20/02/2018 |
3409 |
L’avis de la Commission de la Transparence adopté le 11 octobre 2017 a fait l’objet d’observations écrites examinées le 24 janvier 2018. |
20/02/2018 |
3408 |
Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK |
20/02/2018 |
3407 |
Lipid-lowering for peripheral arterial disease of the lower limb (Review) |
20/02/2018 |
3406 |
Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients |
20/02/2018 |
3405 |
AHA Statement Adds Meditation to CV Risk-Reduction Strategies |
20/02/2018 |
3404 |
 |
21/02/2018 |
3403 |
Upper extremity deep venous thrombosis after port insertion: What are the risk factors? |
21/02/2018 |
3402 |
Association of Intracerebral Hemorrhage Among Patients taking VKA vs DOAC Jama2018 |
21/02/2018 |
3401 |
An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population StudyTR2018 |
21/02/2018 |
3400 |
Ultrasonographic analysis of arteriosclerotic plaques in the internal carotid artery |
21/02/2018 |
3399 |
Stroke Risk Factors Unique to Women |
21/02/2018 |
3398 |
Rosuvastatin use improvesmeasures of coagulation in patients with venous thrombosis |
21/02/2018 |
3397 |
Risk of early onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartumJTH2018 |
21/02/2018 |
3396 |
Population impact of lung cancer screening in the United States Projections from a microsimulation modelPlos2018 |
21/02/2018 |
3395 |
Phlegmasia Cerulea Dolens with Compartment Syndrome NEJM2018 |
21/02/2018 |
3394 |
Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation A systematic review and meta-analysisRPTH2018 |
21/02/2018 |
3393 |
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine NEJM2018 |
21/02/2018 |
3392 |
nter-Scan Reproducibility of Carotid Plaque Volume Measurements by 3-D Ultrasound UMB2018 |
21/02/2018 |
3391 |
Maladie de Kawasaki : mise à jour |
21/02/2018 |
3390 |
How I use catheter-directed interventional therapy to treat patients with venous thromboembolism Blood2018 |
21/02/2018 |
3389 |
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer |
21/02/2018 |
3388 |
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer |
21/02/2018 |
3387 |
DUPLEX SONOGRAPHY OF VERTEBRALARTERIES FOR EVALUATION OF PATIENTS WITH ACUTE VERTIGO |
21/02/2018 |
3386 |
COMMISSION DE LA TRANSPARENCE Avis 24 janvier 2018 |
18/02/2018 |
3385 |
Special Issue: Late Consequences of Venous Thromboembolism |
18/02/2018 |
3384 |
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians |
18/02/2018 |
3383 |
Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban |
18/02/2018 |
3382 |
Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease A Patient-Level Meta-Analysis |
18/02/2018 |
3381 |
Genetic Predisposition to High Blood Pressure and Lifestyle Factors |
18/02/2018 |
3380 |
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis |
18/02/2018 |
3379 |
Direct oral anticoagulant considerations in solid organ transplantation: A review |
18/02/2018 |
3378 |
Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis |
18/02/2018 |
3377 |
Developing a Clinical Approach to Air Pollution and Cardiovascular Health |
18/02/2018 |
3376 |
Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis |
18/02/2018 |
3375 |
Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice |
18/02/2018 |
3374 |
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis |
18/02/2018 |
3373 |
Mortality Reduction in EMPAREG OUTCOME Trial: Beyond the Antidiabetes Effect |
18/02/2018 |
3372 |
How fragile are clinical trial outcomes that support the CHEST clinical practice guidelines for venous thromboembolism? |
18/02/2018 |
3371 |
rapport_reev_aco_cteval234 |
14/02/2018 |
3370 |
Statins Have a Dose-Dependent Effect on Amputation and Survival in Peripheral Artery Disease Patients. |
13/02/2018 |
3369 |
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study |
13/02/2018 |
3368 |
Prognostic assessment for patients with cancer and incidental pulmonary embolism |
13/02/2018 |
3367 |
Arteriovenous Fistula: An Uncommon Cause of Heart Failure |
13/02/2018 |
3366 |
Artériopathies oblitérantes périphériques : effet protecteur sur les amputations des statines à forte dose |
13/02/2018 |
3365 |
Quel traitement anticoagulant au décours d’une embolie pulmonaire |
13/02/2018 |
3364 |
Duree optimale du traitement anticoagulant au decours d une embolie pulmonaire |
13/02/2018 |
3363 |
Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulation |
13/02/2018 |
3362 |
Aninstitution-widealgorithmfor direct-stickembolization of peripheral venousmalformations |
13/02/2018 |
3361 |
Natural history of spontaneous isolated celiac artery dissection after conservative treatment |
13/02/2018 |
3360 |
Natural history and management of renal artery aneurysms in a single tertiary referral center |
13/02/2018 |
3359 |
Implementation of a virtual vascular clinic with point-of-care ultrasound in an integrated health care system |
13/02/2018 |
3358 |
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors |
13/02/2018 |
3357 |
Transthoracic Ultrasound Evaluation of Arch and Descending Thoracic Aortic Pathology |
13/02/2018 |
3356 |
Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice |
13/02/2018 |
3355 |
Recommandations 2018 MTEV |
11/02/2018 |
3354 |
 |
11/02/2018 |
3353 |
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial |
11/02/2018 |
3352 |
Prise en charge des AVC : quoi de neuf dans les recommandations américaines? |
11/02/2018 |
3351 |
L’artériopathie oblitérantedesmembres inférieurs chezlafemme |
11/02/2018 |
3350 |
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke |
11/02/2018 |
3349 |
la seule re?duction du tabagisme ne diminue pas le risque de morbi-mortalite? cardiovasculaire |
11/02/2018 |
3348 |
UIP18_Publication-of-Abstracts |
06/02/2018 |
3347 |
Suitability for catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis according to various international consensus guidelines |
06/02/2018 |
3346 |
Pas assez de statines en prévention primaire chez les européens ? L’ESC défend ses recommandations |
06/02/2018 |
3345 |
Nouvelles recommandations européennes sur les artériopathies périphériques : quoi de neuf ? |
06/02/2018 |
3344 |
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study |
06/02/2018 |
3343 |
Analysis ofclinicalfactors affecting theratesoffatal pulmonary embolismand bleeding incancerpatients with venousthromboembolism |
06/02/2018 |
3342 |
Characterisation of carotid plaques with ultrasound elastography: feasibility and correlation with high-resolution magnetic resonance imaging |
06/02/2018 |
3341 |
Cancer risk associated with chronic diseases and disease markers: prospective cohort study |
06/02/2018 |
3340 |
Abdominal aortic aneurysm follow-up by shear wave elasticity imaging after endovascular repair in a canine model |
06/02/2018 |
3339 |
THROMBOSE ET CANCER UNE RELATION ÉTROITE ET COMPLEXE |
06/02/2018 |
3338 |
Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future |
06/02/2018 |
3337 |
syndromes_des_jambes_sans_repos_medicamenteux,_actualisation_fiche_novembre_2017-3 |
04/02/2018 |
3336 |
Reversal agents for non-vitamin K antagonist oral anticoagulants |
04/02/2018 |
3335 |
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection |
04/02/2018 |
3334 |
UNE MALADIE HÉRÉDITAIRE DE LA COAGULATION DU SANG |
04/02/2018 |
3333 |
Cancer risk associated with chronic diseases and disease markers: prospective cohort study |
04/02/2018 |
3332 |
Calcifications vasculaires dans le pseudoxanthome élastique chez l’enfant Vascular calcification in pseudoxanthoma elasticum in children |
04/02/2018 |
3331 |
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism |
04/02/2018 |
3330 |
2018-Journal_of_Ultrasound_in_MedicineYou have full text access to this contentRecommendations for Low-Grade Carotid Stenosis Follow-up Based on a Single-Institution Database |
04/02/2018 |
3329 |
Shear wave elastography imaging of carotid plaques: feasible, reproducible and of clinical potential |
04/02/2018 |
3328 |
Inferior Vena Cava Filters in Stable Patients with Acute Pulmonary Embolism Who Receive Thrombolytic Therapy |
04/02/2018 |
3327 |
Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy |
04/02/2018 |
3326 |
syndromes_des_jambes_sans_repos_medicamenteux,_actualisation_fiche_novembre_2017-3 |
04/02/2018 |
3325 |
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study |
04/02/2018 |
3324 |
Cancer risk associated with chronic diseases and disease markers: prospective cohort study |
04/02/2018 |
3323 |
Is real-time elastography helpful to differentiate acute from subacute deep venous thrombosis? A preliminary study |
04/02/2018 |
3322 |
Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia |
04/02/2018 |
3321 |
Urgent reversal of vitamin K antagonists |
04/02/2018 |
3320 |
Underuse of vitamin K antagonist and direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: A contemporary review |
04/02/2018 |
3319 |
Time-dependent trends in cardiovascular adverse events during follow-up after carotid or iliofemoral endarterectomy |
04/02/2018 |
3318 |
Thrombose veineuse profonde du membre supérieur chez une violoniste : « le syndrome de l’archet |
04/02/2018 |
3317 |
The history and historical treatments of deep vein thrombosis |
04/02/2018 |
3316 |
The diagnosis and treatment of venous thromboembolism in Asian patients |
04/02/2018 |
3315 |
The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer |
04/02/2018 |
3314 |
The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer |
04/02/2018 |
3313 |
The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer |
04/02/2018 |
3312 |
Temporal trends in the premorbid use of preventive treatments in patients with acute ischemic cerebrovascular events and a history of vascular disease: The Dijon Stroke Registry (1985–2010) |
04/02/2018 |
3311 |
Systematic review and meta-analysis of high-pressure intermittent limb compression for the treatment of intermittent claudication |
04/02/2018 |
3310 |
Statins Have a Dose-Dependent Effect on Amputation and Survival in Peripheral Artery Disease Patients. |
04/02/2018 |
3309 |
Smoking Even One Cigarette a Day Raises Cardiovascular Risk |
04/02/2018 |
3308 |
Detection and localization of surgically resectable cancers with a multi-analyte blood test |
04/02/2018 |
3307 |
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial |
04/02/2018 |
3306 |
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial |
04/02/2018 |
3305 |
Research ethics for emerging trial designs: does equipoise need to adapt? |
04/02/2018 |
3304 |
Repurposing Metformin for Cardiovascular Disease |
04/02/2018 |
3303 |
Recanalization after Extracranial Dissection: Effect of Antiplatelet Compared with Anticoagulant Therapy |
04/02/2018 |
3302 |
Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants |
04/02/2018 |
3301 |
Protecting Life and Limb in Peripheral Artery Disease |
04/02/2018 |
3300 |
Propranolol : un effet synergique avec l’immunothérapie dans le mélanome métastatique |
04/02/2018 |
3299 |
Prise en charge d’un nodule pulmonaire (pour généraliste) |
04/02/2018 |
3298 |
Predictors of Change in the Ankle Brachial Index with Exercise |
04/02/2018 |
3297 |
Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score |
04/02/2018 |
3296 |
Pour mieux soigner, des médicaments à écarter : bilan 2018 |
04/02/2018 |
3295 |
Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism—A Prospective Observational Study |
04/02/2018 |
3294 |
Parcours de soins, vers la mise en place d’unfinancement adapté : raisons et conditions deréussite |
04/02/2018 |
3293 |
Novel oral anticoagulants in the preoperative period: a meta-analysis |
04/02/2018 |
3292 |
Nouvelles recommandations européennes sur les artériopathies périphériques : quoi de neuf ? |
04/02/2018 |
3291 |
New Stroke Guidelines Extend Thrombectomy to 24 Hours |
04/02/2018 |
3290 |
EMTÉ PDAETCIEINNST S DANS LDEE MS AOLNGDOER DITEHSM DEAST A , EATR DTIEF ILC’IINETLLEELLIGENCE |
04/02/2018 |
3289 |
Maladies cardiopulmonaires et plongée |
04/02/2018 |
3288 |
Maladies cardiopulmonaires et plongée |
04/02/2018 |
3287 |
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) |
04/02/2018 |
3286 |
Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports |
04/02/2018 |
3285 |
Limb flexion-induced axial compression and bending in human femoropopliteal artery segments |
04/02/2018 |
3284 |
Le point sur la dysplasie fibromusculaire |
04/02/2018 |
3283 |
Initial Clinical Experience with Dual-Agent Relaxation Contrast for Isolated Lymphatic Channel Mapping1 |
04/02/2018 |
3282 |
High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia) |
04/02/2018 |
3281 |
Hémorragies sous AOD: les antidotes associés à un sur-risque thromboembolique |
04/02/2018 |
3280 |
Frailty and cardiovascular disease: A two-way street? |
04/02/2018 |
3279 |
Evaluation of the Time-Dependent Changes and the Vulnerability of Carotid Plaques Using Contrast-Enhanced Carotid Ultrasonography |
04/02/2018 |
3278 |
Endovascular recanalization for nonmalignant obstruction of the inferior vena cava |
04/02/2018 |
3277 |
Dyspnée chez le sportif |
04/02/2018 |
3276 |
Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis |
04/02/2018 |
3275 |
First release: 18 January 2018 www.sciencemag.org (Page numbers not final at time of first release) 1 The majority of localized cancers can be cured by surgery alone, without any systemic therapy (1). Once distant metas-tasis has occurred, however, surgic |
04/02/2018 |
3274 |
Detection and localization of surgically resectable cancers with a multi-analyte blood test |
04/02/2018 |
3273 |
Comment motiver le patient à arrêter de fumer ? |
04/02/2018 |
3272 |
Changes in Transcranial Doppler Flow Velocities in Children with Sickle Cell Disease: The Impact of Hydroxyurea Therapy |
04/02/2018 |
3271 |
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH |
04/02/2018 |
3270 |
CancerSEEK: Blood Test That Detects Eight Common Cancers |
04/02/2018 |
3269 |
CancerSEEK: Blood Test That Detects Eight Common Cancers |
04/02/2018 |
3268 |
E-cigarettes are beneficial in short term but longer forecast is uncertain, landmark US report finds |
04/02/2018 |
3267 |
Activité physique chez les seniors : quelle surveillance cardiovasculaire ? |
04/02/2018 |
3266 |
Acouphènes: des résultats prometteurs avec la stimulation électro-acoustique |
04/02/2018 |
3265 |
A single blood test to rule out acute coronary syndrome |
04/02/2018 |
3264 |
Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy |
04/02/2018 |
3263 |
Liver Stiffness Reflecting Right-Sided Filling Pressure Can Predict Adverse Outcomes in Patients With Heart Failure |
04/02/2018 |
3262 |
Pulmonary Emboli and Deep Venous Thrombosis during Adolescence |
04/02/2018 |
3261 |
InternationalSocietyfortheStudyofVascularAnomaliesClassification of SoftTissueVascularAnomalies:Survey-BasedAssessmentof Musculoskeletal Radiologists’ Use inClinicalPractice |
04/02/2018 |
3260 |
Systematic review of May-Thurner syndrome with emphasis on gender differences |
01/02/2018 |
3259 |
Statines en prévention primaire des événements cardiovasculaires Statins in primary prevention of cardiovascular disease |
01/02/2018 |
3258 |
POINTStandards de qualité pour la pratique del’examen écho-Doppler dans l’étude desmalformations et tumeurs vasculaires.Rapport de la Société franc¸aise demédecine vasculaire (SFMV) : actualisation2017 |
01/02/2018 |
3257 |
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial |
01/02/2018 |
3256 |
Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease |
01/02/2018 |
3255 |
Recommandations américaines sur la prise en charge des nausées pendant la grossesse |
01/02/2018 |
3254 |
Raynaud’s phenomenon |
01/02/2018 |
3253 |
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial |
01/02/2018 |
3252 |
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’ |
01/02/2018 |
3251 |
Expert consensus document on themeasurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity |
01/02/2018 |
3250 |
Prise en charge de la thrombose veineuse profonde des membres inférieurs à la phase aiguë STV 2017 |
01/02/2018 |
3249 |
Prophylaxie péri-opératoire des accidents thrombo-emboliques en cas de cancer |
01/02/2018 |
3248 |
President Trump’s Mental Health — Is It Morally Permissible for Psychiatrists to Comment? |
01/02/2018 |
3247 |
Pregnancy-associated thrombosis |
01/02/2018 |
3246 |
Prediction Score for Anticoagulation Control Quality Among Older Adults |
01/02/2018 |
3245 |
POURQUOI VOUS INTÉRESSER À LA CONSOMMATION DE FRUITS ET LéGUMES DE VOS PATIENTS ? |
01/02/2018 |
3244 |
Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer A Systematic Review and Meta-analysis |
01/02/2018 |
3243 |
Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer |
01/02/2018 |
3242 |
Panvascular disease – Epidemiology and prevention |
01/02/2018 |
3241 |
Overview of VTE treatment in cancer according to clinical guidelines |
01/02/2018 |
3240 |
Outcomes of Spontaneous Isolated Superior Mesenteric Artery Dissection Without Antithrombotic Use |
01/02/2018 |
3239 |
OPTIMAL ULTRASOUND CRITERIA FOR GRADING STENOSIS OF THE SUPERFICIAL FEMORALARTERY |
01/02/2018 |
3238 |
Non-Inferiority Trials in Medicine: Practice Changing or a Self-Fulfilling Prophecy? |
01/02/2018 |
3237 |
Neuropathies périphériques : démarche diagnostique |
01/02/2018 |
3236 |
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct |
01/02/2018 |
3235 |
National trends in open surgical, endovascular, and branched-fenestrated endovascular aortic aneurysm repair in Medicare patients |
01/02/2018 |
3234 |
Morphological changes of the internal carotid artery: prevalence and characteristics. A clinical and ultrasonographic study in a series of 19 804 patients over 25 years old |
01/02/2018 |
3233 |
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time |
01/02/2018 |
3232 |
Long-term outcome of endovascular popliteal artery aneurysm repair |
01/02/2018 |
3231 |
Lessons learned about prevalence and growth rates of abdominal aortic aneurysms from a 25-year ultrasound population screening programme |
01/02/2018 |
3230 |
Lessons from VTE registries: the RIETE experience |
01/02/2018 |
3229 |
La maladie thromboembolique en oncologie pédiatrique Arc Ped 2018 |
01/02/2018 |
3228 |
Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study |
01/02/2018 |
3227 |
Mesurer la vélocité de l’onde …s dans l’insuffisance rénale chronique |
01/02/2018 |
3226 |
Ischaemic stroke |
01/02/2018 |
3225 |
In-Hospital Mortality with Deep Venous Thrombosis |
01/02/2018 |
3224 |
Influence d’un traitement anticoagulant pendant la grossesse sur l’anesthe´ sie per-partum et les modalite´ s d’accouchement |
01/02/2018 |
3223 |
Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study |
01/02/2018 |
3222 |
Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis |
01/02/2018 |
3221 |
HOW I TREAT DISSEMINATED INTRAVASCULAR COAGULATION |
01/02/2018 |
3220 |
How good is the evidence to support primary care practice? |
01/02/2018 |
3219 |
High Costs and Caution Yield Slow Start for New Heart Drugs |
01/02/2018 |
3218 |
Heparin-induced thrombocytopenia (HIT) |
01/02/2018 |
3217 |
Infantile hemangioma: pathogenesis and mechanisms of action of propranolol |
01/02/2018 |
3216 |
Evaluation of a pharmacist-led outpatient direct oral anticoagulant service |
01/02/2018 |
3215 |
Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients |
01/02/2018 |
3214 |
Editor’s Choice e Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) |
01/02/2018 |
3213 |
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin-K Oral Anticoagulants (RAF-NOACs) Study |
01/02/2018 |
3212 |
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent |
01/02/2018 |
3211 |
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent |
01/02/2018 |
3210 |
Direct oral anticoagulant considerations in solid organ transplantation: A review |
01/02/2018 |
3209 |
Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique |
01/02/2018 |
3208 |
Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria |
01/02/2018 |
3207 |
Fibromuscular dysplasia (FMD) |
01/02/2018 |
3206 |
Original Article – Clinical Haemostasis and Thrombosis |
01/02/2018 |
3205 |
Des douleurs abdominales de cause vasculaireAbdominal pain of vascular causeA. |
01/02/2018 |
3204 |
Contemporary management of arteriovenous haemodialysis fistula aneurysms |
01/02/2018 |
3203 |
Chronic lung disorders and abdominal aortic aneurysms: An old clinical observation now proven? |
01/02/2018 |
3202 |
Characteristics of provoked deep venous thrombosis in a tertiary care center |
01/02/2018 |
3201 |
Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcication |
01/02/2018 |
3200 |
Body Mass Index and Vascular Disease in Men Aged 65 Years and Over: HIMS (Health In Men Study) |
01/02/2018 |
3199 |
Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin |
01/02/2018 |
3198 |
Better With Ultrasound Pleural Procedures in Critically Ill Patients |
01/02/2018 |
3197 |
Bayer, J&J Win Reversal of $28 Mln Verdict in Xarelto Lawsuit |
01/02/2018 |
3196 |
Association between intake of less-healthy foods defined by the United Kingdom’s nutrient profile model and cardiovascular disease: A population-based cohort study |
01/02/2018 |
3195 |
What are antiphospholipid antibodies (APLAs)? |
01/02/2018 |
3194 |
Acute Effects of Graduated Elastic Compression Stockings in Patients with Symptomatic Varicose Veins: A Randomised Double Blind Placebo Controlled Trial5 |
01/02/2018 |
3193 |
Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options |
01/02/2018 |
3192 |
Research: Complications Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study |
01/02/2018 |
3191 |
Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study |
01/02/2018 |
3190 |
Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study |
01/02/2018 |
3189 |
Leiomyosarcoma of the inferior vena cava presenting as a cardiac mass |
01/02/2018 |
3188 |
Evaluation of the age-dependent dosing recommendations for the administration of daily tinzaparin in children with thrombosis |
01/02/2018 |
3187 |
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study |
01/02/2018 |
3186 |
Association between metformin prescription and growth rates of abdominal aortic aneurysms |
01/02/2018 |
3185 |
A progressive, systemic, polyvascular disease caused by atherosclerosis |
01/02/2018 |
3184 |
When can we stop anticoagulation in patients with cancer-associated thrombosis? |
01/02/2018 |
3183 |
What Is the Optimal Abdominal Aortic Aneurysm Sac Measurement on CT Images during Follow-up after Endovascular Repair?1 |
01/02/2018 |
3182 |
Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice |
01/02/2018 |
3181 |
Pelvic vein incompetence: clinical perspectives |
01/02/2018 |
3180 |
Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis |
01/02/2018 |
3179 |
Venous disease patient registries available in the United States |
01/02/2018 |
3178 |
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia |
01/02/2018 |
3177 |
Update of the Society for Vascular Surgery abdominal aortic aneurysm guidelines |
01/02/2018 |
3176 |
Update of the Society for Vascular Surgery abdominal aortic aneurysm guidelines |
01/02/2018 |
3175 |
Une cause inhabituelle de claudication des membres inférieurs |
01/02/2018 |
3174 |
Traitement des malformations veineuses chez l’adulte : rôle de la sclérothérapie échoguidée |
01/02/2018 |
3173 |
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial |
01/02/2018 |
3172 |
Thromboses veineuses splanchniques |
01/02/2018 |
3171 |
Thromboses veineuses profondes de localisation inhabituelle |
01/02/2018 |
3170 |
Thrombophilia Testing and Venous Thrombosis |
01/02/2018 |
3169 |
Thromboangéite oblitérante : notions pour la pratique |
01/02/2018 |
3168 |
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis |
01/02/2018 |
3167 |
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm |
01/02/2018 |
3166 |
The Practice and Implications of Finding Fluid During Point-of-Care Ultrasonography A Review |
01/02/2018 |
3165 |
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale |
01/02/2018 |
3164 |
The impact of contralateral carotid artery stenosis on outcomes after carotid endarterectomy |
01/02/2018 |
3163 |
The High Costs of Unnecessary Care |
01/02/2018 |
3162 |
The distribution of P-values in medical research articles suggested selective reporting associated with statistical significance |
01/02/2018 |
3161 |
The digital technology revolution and its impact on the public’s health |
01/02/2018 |
3160 |
Tecarfarin: A Novel Vitamin K Antagonist |
01/02/2018 |
3159 |
Systematic review and meta-analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts |
01/02/2018 |
3158 |
Symptomatic, unilateral, isolated, complete persistent sciatic vein |
01/02/2018 |
3157 |
Summary of Revisions: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3156 |
Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) |
01/02/2018 |
3155 |
Statins for Neuroprotection After Acute Ischemic Stroke ASSORTed Results But More Trials Needed |
01/02/2018 |
3154 |
Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition |
01/02/2018 |
3153 |
Spectral Doppler Waveforms for Diagnosis of Appendicitis: Potential Utility of Point Peak Systolic Velocity and Resistive Index Values1 |
01/02/2018 |
3152 |
SHU et syndromes de microangiopathie thrombotique apparentés : épidémiologie, physiopathologie et tableaux cliniques |
01/02/2018 |
3151 |
Short- and long-term readmission rates after infrainguinal bypass in a safety net hospital are higher than expected |
01/02/2018 |
3150 |
Sécurité des patients : importance des transmissions médicales |
01/02/2018 |
3149 |
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism (Review) |
01/02/2018 |
3148 |
Safety of Pregnancy After Cerebral Venous Thrombosis Results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study |
01/02/2018 |
3147 |
Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices |
01/02/2018 |
3146 |
Quand Facebook menace l’éthique des essais cliniques |
01/02/2018 |
3145 |
Scores cliniques pour le risque de récidive de maladie veineuse thromboembolique (MVTE) et pour les relations cancer-MVTE* |
01/02/2018 |
3144 |
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial |
01/02/2018 |
3143 |
Risk factors of occult malignancy in patients with unprovoked venous thromboembolism |
01/02/2018 |
3142 |
Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis |
01/02/2018 |
3141 |
Risk and prognosis of cancer after upper-extremity deep venous thrombosis: A population-based cohort study |
01/02/2018 |
3140 |
Review of the cost of venous thromboembolism |
01/02/2018 |
3139 |
Retroperitoneoscopic lumbar sympathectomy for plantar hyperhidrosis Sonia O. Lima, MD, MSc, |
01/02/2018 |
3138 |
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study |
01/02/2018 |
3137 |
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient |
01/02/2018 |
3136 |
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries |
01/02/2018 |
3135 |
Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism |
01/02/2018 |
3134 |
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial |
01/02/2018 |
3133 |
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial |
01/02/2018 |
3132 |
recommandations festion peri operatoire 2015 court |
01/02/2018 |
3131 |
recommandations festion peri operatoire 2015 court |
01/02/2018 |
3130 |
Recommandations AHAACC sur l’HTA pourquoi ce virement à 180° MedScape2017 |
01/02/2018 |
3129 |
rapport dialyse chronique France 2016 SFNDT |
01/02/2018 |
3128 |
Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient) |
01/02/2018 |
3127 |
Quoi de neuf dans l’embolie pulmonaire ? |
01/02/2018 |
3126 |
Quel bilan pour les syndromes de Raynaud ? |
01/02/2018 |
3125 |
Quantitative comparison between the laser scanner three-dimensional method and the circumferential method for evaluation of arm volume in patients with lymphedema |
01/02/2018 |
3124 |
Qu’apportera l’evidence-based medicine demain RP2017 |
01/02/2018 |
3123 |
Quantitative comparison between the laser scanner three-dimensional method and the circumferential method for evaluation of arm volume in patients with lymphedema |
01/02/2018 |
3122 |
Non-vitamin-Koral anticoagulants and laboratory testing: now and in the future |
01/02/2018 |
3121 |
Prospective comparative cohort study evaluating incompetent great saphenous vein closure using radiofrequency-powered segmental ablation or 1470-nm endovenous laser ablation with radial-tip fibers (Varico 2 study) |
01/02/2018 |
3120 |
L’essentiel de l’information scientifique et m´edicale |
01/02/2018 |
3119 |
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults |
01/02/2018 |
3118 |
Prediction Score for Anticoagulation Control Quality Among Older Adults |
01/02/2018 |
3117 |
Potential Effect of Substituting Estimated Glomerular Filtration Rate for Estimated Creatinine Clearance for Dosing of Direct Oral Anticoagulants |
01/02/2018 |
3116 |
Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies |
01/02/2018 |
3115 |
Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies |
01/02/2018 |
3114 |
Place de l’angioplastie percutanée dans le traitement de l’hypertension pulmonaire postembolique |
01/02/2018 |
3113 |
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3112 |
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism |
01/02/2018 |
3111 |
Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease |
01/02/2018 |
3110 |
Peut-on réverser avant thrombolyse ? Que ferait le juge face à un infarctuscérébral ? |
01/02/2018 |
3109 |
Pelvic vein incompetence: clinical perspectives |
01/02/2018 |
3108 |
PCSK9 Inhibitors Economics and Policy |
01/02/2018 |
3107 |
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease |
01/02/2018 |
3106 |
Pas de surrisque d’amputations sous empagliflozine dans EMPAREG |
01/02/2018 |
3105 |
Six MonthsvsExtendedOralAnticoagulation AfteraFirstEpisodeofPulmonaryEmbolism ThePADIS-PERandomizedClinicalTrial |
01/02/2018 |
3104 |
Outcomes of Spontaneous Isolated Superior Mesenteric Artery Dissection Without Antithrombotic Use |
01/02/2018 |
3103 |
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial5 |
01/02/2018 |
3102 |
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine |
01/02/2018 |
3101 |
Oral health and cardiovascular care: Perceptions of people with cardiovascular disease |
01/02/2018 |
3100 |
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis |
01/02/2018 |
3099 |
Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance |
01/02/2018 |
3098 |
Older Adults: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3097 |
Occult cancer detection in patients with hemostatic disorder and venous thromboembolism |
01/02/2018 |
3096 |
Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3095 |
Nouvelles recommandations internationalespour le traitement curatif et prophylactiquede la maladie thromboembolique veineusechez les patients atteints d’un cancer etapplication dédiée pour smartphone |
01/02/2018 |
3094 |
Nouvelles propositions de la SFHTA pour améliorer la prise en charge de l’hypertension |
01/02/2018 |
3093 |
No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism |
01/02/2018 |
3092 |
No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism |
01/02/2018 |
3091 |
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials |
01/02/2018 |
3090 |
Supplementary Appendix |
01/02/2018 |
3089 |
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis |
01/02/2018 |
3088 |
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis |
01/02/2018 |
3087 |
Necrotizing Soft-Tissue Infections |
01/02/2018 |
3086 |
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: Differences in methodological quality and conclusions |
01/02/2018 |
3085 |
Navigating the anticoagulant landscape in 2017 |
01/02/2018 |
3084 |
Five ways to fix statistics |
01/02/2018 |
3083 |
National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014 |
01/02/2018 |
3082 |
Midterm and long-term follow-up in competitive athletes undergoing thoracic outlet decompression for neurogenic thoracic outlet syndrome |
01/02/2018 |
3081 |
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3080 |
Medicinal plants with antithrombotic property in Persian medicine: a mechanistic review |
01/02/2018 |
3079 |
Medical management of acute superficial vein thrombosis of the saphenous vein |
01/02/2018 |
3078 |
Management of Diabetes in Pregnancy: Standards ofMedical Care in Diabetesd2018 |
01/02/2018 |
3077 |
Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence |
01/02/2018 |
3076 |
Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence |
01/02/2018 |
3075 |
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV |
01/02/2018 |
3074 |
Maladie thromboembolique et cancer : vers un traitement standard par AOD ? |
01/02/2018 |
3073 |
Pathophysiology and clinical manifestations |
01/02/2018 |
3072 |
Diagnostic workup and management |
01/02/2018 |
3071 |
Lutter contre le gaspillage dans les syste?mes de sante? Synthe?se2017 |
01/02/2018 |
3070 |
Low-dose aspirin and risk of intracranial bleeds An observational study in UK general practice. Neurology2017 |
01/02/2018 |
3069 |
Low-Dose Aspirin after an Episode of Haemorrhagic Stroke Is Associated with Improved Survival |
01/02/2018 |
3068 |
Long-term mental wellbeing of adolescents and young adults diagnosed with venous thromboembolism: results from a multistage mixed methods study |
01/02/2018 |
3067 |
Les LDL sont un facteur causal de l’athérosclérose, John M. Chapman, Paris, France. |
01/02/2018 |
3066 |
Les alternatives à l evidence based medicine RP2017 |
01/02/2018 |
3065 |
L’échographie pleuro-pulmonaire pour le pneumologue |
01/02/2018 |
3064 |
Learning From Major Clinical Trials |
01/02/2018 |
3063 |
La méditation à « haute dose » protège le cerveau du vieillissement |
01/02/2018 |
3062 |
L’utilisation des anticoagulants oraux directs chez les patients âgés : les limites de la médecine fondée sur les preuves ? |
01/02/2018 |
3061 |
L’intensité de l’activité physique au-delà de 70 ans influe sur le bénéfice de survie |
01/02/2018 |
3060 |
Pourquoi les médecins souvent n’appliquent pas les recommandations ? |
01/02/2018 |
3059 |
Les LDL sont un facteur causal de l’athérosclérose, John M. Chapman, Paris, France. |
01/02/2018 |
3058 |
Les directives anticipées et le désir de maîtrise de sa fin de vie |
01/02/2018 |
3057 |
Les alternatives à l’evidence-based medicine RP2017 |
01/02/2018 |
3056 |
Learning From Major Clinical Trials Bending Without Breaking |
01/02/2018 |
3055 |
La méditation à « haute dose » protège le cerveau du vieillissement |
01/02/2018 |
3054 |
L’utilisation des anticoagulants oraux directs chez les patients âgés : les limites de la médecine fondée sur les preuves ? |
01/02/2018 |
3053 |
L’échographie pleuro-pulmonaire pour le pneumologue |
01/02/2018 |
3052 |
The advent of ultrafast ultrasound in vascular imaging: a review |
01/02/2018 |
3051 |
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study |
01/02/2018 |
3050 |
Intraluminal thrombus is associated with early rupture of abdominal aortic aneurysm |
01/02/2018 |
3049 |
Internal carotid artery dissection and Villeret’s syndrome |
01/02/2018 |
3048 |
Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban |
01/02/2018 |
3047 |
Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism |
01/02/2018 |
3046 |
Inferior Vena Cava Filters in Patients with Acute Pulmonary Embolism and Cancer |
01/02/2018 |
3045 |
Industry sponsorship and research outcome (Review) |
01/02/2018 |
3044 |
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial |
01/02/2018 |
3043 |
Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials |
01/02/2018 |
3042 |
Incidence of Venous Thromboembolism in Asian Populations: A Systematic Review |
01/02/2018 |
3041 |
Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3040 |
Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease |
01/02/2018 |
3039 |
Imaging manifestations of Behcet’s disease: Key considerations and major features |
01/02/2018 |
3038 |
Interventional approaches to deep venous thrombosis |
01/02/2018 |
3037 |
Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC/AHA very high risk criteria |
01/02/2018 |
3036 |
New ACC/AHA Hypertension Guidelines Make 130 the New 140 |
01/02/2018 |
3035 |
La FDA autorise le dépistage de la FA via l’Apple Watch |
01/02/2018 |
3034 |
HTA: l’AHA et l’ACC révolutionnent la définition en abaissant la barre à 130/80 mm Hg |
01/02/2018 |
3033 |
How I treat heavy menstrual bleeding associated with anticoagulants |
01/02/2018 |
3032 |
History of Venous Ultrasound |
01/02/2018 |
3031 |
High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 |
01/02/2018 |
3030 |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
01/02/2018 |
3029 |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
01/02/2018 |
3028 |
Handheld Echocardiography |
01/02/2018 |
3027 |
Half of NHS services do not provide recommended care for diabetic foot ulcers, shows audit |
01/02/2018 |
3026 |
Gut microbiome and its role in cardiovascular diseases |
01/02/2018 |
3025 |
Glycemic Targets: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
3024 |
FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms |
01/02/2018 |
3023 |
Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study |
01/02/2018 |
3022 |
From Evidence Based Medicine to Medicine Based Evidence |
01/02/2018 |
3021 |
Faut-il arrêter les statines chez les personnes âgées ?Should statin therapy be discontinued in the elderly? |
01/02/2018 |
3020 |
Faut-il arrêter les antiagrégants plaquettaires avant une opération non cardiaque ? |
01/02/2018 |
3019 |
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry |
01/02/2018 |
3018 |
Exploration des saignements post-ménopausiques : se donner les moyens ! |
01/02/2018 |
3017 |
Expanding anticoagulation management services to include direct oral anticoagulants |
01/02/2018 |
3016 |
The Evolution of Patient Diagnosis From Art to Digital Data-Driven Science |
01/02/2018 |
3015 |
Evaluation RCV chez le diabe?tique |
01/02/2018 |
3014 |
Evaluation of bleeding in patients receiving direct oral anticoagulants |
01/02/2018 |
3013 |
Évaluationdelaconnaissancedespatientsdeleurtraitementpar anticoagulant oraldirect(AOD) |
01/02/2018 |
3012 |
European Society of Cardiology: Cardiovascular Disease Statistics 2017 |
01/02/2018 |
3011 |
Dermohypodermite aiguë streptococcique. |
01/02/2018 |
3010 |
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines |
01/02/2018 |
3009 |
Elevated Lipids Probably a Cause of AAA: Genomic Study |
01/02/2018 |
3008 |
Efforts Aim to Promote Safer Anticoagulant Prescribing |
01/02/2018 |
3007 |
Effect of graduated compression stockings on venous lower limb hemodynamics in healthy amateur runners |
01/02/2018 |
3006 |
Edoxaban for the Treatment of Cancer- Associated Venous Thromboembolism |
01/02/2018 |
3005 |
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin-K Oral Anticoagulants (RAF-NOACs) Study |
01/02/2018 |
3004 |
Early carotid endarterectomy performed 2 to 5 days after the onset of neurologic symptoms leads to comparable results to carotid endarterectomy performed at later time points |
01/02/2018 |
3003 |
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions |
01/02/2018 |
3002 |
Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH |
01/02/2018 |
3001 |
Diversemanagement of isolated calf deep venous thrombosis in a university hospital |
01/02/2018 |
3000 |
Diplopie : un symptôme important en médecine interne ! Diplopia: An important symptom in internal medicine! |
01/02/2018 |
2999 |
Differential trends in myocardial infarction mortality over 1975–2010 in France according to gender: An age-period-cohort analysis |
01/02/2018 |
2998 |
Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS |
01/02/2018 |
2997 |
Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study |
01/02/2018 |
2996 |
Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria |
01/02/2018 |
2995 |
Diabetic foot |
01/02/2018 |
2994 |
Navigating the anticoagulant landscape in 2017 |
01/02/2018 |
2993 |
Diabetes medications and cardiovascular outcome trials: Lessons learned |
01/02/2018 |
2992 |
Diabetes Care in the Hospital: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
2991 |
Diabetes Advocacy: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
2990 |
Diabète : traiter les hommes et les femmes différemment ? |
01/02/2018 |
2989 |
Development of New Deep Venous Thrombosis While on Apixaban |
01/02/2018 |
2988 |
Development and validation of a score to predict life expectancy after carotid endarterectomy in asymptomatic patients |
01/02/2018 |
2987 |
Determining patient risk factors associated with accelerated growth of popliteal artery aneurysms |
01/02/2018 |
2986 |
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II |
01/02/2018 |
2985 |
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study |
01/02/2018 |
2984 |
Currentuseofdirectoralanticoagulantsforatrial fibrillation inJapan: Findings fromtheSAKURAAFRegistry |
01/02/2018 |
2983 |
Currentuseofdirectoralanticoagulantsforatrial fibrillation inJapan: Findings fromtheSAKURAAFRegistry |
01/02/2018 |
2982 |
Current evidence of oral anticoagulant reversal: A systematic review |
01/02/2018 |
2981 |
Current evidence of oral anticoagulant reversal: A systematic review |
01/02/2018 |
2980 |
Vol 67 Novembre 2017 CRITIQUE DE L EVIDENCE BASED MEDICINE II |
01/02/2018 |
2979 |
Critères composites : interprétation clinique |
01/02/2018 |
2978 |
Coût direct des AVK en France |
01/02/2018 |
2977 |
Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation |
01/02/2018 |
2976 |
Coronarien stable : même sur le plan fonctionnel, le bénéfice de l’angioplastie est nul |
01/02/2018 |
2975 |
Contemporary Hormonal Contraception and the Risk of Breast Cancer |
01/02/2018 |
2974 |
Complex iliocaval endovascular recanalization combined with thrombolysis for extensive acute deep venous thrombosis |
01/02/2018 |
2973 |
Competent and incompetent calf perforators in primary varicose veins: a resistant myth |
01/02/2018 |
2972 |
Compass overall speaker deck |
01/02/2018 |
2971 |
Comparison between two-point and three-point compression ultrasound for the diagnosis of deep vein thrombosis |
01/02/2018 |
2970 |
Comparative clinical effectiveness and cost effectiveness of endovascular strategy v open repair for ruptured abdominal aortic aneurysm: three year results of the IMPROVE randomised trial |
01/02/2018 |
2969 |
Comorbidity and the increased mortality after hospitalization for stroke: a population-based cohort study |
01/02/2018 |
2968 |
Common pitfalls in point?of?care ultrasound: a practical guide for emergency and critical care physicians |
01/02/2018 |
2967 |
Combined capillary-venous-lymphatic malformations without overgrowth in patients with Klippel-Trénaunay syndrome |
01/02/2018 |
2966 |
Collateral Circulation in Chronic Aortic Occlusive Disease |
01/02/2018 |
2965 |
Clinician-Level Predictors for Ordering Low-Value Imaging |
01/02/2018 |
2964 |
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism |
01/02/2018 |
2963 |
Clinical Decision Rules for Pulmonary Embolism in Hospitalized Patients: A Systematic Literature Review and Meta-analysis |
01/02/2018 |
2962 |
Clinical Assessment of Warfarin Therapy in Patients with Maintenance Dialysis-Clinical Efcacy, Risks and Development of Calciphylaxis |
01/02/2018 |
2961 |
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
2960 |
Chirurgie ambulatoire : le modèle d’anesthésie optimisée du Dr Vulliez |
01/02/2018 |
2959 |
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial |
01/02/2018 |
2958 |
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial |
01/02/2018 |
2957 |
Carotid Stent Fractures Are Not Associated With Adverse Events |
01/02/2018 |
2956 |
Carotid artery revascularization in patients with contralateral carotid artery occlusion: Stent or endarterectomy? |
01/02/2018 |
2955 |
Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetesd2018 |
01/02/2018 |
2954 |
Calcification of Thoracic and Abdominal Aneurysms is Associated with Mortality and Morbidity |
01/02/2018 |
2953 |
BRUISE-CONTROL 2 : pas d’indication à suspendre les AOD pour pose de défibrillateurs ou pacemakers |
01/02/2018 |
2952 |
Recommendations for standardized risk factor definitions in pediatric hospital-acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH |
01/02/2018 |
2951 |
Body Mass Index and Vascular Disease in Men Aged 65 Years and Over: HIMS (Health In Men Study) |
01/02/2018 |
2950 |
Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score |
01/02/2018 |
2949 |
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study |
01/02/2018 |
2948 |
Balloon Angioplasty Versus Stenting for the Treatment of Failing Arteriovenous Grafts: A Meta-Analysis5 |
01/02/2018 |
2947 |
Association between the gut microbiome and atherosclerosis |
01/02/2018 |
2946 |
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study |
01/02/2018 |
2945 |
Association ofWarfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years |
01/02/2018 |
2944 |
Aspirine : indications et utilisation durant la grossesse |
01/02/2018 |
2943 |
Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting |
01/02/2018 |
2942 |
Arterial reconstructions for chronic lower extremity ischemia in preadolescent and adolescent children |
01/02/2018 |
2941 |
Are Meta-Analyses a Form of Medical Fake News? |
01/02/2018 |
2940 |
Après COMPASS, Bayer demande une extension d’indication pour Xarelto |
01/02/2018 |
2939 |
Appropriate dosingofnonvitaminKantagonistoral anticoagulantsforstrokepreventioninatrial fibrillation |
01/02/2018 |
2938 |
Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests |
01/02/2018 |
2937 |
Traiter une claudication intermittente ischémique |
01/02/2018 |
2936 |
LBA-6 A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study |
01/02/2018 |
2935 |
Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease |
01/02/2018 |
2934 |
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial |
01/02/2018 |
2933 |
Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair |
01/02/2018 |
2932 |
CASEAnaphylactic shock with an ultrasoundcontrast agent |
01/02/2018 |
2931 |
Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial |
01/02/2018 |
2930 |
An Unusual Cause of Leg Pain |
01/02/2018 |
2929 |
Air pollution and venous thrombosis: a meta-analysis |
01/02/2018 |
2928 |
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults |
01/02/2018 |
2927 |
AHA 2017 : 130/80 : la nouvelle norme pour l’HTA |
01/02/2018 |
2926 |
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary |
01/02/2018 |
2925 |
Les anticoagulants oraux directs : quelle est la place de la biologie dans leur suivi et/ou leur utilisation ? |
01/02/2018 |
2924 |
Gestion périoperatoire des nouveaux anticoagulants oraux anticoagulants direct s (AODs) Anti-lla Ou anti-Xa |
01/02/2018 |
2923 |
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism |
01/02/2018 |
2922 |
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) |
01/02/2018 |
2921 |
2017 ESC Focused Update on dual antiplatelet therapy in coronary artery diseas Developed in collaboration with EACTS |
01/02/2018 |
2920 |
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults |
01/02/2018 |
2919 |
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults |
01/02/2018 |
2918 |
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants |
01/02/2018 |
2917 |
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines |
01/02/2018 |
2916 |
Position Paper on cancer treatments and cardiovascular toxicity developed under auspies of the ESC committee for practice guidelines |
01/02/2018 |
2915 |
Coronarien stable : même sur le plan fonctionnel, le bénéfice de l’angioplastie est nul |
01/02/2018 |
2914 |
Nouveaux anticoagulants oraux et endoscopie digestive |
01/02/2018 |
2913 |
Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry |
01/02/2018 |
2912 |
Nouvelles recommandations internationales pour le traitement curatif et prophylactique de la maladie thromboembolique veineuse chez les patients atteints d’un cancer et application dédiée pour smartphone |
01/02/2018 |
2911 |
Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry |
01/02/2018 |
2910 |
Bleeding complications during anticoagulant treatment in patients with cancer |
01/02/2018 |
2909 |
Ageing of the venous valves as a new risk factor for venous thrombosis in the elderly – the BATAVIA study |
28/01/2018 |
2908 |
White Clot Syndrome |
28/01/2018 |
2907 |
WFUMB GUIDELINES AND RECOMMENDATIONS FOR CLINICAL USE OF ULTRASOUND ELASTOGRAPHY: PART 1: BASIC PRINCIPLES AND TERMINOLOGY |
28/01/2018 |
2906 |
Wearing graduated compression stockings augments cutaneous vasodilation in heat-stressed resting humans |
28/01/2018 |
2905 |
Warfarin Linked to Lower Cancer Risk |
28/01/2018 |
2904 |
Venous ultrasonography findings and clinical correlations in 104 Thai patients with chronic venous insufficiency of the legs |
28/01/2018 |
2903 |
Value of Multiparametric US in the Assessment of Intratesticular Lesions1 |
28/01/2018 |
2902 |
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study |
28/01/2018 |
2901 |
Utilisation du courrier électronique en médecine générale : recommandations pratiques |
28/01/2018 |
2900 |
Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysmrepair (Review) |
28/01/2018 |
2899 |
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people |
28/01/2018 |
2898 |
Tumescent technique without epinephrine for endovenous laser therapy and serum lidocaine concentration |
28/01/2018 |
2897 |
trente huitiemes journees francaises de pharmacovigilance Les fait marquants |
28/01/2018 |
2896 |
Trends in Inferior Vena Cava Filter Placement by Indication in the United States From 2005 to 2014 |
28/01/2018 |
2895 |
Traitements hormonaux et risque de thrombose veineuse chez la femme |
28/01/2018 |
2894 |
Topical timolol promotes healing of chronic leg ulcer |
28/01/2018 |
2893 |
TIME-HARMONIC ULTRASOUND ELASTOGRAPHY OF THE DESCENDING ABDOMINAL AORTA: INITIAL RESULTS |
28/01/2018 |
2892 |
TIME-HARMONIC ULTRASOUND ELASTOGRAPHY OF THE DESCENDING ABDOMINAL AORTA: INITIAL RESULTS |
28/01/2018 |
2891 |
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? |
28/01/2018 |
2890 |
Thromboembolisme veineux : Xarelto 10 mg/j autorisé en Europe en prévention prolongée des récidives |
28/01/2018 |
2889 |
Thromboembolisme veineux : Xarelto 10 mg/j autorisé en Europe en prévention prolongée des récidives |
28/01/2018 |
2888 |
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct |
28/01/2018 |
2887 |
Therapeutic ultrasound for venous leg ulcers (Review) |
28/01/2018 |
2886 |
The use of medicinal plants in venous ulcers: a systematic review with meta-analysis |
28/01/2018 |
2885 |
The Practice and Implications of Finding Fluid During Point-of-Care Ultrasonography A Review |
28/01/2018 |
2884 |
The future of atrial fibrillation management: integrated care and stratified therapy |
28/01/2018 |
2883 |
The comparative efficacy of angiosomedirected and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review |
28/01/2018 |
2882 |
Tecarfarin: A Novel Vitamin K Antagonist |
28/01/2018 |
2881 |
Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease |
28/01/2018 |
2880 |
Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease |
28/01/2018 |
2879 |
Symptomatic lower-limb giant-cell arteritis: Characteristics, management and long-term outcome |
28/01/2018 |
2878 |
Surprescription des inhibiteurs de la pompe à protons |
28/01/2018 |
2877 |
Treatment of Super ficial Venous Disease of the Lower Leg |
28/01/2018 |
2876 |
Statines : un sur-risque de diabète de 30 % chez les patients à haut risque |
28/01/2018 |
2875 |
Standards de qualité pour la pratique de l’écho-Doppler dans la surveillance des endoprothèses aortiques abdominales |
28/01/2018 |
2874 |
Electronic alert system for improving appropriate thromboprophylaxis in hospitalized medical patients: a randomized controlled trial |
28/01/2018 |
2873 |
Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study |
28/01/2018 |
2872 |
Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm |
28/01/2018 |
2871 |
Screening of siblings to patients with abdominal aortic aneurysms in Sweden |
28/01/2018 |
2870 |
A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities |
28/01/2018 |
2869 |
Ruptured abdominal aortic aneurysm after endovascular aortic aneurysm repair thrombosis |
28/01/2018 |
2868 |
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial |
28/01/2018 |
2867 |
Risk factors for unplanned readmission and stump complications after major lower extremity amputation |
28/01/2018 |
2866 |
Retour annoncé de la recertification obligatoire des médecins |
28/01/2018 |
2865 |
Results of open pararenal abdominal aortic aneurysm repair: single centre series and pooled analysis of literature |
28/01/2018 |
2864 |
Remnant epitope Autoimmunity in human abdominal aortic aneurysm: a pilot study with elastin PEPTIDEs |
28/01/2018 |
2863 |
Relationship between biochemical factors and skin symptoms in chronic venous disease |
28/01/2018 |
2862 |
Radiation Awareness for Endovascular Abdominal Aortic Aneurysm Repair in the Hybrid Operating Room. An Instant Patient Risk Chart for Daily Practice |
28/01/2018 |
2861 |
Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease |
28/01/2018 |
2860 |
Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies |
28/01/2018 |
2859 |
Prolonged ICU Length of Stay after AAA Repair: Analysis of Time Trends and Long-term Outcome |
28/01/2018 |
2858 |
Pre-operative Duplex Ultrasonography in Arteriovenous Fistula Creation: Intra- and Inter-observer Agreement |
28/01/2018 |
2857 |
Premières recommandations européennes de la sclérose en plaques |
28/01/2018 |
2856 |
Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis |
28/01/2018 |
2855 |
Predictors of delayed wound healing after successful isolated below-the-knee endovascular intervention in patients with ischemic foot ulcers |
28/01/2018 |
2854 |
Post-carotid Endarterectomy Hypertension. Part 2: Association with Peri-operative Clinical, Anaesthetic, and Transcranial Doppler Derived Parameters |
28/01/2018 |
2853 |
Post-Carotid Endarterectomy Hypertension. Part 1: Association with Pre-operative Clinical, Imaging, and Physiological Parameters |
28/01/2018 |
2852 |
Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study |
28/01/2018 |
2851 |
Peri-procedural management of patients taking oral anticoagulants |
28/01/2018 |
2850 |
Peripheral Vascular Disease and Death in Southern European Kidney Transplant Candidates: A Competing Risk Modeling Approach |
28/01/2018 |
2849 |
Perioperative outcome of endovascular repair for complex abdominal aortic aneurysms |
28/01/2018 |
2848 |
Pathophysiology of varicose veins |
28/01/2018 |
2847 |
Patency and Clinical Outcome After Stent Placement for Chronic Obstruction of the Inferior Vena Cava |
28/01/2018 |
2846 |
Outcomes of foam sclerotherapy plus ligation versus foam sclerotherapy alone for venous ulcers in lower extremities |
28/01/2018 |
2845 |
Oral Steroid Use and Abdominal Aortic Aneurysm Expansion |
28/01/2018 |
2844 |
Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression |
28/01/2018 |
2843 |
Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysis |
28/01/2018 |
2842 |
Migraine and risk of stroke: a national population-based twin study |
28/01/2018 |
2841 |
Mid-term Results of Catheter Directed Foam Sclerotherapy Combined with Tumescent Local Anaesthesia for Treatment of Great Saphenous Vein Incompetence |
28/01/2018 |
2840 |
Faut-il changer le statut de l’hôpital public ? Question à la Fédération hospitalière de France |
28/01/2018 |
2839 |
Lower extremity ischemia after abdominal aortic aneurysm repair |
28/01/2018 |
2838 |
Low-dose Paclitaxel-coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: 1-year Results of the ILLUMENATE European Randomized Clinical Trial |
28/01/2018 |
2837 |
Les anglais inaugurent le «NHS Airbnb» ou comment passer sa convalescence chez l’habitant |
28/01/2018 |
2836 |
La stimulation ovarienne, situation à risque de thrombose |
28/01/2018 |
2835 |
Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective |
28/01/2018 |
2834 |
Is Conventional Open Repair for Abdominal Aortic Aneurysm Feasible in Nonagenarians? |
28/01/2018 |
2833 |
Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes |
28/01/2018 |
2832 |
Infection de plaies chroniques : particularités chez la personne âgée |
28/01/2018 |
2831 |
Infected abdominal aortic aneurysm due to Escherichia coli |
28/01/2018 |
2830 |
Incidence of venous leg ulcer healing and recurrence after treatment with endovenous laser ablation |
28/01/2018 |
2829 |
Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam |
28/01/2018 |
2828 |
Immediate Impact of Centralization on Abdominal Aortic Aneurysm Repair Outcomes for a Vascular Network in the South West of England |
28/01/2018 |
2827 |
Hypertension, diabète, hyperlipidémie : quelles cibles de traitement pour les seniors ? |
28/01/2018 |
2826 |
How will Brexit affect health and health services in the UK? Evaluating three possible scenarios |
28/01/2018 |
2825 |
HIGH-RESOLUTION ULTRASOUND OF SCHWANNOMAS OF THE LIMBS: ANALYSIS OF 72 CASES |
28/01/2018 |
2824 |
Higher 30 Day Mortality in Patients with Familial Abdominal Aortic Aneurysm after EVAR |
28/01/2018 |
2823 |
High serum thrombospondin-1 concentration is associated with slower abdominal aortic 2 aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice |
28/01/2018 |
2822 |
The use of eConsults to improve access to specialty care in thrombosis medicine |
28/01/2018 |
2821 |
Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability |
28/01/2018 |
2820 |
Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial |
28/01/2018 |
2819 |
FOREWORD TO THE SECOND SET OF WFUMB GUIDELINES AND RECOMMENDATIONS ON THE CLINICAL USE OF ULTRASOUND ELASTOGRAPHY |
28/01/2018 |
2818 |
Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms |
28/01/2018 |
2817 |
Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms |
28/01/2018 |
2816 |
First 10-month results of the Vascular Quality Initiative Varicose Vein Registry |
28/01/2018 |
2815 |
Feasibility and safety of foam sclerotherapy followed by a multiple subcutaneously interrupt ligation under local anaesthesia for outpatients with varicose veins |
28/01/2018 |
2814 |
Faut-il rechercher un cancer devant une maladie thrombo emboliques veineuse (MTEV) spontanée ? |
28/01/2018 |
2813 |
Faecal impaction causing bilateral pelvic venous thrombosis |
28/01/2018 |
2812 |
Experiences of the screening process and the diagnosis abdominal aortic aneurysm among 65-year-old men from invitation to a 1-year surveillance |
28/01/2018 |
2811 |
EVOLUTION OF ULTRASONOGRAPHY SINCE THE 1970S |
28/01/2018 |
2810 |
European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults |
28/01/2018 |
2809 |
European guidelines on perioperative venous thromboembolism prophylaxis |
28/01/2018 |
2808 |
Erythrocytes properties in varicose veins patients |
28/01/2018 |
2807 |
PERFORMANCES AND LIMITATIONS OF SEVERAL ULTRASOUND-BASED ELASTOGRAPHY TECHNIQUES: A PHANTOM STUDY |
28/01/2018 |
2806 |
Endovenous laser ablation therapy in children: applications and outcomes |
28/01/2018 |
2805 |
Endovascular treatment of asymptomatic abdominal aortic aneurysms in octogenarians: factors influencing long term survival |
28/01/2018 |
2804 |
Effects of anatomical characteristics as factors in abdominal aortic aneurysm rupture |
28/01/2018 |
2803 |
Editor s Choice Mid term Outcomes of Endovenous Laser Ablation in Patients with Active and Healed Venous Ulcers A Follow up Study |
28/01/2018 |
2802 |
Early Results of the Bolton Treovance Endograft in the Treatment of Abdominal Aortic Aneurysms |
28/01/2018 |
2801 |
Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH |
28/01/2018 |
2800 |
Diagnosing of pelvic vein incompetence using minimally invasive ultrasound techniques |
28/01/2018 |
2799 |
Defining the optimum tumescent anaesthesia solution in endovenous laser ablation |
28/01/2018 |
2798 |
Conseil d Etat un arbitre influent dans le domaine du medicament |
28/01/2018 |
2797 |
Comparison of microbubble presence in the right heart during mechanochemical and radiofrequency ablation for varicose veins |
28/01/2018 |
2796 |
Combined treatment with endovenous laser ablation and compression therapy of incompetent perforating veins for treatment of recalcitrant venous ulcers |
28/01/2018 |
2795 |
Clinical presentation of women with pelvic source varicose veins in the perineum as a first step in the development of a disease-specific patient assessment tool |
28/01/2018 |
2794 |
Clinical correlation with failure of endovenous therapy for leg swelling |
28/01/2018 |
2793 |
Clinical characteristics and outcome of isolated infrarenal aortic stenosis in young patients |
28/01/2018 |
2792 |
Changing Medicare Utilization of Minimally Invasive Procedures for the Treatment of Chronic Venous Insufficiency |
28/01/2018 |
2791 |
Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden |
28/01/2018 |
2790 |
Recommendations for standardized risk factor definitions in pediatric hospital-acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH |
28/01/2018 |
2789 |
B-MODE ULTRASOUND COMBINED WITH COLOR DOPPLER AND STRAIN ELASTOGRAPHY IN THE DIAGNOSIS OF NON-MASS BREAST LESIONS: A PROSPECTIVE STUDY |
28/01/2018 |
2788 |
Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score |
28/01/2018 |
2787 |
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study |
28/01/2018 |
2786 |
Atlas du CNOM 2017 : toujours moins de généralistes et plus de spécialistes |
28/01/2018 |
2785 |
Association between metformin prescription and growth rates of abdominal aortic aneurysms |
28/01/2018 |
2784 |
Antithrombotic therapy in peripheral artery disease |
28/01/2018 |
2783 |
Amyotrophic lateral sclerosis |
28/01/2018 |
2782 |
A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives |
28/01/2018 |
2781 |
 |
28/01/2018 |
2780 |
 |
25/01/2018 |
2779 |
A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms |
25/01/2018 |
2778 |
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization |
25/01/2018 |
2777 |
A retrospective observational cohort study investigating the association between acute kidney injury and all?cause mortality among patients undergoing endovascular repair of abdominal aortic aneurysms |
25/01/2018 |
2776 |
A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke |
24/01/2018 |
2775 |
Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins |
25/01/2018 |
2774 |
A minimally interactive and reproducible method for abdominalaortic aneurysm quantification in 3D ultrasound and computedtomography with implicit template deformationsL. |
25/01/2018 |
2773 |
A comprehensive characterisation of the metabolic profile of varicose veins; implications in elaborating plausible cellular pathways for disease pathogenesis |
25/01/2018 |
2772 |
59th Annual Meeting and Exposition (December 9-12, 2017) quelques abstracts |
25/01/2018 |
2771 |
Rezidivprophylaxe des Ulcus cruris venosum |
25/01/2018 |
2770 |
 |
25/01/2018 |
2769 |
Ageing of the venous valves as a new risk factor for venous thrombosis in the elderly – the BATAVIA study |
24/01/2018 |
2768 |
White Clot Syndrome |
24/01/2018 |
2767 |
Wearing graduated compression stockings augments cutaneous vasodilation in heat-stressed resting humans |
24/01/2018 |
2766 |
Venous ultrasonography findings and clinical correlations in 104 Thai patients with chronic venous insufficiency of the legs |
24/01/2018 |
2765 |
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study |
24/01/2018 |
2764 |
Unnecessary Use of Inferior Vena Cava Filters A Teachable Moment |
24/01/2018 |
2763 |
Traitements hormonaux et risque de thrombose veineuse chez la femme |
24/01/2018 |
2762 |
Traitements hormonaux et risque de thrombose veineuse chez la femme |
24/01/2018 |
2761 |
Topical timolol promotes healing of chronic leg ulcer |
24/01/2018 |
2760 |
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? |
24/01/2018 |
2759 |
The Practice and Implications of Finding Fluid During Point-of-Care Ultrasonography A Review |
24/01/2018 |
2758 |
The future of atrial fibrillation management: integrated care and stratified therapy |
24/01/2018 |
2757 |
The FAST-ED App: A Smartphone Platform for the Field Triage of Patients With Stroke |
24/01/2018 |
2756 |
The comparative efficacy of angiosomedirected and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review |
24/01/2018 |
2755 |
Tecarfarin: A Novel Vitamin K Antagonist |
24/01/2018 |
2754 |
Symptomatic lower-limb giant-cell arteritis: Characteristics, management and long-term outcome |
24/01/2018 |
2753 |
Surprescription des inhibiteurs de la pompe à protons |
24/01/2018 |
2752 |
Treatment of Super ficial Venous Disease of the Lower Leg |
24/01/2018 |
2751 |
Standards de qualité pour la pratique de l’écho-Doppler dans la surveillance des endoprothèses aortiques abdominales |
24/01/2018 |
2750 |
Score YEA RS dans le diagnostic de l’embolie pulmonaire : un moyen de réduire le nombre de CT-scan sans risque ? |
24/01/2018 |
2749 |
A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities |
24/01/2018 |
2748 |
Ruptured abdominal aortic aneurysm after endovascular aortic aneurysm repair thrombosis |
24/01/2018 |
2747 |
Risk factors of occult malignancy in patients with unprovoked venous thromboembolism |
24/01/2018 |
2746 |
Risk factors for unplanned readmission and stump complications after major lower extremity amputation |
24/01/2018 |
2745 |
Risk factors and outcomes for nosocomial infection after prosthetic vascular grafts |
24/01/2018 |
2744 |
Review of aspirin and clopidogrel resistance in peripheral arterial disease |
24/01/2018 |
2743 |
Results of open pararenal abdominal aortic aneurysm repair: single centre series and pooled analysis of literature |
24/01/2018 |
2742 |
Relationship between biochemical factors and skin symptoms in chronic venous disease |
24/01/2018 |
2741 |
Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio |
24/01/2018 |
2740 |
Radiation Awareness for Endovascular Abdominal Aortic Aneurysm Repair in the Hybrid Operating Room. An Instant Patient Risk Chart for Daily Practice |
24/01/2018 |
2739 |
Molecular BioSystems |
24/01/2018 |
2738 |
Pre-operative Duplex Ultrasonography in Arteriovenous Fistula Creation: Intra- and Inter-observer Agreement |
24/01/2018 |
2737 |
Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis |
24/01/2018 |
2736 |
Predictors of delayed wound healing after successful isolated below-the-knee endovascular intervention in patients with ischemic foot ulcers |
24/01/2018 |
2735 |
Practical issues in suspected venous thrombosis in general practice: Amulticentre prospective cohort in primary care |
24/01/2018 |
2734 |
Post-carotid Endarterectomy Hypertension. Part 2: Association with Peri-operative Clinical, Anaesthetic, and Transcranial Doppler Derived Parameters |
24/01/2018 |
2733 |
Post-Carotid Endarterectomy Hypertension. Part 1: Association with Pre-operative Clinical, Imaging, and Physiological Parameters |
24/01/2018 |
2732 |
Peripheral Vascular Disease and Death in Southern European Kidney Transplant Candidates: A Competing Risk Modeling Approach Domingo Hernández, MD, PhD,1 Pablo Castro de la Nuez, MD,2 AlfonsoMuriel, PhD, |
24/01/2018 |
2731 |
Perioperative outcomes after reoperative carotid endarterectomy are worse than expected |
24/01/2018 |
2730 |
Perioperative outcome of endovascular repair for complex abdominal aortic aneurysms |
24/01/2018 |
2729 |
Patient Preferences for Receiving Education on Venous Thromboembolism Prevention – A Survey of Stakeholder Organizations |
24/01/2018 |
2728 |
Patency and Clinical Outcome After Stent Placement for Chronic Obstruction of the Inferior Vena Cava |
24/01/2018 |
2727 |
Opportunities for Improving Population- Based Management of Abdominal Aortic Aneurysms |
24/01/2018 |
2726 |
Original Article – Clinical Haemostasis and Thrombosis |
24/01/2018 |
2725 |
Obesity and lower limb venous disease – The epidemic of phlebesity |
24/01/2018 |
2724 |
Increasing prevalence of vascular risk factors in patients with stroke |
24/01/2018 |
2723 |
Migraine and risk of stroke: a national population-based twin study |
24/01/2018 |
2722 |
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes |
24/01/2018 |
2721 |
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis |
24/01/2018 |
2720 |
IPP et Rein : Nouvelles Données 2016 |
24/01/2018 |
2719 |
Indications for anticoagulant and antiplatelet combined therapy |
24/01/2018 |
2718 |
In vitro effects of Apixaban on 5 different cancer cell lines |
24/01/2018 |
2717 |
Impact of angiosome- and nonangiosome-targeted peroneal bypass on limb salvage and healing in patients with chronic limb-threatening ischemia |
24/01/2018 |
2716 |
Identifying the factors influencing practice variation in thrombosis medicine: A qualitative content analysis of published practice-pattern surveys |
24/01/2018 |
2715 |
 |
24/01/2018 |
2714 |
Nouveaux traitements du cancer, nouvelles toxicités |
23/01/2018 |
2713 |
High serum thrombospondin-1 concentration is associated with slower abdominal aortic 2 aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice |
23/01/2018 |
2712 |
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy |
23/01/2018 |
2711 |
Gastric Cancer Risk Doubled With Long-term PPI Use |
23/01/2018 |
2710 |
Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents |
23/01/2018 |
2709 |
First 10-month results of the Vascular Quality Initiative Varicose Vein Registry |
23/01/2018 |
2708 |
Effect of Systematic Intensive Care Unit Triage on Long-term Mortality Among Critically Ill Elderly Patients in France A Randomized Clinical Trial |
23/01/2018 |
2707 |
FDA Clears Betrixaban (Bevyxxa) for VTE Prophylaxis |
23/01/2018 |
2706 |
Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention |
23/01/2018 |
2705 |
Experiences of the screening process and the diagnosis abdominal aortic aneurysm among 65-year-old men from invitation to a 1-year surveillance |
23/01/2018 |
2704 |
Evidence-Based Guidelines to Eliminate Repetitive Laboratory Testing |
23/01/2018 |
2703 |
Evaluation and Management of Lower-Extremity Ulcers |
23/01/2018 |
2702 |
Endovenous laser ablation therapy in children: applications and outcomes |
23/01/2018 |
2701 |
Effects of anatomical characteristics as factors in abdominal aortic aneurysm rupture CT aortography analysis |
23/01/2018 |
2700 |
Mid-term Outcomes of Endovenous Laser Ablation in Patients with Active and Healed Venous Ulcers: A Follow-up Study |
23/01/2018 |
2699 |
E-cigarette et tabac à chauffer : les nouvelles stratégies des cigarettiers expliquées aux oncologues |
23/01/2018 |
2698 |
Early Results of the Bolton Treovance Endograft in the Treatment of Abdominal Aortic Aneurysms |
23/01/2018 |
2697 |
Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials |
23/01/2018 |
2696 |
Diabetes and Vascular Disease in Different Arterial Territories |
23/01/2018 |
2695 |
Dépistage des cancers gynécologiques : quels bénéfices pour les patientes ? |
23/01/2018 |
2694 |
Contemporary outcomes of elective iliocaval and infrainguinal venous intervention for post-thrombotic chronic venous occlusive disease |
23/01/2018 |
2693 |
Combining antiplatelets and anticoagulants |
23/01/2018 |
2692 |
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial |
23/01/2018 |
2691 |
Clinical conditions responsible for 1 hyperviscosity and skin ulcers 2 complications |
23/01/2018 |
2690 |
Clinical characteristics of spontaneous isolated visceral artery dissection |
23/01/2018 |
2689 |
Clinical characteristics and outcome of isolated infrarenal aortic stenosis in young patients |
23/01/2018 |
2688 |
Chronic venous insuffi ciency – a review of pathophysiology, diagnosis, and treatment |
23/01/2018 |
2687 |
Chronic refractory venous ulcer exacerbated by a congenital pelvic arteriovenous malformation successfully treated by transarterial Onyx embolization |
23/01/2018 |
2686 |
Chronic kidney disease |
23/01/2018 |
2685 |
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial |
23/01/2018 |
2684 |
Carotid occlusion is associated with more frequent neurovascular events than moderately severe carotid stenosis |
23/01/2018 |
2683 |
Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden |
23/01/2018 |
2682 |
Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study |
23/01/2018 |
2681 |
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials |
23/01/2018 |
2680 |
Association of impaired renal function with venous thrombosis: A genetic risk score approach |
23/01/2018 |
2679 |
Association between metformin prescription and growth rates of abdominal aortic aneurysms |
23/01/2018 |
2678 |
Association Between Diverticular Disease and Abdominal Aortic Aneurysms: Pooled Analysis of Two Population Based Screening Cohorts |
23/01/2018 |
2677 |
Association between antithrombotic therapy and risk of postoperative complications among patients undergoing endovenous laser ablation |
23/01/2018 |
2676 |
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients |
23/01/2018 |
2675 |
AOD : majoration du risque hémorragique avec 4 médicaments dont l’amiodarone |
23/01/2018 |
2674 |
AOD : majoration du risque hémorragique avec 4 médicaments dont l’amiodarone |
23/01/2018 |
2673 |
Interaction between NOACs and other drugs increases bleeding risk |
23/01/2018 |
2672 |
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism |
23/01/2018 |
2671 |
Anatomic variations of lower extremity venous system in varicose vein patients: demonstration by three-dimensional CT venography |
23/01/2018 |
2670 |
Alcohol consumption, high density lipoprotein cholesterol, antithrombin III, and body mass index are associated with great saphenous vein reflux in the thigh |
23/01/2018 |
2669 |
A systematic review of the compression regimes used in randomised clinical trials following endovenous ablation |
23/01/2018 |
2668 |
A systematic review of the compression regimes used in randomised clinical trials following endovenous ablation |
23/01/2018 |
2667 |
A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms |
23/01/2018 |
2666 |
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization |
23/01/2018 |
2665 |
A retrospective observational cohort study investigating the association between acute kidney injury and all.cause mortality among patients undergoing endovascular repair of abdominal aortic aneurysms |
23/01/2018 |
2664 |
A Population-Based Study of Abdominal Aortic Aneurysm Treatment in Finland 2000 to 2014 |
23/01/2018 |
2663 |
A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities |
23/01/2018 |
2662 |
A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities |
23/01/2018 |
2661 |
New Developments in Compression Treatment |
23/01/2018 |
2660 |
Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review |
22/01/2018 |
2659 |
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics |
22/01/2018 |
2658 |
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis |
22/01/2018 |
2657 |
Wine and Cardiovascular Health |
22/01/2018 |
2656 |
Will mesh-coveredstentshelpreducestroke associated withcarotidstentangioplasty? |
22/01/2018 |
2655 |
For Hazardous and Harmful Drinking |
22/01/2018 |
2654 |
Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes |
22/01/2018 |
2653 |
Validity of Cardiovascular Data From Electronic Sources |
22/01/2018 |
2652 |
Un tatouage qui change de couleur en fonction de la glycémie |
22/01/2018 |
2651 |
Meta-analysis of the current prevalence of screen-detected abdominal aortic aneurysm in women |
22/01/2018 |
2650 |
Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis |
22/01/2018 |
2649 |
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939) The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study |
22/01/2018 |
2648 |
Treating Raynaud phenomenon: Beyond staying warm |
22/01/2018 |
2647 |
TranscranialDopplermonitoringformicroemboli:a marker ofahigh-riskcarotidplaque |
22/01/2018 |
2646 |
Transcatheter embolization of persistent embryonic veins in venous malformation syndromes |
22/01/2018 |
2645 |
Traiter le diabète en fonction des situations : 6 fiches thérapeutiques de la SFD |
22/01/2018 |
2644 |
Thrombophilia Testing and Venous Thrombosis |
22/01/2018 |
2643 |
The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials |
22/01/2018 |
2642 |
The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients |
22/01/2018 |
2641 |
The natural history and outcomes of line-associated upper extremity deep venous thromboses in critically ill patients |
22/01/2018 |
2640 |
The impact of body weight on rivaroxaban pharmacokinetics |
22/01/2018 |
2639 |
The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study |
22/01/2018 |
2638 |
The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model |
22/01/2018 |
2637 |
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study |
22/01/2018 |
2636 |
Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice |
22/01/2018 |
2635 |
Risk stratification with the DAPT score: Carefully read the instructions and use as intended |
22/01/2018 |
2634 |
Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years |
22/01/2018 |
2633 |
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism |
22/01/2018 |
2632 |
Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation |
22/01/2018 |
2631 |
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II |
22/01/2018 |
2630 |
Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism |
22/01/2018 |
2629 |
Clinical impact of major bleeding in patients with venous thrombo – embolism treated with factor Xa inhibitors or vitamin K antagonists |
22/01/2018 |
2628 |
Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests |
22/01/2018 |
2627 |
Apixaban and dalteparin in active malignancy associated venous thromboembolism |
22/01/2018 |
2626 |
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease |
22/01/2018 |
2625 |
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents |
22/01/2018 |
2624 |
Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke Primary Results of the STRATIS Registry |
22/01/2018 |
2623 |
Switching between Oral Anticoagulants |
22/01/2018 |
2622 |
Stopping Longterm Aspirin Linked to CVEvent Spike |
22/01/2018 |
2621 |
Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study |
22/01/2018 |
2620 |
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus |
22/01/2018 |
2619 |
Seasonal variations in cardiovascular disease |
22/01/2018 |
2618 |
Sclérodermie systémique |
22/01/2018 |
2617 |
Rivaroxan en prévention secondaire des AVC inexpliqués : essai interrompu |
22/01/2018 |
2616 |
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial |
22/01/2018 |
2615 |
Risk factors of occult malignancy in patients with unprovoked venous thromboembolism |
22/01/2018 |
2614 |
Risk factors of occult malignancy in patients with unprovoked venous thromboembolism |
22/01/2018 |
2613 |
Review of the endothelial pathogenic mechanism of TIE2-related venous malformation |
22/01/2018 |
2612 |
Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism |
22/01/2018 |
2611 |
Réévaluation de l’ordonnance du sujet âgé |
22/01/2018 |
2610 |
Quel traitement anticoagulant au décours d’une embolie pulmonaire |
22/01/2018 |
2609 |
Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients |
22/01/2018 |
2608 |
Principles and theory guiding development and delivery of patient education in disorders of thrombosis and hemostasis: Reviewing the current literature |
22/01/2018 |
2607 |
Prevention and treatment ofcancer-associated thrombosis in France: Anational survey among vascular disease andsupportive care specialists |
22/01/2018 |
2606 |
Pre-operative Duplex Ultrasonography in Arteriovenous Fistula Creation: Intra- and Inter-observer Agreement |
22/01/2018 |
2605 |
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial |
22/01/2018 |
2604 |
Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations |
22/01/2018 |
2603 |
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies |
22/01/2018 |
2602 |
Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications |
22/01/2018 |
2601 |
Blood pressure target in 2017A. |
22/01/2018 |
2600 |
Thrombosis as an intravascular effector of innate immunity |
22/01/2018 |
2599 |
Anticoagulation regimens |
22/01/2018 |
2598 |
Diagnostic signs of venous thromboembolism |
22/01/2018 |
2597 |
The coagulation cascade and existing and emerging anticoagulant drugs |
22/01/2018 |
2596 |
Mechanisms that protect from or promote thrombogenesis |
22/01/2018 |
2595 |
Nouveautés dans la dysfonction érectile RP2017 |
22/01/2018 |
2594 |
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction |
22/01/2018 |
2593 |
New European Guidelines for Cerebral Venous Thrombosis |
22/01/2018 |
2592 |
Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications |
22/01/2018 |
2591 |
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran |
22/01/2018 |
2590 |
Navigating the anticoagulant landscape in 2017 |
22/01/2018 |
2589 |
National trends in hospitalizations for venous thromboembolism |
22/01/2018 |
2588 |
Quelle est l’efficacité de la CPAP en prévention secondaire de maladies cardiovasculaires ? |
22/01/2018 |
2587 |
QRISK3, la nouvelle mise à jour de l’instrument britannique pour le calcul du risque cardiovasculaire |
22/01/2018 |
2586 |
La pratique factuelle (Evidence Based Practice) ne se limite pas aux preuves et aux guides de pratique clinique. Elle associe aussi connaissances, communication et sagesse |
22/01/2018 |
2585 |
Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms |
22/01/2018 |
2584 |
Efficacité/sécurité de l’hypolipémiant évolocumab chez les diabétiques dans FOURIER |
22/01/2018 |
2583 |
Meditation and Cardiovascular Risk Reduction A Scientific Statement From the American Heart Association |
22/01/2018 |
2582 |
Medical treatmentstrategiestoreduceperioperative morbidity andmortalityaftercarotidsurgery |
22/01/2018 |
2581 |
À la chirurgie s’ajoute désormais la possibilité d’un médicament par voie injectable |
22/01/2018 |
2580 |
How Quickly Do Asymptomatic Infrarenal Abdominal Aortic Aneurysms Grow and What Factors Affect Aneurysm Growth Rates? Analysis of a Single Centre Surveillance Cohort Database |
22/01/2018 |
2579 |
Imaging ofhigh-riskcarotidplaques:ultrasound |
22/01/2018 |
2578 |
Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events |
22/01/2018 |
2577 |
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis |
22/01/2018 |
2576 |
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis |
22/01/2018 |
2575 |
Les critères STOPP/START.v2 : adaptation en langue franc¸aise |
22/01/2018 |
2574 |
Le score de fibrose souscutanée FAT pour prédire le succès de la chirurgie bariatrique |
22/01/2018 |
2573 |
La pharmaco-épidémiologie ou comment évaluer les médicaments dans la vraie vie ? |
22/01/2018 |
2572 |
Sevrage tabagique et BPCO : l’arrêt du tabac est du ressort du médecin pas la responsabilité du patient. Interview du Pr Dautzenberg |
22/01/2018 |
2571 |
Title: Is Infection an Independent Risk Factor for Venous Thromboembolism? a Population-Based Case-Control Study |
22/01/2018 |
2570 |
Infarctus rénal : modalités de prise en charge aux urgences |
22/01/2018 |
2569 |
Industriels du médicament : quelle évolution des pratiques sur le plan déontologique et éthique |
22/01/2018 |
2568 |
Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluation |
22/01/2018 |
2567 |
Imaging ofthehigh-riskcarotidplaque:magnetic resonance imaging |
22/01/2018 |
2566 |
Identifying the factors influencing practice variation in thrombosis medicine: A qualitative content analysis of published practice-pattern surveys |
22/01/2018 |
2565 |
Identifying predictors for bleeding in hospitalized cancer patients: A cohort study |
22/01/2018 |
2564 |
High-risk carotidplaque:lessonslearnedfrom histopathology |
22/01/2018 |
2563 |
High mortality rates after both open surgical and endovascular thoracic aortic interventions in patients with end-stage renal disease |
22/01/2018 |
2562 |
HBPM et Insuffisance Rénale : Modification de RCP à ne pas prendre en compte pour un Bon Usage CLINIQUE de ces médicaments |
22/01/2018 |
2561 |
Gestion de l’équilibre |
22/01/2018 |
2560 |
Gender, smoking, body size, and aneurysm geometry influence the biomechanical rupture risk of abdominal aortic aneurysms as estimated by finite element analysis |
22/01/2018 |
2559 |
Game of TOR — The Target of Rapamycin Rules Four Kingdoms |
22/01/2018 |
2558 |
Follow-up on Small Abdominal Aortic Aneurysms Using Three Dimensional Ultrasound: Volume Versus Diameter |
22/01/2018 |
2557 |
AVC cryptogénique : la fermeture des FOP à haut risque est validée |
22/01/2018 |
2556 |
Fluindione: A ne pas utiliser pour commencer un traitment antivitamine K |
22/01/2018 |
2555 |
Five Year Results of Great Saphenous Vein Treatment: A Meta-analysis |
22/01/2018 |
2554 |
Thresholds in women with abdominal aortic aneurysm |
22/01/2018 |
2553 |
Five Year Natural History of Screening Detected Sub-Aneurysms and Abdominal Aortic Aneurysms in 70 Year Old Women and Systematic Review of Repair Rate in Women |
22/01/2018 |
2552 |
Five Year Natural History of Screening Detected Sub-Aneurysms and Abdominal Aortic Aneurysms in 70 Year Old Women and Systematic Review of Repair Rate in Women |
22/01/2018 |
2551 |
Evaluation of popliteal artery branching patterns and a new subclassification of the ‘usual’ branching pattern |
22/01/2018 |
2550 |
Evaluating the Impact and Cost- Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke |
22/01/2018 |
2549 |
Epidemiology of cardiovascular disease in young individuals |
22/01/2018 |
2548 |
En altérant la réponse intestinale au glucose, les édulcorants favoriseraient le diabète |
22/01/2018 |
2547 |
Effet rebond à l’arrêt de l’aspirine : les commentaires du Pr JP Collet |
22/01/2018 |
2546 |
Effects of statin therapy on ascending aorta aneurysms growth: A propensity-matched analysis? |
22/01/2018 |
2545 |
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes |
22/01/2018 |
2544 |
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease |
22/01/2018 |
2543 |
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? |
22/01/2018 |
2542 |
Diagnosis of deep-vein thrombosis |
22/01/2018 |
2541 |
Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors |
22/01/2018 |
2540 |
Diabetes medications and cardiovascular outcome trials: Lessons learned |
22/01/2018 |
2539 |
Traitement du diabète : la SFD s’affranchit des recommandations de la HAS |
22/01/2018 |
2538 |
Demandes injustifiées de marqueurs tumoraux : l’addition est salée |
22/01/2018 |
2537 |
Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors |
22/01/2018 |
2536 |
OUTIL DE PRISE EN CHARGE DES INTERACTIONS MÉDICAMENT-MÉDICAMENT CONTRE LE V&H |
22/01/2018 |
2535 |
Cost-effectiveness of screening for abdominal aortic aneurysm in the Netherlands and Norway |
22/01/2018 |
2534 |
Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms |
22/01/2018 |
2533 |
Contemporary medicaltherapiesofatherosclerotic carotid arterydisease |
22/01/2018 |
2532 |
COMPASS: Rivaroxaban Success in Secondary CV Prevention |
22/01/2018 |
2531 |
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism |
22/01/2018 |
2530 |
Clinical need,design,andgoalsfortheCarotid RevascularizationandMedicalManagementfor Asymptomatic CarotidStenosistrial |
22/01/2018 |
2529 |
Challenges in the Design and Interpretation of Noninferiority Trials |
22/01/2018 |
2528 |
Risk factors associated with increased prevalence of abdominal aortic aneurysm in women |
22/01/2018 |
2527 |
Carotid Stenosis Role of Plaque Morphology in Recurrent Stroke Risk |
22/01/2018 |
2526 |
Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014 |
22/01/2018 |
2525 |
Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden |
22/01/2018 |
2524 |
CANCER Cancérogenèse, oncogénétique |
22/01/2018 |
2523 |
Look beyond technology in cancer care |
22/01/2018 |
2522 |
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis |
22/01/2018 |
2521 |
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specifi c associations in 1·25 million people |
22/01/2018 |
2520 |
Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation |
22/01/2018 |
2519 |
Association Between Use of Antithrombotic Medication and Hematuria-Related Complications |
22/01/2018 |
2518 |
Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients |
22/01/2018 |
2517 |
ASSESSING HEPATIC FIBROSIS USING 2-D SHEAR WAVE ELASTOGRAPHY IN PATIENTS WITH LIVER TUMORS: A PROSPECTIVE SINGLE-CENTER STUDY |
22/01/2018 |
2516 |
Après un AVC, deux fois plus de cancers diagnostiqués dans les 6 mois |
22/01/2018 |
2515 |
Aspirin in the elderly — tailored approaches ahead? |
22/01/2018 |
2514 |
Anatomical study to the vessels of the lower limb by using CT scan and 3D reconstructions of the injected material |
22/01/2018 |
2513 |
Acute Coronary Syndromes |
22/01/2018 |
2512 |
Abdominal aortic aneurysms in women |
22/01/2018 |
2511 |
A systematic review of muscle morphology and function in intermittent claudication |
22/01/2018 |
2510 |
A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives |
22/01/2018 |
2509 |
A registry-based rationale for discrete intervention thresholds for open and endovascular elective abdominal aortic aneurysm repair in female patients |
22/01/2018 |
2508 |
A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure |
22/01/2018 |
2507 |
A minimally interactive and reproducible method for abdominalaortic aneurysm quantification in 3D ultrasound and computedtomography with implicit template deformationsL. |
22/01/2018 |
2506 |
Traitement prolongé de la MTEV : études de cas |
22/01/2018 |
2505 |
ASH Draft Recommendations for VTE in the Context of Pregnancy |
22/01/2018 |
2504 |
ASH Draft Recommendations for Heparin-Induced Thrombocytopenia |
22/01/2018 |
2503 |
How I treat pediatric venous thromboembolism |
22/01/2018 |
2502 |
Cancer-associated pathways and biomarkers of venous thrombosis |
22/01/2018 |
2501 |
Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events |
22/01/2018 |
2500 |
RÉVISER LES ORDONNANCES À RALLONGE CHEZ LES SENIORS POUR LIMITER LES RISQUES |
22/01/2018 |
2499 |
Factors associating with the presence of residual thrombosis after 3-month treatment of acute pulmonary embolism |
22/01/2018 |
2498 |
Améliorer la pertinence des STRATEGIES MEDICALES |
22/01/2018 |
2497 |
The natural history and outcomes of line-associated upper extremity deep venous thromboses in critically ill patients |
22/01/2018 |
2496 |
The hemodynamic effects of pregnancy on the lower extremity venous system |
22/01/2018 |
2495 |
Une puce qui ferait faire un saut de géant à l’administration de médicaments La non-publication de certains essais, un biais pour les méta-analyses |
22/01/2018 |
2494 |
Abdominal aortic aneurysms in women |
22/01/2018 |
2493 |
The Importance of Breakfast in Atherosclerosis Disease |
22/01/2018 |
2492 |
PERFORMANCES AND LIMITATIONS OF SEVERAL ULTRASOUND-BASED ELASTOGRAPHY TECHNIQUES: A PHANTOM STUDY |
22/01/2018 |
2491 |
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation |
22/01/2018 |
2490 |
High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy |
22/01/2018 |
2489 |
Inhibiteur de la DPP-4 ou des SGLT2 après échec de la metformine seule dans le diabète de type 2 |
14/01/2018 |
2488 |
Pourquoi traiter une occlusion coronaire totale chronique ? |
14/01/2018 |
2487 |
Systematic review and meta-analysis of sex differences in outcome after intervention for abdominal aortic aneurysm |
14/01/2018 |
2486 |
Risk factors associated with increased prevalence of abdominal aortic aneurysm in women |
14/01/2018 |
2485 |
Update on Screening for Abdominal Aortic Aneurysm: A Topical Review |
14/01/2018 |
2484 |
Update on Screening for Abdominal Aortic Aneurysm: A Topical Review |
14/01/2018 |
2483 |
The association of venous thromboembolism chemoprophylaxis timing on venous thromboembolism after major vascular surgery |
14/01/2018 |
2482 |
Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms |
14/01/2018 |
2481 |
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease |
14/01/2018 |
2480 |
Sex differences in the association between smoking and abdominal aortic aneurysm |
14/01/2018 |
2479 |
Reproducibility of ultrasound measurement of the abdominal aorta |
14/01/2018 |
2478 |
Rationale and Design of the ARREST Trial Investigating Mesenchymal Stem Cells in the Treatment of Small AAA |
14/01/2018 |
2477 |
Proximal radial artery arteriovenous fistula for hemodialysis vascular access |
14/01/2018 |
2476 |
Pathophysiology of Venous Thromboembolism with Respect to the Anatomical Features of the Deep Veins of Lower Limbs: A Review |
14/01/2018 |
2475 |
Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions |
14/01/2018 |
2474 |
Higham |
14/01/2018 |
2473 |
Safety of multidetector computed tomography pulmonary angiography to exclude pulmonary embolism in patients with a likely pretest clinical probability |
14/01/2018 |
2472 |
Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism |
14/01/2018 |
2471 |
Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism |
14/01/2018 |
2470 |
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of ISTH |
14/01/2018 |
2469 |
Tramadol : 1 512 effets secondaires graves en 4 ans, à quand l’arrêt de commercialisation ? |
14/01/2018 |
2468 |
Overdoses : 8 vies sauvées par la naloxone spray en France |
14/01/2018 |
2467 |
Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism |
14/01/2018 |
2466 |
Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study |
14/01/2018 |
2465 |
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia |
14/01/2018 |
2464 |
Chronic complications of venous thromboembolism |
14/01/2018 |
2463 |
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels |
14/01/2018 |
2462 |
DERMATOMYOSITE |
14/01/2018 |
2461 |
A propos du concept de pharmacorésistance |
14/01/2018 |
2460 |
Surveillance after endovascular aortic repair |
04/07/2017 |
2459 |
The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model |
04/07/2017 |
2458 |
Les 7 péchés mortels de la science |
04/07/2017 |
2457 |
Reduced high-density lipoprotein cholesterol- A valuable, independent prognostic marker in peripheral arterial disease |
04/07/2017 |
2456 |
Carotid artery revascularization in patients with contralateral carotid artery occlusion- Stent or endarterectomy |
04/07/2017 |
2455 |
Medical management of claudication |
04/07/2017 |
2454 |
Vascular applications of contrast-enhanced ultrasound imaging |
04/07/2017 |
2453 |
Des nouveautés sur le site du GITA |
04/07/2017 |
2452 |
Phenotypic and functional transformation in smooth muscle cells derived from varicose veins |
04/07/2017 |
2451 |
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 |
04/07/2017 |
2450 |
New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism |
04/07/2017 |
2449 |
Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry |
04/07/2017 |
2448 |
The natural history and outcomes of line-associated upper extremity deep venous thromboses in critically ill patients |
04/07/2017 |
2447 |
Diagnosis and management of the venous malformations of Klippel-Trénaunay syndrome |
04/07/2017 |
2446 |
Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies |
04/07/2017 |
2445 |
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation |
04/07/2017 |
2444 |
Mise au point: Prévenir la iatrogénèse médicamenteuse chez le sujet âgé |
04/07/2017 |
2443 |
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses |
04/07/2017 |
2442 |
Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial) |
04/07/2017 |
2441 |
Symptomatic compression of right iliac vein after right iliac |
04/07/2017 |
2440 |
Near-infrared fluorescence lymphatic imaging of KT Syndrome |
04/07/2017 |
2439 |
Routine extended follow-up surveillance of iliac vein stents for iliocaval venous obstruction may not be warranted |
04/07/2017 |
2438 |
Management of refractory chylous ascites with peritoneovenous shunts |
04/07/2017 |
2437 |
Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosis |
04/07/2017 |
2436 |
Lettre d’ICAR septembre 2017 : Princeps, Génériques, Hybrides et Biosimilaires. |
04/07/2017 |
2435 |
Extended Treatment of Venous Thromboembolism |
04/07/2017 |
2434 |
Lettre d’ICAR mars 2017: Adaptations posologiques : non, les études ne sont pas toutes faites avec Cockcroft Gault ! |
04/07/2017 |
2433 |
Lettre d’ICAR juin 2017: Maniement des antibiotiques chez le patient insuffisant rénal : Actualisation des adaptations posologiques à la pratique clinique en infectiologie |
04/07/2017 |
2432 |
Lettre d’ICAR décembre 2016: IPP et Rein – Nouvelles Données 2016 |
04/07/2017 |
2431 |
Dilation of inferior vena cava and iliac veins in elite athlete |
04/07/2017 |
2430 |
Déprescrire une statine en fin de vie: beaucoup de patients y sont favorables |
04/07/2017 |
2429 |
Clinical characteristics and prognostic features of intravenous leiomyomatosis with inferior vena cava or intracardiac extension |
04/07/2017 |
2428 |
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia |
04/07/2017 |
2427 |
The Cardiovascular Effects of Cocaine |
04/07/2017 |
2426 |
Lettre aux professionnels de santé |
04/07/2017 |
2425 |
Venous thromboembolism management in Northeast Melbourne – How does it compare to international guidelines and data |
04/07/2017 |
2424 |
Prescribing in the Oldest Old Inpatients- A Retrospective Analysis of Patients Referred for Specialist Geriatric Consultation |
04/07/2017 |
2423 |
Risk Factors for Recurrent Cardiovascular Events Before Age 65 Years or Within 2.5 Years of a Recent First Cardiovascular Event |
04/07/2017 |
2422 |
Potential Effect of Substituting Estimated Glomerular Filtration Rate for Estimated Creatinine Clearance for Dosing of Direct Oral Anticoagulants |
04/07/2017 |
2421 |
Management of chronic venous disease: clinical practice guidelines of the european society for vascular surgery |
23/06/2017 |
2420 |
Inflammation as a cause of venous thromboembolism |
23/06/2017 |
2419 |
Diabetic Foot Ulcers and Their Recurrence |
23/06/2017 |
2418 |
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism |
23/06/2017 |
2417 |
Venous thromboembolism in radiation therapy cancer patients riete registry |
23/06/2017 |
2416 |
Statin use and risk of recurrent venous thrombosis: results from the MEGA follow- up study |
23/06/2017 |
2415 |
Seasonal variations in cardiovascular disease |
23/06/2017 |
2414 |
Occult cancer detection in venous thromboembolism: the past, the present, and the future |
23/06/2017 |
2413 |
Novel target with antithrombotic potential and low bleeding risk |
23/06/2017 |
2412 |
Epidemiology and treatment of pulmonary arterial hypertension |
23/06/2017 |
2411 |
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes |
23/06/2017 |
2410 |
Diabète: la canagliflozine réduit les évènements CV mais augmente les amputations |
23/06/2017 |
2409 |
Statin-associated muscle symptoms — really all in the mind? |
23/06/2017 |
2408 |
Current practice patterns and patient persistence with anticoagulant treatments for cancer-a ssociated thrombosis |
23/06/2017 |
2407 |
Cost- minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D- dimer for exclusion of venous thromboembolism |
23/06/2017 |
2406 |
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization |
23/06/2017 |
2405 |
Common Reasons That Asymptomatic Patients Who Are 65 Years and Older Receive Carotid Imaging |
23/06/2017 |
2404 |
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes |
23/06/2017 |
2403 |
Causes of venous thrombosis |
23/06/2017 |
2402 |
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study |
23/06/2017 |
2401 |
Agent specific effects of anticoagulant induced alopecia |
23/06/2017 |
2400 |
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates |
23/06/2017 |
2399 |
Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes with a Low Atherosclerotic Risk Profile |
23/06/2017 |
2398 |
Thirty-Day Readmissions After Endovascular or Surgical Therapy for CriticalLimb Ischemia: Analysis of the 2013-2014 Nationwide Readmissions Databases |
23/06/2017 |
2397 |
Noninvasive characterization of carotid plaque strain |
23/06/2017 |
2396 |
Conflict of Interest Policies at French Medical Schools: Starting from the Bottom |
23/06/2017 |
2395 |
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study |
23/06/2017 |
2394 |
Antiphospholipid Syndrome Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics |
23/06/2017 |
2393 |
Lupus érythémateux systémique et contraception revue systématique de la littérature |
23/06/2017 |
2392 |
Prise en charge du risque hémorragique associé aux agents antiplaquettaires |
23/06/2017 |
2391 |
Aspirin and Risk of Subarachnoid Hemorrhage Systematic Review and Meta-Analysis |
23/06/2017 |
2390 |
How I treat central venous access device–related upper extremity deep vein thrombosis |
23/06/2017 |
2389 |
Detection of Anomalous Cervical Internal Carotid Artery Branches by Colour Duplex Ultrasound |
23/06/2017 |
2388 |
Should a Reduction in All-Cause Mortality Be the Goal When Assessing Preventive Medical Therapies? |
23/06/2017 |
2387 |
Restenosis after Carotid Interventions and Its Relationship with Recurrent Ipsilateral Stroke A Systematic Review and Meta-analysis |
23/06/2017 |
2386 |
Corresponding author email id: s.jowett@bham.ac.uk Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism |
23/06/2017 |
2385 |
Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study |
23/06/2017 |
2384 |
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study |
23/06/2017 |
2383 |
Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies |
23/06/2017 |
2382 |
Statine en prévention cardiovasculaire secondaire: pravastatine en pramier choix, quand une statine est justifiée |
23/06/2017 |
2381 |
Observance du traitement anticoagulant oral chez le sujet âgé à l’ère des anticoagulants oraux directs |
23/06/2017 |
2380 |
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial |
23/06/2017 |
2379 |
Deep vein thrombosis and pulmonary embolism |
23/06/2017 |
2378 |
Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease |
23/06/2017 |
2377 |
Cœur et sport |
23/06/2017 |
2376 |
Exercice, liens d’intérêts: ce qu’elle disait avant |
23/06/2017 |
2375 |
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry |
23/06/2017 |
2374 |
Increased risks of venous thromboembolism in patients with psoriasis A Nationwide Cohort Study |
23/06/2017 |
2373 |
Logigramme : conduite à tenir en cas d’oubli de prise |
23/06/2017 |
2372 |
Which are the best conservative interventions for lymphoedema after breast cancer surgery? |
23/06/2017 |
2371 |
Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs |
23/06/2017 |
2370 |
Five Year Natural History of Screening Detected Sub-Aneurysms and Abdominal Aortic Aneurysms in 70 year old women and systematic review of repair rate in women |
23/06/2017 |
2369 |
Dépistage de l’hypertension artérielle pulmonaire au cours de la Sclérodermie |
23/06/2017 |
2368 |
The aspirin story – from willow to wonder drug |
23/06/2017 |
2367 |
Acute Myocardial Infarction |
23/06/2017 |
2366 |
Early Outcomes After Carotid Artery Stenting Compared With Endarterectomy for Asymptomatic Carotid Stenosis |
23/06/2017 |
2365 |
Prevalence of Tibial Artery and Pedal Arch Patency by Angiography in Patients With Critical Limb Ischemia and Noncompressible Ankle Brachial Index |
23/06/2017 |
2364 |
Choosingaparticularoralanticoagulantanddose for stroke prevention in individual patients with non-valvular atrial ?brillation: part 2 |
23/06/2017 |
2363 |
Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence |
23/06/2017 |
2362 |
Diagnosis and management of deep vein thrombosis in pregnancy |
23/06/2017 |
2361 |
CLINICAL PLATELET DISORDERS Heparin-induced thrombocytopenia |
23/06/2017 |
2360 |
Optimal management of patients with asymptomatic carotid stenosis |
23/06/2017 |
2359 |
Factors associated with thrombotic complications in pediatric patients with vascular malformations |
23/06/2017 |
2358 |
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study |
23/06/2017 |
2357 |
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patientswithnon-valvularatrial?brillation:part1 |
23/06/2017 |
2356 |
Asymptomatic carotid stenosis Medicine alone or combined with carotid revascularization |
23/06/2017 |
2355 |
Une application permet d’allonger l’espérance de vie des cancéreux |
23/06/2017 |
2354 |
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials |
23/06/2017 |
2353 |
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial |
23/06/2017 |
2352 |
Coût direct des AVK en France |
23/06/2017 |
2351 |
Prévention primaire par statines après 75 ans, pas de bénéfice ? |
23/06/2017 |
2350 |
Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease |
23/06/2017 |
2349 |
76ème journées de la SFP Paris |
23/06/2017 |
2348 |
Statement for Doppler waveforms analysis |
23/06/2017 |
2347 |
LDL cholestérol et maladies cardiovasculaires : la preuve par 7 |
23/06/2017 |
2346 |
Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients |
23/06/2017 |
2345 |
Successful endovascular treatment of popliteal artery entrapment syndrome: a case report with 3-years follow-up |
23/06/2017 |
2344 |
Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation |
23/06/2017 |
2343 |
The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV) |
23/06/2017 |
2342 |
Ultrasound Examination of Solid-Organ Transplants |
23/06/2017 |
2341 |
The Treatment Gap in Peripheral Artery Disease |
23/06/2017 |
2340 |
Seasonal variations in cardiovascular disease |
23/06/2017 |
2339 |
Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria |
23/06/2017 |
2338 |
Cancer |
23/06/2017 |
2337 |
Formation Médicale Continue: numéro 27 |
23/06/2017 |
2336 |
Pulmonary embolism response teams |
23/06/2017 |
2335 |
Primary Prevention With Statin Therapy in the Elderly |
23/06/2017 |
2334 |
Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease |
23/06/2017 |
2333 |
Peripheral artery disease Drug-coated balloon superior to standard balloon angioplasty |
23/06/2017 |
2332 |
Néphrotoxicité des thérapies oncologiques |
23/06/2017 |
2331 |
New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation |
23/06/2017 |
2330 |
Complications vasculaires de la transplantation rénale: conduite diagnostique |
23/06/2017 |
2329 |
formation médicale continue |
23/06/2017 |
2328 |
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease |
23/06/2017 |
2327 |
Principales causes de décès et de morbidité |
23/06/2017 |
2326 |
Contrast-enhanced US–guided Interventions: Improving Success Rate and Avoiding Complications Using US Contrast Agents |
23/06/2017 |
2325 |
Altération aiguë de la fonction du greffon rénal |
23/06/2017 |
2324 |
The PCSK9 adventure — humanizing extreme LDL lowering |
23/06/2017 |
2323 |
Carotid diaphragm Atypical fibromuscular dysplasia or atheromatous lesions |
23/06/2017 |
2322 |
Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention A Meta-Analysis of Clinical Trials |
23/06/2017 |
2321 |
Concerns about andexanet |
23/06/2017 |
2320 |
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease (Review) |
23/06/2017 |
2319 |
Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack |
23/06/2017 |
2318 |
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults |
23/06/2017 |
2317 |
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE |
23/06/2017 |
2316 |
A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients |
23/06/2017 |
2315 |
New score for predicting bleeding risk after DAP |
23/06/2017 |
2314 |
AntithromboticTherapyforVenousThromboembolicDisease |
23/06/2017 |
2313 |
Comment enseigner le raisonnement clinique?: un fascinant travail de détective |
23/06/2017 |
2312 |
Echographie?: un outil utile pour la démarche diagnostique en médecine de famille |
23/06/2017 |
2311 |
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries |
23/06/2017 |
2310 |
Myopathies médicamenteuses |
23/06/2017 |
2309 |
Raisonnement clinique?: de la théorie à la pratique… et retour |
23/06/2017 |
2308 |
Prise en charge des patients en médecine de famille?: quoi de neuf dans la littérature en 2016?? |
23/06/2017 |
2307 |
Validity of Peripheral Arterial Disease Diagnoses in the Danish National Patient Registry |
23/06/2017 |
2306 |
The Direct Factor Xa Inhibitor Rivaroxaban Passes Into Human Breast Milk |
23/06/2017 |
2305 |
Text Messaging and Protected Health Information What Is Permitted ? |
23/06/2017 |
2304 |
Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia |
23/06/2017 |
2303 |
Oral contraceptive use is a provoking factor for venous thromboembolism |
23/06/2017 |
2302 |
The Atherosclerosis Burden Score (ABS): a Convenient Ultrasound-Based Score of Peripheral Atherosclerosis for Coronary Artery Disease Prediction |
23/06/2017 |
2301 |
Douleurs musculaires sous statines : un effet nocebo ? |
23/06/2017 |
2300 |
Épidémiologie et histoire naturelle de l’artérite à cellules géantes (Horton) |
23/06/2017 |
2299 |
Quelle durée de traitement après un épisode thromboembolique veineux |
23/06/2017 |
2298 |
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin |
23/06/2017 |
2297 |
Variation in hospital costs and reimbursement for endovascular aneurysm repair- A Vascular Quality Initiative pilot project |
23/06/2017 |
2296 |
Fiche mémo Évaluation du risque cardio-vasculaire Février 2017 |
23/06/2017 |
2295 |
Trends and outcomes in endovascular and open surgical treatment of visceral aneurysms |
23/06/2017 |
2294 |
Routine extended follow-up surveillance of iliac vein stents for iliocaval venous obstruction may not be warranted |
23/06/2017 |
2293 |
Prolonged stance phase during walking in intermittent claudication |
23/06/2017 |
2292 |
Pathophysiology of varicose veins |
23/06/2017 |
2291 |
Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome |
23/06/2017 |
2290 |
Outcomes of iliac vein stents after pregnancy |
23/06/2017 |
2289 |
Medical therapy and intervention do not improve uncomplicated isolated mesenteric artery dissection outcomes over observation alone |
23/06/2017 |
2288 |
Characteristics of provoked deep venous thrombosis in a tertiary care center |
23/06/2017 |
2287 |
Carotid artery stenting is associated with a higher incidence of major adverse clinical events than carotid endarterectomy in female patients |
23/06/2017 |
2286 |
Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia |
23/06/2017 |
2285 |
A novel duplex finding of superficial epigastric vein flow reversal to diagnose iliocaval occlusion |
23/06/2017 |
2284 |
DRUG SAFETY Safetypro?leofthedirectoralanticoagulants: an analysis of the WHO database of adverse drug reactions |
23/06/2017 |
2283 |
Outpatient management of pulmonary embolism |
23/06/2017 |
2282 |
Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge |
23/06/2017 |
2281 |
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy) |
23/06/2017 |
2280 |
Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs |
23/06/2017 |
2279 |
Etiology and complications of thrombocytopenia in hospitalized medical patients |
23/06/2017 |
2278 |
NonvitaminK-dependentoralanticoagulants(NOACs)inchronic kidney disease patients with atrial fibrillation |
23/06/2017 |
2277 |
Adjusted value of thromboprophylaxis in hospitalized obese patients- A comparative study of two regimens of enoxaparin- The ITOHENOX study |
23/06/2017 |
2276 |
The FAST-ED App: A Smartphone Platform for the Field Triage of Patients With Stroke |
23/06/2017 |
2275 |
Standards de qualité pour la pratique de l’échoDoppler dans la surveillance des endoprothèses aortiques abdominales |
23/06/2017 |
2274 |
Symptomatic lower limb giant cell arteritis Characteristic,management and longterm outcome |
23/06/2017 |
2273 |
ETUDE M2M THROMBOSE : Traumatismes des MI = HBPM ? |
23/06/2017 |
2272 |
Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease |
23/06/2017 |
2271 |
D-dimer at venous thrombosis diagnosis is associated with risk of recurrence |
23/06/2017 |
2270 |
e-Health based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study |
23/06/2017 |
2269 |
Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism |
23/06/2017 |
2268 |
Sex-specific differences in the presenting location of a first venous thromboembolism |
23/06/2017 |
2267 |
Recurrent Venous Thrombosis Related to Overweight and Obesity: Results From The Mega Follow-Up Study |
23/06/2017 |
2266 |
Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment |
23/06/2017 |
2265 |
Outcome After Ruptured AAA Repair in Octo- and Nonagenarians in Sweden 1994–2014 |
23/06/2017 |
2264 |
Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism |
23/06/2017 |
2263 |
Major bleeding risks of different low-molecular-meight-heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis |
23/06/2017 |
2262 |
Du point de vue des mauvaises herbes |
23/06/2017 |
2261 |
Inhibiteurs de la PCSK9 |
16/04/2017 |
2260 |
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes |
16/04/2017 |
2259 |
Communiquer, converser, s’émerveiller |
16/04/2017 |
2258 |
Guidelines?: fausse route ou voie dorée?? |
16/04/2017 |
2257 |
The Perils of Trumping Science in Global Health — The Mexico City Policy and Beyond |
16/04/2017 |
2256 |
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease |
16/04/2017 |
2255 |
Du point de vue des mauvaises herbes |
16/04/2017 |
2254 |
Revised Framingham Stroke Risk Profile to Reflect Temporal Trends |
16/04/2017 |
2253 |
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation |
16/04/2017 |
2252 |
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations |
16/04/2017 |
2251 |
Decision Tools to Improve Personalized Care in Cardiovascular Disease Moving the Art of Medicine Toward Science |
16/04/2017 |
2250 |
Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review |
16/04/2017 |
2249 |
Periprocedural Anticoagulation Management of Patients with Thrombophilia |
16/04/2017 |
2248 |
Neuropathies pe?riphe?riques – de?marche diagnostique |
16/04/2017 |
2247 |
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation |
16/04/2017 |
2246 |
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French working group on perioperative Hemostasis (GIHP) |
16/04/2017 |
2245 |
Uses of polypills for cardiovascular disease and evidence to date |
16/04/2017 |
2244 |
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation |
16/04/2017 |
2243 |
Une cause rare d’ische?mie digitale |
16/04/2017 |
2242 |
Treatment strategy based on the natural course for patients with spontaneous isolated superior mesenteric artery dissection |
16/04/2017 |
2241 |
The Significance of Inflow Artery and Tourniquet Derived Cephalic Vein Diameters on Predicting Successful Use and Patency of Arteriovenous Fistulas for Haemodialysis |
16/04/2017 |
2240 |
The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population |
16/04/2017 |
2239 |
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site |
16/04/2017 |
2238 |
The american college of surgeons – preventive mesures for lymphedema: Separating fact from fiction |
16/04/2017 |
2237 |
Tailoring duration of DAPT with risk scores |
16/04/2017 |
2236 |
Surgical Treatment of Splenic Artery Aneurysm |
16/04/2017 |
2235 |
Sex differences in mortality and morbidity following repair of intact abdominal aortic aneurysms |
16/04/2017 |
2234 |
Putting polypills into practice: challenges and lessons learned |
16/04/2017 |
2233 |
Venous thromboembolic diseases diagnosis management and thrombophilia testing |
16/04/2017 |
2232 |
US deaths from cancer continue to fall |
16/04/2017 |
2231 |
Testing for thrombophilia in mesanteric venous thrombosis – Retrospective original study and systematic review |
16/04/2017 |
2230 |
Thrombophilia Screening: Universal, Selected, or Neither? |
16/04/2017 |
2229 |
Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice Combined results of a systematic review, expert panel opinion and an international survey |
16/04/2017 |
2228 |
Net clinical bene?t of hospitalization versus outpatient management of patients with acute pulmonary embolism |
16/04/2017 |
2227 |
Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study |
16/04/2017 |
2226 |
Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism |
16/04/2017 |
2225 |
Family history of coronary heart disease and the incidence and progression of coronary artery calcification- Multi-Ethnic Study of Atherosclerosis (MESA) |
16/04/2017 |
2224 |
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease |
16/04/2017 |
2223 |
Coca-Cola’s secret influence on medical and science journalists |
16/04/2017 |
2222 |
Chocolate consumption and risk of stroke among men and women- A large population-based, prospective cohort study |
16/04/2017 |
2221 |
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2) |
16/04/2017 |
2220 |
Management of the Diseases of Mesenteric Arteries and Veins- Clinical Practice Guidelines of the European Society of Vascular Surgery |
16/04/2017 |
2219 |
Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations |
16/04/2017 |
2218 |
Preferred Management of Primary Deep Arm Vein Thrombosis |
16/04/2017 |
2217 |
Nutcracker Syndrome- An Update on Current Diagnostic Criteria and Management Guidelines |
16/04/2017 |
2216 |
Fibromuscular dysplasia: Advances in understanding and management |
16/04/2017 |
2215 |
Efficacy and Safety of Alprostadil in Patients with Peripheral Arterial Occlusive Disease Fontaine Stage IV- Results of a Placebo Controlled Randomised Multicentre Trial (ESPECIAL) |
16/04/2017 |
2214 |
Fall risk and anticoagulation for atrial fi brillation in the elderly: A delicate balance |
16/04/2017 |
2213 |
Carotid Stenosis Treatment- Variation in International Practice Patterns |
16/04/2017 |
2212 |
Angiosome Targeted PTA is More Important in Endovascular Revascularisation than in Surgical Revascularisation- Analysis of 545 Patients with Ischaemic Tissue Lesions |
16/04/2017 |
2211 |
Un point sur le traitement des dyslipidémies en prévention cardiovasculaire |
16/04/2017 |
2210 |
DOSSIER: CONSENSUS RELATIF À LA PRISE EN CHARGE DES DYSLIPIDÉMIES DE L’ADULTE |
16/04/2017 |
2209 |
Dalteparin thromboprophylaxis in cancer patients at high risk for Venous Thromboembolism: a randomised trial |
16/04/2017 |
2208 |
Throbophilias 2016: When to Test ? |
16/04/2017 |
2207 |
The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism – still a challenging issue |
16/04/2017 |
2206 |
L’érythromélalgie: approche diagnostique et thérapeutique actuelle |
16/04/2017 |
2205 |
Une cause rare d’ischemie digitale |
16/04/2017 |
2204 |
Varicose vein therapy and nerve lesions |
16/04/2017 |
2203 |
Ultrasound-Guided Central Venous Catheterization: A Review of the Relevant Anatomy, Technique, Complications, and Anatomical Variations |
16/04/2017 |
2202 |
Renal artery stenosis in patients with Peripheral Artery Disease: Prevalence, risk factors and long-term prognosis |
16/04/2017 |
2201 |
Women, thrombosis, and cancer: A gender-speci?c analysis |
16/04/2017 |
2200 |
Uterine bleeding during anticoagulation in women with venous thromboembolism |
16/04/2017 |
2199 |
Risk-adapted management of pulmonary embolism |
16/04/2017 |
2198 |
Prevention and management of ovarian hyperstimulation syndrome |
16/04/2017 |
2197 |
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use |
16/04/2017 |
2196 |
Genetic factors in pediatric venous thromboembolism |
16/04/2017 |
2195 |
Genetic factors in pediatric venous thromboembolism |
16/04/2017 |
2194 |
Gender differences in patients with venous thromboembolism and ?ve common sites of cancer |
16/04/2017 |
2193 |
Antiphospholipid syndrome |
16/04/2017 |
2192 |
Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away? |
16/04/2017 |
2191 |
Antiphospholid antibodies and the risk of pregnancy complications |
16/04/2017 |
2190 |
Pitfalls in the diagnostic management of pulmonary embolism in pregnancy |
16/04/2017 |
2189 |
Fiche mémo Évaluation du risque cardio-vasculaire |
16/04/2017 |
2188 |
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment |
16/04/2017 |
2187 |
The epidemiology of venous thromboembolism |
16/04/2017 |
2186 |
Synthèse fiche mémo Principales dyslipidémies : stratégies de prise en charge |
16/04/2017 |
2185 |
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia |
16/04/2017 |
2184 |
Guidance for the management of venous thrombosis in unusual sites |
16/04/2017 |
2183 |
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism |
16/04/2017 |
2182 |
Guidance for the treatment of deep vein thrombosis and pulmonary embolism |
16/04/2017 |
2181 |
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism |
16/04/2017 |
2180 |
Guidance for the prevention and treatment of cancer-associated venous thromboembolism |
16/04/2017 |
2179 |
Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism |
16/04/2017 |
2178 |
Guidance for the prevention and treatment of the post-thrombotic syndrome |
16/04/2017 |
2177 |
Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism |
16/04/2017 |
2176 |
Utility of thrombophilia testing in patients with venous thromboembolism |
16/04/2017 |
2175 |
Accelerated Atherosclerosis in Takayasu Disease: Case-Control Study |
16/04/2017 |
2174 |
 |
16/04/2017 |
2173 |
Antalgiques et grossesse?: la nouvelle équation de pharmacovigilance |
16/04/2017 |
2172 |
Regression of Coronary Atherosclerosis with Medical Therapy |
16/04/2017 |
2171 |
Registries reveal real-world use of anticoagulant drugs in AF |
16/04/2017 |
2170 |
Questions spécifiques au diabète chez les personnes âgées Prise en charge multidisciplinaire du diabète?: recommandations pour la pratique clinique |
16/04/2017 |
2169 |
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial |
16/04/2017 |
2168 |
Accelerated Atherosclerosis in Takayasu Disease: Case-Control Study |
16/04/2017 |
2167 |
Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke |
16/04/2017 |
2166 |
Médiolyse artérielle segmentaire?: un diagnostic différentiel de vasculite |
16/04/2017 |
2165 |
La vieillesse et notre futur |
16/04/2017 |
2164 |
Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease Why and Who to Test |
16/04/2017 |
2163 |
Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia |
16/04/2017 |
2162 |
Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study |
16/04/2017 |
2161 |
Evaluation et prise en charge de l’hyperhidrose |
16/04/2017 |
2160 |
Choisir le bon médicament pour votre patient?: evidence vs eminence-based medicine |
16/04/2017 |
2159 |
Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism |
16/04/2017 |
2158 |
Association of Testosterone Replacement With Cardiovascular outcomes among men with androgen deficiency |
16/04/2017 |
2157 |
Artérites des grands vaisseaux?: pathogenèse, diagnostic et prise en charge |
16/04/2017 |
2156 |
Antiphospholid antibodies and the risk of pregnancy complications |
16/04/2017 |
2155 |
 |
16/04/2017 |
2154 |
Inscription 3ème édition Phlébo-pratique bordeaux |
16/04/2017 |
2153 |
Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network |
16/04/2017 |
2152 |
Carotid stenosis treatment: Variation in international practice patterns |
16/04/2017 |
2151 |
Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study |
16/04/2017 |
2150 |
Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations |
16/04/2017 |
2149 |
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial |
16/04/2017 |
2148 |
A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients |
16/04/2017 |
2147 |
Nouvelles recommandations HAS dyslipidémies : la place des statines réaffirmée |
16/04/2017 |
2146 |
La main des sclérodermies |
16/04/2017 |
2145 |
Familial Clustering of Venous Thromboembolism ± A Danish Nationwide Cohort Study |
31/03/2017 |
2144 |
Les lymphoedèmes : du diagnostic au traitement |
31/03/2017 |
2143 |
Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM® Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT |
31/03/2017 |
2142 |
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015 |
31/03/2017 |
2141 |
Long-term Risk of Venous Thromboembolism Recurrence after Isolated Superficial Vein Thrombosis |
31/03/2017 |
2140 |
Lymphoedème: un diagnostic difficile et pourtant indispensable |
31/03/2017 |
2139 |
Chronic kidney disease |
31/03/2017 |
2138 |
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention |
31/03/2017 |
2137 |
Carotid endarterectomy should not be based on consensus statement duplex velocity criteria |
31/03/2017 |
2136 |
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis |
31/03/2017 |
2135 |
Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis |
31/03/2017 |
2134 |
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials |
31/03/2017 |
2133 |
Suivre la règle HERDOO2 pour apprécier le risque de récidive thromboembolique |
31/03/2017 |
2132 |
Upper extremity deep vein thrombosis in a triathlete: Again intense endurance exercise as a thrombogenic risk |
31/03/2017 |
2131 |
Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score |
31/03/2017 |
2130 |
Patient claudicant et ischémie critique : du diagnostic à la prise en charge C |
31/03/2017 |
2129 |
Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review |
31/03/2017 |
2128 |
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding A risk modelling analysis |
31/03/2017 |
2127 |
MALADIE THROMBOEMBOLIQUE VEINEUSE Gérer l’urgence et organiser le suivi au-delà de l’épisode aigu |
31/03/2017 |
2126 |
More than an anticoagulant: Do heparins have direct anti-inflammatory effects? |
31/03/2017 |
2125 |
Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know |
31/03/2017 |
2124 |
Predicting Risk Of Venous Thromboembolism In Hospitalized Cancer Patients: Utility of A Risk Assessment Tool |
31/03/2017 |
2123 |
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence |
31/03/2017 |
2122 |
Efficacy and safety of extended thromboprophylaxis for medically ill patients A meta-analysis of randomised controlled trials |
31/03/2017 |
2121 |
Discontinuation and management of direct-acting anticoagulants for emergency procedures |
31/03/2017 |
2120 |
Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age |
31/03/2017 |
2119 |
Les anticoagulants oraux directs (AODs) chez le sujet âgé : données de pharmacovigilance sur le territoire national |
31/03/2017 |
2118 |
Renal Artery Stenosis in Patients with Peripheral Artery Disease: Prevalence, Risk Factors and Long-term Prognosis |
31/03/2017 |
2117 |
Detection of lupus anticoagulant in the era of direct oral anticoagulants |
31/03/2017 |
2116 |
When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found |
31/03/2017 |
2115 |
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study |
31/03/2017 |
2114 |
Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicentre, cross-sectional study |
31/03/2017 |
2113 |
The new Dutch antithrombotic management guideline Treating venous thrombosis with direct oral anticoagulants for a lifetime? |
31/03/2017 |
2112 |
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease |
31/03/2017 |
2111 |
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications |
31/03/2017 |
2110 |
Neuropathies périphériques : démarche diagnostique |
31/03/2017 |
2109 |
Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism A Danish nationwide registry-based study |
31/03/2017 |
2108 |
L’ischémie mésentérique à l’ère des structures d’urgences vasculairesintestinalesManagement of mesenteric ischemia in the era of intestinal stroke centers:The gut and lifesaving strategy |
31/03/2017 |
2107 |
Une cause rare d’ischémie digitale An unusual cause of digital ischemia |
31/03/2017 |
2106 |
L’acrocyanose essentielle : un trouble vasomoteur fréquent pourtant méconnu |
31/03/2017 |
2105 |
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting A Scientific Statement From the American Heart Association |
31/03/2017 |
2104 |
Patients’ experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study |
31/03/2017 |
2103 |
Rivaroxaban for thrombosis prophylaxis in endovenous laser ablation with and without phlebectomy |
31/03/2017 |
2102 |
Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study |
31/03/2017 |
2101 |
Lymphoscintigraphic abnormalities in the contralateral lower limbs of patients with unilateral lymphedema |
31/03/2017 |
2100 |
Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulant. |
31/03/2017 |
2099 |
Lack of symmetry in the major lower limb veins |
31/03/2017 |
2098 |
Indications, complications and outcomes of inferior vena cava filters: A retrospective study |
31/03/2017 |
2097 |
Effects of rivaroxaban on coagulation tests in patients with nonvalvular atrial fibrillation under real-life conditions |
31/03/2017 |
2096 |
Chronic refractory venous ulcer exacerbated by a congenital pelvic arteriovenous malformation successfully treated by transarterial Onyx embolization |
31/03/2017 |
2095 |
Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban |
31/03/2017 |
2094 |
Acute apixaban treatment of heparin-induced thrombocytopenia |
31/03/2017 |
2093 |
Association between antithrombotic therapy and risk of postoperative complications among patients undergoing endovenous laser ablation |
31/03/2017 |
2092 |
ABO blood group is associated with peripheral arterial disease in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) |
31/03/2017 |
2091 |
Des avantages (faibles) de limmunossupression dans la sclérodermie systémique cutanée diffuse |
31/03/2017 |
2090 |
Should we screen extensively for cancer after unprovoked venous thrombosis? |
31/03/2017 |
2089 |
Evolocumab reduces cardiovascular events in patients with heart disease, finds study |
31/03/2017 |
2088 |
Statins Increase Diabetes Risk by up to 50% in Older Women |
31/03/2017 |
2087 |
Heart Disease and Stroke Statistics—2017 Update A Report From the American Heart Association |
31/03/2017 |
2086 |
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study |
31/03/2017 |
2085 |
Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke |
31/03/2017 |
2084 |
Evaluation of anticoagulation selection for acute venous thromboembolism |
31/03/2017 |
2083 |
Long-Term Risk of Stroke after Transient Ischemic Attack |
31/03/2017 |
2082 |
Disproportional increase of pulmonary embolism in young females in Germany- trends from 2005 to 2014 |
31/03/2017 |
2081 |
Direct oral anticoagulants in hypercoagulable states |
31/03/2017 |
2080 |
Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism |
31/03/2017 |
2079 |
Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism- a case control study |
31/03/2017 |
2078 |
Risque damputation sous gliflozine les propositions d’avertissements de lEMA |
31/03/2017 |
2077 |
Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism |
31/03/2017 |
2076 |
Trump cherche à politiser la science et manipuler les scientifiques |
31/03/2017 |
2075 |
Inferior Vena Cava Filters: When to Place and When to Remove |
31/03/2017 |
2074 |
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing |
31/03/2017 |
2073 |
The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead? |
31/03/2017 |
2072 |
Catheter-Based Approaches for the Treatment of Acute Pulmonary Embolism |
31/03/2017 |
2071 |
Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate? |
31/03/2017 |
2070 |
Antibiotic use associated with VTE and its implications: a new trigger for thromboprophylaxis and for reclassification of some unprovoked to provoked VTEs? |
31/03/2017 |
2069 |
The Pulmonary Embolism Response Team: What Is the Ideal Model? |
31/03/2017 |
2068 |
Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis |
31/03/2017 |
2067 |
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials |
31/03/2017 |
2066 |
Prise en charge interventionnelle de l’insuffisance veineuse superficielle des membres inférieurs |
19/03/2017 |
2065 |
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism |
19/03/2017 |
2064 |
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism |
19/03/2017 |
2063 |
Evolocumab and Clinical Outcomes FOURIER |
19/03/2017 |
2062 |
Management of direct oral anticoagulants in women of childbearing potential guidance from the SSC of the ISTH reply |
19/03/2017 |
2061 |
Lipid levels and risk of recurrent venous thrombosis results from the MEGA follow-up study |
19/03/2017 |
2060 |
Inferior vena cava filters |
19/03/2017 |
2059 |
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54 |
19/03/2017 |
2058 |
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH |
19/03/2017 |
2057 |
Real-life treatment of venous thromboembolism with direct oral anticoagulants The influence of recommended dosing and regimens |
19/03/2017 |
2056 |
Prediction of major and clinically relevant bleeding in patients with Edocaban anbd Warfarin |
19/03/2017 |
2055 |
Practical Considerations for the use of DOAC |
19/03/2017 |
2054 |
Pour mieux soigner, des médicaments à écarter : bilan 2017 |
19/03/2017 |
2053 |
Once- versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism |
19/03/2017 |
2052 |
Improving the diagnostic management of upper extremity deep vein thrombosis |
19/03/2017 |
2051 |
LES PALMARÈS PRESCRIRE 2016 |
19/03/2017 |
2050 |
Is decreasing mortality in total hip and knee arthroplasty patients dependent on patients’ comorbidity? |
19/03/2017 |
2049 |
Identification of Factors Associated With Improved Survival After Renal Artery Stenting |
19/03/2017 |
2048 |
Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular Intervention |
19/03/2017 |
2047 |
Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice |
19/03/2017 |
2046 |
Les anomalies vasculaires: fiches d’information |
19/03/2017 |
2045 |
Cancérologie 10 choses à ne pas faire quand on parle avec un patient |
19/03/2017 |
2044 |
Anti-PCSK9 : Amgen annonce que levolocumab réduit les événements CV dans FOURIER |
19/03/2017 |
2043 |
AVIS relatif aux bénéfices-risques de la cigarette électronique ou e-cigarette étendus en population générale |
19/03/2017 |
2042 |
Cigarette électronique |
19/03/2017 |
2041 |
Self-Care for Management of Secondary Lymphedema A Systematic Review |
15/03/2017 |
2040 |
Venous Adventitial Cystic Disease A Review of 45 Cases Treated Since 1963 |
15/03/2017 |
2039 |
Lymphœdème le patient peut gérer ! |
15/03/2017 |
2038 |
Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation |
15/03/2017 |
2037 |
Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients |
15/03/2017 |
2036 |
Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients |
15/03/2017 |
2035 |
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves |
15/03/2017 |
2034 |
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes |
15/03/2017 |
2033 |
Incidence of venous thromboembolism in care homes- a prospective cohort study |
15/03/2017 |
2032 |
Impact of thrombophilia screening on venous thromboembolism management practices |
15/03/2017 |
2031 |
Care home residents show higher incidence of venous thromboembolism |
15/03/2017 |
2030 |
Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism |
15/03/2017 |
2029 |
Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin |
15/03/2017 |
2028 |
Remote pre-procedural ischemic stroke was the strongest risk for stroke and death associated with carotid stenting. A single center experience |
15/03/2017 |
2027 |
Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review |
15/03/2017 |
2026 |
Transition from apixaban to warfarin— addressing excess stroke, systemic embolism, and major bleeding |
15/03/2017 |
2025 |
Symptomatic carotid stenosis: is stenting as safe and effective as carotid endarterectomy? |
15/03/2017 |
2024 |
Outcomes after Early Neurological Deterioration and Transitory Deterioration in Acute Ischemic Stroke Patients |
15/03/2017 |
2023 |
Nonfocal Symptoms in Patients with Transient Ischemic Attack or Ischemic Stroke: Occurrence, Clinical Determinants, and Association with Cardiac History |
15/03/2017 |
2022 |
L’e-cigarette moins dangereuse que la clope ! |
15/03/2017 |
2021 |
Recommandation SSED/SGED : Mesures visant contrôle de la glycémie chez les patients atteints de diabète sucré de type 2 |
15/03/2017 |
2020 |
Prévention CV secondaire : rivaroxaban supérieur à l’aspirine dans COMPASS |
15/03/2017 |
2019 |
DE LA GRANDE CONSULTATION AUX PROPOSITIONS |
15/03/2017 |
2018 |
Etude COMPASS Re?sultats anticipe?s 2017 |
15/03/2017 |
2017 |
L’IRM cardiovasculaire entre mythes et réalités? quelle utilité pour le médecin praticien |
15/03/2017 |
2016 |
Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations |
15/03/2017 |
2015 |
Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease |
15/03/2017 |
2014 |
Pour mieux soigner, des médicaments à écarter : bilan 2017 |
15/03/2017 |
2013 |
AINS et grossesse piqure de rappel de l’ANSM |
15/03/2017 |
2012 |
Fermeture du foramen ovale perméable (FOP)? toujours pertinent |
15/03/2017 |
2011 |
Ultrasonography of Skin Changes in Legs with Chronic Venous Disease |
15/03/2017 |
2010 |
Venous malformations of the head and neck current concepts in management |
15/03/2017 |
2009 |
Maladie d’Alzheimer et syndromes apparentés? recommandations diagnostiques et thérapeutiques |
15/03/2017 |
2008 |
Quelques nouveautés dans la prise en charge de l’insuffisance cardiaque chronique. A la lumière des recommandations 2016 de la Société européenne de cardiologie |
15/03/2017 |
2007 |
NET CLINICAL BENEFIT OF HOSPITALIZATION VERSUS OUTPATIENT MANAGEMENT OF PATIENTS WITH ACUTE PULMONARY EMBOLISM |
15/03/2017 |
2006 |
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban |
15/03/2017 |
2005 |
Sclerotherapy complications of peripheral venous malformations |
15/03/2017 |
2004 |
Rapamycin inhibits the proliferation of endothelial cells in hemangioma |
15/03/2017 |
2003 |
Reducing Postoperative Venous Thromboembolism complications |
15/03/2017 |
2002 |
Trends in Patient Safety of Intact Abdominal Aortic Aneurysm Repair German Registry Data on 36,594 Procedures |
15/03/2017 |
2001 |
Right heart thrombi in pulmonary embolism |
15/03/2017 |
2000 |
Reoperation rates after open and endovascular abdominal aortic aneurysm repairs |
15/03/2017 |
1999 |
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment |
15/03/2017 |
1998 |
Prospective 30-Day Outcome Evaluation of a Fast-Track Protocol for 23-Hour Ambulatory Primary and Revisional Laparoscopic Roux-en-Y Gastric Bypass in 820 Consecutive Unselected Patients |
15/03/2017 |
1997 |
Practical issues for the use of tranexamic acid in total knee arthroplasty- a systematic review |
15/03/2017 |
1996 |
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism |
15/03/2017 |
1995 |
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism- A randomized trial |
15/03/2017 |
1994 |
Hospitalization with infection and incident venous thromboembolism- The ARIC study |
15/03/2017 |
1993 |
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary |
15/03/2017 |
1992 |
Statines et cholestérol bienvenue dans la postvérité |
15/03/2017 |
1991 |
L’étude en big data CANHEART ébranle les certitudes sur le bon cholestérol HDL |
15/03/2017 |
1990 |
Mettre en oeuvre la conciliation des traitements médicamenteux en établissement de santé |
15/03/2017 |
1989 |
SYNTHESE D’AVIS DE LA COMMISSION DE LA TRANSPARENCE: mai 2016 |
15/03/2017 |
1988 |
SYNTHESE D’AVIS DE LA COMMISSION DE LA TRANSPARENCE: juillet 2016 |
15/03/2017 |
1987 |
COMMISSION DE LA TRANSPARENCE: Avis 6 juillet 2016 |
15/03/2017 |
1986 |
Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke |
15/03/2017 |
1985 |
Phlébo-info: les séquences flash du mois |
15/03/2017 |
1984 |
Transitions in the Prophylaxis, Treatment and Care of Patients with Venous Thromboembolism |
15/03/2017 |
1983 |
Newer Oral Anticoagulants: Stroke Prevention and Pitfalls |
15/03/2017 |
1982 |
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions |
15/03/2017 |
1981 |
Migraine and risk of perioperative ischemic stroke and hospital readmission- hospital based registry study |
15/03/2017 |
1980 |
Médecine d’urgence |
15/03/2017 |
1979 |
Low risk of thromboembolic complications after fast-track hip and knee arthroplasty |
15/03/2017 |
1978 |
Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty |
15/03/2017 |
1977 |
Ischaemic colitis |
15/03/2017 |
1976 |
Low Risk of Thromboembolic Complications After Fast-Track Abdominal Surgery With Thrombosis-Prophylaxis Only During Hospital Stay |
15/03/2017 |
1975 |
Hypertension : quoi de neuf ? |
15/03/2017 |
1974 |
Gériatrie |
15/03/2017 |
1973 |
Early thromboembolic events ? 1 week after fast-track total hip and knee arthroplasty |
15/03/2017 |
1972 |
Diabétologie |
15/03/2017 |
1971 |
Complications Following Outpatient Total Joint Arthroplasty- An Analysis of a National Database |
15/03/2017 |
1970 |
Cardiologie |
15/03/2017 |
1969 |
Angiologie et hémostase |
15/03/2017 |
1968 |
Take control of your health You have the power to manage your health |
15/03/2017 |
1967 |
Treating blocked leg arteries When you need a procedure—and when you don’t |
15/03/2017 |
1966 |
Carotid artery surgery When you need it—and when you don’t |
15/03/2017 |
1965 |
Blood tests to show your risk for miscarriage When they can help—and when they don’t |
15/03/2017 |
1964 |
Clogged neck arteries: When you need a screening test—and when you don’t |
15/03/2017 |
1963 |
Advice for caregivers Treatments and tests for seniors |
15/03/2017 |
1962 |
Cholesterol drugs for people 75 and older When you need them—and when you don’t |
15/03/2017 |
1961 |
Screening tests for brain aneurysms When you need them—and when you don’t |
15/03/2017 |
1960 |
Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy |
15/03/2017 |
1959 |
Ask Your Doctor Do I need this cancer test or treatment? |
15/03/2017 |
1958 |
Artery and vein problems Some tests and treatments may not be helpful |
15/03/2017 |
1957 |
Heavy menstrual bleeding: work-up and management |
15/03/2017 |
1956 |
Congenital and acquired bleeding disorders in pregnancy |
15/03/2017 |
1955 |
Reversing vitamin K antagonists: making the old new again |
15/03/2017 |
1954 |
Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis |
15/03/2017 |
1953 |
Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism |
15/03/2017 |
1952 |
Inherited risk factors for venous thromboembolism |
15/03/2017 |
1951 |
Reversal of direct oral anticoagulants: a practical approach |
15/03/2017 |
1950 |
Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication |
15/03/2017 |
1949 |
Incidence of venous thromboembolism in COPD- linking inflammation and thrombosis |
15/03/2017 |
1948 |
Thrombosis in the setting of cancer |
15/03/2017 |
1947 |
What to do after the bleed: resuming anticoagulation after major bleeding |
15/03/2017 |
1946 |
Thrombosis and anticoagulation in the setting of renal or liver disease |
15/03/2017 |
1945 |
Venous thromboembolism and stroke in pregnancy |
15/03/2017 |
1944 |
Comparative Efficacy and Safety of Different antiplatelet agents prevention major CV events and leg amputations |
15/03/2017 |
1943 |
Thrombosis in the setting of obesity or inflammatory bowel disease |
15/03/2017 |
1942 |
Guideline for Reversal of Antithrombotics in Intracranial hemorhage |
15/03/2017 |
1941 |
Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer |
15/03/2017 |
1940 |
Contemporary evaluation and management of lower extremity peripheral artery disease |
15/03/2017 |
1939 |
Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients- impact on short-term survival |
15/03/2017 |
1938 |
Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism |
15/03/2017 |
1937 |
Ankle?brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study |
15/03/2017 |
1936 |
Clinical features of venous insuf?ciency and the risk of venousthrombosis in older people |
15/03/2017 |
1935 |
What Is the Most Effective Treatment of Superficial Thrombophlebitis ? |
15/03/2017 |
1934 |
Major Bleeding in VTE Patients Treated With Rivaroxaban An Analysis of Patients With Select Characteristics |
15/03/2017 |
1933 |
Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology |
15/03/2017 |
1932 |
A randomised clinical trial comparing the patient comfort and efficacy of three different graduated compression stockings in the prevention of postoperative deep vein thrombosis |
15/03/2017 |
1931 |
Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review |
15/03/2017 |
1930 |
The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population |
15/03/2017 |
1929 |
To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism |
15/03/2017 |
1928 |
Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism |
15/03/2017 |
1927 |
Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial |
15/03/2017 |
1926 |
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers |
15/03/2017 |
1925 |
Choosing wisely The impact of patient selection on efficacy and safety outcomes in the EINSTEIN DVT EP and AMPLIFY Trials |
15/03/2017 |
1924 |
Recent advances in the management of pulmonary embolism- focus on the critically ill patients |
15/03/2017 |
1923 |
Bleeding risk of terminally ill patients hospitalized in palliative care units the RHESO study |
15/03/2017 |
1922 |
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations |
15/03/2017 |
1921 |
Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression |
15/03/2017 |
1920 |
Hypertensions artérielles et grossesse consensus |
15/03/2017 |
1919 |
Sclérodermie : de quoi meurent les patients ? |
15/03/2017 |
1918 |
Quelle définition de la maladie rénale chronique? |
15/03/2017 |
1917 |
Prise en charge de la leucémie lymphoïde chronique en ambulatoire un nouveau concept |
15/03/2017 |
1916 |
Outcomes and Radiographic Findings of Isolated Spontaneous Superior Mesenteric Artery Dissection |
15/03/2017 |
1915 |
INTÉGRITÉ SCIENTIFIQUE |
15/03/2017 |
1914 |
Dossier Leucémie lymphoïde chronique |
15/03/2017 |
1913 |
Management of Dural Venous Sinus Thrombosis in Pregnancy |
15/03/2017 |
1912 |
Indications thérapeutiques dans la leucémie lymphoïde chronique |
15/03/2017 |
1911 |
Comment au XVII siècle la dépendance au tabac s’est mondialisée |
15/03/2017 |
1910 |
Définition, classification et facteurs pronostiques de la leucémie lymphoïde chronique |
15/03/2017 |
1909 |
Aspirin, stroke and drug-drug interactions |
15/03/2017 |
1908 |
The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome |
15/03/2017 |
1907 |
The risk of venous thromboembolism in patients with cirrhosis |
15/03/2017 |
1906 |
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding |
15/03/2017 |
1905 |
New evidence on old drugs_ warfarin versus aspirin after bioprosthetic |
15/03/2017 |
1904 |
Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A costeffectiveness analysis |
15/03/2017 |
1903 |
Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding |
15/03/2017 |
1902 |
Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrence |
15/03/2017 |
1901 |
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer |
15/03/2017 |
1900 |
Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism A retrospective analysis |
15/03/2017 |
1899 |
Cirrhosis as a risk factor for venous thrombosis |
15/03/2017 |
1898 |
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR |
15/03/2017 |
1897 |
Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies |
15/03/2017 |
1896 |
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 |
15/03/2017 |
1895 |
Who, when, and how to reverse non-vitamin K oral anticoagulants |
15/03/2017 |
1894 |
Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies |
15/03/2017 |
1893 |
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial |
15/03/2017 |
1892 |
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens |
15/03/2017 |
1891 |
The expanding role of direct oral anticoagulants in the management of thromboembolic disease |
15/03/2017 |
1890 |
Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study |
15/03/2017 |
1889 |
Prevention and Treatment of Lower Limb Deep Vein Thrombosis after Radiofrequency Catheter Ablation: Results of a Prospective active controlled Study |
15/03/2017 |
1888 |
Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting |
15/03/2017 |
1887 |
Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population |
15/03/2017 |
1886 |
Leukocytoclastic vasculitis associated a new anticoagulant: Rivaroxaban |
15/03/2017 |
1885 |
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation? |
15/03/2017 |
1884 |
New Direct Oral Anticoagulants (DOAC) and Their Use Today |
15/03/2017 |
1883 |
ADE Action Plan Anticoagulants |
15/03/2017 |
1882 |
Prevention of Gastrointestinal Bleeding in Patients Receiving Direct Oral Anticoagulants |
15/03/2017 |
1881 |
SGLT2 inhibitors – a health gamble with a new class of drugs for diabetes Oral anticoagulants linked to nearly 3,000 reported patient deaths, 16,000 hemorrhages Overall opioid use drops, but oxycodone use grows |
15/03/2017 |
1880 |
Reduction in cardiovascular and all-cause mortality in the EMPA-REGOUTCOME trial: A critical analysis |
15/03/2017 |
1879 |
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes |
15/03/2017 |
1878 |
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies |
15/03/2017 |
1877 |
Le diagnostic est en général aisé mais l’annonce toujours délicate |
15/03/2017 |
1876 |
Polykystose rénale autosomique dominante |
15/03/2017 |
1875 |
« L’enkystement » concerne aussi l’espace d’écoute et de parole |
15/03/2017 |
1874 |
Enquête familiale et conseil génétique |
15/03/2017 |
1873 |
Gestion pratique des situations d’urgence |
15/03/2017 |
1872 |
L’ETP : essentielle et à développer |
15/03/2017 |
1871 |
Planifier le programme personnalisé de soins en milieu spécialisé |
15/03/2017 |
1870 |
Problématique du dépistage des anévrismes intracrâniens |
15/03/2017 |
1869 |
Transplantations rénales et hépatiques : modalités, résultats |
15/03/2017 |
1868 |
Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling—Are Useful Drugs Already Available? |
15/03/2017 |
1867 |
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study |
15/03/2017 |
1866 |
Safety of warfarin in “high-risk” populations: A meta-analysis of randomized and controlled trials |
15/03/2017 |
1865 |
Reduction in cardiovascular and all-cause mortality in the EMPA-REG OUTCOME trial: A critical analysis |
15/03/2017 |
1864 |
Empagliflozin, Cardiovascular Outcomes and mortality in type diabetes |
15/03/2017 |
1863 |
Dual antiplatelet therapy for acute coronary syndromes How long to continue ? |
15/03/2017 |
1862 |
Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes |
15/03/2017 |
1861 |
The Changing Face of Clinical Trial The Large Pharmaceutical Company Perspective |
15/03/2017 |
1860 |
Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study)- Analysis of 6-month outcomes |
15/03/2017 |
1859 |
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus A Clinical Practice Guideline Update From the American College of Physicians |
15/03/2017 |
1858 |
Oligonucleotide Therapeutics — A New Class |
15/03/2017 |
1857 |
Meta-analysis of major bleeding events on aspirin versus vitamin K antagonists in randomized trials |
15/03/2017 |
1856 |
Comparison of risk scoring systems for patients presenting with upper gastro intestinal bleeding |
15/03/2017 |
1855 |
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life |
15/03/2017 |
1854 |
Results of study of low molecular weight heparin in patients with venous thromboembolism |
15/03/2017 |
1853 |
YouTube as a source of patient information for varicose vein treatment options |
15/03/2017 |
1852 |
The effect of surgeon and hospital volume on mortality after open and endovascular repair of abdominal aortic aneurysms |
15/03/2017 |
1851 |
Surveillance, anticoagulation, or filter in calf vein thrombosis |
15/03/2017 |
1850 |
Surgical Treatment of Intravenous Leiomyomatosis: The Role of the IVC Filter |
15/03/2017 |
1849 |
Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines- Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg |
15/03/2017 |
1848 |
Phlegmasia cerulea dolens from radiation-induced venous stenosis |
15/03/2017 |
1847 |
Deep venous thrombosis associated with caval extension of iliac stents |
15/03/2017 |
1846 |
PCSK9 inhibition- A promise fulfilled |
15/03/2017 |
1845 |
Low risk is not enough- the dilemma of calf vein thrombosis |
15/03/2017 |
1844 |
Incidence of pulmonary embolism in patients with isolated calf deep vein thrombosis |
15/03/2017 |
1843 |
Do patients with submassive pulmonary embolism benefit from thrombolytic therapy |
15/03/2017 |
1842 |
Deep vein thrombosis and pulmonary embolism |
15/03/2017 |
1841 |
Anticoagulation in dental surgery- Is it rude to interrupt |
15/03/2017 |
1840 |
Upper-extremity Deep Venous Thrombosis- A Review |
15/03/2017 |
1839 |
The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities |
15/03/2017 |
1838 |
Screening for Abdominal Aortic Aneurysms in Outpatient Primary Care Clinics |
15/03/2017 |
1837 |
Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism- a prospective cohort study |
15/03/2017 |
1836 |
Inferior Vena Cava Filters in Elderly Patients with Stable Acute Pulmonary Embolism |
15/03/2017 |
1835 |
Home Treatment of Deep Venous Thrombosis According to Comorbid Conditions |
15/03/2017 |
1834 |
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy |
15/03/2017 |
1833 |
Effectiveness of Inferior Vena Cava Filters on Mortality as an Adjuvant to Antithrombotic Therapy |
15/03/2017 |
1832 |
Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism- A Population-Based Longitudinal Study |
15/03/2017 |
1831 |
Atherosclerotic Renal Artery Stenosis and Hypertension- Pragmatism, Pitfalls, and Perspectives |
15/03/2017 |
1830 |
Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma |
15/03/2017 |
1829 |
Diagnosis and management of ovarian vein thrombosis in a healthy individual- a case report and a literature review |
15/03/2017 |
1828 |
Recurrence and mortality after first venous thromboembolism in a large population-based cohort |
15/03/2017 |
1827 |
Inferior Vena Cava Filters |
15/03/2017 |
1826 |
Continuation of low-molecular-weight heparin treatment for cancer related venous thromboembolism: a prospective cohort study in daily clinical practice |
15/03/2017 |
1825 |
Stand-alone D-dimer testing to rule out acute pulmonary embolism |
15/03/2017 |
1824 |
Inappropriate documentation of heparin as an allergy in the medical record due to misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences |
15/03/2017 |
1823 |
The postthrombotic syndrome: current evidence and future challenges |
15/03/2017 |
1822 |
During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time |
15/03/2017 |
1821 |
COMMISSION DE LA TRANSPARENCE: Avis 16 juillet 2008 |
15/03/2017 |
1820 |
Transient inherited antithrombin deficiency: a real phenomenon? |
15/03/2017 |
1819 |
Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial |
15/03/2017 |
1818 |
Ten years of cerebral venous thrombosis- male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events |
15/03/2017 |
1817 |
Reasons for the persistent incidence of venous thromboembolism |
15/03/2017 |
1816 |
Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis |
15/03/2017 |
1815 |
Patient satisfaction with extended-interval warfarin monitoring |
15/03/2017 |
1814 |
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism |
15/03/2017 |
1813 |
More than an anticoagulant- Do heparins have direct anti-inflammatory effects |
15/03/2017 |
1812 |
Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients- a systematic review and meta-analysis of randomized controlled trials |
15/03/2017 |
1811 |
Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode- an observational study |
15/03/2017 |
1810 |
Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation |
15/03/2017 |
1809 |
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum- A prospective cohort study |
15/03/2017 |
1808 |
Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci stud |
15/03/2017 |
1807 |
Betrixaban in Acutely Ill Medical Patients |
15/03/2017 |
1806 |
Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology |
15/03/2017 |
1805 |
The Influence of Preoperative Aneurysmal Thrombus Quantity and Distribution on the Development of Type II Endoleaks with Aneurysm Sac Enlargement After EVAR of AAA |
15/03/2017 |
1804 |
High proportion of known abdominal aortic aneurysm in patients with rupture indicates surveillance deficiency |
15/03/2017 |
1803 |
Population-based study of ruptured abdominal aortic aneurysm |
15/03/2017 |
1802 |
Nationwide Study of the Treatment of Mycotic Abdominal Aortic Aneurysms Comparing Open and Endovascular Repair |
15/03/2017 |
1801 |
Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm |
15/03/2017 |
1800 |
Aortic Aneurysm In Defense of the Vascular Smooth Muscle Cell |
15/03/2017 |
1799 |
De l’impertinence clinique de méta-analyses versus RCTs |
15/03/2017 |
1798 |
Pregnancy-AssociatedChanges in Pharmacokinetics:A Systematic Review |
15/03/2017 |
1797 |
Référentiel de bonnes pratiques sur les applications et les objets connectés en santé (Mobile Health ou mHealth) |
15/03/2017 |
1796 |
Intérêt de l’échographie de contraste aux microbulles en médecine vasculaire |
15/03/2017 |
1795 |
Pathways for outpatient management of venous thromboembolism in a UK centre |
15/03/2017 |
1794 |
Contraception de la femme diabétique |
15/03/2017 |
1793 |
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial |
15/03/2017 |
1792 |
Les complications des accès artériels fémoraux percutanés et leurs prises en charge |
15/03/2017 |
1791 |
La maladie thromboembolique veineuse pathologie souvent oubliée |
15/03/2017 |
1790 |
Evolution des techniques d’imagerie dans le diagnostic de l’embolie pulmonaire |
15/03/2017 |
1789 |
Chronic Kidney Disease |
15/03/2017 |
1788 |
Anticoagulants oraux directs (ACOD) une aide à la prescription dans la pratique quotidienne |
15/03/2017 |
1787 |
Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions |
15/03/2017 |
1786 |
Development and validation of risk prediction model for venous thromboembolism in postpartum women |
15/03/2017 |
1785 |
Testosterone treatment and risk of venous thromboembolism- population based case-control study |
15/03/2017 |
1784 |
Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting |
15/03/2017 |
1783 |
Significant regional variation exists in morbidity and mortality after repair of abdominal aortic aneurysm |
15/03/2017 |
1782 |
Haemodynamic Variations of Flow to Renal Arteries in Custom-Made and Pivot Branch Fenestrated Endografting |
15/03/2017 |
1781 |
Not All Patients with Critical Limb Ischaemia Require Revascularisation |
15/03/2017 |
1780 |
Renal Artery Stenosis in Patients with Peripheral Artery Disease- Prevalence, Risk Factors and Long-term Prognosis |
15/03/2017 |
1779 |
Development and External Validation of a Model Predicting Death After Surgery in Patients With a Ruptured Abdominal Aortic Aneurysm |
15/03/2017 |
1778 |
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease |
15/03/2017 |
1777 |
Cancer-associated venous thromboembolism Burden mechanismes and management |
15/03/2017 |
1776 |
Do patients with submassive pulmonary embolism benefit from thrombolytic therapy |
15/03/2017 |
1775 |
Frostbite Spectrum of Imaging Findings and Guidelines for Management Radiographics |
15/03/2017 |
1774 |
Phlegmasia cerulea dolens from radiation-induced venous stenosis |
15/03/2017 |
1773 |
Women’s health 2016 An update for internists |
15/03/2017 |
1772 |
US of the Inguinal Canal: Comprehensive Review of Pathologic Processes with CT and MR Imaging Correlation |
15/03/2017 |
1771 |
Fibromuscular dysplasia Advances in understanding and management |
15/03/2017 |
1770 |
Lymphatic Intervention for Various Types of Lymphorrhea: Access and Treatment |
15/03/2017 |
1769 |
Impact of a dedicated cancer-associated thrombosis service on clinical outcomes: a mixed-methods evaluation of a clinical improvement exercise |
15/03/2017 |
1768 |
Primary prophylaxis for venous thromboembolismin ambulatory cancer patients receiving chemotherapy (Review) |
15/03/2017 |
1767 |
Invited Commentary: Lymphatic (or “Forgotten”) Circulation Has to Be Rediscovered |
15/03/2017 |
1766 |
US Emergency Department Visits for Outpatient Adverse Drugs Events |
15/03/2017 |
1765 |
Reducing Adverse Drug EventsThe Need to Rethink Outpatient Prescribing |
15/03/2017 |
1764 |
Palmarès de la iatrogénie des médicaments |
15/03/2017 |
1763 |
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin |
15/03/2017 |
1762 |
Extended-Duration Betrixaban Reduces the Risk of stroke |
15/03/2017 |
1761 |
Inflammation and thrombosis testing the hypothesis with anti-inflammatory drug trials |
15/03/2017 |
1760 |
Global Anticoagulant Registry in the Field Venous Thromboembolism (GARFIELDVTE) |
15/03/2017 |
1759 |
Recommendations for Management of Clinically Significant DrugDrug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association |
15/03/2017 |
1758 |
Managing reversal of direct oral anticoagulants in emergency situations |
15/03/2017 |
1757 |
Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists |
15/03/2017 |
1756 |
2016 AHA CC Guideline on the Management of Patients With PAD Circ 2016 |
15/03/2017 |
1755 |
2016 AHA ACC Guideline on the Management of Patients With PAD SUMMARY Circ 2016 |
15/03/2017 |
1754 |
Usefulness of Health Registers for detection of bleeding events in outcome studies |
15/03/2017 |
1753 |
Artérite des membres inférieurs |
15/03/2017 |
1752 |
The bulls eye sign and other suprainguinal venographic findings to limit the use of intravascular ultrasound in patients with severe venous stasis |
15/03/2017 |
1751 |
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus |
15/03/2017 |
1750 |
Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease- A Systematic Review and Meta-Analysis |
15/03/2017 |
1749 |
Post-operative Benefit of Compression Therapy after Endovenous Laser Ablation for Uncomplicated Varicose Veins- A Randomised Clinical Trial |
15/03/2017 |
1748 |
Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management |
15/03/2017 |
1747 |
Endovascular management of chronic total occlusions of the inferior vena cava and iliac veins |
15/03/2017 |
1746 |
Diagnosis of Aortic Graft Infection A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC) |
15/03/2017 |
1745 |
Antibiotics and antiseptics for venous leg ulcers |
15/03/2017 |
1744 |
Contrast Enhanced Ultrasound can Replace Computed Tomography Angiography for Surveillance After Endovascular Aortic Aneurysm Repair |
15/03/2017 |
1743 |
Arterial duplex for diagnosis of peripheral arterial emboli |
15/03/2017 |
1742 |
A multi-institutional experience in adventitial cystic disease |
15/03/2017 |
1741 |
Statine for use for the primary Prevention of cardio vascular Diseases in adult JAMA |
15/03/2017 |
1740 |
Outcomes of Stent Placement for Chronic Occlusion of a Filter-bearing Inferior Vena Cava in Patients with Severe Post-thrombotic Syndrome |
15/03/2017 |
1739 |
Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors |
15/03/2017 |
1738 |
Maladie de Behçet |
15/03/2017 |
1737 |
Thromboangéite oblitérante ou maladie de buerger |
15/03/2017 |
1736 |
Doppler et échodoppler transcrâniens |
15/03/2017 |
1735 |
Elastopathies et atteintes vasculaires |
15/03/2017 |
1734 |
Facteurs de risque de l’artériopathie athéromateuse des membres inférieurs |
15/03/2017 |
1733 |
Index de pression systolique |
15/03/2017 |
1732 |
Stratégie de la conduite des examens chez le patient polyvasculaire |
15/03/2017 |
1731 |
Traumatismes Artériels |
15/03/2017 |
1730 |
Thrombose veineuse profonde des membres inférieurs |
15/03/2017 |
1729 |
Thèse Marie LE BAS: Infections ostéo-articulaires des pieds sur plaies chroniques Etude de l’écologie bactérienne de la cohorte de 166 prélèvements du centre de cicatrisation de l’hôpital de Libourne |
15/03/2017 |
1728 |
Stenting sous anticoagulant |
15/03/2017 |
1727 |
Thresholds for Abdominal Aortic Aneurysm Repair in England and the United States |
15/03/2017 |
1726 |
Dabigatran antidoté en conditions réelles |
15/03/2017 |
1725 |
test |
15/03/2017 |
1724 |
The natural history of type II endoleaks after endovascular aneurysm repair for ruptured abdominal aortic aneurysm |
27/11/2016 |
1723 |
Diaphragms of the carotid and vertebral arteries: an underdiagnosed cause of ischaemic stroke |
27/11/2016 |
1722 |
Intrathoracic origin of the left renal artery |
27/11/2016 |
1721 |
Statin use in patients with peripheral arterial disease |
27/11/2016 |
1720 |
The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers |
27/11/2016 |
1719 |
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization |
27/11/2016 |
1718 |
16ème congrès de la SFMV |
27/11/2016 |
1717 |
Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data |
27/11/2016 |
1716 |
Current surgical management of carotid body tumors |
27/11/2016 |
1715 |
Clinical results of single-vessel versus multiple-vessel infrapopliteal intervention |
27/11/2016 |
1714 |
Prévention primaire par statines aux US: nouvelles recommandations |
27/11/2016 |
1713 |
Educational course on Diabetic Kidney Disease |
27/11/2016 |
1712 |
Contrast-enhanced ultrasonography for detecting histological carotid plaque rupture: Quantitative analysis of ulcer |
15/11/2016 |
1711 |
A sibling based design to quantify genetic and shared environmental effects of VTE in Sweden |
15/11/2016 |
1710 |
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia |
15/11/2016 |
1709 |
Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort |
15/11/2016 |
1708 |
A systematic review of biomarkers for the prediction of thromboembolism in lung cancer —Results, practical issues and proposed strategies for future risk prediction models Review |
15/11/2016 |
1707 |
Risk stratifying emergency department patients with acute pulmonary embolism |
15/11/2016 |
1706 |
Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia |
15/11/2016 |
1705 |
Syndrome post-thrombotique |
15/11/2016 |
1704 |
Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France |
15/11/2016 |
1703 |
LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia |
15/11/2016 |
1702 |
Management of the multiple phases of heparin-induced thrombocytopenia |
15/11/2016 |
1701 |
Venous thromboembolism: A Call for risk assessment in all hospitalised patients |
15/11/2016 |
1700 |
Dabigatran: how the drug company withheld important analyses |
15/11/2016 |
1699 |
GradualVersusAbruptSmokingCessation ARandomized,ControlledNoninferiorityTrial |
15/11/2016 |
1698 |
Médecine personnalisée?: quelques questions |
15/11/2016 |
1697 |
Apnées du sommeil et grossesse |
15/11/2016 |
1696 |
Conséquences économiques du suivi biologique et des complications médicales en lien avec l’utilisation des anticoagulants injectables en France |
15/11/2016 |
1695 |
Antivitaminiques K, anticoagulants oraux directs: où est la vérité? |
15/11/2016 |
1694 |
Traitement hormonal de la ménopause en 2016 |
15/11/2016 |
1693 |
Ostéoporose chez les femmes ménopausées entre 40 et 65 ans?: algorithme pour le gynécologue |
15/11/2016 |
1692 |
Direct Oral Anticoagulants and Women |
15/11/2016 |
1691 |
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review |
15/11/2016 |
1690 |
Cholestérol et statine: les arguments du pharmacologue Atul Pathak |
15/11/2016 |
1689 |
Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease A Systematic Review and MetaAnalysis |
15/11/2016 |
1688 |
Direct Oral Anticoagulants and Women |
15/11/2016 |
1687 |
Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies |
15/11/2016 |
1686 |
Renal function and VTE |
15/11/2016 |
1685 |
The Implications of Different Criteria for Grading Carotid Artery Stenosis by Duplex Ultrasound |
15/11/2016 |
1684 |
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study |
15/11/2016 |
1683 |
Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion |
15/11/2016 |
1682 |
Update on the Treatment of Venous Thromboembolism |
15/11/2016 |
1681 |
Thrombosis and Hemostasis Related Issues in Women and Pregnancy |
15/11/2016 |
1680 |
The Outpatient Treatment of Venous Thromboembolism: Operational Impact and the Role of Novel Anticoagulants |
15/11/2016 |
1679 |
Management of Coagulopathy in Postpartum Hemorrhage |
15/11/2016 |
1678 |
The Management of Factor XI De?ciency in Pregnancy |
15/11/2016 |
1677 |
Pregnancy and Antiphospholipid Syndrome |
15/11/2016 |
1676 |
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association |
15/11/2016 |
1675 |
Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves |
15/11/2016 |
1674 |
Laboratory Monitoring of Oral Vitamin K Anticoagulation |
15/11/2016 |
1673 |
Classic and Global Hemostasis Testing in Pregnancy and during Pregnancy Complications |
15/11/2016 |
1672 |
Diagnosis and Management of Deep Vein Thrombosis and Pulmonary Embolism in Pregnancy |
15/11/2016 |
1671 |
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines |
15/11/2016 |
1670 |
Three dimensional US in the management of AAA. Topical review |
15/11/2016 |
1669 |
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48 |
15/11/2016 |
1668 |
Diagnosis and treatment of effort-induced thrombosis of the axillary subclavian vein due to venous thoracic outlet syndrome |
15/11/2016 |
1667 |
Syncope : ce serait une embolie pulmonaire chez un malade sur six ! |
15/11/2016 |
1666 |
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment |
15/11/2016 |
1665 |
Direct oral anticoagulants: New drugs with practical problems. How can nurses help prevent patient harm? |
15/11/2016 |
1664 |
Ajuster le traitement par AOD en cas d’insuffisance rénale |
15/11/2016 |
1663 |
Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice? |
15/11/2016 |
1662 |
Risk of VTE after cesarean sections: A meta-analysis |
15/11/2016 |
1661 |
Prevalence of renal vascular variations. Evaluation with MDCT angiography |
15/11/2016 |
1660 |
Prevalence of Pulmonary Embolism amon patients hospitalized for syncope |
15/11/2016 |
1659 |
Imaging Angiogenesis Using 99mTc-Macroaggregated Albumin Scintigraphy in Patients with Peripheral Artery Disease |
15/11/2016 |
1658 |
Contemporary CV risk and IIary preventive drug Tt patterns in PAD patients undergoing revascularization |
15/11/2016 |
1657 |
Multiparametric US criteria for ICA disease, comparison with CTA |
15/11/2016 |
1656 |
Therapeutic AC for isolated calf DVT |
15/11/2016 |
1655 |
Artériopathies périphériques juvéniles |
15/11/2016 |
1654 |
Pregnancy outcome in patients exposed to DOAC, and the challenge of event reporting |
15/11/2016 |
1653 |
Peut-on abaisser son taux de choleste?rol avec des comple?ments alimentaires |
15/11/2016 |
1652 |
Urgent Carotid Endarterectomy Does Not Increase Risk and Will Prevent More Strokes |
15/11/2016 |
1651 |
Screening,Evaluation,andTreatmentofPeripheralArterialDisease |
15/11/2016 |
1650 |
Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication |
15/11/2016 |
1649 |
Genetic risk factors for VTE in the elderly in a case-control study |
15/11/2016 |
1648 |
Elevated PSV and SVR from DUS are associated with hemodynamically significant lesions in AV access |
15/11/2016 |
1647 |
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes |
15/11/2016 |
1646 |
Aspirin, platelets, and cancer: the point of view of the internist |
15/11/2016 |
1645 |
Vascular Graft Infections Mycotic Aneurysms and Endovascular Infections A Scientific Statement From the American Heart Association |
15/11/2016 |
1644 |
Commissoin nationale d’évalutation des dispositifs médicaux et des technologies de santé: avis de la CNEDiMTS |
15/11/2016 |
1643 |
Statin use decreases coagulation in users of vitamin K antagonists |
15/11/2016 |
1642 |
Un possible effet anticoagulant des statines ? |
15/11/2016 |
1641 |
Commissoin nationale d’évalutation des dispositifs médicaux et des technologies de santé: avis de la CNEDiMTS |
15/11/2016 |
1640 |
Home-Based Exercise A Therapeutic Option for Peripheral Artery Disease |
15/11/2016 |
1639 |
Outcome of the Swedish Nationwide Abdominal Aortic Aneurysm Screening Program |
15/11/2016 |
1638 |
diverse requirements for Efficient Population Screening for abdominal aortic aneurysm: From Program Management to Maintaining Skills in open repair |
15/11/2016 |
1637 |
Endovascular versus open repair of abdominal aortic aneurysm in 15-years follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1) a randomised controlled trial |
15/11/2016 |
1636 |
Low-molecular-weight heparin and recurrent placentamediated pregnancy complications |
15/11/2016 |
1635 |
Where do we stand on vascular calcification ? |
15/11/2016 |
1634 |
The new oral anticoagulants in atrial fibrillation- Once daily or twice daily? |
15/11/2016 |
1633 |
Outcomes of Stent Placement for Chronic Occlusion of a Filter-bearing Inferior Vena Cava in Patients with Severe Post-thrombotic Syndrome |
15/11/2016 |
1632 |
Resuming anticoagulant therapy after intracerebral bleeding |
15/11/2016 |
1631 |
Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura |
15/11/2016 |
1630 |
Safety of Direct Oral Anticoagulants- Insights from Postmarketing Studies |
15/11/2016 |
1629 |
Optimisation du bon usage des anticoagulants oraux directs (ACOD) via une de?marche d’e?valuation des pratiques professionnelles |
15/11/2016 |
1628 |
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function |
15/11/2016 |
1627 |
Bleeding with Direct Oral Anticoagulants vs Warfarin- Clinical Experience |
15/11/2016 |
1626 |
The Influence of Preoperative Aneurysmal Thrombus Quantity and Distribution on the Development of Type II Endoleaks with Aneurysm Sac Enlargement After EVAR of AAA |
15/11/2016 |
1625 |
Interpretation of the evidence for the efficacy and safety of statin therapy |
15/11/2016 |
1624 |
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism HAEMAT |
15/11/2016 |
1623 |
Treatment of Subclavian Arterial Occlusive Disease- A Systematic Review and Meta-Analysis |
15/11/2016 |
1622 |
The Role of Interventional Radiology in the Treatment of Arterial Diabetic Foot Disease |
15/11/2016 |
1621 |
The In?uence of Preoperative Aneurysmal Thrombus Quantity and Distribution on the Development of Type II Endoleaks with Aneurysm Sac Enlargement After EVAR of AAA |
15/11/2016 |
1620 |
Une prévalence élevée de dissections artérielles et d’anévrismes au moment du diagnostic de dysplasie fibromusculaire |
15/11/2016 |
1619 |
Supplementary Material to Shahabi et al. “An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance” (Thromb Haemost 2016; 116.2) |
15/11/2016 |
1618 |
Utilisation des anticoagulants directs chez le sujet âgé le point de vue du cardiologue |
15/11/2016 |
1617 |
Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment |
15/11/2016 |
1616 |
Surgical management of iliofemoral vein thrombosis during pregnancy and the puerperium |
14/11/2016 |
1615 |
Maladie thromboembolique veineuse et grossesse |
14/11/2016 |
1614 |
Gestion périoperatoire des antiplaquettaires |
14/11/2016 |
1613 |
The association of statin therapy with the risk of recurrent venous thrombosis |
14/11/2016 |
1612 |
Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case–control study |
14/11/2016 |
1611 |
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICE |
14/11/2016 |
1610 |
Usefulness of Health Registers for detection of bleeding events in outcome studies |
14/11/2016 |
1609 |
Thromboembolic complications following a first isolated episode of superficial vein thrombosis a cross-sectional retrospective study |
14/11/2016 |
1608 |
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux rationale and design of the SURPRISE trial |
14/11/2016 |
1607 |
Self-referral to the NHS Abdominal Aortic Aneurysm Screening Programme |
14/11/2016 |
1606 |
Role of Vitamin K Antagonists in the Prevention of Thrombotic Bypass |
14/11/2016 |
1605 |
Nouvelles thérapeutiques |
16/10/2016 |
1604 |
Nouvelles thérapeutiques |
16/10/2016 |
1603 |
Gestion péri-opératoire des patients traités par antithrombotiques en chirurgie orale |
16/10/2016 |
1602 |
Quand s’inquiéter devant un ulcère de jambe d’origine vasculaire ? |
16/10/2016 |
1601 |
Recommandations de prise en charge des dyslipidémies en 2016 en Suisse |
16/10/2016 |
1600 |
Prophylaxie postopératoire de la maladie thrombo-embolique : des motifs d’échec |
16/10/2016 |
1599 |
Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients Implementation and Evaluation of a Caprini Risk Assessment Protocol |
16/10/2016 |
1598 |
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis A post-hoc analysis |
16/10/2016 |
1597 |
Polémique sur les statines: une étude confirme la hausse des arrêts de traitements |
16/10/2016 |
1596 |
Nouvelles recommandations pour le dépistage et la prise en charge des dyslipidémies familiales |
16/10/2016 |
1595 |
Peut-on abaisser son taux de cholestérol avec des compléments alimentaires?? |
16/10/2016 |
1594 |
Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol |
16/10/2016 |
1593 |
Patient Evaluation and Preparation in Vascular and Interventional Radiology: What Every Interventional Radiologist Should Know (Part 1: Patient Assessment and Laboratory Tests) |
16/10/2016 |
1592 |
Novel oral anticoagulants for heparin-induced thrombocytopenia |
16/10/2016 |
1591 |
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures |
16/10/2016 |
1590 |
NEJM Group: 20 YEARS ON THE WEB 1996–2016 |
16/10/2016 |
1589 |
Nouvelles recommandations européennes sur le cholestérol : nos questions au Pr Catapano |
16/10/2016 |
1588 |
Ne tirez pas sur la e-cigarette ! |
16/10/2016 |
1587 |
Impact of gender on safety and ef?cacy of Rivaroxaban in adolescents & young adults with venous thromboembolism |
16/10/2016 |
1586 |
Mortality and Rates of Secondary Intervention After EVAR in an Unselected Population: In?uence of Simple Clinical Categories and Implications for Surveillance |
16/10/2016 |
1585 |
Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia |
16/10/2016 |
1584 |
Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions |
16/10/2016 |
1583 |
Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents |
16/10/2016 |
1582 |
MÉDICAMENTS ET GROSSESSE |
16/10/2016 |
1581 |
Medical Considerations before International Travel |
16/10/2016 |
1580 |
Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial |
16/10/2016 |
1579 |
Managing reversal of direct oral anticoagulants in emergency situations Anticoagulation Education Task Force White Paper |
16/10/2016 |
1578 |
Les scores cliniques dans la maladie veineuse thromboembolique (MVTE). Une aide dans la décision diagnostique et thérapeutique?? Scores cliniques pour le risque de saignement avec ou sans anticoagulation |
16/10/2016 |
1577 |
Les résultats sont négatifs ! What else ? |
16/10/2016 |
1576 |
Les nouveaux anticoagulants oraux directs (NACO) chez le sujet âgé : point de vue de l’urgentiste The New Oral Anticoagulants in the Elderly: The View of the Emergency Physician |
16/10/2016 |
1575 |
Les anticoagulants oraux directs (AODs) chez le sujet âgé : données de pharmacovigilance sur le territoire national Direct Oral Anticoagulant Drugs in Elderly Patients: Adverse Drug Events Data in France |
16/10/2016 |
1574 |
Les anticoagulants oraux directs chez le sujet âgé : point de vue du pharmacologue Direct Oral Anticoagulants for Elderly Patients: from a Pharmacologist’s Perspective |
16/10/2016 |
1573 |
Les anticoagulants oraux directs en 2015 chez le patient âgé : focus chez le sujet fragile Direct Oral Anticoagulants in 2015 for the Elderly: a Focus on Frail Patients |
16/10/2016 |
1572 |
L’aspirine en prévention primaire ? |
16/10/2016 |
1571 |
Changes in Practice Patterns of Clopidogrelin Combination with Proton Pump Inhibitors after an FDA Safety Communication |
16/10/2016 |
1570 |
Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease |
16/10/2016 |
1569 |
Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta Analysis |
16/10/2016 |
1568 |
Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis |
16/10/2016 |
1567 |
Effects of Combined Aspirin and Clopidogrel Therapy on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis |
16/10/2016 |
1566 |
It Is Time for Carotid Artery Stenting to Rise from the Ashes |
16/10/2016 |
1565 |
Intravenous leiomyomatosis of the subclavian vein |
16/10/2016 |
1564 |
Inhibiteurs de la PCSK9 – un nouveau traitement pour l’hypercholeste?role?mie |
16/10/2016 |
1563 |
 |
16/10/2016 |
1562 |
Impact d’un événement médiatique public sur l’utilisation des statines dans la population française |
16/10/2016 |
1561 |
Impact of inferior vena cava thrombus extension on thrombolysis for acute iliofemoral thrombosis |
16/10/2016 |
1560 |
nternational clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer |
16/10/2016 |
1559 |
Inter-observer variability of compression ultrasound for the assessment of residual vein thrombosis |
16/10/2016 |
1558 |
High Heritability of Liability to Abdominal Aortic Aneurysms: A Population Based Twin Study |
16/10/2016 |
1557 |
Engineering Reversal — Finding an Antidote for Direct Oral Anticoagulants |
16/10/2016 |
1556 |
Factors Associated with Advanced Inferior Vena Cava Filter Removals: A Single-Center Retrospective Study of 203 Patients Over 7 Years |
16/10/2016 |
1555 |
Factor XIa–specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis |
16/10/2016 |
1554 |
Explosion Injuries from E-Cigarettes |
16/10/2016 |
1553 |
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban |
16/10/2016 |
1552 |
Evaluation of five different aneurysm scoring systems to predict mortality in ruptured abdominal aortic aneurysm patients |
16/10/2016 |
1551 |
La lettre d’ICAR L’information évidence-based, analysée, mise en perspective pour le Bon Usage Clinique Du Médicament: Princeps, Génériques, Hybrides et Biosimilaires |
16/10/2016 |
1550 |
Epidemiology of stroke and transient ischemic attacks- Current knowledge and perspectives |
16/10/2016 |
1549 |
Epidemiology of venous thromboembolism in the Framingham heart study |
16/10/2016 |
1548 |
Epidemiology of migraine- French key descriptive data |
16/10/2016 |
1547 |
Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic |
16/10/2016 |
1546 |
Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels A Randomized Clinical Trial |
16/10/2016 |
1545 |
CONSENSUS RELATIF À LA PRISE EN CHARGE DES DYSLIPIDEMIES DE L’ADULTE |
16/10/2016 |
1544 |
E-cigarette : actualisation de la revue Cochrane sur efficacité et sécurité |
16/10/2016 |
1543 |
Does Technical Success of Angioplasty in Dysfunctional Hemodialysis Accesses Correlate with Access Patency? |
16/10/2016 |
1542 |
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia- Findings From the U.S. Registry for FMD |
16/10/2016 |
1541 |
Cost-effectiveness of Elective Endovascular Aneurysm Repair Versus Open Surgical Repair of Abdominal Aortic Aneurysms |
16/10/2016 |
1540 |
Urgent Need to Measure Effects of Direct Oral Anticoagulants |
16/10/2016 |
1539 |
Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists, A French Nationwide Propensity-Matched Cohort Study |
16/10/2016 |
1538 |
Comparaison de l’efficacité des scores HAS-BLED et ATRIA dans la prédiction du risque hémorragique des patients de plus de 75 ans traités par anti-vitamine K (AVK) après démarche d’éducation thérapeutique |
16/10/2016 |
1537 |
Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis |
16/10/2016 |
1536 |
Clinical results of single-vessel versus multiple-vessel infrapoplital intervention |
16/10/2016 |
1535 |
Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends |
16/10/2016 |
1534 |
Biomarkers forthe Predictionof Venous Thromboembolismin the Community |
16/10/2016 |
1533 |
Bénéfice/risque des statines : le ton monte entre le Lancet et le BMJ |
16/10/2016 |
1532 |
Centralizing Care of Cancer-Associated Thromboembolism: The Cleveland Clinic experience |
16/10/2016 |
1531 |
Anticoagulants oraux directs?: quelques considérations pratiques |
16/10/2016 |
1530 |
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH |
16/10/2016 |
1529 |
Anticoagulants oraux : gérer le risque hémorragique après 75 ans |
16/10/2016 |
1528 |
ANNEXA-4 : résultats préliminaires satisfaisants pour l’antidote aux anti-Xa |
16/10/2016 |
1527 |
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors |
16/10/2016 |
1526 |
An institutional study of time delays for symptomatic carotid endartrectomy |
16/10/2016 |
1525 |
2016 ESC EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology ESC and European Artherosclerosis Society (EAS) Developed with the special contribution of the European |
16/10/2016 |
1524 |
Adhésion aux statines?: mise à jour et plan d’action |
16/10/2016 |
1523 |
2016 European Guidelines on cardiovascular disease prevention in clinical practice |
16/10/2016 |
1522 |
Aspirin for Disease Prevention: Public Policy or Personal Choice? |
16/10/2016 |
1521 |
AspirinforthePreventionofCancerIncidenceandMortality: SystematicEvidenceReviewsfortheU.S.PreventiveServices TaskForce |
16/10/2016 |
1520 |
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk |
16/10/2016 |
1519 |
AspirinforthePrimaryPreventionofCardiovascularEvents: ASystematicEvidenceReviewfortheU.S.PreventiveServices TaskForce |
16/10/2016 |
1518 |
A Retrospective Comparison of Ultrasound-Assisted CatheterDirected Thrombolysis and Catheter-Directed Thrombolysis Alone for Treatment of Proximal Deep Vein Thrombosis |
16/10/2016 |
1517 |
Raynaud’s Phenomenon |
16/10/2016 |
1516 |
Duplex ultrasound criteria for in-stent restenosis of mesenteric arteries |
16/10/2016 |
1515 |
Venous thrombosis |
29/08/2016 |
1514 |
Vein graft failure: from pathophysiology to clinical outcomes |
29/08/2016 |
1513 |
Vorapaxar for the treatment of PAD |
29/08/2016 |
1512 |
Venous leg symptoms in healthy subjects assessed during prolonged standing |
29/08/2016 |
1511 |
Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2) |
29/08/2016 |
1510 |
Validation of venous duplex ultrasound imaging in determining iliac vein stenosis after standard treatment of active chronic venous ulcers |
29/08/2016 |
1509 |
Use of the Direct Oral Anticoagulants in Obese Patients: guidance from the SSC of the ISTH |
29/08/2016 |
1508 |
Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study |
29/08/2016 |
1507 |
Ultrasound of wrist and hand masses |
29/08/2016 |
1506 |
Use of a proactive duplex ultrasound protocol for hemodialysis access |
29/08/2016 |
1505 |
ACR–AIUM–SRU PRACTICE PARAMETER FOR THE PERFORMANCE OF PERIPHERAL VENOUS ULTRASOUND EXAMINATION |
29/08/2016 |
1504 |
Update of Antithrombotic Guidelinees |
29/08/2016 |
1503 |
Toxicité médicamenteuse et ophtalmologie |
29/08/2016 |
1502 |
Traitement des cancers?: n’oublions pas les enjeux humains et sociaux des progrès actuels et à venir?! |
29/08/2016 |
1501 |
The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center |
29/08/2016 |
1500 |
Too much medicine in older people ? Deprescribing through shared decision making |
29/08/2016 |
1499 |
Ticagrelor reduces cardiac events in patients with PAD or diabetes |
29/08/2016 |
1498 |
Thromboprophylaxis for patients with HF |
29/08/2016 |
1497 |
The use of machine learning for the identification of peripheral artery disease and future mortality risk |
29/08/2016 |
1496 |
Thérapie de deuxième et troisième lignes pour la prise en charge de la dysfonction érectile |
29/08/2016 |
1495 |
The MARINER trial* of rivaroxaban after hospital discharge for medical patients at high risk of VTE Design, rationale, and clinical implications |
29/08/2016 |
1494 |
The Future of Cardiovascular Imaging |
29/08/2016 |
1493 |
The Future of Cardiovascular Therapeutics |
29/08/2016 |
1492 |
The Future of Genetics and Genomics Closing the Phenotype Gap in Precision Medicine |
29/08/2016 |
1491 |
The Future of Clinical Trials in Cardiovascular Medicine |
29/08/2016 |
1490 |
The Future of Cardiovascular Epidemiology |
29/08/2016 |
1489 |
What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis |
29/08/2016 |
1488 |
Survival in primary antiphospholipid syndrome A single-centre cohort study |
29/08/2016 |
1487 |
Stenting for chronic obstructive venous disease: A current comprehensive meta-analysis and systematic review |
29/08/2016 |
1486 |
Surgical management of venous malformation in soft tissue with the guidance of magnetic resonance imaging and percutaneous sinus angiography/ three-dimensional computed tomography imaging |
29/08/2016 |
1485 |
STATUT DE LA SOCIETE ALGERIENNE DE DIABETOLOGIE |
29/08/2016 |
1484 |
75ème Journées de la SFP Paris, programme préliminaire |
29/08/2016 |
1483 |
Sécurité cardiovasculaire des antidiabétiques |
29/08/2016 |
1482 |
Santé digitale?: petit guide à l’usage du néophyte |
29/08/2016 |
1481 |
Safety and Effectiveness of Stent Placement for Iliofemoral Venous Outflow Obstruction Systematic Review and Meta-Analysis |
29/08/2016 |
1480 |
Risks of venous thromboembolism after cesarean sections: A meta-analysis |
29/08/2016 |
1479 |
Requiem for Liberalizing Indications for Vena Caval Filters? |
29/08/2016 |
1478 |
Recent Endovascular Stroke Trials and Their Impact on Stroke Systems of Care |
29/08/2016 |
1477 |
Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL |
29/08/2016 |
1476 |
Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories |
29/08/2016 |
1475 |
Primary venous insufficiency increases risk of deep vein thrombosis |
29/08/2016 |
1474 |
Prévention des complications du pied diabétique |
29/08/2016 |
1473 |
Prevalence of renal vascular variations- Evaluation with MDCT angiography |
29/08/2016 |
1472 |
Prevalence of Abdominal Aortic Aneurysm in Men Aged 65–74 Years in a Metropolitan Area in North-East Spain |
29/08/2016 |
1471 |
Recommandations pour la prévention de la maladie thromboembolique veineuse chez le patient âgé hospitalisé en service de soins de suite et réadaptation fonctionnelle |
29/08/2016 |
1470 |
Pregnancy Complications and Cardiovascular Disease Death: Fifty-Year Follow-Up of the Child Health and Development Studies Pregnancy Cohort |
29/08/2016 |
1469 |
Pre-pregnancy BMI, delivery BMI, gestational weight gain and the risk of postpartum venous thrombosis |
29/08/2016 |
1468 |
Place des nouveaux antidiabétiques dans la population gériatrique |
29/08/2016 |
1467 |
Percutaneous Transluminal Angioplasty in Patients With Infrapopliteal Arterial Disease Systematic Review and Meta-Analysis |
29/08/2016 |
1466 |
Pediatric en Bloc Kidney Transplants: Clinical and Immediate Postoperative US Factors Associated with Vascular Thrombosis |
29/08/2016 |
1465 |
Thromboprophylaxie et obésité |
29/08/2016 |
1464 |
Heart Disease and Stroke Statistics—2013 Update A Report From the American Heart Association |
29/08/2016 |
1463 |
How I treat recurrent deep-vein thrombosis |
29/08/2016 |
1462 |
Insuline et antidiabétiques oraux?: comment les associer dans la pratique ambulatoire?? |
14/07/2016 |
1461 |
Nutcracker syndrome- The role of three-dimensional imaging for the diagnosis |
14/07/2016 |
1460 |
Infrainguinal Vein Graft Stenoses- Long-Term Outcomes of Graft Angioplasty |
14/07/2016 |
1459 |
Number of infrapopliteal arteries undergoing endovascular treatment is not associated with the limb salvage rate in patients with critical limb ischemia |
14/07/2016 |
1458 |
Primeview VENOUS TRHOMBOSIS |
14/07/2016 |
1457 |
More than one in two venous thromboembolism treated in French hospitals occurs during the hospital stays |
14/07/2016 |
1456 |
Etude de non infériorité : intérêt, limites et pièges |
14/07/2016 |
1455 |
Migraine?: des recommandations générales à la prise en charge pratique |
14/07/2016 |
1454 |
Les essais de non-infériorité |
14/07/2016 |
1453 |
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses |
14/07/2016 |
1452 |
Long-term anticoagulation with rivaroxaban for preventing recurrent VTE: A benefit– risk analysis of EINSTEIN EXTENSION |
14/07/2016 |
1451 |
La polypharmacie?: une nouvelle épidémie |
14/07/2016 |
1450 |
Interprétation des anticorps anti-noyaux et des anca |
14/07/2016 |
1449 |
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism |
14/07/2016 |
1448 |
Impact of femoropopliteal endovascular interventions on subsequent open bypass |
14/07/2016 |
1447 |
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists |
14/07/2016 |
1446 |
High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy |
14/07/2016 |
1445 |
Efficacy of endovascular treatment for pelvic congestion syndrome |
14/07/2016 |
1444 |
Evolocumab — alternative therapy in statin intolerance |
14/07/2016 |
1443 |
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease |
14/07/2016 |
1442 |
Environmental factors in cardiovascular disease |
14/07/2016 |
1441 |
Effectiveness of self-managed oral anticoagulant therapy in patients with recurrent venous thromboembolism |
14/07/2016 |
1440 |
Carotid artery stenosis — stenting or endarterec tomy? |
14/07/2016 |
1439 |
Douleur chronique postopératoire |
14/07/2016 |
1438 |
Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries A Meta-Analysis of Randomized Trials |
14/07/2016 |
1437 |
Diagnostic biomarkers in venous thromboembolic disease |
14/07/2016 |
1436 |
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment |
14/07/2016 |
1435 |
Determining the Safety of Enoxaparin Prophylaxis in Critically Ill Patients with Severe Renal Insuf?ciency – The PACER Pilot Study |
14/07/2016 |
1434 |
Essais thérapeutiques d’équivalence et de non infériorité |
14/07/2016 |
1433 |
Cost-of-illness model for venous thromboembolism |
14/07/2016 |
1432 |
Counting the platelets: a robust and sensitive quantification method for thrombus formation |
14/07/2016 |
1431 |
Combination therapy for PAD |
14/07/2016 |
1430 |
Anatomic variations of popliteal artery- Evaluation with 128-section CT-angiography in 1261 lower limbs |
14/07/2016 |
1429 |
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants |
14/07/2016 |
1428 |
Automated plethysmographic measurement of the ankle-brachial index: a comparison with the doppler ultrasound method |
14/07/2016 |
1427 |
Ankle-brachial index predicts change over time in functional status in the San Diego Population Study |
14/07/2016 |
1426 |
Anatomy of the lymph node venous networks of the groin and their investigation by ultrasonography |
14/07/2016 |
1425 |
Association of peripheral artery disease with abdominal aortic aneurysm growth |
14/07/2016 |
1424 |
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendations From the U.S. Preventive Services Task Force |
14/07/2016 |
1423 |
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement |
14/07/2016 |
1422 |
Aspirin for Disease Prevention: Public Policy or Personal Choice ? |
14/07/2016 |
1421 |
Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer:A Decision Analysis for the U.S. Preventive Services Task Force |
14/07/2016 |
1420 |
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force |
14/07/2016 |
1419 |
Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force |
14/07/2016 |
1418 |
Acute renal artery occlusion |
14/07/2016 |
1417 |
Acute Ischemic Stroke Intervention |
14/07/2016 |
1416 |
Is Statin Monotherapy the Perfect Polypill? |
14/07/2016 |
1415 |
NOACs vs Warfarin |
14/07/2016 |
1414 |
Does a normal screening ultrasound of the abdominal aorta reduce the likelihood of rupture in emergency department patients? |
14/07/2016 |
1413 |
Prediction models for cardiovascular disease risk in the general population: systematic review |
14/07/2016 |
1412 |
Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients |
14/07/2016 |
1411 |
Hippocrate, ils sont devenus fous ! |
14/07/2016 |
1410 |
Cost-effectiveness analysis of percutaneous sclerotherapy for venous malformations |
14/07/2016 |
1409 |
Wells Rule and D-Dimer Testing to Rule Out Pulmonary Embolism |
14/07/2016 |
1408 |
8th ICTHIC Abstracts |
14/07/2016 |
1407 |
Poster session 1: Epidemiology and risk assessment |
14/07/2016 |
1406 |
risk of arterial thromboembolism in patients with breast cancer |
14/07/2016 |
1405 |
Long-term arterial complications of chemotherapy in patients with cancer |
14/07/2016 |
1404 |
Update of thrombosis in multiple myeloma |
14/07/2016 |
1403 |
LMWH in cancer patients with renal impairment – better than warfarin? |
14/07/2016 |
1402 |
Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes |
14/07/2016 |
1401 |
The treatment of cancer associated thrombosis: does one size fit all? Who should get LMWH/warfarin/DOACs? |
14/07/2016 |
1400 |
Management of recurrent venous thromboembolism in cancer patients |
14/07/2016 |
1399 |
Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology |
14/07/2016 |
1398 |
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study |
14/07/2016 |
1397 |
Primary prophylaxis of VTE in cancer outpatients |
14/07/2016 |
1396 |
The International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) at the Peak of Adolescence – 15 Years and Counting |
14/07/2016 |
1395 |
Predictors of recurrent venous thromboembolism and bleeding on anticoagulation |
14/07/2016 |
1394 |
Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors) |
14/07/2016 |
1393 |
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review |
14/07/2016 |
1392 |
Management of cancer-associated disseminated intravascular coagulation |
14/07/2016 |
1391 |
Intracranial hemorrhage in cancer patients treated with anticoagulation |
14/07/2016 |
1390 |
Polymorphisms of the coagulation system and risk of cancer |
14/07/2016 |
1389 |
Heparanase procoagulant activity in cancer progression |
14/07/2016 |
1388 |
Cancer associated thrombosis: risk factors and outcomes |
14/07/2016 |
1387 |
Incidental venous thromboembolic events in cancer patients: what we know in 2016 |
14/07/2016 |
1386 |
Venous thromboembolism and occult cancer: impact on clinical practice |
14/07/2016 |
1385 |
Maladie thrombo-embolique veineuse au cours du cancer. Indication des héparines de bas poids moléculaires |
14/07/2016 |
1384 |
Management of bleeding complications in patients with cancer on DOACs |
14/07/2016 |
1383 |
Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: a multi-national cohort |
10/07/2016 |
1382 |
Ultrasonography of skin changes in legs with chronic venous disease |
10/07/2016 |
1381 |
Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: findings from the RIETE registry |
10/07/2016 |
1380 |
Management of catheter-associated upper extremity deep venous thrombosis |
10/07/2016 |
1379 |
Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism |
10/07/2016 |
1378 |
Metformin treatment status and abdominal aortic aneurysm disease progression |
10/07/2016 |
1377 |
Iliac artery endofibrosys |
10/07/2016 |
1376 |
Cost effectiveness of elective endovascular aneurysm repair vs open surgical repair for abdominal aortic aneurysms |
10/07/2016 |
1375 |
High heritability of liability to Abdominal Aortic Aneurysms Population based twin study |
10/07/2016 |
1374 |
ANTIPALUDÉENS le point |
10/07/2016 |
1373 |
Vascular Anomalies Classi?cation: Recommendations From the International Society for the Study of Vascular Anomalies |
10/07/2016 |
1372 |
Ultrasound Guided Compression Versus Ultrasound Guided Thrombin Injection for the Treatment of Post-Catheterization Femoral Pseudoaneurysms Systematic Review and Meta-Analysis of Comparative Studies |
10/07/2016 |
1371 |
Ulcères chroniques du pied diabétique l’oxygénothérapie hyperbare en échec |
10/07/2016 |
1370 |
Adherence to long-term anticoagulation treatment, what is known and what the future might hold |
10/07/2016 |
1369 |
Who is at high risk of recurrent venous thrombosis and do they really bene?t from continuation of anticoagulation? Clinicians wield a double-edged sword that might cut nothing at all |
10/07/2016 |
1368 |
Use of decision aids for shared decision making in venous thromboembolism- A systematic review |
10/07/2016 |
1367 |
Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation |
10/07/2016 |
1366 |
Un moindre risque thrombo-embolique avec la combinaison lévonorgestrel et 20 ? d’œstrogènes |
10/07/2016 |
1365 |
Une synthèse sur la prévention primaire de la maladie cardiovasculaire |
10/07/2016 |
1364 |
The management of diabetic foot- A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine |
10/07/2016 |
1363 |
Systematic Review and Meta-Analysis of Utility of Graduated Compression Stockings in Prevention of Post-Thrombotic Syndrome |
10/07/2016 |
1362 |
Traitement des cancers n’oublions pas les enjeux humains et sociaux desprogrès actuels et à venir |
10/07/2016 |
1361 |
The laboratory’s 2015 perspective on direct oral anticoagulant testing |
10/07/2016 |
1360 |
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis- a systematic review and meta-analysis |
10/07/2016 |
1359 |
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial ? brillation: a derivation and validation study |
10/07/2016 |
1358 |
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack |
10/07/2016 |
1357 |
Serons-nous un jour remplacés par des pigeons ? |
10/07/2016 |
1356 |
SPACE-2 A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses |
10/07/2016 |
1355 |
Smoking Behavior and Healthcare Expenditure in the United States, 1992– 2009: Panel Data Estimates |
10/07/2016 |
1354 |
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis- a systematic review and meta-analysis |
10/07/2016 |
1353 |
Results of Infrainguinal Bypass in Acute Limb Ischaemia |
10/07/2016 |
1352 |
Requiem for Liberalizing Indications for Vena Caval Filters Circulation |
10/07/2016 |
1351 |
Risk of peripheral arterial occlusive disease in patients with systemic lupus erythematosus |
10/07/2016 |
1350 |
Contemporary Reviews in Cardiovascular Medicine: Recent Update to the US Cholesterol Treatment Guidelines A Comparison With International Guidelines |
10/07/2016 |
1349 |
Primary venous insufficiency increases risk of deep vein thrombosis |
10/07/2016 |
1348 |
Quand faut-il demander une consultation d’oncogénétique ? |
10/07/2016 |
1347 |
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation- post hoc analysis of the ARISTOTLE trial |
10/07/2016 |
1346 |
Prevalence of Abdominal Aortic Aneurysm in Men Aged 65–74 Years in a Metropolitan Area in North-East Spain |
10/07/2016 |
1345 |
Prediction models for cardiovascular disease risk in the general population- systematic review |
10/07/2016 |
1344 |
Prévalence élevée de l’artériopathie oblitérante des membres inférieurs au cours du lupus |
10/07/2016 |
1343 |
Plus d’un d’AVC sur 2 serait évité lorsque l’AIT est pris en charge dans les 24h |
10/07/2016 |
1342 |
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation |
10/07/2016 |
1341 |
Maladie de Rendu-Osler Manifestations cliniques et prise en charge multidisciplinaire |
10/07/2016 |
1340 |
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke |
10/07/2016 |
1339 |
One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study)- randomised controlled trial |
10/07/2016 |
1338 |
On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism |
10/07/2016 |
1337 |
Multimorbidité en médecine de famille |
10/07/2016 |
1336 |
Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women- cohort study |
10/07/2016 |
1335 |
Microbiologie et traitement antibiotique du pied diabétique infecté |
10/07/2016 |
1334 |
Migraine and risk of cardiovascular disease in women- prospective cohort study |
10/07/2016 |
1333 |
More HOPE for Prevention with Statins |
10/07/2016 |
1332 |
Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Reviewand Network Meta Analysis |
10/07/2016 |
1331 |
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke |
10/07/2016 |
1330 |
Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women- cohort study |
10/07/2016 |
1329 |
La polypharmacie une nouvelle épidémie |
10/07/2016 |
1328 |
Je veux un scanner |
10/07/2016 |
1327 |
Lost in SPACE |
10/07/2016 |
1326 |
Le groupe sanguin influe-t-il sur le risque thrombo-embolique |
10/07/2016 |
1325 |
AHA/ACC/AGS Scientific Statement: Knowledge Gaps in Cardiovascular Care of the Older Adult Population A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society |
10/07/2016 |
1324 |
Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma |
10/07/2016 |
1323 |
Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma |
10/07/2016 |
1322 |
Individualizing Duration of Dual Antiplatelet after coronary circulation intervention |
10/07/2016 |
1321 |
Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism: A study in six european countries |
10/07/2016 |
1320 |
Endovascular treatment versus medical care alone for ischaemic stroke systematic review and meta-analysis |
10/07/2016 |
1319 |
Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors |
10/07/2016 |
1318 |
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease An Overview of Systematic Reviews |
10/07/2016 |
1317 |
Hypercoagulabilty, venous thromboembolism, and death in patients with cancer |
10/07/2016 |
1316 |
How can I predict bleeding in my elderly patient taking anticoagulants ? |
10/07/2016 |
1315 |
Hémorragie survenant chez un patient sous AOD |
10/07/2016 |
1314 |
Peripheral Vascular Disease: Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial |
10/07/2016 |
1313 |
Haemodynamic Performance of Low Strength Below Knee Graduated Elastic Compression Stockings in Health, Venous Disease, and Lymphoedema |
10/07/2016 |
1312 |
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients |
10/07/2016 |
1311 |
Evaluation and management of peripheral venous and lymphatic malformations |
10/07/2016 |
1310 |
GAPSS:theGlobalAnti-PhospholipidSyndromeScore |
10/07/2016 |
1309 |
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin_warfarin therapy |
10/07/2016 |
1308 |
European Union-28: An annualised cost-of-illness model for venous thromboembolism |
10/07/2016 |
1307 |
Double antiagrégation plaquettaire pour le traitement et la prévention secondaire de la maladie coronarienne Indications, modalités et durées de traitement |
10/07/2016 |
1306 |
Davantage de thromboses veineuses des membres supérieurs à cause des cathéters veineux centraux |
10/07/2016 |
1305 |
Diagnosis and Management of Iliac Artery Endofibrosis |
10/07/2016 |
1304 |
Dans l’AVC, thrombolyse et thrombectomie unis pour un duo gagnant |
10/07/2016 |
1303 |
Du bon usage des D-dimères au cours de la maladie thromboembolique veineuse |
10/07/2016 |
1302 |
Coronary or thoracic artery calcium score in provoked and unprovoked pulmonary embolism- a case-control study |
10/07/2016 |
1301 |
COMMISSION DE LA TRANSPARENCE: Avis 11 mai 2016 |
10/07/2016 |
1300 |
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant |
10/07/2016 |
1299 |
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation |
10/07/2016 |
1298 |
Clinical Significance of Symptoms in Smokers |
10/07/2016 |
1297 |
Clinical and laboratory predictors of deep vein thrombosis after acute stroke |
10/07/2016 |
1296 |
Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital |
10/07/2016 |
1295 |
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
10/07/2016 |
1294 |
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
10/07/2016 |
1293 |
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease |
10/07/2016 |
1292 |
Aortite: quel role pour la TEP-TDM ? |
10/07/2016 |
1291 |
L’IMAGERIE MÉDICALE: Communication à la commission des affaires sociales du Sénat |
10/07/2016 |
1290 |
An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery 2016 |
10/07/2016 |
1289 |
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study |
10/07/2016 |
1288 |
Anévrysme de l’aorte abdominale opéré en ambulatoire une première à Lyon |
10/07/2016 |
1287 |
An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm |
10/07/2016 |
1286 |
Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations MED HYPOTHESES 2015 |
10/07/2016 |
1285 |
A systematic review and meta-analysis of tests to predict wound healing in diabetic foot |
10/07/2016 |
1284 |
A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers |
10/07/2016 |
1283 |
A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers |
10/07/2016 |
1282 |
A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome |
10/07/2016 |
1281 |
A systematic review and meta-analysis of de?bridement methods for chronic diabetic foot ulcers |
10/07/2016 |
1280 |
A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma |
10/07/2016 |
1279 |
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin: The EmbraceAC Trial |
10/07/2016 |
1278 |
Obesity-Induced Lymphedema: Clinical and Lymphoscintigraphic Features |
10/07/2016 |
1277 |
A patent sciatic artery aneurysm |
10/07/2016 |
1276 |
Reproductive Risk Factors and Coronary Heart Disease in the Women’s Health Initiative Observational Study |
10/07/2016 |
1275 |
AHA/WHF Scientific Statement: The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke A Modeling Study From the American Heart Association and World Heart Federation |
10/07/2016 |
1274 |
Epidemiology and Prevention: Menthol and Nonmenthol Cigarette Smoking All-Cause Deaths, Cardiovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites |
10/07/2016 |
1273 |
Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease, Sixteen Years of Follow-Up of the LIPID Study |
10/07/2016 |
1272 |
UTILISATION DE LA CIGARETTE ÉLECTRONIQUE ET DU TABAC : PREMIÈRES DONNÉES DE LA COHORTE CONSTANCES, FRANCE, 2014 |
10/07/2016 |
1271 |
L’EXPOSITION À LA FUMÉE DE TABAC DANS LES LIEUX À USAGE COLLECTIF ET LES LIEUX DE CONVIVIALITÉ EN FRANCE EN 2014 |
10/07/2016 |
1270 |
SE MOBILISER POUR LUTTER CONTRE LE TABAGISME |
10/07/2016 |
1269 |
Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions |
10/07/2016 |
1268 |
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis |
10/07/2016 |
1267 |
Peripheral arterial disease incidence and associated risk factors in a mediterranean population-based cohort. The REGICOR study |
10/07/2016 |
1266 |
Long term use of aspirine and the risk of GI bleeding_Huang, Am J Med |
21/04/2016 |
1265 |
Abords veineux périphériques échoguidés |
21/04/2016 |
1264 |
Association of Aspirin use with major bleeding in patients with and without diabetes_Berardis, jama |
21/04/2016 |
1263 |
Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy subjects_Mauer, JTH |
21/04/2016 |
1262 |
Bleeding complications with dual antiplatelet therapy ….Charisma_Berger, Circulation |
21/04/2016 |
1261 |
Hemorrhagic complications associated with Aspirin. An underestimated hazard in CP …_Siller Matula, jama |
21/04/2016 |
1260 |
Monitoring platelet function to reduce the risk of ischemic bleeding complications (Price, Am J Cardiol) |
21/04/2016 |
1259 |
Effect of oral antiplatelets agents on major bleeding in users of coumarins (Schalekamp, TH) |
21/04/2016 |
1258 |
Prévenir les saignements digestifs dus aux antiagrégants plaquettaires: le labyrinthe ! |
21/04/2016 |
1257 |
Cerebral microbleeds, Evidence of heightened risk associated with aspirin use (Gorelick, Arch Int Med) Editorial |
21/04/2016 |
1256 |
Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in Iary care (Cohen, Mayo Clin Proc) |
21/04/2016 |
1255 |
Predicting risk in elective abdominal aortic aneurysm repair: a systematic revie of current evidence |
21/04/2016 |
1254 |
Reducing the Gastrointestinal risks of Antiplatelet therapy and NSAID Use (ACC Consensus Expert Document, Circulation) |
21/04/2016 |
1253 |
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study |
21/04/2016 |
1252 |
Risk of Hemorrhagic Stroke With Aspirin Use An Update |
21/04/2016 |
1251 |
Venous flow volume measured by duplex ultrasound can be used as an indicator of impaired tissue perfusion in patients with peripheral arterial disease |
21/04/2016 |
1250 |
Major Bleeding and Hemorrhagic Stroke with Direct Oral Anticoagulants in Patients with Renal Failure |
21/04/2016 |
1249 |
Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery |
21/04/2016 |
1248 |
Vascular Toxicities of Cancer Therapies The Old and the New – An Evolving Avenue |
01/04/2016 |
1247 |
Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-inducedthrombocytopenia |
01/04/2016 |
1246 |
Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol |
01/04/2016 |
1245 |
Ultrasound Guided Compression versus Ultrasound Thrombin Injection for the treatment of Post-Catheterization Femoral Pseudoaneurysms: Systematic review and Meta-Analysis of Comparative Studies |
01/04/2016 |
1244 |
The Science of Choosing Wisely — Overcoming the Therapeutic Illusion |
01/04/2016 |
1243 |
Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke- A Randomized Clinical Trial |
01/04/2016 |
1242 |
La maladie de Takayasu |
01/04/2016 |
1241 |
Research Article: The Impact of Warfarin on Patients with End Stage Renal Disease |
01/04/2016 |
1240 |
Stent Retrievers for the Treatment of Acute Ischemic Stroke- A Systematic Review and Meta-analysis of Randomized Clinical Trials |
01/04/2016 |
1239 |
Systematic review and Meta-Analysis of Utility of Graduation Compression Stockings in Prevention of Post-Thrombotic Syndrome |
01/04/2016 |
1238 |
The influence of corticosteroids on hemostasis in healthy subjects |
01/04/2016 |
1237 |
Gestion des Anticoagulants Oraux Directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d’Intérêt en Hémostase Périopératoire (GIHP)-Septembre 2015 |
01/04/2016 |
1236 |
Physiopathologie des vascularites primitives des gros vaisseaux |
01/04/2016 |
1235 |
Scores pronostiques pour l’embolie pulmonaire |
01/04/2016 |
1234 |
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use |
01/04/2016 |
1233 |
Place de l’imagerie dans l’e?valuation des vascularites de gros vaisseaux |
01/04/2016 |
1232 |
Risk factors for venous thromboembolism after acute trauma: A populationbased case-cohort study |
01/04/2016 |
1231 |
Place du traitement endovasculaire dans les aortites inflammatoires |
01/04/2016 |
1230 |
Prise en charge chirurgicale des maladies inflammatoires de l’aorte |
01/04/2016 |
1229 |
Postmenopausal Hormone Therapy and Atherosclerosis Time Is of the Essence |
01/04/2016 |
1228 |
Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event- A multi-national cohort |
01/04/2016 |
1227 |
Use of the Direct Oral Anticoagulants in Obese Patients: guidance from the SSC of the ISTH |
01/04/2016 |
1226 |
Pathogenesis of the Antiphospholipid Syndrome Revisited – Time to Challenge the Dogma |
01/04/2016 |
1225 |
Less menorrhagia for women with VTE |
01/04/2016 |
1224 |
Les aortites |
01/04/2016 |
1223 |
INSCRIPTION Mulhouse en 2 pages |
01/04/2016 |
1222 |
JOURNEE MULHOUSIENNE DE LYMPHOLOGIE LYMPHOEDEME ET SPORT |
01/04/2016 |
1221 |
Incidence of venous thromboembolism in France a retrospective analysis of a national insurance claims database |
01/04/2016 |
1220 |
Imagerie thoracique de la sclérodermie |
01/04/2016 |
1219 |
When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data |
01/04/2016 |
1218 |
ReviewArticle A Critical Evaluation of Carotid Duplex Scanning in the Diagnosis of Significant Carotid Artery Occlusive Disease |
01/04/2016 |
1217 |
Early results of Brachial arterio-arterial prosthetic Loop (AAPL) for Hemodialysis |
01/04/2016 |
1216 |
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial |
01/04/2016 |
1215 |
Prise en charge chirurgicale des maladies inflammatoires de l’aorte |
01/04/2016 |
1214 |
Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study |
01/04/2016 |
1213 |
Duplex Ultrasound in the diagnostic of acute leg-swelling |
01/04/2016 |
1212 |
Artériopathie Chronique Oblitérante des MI – Classifications de Fontaine et de Rutherford |
01/04/2016 |
1211 |
Carotid–Cavernous Sinus Fistula |
01/04/2016 |
1210 |
Biotherapies in large vasculitis |
01/04/2016 |
1209 |
Atteinte aortique inflammatoire associées à la maladie de Behçet |
01/04/2016 |
1208 |
Atteinte aortique dans la maladie de Horton |
01/04/2016 |
1207 |
Aortites |
01/04/2016 |
1206 |
Value of delayed duplex ultrasound assessement after endothermal ablation of the great saphenous vein |
01/04/2016 |
1205 |
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis |
01/04/2016 |
1204 |
Relation of Nailfold Capillaries and Autoantibodies to Mortality in Patients With Raynaud Phenomenon |
01/04/2016 |
1203 |
Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy 20-Year Follow-Up of West of Scotland Coronary Prevention Study |
01/04/2016 |
1202 |
The natural history of penetrating ulcers of the iliac arteries |
01/04/2016 |
1201 |
THE 42nd CONGRESS OF EUROPEAN SOCIETY OF LYMPHOLOGY |
01/04/2016 |
1200 |
Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children |
21/03/2016 |
1199 |
Ubérisation de la médecine ignorer, combattre ou rivaliser ? |
21/03/2016 |
1198 |
Les femmes au cœur du risque cardiovasculaire |
21/03/2016 |
1197 |
PCSK9 sérique : futur marqueur du risque cardiovasculaire ? |
21/03/2016 |
1196 |
Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist |
21/03/2016 |
1195 |
Evaluation of the new simple and objective clinical decision rule “I-DVT” in patients with clinically suspected acute deep vein thrombosisOriginal TR2016 |
21/03/2016 |
1194 |
Inter-observer reliability of the HERDOO2 clinical decision rule TR2016 |
21/03/2016 |
1193 |
Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia TR2016 |
17/03/2016 |
1192 |
Unprovoked venous thromboembolism and subsequent cancer risk a population-based cohort study JTH2016 |
17/03/2016 |
1191 |
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack NEJM 2016 |
17/03/2016 |
1190 |
The Genetics of Dyslipidemia: When Less Is More –NEJM2016 |
17/03/2016 |
1189 |
Anticoagulation-related nephropathy |
17/03/2016 |
1188 |
Venous thromboembolism after surgical treatment of non-spinal skeletal metastases — An underdiagnosed complication TR 2016 |
17/03/2016 |
1187 |
Médecine vasculaire: spécialité. STV |
17/03/2016 |
1186 |
Scores cliniques pour le risque de récidive de maladie veineuse thromboembolique (MVTE) et pour les relations cancer-MVTE RMS 2016 |
17/03/2016 |
1185 |
Rapid quantitative D-dimer to exclude pulmonary embolism a prospective cohort management study JTH2016 |
17/03/2016 |
1184 |
Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis NEJM2016 |
17/03/2016 |
1183 |
RECO EI Vasculaires – Rea et al. Bulletin du Cancer 2016-1 |
17/03/2016 |
1182 |
Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism TR2016 |
17/03/2016 |
1181 |
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study JTH2016 |
17/03/2016 |
1180 |
Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor validation of a new algorithm JTH2016 |
17/03/2016 |
1179 |
Les nouveaux anticoagulants directs (NACO) chez le sujet âgé: point de vue de l’urgentiste |
17/03/2016 |
1178 |
Cardiovascular Complications of Novel Multiple Myeloma Treatments |
17/03/2016 |
1177 |
How I treat recurrent deep-vein thrombosis BLOOD 2016 |
17/03/2016 |
1176 |
Inactivating Variants in ANGPTL4 and Risk of coronary artery disease NEJM2016 |
17/03/2016 |
1175 |
Gender-related differences in the management of HTA by cardiologistq PARITE STUDY Arch CVD 2012 |
17/03/2016 |
1174 |
Efficacy and safety of anticoagulant therapy in three specific populations with sepsis a meta-analysis of randomized controlled trials JTH2016 |
17/03/2016 |
1173 |
Cost-effectiveness of Screening for Abdominal Aortic Aneurysm in Combination with Medical Intervention in Patients with Small Aneurysms EJVES2016 |
17/03/2016 |
1172 |
Effectiveness-Based Guidelines for the Prevention of CV in womemen 2011 UPDATE CIRCULATION 2011 |
17/03/2016 |
1171 |
Edito STV JPL 2016 |
17/03/2016 |
1170 |
Cœur, artères et femmes, un circuit de soins dédié aux femmes à risque cardiovasculaire Ann Card Ang 2014 |
17/03/2016 |
1169 |
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease NEJM2016 |
17/03/2016 |
1168 |
Biosimilars of low-molecular-weight heparin products fostering competition or reducing biodiversity JTH2016 |
17/03/2016 |
1167 |
 |
17/03/2016 |
1166 |
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk MESE |
11/02/2016 |
1165 |
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report |
11/02/2016 |
1164 |
Periodontitis Increases the Risk of a First Myocardial Infarction A Report From the PAROKRANK Study |
11/02/2016 |
1163 |
Update of Antithrombotic Guidelinees |
11/02/2016 |
1162 |
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey |
11/02/2016 |
1161 |
Inferior Vena Cava Filters, May-Thurner Syndrome, and Vein Stents |
11/02/2016 |
1160 |
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients with Peripheral Artery Disease: Results From TRA2°P-TIMI 50 |
11/02/2016 |
1159 |
The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected- A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease |
08/02/2016 |
1158 |
The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE A real-life inception cohort study |
08/02/2016 |
1157 |
An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) |
08/02/2016 |
1156 |
EDV 19 |
06/02/2016 |
1155 |
Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy A cross-sectional interview study |
06/02/2016 |
1154 |
Risk factors and clinical features of acute pulmonary embolism in children from the community |
06/02/2016 |
1153 |
Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis |
06/02/2016 |
1152 |
Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia- A Retrospective Analysis |
06/02/2016 |
1151 |
Risk Of Recurrent Venous Thromboembolism On Progestin-Only Contraception A Cohort Study Haematol 2016 |
06/02/2016 |
1150 |
Safety and e? ectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study |
06/02/2016 |
1149 |
A Compression Kit of a Stocking and Three Superimposed Leggings Is Easy to Don and Dose Adjustable |
06/02/2016 |
1148 |
Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism |
06/02/2016 |
1147 |
Colloque « les femmes au cœur du risque cardiovasculaire » |
06/02/2016 |
1146 |
Rein en fer à cheval, quelles complications |
06/02/2016 |
1145 |
ARTÉRIOPATHIES OBLITÉRANTES DES MEMBRES INFÉRIEURS |
06/02/2016 |
1144 |
Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis |
30/01/2016 |
1143 |
Trends in the management and outcomes of acute pulmonary embolism |
30/01/2016 |
1142 |
Unprovoked Venous Thromboembolism and Subsequent Cancer Risk: a Population-based Cohort Study |
30/01/2016 |
1141 |
Recommandations de bonne pratique concernant la sécurité de l’environnement en médecine vasculaire, notamment pour le traitement des varices, proposées par la société française de médecine vasculaire |
30/01/2016 |
1140 |
Risk Recurrent VTE and major hemorrghage in cancer assocoated incidental PE among treated and untreted patients |
30/01/2016 |
1139 |
Obesity and risk of bleeding the SMART study JTH 2016 |
29/01/2016 |
1138 |
Quelle place pour les anticoagulants oraux directs en pratique hospitalière quotidienne |
29/01/2016 |
1137 |
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences |
29/01/2016 |
1136 |
Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy: a systematic review and external validation study |
29/01/2016 |
1135 |
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Tria |
29/01/2016 |
1134 |
Management of Hyperglycemia in Type 2 Diabetes, 2015: A PatientCentered Approach |
29/01/2016 |
1133 |
Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials |
29/01/2016 |
1132 |
La prophylaxie par héparine n’améliore pas la survie dans le cancer bronchique |
29/01/2016 |
1131 |
Embolie pulmonaire |
29/01/2016 |
1130 |
Diabétologie RMS 2016 |
29/01/2016 |
1129 |
Conséquences thérapeutiques de la mise en évidence d’une thrombophilie |
29/01/2016 |
1128 |
Comorbid risks of deep vein thrombosis and pulmonary thromboembolism in patients with chronic pancreatitis a nationwide cohort study |
29/01/2016 |
1127 |
CHEST 2016 – Résumé |
29/01/2016 |
1126 |
Cigarette électronique – et si ce n’était que de l’enfumage |
29/01/2016 |
1125 |
Blood 2009 Thrombophilie Que rechercher |
29/01/2016 |
1124 |
Associer AVK et sulfonylurées n’est pas une bonne idée ! |
25/01/2016 |
1123 |
Association between use of warfarin with common sulfonylureas and serious hypoglycemic events retrospective cohort analysis |
25/01/2016 |
1122 |
An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery |
25/01/2016 |
1121 |
Clot structure and fibrinolytic potential in patients with post thrombotic syndrome TR 2015 |
10/01/2016 |
1120 |
European Union-28 An annualised cost-of-illness model for venous TH 2015 |
10/01/2016 |
1119 |
Venous thromboembolism at time of diagnosis of ovarian cancer- Survival differs in symptomatic and asymptomatic cases TR 2015 |
10/01/2016 |
1118 |
Early Post-operative Mortality After Major Lower Limb Amputation- A Systematic Review of Population and Regional Based Studies EJVES 2015 |
10/01/2016 |
1117 |
Design of a New Risk Score in Critical Limb Ischaemia- The ERICVA Model EJVES 2015 |
10/01/2016 |
1116 |
Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism TR 2015 |
10/01/2016 |
1115 |
Des résultats prometteurs avec l’imetelstat dans la thrombocytémie essentielle |
10/01/2016 |
1114 |
Cathetet upper extemity thrombois MITH Study JTH 2015 |
10/01/2016 |
1113 |
Planification de soins personnalisés en cas de maladie chronique ? |
10/01/2016 |
1112 |
Tripodi et al 2015 Journal of Thrombosis and Haemostasis |
10/01/2016 |
1111 |
Api?xaban VTE Cancer Amplify JTH 2015 |
10/01/2016 |
1110 |
Revisting the tale of VTE hosp Patients JTH2015 |
10/01/2016 |
1109 |
Family History VTE Thrombophilia predictors JTH 2015 |
10/01/2016 |
1108 |
Bemiparin Gyneco Sur JTH 2015 |
10/01/2016 |
1107 |
Meta-Analysis of Abdominal Aortic Aneurysm in Patients With Coronary Artery Disease |
10/01/2016 |
1106 |
Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation |
10/01/2016 |
1105 |
Plus d’AAA chez les coronariens |
10/01/2016 |
1104 |
Statines ce qu’en disent les médias déteint sur l’observance |
10/01/2016 |
1103 |
FA non valvulaire les AODs sont supérieurs aux AVK en cas d’altération de la fonction rénale |
10/01/2016 |
1102 |
Limited screening with versus without ¹?F-fl uorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial |
10/01/2016 |
1101 |
Takayasu Arteritis and Pregnancy |
10/01/2016 |
1100 |
Maladie de Takayasu et grossesse : quels facteurs de risque ? |
10/01/2016 |
1099 |
Cardiovascular-Specific Mortality and Kidney Disease in Patients Undergoing Vascular Surgery |
10/01/2016 |
1098 |
HYPERTENSIONS ARTÉRIELLES D’ORIGINE MÉDICAMENTEUSE OU TOXIQUE |
10/01/2016 |
1097 |
HTA ET GROSSESSE |
10/01/2016 |
1096 |
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study) |
10/01/2016 |
1095 |
L’association simvastatine/ézétimibe réduit de façon drastique la survenue d’une cataracte |
10/01/2016 |
1094 |
Nisio et al The Cochrane Library TVS post Perfusion 2015 |
10/01/2016 |
1093 |
Closing the Gap in Secondary Prevention of Atherothrombotic Events in Patients With a History of ACS or PAD |
10/01/2016 |
1092 |
Robertson et al The Cochrane Library 2015 Full text |
10/01/2016 |
1091 |
Early thromboembolic events ? 1 week after fast-track total hip and knee arthroplasty TR 2016 |
10/01/2016 |
1090 |
A Randomized Trial of Intensive versus Standard Blood-Pressure Control |
10/01/2016 |
1089 |
Gestion péri-opératoire des patients traités par antithrombotiques en chirurgie orale |
10/01/2016 |
1088 |
Le selexipag, une nouvelle option pour l’hypertension artérielle pulmonaire ? |
10/01/2016 |
1087 |
Venous thromboembolism in Croatia Croat Med J 2015 |
10/01/2016 |
1086 |
Use of New Oral Anticoagulants in the Treatment of Venous ThromboembolismCard Haemat |
10/01/2016 |
1085 |
Risk of Post Discharge Venous Thromboembolism and Associated Mortality in Surger A PopulationBased Cohort Study Using Linked Hospital and Primary Care Data in England |
10/01/2016 |
1084 |
Rationale for Development of New Oral Anticoagulants Car Haematol Dis Dr 2016 |
10/01/2016 |
1083 |
New Oral Anticoagulants in Coronary Artery Disease Card Haemat Dis Dr 2016 |
10/01/2016 |
1082 |
Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists a self-controlled register study |
10/01/2016 |
1081 |
Multidisciplinary Pulmonary Embolism Response Teams Circulation 2016 |
10/01/2016 |
1080 |
Bénéfice de l’anticoagulation systématique avant chirurgie lourde du cancer |
10/01/2016 |
1079 |
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients |
10/01/2016 |
1078 |
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients |
10/01/2016 |
1077 |
Takayasu Arteritis It Is Time to Work Together |
10/01/2016 |
1076 |
Antithrombotic therapy for VTE disease. CHEST guideline |
10/01/2016 |
1075 |
Antithrombotic Therapy for VTE Disease: CHEST Guideline |
10/01/2016 |
1074 |
Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases |
07/12/2015 |
1073 |
European Union-28: An annualised cost-of-illness model for venous thromboembolism |
07/12/2015 |
1072 |
Design of a New Risk Score in Critical Limb Ischaemia: The ERICVA Model |
07/12/2015 |
1071 |
Clot structure and fibrinolytic potential in patients with post thrombotic syndrome |
07/12/2015 |
1070 |
Early Post-operative Mortality After Major Lower Limb Amputation: A Systematic Review of Population and Regional Based Studies |
07/12/2015 |
1069 |
Thrombophilia testing in young patients with ischemic stroke |
30/11/2015 |
1068 |
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs |
30/11/2015 |
1067 |
Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review |
30/11/2015 |
1066 |
Real life thromboprophylaxis in orthopedic surgery in Italy. Results of the GIOTTO study |
30/11/2015 |
1065 |
Harmonisation of D-dimer — A call for action |
30/11/2015 |
1064 |
Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism |
30/11/2015 |
1063 |
Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism |
30/11/2015 |
1062 |
Statines en prévention primaire : comment décider avec le patient ? |
29/11/2015 |
1061 |
XVIIème journée du GITA et nouvelle veille bibliographique |
29/11/2015 |
1060 |
When do patients prefer a direct oral anticoagulant over a vitamin K antagonist? |
29/11/2015 |
1059 |
Prise en charge des facteurs de risque des maladies cardiovasculaires : qu’est-ce qui a vraiment changé en 15 ans ? |
29/11/2015 |
1058 |
Meta-analysis Comparing the Effects of Rosuvastatin Versus Atorvastatin on Regression of Coronary Atherosclerotic Plaques |
29/11/2015 |
1057 |
Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis |
29/11/2015 |
1056 |
European Union-28 An annualised cost-of-illness model for venous thromboembolism |
29/11/2015 |
1055 |
Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial |
29/11/2015 |
1054 |
Ce qui se prescrit aux Etats-Unis |
29/11/2015 |
1053 |
Angioplastie inutile dans l’angor stable : COURAGE reste négatif à 12 ans |
29/11/2015 |
1052 |
Algorithm-based approach to management of venous leg ulceration |
29/11/2015 |
1051 |
Treatment of iliac-caval outflow obstruction |
29/11/2015 |
1050 |
Deep venous reconstructive surgery |
29/11/2015 |
1049 |
Treatment of superficial venous incompetence |
29/11/2015 |
1048 |
Medical management of venous ulcers |
29/11/2015 |
1047 |
Investigation of venous ulcers |
29/11/2015 |
1046 |
Pathogenesis of venous ulcer |
29/11/2015 |
1045 |
Venous ulcers of the lower extremity: Definition, epidemiology, economic and social burdens |
29/11/2015 |
1044 |
Cochrane for Clinicians Putting Evidence into Practice |
24/11/2015 |
1043 |
Bon usage des me?dicaments chez le sujet a?ge? |
24/11/2015 |
1042 |
Prophylaxie de la maladie veineuse thromboembolique en post-partum : ´etude de pratique au CHU de Brest en 2013-2014 |
22/11/2015 |
1041 |
Recommandations pour la pratique clinique : post-partum — Méthode et organisation |
22/11/2015 |
1040 |
Post-partum : recommandations pour la pratique clinique – texte court |
22/11/2015 |
1039 |
Use of direct oral anticoagulants (DOACs) in patients with splanchnic vein thrombosis and or cirrhosis |
22/11/2015 |
1038 |
The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk |
22/11/2015 |
1037 |
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial |
22/11/2015 |
1036 |
Anticoagulants orauxdirects(AOD):du retour d’expe´rience a` la se´curisation dela prise enchargeme´dicamenteuse |
22/11/2015 |
1035 |
HTA : faut-il cibler 120 mmHg après SPRINT? Nos questions à 3 hypertensiologues |
22/11/2015 |
1034 |
How Can Follow-Up of Patients with Raynaud Phenomenon be Optimized? |
22/11/2015 |
1033 |
Focus on direct oral anticoagulants (DOAC) for prophylaxis of venous thrombosis and pulmonary embolism in medically ill patients |
22/11/2015 |
1032 |
Cochrane for Clinicians: Putting Evidence into Practice |
22/11/2015 |
1031 |
Comparison of the effi cacy and safety of new oral anticoagulants with warfarin in patients with atrial fi brillation: a meta-analysis of randomised trials |
22/11/2015 |
1030 |
Artérite à cellules géantes et hypoxie inexpliquée |
17/11/2015 |
1029 |
Algie vasculaire de la face: place de l’imagerie |
17/11/2015 |
1028 |
Bénéfices et risques des statines en prévention primaire chez la personne âgée |
17/11/2015 |
1027 |
Ce que recommande l’American College of Physicians en cas de suspicions d’embolie pulmonaire |
17/11/2015 |
1026 |
Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies |
16/11/2015 |
1025 |
Prescription médicamenteuse inappropriée? les nouveaux critères STOPP START RMS 2015 |
16/11/2015 |
1024 |
Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events Implications for Prevention Circulation |
16/11/2015 |
1023 |
Mortality outcomes in patients receiving direct oral anticoagulants a systematic review and meta-analysis of randomized controlled trials |
16/11/2015 |
1022 |
Mon patient est trop âgé pour une statine? mythes et réalités |
16/11/2015 |
1021 |
Identifying people with diabetes at high risk of blindness and amputation |
16/11/2015 |
1020 |
Dose–Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis Circulation |
16/11/2015 |
1019 |
Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes cohort study |
16/11/2015 |
1018 |
Arte?rite a? cellules ge?antes et hypoxie inexplique?e |
16/11/2015 |
1017 |
Be?ne?fices et risques des statines en pre?vention primaire chez la personne a?ge?e |
16/11/2015 |
1016 |
Algie vasculaire de la face: place de l’imagerie |
16/11/2015 |
1015 |
Prescription médicamenteuse inappropriée : les nouveaux critères STOPP/START |
15/11/2015 |
1014 |
Mon patient est trop âgé pour une statine : mythes et réalités |
15/11/2015 |
1013 |
Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study |
15/11/2015 |
1012 |
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity |
12/11/2015 |
1011 |
 |
12/11/2015 |
1010 |
Thrombolyse à la phase aiguë de l’AVC : ajouter un immunomodulateur ? |
12/11/2015 |
1009 |
Le cancer serait toxique pour le coeur, même en l’absence de chimiothérapie |
12/11/2015 |
1008 |
L’embolie pulmonaire, toujours fréquente et grave chez les personnes âgées |
12/11/2015 |
1007 |
Real life thromboprophylaxis in orthopaedic surgery in Italy. Results of the GIOTTO study |
12/11/2015 |
1006 |
Predictors of hospital mortality and serious complications in patients admitted with excessive warfarin anticoagulation |
12/11/2015 |
1005 |
Suivi du diabète et poids de ses complications sévères en France, Journée mondiale du diabète 2015 |
12/11/2015 |
1004 |
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma |
12/11/2015 |
1003 |
History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism |
12/11/2015 |
1002 |
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality |
12/11/2015 |
1001 |
Should preoperative duplex for orthopedic operations be performed? The answer seems to be negative |
12/11/2015 |
1000 |
Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols |
09/11/2015 |
999 |
Comprehensive Imaging Review of the Superior Vena Cava |
09/11/2015 |
998 |
Obesity and risk of bleeding. The SMART study. |
09/11/2015 |
997 |
Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication A Randomized Clinical Trial |
09/11/2015 |
996 |
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials |
09/11/2015 |
995 |
Identification by Ultrasound Evaluation of the Carotid and Femoral Arteries of High-Risk Subjects Missed by Three Validated Cardiovascular Disease Risk Algorithms |
09/11/2015 |
994 |
Improving Awareness and Outcomes Related to Venous Thromboembolism |
09/11/2015 |
993 |
Effect of Bosentan on Claudication Distance and Endothelium- Dependent Vasodilation in Hispanic Patients with Peripheral Arterial Disease |
09/11/2015 |
992 |
Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis?: comment |
09/11/2015 |
991 |
Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians |
09/11/2015 |
990 |
Erasing Disability in Peripheral Artery Disease The Role of Endovascular Procedures and Supervised Exercise |
09/11/2015 |
989 |
Endovascular Treatment of Femoropopliteal Lesions: So Many Options, Little Consensus |
09/11/2015 |
988 |
Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels A Randomized Clinical Trial |
09/11/2015 |
987 |
Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of Over 500 Patients |
07/11/2015 |
986 |
Recommandations festion peri-operatoire 2015: argumentaire |
07/11/2015 |
985 |
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults |
07/11/2015 |
984 |
Introduction to the analysis of next generation sequencing data and its application to venous thromboembolism |
07/11/2015 |
983 |
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry |
07/11/2015 |
982 |
WHO contraception 2015 |
07/11/2015 |
981 |
Recommandations festion peri-operatoire 2015: court |
07/11/2015 |
980 |
Family history of venous thromboembolism as a risk factor and genetic research tool |
07/11/2015 |
979 |
Genetics of Venous Thrombosis: update in 2015 |
07/11/2015 |
978 |
Les statines pourraient améliorer le pronostic cardiovasculaire pour le sujet âgé victime d’un AVC |
07/11/2015 |
977 |
Traitement des dyslipidémies en 2014 : recommandations européennes versus américaines |
07/11/2015 |
976 |
Genetic aspects of thrombotic disease |
07/11/2015 |
975 |
Ethnic diversity in the genetics of venous thromboembolism |
07/11/2015 |
974 |
Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism |
07/11/2015 |
973 |
Classic thrombophilic gene variants |
07/11/2015 |
972 |
Du nouveau dans le diagnostic des infections sévères |
07/11/2015 |
971 |
A Pragmatic View of the New Cholesterol Treatment Guidelines |
07/11/2015 |
970 |
Warfarin treatment complications do not correlate to cTTR when above 70% |
07/11/2015 |
969 |
Thromboprophylaxis after major orthopedic surgery: Improving compliance with clinical practice guidelines. |
07/11/2015 |
968 |
Thrombophilia testing patterns amongst patients with acute venous thromboembolism |
07/11/2015 |
967 |
The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry |
07/11/2015 |
966 |
Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose–response meta-analysis and network meta-analysis |
07/11/2015 |
965 |
Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis |
07/11/2015 |
964 |
Long-Term Prognostic Risk in Lower Extremity Peripheral Arterial Disease as a Function of the Number of Peripheral Arterial Lesions |
07/11/2015 |
963 |
Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response |
07/11/2015 |
962 |
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement |
07/11/2015 |
961 |
Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All |
07/11/2015 |
960 |
ACTES ET PRESTATIONS – AFFECTION DE LONGUE DURÉE |
07/11/2015 |
959 |
Contrast-enhanced ultrasonography in Takayasu arteritis: watching and monitoring the arterial inflammation |
07/11/2015 |
958 |
High Ankle–Brachial Index Indicates Cardiovascular and Peripheral Arterial Disease in Patients With Type 2 Diabetes |
07/11/2015 |
957 |
A Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction |
07/11/2015 |
956 |
Catheter-related thrombosis: Unresolved issues |
07/11/2015 |
955 |
Seasonal variation in the superficial vein thrombosis frequency |
07/11/2015 |
954 |
THROMBOSIS AND HEMOSTASIS: Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model |
27/10/2015 |
953 |
Polypathologies : le mieux est-il l’ennemi du bien ? |
27/10/2015 |
952 |
Difficile de prédire le risque de rechute après une thrombose veineuse spontanée ! |
27/10/2015 |
951 |
L’antidote du dabigatran, Praxbind, reçoit un avis favorable de l’EMA |
27/10/2015 |
950 |
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia |
20/10/2015 |
949 |
Vers de nouvelles normes personnalisées pour la numération plaquettaire |
20/10/2015 |
948 |
THS : un effet protecteur lors d’un premier IDM et aggravant lors d’un second ? |
20/10/2015 |
947 |
Un nouveau mécanisme pour le syndrome de Trousseau |
20/10/2015 |
946 |
Stent à élution médicamenteuse : traitement antiplaquettaire court ou long ? |
20/10/2015 |
945 |
Une nouvelle veille bibliographique est en ligne |
20/10/2015 |
944 |
Risk of Recurrent Venous Thromboembolism and Major Haemorrhage in Cancer-Associated Incidental Pulmonary Embolism amongst Treated and Untreated Patients: a pooled analysis of 926 patients |
20/10/2015 |
943 |
Maladie artérielle périphérique: un marqueur de risque de 11 types de pathologies vasculaires |
20/10/2015 |
942 |
Intravascular Complications of Central Venous Catheterization by Insertion Site |
20/10/2015 |
941 |
L’aspirine bénéficie à presque tous les cancers digestifs sauf le pancréas |
20/10/2015 |
940 |
Hypercholestérolémies familiales : la lumière au bout du tunnel avec les antiPCSK9 ? |
20/10/2015 |
939 |
Hémangiomes infantiles : l’aventure des bêtabloquants continue ! |
20/10/2015 |
938 |
En pratique de ville, que valent les scores de prédiction de l’embolie pulmonaire ? |
20/10/2015 |
937 |
Flash-Actualités : les AOD au congrès de l’ISTH |
20/10/2015 |
936 |
Cathéters veineux centraux: quelles complications selon le site d’insertion ? |
20/10/2015 |
935 |
Beta blocker treatment for infantile hemangiomas |
20/10/2015 |
934 |
Double anti-agrégation plaquettaire après PCI : le score HAS-BLED conserve sa valeur prédictive |
20/10/2015 |
933 |
Diabète : l’empagliflozine réduit la mortalité CV dans EMPA-REG |
20/10/2015 |
932 |
AVK : aussi efficaces dans la “vraie vie” que dans les essais cliniques ! |
20/10/2015 |
931 |
Avantage aux HBPM pour la thromboprophylaxie en réanimation |
20/10/2015 |
930 |
Anticoagulants 2015 AOD or not AOD ? |
20/10/2015 |
929 |
Registre des patients en dialyse |
20/10/2015 |
928 |
AVK Take home messages |
20/10/2015 |
927 |
The Management of Suspected Heparin-Induced Thrombocytopenia in US Hospitals |
20/10/2015 |
926 |
The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease |
20/10/2015 |
925 |
Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The SURVET Study: A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial |
20/10/2015 |
924 |
Comparaison entre revascularisation avec stents actifs de deuxième génération (évérolimus) et pontage aorto-coronaire : étude BEST |
20/10/2015 |
923 |
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited? |
20/10/2015 |
922 |
Secondary Prevention of Venous Thromboembolism Circulation 2015 |
20/10/2015 |
921 |
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage |
20/10/2015 |
920 |
Hot Off the Press: Outpatient Anticoagulation for Venous Thromboembolism Diagnosed in the Emergency Department |
20/10/2015 |
919 |
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged _65 Years in the United States (1999 to 2010) |
20/10/2015 |
918 |
Inhalational use of antithrombotics in humans: review of the literature |
20/10/2015 |
917 |
FACTORS INFLUENCING THE USE OF THROMBOPROPHYLAXIS IN CANCER OUTPATIENTS IN CLINICAL PRACTICE: A PROSPECTIVE STUDY |
20/10/2015 |
916 |
Estimates of Global and Regional Premature Cardiovascular Mortality in 2025 |
20/10/2015 |
915 |
Easonal variation in the superficial vein thrombosis frequency |
20/10/2015 |
914 |
Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease |
20/10/2015 |
913 |
Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults |
20/10/2015 |
912 |
Projet de plan d’action pour la lutte contre les maladies non transmissibles (2013-2020) |
20/10/2015 |
911 |
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study |
20/10/2015 |
910 |
Aspirine à vie et maladie coronarienne stable avec indication à une anticoagulation: est-ce bien raisonnable ? |
20/10/2015 |
909 |
Anticoagulation chez le patient en fibrillation auriculaire à risque de chutes |
20/10/2015 |
908 |
A Health Systems Approach To Risk Stratification |
20/10/2015 |
907 |
Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study |
20/10/2015 |
906 |
Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study |
20/10/2015 |
905 |
Preoperative vascular access evaluation for haemodialysis patients (Review) |
20/10/2015 |
904 |
Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients |
20/10/2015 |
903 |
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ‡65 Years in the United States (1999 to 2010) |
20/10/2015 |
902 |
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants |
20/10/2015 |
901 |
Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials |
20/10/2015 |
900 |
Clinical outcomes of venous thromboembolism with dalteparin therapy in MULTiPLE MYELOME PATIENTS |
20/10/2015 |
899 |
Perspectives thérapeutiques dans la prise en charge de l’acouphène subjectif chronique |
20/10/2015 |
898 |
A Genetic Risk Score Comprising Known Venous Thromboembolism Loci is Associated with Chronic Venous Disease in a Multi-Ethnic Cohort |
20/10/2015 |
897 |
A CLINICAL SCORE TO RULE OUT THE CONCOMITANT PRESENCE OF DEEP VEIN THROMBOSIS IN PATIENTS PRESENTING WITH SUPERFICIAL VEIN THROMBOSIS : The ICARO study. |
20/10/2015 |
896 |
The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis |
20/10/2015 |
895 |
Key coagulation cancer Editorial Blood |
20/10/2015 |
894 |
Thrombose Veineuse des membres inférieurs |
20/10/2015 |
893 |
The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture |
20/10/2015 |
892 |
Stroke, Major Bleeding and Mortality Outcomes in Warfarin Users with Atrial Fibrillation and Chronic Kidney Disease: A Meta-analysis of Observational Studies |
20/10/2015 |
891 |
Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale |
20/10/2015 |
890 |
Quelle place pour les anticoagulants oraux directs en pratique hospitalie?re quotidienne |
20/10/2015 |
889 |
Quel traitement choisir pour la ménopause ? Représentations et usages des Suissesses |
20/10/2015 |
888 |
PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain |
20/10/2015 |
887 |
Primum Non Nocere: Does Screening For Abdominal Aortic Aneurysm Do More Harm Than Good? |
20/10/2015 |
886 |
Peri-proceduralmanagement of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations |
20/10/2015 |
885 |
Outcome in Men with a Screen-detected Abdominal Aortic Aneurysm Who are not Fit for Intervention |
20/10/2015 |
884 |
Les deux visages du syndrome de Gougerot-Sjo?gren |
20/10/2015 |
883 |
Les causes de mortalité chez la femme, entre coeur et cancer |
20/10/2015 |
882 |
Le syndrome des jambes sans repos : fréquent et handicapant |
20/10/2015 |
881 |
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma |
20/10/2015 |
880 |
Impact of thrombosis on standard treatment in solid tumors |
20/10/2015 |
879 |
Identification by Ultrasound Evaluation of the Carotid and Femoral Arteries of High- Risk Subjects Missed by Three Validated Cardiovascular Disease Risk Algorithms |
20/10/2015 |
878 |
Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis |
20/10/2015 |
877 |
Des lésions cutanées au froid |
20/10/2015 |
876 |
How I treat catastrophic thrombotic syndromes |
20/10/2015 |
875 |
Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort |
20/10/2015 |
874 |
Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis |
20/10/2015 |
873 |
Dépistage échographique de l’anévrisme de l’aorte abdominale – les enseignements de Vésale 2013 |
20/10/2015 |
872 |
Syndrome du défilé thoracique syndrome de Paget-Shroetter et artère sous-clavière aberrante chez un homme jeune |
20/10/2015 |
871 |
Contraception et interruption de grossesse |
20/10/2015 |
870 |
Compression Therapy in the Prevention of Postthrombotic Syndrome |
20/10/2015 |
869 |
Clinical outcomes of venous thromboembolism with dalteparin therapy in MULTiPLE MYELOME PATIENTS tr 2015 |
20/10/2015 |
868 |
Cancer Screening in Patients with Idiopathic Venous Thromboembolism – a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis |
20/10/2015 |
867 |
Fibrillation auriculaire non valvulaire Quelle place pour les anticoagulants oraux ? |
20/10/2015 |
866 |
Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach |
20/10/2015 |
865 |
Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis |
20/10/2015 |
864 |
Anticoagulants oraux : gérer le risque hémorragique après 75 ans |
20/10/2015 |
863 |
VESALE 2014 / 2015 : résultats (21 Septembre 2015, M+10) |
20/10/2015 |
862 |
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis – The ICARO study TH 2015 |
20/10/2015 |
861 |
A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency |
20/10/2015 |
860 |
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study |
20/10/2015 |
859 |
Vitamin K antagonists use and fracture risk: results from a systematic review and meta-analysis |
20/10/2015 |
858 |
Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants |
20/10/2015 |
857 |
The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers |
20/10/2015 |
856 |
Systematic review of anticoagulant treatment of catheter-related thrombosis |
20/10/2015 |
855 |
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle–Brachial Index in Adults: U.S. Preventive Services Task Force Recommendation Statement |
20/10/2015 |
854 |
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia |
20/10/2015 |
853 |
Predicting pulmonary embolus in primary care |
20/10/2015 |
852 |
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings |
20/10/2015 |
851 |
Management of catheter-associated upper extremity deep venous thrombosis |
20/10/2015 |
850 |
Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France |
20/10/2015 |
849 |
Genetics of Venous Thrombosis : update in 2015 |
20/10/2015 |
848 |
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial |
20/10/2015 |
847 |
Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care |
20/10/2015 |
846 |
Diagnostic performance of magnetic resonance imaging for acute pulmonary embolism: a systematic review and meta-analysis |
20/10/2015 |
845 |
Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism? |
20/10/2015 |
844 |
Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model |
20/10/2015 |
843 |
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism |
20/10/2015 |
842 |
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension |
20/10/2015 |
841 |
Progress in the management of acute pulmonary embolism |
20/10/2015 |
840 |
Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals |
20/10/2015 |
839 |
The hidden economics of Telemedicine_Asch, Ann Intern Med |
20/10/2015 |
838 |
Venous thromboembolism Predicting recurrence and the need for extended anticoagulation VM 2015 |
18/05/2015 |
837 |
thrombophilie Jude |
18/05/2015 |
836 |
Thrombophilie INSERM |
18/05/2015 |
835 |
The History of US Radiographics 2015 |
18/05/2015 |
834 |
The Celiac Axis Revisited Anatomic Variants, Pathologic Features and Implications for Modern Endovascular Management Radiographics 2015 |
18/05/2015 |
833 |
Screening of Patients with Idiopathic Venous Thromboembolism for HPN TR 2015 |
18/05/2015 |
832 |
Safety of the direct-acting anticoagulants in patients with atrial fibrillation a meta-analysis TR 2015 |
18/05/2015 |
831 |
Ruptured Aneurysm Trials The Importance of Longer-term Outcomes and Meta-analysis for 1-year Mortality ejves 2015 |
18/05/2015 |
830 |
Residual vein thrombosis and the risk of subsequent serious complications TR 2015 |
18/05/2015 |
829 |
Reponse de Kearon à Palareti Ann Intern Med 2015 |
18/05/2015 |
828 |
Quality of life after pulmonary embolism Prospective validation of the German version of the PEmb-QoL questionnaire TR 2015 |
18/05/2015 |
827 |
Pleomorphic Liposarcoma of IVC Radiographics 2015 |
18/05/2015 |
826 |
maladie_coronaire_chez_la_femme_existe_t_il_des_specificites_STV 2015 |
18/05/2015 |
825 |
Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss. Ann Inter Med 2015 |
18/05/2015 |
824 |
Le manifeste de Leiden pour la mesure de la recherche 2015 |
18/05/2015 |
823 |
Is lipid lowering therapy an independent risk factor for venous thromboembolism A population-based case–control study TR 2015 |
18/05/2015 |
822 |
Incidence and risk factors of early deep venous thrombosis after varicose vein surgery with routine use of a tourniquet TR 2015 |
18/05/2015 |
821 |
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy TR 2015 |
18/05/2015 |
820 |
How the Direct Oral Anticoagulant Apixaban Affects Thrombin Generation Parameters TR 2015 |
18/05/2015 |
819 |
gui308CPG1406F |
18/05/2015 |
818 |
Fondaparinux in pregnancy Could it be a safe option A review of the literature TR 2015 |
18/05/2015 |
817 |
Erreur PR MED 2015 |
18/05/2015 |
816 |
Dynamic High-Resolution US of anlke Radiographics 2015 |
18/05/2015 |
815 |
Denervartion Rénale Simplicity 3 NEJM 2014 |
18/05/2015 |
814 |
Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism The Population-based Worcester VTE Study (1999 to 2009) TR 2015 |
18/05/2015 |
813 |
D-Dimer Testing in Patients With a First Unprovoked Venous Ann Inter Med 2015 |
18/05/2015 |
812 |
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice TR 2015 |
18/05/2015 |
811 |
Capillaroscopie Med Int 2015 |
18/05/2015 |
810 |
B blood group A strong risk factor for venous thromboembolism recurrence TR 2015 |
18/05/2015 |
809 |
avc_argumentaire HAS 2014 |
18/05/2015 |
808 |
Application of ROTEM to assess hypercoagulability in patients with lung cancer TR 2015 |
18/05/2015 |
807 |
Anemia predicts thromboembolic events, bleeding TH 2015 |
18/05/2015 |
806 |
AC personnes a^ge´es R Med Int 2015 |
18/05/2015 |
805 |
653.1312-VTE and Cancer_Piazza, Circulation (Clinician Update) |
18/05/2015 |
804 |
70.1302-Coagulation and Cancer. Biological and Clinical aspects_Falanga, JTH |
18/05/2015 |
803 |
1-s2.0-S0049384813006075-main |
18/05/2015 |
802 |
1-s2.0-S0049384812007906-main |
18/05/2015 |
801 |
1-s2.0-S0002934313008383-main |
18/05/2015 |
800 |
1-s2.0-S0002914913017013-main |
18/05/2015 |
799 |
Mesenteric Venous Thrombosis Circulation 2015 |
07/05/2015 |
798 |
FRtot4_2015 |
06/05/2015 |
797 |
fluindione atteintes cutanees et renales graves d origine immunoallergique |
06/05/2015 |
796 |
KDOQI. AJKD 2002 |
06/05/2015 |
795 |
Wattanatik_J_Am_Soc_Nephrol_2008 |
06/05/2015 |
794 |
Scherz_et_al-2013-Journal_of_Thrombosis_and_Haemostasis |
06/05/2015 |
793 |
Poli_Thromb_Haemost_2012_CG_MDRD_CKE-EPI_Bleeding_AVK |
06/05/2015 |
792 |
Parikh AM. AJKD 2011. Thrombose Epidemiologie |
06/05/2015 |
791 |
Mahmoodi BK Circulation 2012 Thrombose Epidemiologie |
06/05/2015 |
790 |
Limdi_AJKD_2013_POAT |
06/05/2015 |
789 |
Levey SA Kidney Int 2005 KDIGO |
06/05/2015 |
788 |
Kearon_Chest_2012 |
06/05/2015 |
787 |
Jun_BMJ_2015_Kidney_Function_Bleeding_VKA |
06/05/2015 |
786 |
Flores-Blanco_2015_European_Journal_of_Clinical_Investigation |
06/05/2015 |
785 |
Fang_ATRIA_J_Am_Coll_Cardiol_2011 |
06/05/2015 |
784 |
Donze´_Am-J-Med_2012_Validatipn_7_Scores |
06/05/2015 |
783 |
Bottger_Thromb_Res_2014 |
06/05/2015 |
782 |
Bottger_Thromb_Res_2014 |
06/05/2015 |
781 |
vascular tumors SPS 2014 |
05/05/2015 |
780 |
vascular malformations review SPS 2014 |
05/05/2015 |
779 |
Vascular Anomalies and Airway Concerns SPS 2014 |
05/05/2015 |
778 |
Radiographic Findings Associated with Vascular Anomalies SPS 2014 |
05/05/2015 |
777 |
Medical Therapy for Pediatric Vascular Anomalies SPS 2014 |
05/05/2015 |
776 |
Beta-Blockers as Therapy for Infantile Hemangiomas |
05/05/2015 |
775 |
Beta-Blockers as Therapy for Infantile Hemangiomas SPS 2014 |
05/05/2015 |
774 |
AVC |
05/05/2015 |
773 |
A Review of Vascular Anomalies- Genetics and Common Syndromes SPS 2014 |
05/05/2015 |
772 |
Risk of Venous Thromboembolism in Patients with VIH Int Ang 2013 |
03/05/2015 |
771 |
MANAGEMENT OF SUPERFICIAL VEIN THROMBOSIS JTH 2015 |
03/05/2015 |
770 |
IUP-VM Consensus-2013 |
03/05/2015 |
769 |
15v1.1504-congenital_abnormalities_of_the_ivc_presenting_clinically_in_adolescent_males_halparin_thromb_res |
03/05/2015 |
768 |
15v.1305-hypoplasia_of_ivc_and_dvt_cei_qjm |
03/05/2015 |
767 |
15v.1202-congenital_anomalies_of_the_ivc_malaki_clin_radiol |
03/05/2015 |
766 |
1-s2.0-S0002914915006955-main |
03/05/2015 |
765 |
1-s2.0-S0002914915006955-main |
03/05/2015 |
764 |
Tinzaparin and VKA use in patients with cancer associated venous thromboembolism A retrospective cohort study TR 2015 |
29/04/2015 |
763 |
750.1504-Ulcères de jambe_Mirault, Rev Prat |
29/04/2015 |
762 |
Vena Cava Filter Use in Cancer Patients with Acute Venous thrombosis en california TR 2015 |
28/04/2015 |
761 |
Une petite molécule contre la maladie de Behçet |
28/04/2015 |
760 |
TV RENALE |
28/04/2015 |
759 |
TV PORTE 2012 |
28/04/2015 |
758 |
TV OVARIENNE |
28/04/2015 |
757 |
Treatment-related frequency of venous thrombosis in lower esophageal TR 2015 |
28/04/2015 |
756 |
The use of optional inferior vena cava filters of type Optease in trauma patients TR 2015 |
28/04/2015 |
755 |
The PESA (Progression of Early Subclinical Atherosclerosis) Study Circulation 2015 |
28/04/2015 |
754 |
Reduction in the soles of graduated compression stockings prevents falls TR 2015 |
28/04/2015 |
753 |
Predictors of Delayed Wound Healing after Endovascular Therapy of Isolated Infrapopliteal Lesions Underlying Critical Limb Ischemia in Patients with High Prevalence of Diabetes Mellitus and Hemodialysis EJVES 2015 |
28/04/2015 |
752 |
Prediction of thrombotic and hemorrhagic events during polycythemia TR 2015 |
28/04/2015 |
751 |
Patterns, risk factors and treatment associated with PICC-DVT TR 2015 |
28/04/2015 |
750 |
Natural anticoagulants deficiency and the risk of venous thrombosis TR 2015 |
28/04/2015 |
749 |
Management of Chronic Venous Disease- Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) EJVES 2015 |
28/04/2015 |
748 |
External validation of a simple non-invasive algorithm to rule out HTAP TR 2015 |
28/04/2015 |
747 |
ethics_manual_fr |
28/04/2015 |
746 |
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism A network meta analysis TR 2015 |
28/04/2015 |
745 |
carotidodynie 2011 |
28/04/2015 |
744 |
Cancer-associated thrombosis investigating the role of new oral anticoagulant TR 2015 |
28/04/2015 |
743 |
Benefits of Completion 3D Angiography Associated with Contrast Enhanced Ultrasound to Assess Technical Success after EVAR EJVES 2015 |
28/04/2015 |
742 |
Adempas, premier traitement contre HTAP thromboembolique chronique, en France |
28/04/2015 |
741 |
A histological and functional description of the tissue causing chronic postthrombotic venous obstruction TR 2015 |
28/04/2015 |
740 |
Periaortitis as a Rare Complication After Endovascular Aneurysm Repair |
28/04/2015 |
739 |
Noninvasive Imaging of Early Venous Thrombosis by 19F Magnetic Resonance Imaging With Targeted Perfluorocarbon Nanoemulsions |
28/04/2015 |
738 |
Easaw reco Canada traitement |
26/04/2015 |
737 |
Easaw reco Canada prophylaxis |
26/04/2015 |
736 |
Carrier recos Canada situations particulie_res |
26/04/2015 |
735 |
Bauersachs MTEV Kc femmes |
26/04/2015 |
734 |
690.1504-Thrombophilia. Clinical-practical aspects_Moll, JTT + |
26/04/2015 |
733 |
Place de l acide tranexamique STV 2015 |
18/04/2015 |
732 |
Durée de la bithérapie antiplaquettaire après implantation d’un stent coronaire actif |
15/04/2015 |
731 |
Recommandations sur l’utilisation de l’échographie lors de la mise en place des accès vasculaires |
15/04/2015 |
730 |
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period |
15/04/2015 |
729 |
Thrombosis in inflammatory bowel diseases TJ 2015 |
12/04/2015 |
728 |
Screening for Asymptomatic Carotid Artery Stenosis A SystematiReview and Meta-analysis for the U.S. Preventive Services Task Forc e Ann Int Med 2014 |
12/04/2015 |
727 |
reatment of venous thromboembolism in cancer patients with dalteparin for up to twelve months. The DALTECAN Study JTH 2015 |
12/04/2015 |
726 |
Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients TR 2015 |
12/04/2015 |
725 |
La medecine basee sur les donnees probantes 2004 |
12/04/2015 |
724 |
Factors Associated with Recurrence of Varicose after themal ablation 2014 |
12/04/2015 |
723 |
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Executive Summary |
12/04/2015 |
722 |
bulletin ANSM |
12/04/2015 |
721 |
la lettre du medecin vasculaire juin 2013 |
08/04/2015 |
720 |
Safety and efficacy of well managed warfarin TH 2014 |
07/04/2015 |
719 |
Cigarettes electroniques |
06/04/2015 |
718 |
The Risk Of Recurrent Venous Thromboembolism After Discontinuing Anticoagulation I Prandoni 2007 Haematologica |
06/04/2015 |
717 |
Safety of vitamin k antagonist treatment for splanchnic vein thrombosis- a multicenter cohort study JTH 2015 |
06/04/2015 |
716 |
reatment of venous thromboembolism in cancer patients with dalteparin for up to twelve months. The DALTECAN Study JTH 2015 |
06/04/2015 |
715 |
Perioperative evaluation of blood volume flow in high flow cerebral arteriovenous malformation using phase contrast magnetic resonance angiography 2015 |
06/04/2015 |
714 |
Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients TR 2015 |
06/04/2015 |
713 |
Antisepsie des plaies quand et quoi RMS 2015 |
06/04/2015 |
712 |
Anomalies veineuses congénitales des membres EMC 2004 |
06/04/2015 |
711 |
Surinfection de plaie chronique par Pseudomonas aeruginosa RMS 2015 |
02/04/2015 |
710 |
Erysipèle et dermohypodermite récidivants prise en charge RMS 2015 |
02/04/2015 |
709 |
COUPEROSE, ANGIOME STELLAIRE ET AUTRES TÉLANGIECTASIES |
31/03/2015 |
708 |
Thrombose veineuse profonde des membres inferieurs |
29/03/2015 |
707 |
imagerie therapeutique des abords d’hemodialise EMC 2015 |
29/03/2015 |
706 |
chirurgie carotidienne 2. generalites, voies d abord |
29/03/2015 |
705 |
chirurgie carotidienne. generalites, voies d abord |
29/03/2015 |
704 |
thombose veineuse profonde des membres inferieurs |
26/03/2015 |
703 |
imagerie therapeutique des abords d’hemodialise |
26/03/2015 |
702 |
chirurgie carotidienne 2 |
26/03/2015 |
701 |
chirurgie carotidienne |
26/03/2015 |
700 |
Urgence chirurgicale sous antivitamine K plasma ou concentre de facteurs |
24/03/2015 |
699 |
Takayasu Arteriitis |
24/03/2015 |
698 |
Les anomalies vasculaires Fiche d information |
21/03/2015 |
697 |
Urgence chirurgicale sous antivitamine K plasma ou concentré de facteurs |
21/03/2015 |
696 |
Use of computed tomography-lymphangiography with direct injection of water-soluble contrast medium to identify the origin of chylous ascites |
15/03/2015 |
695 |
Ultrasound-guided Intralesional Diode Laser Treatment of Congenital Extratruncular Venous Malformations Mid-term Results |
15/03/2015 |
694 |
Non-Invasive Imaging of Early Venous Thrombosis by 19F MRI Using Targeted Perfluorocarbon Nanoemulsions |
15/03/2015 |
693 |
Management of an enormous arteriovenous malformation |
15/03/2015 |
692 |
Internal Jugular Vein Aneurysm Presenting after Emesis Episode |
15/03/2015 |
691 |
Embolization techniques for high-flow arteriovenous malformations with a dominant outflow vein |
15/03/2015 |
690 |
Curative Treatment of Pelvic Arteriovenous Malformation e An Alternative Strategy Transvenous Intra-operative Embolisation |
15/03/2015 |
689 |
Curative Treatment of Pelvic Arteriovenous Malformation e An Alternative Strategy: Transvenous Intra-operative Embolisation |
15/03/2015 |
688 |
Early and Long-Term Outcomes of Venous Stent Implantation for Iliac Venous Stenosis After Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis |
15/03/2015 |
687 |
La cigarette électronique permet-elle de sortir la société du tabac |
15/03/2015 |
686 |
Prolonged antiplatelet therapy after drug-eluting stents |
15/03/2015 |
685 |
Oral anticoagulants for stroke prevention in atrial fi brillation current status special situations and unmet needs |
15/03/2015 |
684 |
Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: An observational analysis from a long-term follow-up study |
15/03/2015 |
683 |
Gestion périopératoire des anticoagulants oraux directs |
15/03/2015 |
682 |
Carotid endarterectomy for symptomatic carotid stenosis |
15/03/2015 |
681 |
Hormone therapy for preventing cardiovascular disease in post-menopausal women |
15/03/2015 |
680 |
Atteinte cardiaque de la maladie de Lyme |
15/03/2015 |
679 |
Apport de l échographie dans les tendinopathies |
15/03/2015 |
678 |
L Academie de Medecine pour une e cigarette médicament |
15/03/2015 |
677 |
PURPURA D EFFORT |
09/03/2015 |
676 |
Scores cliniques dans la maladie veineuse thromboembolique une aide dans la décision diagnostique et thérapeutique |
06/03/2015 |
675 |
Gestion péri opératoire des anticoagulants vers de nouvelles recommandations |
06/03/2015 |
674 |
Dispensation au comptoir d’une prescription d’anticoagulant oral direct |
06/03/2015 |
673 |
Anticoagulants oraux directs, fibrillation atriale et accidents vasculaires cérébraux |
06/03/2015 |
672 |
originalEnquête prospective sur les nouveaux anticoagulants oraux en médecinelibérale un enthousiasme prudent |
06/03/2015 |
671 |
Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment EPAHK study |
06/03/2015 |
670 |
Treatment of Pressure Ulcers A Clinical Practice Guideline From the American College of Physicians |
05/03/2015 |
669 |
Thrombose veineuse profonde une thrombolyse est-elle efficace |
05/03/2015 |
668 |
Thrombose veineuse profonde une thrombolyse est-elle efficace |
05/03/2015 |
667 |
Scoring systems for heparin-induced thrombocytopenia HIT Whither now |
05/03/2015 |
666 |
Risk of site-specific cancer in incident venous thromboembolism A population-based study |
05/03/2015 |
665 |
Risk of recurrence after a first unprovoked venous thromboembolism External validation of the Vienna Prediction Model using pooled individual patient data |
05/03/2015 |
664 |
Risk factors for idiopathic sudden sensorineural hearing loss and their association with clinical outcome |
05/03/2015 |
663 |
Risk Assessment and Prevention of Pressure Ulcers A Clinical Practice Guideline From the American College of Physicians |
05/03/2015 |
662 |
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure |
05/03/2015 |
661 |
Epidemiological Study on Chronic Venous Disease in Belgium and Luxembourg Prevalence Risk Factors and Symptomatology |
05/03/2015 |
660 |
Epidemiological Study on Chronic Venous Disease in Belgium and Luxembourg Prevalence Risk Factors and Symptomatology |
05/03/2015 |
659 |
Digital ulcers predict a worse disease course in patients with systemic sclerosis |
05/03/2015 |
658 |
Determinants of premature familial arterial thrombosis in patients with juvenile ischaemic stroke |
05/03/2015 |
657 |
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer |
05/03/2015 |
656 |
CADISS a feasibility trial that answered its question |
05/03/2015 |
655 |
Maladie veineuse thromboembolique chez les patients atteints d un cancer |
05/03/2015 |
654 |
Hypertension pulmonaire post-embolique |
05/03/2015 |
653 |
Traitement au long cours de la maladie veineuse thromboembolique |
05/03/2015 |
652 |
Prise en charge des thromboses veineuses |
05/03/2015 |
651 |
Les cliniques d anticoagulation |
05/03/2015 |
650 |
Y a-t-il encore une place pour l héparine non fractionnee dans la maladie thromboembolique veineuse |
05/03/2015 |
649 |
Evaluation pour un traitement a domicile de l embolie pulmonaire |
05/03/2015 |
648 |
Prise en charge initiale de la maladie veineuse thromboembolique |
05/03/2015 |
647 |
Maladie veineuse thromboembolique et grossesse |
05/03/2015 |
646 |
Bilan étiologique de la maladie veineuse thromboembolique |
05/03/2015 |
645 |
Diagnostic positif de la maladie veineuse thromboembolique |
05/03/2015 |
644 |
Maladie veineuse thromboembolique |
05/03/2015 |
643 |
Effect of Physical Activity Assessment on Prognostication for Peripheral Artery Disease and Mortality |
05/03/2015 |
642 |
The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study |
22/02/2015 |
641 |
L antecedent d ulcere digital de mauvais pronostic dans la sclerodermie systemique |
22/02/2015 |
640 |
Digital ulcers predict a worse disease course in patients with systemic sclerosis |
22/02/2015 |
639 |
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma |
22/02/2015 |
638 |
Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates |
17/02/2015 |
637 |
Renal Angioplasty for Atherosclerotic Renal Artery Stenosis Revisited |
17/02/2015 |
636 |
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation |
17/02/2015 |
635 |
Early and Long-Term Outcomes of Venous Stent Implantation for Iliac Venous Stenosis After Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis |
17/02/2015 |
634 |
Clinical Significance of Collateral Superficial Vein Across Clavicle in Patients With Cardiovascular Implantable Electronic Device |
17/02/2015 |
633 |
Adequate Management of Venous Thromboembolism |
17/02/2015 |
632 |
Current Venous Thromboembolism Management and Outcomes in Japan |
17/02/2015 |
631 |
Premiers resultats de l observatoire GIHP NACO des hemorragies sous anticoagulants |
16/02/2015 |
630 |
Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease |
10/02/2015 |
629 |
Le choix du patient |
10/02/2015 |
628 |
Traitement percutané de la thrombose veineuse profonde aiguë |
06/02/2015 |
627 |
Time trends in pulmonary embolism mortality in France, 2000 2010 |
06/02/2015 |
626 |
Thrombose veineuse profonde du membre supérieur une forme particulière de maladie thromboembolique veineuse |
06/02/2015 |
625 |
The use of rivaroxaban in patients with antiphospholipid syndrome A series of 12 cases |
06/02/2015 |
624 |
The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders |
06/02/2015 |
623 |
Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism |
06/02/2015 |
622 |
Quelle prise en charge pour une suspicion de thrombose veineuse profonde des membres inférieurs |
06/02/2015 |
621 |
Pathologies vasculaires lymphatiques apport de la lympho fluoroscopie |
06/02/2015 |
620 |
La maladie thromboembolique veineuse cette inconnue |
06/02/2015 |
619 |
Artériopathies non athéromateuses des membres inférieurs |
06/02/2015 |
618 |
Anomalies vasculaires exemple du syndrome de Klippel Trenaunay |
06/02/2015 |
617 |
Guide_Interactions_Prescrire_2015 |
01/02/2015 |
616 |
GUIDE PARCOURS DE SOINS Diabete de type 2 de l adulte |
01/02/2015 |
615 |
Why is factor V Leiden so rare in the Basques |
01/02/2015 |
614 |
Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer a clinical prospective study of outcome and prognostic factors |
01/02/2015 |
613 |
Topical use of antithrombotics Review of literature |
01/02/2015 |
612 |
Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system |
01/02/2015 |
611 |
Parcours de soins Questions Réponses |
01/02/2015 |
610 |
New Oral Anticoagulants in the Treatment of Heparin- Induced Thrombocytopenia |
01/02/2015 |
609 |
Life Threatening Complications and Outcomes in Patients with Malignancies and Severe Pulmonary Embolism |
01/02/2015 |
608 |
Diagnostic Performance of 18F-FDG-PET/CT in Vascular Graft Infections |
01/02/2015 |
607 |
Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines |
01/02/2015 |
606 |
carotide gestion |
01/02/2015 |
605 |
Body height, mobility, and risk of first and recurrent venous thrombosis |
01/02/2015 |
604 |
Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force |
24/01/2015 |
603 |
A Controlled Trial of Renal Denervation for Resistant Hypertension |
24/01/2015 |
602 |
Abdominal Aortic Aneurysms Revisited: MDCT with Multiplanar Reconstructions for Identifying Indicators of Instability in the Pre- and Postoperative Patient |
24/01/2015 |
601 |
Ultrasound-Assisted Versus Conventional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis |
24/01/2015 |
600 |
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study |
24/01/2015 |
599 |
A contemporary review of venous adventitial cystic disease and three case reports |
24/01/2015 |
598 |
Endovascular Aneurysm Repair: Is Imaging Surveillance Robust, and Does It Influence Long-term Mortality |
24/01/2015 |
597 |
Prevalence of abdominal aortic aneurysm in patients referred for transthoracic echocardiography |
24/01/2015 |
596 |
Abdominal Aortic Aneurysms Revisited: MDCT with Multiplanar Reconstructions for Identifying Indicators of Instability in the Pre- and Postoperative Patient |
24/01/2015 |
595 |
AAAs and Risk Factors for Adverse Events: A Review |
24/01/2015 |
594 |
Screening for Asymptomatic Carotid Artery Stenosis |
24/01/2015 |
593 |
Assessment of microcirculation by contrast-enhanced ultrasound: a new approach in vascular medicine |
24/01/2015 |
592 |
Accidents ischémiques cérébraux |
17/01/2015 |
591 |
Vascular malformations revisited |
14/01/2015 |
590 |
The risk of bacteria in foam sclerotherapy |
14/01/2015 |
589 |
Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis |
14/01/2015 |
588 |
Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis |
14/01/2015 |
587 |
Fifteen-Year Experience With Carotid Artery Stenting |
14/01/2015 |
586 |
Fifteen-Year Experience With Carotid Artery Stenting |
14/01/2015 |
585 |
Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs |
14/01/2015 |
584 |
Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs |
14/01/2015 |
583 |
Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs |
14/01/2015 |
582 |
A rare variant of Stewart Treves syndrome |
14/01/2015 |
581 |
Fifteen-Year Experience With Carotid Artery Stenting |
13/01/2015 |
580 |
Montée en puissance pour le stenting carotidien |
13/01/2015 |
579 |
Une thromboprophylaxie ou l anti sens du facteur XI prend tout son sens |
09/01/2015 |
578 |
Rapport de l’ANSM sur les anticoagulants en France en 2014 : état des lieux, synthèse et surveillance |
09/01/2015 |
577 |
Rapport de l ANSM sur les anticoagulants en France en 2014 etat des lieux synthese et surveillance |
09/01/2015 |
576 |
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis |
09/01/2015 |
575 |
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis |
09/01/2015 |
574 |
D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy |
07/01/2015 |
573 |
Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: A retrospective cohort study |
04/01/2015 |
572 |
The S curve: A novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia |
04/01/2015 |
571 |
Risk Factors and Outcome of Splanchnic venous thrombosis in Patients with necrotizing |
04/01/2015 |
570 |
Presence of external carotid artery plaque independently predicts mortality in patients without internal carotid artery atherosclerosis |
04/01/2015 |
569 |
Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule |
04/01/2015 |
568 |
Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism |
04/01/2015 |
567 |
Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case- Control Study |
04/01/2015 |
566 |
Multidisciplinary Stepwise Management Strategy for Acute Superior Mesenteric Venous Thrombosis: An Intestinal Stroke Center Experience |
04/01/2015 |
565 |
Management Strategies for Patients with Varicose Veins (C2eC6): Results of a Worldwide Survey |
04/01/2015 |
564 |
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant |
04/01/2015 |
563 |
Fever as a Risk Factor for Increased Response to Vitamin K Antagonists: A Review of the Evidence and Potential Mechanisms |
04/01/2015 |
562 |
Carotid artery disease |
04/01/2015 |
561 |
Analytical accuracy and precision of two novel Point-of-Care systems for INR determination |
04/01/2015 |
560 |
Statine cinq ans de traitement pour un bénéfice a vie |
26/12/2014 |
559 |
MÉTHOTREXATE |
26/12/2014 |
558 |
DOCTEUR, JE VAIS ME FAIRE OPERER |
21/12/2014 |
557 |
Venous thrombosis and risk of cancer in patients with arterial cardiovascular disease |
20/12/2014 |
556 |
Risk of venous thromboembolismoccurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees |
20/12/2014 |
555 |
Risk of Site-Specific Cancer in Incident Venous Thromboembolism: A Population-Based Study |
20/12/2014 |
554 |
Mesenteric Venous Thrombosis and the need for a specialized Intestinal Stroke Center |
20/12/2014 |
553 |
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant |
20/12/2014 |
552 |
How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis |
20/12/2014 |
551 |
Fever as a Risk Factor for Increased Response to Vitamin K Antagonists: A Review of the Evidence and Potential Mechanisms |
20/12/2014 |
550 |
Emergency admissions for major haemorrhage associated with antithrombotics: A cohort study |
20/12/2014 |
549 |
Diabetes is associatedwith increased risk of venous thromboembolism: A systematic review and meta-analysis |
20/12/2014 |
548 |
Global, regional, and national age–sex specifi c all-cause and cause-specifi c mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease |
19/12/2014 |
547 |
Traitement des dyslipidémies par les statines en prévention primaire et secondaire |
18/12/2014 |
546 |
Amputations du membre inférieur : indications, bilan et complications |
18/12/2014 |
545 |
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke |
18/12/2014 |
544 |
AVC sévère : pour la première fois, un traitement invasif réduit le handicap |
18/12/2014 |
543 |
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis |
17/12/2014 |
542 |
Vous avez dit antidote |
16/12/2014 |
541 |
Venous thromboembolism diagnosis: unresolved issues |
15/12/2014 |
540 |
Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire |
15/12/2014 |
539 |
Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire |
15/12/2014 |
538 |
Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire |
15/12/2014 |
537 |
Prévention vasculaire après un infarctus cérébral (IC) ou un accident ischémique transitoire (AIT) |
15/12/2014 |
536 |
Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire |
15/12/2014 |
535 |
Les recommandations relatives à la fibrillation atriale non valvulaire sont susceptibles d’évoluer en fonction des prochains avis de la commission de la transparence sur les médicaments anticoagulants non anti-vitamine K (à paraître d’ici fin 2014) |
15/12/2014 |
534 |
Les recommandations relatives à la fibrillation atriale non valvulaire sont susceptibles d’évoluer en fonction des prochains avis de la Commission de la Transparence sur les médicaments anticoagulants non anti-vitamine K (à paraître d’ici fin 2014) |
15/12/2014 |
533 |
Treatment options for venous thromboembolism: lessons learnt from clinical trials |
13/12/2014 |
532 |
Quality ImprovementGuidelinesfor Diagnostic Arteriography |
13/12/2014 |
531 |
Prothrombin G20210A mutation is associated with recurrent pregnancy loss: A systematic review and meta-analysis update |
13/12/2014 |
530 |
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies |
13/12/2014 |
529 |
L’homme vieillissant : approche globale du déficit androgénique lié à l’âge et de la dysfonction érectile |
13/12/2014 |
528 |
Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy |
13/12/2014 |
527 |
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study |
13/12/2014 |
526 |
Diabetes is associatedwith increased risk of venous thromboembolism: A systematic review and meta-analysis |
13/12/2014 |
525 |
Clinical Outcomes After Infrainguinal Bypass Grafting for Critical Limb Ischaemia in Patients with Dialysis-dependent End-stage Renal Failure |
13/12/2014 |
524 |
Accidents vasculaires cérébraux : actualités thrombolytiques dans une fenêtre étroite |
13/12/2014 |
523 |
Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects |
13/12/2014 |
522 |
Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease |
13/12/2014 |
521 |
The real cost of treating venous ulcers in a contemporary vascular practice |
13/12/2014 |
520 |
Surveillance of endovascular aneurysm repair: an audit of sonographer-led ultrasound and radiologist-led computed tomography services |
13/12/2014 |
519 |
Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program |
13/12/2014 |
518 |
Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study |
13/12/2014 |
517 |
Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy |
13/12/2014 |
516 |
Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort |
13/12/2014 |
515 |
Épistaxis et traitements antithrombotiques |
09/12/2014 |
514 |
Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus |
08/12/2014 |
513 |
Un avenir pour la FDG-TEP-TDM dans la détection des récidives de thromboses veineuses profondes |
08/12/2014 |
512 |
Toxicité cardiovasculaire des agents anticancéreux |
06/12/2014 |
511 |
Surgical Duration and Risk of Venous Thromboembolism |
05/12/2014 |
510 |
ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014) |
05/12/2014 |
509 |
Abandon des cibles de cholesterol un an après les Américains n ont toujours pas digere |
21/11/2014 |
508 |
Thrombolyse de l AVC meta analyse du benefice risque |
05/12/2014 |
507 |
Eff ect of treatment delay, age, and stroke severity on the eff ects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials |
05/12/2014 |
506 |
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents |
04/12/2014 |
505 |
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries |
01/12/2014 |
504 |
Cannabis-Associated Angiopathy An Uncommon Cause of Crescendo Transient Ischemic Attacks |
01/12/2014 |
503 |
Venous thromboembolism in pregnant women with sickle cell disease: A retrospective database analysis |
28/11/2014 |
502 |
Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: A meta-analysis |
28/11/2014 |
501 |
Screening high-risk cancer patients for VTE: A prospective observational study |
28/11/2014 |
500 |
Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease |
28/11/2014 |
499 |
Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis |
28/11/2014 |
498 |
Echocardiographic evolution of pulmonary artery pressure after acute pulmonary embolism. Results from IPER registry |
28/11/2014 |
497 |
A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: Comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens |
28/11/2014 |
496 |
A case series of LMWH use in pregnancy: Should trough anti-Xa levels guide dosing |
28/11/2014 |
495 |
L erreur en medecine une opportunite d amelioration des pratiques un defi pour l’EBM |
21/11/2014 |
494 |
Physical Activity and Risk of Bleeding in Elderly Patients Taking Anticoagulants |
18/11/2014 |
493 |
Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study |
17/11/2014 |
492 |
NEWS VASC 2014 N° 115 |
16/11/2014 |
491 |
Optimal management of infrainguinal arterial occlusive disease |
16/11/2014 |
490 |
Se méfier des plaques d’athérome coronariennes non obstructives |
16/11/2014 |
489 |
Bon usage Apixaban JMV 2014 |
12/11/2014 |
488 |
Etude COC Embolie pulmonaire 2014 2 |
12/11/2014 |
487 |
Vers un antidote pour les AOD |
10/11/2014 |
486 |
623b.1411 Antepartum dalteparin vs No for the prevention of pregnancy Cns in pregnant women with thrombophilia TIPPS Rodger Lancet |
07/11/2014 |
485 |
Thrombosis A major contributor to global disease burden TH 2014 |
03/11/2014 |
484 |
Solving the mystery of excessive warfarin-induced bleeding TH 2014 |
03/11/2014 |
483 |
Trend and seasonality in hospitalizations for pulmonary embolism.A time series analysis JTH 2014 |
02/11/2014 |
482 |
Co-trimoxazole and sudden death in patients receiving IEC PLOS One 2014 |
02/11/2014 |
481 |
Traitement de l ischemie critique des 2014 RMS 2014 |
28/10/2014 |
480 |
Incidence de l amputation majeure des MI RMS 2014 |
28/10/2014 |
479 |
EP et Grossesse RMS 2014 |
28/10/2014 |
478 |
Traitements antiagrégants dans la prévention secondaire des accidents vasculaires cérébraux non cardioemboliques |
16/10/2014 |
477 |
D-dimeres et suspicion d embolie pulmonaire seuil adapte à l age |
16/10/2014 |
476 |
Antibiothérapie par voie sous-cutanée chez le patient âgé |
16/10/2014 |
475 |
Les cannabis de synthèse qui envoient les jeunes américains aux urgences arriveront-ils en France |
31/10/2014 |
474 |
Statines les génériques sont tout aussi efficaces |
31/10/2014 |
473 |
Traitement de l ischemie critique chronique des membres inferieurs en 2014 |
28/10/2014 |
472 |
Incidence de l amputation majeure des membres inferieurs à Geneve vingt et un ans d observation |
28/10/2014 |
471 |
Diagnostic de l’embolie pulmonaire chez la femme enceinte comment faire |
28/10/2014 |
470 |
HEXAFLUORURE DE SOUFRE |
28/10/2014 |
469 |
Risque cardiovasculaire accru dans la maladie de Horton, à court et à long terme |
16/10/2014 |
468 |
Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial |
16/10/2014 |
467 |
Renal Artery Duplex Ultrasound Criteria for the Detection of Significant In-Stent Restenosis |
16/10/2014 |
466 |
Short- and Medium-term Duplex Sonography Follow-Up of Deep Venous Thrombosis of the Lower Limbs |
16/10/2014 |
465 |
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity |
13/10/2014 |
464 |
Thrombosis: a major contributor to the global disease burden |
13/10/2014 |
463 |
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study |
13/10/2014 |
462 |
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography–pulmonary angiography |
13/10/2014 |
461 |
Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH |
13/10/2014 |
460 |
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment |
13/10/2014 |
459 |
Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants |
13/10/2014 |
458 |
Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity |
13/10/2014 |
457 |
10 questions réponses sur la cigarette électronique |
13/10/2014 |
456 |
Low Post-operative Mortality after Surgery on Patients with Screeningdetected Abdominal Aortic Aneurysms: A Swedvasc Registry Study |
13/10/2014 |
455 |
Giant Symptomatic Aneurysm of the Inferior Vena Cava |
13/10/2014 |
454 |
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity |
13/10/2014 |
453 |
Massive human rivaroxaban overdose |
13/10/2014 |
452 |
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) |
13/10/2014 |
451 |
Syndromes of Thrombotic Microangiopathy |
08/10/2014 |
450 |
Silent Pulmonary Embolism in Patients with Distal Deep Venous Thrombosis: Systematic Review |
08/10/2014 |
449 |
Peut-on faire confiance aux publications scientifiques |
08/10/2014 |
448 |
Anticoagulation for Central Venous Catheters in Patients with Cancer |
08/10/2014 |
447 |
A new era for venous thromboembolism prevention in medical inpatients |
08/10/2014 |
446 |
Silent Pulmonary Embolism in Patients with Distal Deep Venous Thrombosis: Systematic Review |
07/10/2014 |
445 |
Arrêter ou pas les statines en cas d’hémorragie cérébrale |
07/10/2014 |
444 |
Bons résultats pour l’antidote des anti-Xa sur 33 volontaires sains |
05/10/2014 |
443 |
Consultation avant de prendre l avion evaluation et conseils par le medecin de premier recours |
01/10/2014 |
442 |
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association |
01/10/2014 |
441 |
Syndromes of Thrombotic Microangiopathy |
30/09/2014 |
440 |
Microangiopathies thrombotiques : une grande famille |
30/09/2014 |
439 |
APM International |
29/09/2014 |
438 |
Safety of ventilation/perfusion single photon emission computed tomography for pulmonary embolism diagnosis |
29/09/2014 |
437 |
Faites encore confiance à la tomoscintigraphie pulmonaire de ventilation et de perfusion pour le diagnostic d’embolie pulmonaire |
29/09/2014 |
436 |
A Randomized Trial Comparing Treatments for Varicose Veins |
29/09/2014 |
435 |
Prophylaxis against Venous Thromboembolism in Patients with Cancer |
29/09/2014 |
434 |
Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer |
29/09/2014 |
433 |
JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate |
23/09/2014 |
432 |
Modèle de valorisation des publications médicales scientifiques le logiciel SIGAPS |
23/09/2014 |
431 |
The role compression ultrasound in hospitalized patients with suspected pulmonary embolism |
21/09/2014 |
430 |
Ulcères veineux : quel effet antalgique des agents topiques et des pansements |
21/09/2014 |
429 |
Quels sont les meilleurs traitements pour la sciatique |
21/09/2014 |
428 |
Fiabilité des recommandations des Guides de Pratique Clinique |
21/09/2014 |
427 |
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial |
21/09/2014 |
426 |
Clinical Decision Rules and D-dimer in Venous Thromboembolism: Current controversies and future research priorities |
21/09/2014 |
425 |
Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice |
21/09/2014 |
424 |
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases |
20/09/2014 |
423 |
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases – web addenda |
20/09/2014 |
422 |
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism |
20/09/2014 |
421 |
Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism |
18/09/2014 |
420 |
Overuse of Compression Ultrasound for Patients with Lower Extremity Cellulitis |
18/09/2014 |
419 |
On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation |
18/09/2014 |
418 |
Low molecular weight heparin in management and prevention of portal vein thrombosis |
18/09/2014 |
417 |
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis |
18/09/2014 |
416 |
Clinical Decision Rules and D-dimer in Venous Thromboembolism: Current controversies and future research priorities |
18/09/2014 |
415 |
Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice |
18/09/2014 |
414 |
Therapy for Peripheral Artery Disease Gaps in Treating Patients With Claudication |
18/09/2014 |
413 |
Statins Reduce Peri-procedural Complications in Carotid Stenting |
18/09/2014 |
412 |
Improved Quality of Life After 1 Year With an Invasive Versus a Noninvasive Treatment Strategy in Claudicants |
18/09/2014 |
411 |
LAST : un nouvel outil dans l’évaluation de l’aphasie à la phase aiguë de l’AVC |
18/09/2014 |
410 |
Marijuana et santé : bilan des connaissances dans le New England |
18/09/2014 |
409 |
SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: Executive summary |
17/09/2014 |
408 |
Statins are Associated with Low Risk of Venous Thromboembolism in Patients with Cancer: A Prospective and Observational Cohort Study |
17/09/2014 |
407 |
Sex differences in the association between smoking and abdominal aortic aneurysm |
17/09/2014 |
406 |
Prevalence Of Renal Insufficiency In Hospitalised Patients With Venous Thromboembolic Events: A Retrospective Analysis Based On 6,725 Vte Patients |
17/09/2014 |
405 |
Réaffirmation de l’intérêt d’un dépistage ciblé des AAA |
08/09/2014 |
404 |
Recommandations de la Société Française de Médecine Vasculaire concernant la sécurité et l’environnement en médecine vasculaire |
08/09/2014 |
403 |
Systemic Lupus Erythematosus Increases the Risks of Deep Vein Thrombosis and Pulmonary Embolism: A Nationwide Cohort Study |
29/01/2014 |
402 |
Increased risk of pre-operative venous thromboembolism in patients with |
29/01/2014 |
401 |
Les activités non anticoagulantes des héparines : intérêt pratique |
30/01/2014 |
400 |
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial |
30/01/2014 |
399 |
Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery |
30/01/2014 |
398 |
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays |
30/01/2014 |
397 |
La première pierre de l art médical |
31/01/2014 |
396 |
Mille patients pendant 10 ans pour voir l’évolution du syndrome des antiphospholipides |
01/02/2014 |
395 |
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation (Review) |
02/02/2014 |
394 |
14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends |
02/02/2014 |
393 |
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups |
02/02/2014 |
392 |
Erectile dysfunction |
02/02/2014 |
391 |
Gestion péri-interventionnelle des «nouveaux» anticoagulants oraux directs |
10/02/2014 |
390 |
Gestion des hémorragies lors de traitement par nouveaux anticoagulants oraux : quel challenge |
10/02/2014 |
389 |
Anticoagulants oraux directs et observance therapeutique de la necessite d une education continue |
10/02/2014 |
388 |
Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model |
10/02/2014 |
387 |
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial |
10/02/2014 |
386 |
Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery |
10/02/2014 |
385 |
Anticoagulation de la FA l apixaban, Eliquis, dosé à 5 mg est arrivé |
10/02/2014 |
384 |
Prévenir l AVC chez la femme |
11/02/2014 |
383 |
Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association |
11/02/2014 |
382 |
Injections intra-lésionnelles d’interféron dans la maladie de La Peyronie, quels résultats |
11/02/2014 |
381 |
Tamoxifen induces resistance to activated protein C |
13/02/2014 |
380 |
Incidental Venous Thromboembolism detected by PET-CT in Patients with Cancer: Prevalence and Impact on Survival rate |
13/02/2014 |
379 |
Improvement of anticoagulant treatment using a dynamic decision support algorithm A Danish Cohort study |
13/02/2014 |
378 |
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer |
13/02/2014 |
377 |
Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism |
13/02/2014 |
376 |
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) a multicentre non-blinded randomised trial |
14/02/2014 |
375 |
Percutaneous renal denervation in patients with treatment-resistant hypertension: fi nal 3-year report of the Symplicity HTN-1 study |
14/02/2014 |
374 |
Artériopathie fémorale traitée par stent actif résultats à 4 ans |
15/02/2014 |
373 |
Statines en prévention secondaire, bénéfiques sur le pronostic cardiovasculaire mêmes chez les prédiabétiques |
15/02/2014 |
372 |
Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy |
15/02/2014 |
371 |
Liste des spécialités concernées par la réévaluation européenne des contraceptifs hormonaux combinés |
16/02/2014 |
370 |
DOCUMENT D’AIDE A LA PRESCRIPTION CONTRACEPTIFS HORMONAUX COMBINÉS |
16/02/2014 |
369 |
Contraceptifs hormonaux combinés : rester conscient des différences entre les spécialités face au risque thromboembolique, de l’importance des facteurs de risque individuels, et être attentif aux manifestations cliniques |
16/02/2014 |
368 |
Toujours un risque de thrombose après la 6ème semaine du post-partum |
18/02/2014 |
367 |
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis |
18/02/2014 |
366 |
Direct Oral Anticoagulants for Acute Venous Thromboembolism Closing the Circle |
18/02/2014 |
365 |
Aneurysm Global Epidemiology Study Public Health Measures Can Further Reduce Abdominal Aortic Aneurysm Mortality |
18/02/2014 |
364 |
Manifestations neurologiques de la maladie de Behc¸ et |
19/02/2014 |
363 |
Atteintes cardiovasculaires de la maladie de Behc¸ et |
19/02/2014 |
362 |
Les manifestations oculaires de la maladie de Behc¸ et |
19/02/2014 |
361 |
Physiopathologie de la maladie de Behc¸ et |
19/02/2014 |
360 |
Épidémiologie de la maladie de Behc¸ et |
19/02/2014 |
359 |
La maladie de Behc¸ et actualités en 2014 |
19/02/2014 |
358 |
Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy |
20/02/2014 |
357 |
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2 |
20/02/2014 |
356 |
La prise occasionnelle de cocaïne multiplie par sept le risque d AVC |
20/02/2014 |
355 |
Accidents thromboemboliques chez l enfant hospitalise trop rares pour etre prévenus |
20/02/2014 |
354 |
Nomogramme d equivalence enttre PREVISCAN et COUMADINR sujets de plus de 70 ans Rev Med Int 2014 |
20/02/2014 |
353 |
STRATÉGIE DE PRÉVENTION CHEZ LA FEMME ENCEINTE ET À RISQUE |
21/02/2014 |
352 |
Alternative to oral dicoumarin anticoagulants: Considerations in dental care |
21/02/2014 |
351 |
Selected adverse events in cancer patients treated with vascular endothelial growth factor inhibitors |
22/02/2014 |
350 |
Lenalidomide in multiple myeloma a practice guideline |
22/02/2014 |
349 |
Cancer-associated thrombosis: prevention and treatment |
22/02/2014 |
348 |
Arterial occlusion precipitated by cisplatinbased chemotherapy |
22/02/2014 |
347 |
Pulmonary Embolism-A Mechanical Compression Effect on Lower Limb Deep Venous Thrombosis |
22/02/2014 |
346 |
Meta-analysis of Infantile Hemangioma Endothelial Cell Microarray Expression Data Reveals Significant Aberrations of Gene Networks Involved in Cell Adhesion and Extracellular Matrix Composition |
22/02/2014 |
345 |
Imaging Features and Diagnosis of Infected Aortic Aneurysms and Inflammatory Diseases Involving the Aorta |
22/02/2014 |
344 |
New oral anticoagulants for the treatment of venous thromboembolism |
23/02/2014 |
343 |
New oral anticoagulants in elderly patients |
23/02/2014 |
342 |
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism |
23/02/2014 |
341 |
Bleeding and antidotes in new oral anticoagulants |
23/02/2014 |
340 |
Pros and cons of new oral anticoagulants |
23/02/2014 |
339 |
Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from national surgical quality improvement program data and a call to reassess prophylaxis strategies |
23/02/2014 |
338 |
Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases |
25/02/2014 |
337 |
Duplex Ultrasound in the Diagnosis of Lower-Extremity Deep Venous Thrombosis |
25/02/2014 |
336 |
Hypertension pulmonaire l’Europe favorable au riociguat |
26/02/2014 |
335 |
Antiagrégants plaquettaires chez les patients avec insuffisance rénale chronique : quelles sont les évidences concernant leur utilisation |
26/02/2014 |
334 |
The importance of extended thromboprophylaxis in patients undergoing major surgery for cancer |
26/02/2014 |
333 |
Bleeding and Coagulopathies in Critical Care |
27/02/2014 |
332 |
ÉRYTHERMALGIES |
02/03/2014 |
331 |
Ultrasound in Suspected Pulmonary Embolism |
07/09/2014 |
330 |
Ultrasound Assessment of Pulmonary Embolism in Patients Receiving CT Pulmonary Angiography |
07/09/2014 |
329 |
Rethinking Guidelines for VTE Risk Among Nursing Home Residents |
07/09/2014 |
328 |
Fibromyalgia |
02/03/2014 |
327 |
Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism |
03/03/2014 |
326 |
Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review |
03/03/2014 |
325 |
Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies |
04/09/2014 |
324 |
Indirect comparison meta-analysis of two enoxaparin regimens in patients undergoing major orthopaedic surgery |
04/09/2014 |
323 |
Effects of impaired renal function on levels and performance of D-dimer in patients with suspected pulmonary embolism |
04/09/2014 |
322 |
Anticoagulation and Survival in Pulmonary Arterial Hypertension |
04/03/2014 |
321 |
HTAP idiopathique les anticoagulants sont bénéfiques |
04/03/2014 |
320 |
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation |
05/03/2014 |
319 |
Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions |
05/03/2014 |
318 |
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation |
05/03/2014 |
317 |
Does This Patient HaveDeepVein Thrombosis |
05/03/2014 |
316 |
Prise en charge des dyslipidémies en 2014 |
05/03/2014 |
315 |
Inhibiteurs de PCSK9 futur traitement pour baisser le cholestérol |
05/03/2014 |
314 |
Quand une embolie pulmonaire est suspectée chez une femme enceinte |
06/03/2014 |
313 |
Diagnosis and Anticoagulant treatment |
06/03/2014 |
312 |
Endogenous sex hormones and risk of venous thromboembolism in women and men |
08/03/2014 |
311 |
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis |
08/03/2014 |
310 |
Consistency of safety profile of new oral anticoagulants in patients with renal failure |
08/03/2014 |
309 |
Deux fois plus de statines en prévention primaire avec les recommandations US |
11/03/2014 |
308 |
Quel risque hémorragique sous dabigatran |
12/03/2014 |
307 |
Peripherally Inserted Central Catheter-Related Deep Vein Thrombosis: Contemporary Patterns and Predictors |
12/03/2014 |
306 |
Antiplatelet therapy in prevention of cardio- and venous thromboembolic events |
13/03/2014 |
305 |
Prevention of VTE in patients having major orthopedic surgery |
13/03/2014 |
304 |
Positions-and-Planes_092013 |
16/03/2014 |
303 |
Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers |
16/03/2014 |
302 |
Anticoagulant effects of statins and their clinical implications |
16/03/2014 |
301 |
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective |
17/03/2014 |
300 |
Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA |
17/03/2014 |
299 |
Intracranial atherosclerosis |
17/03/2014 |
298 |
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes |
17/03/2014 |
297 |
Comparison of the effi cacy and safety of new oral anticoagulants with warfarin in patients with atrial fi brillation: a meta-analysis of randomised trials |
17/03/2014 |
296 |
Thromboprophylaxie systématique pour les patients atteints de cancer hospitalisés |
17/03/2014 |
295 |
Application of New Cholesterol Guidelines to a Population-Based Sample |
22/03/2014 |
294 |
Toxicité des statines une méta analyse tente de démêler le vrai du faux |
22/03/2014 |
293 |
Assessing Causality in the Association between Child Adiposity and Physical Activity Levels: A Mendelian Randomization Analysis |
22/03/2014 |
292 |
Practices to prevent venous thromboembolism: a brief review |
23/03/2014 |
291 |
A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients |
23/03/2014 |
290 |
Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism |
23/03/2014 |
289 |
Two years outcome of isolated distal deep vein thrombosis |
23/03/2014 |
288 |
Time Dependent Changes in Atherosclerotic Plaque Composition in Patients Undergoing Carotid Surgery |
23/03/2014 |
287 |
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multicentre registry study |
23/03/2014 |
286 |
Phlébite le score de Wells peut il s appliquer a tous les patients |
24/03/2014 |
285 |
Sfd Plexique et Vasculaire MS |
24/03/2014 |
284 |
Ultrasound-guided Intralesional Diode Laser Treatment of Congenital Extratruncular Venous Malformations: Mid-term Results |
25/03/2014 |
283 |
Risque thromboembolique des thérapeutiques antiangiogéniques utilisées dans les cancers |
25/03/2014 |
282 |
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) |
25/03/2014 |
281 |
Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations |
25/03/2014 |
280 |
Anti-angiogéniques et anticoagulants |
25/03/2014 |
279 |
Long-term use of vitamin K antagonists and incidence of cancer a population-based study |
25/03/2014 |
278 |
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel |
26/03/2014 |
277 |
Les Anti X MM samama JMV 2014 |
26/03/2014 |
276 |
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk |
27/03/2014 |
275 |
Syndromes myéloprolifératifs sans mutation sur JAK2 rechercher des mutations sur CARL |
30/03/2014 |
274 |
Warfarin Interactions With Antibiotics in the Ambulatory Care Setting |
30/03/2014 |
273 |
Nonleg Venous Thrombosis in Critically Ill Adults A Nested Prospective Cohort Study |
30/03/2014 |
272 |
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE Study |
30/03/2014 |
271 |
Annual diagnosis rate of superficial-vein thrombosis of the lower limbs: the STEPH community-based study |
30/03/2014 |
270 |
Annual diagnosis rate of superficial-vein thrombosis of the lower limbs the STEPH community-based study |
30/03/2014 |
269 |
Dénervation rénale pas mieux que le placebo dans SYMPLICITY HTN-3 |
31/03/2014 |
268 |
Après la négativité de SYMPLICITY la feuille de route de Medtronic |
31/03/2014 |
267 |
Non-vitamin K antagonist oral anticoagulants (NOACs) No longer new or novel |
01/04/2014 |
266 |
New oral anticoagulant agents general features and outcomes in subsets of patients |
01/04/2014 |
265 |
Medical literature, vena cava filters and evidence of efficacy |
01/04/2014 |
264 |
Evidence and Clinical Judgment Vena cava filters |
01/04/2014 |
263 |
Study finds that aspirin improves survival after colon cancer diagnosis |
02/04/2014 |
262 |
Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer |
02/04/2014 |
261 |
Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer |
02/04/2014 |
260 |
Aspirin as Adjuvant Therapy for Stage III Colon Cancer Standard of Care |
02/04/2014 |
259 |
Symptomatic Thromboembolic events in patients treated with Intravenous- Immunoglobulins: Results from a retrospective cohort study |
02/04/2014 |
258 |
Personalised anticoagulation approach to improve the prevention and treatment of thrombosis |
02/04/2014 |
257 |
Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm |
02/04/2014 |
256 |
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism |
02/04/2014 |
255 |
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE Study |
02/04/2014 |
254 |
Practical guidance for using rivaroxaban in patients with atrial fibrillation balancing benefit and risk |
03/04/2014 |
253 |
Risk of a Thrombotic Event after the 6-Week Postpartum Period |
03/04/2014 |
252 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial |
03/04/2014 |
251 |
EP Hyperhomocystéinémie Ann Card Angeio 2014 |
03/04/2014 |
250 |
Nonleg Venous Thrombosis in Critically Ill Adults A Nested Prospective Cohort Study |
04/04/2014 |
249 |
Evidence and Clinical Judgment Vena cava filters |
04/04/2014 |
248 |
Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort |
04/04/2014 |
247 |
Réaffirmation de l intérêt d’un dépistage ciblé des AAA |
06/04/2014 |
246 |
Dermatopolymyosites un peu plus de données |
10/04/2014 |
245 |
Patients gériatriques insuffisants rénaux chroniques quelle antalgie |
10/04/2014 |
244 |
Nouveautés en oncologie beaucoup de bruit pour rien |
10/04/2014 |
243 |
Microangiopathie thrombotique : quand le temps presse |
10/04/2014 |
242 |
Infarctus lacunaire et microangiopathie cérébrale : plaidoyer pour une reconnaissance |
10/04/2014 |
241 |
Fibrinolysis for Patients with Intermediate- Risk Pulmonary Embolism |
10/04/2014 |
240 |
A Controlled Trial of Renal Denervation for Resistant Hypertension |
10/04/2014 |
239 |
Prise en charge des AVC aigus selon le sexe, pas de discrimination |
12/04/2014 |
238 |
Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism |
12/04/2014 |
237 |
Compliance with guidelines for the perioperative management of vitamin K antagonists |
12/04/2014 |
236 |
Venous thromboembolism in children with cancer – A population-based cohort study |
13/04/2014 |
235 |
Red cell distribution width and risk for venous thromboembolism: A population-based cohort study |
13/04/2014 |
234 |
Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism |
13/04/2014 |
233 |
Distal deep vein thrombosis a benign disea |
13/04/2014 |
232 |
Fibrinolyse des embolies pulmonaires à risque intermédiaire des résultats très mitigés |
14/04/2014 |
231 |
Cholestérol traiter des chiffres ou le risque |
14/04/2014 |
230 |
Anticoagulation in atrial fibrillation |
16/04/2014 |
229 |
Statine et un autre hypolipémiant ou statine à forte dose |
16/04/2014 |
228 |
Further data about catheter related venous thrombosis in oncology |
17/04/2014 |
227 |
Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study |
17/04/2014 |
226 |
Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality |
17/04/2014 |
225 |
Pas assez de statines dans l’artériopathie isolée des membres inférieurs |
17/04/2014 |
224 |
Vascularites systémiques nouvelles nomenclature et approches thérapeutiques |
17/04/2014 |
223 |
Manifestations digestives de la sclérodermie |
17/04/2014 |
222 |
Information «suffisante», devoir de ne pas «inquiéter» le patient et décision partagée triple contrainte pour le médecin |
17/04/2014 |
221 |
De l aviation a la chirurgie le defi de la securite |
17/04/2014 |
220 |
Carmen Study Prevention MTEV cancer JMV 2014 |
19/04/2014 |
219 |
Gestion péri opératoires AOD 2014 |
21/04/2014 |
218 |
Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism |
21/04/2014 |
217 |
Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality |
21/04/2014 |
216 |
Carmen Study Prevention MTEV cancer JMV 2014 |
22/04/2014 |
215 |
Le chocolat noir est bon pour les artères |
21/04/2014 |
214 |
Vieillissement du rein comment distinguer le physiologique du pathologique |
22/04/2014 |
213 |
Bruxelles impose plus de transparence pour les essais cliniques |
25/04/2014 |
212 |
Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins |
24/04/2014 |
211 |
Pressure ulcers: prevention and management of pressure ulcers |
24/04/2014 |
210 |
Les anticoagulants en France en 2014 : état des lieux, synthèse et surveillance |
24/04/2014 |
209 |
Prendre l avion avec une carotide bouchee |
25/04/2014 |
208 |
Bas de contention : des recommandations à la pratique |
25/04/2014 |
207 |
Nouveaux anticoagulants stabilisation des ventes depuis octobre 2013 |
26/04/2014 |
206 |
Avis favorable des experts de l’EMA au dabigatran dans le traitement des TVP |
28/04/2014 |
205 |
Ensuring medication adherence with direct oral anticoagulant drugs Lessons from adherence with vitamin K antagonists (VKAs) |
29/04/2014 |
204 |
Patients pourquoi ne prenez-vous pas votre traitement |
29/04/2014 |
203 |
La FDA décide de réglementer la e-cigarette et tous les dérivés du tabac |
29/04/2014 |
202 |
Anticoagulants dans la thrombo embolie veineuse aigue l ajout d AINS ou d aspirine augmente le risque d hemorragie |
30/04/2014 |
201 |
Anticoagulants dans la thrombo embolie veineuse aigue l ajout d AINS ou d aspirine augmente le risque d hemorragie |
03/09/2014 |
200 |
Neuropathies diabétiques : tableaux cliniques, détection précoce et appel au spécialiste |
30/04/2014 |
199 |
Neuropathies périphériques d’origine médicamenteuse |
05/05/2014 |
198 |
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study |
05/05/2014 |
197 |
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry |
05/05/2014 |
196 |
Development of a clinical diagnosis support tool to identify patients with lumbar spinal stenosis |
05/05/2014 |
195 |
determiner la balance benefices risques d une intervention pour chaque patient |
05/05/2014 |
194 |
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism |
12/05/2014 |
193 |
Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: A physician survey |
13/05/2014 |
192 |
Dose Escalation of Low MolecularWeight Heparin in Patients with Recurrent Cancer-Associated Thrombosis |
13/05/2014 |
191 |
The incidence and risk factors of recurrent venous thromboembolism during pregnancy |
13/05/2014 |
190 |
Les statines bénéfiques après l’angioplastie, y compris en cas d’insuffisance rénale |
13/05/2014 |
189 |
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study |
14/05/2014 |
188 |
International consensus criteria for the diagnosis of Raynaud’s phenomenon |
15/05/2014 |
187 |
Raynaud’s phenomenon: From molecular pathogenesis to therapy |
15/05/2014 |
186 |
Absence de sur-risque d’infarctus sous dabigatran, conclut la FDA |
15/05/2014 |
185 |
Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer – A real-world, prospective, observational French study: PRéOBS |
15/05/2014 |
184 |
Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm |
15/05/2014 |
183 |
Compliance with guidelines for the perioperative management of vitamin K antagonists |
15/05/2014 |
182 |
Schizophrénie : la warfarine pourrait avoir des vertus antipsychotiques |
19/05/2014 |
181 |
Venous thromboembolism in patients undergoing shoulder surgery: Findings from the RECOS Registry |
21/05/2014 |
180 |
Thromboembolism in Ultrasound Killing Three Birds With One Stone |
21/05/2014 |
179 |
Systematic Review and Meta-analysis of Direct Versus Indirect Angiosomal Revascularisation of Infrapopliteal Arteries |
21/05/2014 |
178 |
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis |
21/05/2014 |
177 |
Comparative Effectiveness and Safety of Drug Therapy for Pulmonary Arterial Hypertension |
21/05/2014 |
176 |
Accuracy of Point-of-Care Multiorgan Ultrasonography for the Diagnosis of Pulmonary Embolism |
21/05/2014 |
175 |
PREDICTS pour prédire le risque d’athérosclérose au cours du lupus |
22/05/2014 |
174 |
The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study |
22/05/2014 |
173 |
Systematic Review and Meta-analysis of Direct Versus Indirect Angiosomal Revascularisation of Infrapopliteal Arteries |
22/05/2014 |
172 |
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis |
22/05/2014 |
171 |
Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis |
22/05/2014 |
170 |
Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH |
22/05/2014 |
169 |
Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics? |
22/05/2014 |
168 |
Dabigatran : un antidote va être testé chez des patients |
25/05/2014 |
167 |
Surgical resection of carotid body paragangliomas: 10 years of experience |
26/05/2014 |
166 |
Global causes of maternal death: a WHO systematic analysis |
26/05/2014 |
165 |
Résection chirurgicale des corpuscules glomiques carotidiens, 10 ans d’expérience |
28/05/2014 |
164 |
Infiltrations et antiagrégants plaquettaires : que faire en pratique ? |
28/05/2014 |
163 |
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease |
04/06/2014 |
162 |
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD |
04/06/2014 |
161 |
HTA : Après SIMPLICITY, les arguments des « pro-dénervation » |
04/06/2014 |
160 |
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis |
04/06/2014 |
159 |
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer |
04/06/2014 |
158 |
Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis |
04/06/2014 |
157 |
Phase III Trials of New Oral Anticoagulants in the Acute Treatment and Secondary Prevention of VTE: Comparison and Critique of Study Methodology and Results |
05/06/2014 |
156 |
New strategies of VTE prevention in cancer patients |
05/06/2014 |
155 |
Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulants |
05/06/2014 |
154 |
Bleeding complications during anticoagulant treatment in patients with cancer |
05/06/2014 |
153 |
Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study |
05/06/2014 |
152 |
Risk stratification strategies for cancer-associated thrombosis: an update |
05/06/2014 |
151 |
Lymphoma and venous thromboembolism: influence on mortality |
05/06/2014 |
150 |
Predicting recurrent venous thromboembolism in cancer: is it possible? |
05/06/2014 |
149 |
HEMORRAGIE INTRACEREBRALE SOUS ANTICOAGULANTS ORAUX DIRECTS |
06/06/2014 |
148 |
Inter-scan variability of coronary artery calcium scoring assessed on 64-multidetector computed tomography vs. dual-source computed tomography: a head-to-head comparison |
09/06/2014 |
147 |
Distribution of coronary calcifications in patients with suspected coronary heart disease |
09/06/2014 |
146 |
NLA Task Force on Statin Safety – 2014 update |
09/06/2014 |
145 |
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
09/06/2014 |
144 |
ATP III Guidelines At-A-Glance Quick Desk Reference |
09/06/2014 |
143 |
JMV 2014 EVAR Réponse |
10/06/2014 |
142 |
Rapport sur les anticoagulants oraux directs (AOD) (antérieurement appelés « nouveaux anticoagulants oraux » ou NACO) |
10/06/2014 |
141 |
AOD Libération du jour 2 |
12/06/2014 |
140 |
AOD Libération du jour 1 |
12/06/2014 |
139 |
The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus |
12/06/2014 |
138 |
Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors |
12/06/2014 |
137 |
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study |
12/06/2014 |
136 |
Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study |
12/06/2014 |
135 |
Quel traitement antithrombotique en prévention secondaire post thromboembolie veineuse |
13/06/2014 |
134 |
Prévention thromboembolique post PTH : aspirine efficace |
13/06/2014 |
133 |
Quel traitement antithrombotique en prévention secondaire post thromboembolie veineuse |
14/06/2014 |
132 |
The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots |
15/06/2014 |
131 |
Reflections after the Diane affair |
15/06/2014 |
130 |
First experiences with the use of rivaroxaban in the treatment of heparininduced thrombocytopenia |
15/06/2014 |
129 |
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study |
15/06/2014 |
128 |
Follow-up after four-year quality improvement program to prevent inferior limb deep vein thrombosis in intensive care unit |
15/06/2014 |
127 |
Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis |
15/06/2014 |
126 |
Distal deep vein thrombosis – a benign disease? |
15/06/2014 |
125 |
Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality |
15/06/2014 |
124 |
Infections etthrombosesveineusesen pe´diatrie :analysed’unese´rie de24cas |
19/06/2014 |
123 |
Déficit modéré en antithrombine : le risque de récidive thrombo-embolique reste réel |
22/06/2014 |
122 |
Seulement des AVK en cas de FA, insuffisance cardiaque et maladie vasculaire ? |
24/06/2014 |
121 |
Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer |
26/06/2014 |
120 |
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases |
26/06/2014 |
119 |
Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study |
26/06/2014 |
118 |
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary |
26/06/2014 |
117 |
La FDA accorde un label « Breakthrough » au futur antidote du dabigatran |
28/06/2014 |
116 |
Bilan cardiaque des accidents vasculaires cérébraux |
28/06/2014 |
115 |
Malformation artério-veineuse cérébrale et grossesse |
28/06/2014 |
114 |
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults |
29/06/2014 |
113 |
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk |
29/06/2014 |
112 |
Ultrasonography in the Assessment of Lymph Node Disease |
29/06/2014 |
111 |
BNP, troponine, D-dimères 3 biomarqueurs à demander à bon escient |
01/07/2014 |
110 |
Why Most Published Research Findings Are False |
02/07/2014 |
109 |
Place and Cause of Death in Centenarians: A Population- Based Observational Study in England, 2001 to 2010 |
07/07/2014 |
108 |
Place and Cause of Death in Centenarians: A Population- Based Observational Study in England, 2001 to 2010 |
02/07/2014 |
107 |
30-Year Mortality Following Venous Thromboembolism: A Population-Based Cohort Study |
03/07/2014 |
106 |
Anticoagulants oraux directs: résultats rassurants sur la sécurité d’études de l’ANSM et de la Cnamts |
03/07/2014 |
105 |
Gestion péri-opératoire des nouveaux anticoagulants oraux |
03/07/2014 |
104 |
Nouveaux anticoagulants en vie réelle: les données à 4 mois de l’ANSM |
03/07/2014 |
103 |
Des thrombopénies induites par l’héparine, mais sans héparine |
03/07/2014 |
102 |
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis |
06/07/2014 |
101 |
Association between obstructive sleep apnea and deep vein thrombosis / pulmonary embolism: A population-based retrospective cohort study |
06/07/2014 |
100 |
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty |
06/07/2014 |
99 |
Impact of Symptoms, Gender, Co-morbidities and Operator Volume on Outcome of Carotid Artery Stenting (From the Nationwide Inpatient Sample [2006 – 2010]) |
07/07/2014 |
98 |
Le Pr Deepak Bhatt fait le point sur la dénervation rénale |
08/07/2014 |
97 |
Screening for Asymptomatic Carotid Artery Stenosis: U.S. Preventive Services Task Force Recommendation Statement |
08/07/2014 |
96 |
Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force |
08/07/2014 |
95 |
Screening for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force |
08/07/2014 |
94 |
La présence d’anticorps antiphospholipides multiplierait par 5 le risque d’AVC avant 50 ans |
09/07/2014 |
93 |
Carotid revascularization: risks and benefits |
09/07/2014 |
92 |
Cannabis l’infarctus aussi |
10/07/2014 |
91 |
European guidelines for sclerotherapy in chronic venous disorders |
14/07/2014 |
90 |
Thrombophilia and Hypercoagulability |
15/07/2014 |
89 |
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study |
15/07/2014 |
88 |
Aspirin Therapy in Primary Cardiovascular Disease Prevention |
16/07/2014 |
87 |
Effets deleteres du tabagisme sur l appareil musculo squelettique |
16/07/2014 |
86 |
Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis |
16/07/2014 |
85 |
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study |
16/07/2014 |
84 |
Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis |
17/07/2014 |
83 |
L’inflammation chronique est un facteur majeur de l’instabilité des plaques d’athérome coronaire |
17/07/2014 |
82 |
New Opportunities in the Changing Landscape of Prevention |
19/07/2014 |
81 |
Deux études rassurantes sur les nouveaux anticoagulants oraux |
20/07/2014 |
80 |
Traitements hormonaux de la ménopause |
20/07/2014 |
79 |
De l’épidémiologie de la maladie veineuse thrombo-embolique en population générale |
22/07/2014 |
78 |
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance |
23/07/2014 |
77 |
Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies |
31/08/2014 |
76 |
Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies |
31/08/2014 |
75 |
Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients |
24/07/2014 |
74 |
D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome |
24/07/2014 |
73 |
Association between obstructive sleep apnea and deep vein thrombosis / pulmonary embolism: A population-based retrospective cohort study |
24/07/2014 |
72 |
Relais d’un traitement anticoagulant oral par antivitamine K en ambulatoire dans le cadre d’un acte invasif ou de chirurgie programmée. enquête de pratique auprès de médecins généralistes |
24/07/2014 |
71 |
Artériopathie des membres inférieurs: Problèmes diagnostiques en 2014 |
24/07/2014 |
70 |
Anévrismes artériels des membres inférieurs |
24/07/2014 |
69 |
The trouble with dabigatran |
25/07/2014 |
68 |
Dabigatran: how the drug company withheld important analyses |
25/07/2014 |
67 |
Dabigatran and statins: faith, hype, and transparency |
25/07/2014 |
66 |
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance Silvia Rabar |
25/07/2014 |
65 |
ANTICOAGULANTS Concerns over data in key dabigatran trial |
25/07/2014 |
64 |
Boehringer Ingelheim withheld safety analyses on new anticoagulant, The BMJ investigation finds |
25/07/2014 |
63 |
Grossesse et thrombophilie : la daltéparine prophylactique serait inutile |
25/07/2014 |
62 |
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial |
25/07/2014 |
61 |
Fausses couches à répétition : un facteur de risque cardio-vasculaire |
26/07/2014 |
60 |
Historical Perspective: Eponyms of Vascular Radiology |
27/07/2014 |
59 |
New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome |
28/07/2014 |
58 |
Rétention d’informations sur le dabigatran à doses ajustées ? |
29/07/2014 |
57 |
Oral anticoagulation with rivaroxaban during pregnancy: a case report |
29/07/2014 |
56 |
Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure |
30/07/2014 |
55 |
Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores |
30/07/2014 |
54 |
Change in Smoking Habits After Having Been Screened for Abdominal Aortic Aneurysm |
31/07/2014 |
53 |
Carotid Intima-media Thickness and/or Carotid Plaque: What is Relevant? |
31/07/2014 |
52 |
t’t’t’t’t’t”t’t |
01/08/2013 |
51 |
Distinguer un Raynaud secondaire d’un Raynaud primitif |
31/07/2014 |
50 |
Même initié avant 60 ans, le THS ne protège pas de l’athérosclérose |
31/07/2014 |
49 |
Identification of Patients with a Histologically Unstable Carotid Plaque Using Ultrasonic Plaque Image Analysis |
01/08/2014 |
48 |
Anemia, an Independent Predictive Factor for Amputation and Mortality in Patients Hospitalized for Peripheral Artery Disease |
01/08/2014 |
47 |
Eliquis autorisé en Europe dans le thromboembolisme veineux |
01/08/2014 |
46 |
Lipids and cardiovascular disease 3 |
31/08/2014 |
45 |
Lipids and cardiovascular disease 2 |
31/08/2014 |
44 |
Lipids and cardiovascular disease 1 |
31/08/2014 |
43 |
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data |
31/08/2014 |
42 |
Hormone Treatment Beginning Near the Onset of Menopause |
01/08/2014 |
41 |
Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women |
01/08/2014 |
40 |
Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer |
02/08/2014 |
39 |
Aspirine et cancer : l’effet préventif se confirme |
16/08/2014 |
38 |
The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots |
17/08/2014 |
37 |
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study |
17/08/2014 |
36 |
Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial |
17/08/2014 |
35 |
Is it time to try or to trial statins to prevent recurrent venous thromboembolism? |
17/08/2014 |
34 |
Le score calcique : vers une meilleure prédiction du risque cardiovasculaire en 2014 |
17/08/2014 |
33 |
Overuse of Compression Ultrasound for Patients with Lower Extremity Cellulitis |
17/08/2014 |
32 |
Low molecular weight heparin in management and prevention of portal vein thrombosis |
17/08/2014 |
31 |
Etat de choc cardiogénique |
17/08/2014 |
30 |
Choc neurogénique RMS 2014 |
17/08/2014 |
29 |
Choc hémorragique |
17/08/2014 |
28 |
Anaphylaxie et état de choc anaphylactique |
17/08/2014 |
27 |
Optimal duration of anticoagulation |
18/08/2014 |
26 |
Un marqueur dans les larmes pour le syndrome de Gougerot Sjögren |
19/08/2014 |
25 |
Cerebral and Sinus Vein Thrombosis |
19/08/2014 |
24 |
Cigarette electronique |
19/08/2014 |
23 |
Therapeutic Effect of Compression Stockings Versus no Compression on Isolated Superficial Vein Thrombosis of the Legs: A Randomized Clinical Trial |
20/08/2014 |
22 |
The Effect of Diabetes Mellitus on Costs and Length of Stay in Patients with Peripheral Arterial Disease Undergoing Vascular Surgery |
20/08/2014 |
21 |
Mural Thrombus and the Progression of Abdominal Aortic Aneurysms: A Large Population-based Prospective Cohort Study |
20/08/2014 |
20 |
Predicting Risk of Perioperative Death and Stroke After Carotid Endarterectomy in Asymptomatic Patients: Derivation and Validation of a Clinical Risk Score |
20/08/2014 |
19 |
Postthrombotic syndrome following upper extremity deep vein thrombosis in children |
21/08/2014 |
18 |
Evolving use of new oral anticoagulants for treatment of venous thromboembolism |
21/08/2014 |
17 |
Evolving use of new oral anticoagulants for treatment of venous thromboembolism |
21/08/2014 |
16 |
Postthrombotic syndrome following upper extremity deep vein thrombosis in children |
21/08/2014 |
15 |
Follow-up after four-year quality improvement program to prevent inferior limb deep vein thrombosis in intensive care unit |
23/08/2014 |
14 |
Defining time in therapeutic range for busy clinicians: Frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin |
23/08/2014 |
13 |
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty |
23/08/2014 |
12 |
Pas d effet preventif demontre de la dalteparine dans la thrombophilie de la femme enceinte |
26/08/2014 |
11 |
L’AHA et le CDC dénoncent la e-cigarette |
26/08/2014 |
10 |
Electronic Cigarettes: A Policy Statement From the American Heart Association |
27/08/2014 |
9 |
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration |
27/08/2014 |
8 |
test2 |
01/01/2013 |
7 |
test |
13/08/2014 |
6 |
Inhalateurs électroniques de nicotine – Rapport de l’OMS |
27/08/2014 |
5 |
Aspirin can continue to reduce blood clot risk after anticoagulants for venous thromboembolism, study finds Ingrid Torjesen |
27/08/2014 |
4 |
Aspirin can continue to reduce blood clot risk after anticoagulants for venous thromboembolism, study finds Ingrid Torjesen |
31/08/2014 |
3 |
TEST |
06/08/2014 |
2 |
Place des nouveaux anticoagulants oraux directs |
31/08/2014 |
1 |
Traitement des dyslipidémies en 2014 : recommandations européennes versus américaines |
31/08/2014 |